Clustering O 0 8.432658660240122e-08
of O 0 1.3028184753238747e-08
missense O 0 7.771997445615852e-08
mutations O 0 1.600549554003905e-10
in O 0 1.072457400663751e-10
the O 0 8.948514960138709e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 1.2359656693661236e-06
in O 0 3.1219296592333023e-10
a O 0 1.6799389657151664e-10
sporadic B-Disease 1 0.9992125034332275
T I-Disease 1 0.9999997615814209
- I-Disease 0 0.2951383888721466
cell I-Disease 1 0.9999045133590698
leukaemia I-Disease 1 0.9999990463256836
. O 0 6.135773134019473e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 1.0
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 5.054673259813347e-12
is O 0 1.2423394290302786e-13
a O 0 7.749286780843467e-13
recessive B-Disease 0 1.8053167849529927e-08
multi I-Disease 1 0.9995237588882446
- I-Disease 1 0.9999890327453613
system I-Disease 1 0.9999802112579346
disorder I-Disease 1 0.9999427795410156
caused O 0 4.5156620109843004e-10
by O 0 2.714745745910352e-13
mutations O 0 3.177359905130045e-13
in O 0 2.3327045590298967e-12
the O 0 8.021464048546534e-11
ATM O 0 1.064910861714452e-07
gene O 0 4.838263678585975e-10
at O 0 4.028529065891462e-09
11q22 O 0 3.008696580764081e-08
- O 0 3.36448096049935e-08
q23 O 0 2.5267478775958807e-08
( O 0 4.40504299703548e-11
ref O 0 1.9404597928485146e-09
. O 0 1.2171154709084142e-11
3 O 0 5.132613778435768e-10
) O 0 1.1842114094884337e-11
. O 0 7.934520263042089e-10

The O 0 3.429877892813238e-08
risk O 0 3.2458011389735475e-08
of O 0 1.0820621731966185e-08
cancer B-Disease 0 4.0377784898737445e-05
, O 0 2.0429331837323872e-10
especially O 0 2.119041470072247e-10
lymphoid B-Disease 0 0.00023717306612525135
neoplasias I-Disease 1 0.6902683973312378
, O 0 6.566938659524624e-11
is O 0 8.633320837739267e-13
substantially O 0 3.2846624725690887e-12
elevated O 0 1.813438982312121e-10
in O 0 3.6840369643798e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 4.813333589481772e-07
and O 0 3.027250325415842e-11
has O 0 3.4773705182705728e-12
long O 0 3.598011374516402e-13
been O 0 1.250770456174069e-13
associated O 0 1.6267456132146307e-12
with O 0 5.048930457746126e-12
chromosomal O 1 1.0
instability O 1 1.0
. O 0 2.718758764785889e-07

By O 0 4.452119228837148e-10
analysing O 0 2.4579935598012526e-07
tumour B-Disease 1 1.0
DNA O 0 4.472106951425303e-08
from O 0 1.6969030347535607e-11
patients O 0 4.829129175536184e-13
with O 0 8.30815518920898e-14
sporadic B-Disease 0 0.034129586070775986
T I-Disease 1 0.9999791383743286
- I-Disease 0 3.784606451517902e-05
cell I-Disease 1 0.997873067855835
prolymphocytic I-Disease 1 0.999718964099884
leukaemia I-Disease 1 1.0
( O 0 1.2098059443133025e-08
T B-Disease 0 0.00969894602894783
- I-Disease 0 1.7792110895697988e-07
PLL I-Disease 0 1.0168114386033267e-06
) O 0 1.311026211637395e-13
, O 0 7.35964905012633e-14
a O 0 5.511252803951094e-13
rare O 0 3.9512542543418405e-11
clonal B-Disease 0 1.969102214616214e-08
malignancy I-Disease 0 1.0526424176759974e-08
with O 0 1.477778809695282e-13
similarities O 0 5.377860917005206e-12
to O 0 5.040491895397237e-12
a O 0 7.053501671627771e-10
mature B-Disease 0 9.852686133626776e-08
T I-Disease 0 0.0021123054903000593
- I-Disease 0 2.841165098743659e-07
cell I-Disease 0 3.471305171842687e-05
leukaemia I-Disease 0 0.0024043587036430836
seen O 0 9.151212426727895e-11
in O 0 1.6130351221388395e-10
A B-Disease 1 1.0
- I-Disease 1 0.9999961853027344
T I-Disease 1 1.0
, O 0 6.8031301078685935e-12
we O 0 7.009582259250025e-13
demonstrate O 0 4.55345125754264e-13
a O 0 2.1839030150266892e-13
high O 0 1.037671467848944e-12
frequency O 0 1.2739287055807402e-11
of O 0 1.1339771482932193e-10
ATM O 0 2.1714711806453124e-07
mutations O 0 2.74343631145868e-10
in O 0 2.4525077524373273e-09
T B-Disease 0 0.0003051292151212692
- I-Disease 0 6.271059191931272e-06
PLL I-Disease 0 9.995394793804735e-05
. O 0 2.5788056134956605e-08

In O 0 3.361751432784388e-10
marked O 0 9.270681444739637e-10
contrast O 0 3.862131447984751e-11
to O 0 8.08872326757415e-12
the O 0 3.2364688706820743e-10
ATM O 0 2.2170276281485712e-07
mutation O 0 6.468531960068802e-11
pattern O 0 9.071589035514194e-10
in O 0 4.617648041715938e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 8.650240940211162e-11
the O 0 3.9476383967285145e-11
most O 0 2.6267388871653585e-13
frequent O 0 4.946308120035159e-13
nucleotide O 0 2.951691668862111e-11
changes O 0 7.897340767448746e-12
in O 0 2.2666948613220272e-12
this O 0 1.2555138352576822e-11
leukaemia B-Disease 0 2.064485215669265e-06
were O 0 1.3438609114402311e-09
missense O 0 1.6281433090625796e-07
mutations O 0 1.5054439472805825e-08
. O 0 1.9633381143080442e-08

These O 0 2.9639086740473886e-09
clustered O 0 6.8506933459389074e-09
in O 0 2.39846503768959e-10
the O 0 7.985838101909337e-10
region O 0 7.621884234865206e-10
corresponding O 0 6.11506456582589e-10
to O 0 2.171752083723888e-10
the O 0 5.058326646434352e-09
kinase O 0 4.308762235893937e-09
domain O 0 2.510442520531342e-09
, O 0 1.9657818775553615e-11
which O 0 1.8534446980661423e-12
is O 0 4.916191152087857e-13
highly O 0 3.983503197441118e-12
conserved O 0 3.795074671186782e-11
in O 0 2.337597337920272e-10
ATM O 0 8.170364708348643e-06
- O 0 5.722135210106671e-09
related O 0 6.959445519871821e-11
proteins O 0 3.906127591518649e-12
in O 0 4.479732557127747e-11
mouse O 0 2.528973919169175e-09
, O 0 8.410443348705332e-12
yeast O 0 1.180797792876831e-09
and O 0 4.963951472092276e-10
Drosophila O 0 2.5467498332432115e-08
. O 0 5.9061742163635245e-09

The O 0 1.0029149422052797e-07
resulting O 0 1.042683592800131e-07
amino O 0 2.2792747245148348e-07
- O 0 1.361379872832913e-06
acid O 0 1.1145977474313895e-08
substitutions O 0 7.643492061504276e-09
are O 0 1.9736073886278405e-11
predicted O 0 7.756810194159414e-10
to O 0 5.4103618286893695e-12
interfere O 0 8.655687278036339e-11
with O 0 3.233783379963384e-11
ATP O 0 1.0937379784081713e-06
binding O 0 9.64169299955131e-10
or O 0 7.474612942481862e-12
substrate O 0 2.617755179290526e-10
recognition O 0 1.8184793670883437e-09
. O 0 2.398452547680563e-09

Two O 0 8.800219997162628e-10
of O 0 5.740150132993449e-09
seventeen O 0 5.6669620107641094e-08
mutated O 0 9.142345192003631e-08
T B-Disease 0 2.0706470422737766e-06
- I-Disease 0 2.0729665095586824e-08
PLL I-Disease 0 1.615808855603973e-07
samples O 0 2.4738487300335343e-11
had O 0 4.711653376482383e-12
a O 0 1.0466023664043589e-12
previously O 0 8.804496715031362e-11
reported O 0 6.236010374749412e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
allele O 0 3.0440580189861066e-07
. O 0 1.803337923433901e-08

In O 0 1.2901641976981182e-09
contrast O 0 4.375027007341714e-10
, O 0 3.383931329592471e-11
no O 0 6.468087870858952e-11
mutations O 0 8.08525208589872e-12
were O 0 4.494210559258249e-12
detected O 0 4.489310399119484e-12
in O 0 7.513449064300293e-12
the O 0 1.0551057250118845e-10
p53 O 0 3.8697930276887504e-11
gene O 0 3.2512856990019046e-11
, O 0 1.0146184023160365e-12
suggesting O 0 2.573739181846446e-12
that O 0 2.721179130551338e-13
this O 0 9.03564376097954e-12
tumour B-Disease 1 1.0
suppressor O 0 1.3952315214282862e-07
is O 0 1.100505320553169e-12
not O 0 1.2228641764564646e-13
frequently O 0 1.1756401245305997e-13
altered O 0 5.786485873793268e-12
in O 0 1.5107739278347188e-12
this O 0 3.574007409468116e-11
leukaemia B-Disease 0 7.873494905652478e-05
. O 0 5.76988909983811e-08

Occasional O 0 1.4981803531100013e-07
missense O 0 1.3488438810327352e-07
mutations O 0 2.434414614338465e-10
in O 0 1.8584273009381036e-10
ATM O 0 2.3406525997415883e-06
were O 0 3.9796724249363535e-10
also O 0 3.253741026609802e-12
found O 0 5.622696861058707e-13
in O 0 1.3424863651301244e-11
tumour B-Disease 1 1.0
DNA O 0 3.29753753192108e-08
from O 0 3.2155883858409062e-12
patients O 0 4.694508670688435e-13
with O 0 5.960642136121352e-13
B B-Disease 0 0.00028128406847827137
- I-Disease 0 6.601923701055057e-07
cell I-Disease 1 0.9999879598617554
non I-Disease 1 1.0
- I-Disease 1 0.9999984502792358
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9909075498580933
( O 0 1.520395753740189e-10
B B-Disease 0 6.918651251908159e-08
- I-Disease 0 3.011305649280871e-10
NHL I-Disease 0 1.293113061073825e-09
) O 0 2.7456829128011395e-13
and O 0 3.666794732432033e-12
a O 0 1.6933152102716065e-10
B B-Disease 0 1.2711774388662889e-07
- I-Disease 0 2.5358970034972117e-08
NHL I-Disease 0 1.784584497954711e-07
cell O 0 5.381759251577023e-07
line O 0 8.413396557216402e-08
. O 0 7.192706430458884e-09

The O 0 2.232297013904372e-09
evidence O 0 2.2060994697703507e-10
of O 0 1.722098158518648e-10
a O 0 6.555959768117514e-12
significant O 0 7.657138811900666e-12
proportion O 0 1.7305400168421414e-11
of O 0 9.40800215509796e-10
loss O 0 4.9123585199595254e-09
- O 0 1.909403080091465e-09
of O 0 1.6553195791857434e-07
- O 0 4.365659833638347e-09
function O 0 6.490982862317196e-09
mutations O 0 1.1531816300480724e-11
and O 0 1.1657111907703577e-12
a O 0 2.6812009643745194e-12
complete O 0 3.7029890265216636e-09
absence O 0 4.742432668791707e-09
of O 0 4.619081506174183e-10
the O 0 3.6838872230493536e-11
normal O 0 2.8193780643448463e-11
copy O 0 7.714991145935102e-11
of O 0 9.680421741986578e-11
ATM O 0 2.764089845896933e-09
in O 0 3.00530629028517e-12
the O 0 1.7051731554529326e-11
majority O 0 1.2205351312966073e-11
of O 0 5.721859652751959e-10
mutated O 0 6.066417768124666e-08
tumours B-Disease 1 1.0
establishes O 0 9.21689391475411e-09
somatic O 0 1.0988589593807774e-08
inactivation O 0 2.6865694735533907e-07
of O 0 5.383787859969402e-10
this O 0 4.460416411222745e-13
gene O 0 1.5396665062686332e-12
in O 0 3.945135776221853e-13
the O 0 6.011303434194648e-12
pathogenesis O 0 1.1027537105690044e-08
of O 0 4.246888951620065e-10
sporadic B-Disease 0 0.1134239062666893
T I-Disease 1 0.999893307685852
- I-Disease 0 3.974430728703737e-05
PLL I-Disease 0 0.0002593945828266442
and O 0 6.474953906376868e-10
suggests O 0 5.191092347645032e-11
that O 0 3.9378604543838236e-12
ATM O 0 1.0693541696582542e-07
acts O 0 5.39453193226791e-09
as O 0 2.643338603558476e-10
a O 0 3.892167033114902e-09
tumour B-Disease 1 1.0
suppressor O 0 3.115603612968698e-05
. O 0 2.2170565827650535e-08

As O 0 3.1488240903598808e-09
constitutional O 0 4.965268090018071e-07
DNA O 0 1.2773857527292876e-08
was O 0 7.633145227003979e-10
not O 0 6.898368595104065e-13
available O 0 2.147324635812242e-12
, O 0 1.6470327705853105e-12
a O 0 7.07500308338993e-11
putative O 0 3.1742970918458013e-08
hereditary O 1 0.9397673606872559
predisposition O 0 1.7136459064204246e-05
to O 0 3.3755244999156275e-07
T B-Disease 1 0.9999979734420776
- I-Disease 0 8.087926835287362e-05
PLL I-Disease 0 0.00015866586181800812
will O 0 2.327954148895195e-11
require O 0 1.958195541482133e-12
further O 0 8.349845337721207e-13
investigation O 0 1.6809790321856144e-12
. O 0 9.63080223209678e-12
. O 0 9.617356910851527e-10

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 6.571623544004979e-06
kinase O 0 1.8835267567851588e-08
is O 0 1.5904446813361228e-12
involved O 0 2.2994649058667195e-14
in O 0 2.5936109881411103e-14
the O 0 3.69293083526262e-13
modulation O 0 5.00866492378349e-12
of O 0 5.666002389492775e-11
the O 0 4.8220833576140265e-11
Ca2 O 0 2.887048378141799e-10
+ O 0 2.2177828462588423e-09
homeostasis O 0 8.552296293373729e-08
in O 0 1.1285726797538587e-09
skeletal O 0 1.4326310520118568e-05
muscle O 0 1.0880140735025634e-06
cells O 0 4.397641646392003e-07
. O 0 7.569977533705696e-09

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 8.238058846199436e-11
, O 0 2.1571758051716627e-13
the O 0 1.4757824953401388e-12
most O 0 4.688488746545927e-12
prevalent O 0 0.00029712560353800654
muscular B-Disease 1 1.0
disorder I-Disease 1 0.9999997615814209
in O 0 1.2037786045748788e-10
adults O 0 1.4020480739937446e-12
, O 0 1.8669191626657922e-13
is O 0 2.8472710300597726e-13
caused O 0 4.416737114931735e-11
by O 0 1.6822692544549156e-11
( O 0 1.4349689839154856e-11
CTG O 0 2.815652955234782e-08
) O 0 1.2413872284722932e-13
n O 0 8.623713722288873e-12
- O 0 1.1167665750488887e-11
repeat O 0 2.1566430932762337e-11
expansion O 0 5.981372515340144e-12
in O 0 1.9990762246523824e-13
a O 0 5.274343787241287e-13
gene O 0 8.182942713187702e-13
encoding O 0 2.9307259744038028e-12
a O 0 8.284969238436801e-11
protein O 0 5.305043071501814e-10
kinase O 0 3.773038059762257e-08
( O 0 1.9199251966028896e-08
DM B-Disease 1 1.0
protein O 0 6.12420736345598e-09
kinase O 0 2.521604702820923e-09
; O 0 1.1825523199560095e-11
DMPK O 0 3.931767196263536e-07
) O 0 3.869168982602311e-13
and O 0 5.246951419353441e-13
involves O 0 4.457805381340857e-13
changes O 0 1.7514056611239726e-12
in O 0 5.856392627789919e-12
cytoarchitecture O 0 1.2439359764471192e-08
and O 0 5.502837074899958e-10
ion O 0 1.7557012199631572e-07
homeostasis O 0 6.896661034261342e-06
. O 0 1.330457024550924e-07

To O 0 5.672179392846033e-10
obtain O 0 4.974405332092147e-10
clues O 0 4.4551856648311627e-10
to O 0 2.2670103641542205e-12
the O 0 8.063691207815804e-12
normal O 0 1.501427107641895e-11
biological O 0 4.540169282196693e-11
role O 0 6.46963906059117e-12
of O 0 1.974425484219111e-10
DMPK O 0 5.513642236110172e-07
in O 0 1.981163011421927e-10
cellular O 0 1.2950415850809804e-08
ion O 0 9.866579553374777e-09
homeostasis O 0 2.2247624542615085e-07
, O 0 7.387802175573555e-11
we O 0 2.055294302805155e-11
have O 0 6.213320873429962e-13
compared O 0 3.188447336016642e-12
the O 0 6.696447563125929e-11
resting O 0 4.154044330739737e-10
[ O 0 3.973517261751658e-12
Ca2 O 0 7.965897364480001e-13
+ O 0 5.248715524708292e-12
] O 0 5.34258878456817e-12
i O 0 1.1446850411989118e-12
, O 0 2.6021087614811443e-14
the O 0 1.5968148569904528e-13
amplitude O 0 3.214883003907487e-12
and O 0 1.0373291852230904e-12
shape O 0 9.483376584018544e-11
of O 0 1.51707618689656e-10
depolarization O 0 1.4642469459147378e-09
- O 0 6.823669407296507e-10
induced O 0 2.447559044327363e-09
Ca2 O 0 5.2803483807650764e-11
+ O 0 6.853353301528031e-11
transients O 0 2.8783281313948805e-10
, O 0 1.35706929634688e-13
and O 0 1.2748340523418417e-13
the O 0 1.6586245181124393e-12
content O 0 1.272029248426676e-12
of O 0 9.84874543030756e-11
ATP O 0 2.0822312762902584e-08
- O 0 1.8479118235603664e-10
driven O 0 1.2679272909377204e-10
ion O 0 2.542379362591163e-10
pumps O 0 1.9803846063037867e-10
in O 0 1.0824036805745507e-10
cultured O 0 3.204701926051712e-08
skeletal O 0 7.488491974072531e-05
muscle O 0 1.223023957663827e-07
cells O 0 7.481827601907298e-09
of O 0 4.276894838284306e-09
wild O 0 8.799485584631839e-09
- O 0 1.0035029751609414e-10
type O 0 6.26932464276031e-11
and O 0 3.108499221915473e-11
DMPK O 0 4.974966145709914e-07
[ O 0 9.463613226401435e-10
- O 0 3.776492452089997e-09
/ O 0 1.0145976148123736e-07
- O 0 4.765838923503907e-08
] O 0 3.8477607766651545e-09
knockout O 0 2.7390073228161782e-05
mice O 0 4.995242193217564e-07
. O 0 5.774410727354962e-09

In O 0 1.4529775604898987e-08
vitro O 0 1.5254100844686036e-06
- O 0 7.578618692605232e-07
differentiated O 0 1.9463178091427835e-07
DMPK O 0 2.9773707865388133e-05
[ O 0 9.649443022397008e-09
- O 0 1.3576397783765515e-08
/ O 0 1.840393935026441e-07
- O 0 1.174733199604816e-08
] O 0 2.8739557955681505e-10
myotubes O 0 1.035311125718863e-08
exhibit O 0 3.153378391740347e-10
a O 0 8.424528435968526e-11
higher O 0 2.545693378319669e-10
resting O 0 1.4863272834730878e-09
[ O 0 2.094021310516947e-11
Ca2 O 0 1.982458468219317e-11
+ O 0 1.5544425469027345e-10
] O 0 9.057147393187748e-11
i O 0 2.356667291869563e-11
than O 0 1.3835164567807534e-12
do O 0 3.322335462296877e-12
wild O 0 1.6614515319091083e-09
- O 0 1.5389370333629415e-10
type O 0 5.182455853347534e-11
myotubes O 0 5.691971782795235e-09
because O 0 5.809266262479795e-12
of O 0 2.41155099361956e-11
an O 0 1.0382153985263529e-13
altered O 0 1.0316450818614875e-11
open O 0 1.777746561071325e-10
probability O 0 3.226217903939954e-11
of O 0 5.055929286346128e-11
voltage O 0 7.54597540009172e-09
- O 0 1.2489754785960372e-09
dependent O 0 1.3409488797133662e-10
l O 0 4.338213469012864e-11
- O 0 9.3015612573355e-12
type O 0 9.258142863455276e-12
Ca2 O 0 4.716103809560002e-12
+ O 0 5.6546529611511964e-12
and O 0 1.7107299734794856e-12
Na O 0 7.728397366513207e-10
+ O 0 9.516603650949751e-12
channels O 0 2.030281359699515e-10
. O 0 4.2052242243961757e-10

The O 0 7.799842194344819e-08
mutant O 0 6.140398056686536e-08
myotubes O 0 3.911496833097772e-07
exhibit O 0 5.955665294266055e-09
smaller O 0 8.99764082684662e-11
and O 0 5.055591709157703e-11
slower O 0 3.1749963769200917e-10
Ca2 O 0 3.0879764023605816e-11
+ O 0 6.543682956605679e-11
responses O 0 1.9438684602940404e-12
upon O 0 8.424331544854002e-12
triggering O 0 1.5470597025668553e-10
by O 0 9.064396911014072e-13
acetylcholine O 0 4.127052921631957e-09
or O 0 9.582745014169447e-11
high O 0 7.592144690704572e-09
external O 0 9.031025882677568e-08
K O 0 2.3586224529026367e-08
+ O 0 2.315437841460266e-09
. O 0 1.6917374168201604e-09

In O 0 2.136383514539375e-09
addition O 0 1.5716172807600515e-10
, O 0 2.8521277353754648e-11
we O 0 6.152801358683124e-12
observed O 0 4.4930790858710434e-12
that O 0 3.052024710975369e-14
these O 0 4.577683176097691e-14
Ca2 O 0 4.492136697342719e-12
+ O 0 7.749530878120581e-11
transients O 0 2.220686523557447e-09
partially O 0 3.3079408656710996e-10
result O 0 5.2105125769585925e-12
from O 0 4.663176312105777e-13
an O 0 1.0033864879374285e-13
influx O 0 8.359613457194215e-13
of O 0 7.945386536201138e-12
extracellular O 0 6.016373597234059e-12
Ca2 O 0 4.6550029456082775e-12
+ O 0 5.4468599769430526e-12
through O 0 1.2698378589956483e-12
the O 0 1.8232809359530755e-11
l O 0 5.899983626656002e-12
- O 0 4.604931887197683e-12
type O 0 9.289079921925847e-12
Ca2 O 0 1.6938925956333506e-11
+ O 0 5.552068874092875e-11
channel O 0 6.181674061522813e-10
. O 0 6.451457701395213e-10

Neither O 0 8.71075087616191e-08
the O 0 2.8445084065964465e-09
content O 0 1.3632847628564093e-10
nor O 0 4.081942284184237e-10
the O 0 1.0008683118400974e-11
activity O 0 3.370475079589319e-11
of O 0 5.194281810227963e-11
Na O 0 1.4298539241508479e-08
+ O 0 2.921564934421639e-10
/ O 0 2.063584414457864e-09
K O 0 4.139009690540263e-10
+ O 0 1.5568360836604178e-11
ATPase O 0 5.564695579329815e-11
and O 0 1.0769747073313685e-11
sarcoplasmic O 0 8.045202837259069e-10
reticulum O 0 1.5276833964517067e-10
Ca2 O 0 2.402044951832494e-10
+ O 0 6.426195686692893e-10
- O 0 3.1606522954419347e-10
ATPase O 0 3.5210498405824353e-10
are O 0 1.0651987104870475e-12
affected O 0 4.295863578057668e-12
by O 0 1.3201941276297369e-11
DMPK O 0 3.427221599849872e-05
absence O 0 5.318219109540223e-07
. O 0 2.0636878872437592e-08

In O 0 3.2336939792543262e-09
conclusion O 0 4.494645988728507e-09
, O 0 6.807975017064649e-11
our O 0 4.838907052828745e-11
data O 0 1.4036863685285006e-11
suggest O 0 1.5041723292266718e-12
that O 0 5.489242415647466e-13
DMPK O 0 1.934445350570968e-07
is O 0 1.929311528245381e-12
involved O 0 1.7143678512389349e-13
in O 0 4.153832226100329e-13
modulating O 0 1.8879056651321946e-10
the O 0 1.0941709344125528e-10
initial O 0 6.922667994402332e-11
events O 0 7.065505732567479e-12
of O 0 2.5788030044715526e-10
excitation O 0 1.1935652821648546e-07
- O 0 4.391731920350139e-07
contraction O 0 3.100587164794888e-08
coupling O 0 1.7819306918909206e-08
in O 0 1.09775855072769e-09
skeletal O 0 4.900729254586622e-05
muscle O 0 1.5018812291600625e-06
. O 0 3.5099143591565962e-09
. O 0 4.784370677413108e-09

Constitutional O 0 0.000497858040034771
RB1 O 0 0.008957735262811184
- O 0 4.7224190780070785e-07
gene O 0 3.014053895356028e-09
mutations O 0 1.9825388553051937e-10
in O 0 1.9853873753361562e-11
patients O 0 6.575181805273944e-12
with O 0 6.901619033217177e-13
isolated O 0 3.6600106056994264e-08
unilateral B-Disease 0 0.0010974145261570811
retinoblastoma I-Disease 1 0.999866247177124
. O 0 5.757493113378587e-07

In O 0 2.297269929840695e-09
most O 0 1.420168288523982e-10
patients O 0 6.964222601379966e-12
with O 0 1.1548913951900386e-12
isolated O 0 1.3867344605955623e-08
unilateral B-Disease 0 9.463689639233053e-05
retinoblastoma I-Disease 1 0.9803167581558228
, O 0 4.2585207582490625e-10
tumor B-Disease 0 1.891483663030158e-07
development O 0 5.743738817898247e-10
is O 0 3.1273302090323307e-13
initiated O 0 1.4264604254743407e-11
by O 0 6.918186184513841e-13
somatic O 0 5.336829311808344e-10
inactivation O 0 8.950685526087909e-08
of O 0 5.975779870937004e-10
both O 0 6.813622582813039e-12
alleles O 0 2.603451959223846e-12
of O 0 3.0818583796055066e-10
the O 0 1.489892920147895e-08
RB1 O 0 1.1874488336616196e-05
gene O 0 7.30388833858342e-08
. O 0 3.0407090179096485e-08

However O 0 6.8945285036647874e-09
, O 0 1.1557057394417924e-10
some O 0 1.896894967490237e-12
of O 0 4.657485508374748e-10
these O 0 7.296052650929141e-11
patients O 0 1.9928194511242836e-11
can O 0 2.2592620049083356e-12
transmit O 0 7.172427096691081e-10
retinoblastoma B-Disease 0 1.2486258356148028e-06
predisposition O 0 1.7556961440234886e-09
to O 0 2.997922743386283e-11
their O 0 9.739952178122735e-10
offspring O 0 2.2085466788723807e-09
. O 0 1.808538208081245e-09

To O 0 7.429021287030935e-11
determine O 0 2.0627246438698066e-11
the O 0 4.97509325403378e-12
frequency O 0 4.9369348886774134e-11
and O 0 1.440634070370983e-12
nature O 0 3.414598118145484e-11
of O 0 3.1471655836945445e-10
constitutional O 0 1.1196890454812092e-06
RB1 O 0 1.9699004042195156e-05
- O 0 9.673417622479974e-09
gene O 0 1.182855202674915e-10
mutations O 0 1.650555733756498e-11
in O 0 4.46931814473972e-12
patients O 0 1.0483164900390585e-12
with O 0 1.8525213643909993e-13
isolated O 0 5.463151708795522e-09
unilateral B-Disease 0 9.631381544750184e-06
retinoblastoma I-Disease 0 0.0006698063807561994
, O 0 2.2704269020401568e-10
we O 0 7.248931316317098e-11
analyzed O 0 1.4359992361878682e-10
DNA O 0 2.2719182091179846e-09
from O 0 4.3884302441954404e-11
peripheral O 0 2.675067207746906e-06
blood O 0 4.785682405916702e-10
and O 0 2.0401490219423835e-10
from O 0 2.1825073692749442e-10
tumor B-Disease 0 2.097515562127228e-06
tissue O 0 4.2798757249329356e-07
. O 0 2.6898629101879123e-08

The O 0 6.930492291168378e-10
analysis O 0 1.2251726022594056e-10
of O 0 2.1667355909471553e-08
tumors B-Disease 1 1.0
from O 0 1.6401877078742189e-10
54 O 0 1.8565612380783136e-09
( O 0 1.5731700664378678e-11
71 O 0 2.3335446908134827e-09
% O 0 7.86992866708136e-12
) O 0 2.6653318766466094e-13
of O 0 5.3607812633416074e-11
76 O 0 4.379261842046844e-09
informative O 0 2.131348875167305e-09
patients O 0 1.6893375587301307e-10
showed O 0 6.977951549913541e-10
loss O 0 2.402426702019511e-09
of O 0 4.768746286742953e-09
constitutional O 0 3.886089416482719e-06
heterozygosity O 0 7.50495837564813e-06
( O 0 3.8450389538979834e-09
LOH O 1 0.9999852180480957
) O 0 2.2375222508141945e-10
at O 0 1.0742661871177006e-08
intragenic O 0 3.885308501594409e-07
loci O 0 5.436367800371045e-08
. O 0 4.076904502881007e-08

Three O 0 6.060714152766877e-09
of O 0 5.855823914657776e-08
13 O 0 5.442820452117303e-07
uninformative O 0 0.001275843707844615
patients O 0 6.668886243232919e-08
had O 0 1.8216290698092052e-08
constitutional O 0 1.8718372984949383e-06
deletions O 0 2.3284535188849986e-07
. O 0 6.651203676710793e-08

For O 0 6.29860030798568e-09
39 O 0 2.1246123083074053e-08
randomly O 0 8.716792843088683e-10
selected O 0 7.122317402519229e-09
tumors B-Disease 1 1.0
, O 0 8.328706613269787e-09
SSCP O 0 0.014374584890902042
, O 0 5.0389332706402e-09
hetero O 0 7.669855506264867e-08
- O 0 7.165494864125321e-10
duplex O 0 1.4627480338091914e-09
analysis O 0 7.839126917041916e-12
, O 0 4.928725613403961e-13
sequencing O 0 3.730574443111534e-12
, O 0 1.7068937409325802e-12
and O 0 8.071415931454329e-12
Southern O 0 1.4716211582666006e-10
blot O 0 3.284567284822515e-09
analysis O 0 1.1758123641403273e-10
were O 0 7.91930618304626e-11
used O 0 5.69904583594405e-12
to O 0 1.0265750055582501e-11
identify O 0 2.707809809709971e-10
mutations O 0 1.176412567360785e-08
. O 0 2.1651038295544822e-08

Mutations O 0 1.985200004384069e-09
were O 0 4.9782185318481e-11
detected O 0 1.9347627666643774e-11
in O 0 1.2556575570976669e-11
21 O 0 1.362874701982264e-09
( O 0 6.869499327016859e-12
91 O 0 4.166240130665244e-10
% O 0 1.1340458953845722e-11
) O 0 8.200753986477294e-13
of O 0 2.9755645170048695e-10
23 O 0 4.958042723046674e-07
tumors B-Disease 1 1.0
with O 0 9.280137192035909e-08
LOH O 1 1.0
. O 0 3.885482442456123e-07

In O 0 2.120647657477548e-09
6 O 0 2.924215714017464e-08
( O 0 1.885281514235615e-11
38 O 0 9.917607013409935e-11
% O 0 6.950912068148796e-12
) O 0 6.770789441265523e-13
of O 0 6.073219704916255e-10
16 O 0 4.5754450184176676e-07
tumors B-Disease 1 1.0
without O 0 3.9621351533014604e-08
LOH O 1 0.9999998807907104
, O 0 9.002615493358679e-12
one O 0 7.223060582810248e-13
mutation O 0 9.113788283082735e-13
was O 0 1.5062400979259927e-11
detected O 0 8.981484826697805e-12
, O 0 3.366083453637536e-13
and O 0 5.747259222352308e-13
in O 0 1.1803935433263302e-11
9 O 0 3.495416844856436e-09
( O 0 2.521365061181058e-12
56 O 0 4.7322805396543544e-11
% O 0 5.394750184767316e-12
) O 0 8.794350339104418e-13
of O 0 5.430517147075875e-10
the O 0 1.2083718559097179e-07
tumors B-Disease 1 1.0
without O 0 6.479271519310714e-08
LOH O 1 0.9999998807907104
, O 0 2.728978501509438e-11
both O 0 6.04510712320927e-12
mutations O 0 5.32273704278996e-11
were O 0 2.024789919063963e-10
found O 0 1.4889880994850557e-10
. O 0 2.8505915405929727e-09

Thus O 0 3.9244749672207035e-09
, O 0 1.8072503563115738e-11
a O 0 4.163320729833053e-12
total O 0 1.2381346815859562e-11
of O 0 2.051054048823886e-10
45 O 0 2.968733314734351e-10
mutations O 0 6.388429368842097e-11
were O 0 6.489651871444124e-11
identified O 0 8.396359302276224e-11
in O 0 3.997047415271737e-10
tumors B-Disease 1 1.0
of O 0 4.461100502339832e-07
36 O 0 3.7634868021996226e-07
patients O 0 1.9052023958465725e-08
. O 0 2.5285942228947533e-08

Thirty O 0 1.3692505262952182e-07
- O 0 1.6194427132631972e-08
nine O 0 2.1539896533084857e-09
of O 0 1.783684422385079e-09
the O 0 7.921364675311793e-10
mutations O 0 1.21650342577162e-10
- O 0 2.0709816084263366e-09
including O 0 4.166272327132958e-10
34 O 0 1.143674155379415e-09
small O 0 8.994707062504048e-11
mutations O 0 5.044957854249965e-11
, O 0 2.997716658237337e-11
2 O 0 3.0489659685883908e-09
large O 0 6.29804125518163e-11
structural O 0 1.3001370007259538e-06
alterations O 0 1.567757408338366e-07
, O 0 1.1394277882326165e-10
and O 0 1.3262747844411393e-10
hypermethylation O 0 9.199169289786369e-05
in O 0 2.2924387721445783e-08
3 O 0 0.00011532903590705246
tumors O 1 1.0
- O 0 2.734881121568833e-08
were O 0 1.5350760940169295e-10
not O 0 7.638259599471175e-13
detected O 0 9.481201414252016e-12
in O 0 1.949869302478313e-12
the O 0 4.7236142081130694e-11
corresponding O 0 4.707472189835471e-10
peripheral O 0 1.585854874974757e-06
blood O 0 4.2439194380961e-09
DNA O 0 5.270414860092387e-08
. O 0 4.864359581802091e-09

In O 0 2.4836475098766186e-09
6 O 0 3.3194474724496104e-08
( O 0 2.925818268217917e-11
17 O 0 3.1536248612518136e-10
% O 0 2.935906942905242e-12
) O 0 7.100650769404845e-14
of O 0 1.3141168708763473e-11
the O 0 1.4057716102300333e-10
36 O 0 3.6465930275397795e-10
patients O 0 2.2185845174882424e-11
, O 0 1.6161315992066494e-12
a O 0 1.0057289202836106e-11
mutation O 0 4.3121426568371035e-12
was O 0 4.13529106790822e-11
detected O 0 4.462435629348782e-12
in O 0 1.0910126968521894e-12
constitutional O 0 1.2719834074914615e-08
DNA O 0 1.2032558283081585e-09
, O 0 4.8835024565874185e-12
and O 0 6.924354319093329e-12
1 O 0 1.3317126290601777e-09
of O 0 3.8502992460998087e-10
these O 0 2.595137863284358e-12
mutations O 0 7.682168269573797e-12
is O 0 9.64785976803606e-13
known O 0 2.0352031691872607e-12
to O 0 5.043288378060728e-13
be O 0 1.4898784246250574e-12
associated O 0 1.0929752762567357e-11
with O 0 4.173194775858313e-12
reduced O 0 2.0690796631583908e-08
expressivity O 0 3.508022814457945e-07
. O 0 1.3259320752467829e-08

The O 0 5.134359160052782e-09
presence O 0 7.655127226557923e-11
of O 0 2.452816616482778e-09
a O 0 3.972482898184637e-10
constitutional O 0 1.6511731359969417e-07
mutation O 0 4.0270289880517396e-10
was O 0 1.7999032819737693e-10
not O 0 5.307663962744562e-14
associated O 0 4.0554964443086094e-13
with O 0 2.159006345014633e-14
an O 0 1.0153187427093535e-13
early O 0 5.941208081061689e-10
age O 0 6.208331071455575e-10
at O 0 2.9379744859170387e-08
treatment O 0 3.653433111594495e-08
. O 0 8.890213010204207e-09

In O 0 1.4015002491873929e-08
1 O 0 3.666124541723548e-07
patient O 0 1.578369079879849e-08
, O 0 1.0475779965712917e-10
somatic O 0 6.130602514531347e-08
mosaicism O 0 5.733975285693305e-07
was O 0 7.408026414523761e-10
demonstrated O 0 3.980617484938831e-12
by O 0 5.461793804771922e-14
molecular O 0 2.775766812582181e-12
analysis O 0 3.155966698913104e-13
of O 0 1.2411800753842073e-11
DNA O 0 1.1449306780431101e-10
and O 0 9.159939300118491e-12
RNA O 0 5.587223461667179e-10
from O 0 2.914839550283155e-11
peripheral O 0 6.193062631609791e-07
blood O 0 8.59795790120188e-09
. O 0 1.7103875649127076e-08

In O 0 9.293612990290967e-09
2 O 0 2.2121867004898377e-07
patients O 0 4.065584327528349e-11
without O 0 4.893264612948478e-12
a O 0 5.949434521423935e-12
detectable O 0 1.5778482520545367e-08
mutation O 0 2.992683878488833e-11
in O 0 6.364139683995296e-12
peripheral O 0 1.6954861337126204e-07
blood O 0 1.4527323788371405e-10
, O 0 4.001199978981296e-12
mosaicism O 0 3.2418168416370463e-07
was O 0 2.0519825838505312e-09
suggested O 0 1.2837782052688151e-11
because O 0 5.655286352060362e-13
1 O 0 8.481020746797796e-11
of O 0 1.3586531205644903e-11
the O 0 8.099657056170884e-11
patients O 0 2.6321328797096477e-11
showed O 0 3.6757018762045846e-08
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 5.993518459312952e-10
the O 0 3.6431796468505695e-10
other O 0 2.2325323013883125e-12
later O 0 1.0542427347770555e-10
developed O 0 3.304006235271828e-10
bilateral B-Disease 0 3.4969524165262555e-08
retinoblastoma I-Disease 0 3.0018436518730596e-06
. O 0 5.994198915004745e-08

In O 0 4.3169448571411806e-10
conclusion O 0 8.191918809963283e-10
, O 0 5.589693638508031e-11
our O 0 1.119881340438944e-10
results O 0 1.5544208281648153e-11
emphasize O 0 2.3760750311740964e-11
that O 0 3.1208469510914105e-13
the O 0 6.088639575158039e-12
manifestation O 0 3.0078859403204206e-09
and O 0 1.4743258697214046e-11
transmissibility O 0 6.323011003672718e-09
of O 0 7.323326389752083e-10
retinoblastoma B-Disease 0 6.080501879779376e-09
depend O 0 2.5811243767326353e-11
on O 0 2.3350574251956857e-10
the O 0 1.3509190294191953e-11
nature O 0 5.554017315501092e-11
of O 0 2.368799878471606e-10
the O 0 1.0763633040422604e-10
first O 0 1.3763062911564816e-10
mutation O 0 2.0242326911890096e-11
, O 0 3.491759832663366e-12
its O 0 9.816258916828247e-12
time O 0 1.5057748450897357e-11
in O 0 3.104417070631804e-11
development O 0 1.5316199419856957e-09
, O 0 2.3357199854801003e-11
and O 0 6.26983950868798e-11
the O 0 4.5413151017470454e-10
number O 0 1.3398273601694655e-09
and O 0 2.5506169398781253e-10
types O 0 1.0057625843273854e-09
of O 0 3.153271643796529e-09
cells O 0 1.0716497134133363e-10
that O 0 2.380183506886513e-12
are O 0 9.215678350646406e-13
affected O 0 1.2214666778032068e-11
. O 0 3.7754799286915386e-11
. O 0 2.4805322240695205e-09

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9998805522918701
the I-Disease 0 5.742973371525295e-06
fifth I-Disease 0 9.763849675437086e-07
component I-Disease 0 4.840040901399334e-08
of I-Disease 0 9.418904767244385e-09
complement I-Disease 0 8.870661982740558e-10
in O 0 5.960143045768973e-09
man O 0 1.605976791552166e-07
. O 0 3.734227149720937e-08

I O 0 0.0006884840549901128
. O 0 7.4914834158335e-07

Clinical O 0 0.00018631864804774523
, O 0 1.5215114501643257e-08
immunochemical O 0 1.8203551007900387e-05
, O 0 2.2561736923165654e-09
and O 0 5.423375082358461e-10
family O 0 1.6536952363033208e-10
studies O 0 2.2396282606251816e-09
. O 0 1.6725202556244767e-08

The O 0 5.239631395426159e-09
first O 0 2.47334069891636e-10
recognized O 0 7.72935604409497e-10
human O 0 6.226704041267794e-09
kindred O 0 3.094808562309481e-06
with O 0 7.353928577202851e-09
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999995231628418
the I-Disease 0 1.816398071241565e-05
fifth I-Disease 0 1.1184969253008603e-06
component I-Disease 0 1.1647938435999095e-07
of I-Disease 0 2.0652420573696872e-07
complement I-Disease 0 1.3863939329894492e-07
( O 0 1.1377914610477546e-08
C5 O 0 0.0018275968031957746
) O 0 7.872379137463525e-11
is O 0 2.9061739126312602e-11
described O 0 1.751678913031185e-09
. O 0 1.6580111505959394e-08

The O 0 1.0232459146664041e-07
proband O 0 2.4981925434985897e-06
, O 0 5.60488822021199e-10
a O 0 1.2469468513298665e-10
20 O 0 4.876356610172827e-11
- O 0 2.5808782194713942e-11
year O 0 8.981279261965902e-12
- O 0 1.4761161737375517e-10
old O 0 1.1465347421468763e-10
black O 0 2.9553913569874135e-12
female O 0 1.1752634998009326e-13
with O 0 2.1794111654260817e-11
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 0 0.00014658494910690933
age O 0 1.577002883834666e-08
11 O 0 1.3495072614944092e-08
, O 0 2.8312118274809173e-11
lacked O 0 1.0853925402898312e-07
serum O 0 8.437851306553057e-09
hemolytic O 0 5.885714926989749e-05
complement O 0 1.1661333010337671e-09
activity O 0 4.5328882869455356e-09
, O 0 5.239283833169406e-12
even O 0 3.919531799817522e-12
during O 0 6.033986088560539e-10
remission O 0 2.2869193117003306e-07
. O 0 5.305369921160263e-09

C5 O 0 0.004339195787906647
was O 0 1.3359421302538976e-07
undetectable O 0 7.13159096221716e-08
in O 0 1.0145188161780894e-10
her O 0 7.557386140499833e-12
serum O 0 6.914666755841736e-12
by O 0 5.2569610990704785e-12
both O 0 1.2912984570512265e-10
immunodiffusion O 0 1.792089960872545e-06
and O 0 8.457025302277543e-09
hemolytic O 1 0.5833016037940979
assays O 0 3.5089901757601183e-06
. O 0 1.5970329059200594e-07

Other O 0 7.791712414162433e-11
complement O 0 7.429602072450692e-11
components O 0 8.466737866363871e-10
were O 0 2.0970470152037457e-11
normal O 0 1.9577110765833794e-11
during O 0 1.096955859480886e-11
remission O 0 7.801356005643356e-09
of O 0 2.6109201467505727e-09
lupus O 0 9.304844570579007e-05
, O 0 5.871744201968454e-10
but O 0 1.154197293296022e-09
C1 O 0 7.031807172097615e-07
, O 0 2.417465394533025e-10
C4 O 0 0.0003261981182731688
, O 0 1.1934754295950256e-09
C2 O 0 2.7475024921841396e-08
, O 0 2.1923777029919655e-11
and O 0 8.917499516591931e-10
C3 O 0 0.0007023678626865149
levels O 0 1.850695525718038e-07
fell O 0 3.0793324867772753e-07
during O 0 3.568583650803703e-08
exacerbations O 0 0.0029668051283806562
. O 0 1.24622587804879e-07

A O 0 4.884762893198058e-05
younger O 0 1.4147436111500156e-08
half O 0 6.593678492095023e-09
- O 0 3.239888002326552e-08
sister O 0 6.905162219794647e-09
, O 0 2.909769647452265e-10
who O 0 3.1892227747576385e-10
had O 0 4.0422273861473457e-10
no O 0 1.7952892505945783e-09
underlying O 1 0.9999876022338867
disease O 1 0.9999966621398926
, O 0 5.142292147652938e-11
was O 0 7.114768330040988e-09
also O 0 2.062795594059974e-11
found O 0 1.818993523514112e-12
to O 0 1.4875963308402795e-11
lack O 0 1.462994987377897e-07
immunochemically O 0 1.609681930858642e-05
detectable O 0 0.01177048496901989
C5 O 0 0.002369375666603446
. O 0 6.559386633853137e-08

By O 0 5.477978959333996e-09
hemolytic O 1 0.7202240824699402
assay O 0 6.373377345880726e-07
, O 0 9.673117862263325e-10
she O 0 3.491934866262092e-11
exhibited O 0 1.210691658037888e-09
1 O 0 1.2118290371176954e-08
- O 0 1.6259002477703177e-10
2 O 0 5.536185399002136e-11
% O 0 4.980796591141923e-13
of O 0 1.8714096244876188e-11
the O 0 1.264454513316693e-10
normal O 0 1.8695750725328253e-08
serum O 0 7.112665567632348e-09
C5 O 0 3.7762063129775925e-06
level O 0 2.1222875901116822e-08
and O 0 4.193341854308308e-12
normal O 0 3.5092810601877744e-11
concentrations O 0 2.028275290777426e-11
of O 0 3.663608999504575e-11
other O 0 2.8900371679130288e-12
complement O 0 6.928708162767805e-10
components O 0 9.79357324126795e-08
. O 0 3.1742487749397696e-08

C5 O 0 0.003969831392168999
levels O 0 9.122052802013059e-08
of O 0 4.3875747479660276e-08
other O 0 1.5961443278200704e-10
family O 0 1.4771359135856699e-10
members O 0 7.383252342840763e-11
were O 0 1.7941004237798097e-10
either O 0 6.782494010870721e-11
normal O 0 8.289024577834425e-09
or O 0 1.585342274124102e-11
approximately O 0 8.983849254795562e-12
half O 0 6.3983797427003e-11
- O 0 1.8105668353474158e-10
normal O 0 2.735405235654298e-10
, O 0 1.804390512873122e-12
consistent O 0 1.6655181400704322e-10
with O 0 5.61192151776746e-12
autosomal O 0 1.7437135113596014e-07
codominant O 0 4.517893614774948e-07
inheritance O 0 3.7646311068506577e-10
of O 0 2.545732236125531e-10
the O 0 1.678757133305453e-10
gene O 0 7.663447654238098e-09
determining O 0 8.640818691674212e-07
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.5103440773600596e-06

Normal O 0 8.744760634726845e-06
hemolytic O 0 0.06566794961690903
titers O 0 1.9446365513431374e-06
were O 0 4.400930175840756e-10
restored O 0 2.958012723652814e-09
to O 0 3.092312647265394e-12
both O 0 4.2501686198237465e-11
homozygous O 0 0.00028595083858817816
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 3.449728467330715e-07
C5D B-Disease 1 1.0
) O 0 9.098455495959445e-12
sera O 0 2.2947814481977247e-10
by O 0 1.519680377631144e-13
addition O 0 1.112904581858365e-12
of O 0 7.519660588650723e-11
highly O 0 1.2950432948244384e-09
purified O 0 5.1175423898541794e-09
human O 0 3.1933531374761515e-08
C5 O 0 8.468739542877302e-05
. O 0 3.963404893170264e-08

In O 0 1.5791368213058377e-08
specific O 0 5.263804325750243e-08
C5 O 0 3.0726972909178585e-05
titrations O 0 9.127656852569999e-08
, O 0 3.865838552052914e-11
however O 0 8.525617711807598e-12
, O 0 7.27414602077342e-13
it O 0 2.0945662467918708e-13
was O 0 3.717081503706865e-11
noted O 0 3.2309517474654603e-12
that O 0 6.116756271412269e-14
when O 0 3.1437168406672766e-13
limited O 0 9.998947199732489e-13
amounts O 0 3.4066991849018846e-12
of O 0 5.548048687131768e-10
C5 O 0 3.662458709641214e-07
were O 0 1.9356866109987436e-10
assayed O 0 2.9284605296275856e-10
in O 0 6.488645992036579e-12
the O 0 4.2350040141414524e-11
presence O 0 3.54463194907062e-11
of O 0 5.452281404139114e-10
low O 0 1.958800766033164e-08
dilutions O 0 9.87036727906343e-08
of O 0 9.108891418918574e-08
either O 0 5.791753210360184e-07
C5D B-Disease 1 1.0
serum O 0 9.774557696573538e-08
, O 0 7.419225789284667e-10
curving O 0 4.482275439698924e-09
rather O 0 2.241783148004828e-12
than O 0 8.476075744057177e-14
linear O 0 2.5088505925530136e-11
dose O 0 2.4842254919832385e-09
- O 0 2.800513987377684e-10
response O 0 9.752397674145374e-12
plots O 0 7.126441797788985e-11
were O 0 1.0580473996935069e-11
consistently O 0 1.5111542659568267e-12
obtained O 0 1.0205906215629557e-12
, O 0 1.6226550268380602e-12
suggesting O 0 6.411314187881878e-12
some O 0 1.1371296699397293e-12
inhibitory O 0 9.734496764224332e-09
effect O 0 8.760972036725434e-08
. O 0 8.64197158279012e-09

Further O 0 1.137187788380345e-09
studies O 0 1.0292399571509847e-10
suggested O 0 4.9930629075767285e-11
that O 0 1.6049867598150191e-12
low O 0 4.1021435137622575e-09
dilutions O 0 3.0080943247412506e-07
of O 0 7.655965418962296e-06
C5D B-Disease 1 1.0
serum O 0 4.205565318216031e-08
contain O 0 5.647738388070422e-10
a O 0 7.332631724032979e-11
factor O 0 5.3452207937620955e-11
( O 0 7.704160118020276e-13
or O 0 2.4406093465656475e-12
factors O 0 2.5952677507046218e-11
) O 0 5.138051984744652e-13
interfering O 0 1.9990630678590193e-11
at O 0 1.1578088487951277e-09
some O 0 3.140374245369504e-12
step O 0 2.6313612400130637e-10
in O 0 1.652225231629778e-11
the O 0 1.4038538109772958e-09
hemolytic O 0 4.504433672991581e-05
assay O 0 1.0840183222171618e-06
of O 0 2.1420250959636178e-06
C5 O 0 0.0006070969393476844
, O 0 4.5211087651431114e-10
rather O 0 1.973949996514346e-11
than O 0 2.1231373863866976e-12
a O 0 1.5237286432601138e-10
true O 0 1.5309401746321782e-08
C5 O 0 5.725902519770898e-05
inhibitor O 0 4.476630266481152e-08
or O 0 1.1598269011869888e-09
inactivator O 0 1.5947271094773896e-06
. O 0 5.678809955611541e-08

Of O 0 1.6588863900324213e-06
clinical O 0 0.47762471437454224
interest O 0 2.533838028284663e-07
are O 0 4.8962080917425155e-11
( O 0 3.981270174646667e-12
a O 0 1.640493643706442e-11
) O 0 1.9483701219243088e-13
the O 0 2.2002057294134847e-12
documentation O 0 9.582512561223666e-10
of O 0 8.443546972713989e-10
membranous O 1 0.9999986886978149
glomerulonephritis B-Disease 1 1.0
, O 0 1.60218522893274e-08
vasculitis B-Disease 1 1.0
, O 0 1.4206945619932299e-09
and O 0 2.1414904040284455e-05
arthritis B-Disease 1 1.0
in O 0 1.7994751244643226e-09
an O 0 1.0337941440397014e-11
individual O 0 3.533058012816781e-10
lacking O 0 0.029217299073934555
C5 O 1 0.9105128645896912
( O 0 1.0183608296909785e-11
and O 0 7.244891752494764e-12
its O 0 9.238809370315515e-12
biologic O 0 5.842544670286998e-09
functions O 0 7.85420201099285e-11
) O 0 1.1522746190366362e-13
, O 0 8.120497411437042e-14
and O 0 5.5378271412998e-13
( O 0 7.822110472364974e-13
b O 0 2.5010962051430496e-11
) O 0 1.0992838312805925e-13
a O 0 1.3025101830432817e-12
remarkable O 0 5.5506283597184236e-11
propensity O 0 2.3403545768019285e-10
to O 0 5.2742359091251245e-12
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 1.6740208177989935e-11
the O 0 1.4783526833261895e-11
proband O 0 1.611077382612791e-09
, O 0 1.895875166926797e-12
even O 0 2.612648324681194e-13
during O 0 4.261408934058686e-12
periods O 0 4.181946455794616e-11
of O 0 2.561078293883412e-10
low O 0 3.3470632931908995e-09
- O 0 1.1107467723370235e-10
dose O 0 3.348274713044219e-10
or O 0 2.3395721124308544e-11
alternate O 0 1.780992131550363e-09
- O 0 1.441084851450114e-08
day O 0 7.625247100406796e-09
corticosteroid O 0 0.00018409077893011272
therapy O 0 6.624112302233698e-06
. O 0 8.383837624137414e-09

Other O 0 6.821314069149764e-10
observations O 0 3.443797469415699e-10
indicate O 0 4.318474397524419e-11
that O 0 3.484368392772663e-12
the O 0 1.55942625479355e-09
C5D B-Disease 1 1.0
state O 0 8.364693659945743e-11
is O 0 1.0471454432725569e-12
compatible O 0 1.6232075406019675e-10
with O 0 3.135847701299377e-13
normal O 0 5.028674004980971e-11
coagulation O 0 2.3934413478921002e-11
function O 0 9.019898161710671e-10
and O 0 1.866624693355745e-12
the O 0 5.7133581719825965e-12
capacity O 0 6.768856308791982e-12
to O 0 1.4336687219340671e-12
mount O 0 1.2459305587242397e-08
a O 0 2.721854297504933e-09
neutrophilic O 0 0.00018024527525994927
leukocytosis O 0 1.6147587302839383e-05
during O 0 1.1652982578880255e-07
pyogenic B-Disease 1 0.5064878463745117
infection I-Disease 0 3.5433238281257218e-06
. O 0 1.5364448602284142e-09
. O 0 6.9648837808244934e-09

Susceptibility O 0 2.0817860786337405e-05
to O 0 2.6387880325273727e-07
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 1 0.9482771158218384
twins O 0 9.548969501338433e-06
: O 0 5.093249173110381e-12
the O 0 1.8307171750775453e-11
role O 0 2.4078787574932647e-11
of O 0 2.0692118851695085e-10
genes O 0 3.31711949574931e-11
, O 0 3.544070939498489e-11
HLA O 0 1.1394163124123224e-07
, O 0 8.582695665282358e-11
and O 0 2.0745863360538408e-10
the O 0 4.568875944244155e-09
environment O 0 3.8338075825095075e-08
. O 0 8.454751565523111e-09

OBJECTIVE O 0 6.0575775933102705e-06
To O 0 9.632717540286606e-11
determine O 0 3.295067690922693e-11
the O 0 1.0199353514539489e-11
relative O 0 7.557317965867227e-11
effects O 0 5.4719428987937135e-09
of O 0 2.449435376750131e-10
genetic O 0 2.365072138132973e-09
and O 0 6.6424435396506e-12
environmental O 0 6.738462565714087e-10
factors O 0 3.0742582958487308e-12
in O 0 2.0735477137406866e-12
susceptibility O 0 1.2248857217400655e-07
to O 0 1.7775720451140842e-08
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 0.4669775664806366
AS B-Disease 1 1.0
) O 0 8.284685437676131e-11
. O 0 6.6423871958321e-10

METHODS O 0 1.5584089851472527e-05
Twins O 0 1.6144069832080277e-06
with O 0 5.23404541930006e-10
AS B-Disease 1 1.0
were O 0 9.787527732729728e-11
identified O 0 1.0863037899766503e-11
from O 0 1.0570665436721027e-12
the O 0 4.424249855361495e-11
Royal O 0 1.3520424779756013e-08
National O 0 2.4317637326021213e-06
Hospital O 0 0.00024808786110952497
for O 0 1.5842111622532684e-08
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 2.2224637064027775e-07
. O 0 1.7693050580191994e-08

Clinical O 0 3.908400685759261e-06
and O 0 3.7974370870053065e-10
radiographic O 0 1.4719292096287973e-07
examinations O 0 3.969229922518025e-08
were O 0 3.53494351845729e-11
performed O 0 1.8485560304704052e-11
to O 0 3.862930754352373e-13
establish O 0 2.941311777471256e-11
diagnoses O 0 1.0382279036491582e-08
, O 0 6.4917528817820536e-12
and O 0 1.321280446164863e-10
disease O 0 0.002133050002157688
severity O 0 1.7638956251175841e-06
was O 0 1.7470043189860007e-09
assessed O 0 5.3487599765977833e-11
using O 0 3.9100314782811174e-13
a O 0 3.5509438271741356e-12
combination O 0 3.05473736583739e-11
of O 0 3.2717351050592924e-10
validated O 0 1.0000893446715509e-08
scoring O 0 9.617434848507855e-09
systems O 0 4.209794894904917e-07
. O 0 3.286812599867517e-08

HLA O 0 2.5811536943365354e-06
typing O 0 1.0590182064618148e-08
for O 0 3.111104707187451e-10
HLA O 0 1.0407483586050148e-07
- O 0 3.125738556875035e-09
B27 O 0 7.619708419781546e-09
, O 0 1.989758358078575e-11
HLA O 0 1.375317637553053e-09
- O 0 1.707295971264955e-10
B60 O 0 7.00108138129707e-10
, O 0 2.1982970999090412e-12
and O 0 3.09870662115741e-12
HLA O 0 8.306052734496916e-09
- O 0 5.972455863201276e-09
DR1 O 0 1.6842413970152847e-05
was O 0 1.7250503803190043e-10
performed O 0 2.0230823960520894e-11
by O 0 7.074999006789762e-12
polymerase O 0 2.472916316165197e-10
chain O 0 2.8733708745676267e-09
reaction O 0 7.264180576505019e-12
with O 0 1.6529997856618017e-12
sequence O 0 2.825354949997916e-10
- O 0 8.486947811192636e-10
specific O 0 8.29595905860181e-11
primers O 0 7.497208964757363e-10
, O 0 1.2593415893435989e-11
and O 0 6.797141322012479e-11
zygosity O 0 1.585862463571175e-07
was O 0 5.158073523858775e-09
assessed O 0 2.5369550904486005e-09
using O 0 1.1952949741100838e-10
microsatellite O 0 1.5149227294841694e-07
markers O 0 1.0977072406603838e-07
. O 0 5.013769666106782e-08

Genetic O 0 2.62742787526804e-07
and O 0 3.0936253558877524e-10
environmental O 0 9.874180362245966e-10
variance O 0 5.983760709149522e-11
components O 0 2.792881925728352e-09
were O 0 4.840005479733733e-11
assessed O 0 8.035230814051886e-11
with O 0 1.0915372338632379e-12
the O 0 2.1865947941179797e-10
program O 0 3.0588900856720613e-10
Mx O 0 3.6412919346417993e-09
, O 0 4.667963606798387e-13
using O 0 5.2872636824297103e-14
data O 0 6.690375792435532e-13
from O 0 8.356978845915075e-14
this O 0 3.9283887151271915e-14
and O 0 1.7066812644118273e-13
previous O 0 1.0915210575668244e-11
studies O 0 1.8796685128524837e-12
of O 0 8.125079775656019e-11
twins O 0 2.599575443795743e-09
with O 0 1.2023834705665593e-10
AS B-Disease 1 1.0
. O 0 2.6560213584048142e-08

RESULTS O 0 6.712044609002987e-08
Six O 0 3.512631296942459e-10
of O 0 1.1767822272190642e-09
8 O 0 1.3105923812872788e-07
monozygotic O 0 4.839440634896164e-07
( O 0 3.1135878320043275e-09
MZ O 1 0.999910831451416
) O 0 9.472462814130722e-10
twin O 0 1.501493102296081e-06
pairs O 0 4.673529341303606e-10
were O 0 1.4597184572195943e-09
disease O 0 0.0019361804006621242
concordant O 0 4.4426656131690834e-07
, O 0 1.2884709792160276e-11
compared O 0 3.8298604738973285e-12
with O 0 1.2752797949600048e-12
4 O 0 4.131274433660792e-09
of O 0 6.018698317511451e-10
15 O 0 6.130597141051908e-10
B27 O 0 5.009398673649912e-09
- O 0 6.956065168317593e-10
positive O 0 1.562321452763804e-11
dizygotic O 0 3.8996518014755566e-08
( O 0 9.482291341011972e-11
DZ O 0 1.2852759937231895e-05
) O 0 3.5721127444876544e-11
twin O 0 1.4103117784713959e-08
pairs O 0 5.088510342254882e-12
( O 0 1.848784146607496e-12
27 O 0 8.952333319101058e-10
% O 0 1.772146145107012e-11
) O 0 3.34719068868089e-13
and O 0 8.138057068507454e-12
4 O 0 1.5275471998421608e-09
of O 0 4.122088892444253e-09
32 O 0 1.115761634196133e-07
DZ O 1 0.9999772310256958
twin O 0 5.153246547706658e-06
pairs O 0 7.41468136888912e-11
overall O 0 7.971157067743206e-09
( O 0 6.323535445273976e-11
12 O 0 8.464283163256425e-10
. O 0 2.0782287349363493e-11
5 O 0 5.894118526583725e-10
% O 0 2.5794904406906127e-11
) O 0 8.071123630548627e-12
. O 0 8.042962962306888e-10

Nonsignificant O 0 1.8950491948999115e-06
increases O 0 2.085425027109622e-10
in O 0 1.931391895373946e-12
similarity O 0 9.736858888609312e-12
with O 0 2.0892037828467575e-13
regard O 0 1.6246006276365854e-11
to O 0 2.9228087506695533e-13
age O 0 1.244143538192688e-10
at O 0 2.1313418585577892e-08
disease O 0 0.0013191377511247993
onset O 0 2.1158337403903715e-05
and O 0 2.648104608857227e-12
all O 0 6.45275174439297e-13
of O 0 7.9006549566496e-12
the O 0 3.2450965525843145e-11
disease O 0 8.962523878608408e-08
severity O 0 9.45979206079528e-09
scores O 0 1.6555826154451836e-10
assessed O 0 7.61533804766179e-12
were O 0 2.515287782743625e-13
noted O 0 8.686258093013044e-13
in O 0 1.6524269799700342e-11
disease O 0 0.12014224380254745
- O 0 2.467673311912222e-06
concordant O 0 0.0001335338019998744
MZ O 1 0.9999998807907104
twins O 0 1.0906907732533e-07
compared O 0 3.651917657165882e-10
with O 0 2.587292047273593e-10
concordant O 0 0.006534452084451914
DZ O 1 0.9999992847442627
twins O 0 7.063279917929322e-05
. O 0 2.3102386137452413e-07

HLA O 0 7.577840733574703e-05
- O 0 4.1796360505941266e-07
B27 O 0 5.6503193235357685e-08
and O 0 8.45018083284188e-11
B60 O 0 3.5754972316226485e-09
were O 0 3.855262897117795e-12
associated O 0 1.609094042905046e-12
with O 0 1.3507863447573265e-13
the O 0 5.4992246867335837e-11
disease O 0 2.4763169292896237e-08
in O 0 2.249621496031029e-12
probands O 0 1.4002123016609858e-08
, O 0 1.1003983097987446e-12
and O 0 3.525203946027483e-13
the O 0 2.862333634001679e-12
rate O 0 5.463073049494227e-11
of O 0 2.8997122411555942e-11
disease O 0 3.054066155527835e-08
concordance O 0 8.274546325903742e-11
was O 0 3.874903869993673e-11
significantly O 0 7.011240004371755e-13
increased O 0 6.761681492495342e-12
among O 0 9.938374775919634e-12
DZ O 1 0.8968992233276367
twin O 0 1.5447693613168667e-07
pairs O 0 2.173303854588471e-12
in O 0 1.563206682153595e-11
which O 0 2.5143500129165552e-11
the O 0 3.1582192416834687e-09
co O 0 2.716126061841351e-07
- O 0 4.2179603809699984e-08
twin O 0 1.6331467733721183e-08
was O 0 3.8530689749904923e-10
positive O 0 2.0376658260018443e-12
for O 0 7.74796112684717e-12
both O 0 7.071778579392785e-11
B27 O 0 1.2358248113741865e-07
and O 0 7.323427642091929e-09
DR1 O 0 0.21512886881828308
. O 0 4.912098461318237e-08

Additive O 0 3.28090976609019e-07
genetic O 0 6.864940615969317e-08
effects O 0 2.8827849973822595e-07
were O 0 4.5495489320313e-11
estimated O 0 1.0013222889737605e-12
to O 0 6.092409156376391e-14
contribute O 0 1.864822993290563e-13
97 O 0 5.098364092015473e-11
% O 0 7.503219508382675e-13
of O 0 4.291171151055151e-12
the O 0 5.51756600478126e-12
population O 0 1.6239018864414728e-13
variance O 0 6.350101694474475e-11
. O 0 1.807079708093795e-09

CONCLUSION O 0 3.197467606241844e-07
Susceptibility O 0 3.153736471972479e-08
to O 0 2.463204640257288e-10
AS B-Disease 1 1.0
is O 0 5.747492325819392e-12
largely O 0 3.705507775619843e-11
genetically O 0 1.120803970466877e-11
determined O 0 1.4187082932048956e-11
, O 0 8.394397373392981e-13
and O 0 4.007623660012838e-12
the O 0 3.5505751116993167e-10
environmental O 0 2.2281513167854428e-07
trigger O 0 6.946270669772048e-09
for O 0 2.9134999968150055e-11
the O 0 7.61581375741116e-09
disease O 0 4.449377229320817e-05
is O 0 5.547844475484176e-11
probably O 0 2.719051095390057e-10
ubiquitous O 0 3.5995714853243044e-08
. O 0 8.631148240567654e-09

HLA O 0 8.92431489774026e-05
- O 0 2.3967760398591054e-07
B27 O 0 3.364590028809289e-08
accounts O 0 6.966281284465081e-12
for O 0 1.2481828721641608e-12
a O 0 4.772906462419124e-12
minority O 0 1.7336906649872974e-12
of O 0 4.608175993570107e-11
the O 0 2.7099644750450125e-10
overall O 0 1.5225332106183487e-08
genetic O 0 4.17715320111256e-08
susceptibility O 0 6.849612077530765e-08
to O 0 6.111322004009878e-10
AS B-Disease 1 1.0
. O 0 2.0791596000435675e-08

Cell O 0 0.0005415478954091668
cycle O 0 6.132939597591758e-05
- O 0 3.4639865020835714e-07
dependent O 0 1.142730621239707e-08
colocalization O 0 1.8205646483693272e-06
of O 0 2.609647538065474e-07
BARD1 O 0 0.00359323900192976
and O 0 4.236422324055411e-09
BRCA1 O 0 3.33909094818452e-10
proteins O 0 2.6709923335588304e-12
in O 0 4.790627963768834e-12
discrete O 0 3.5308502788211626e-09
nuclear O 0 1.2908598137073568e-06
domains O 0 1.0116063720033708e-07
. O 0 4.176022372348598e-08

Germ O 0 0.0002429137093713507
- O 0 6.263751402002526e-07
line O 0 1.2669809201781845e-08
mutations O 0 6.612513314685486e-11
of O 0 1.136281402303041e-09
the O 0 4.4689927314323086e-09
BRCA1 O 0 1.4101422252110751e-08
gene O 0 9.132315459403628e-10
predispose O 0 7.730280304762971e-11
women O 0 4.083483835901243e-14
to O 0 3.6527601283324954e-14
early O 0 1.2183279807231884e-07
- O 1 0.9967273473739624
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 3.666512498057273e-07
compromising O 0 2.3845603891459177e-07
the O 0 1.588576492572713e-09
genes O 0 2.3694223666437253e-11
presumptive O 0 4.289099297949406e-09
function O 0 1.9271555462552215e-09
as O 0 2.120321973553274e-11
a O 0 6.802225449575872e-11
tumor B-Disease 0 4.0683286073317504e-08
suppressor O 0 3.111577200343163e-07
. O 0 6.105383310028856e-09

Although O 0 5.9745066671723634e-09
the O 0 7.855254224864439e-10
biochemical O 0 6.280581388296014e-09
properties O 0 5.1107857501619947e-08
of O 0 1.282417514403278e-07
BRCA1 O 0 6.1437810394693315e-09
polypeptides O 0 6.107570005298157e-10
are O 0 1.1615807057538396e-12
not O 0 4.872651761245184e-13
understood O 0 4.86147710629381e-12
, O 0 5.537277992899436e-13
their O 0 1.2017219901475085e-12
expression O 0 2.278312261072557e-11
pattern O 0 7.869556395423416e-11
and O 0 7.483957030485211e-12
subcellular O 0 5.780320577741804e-08
localization O 0 2.1986124920658767e-07
suggest O 0 1.6547293049673506e-11
a O 0 4.398618188433678e-12
role O 0 1.2112216611626092e-11
in O 0 5.623571400215077e-11
cell O 0 7.12414021108998e-07
- O 0 1.0367085678808508e-07
cycle O 0 6.645522603321297e-07
regulation O 0 3.850652319670189e-06
. O 0 1.156926554557458e-08

When O 0 2.1616504852772778e-07
resting O 0 1.1287138477200642e-05
cells O 0 1.0318650822682685e-08
are O 0 5.001944171356687e-12
induced O 0 1.3321140857058822e-09
to O 0 4.617673431128733e-13
proliferate O 0 8.118135504109336e-12
, O 0 2.6262480146317657e-13
the O 0 1.8253467314044425e-12
steady O 0 3.781144494729993e-11
- O 0 4.4832068829894767e-13
state O 0 2.1083545879204552e-13
levels O 0 8.3283605706308e-12
of O 0 2.0394155114678014e-12
BRCA1 O 0 1.168964122548466e-12
increase O 0 6.609880557392062e-14
in O 0 6.594507925838933e-13
late O 0 1.4316788865542662e-09
G1 O 0 5.2691728757992e-10
and O 0 7.103147280432265e-13
reach O 0 1.7600934598682727e-11
a O 0 3.5026126964099458e-12
maximum O 0 2.4479407390032293e-10
during O 0 1.4775309864489827e-09
S O 0 7.880728247755542e-08
phase O 0 1.4187787655828288e-07
. O 0 1.6993672247167524e-08

Moreover O 0 3.8577571359610374e-08
, O 0 7.2829581254652e-10
in O 0 9.686816904164175e-10
S O 0 1.246633445362022e-07
phase O 0 7.484742781116438e-08
cells O 0 7.533417778482487e-10
, O 0 4.064762415545431e-11
BRCA1 O 0 4.128397346203627e-10
polypeptides O 0 1.806775562496199e-10
are O 0 2.5091749424749343e-12
hyperphosphorylated O 0 2.626498796232113e-09
and O 0 7.546816643833054e-11
accumulate O 0 6.890810404919234e-12
into O 0 7.819548827892042e-12
discrete O 0 9.08899888685255e-09
subnuclear O 0 3.405599954930949e-06
foci O 0 7.130895482987398e-06
termed O 0 1.3850750235633313e-07
" O 0 3.17555084450305e-08
BRCA1 O 0 8.9399323499606e-09
nuclear O 0 2.139098569386988e-07
dots O 0 9.781155441146439e-09
. O 0 1.8828192338560257e-08

" O 0 5.851106834597886e-06
BRCA1 O 0 2.8013107566948747e-07
associates O 0 1.0980795828174905e-08
in O 0 4.086801383418326e-11
vivo O 0 1.5970130773368396e-09
with O 0 1.846998248788978e-11
a O 0 1.2579216557284667e-09
structurally O 0 2.4486157101932804e-08
related O 0 3.3652303166320507e-09
protein O 0 9.191791860985177e-08
termed O 0 1.9695751234394265e-06
BARD1 O 0 0.008256434462964535
. O 0 1.2708041197129205e-07

Here O 0 1.863412535385578e-08
we O 0 3.782197471879911e-11
show O 0 6.07926695095351e-11
that O 0 4.264227859707148e-13
the O 0 1.8263855705580312e-11
steady O 0 7.966638460032982e-10
- O 0 2.416422444084798e-11
state O 0 2.6669606193602258e-12
levels O 0 8.485616376230354e-11
of O 0 4.534855824189776e-11
BARD1 O 0 4.880802748630231e-07
, O 0 7.574718630110056e-12
unlike O 0 8.363748929540726e-12
those O 0 2.339927947583864e-12
of O 0 4.1611578072142663e-10
BRCA1 O 0 9.023425340259905e-10
, O 0 9.705449985353276e-12
remain O 0 6.554487508303453e-11
relatively O 0 3.139881475482109e-13
constant O 0 1.958887566044787e-11
during O 0 6.071424474285436e-10
cell O 0 4.796868893208739e-07
cycle O 0 1.2513586966633738e-07
progression O 0 3.3798860954448173e-07
. O 0 4.365576344866895e-09

However O 0 3.8606057017886997e-08
, O 0 8.783718752347625e-10
immunostaining O 0 2.048902416618148e-07
revealed O 0 5.517847956326705e-09
that O 0 4.2609558242867607e-11
BARD1 O 0 3.5010948522540275e-06
resides O 0 3.1380678056081024e-09
within O 0 9.769572928419734e-10
BRCA1 O 0 5.45653633388099e-10
nuclear O 0 1.8663721235157027e-08
dots O 0 1.061553137060578e-10
during O 0 2.907851293088015e-09
S O 0 1.3724096525891127e-08
phase O 0 5.5476920834962584e-09
of O 0 1.0584321197271152e-09
the O 0 1.2586777176082364e-09
cell O 0 1.5286030219385793e-08
cycle O 0 1.003415350808723e-09
, O 0 1.797932028951843e-12
but O 0 4.043771339914265e-13
not O 0 6.021410041585906e-13
during O 0 8.791709027455852e-11
the O 0 3.9486044989267555e-10
G1 O 0 3.544035820368663e-08
phase O 0 7.404530322219216e-08
. O 0 5.056532526026558e-09

Nevertheless O 0 1.9773365238506813e-06
, O 0 1.3652898367411126e-08
BARD1 O 0 2.2106603864813223e-05
polypeptides O 0 1.052234921417039e-08
are O 0 3.0445565773334904e-12
found O 0 2.4153601211121534e-13
exclusively O 0 3.663493391026923e-13
in O 0 1.7762534065129953e-12
the O 0 9.879218970665349e-12
nuclear O 0 1.0748579803987468e-09
fractions O 0 6.7514492260722925e-12
of O 0 9.393222311082638e-11
both O 0 4.3761178708523474e-11
G1 O 0 1.0805318417794751e-08
- O 0 1.6242305278524327e-09
and O 0 5.309315209700571e-10
S O 0 9.048785898357892e-08
- O 0 2.442941848812552e-09
phase O 0 3.7631057381304345e-08
cells O 0 6.115628004010887e-09
. O 0 2.8641948812691e-09

Therefore O 0 1.4929652181194797e-08
, O 0 2.2298321522562503e-10
progression O 0 1.2527576309651067e-08
to O 0 1.533601162728715e-10
S O 0 3.564223405305711e-08
phase O 0 1.0374222370046482e-08
is O 0 8.656520595826112e-13
accompanied O 0 7.026434555718053e-13
by O 0 7.1724982723953e-13
the O 0 1.3152302164032292e-11
aggregation O 0 4.546287304951768e-11
of O 0 2.5574367623626415e-10
nuclear O 0 1.8528058376432455e-07
BARD1 O 0 1.6371457149944035e-06
polypeptides O 0 1.3552543087769209e-08
into O 0 7.773369170571698e-10
BRCA1 O 0 1.1812692157775473e-08
nuclear O 0 8.168894396476389e-07
dots O 0 4.543156606473531e-08
. O 0 5.529904001377872e-08

This O 0 1.2920726710774488e-09
cell O 0 9.000194012287466e-08
cycle O 0 4.261474373379315e-08
- O 0 3.3447851155443686e-09
dependent O 0 2.7824909043516755e-10
colocalization O 0 2.7029209093143436e-08
of O 0 1.2454743902878818e-08
BARD1 O 0 0.010543367825448513
and O 0 4.814788567841788e-10
BRCA1 O 0 3.865015252291215e-10
indicates O 0 5.503755003827271e-12
a O 0 1.5397428341015762e-12
role O 0 8.547419716453675e-12
for O 0 2.651082652016523e-11
BARD1 O 0 1.1922440535272472e-05
in O 0 3.163892703383908e-09
BRCA1 O 0 2.1160714425150218e-07
- O 0 2.7888410158993793e-07
mediated O 0 2.506748387531843e-05
tumor B-Disease 0 5.8025718317367136e-05
suppression O 0 0.0019325771136209369
. O 0 3.943926785154872e-08

Ethnic O 0 8.149844354932156e-09
differences O 0 1.9392758510150543e-09
in O 0 1.173397823350797e-09
the O 0 1.278506989166317e-08
HFE O 0 9.358520765090361e-05
codon O 0 1.7786005912512337e-07
282 O 0 2.1635804259290126e-08
( O 0 5.880399722713037e-09
Cys O 0 0.0017556853126734495
/ O 0 3.837236363324337e-05
Tyr O 0 3.6730921237904113e-06
) O 0 4.118872465319612e-10
polymorphism O 0 6.359843496284157e-08
. O 0 2.9426123759890288e-08

Recent O 0 1.2887449996057398e-09
studies O 0 8.045705074399834e-11
have O 0 1.497965163368975e-12
shown O 0 1.869943089261028e-11
that O 0 1.505368496523829e-09
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 8.366615475097205e-06
HH B-Disease 1 0.9998989105224609
) O 0 1.6203177688467463e-11
is O 0 1.3328566765904992e-12
likely O 0 5.981905509128138e-13
to O 0 1.2044957587754868e-13
be O 0 1.0781004994991905e-12
caused O 0 1.9508486839847627e-11
by O 0 1.9926664485137024e-12
homozygosity O 0 1.1157206714074164e-08
for O 0 8.886118230133633e-11
a O 0 3.035097451142832e-10
Cys282Tyr O 0 3.1833980784767846e-08
mutation O 0 2.9621086833353516e-11
in O 0 1.604054215842421e-11
the O 0 3.8108821653892733e-10
HFE O 0 1.001154373625468e-06
gene O 0 4.784185825279508e-10
located O 0 5.593845386897556e-10
4 O 0 4.2489674001444655e-08
. O 0 1.530470150612473e-08

5 O 0 4.904823981632944e-06
Mb O 0 4.361957689980045e-05
telomeric O 0 4.202360287308693e-06
to O 0 1.0325187815851677e-08
HLA O 0 8.436770440312102e-05
- O 0 1.497002131145564e-06
A O 0 2.067802142846631e-07
. O 0 9.74569935863201e-09

Population O 0 3.1637810427032065e-11
studies O 0 3.192221487147151e-11
of O 0 9.452551241739826e-11
this O 0 9.201680216397445e-13
polymorphism O 0 3.016352723150817e-10
are O 0 4.513330085099271e-13
facilitated O 0 6.1403742333820954e-12
by O 0 2.949073494087906e-12
the O 0 1.0009604950456108e-10
fact O 0 7.611562422016327e-12
that O 0 1.568947012239863e-12
the O 0 3.0585284305217897e-10
Cys282Tyr O 0 2.7888597742276033e-07
mutation O 0 4.041381895802942e-09
creates O 0 6.070417502002101e-10
a O 0 1.2412642025338982e-09
Rsal O 0 1.132588295149617e-06
restriction O 0 1.869625378958517e-07
site O 0 4.057030622561797e-08
. O 0 6.786370132516595e-09

We O 0 4.592010327542084e-09
have O 0 9.191336060310196e-12
studied O 0 4.437435696669212e-10
the O 0 5.925183677035761e-10
codon O 0 5.612679210287297e-09
282 O 0 4.076031512312284e-09
( O 0 6.529202511984522e-09
Cys O 0 0.006262292619794607
/ O 0 2.016904909396544e-05
Tyr O 0 2.3427155326771754e-07
) O 0 1.7923440509548527e-12
polymorphism O 0 2.440750206111897e-11
in O 0 2.0408397194415784e-12
different O 0 5.224781111229371e-13
ethnic O 0 5.873368458253481e-10
groups O 0 1.5658879748414734e-09
. O 0 1.1549267320276613e-08

In O 0 2.371078333673893e-10
agreement O 0 7.634397003464244e-10
with O 0 6.532256506541767e-12
previous O 0 1.2036507346380176e-09
observations O 0 8.057504108371916e-10
the O 0 1.1899369489754008e-08
Tyr O 0 2.059762067574411e-07
allele O 0 7.78212161378633e-10
appeared O 0 9.675515943996515e-10
to O 0 3.5202873602258045e-12
be O 0 4.270864044364497e-12
rare O 0 2.725951964155371e-10
or O 0 9.528486333287844e-11
absent O 0 6.298119803460622e-09
in O 0 4.229506675446082e-11
Asiatic O 0 4.195134550855073e-08
( O 0 2.0629527600068975e-11
Indian O 0 1.304219371389692e-10
, O 0 2.3200330545591896e-11
Chinese O 0 1.2692483175591462e-10
) O 0 3.704156339295883e-12
populations O 0 1.0256635818439719e-10
. O 0 1.2067309373975377e-09

The O 0 1.1601327898347336e-08
highest O 0 7.601824059122464e-09
allele O 0 1.762142341765749e-11
frequency O 0 2.377880947701527e-10
( O 0 4.6597998897002224e-12
7 O 0 3.0771593606537806e-10
. O 0 9.523244822937094e-13
5 O 0 1.392542331446478e-11
% O 0 4.796174850503487e-13
) O 0 5.854734421882266e-14
was O 0 2.0461375649372116e-11
found O 0 5.727957604756417e-12
in O 0 6.15660855629585e-11
Swedes O 0 1.488264587123922e-07
. O 0 6.093902271686602e-08

Saamis O 0 3.682596798171289e-05
( O 0 3.7645686568055226e-09
2 O 0 7.46150519148614e-09
% O 0 2.4825745625900453e-11
) O 0 9.793269710803298e-13
and O 0 9.7804134582824e-12
Mordvinians O 0 1.0228279556656616e-08
( O 0 4.734860073463132e-12
1 O 0 1.0830687041663012e-10
. O 0 3.417096792156238e-13
8 O 0 1.1397227779597063e-11
% O 0 3.522380954620874e-13
) O 0 4.165707356970291e-14
had O 0 2.892827687464572e-12
significantly O 0 6.533349707592284e-13
lower O 0 2.101804147391917e-11
frequencies O 0 1.6838037908417647e-11
of O 0 4.779197038118355e-10
the O 0 3.359631461918866e-09
Tyr O 0 2.999483115218027e-07
allele O 0 3.892018707318812e-09
. O 0 4.030942690746997e-09

Comparisons O 0 4.3427275664420506e-10
with O 0 3.481306172156695e-12
allele O 0 2.7224330428898824e-11
frequencies O 0 1.5608025288882388e-11
based O 0 2.773686879134485e-12
on O 0 2.274089111464761e-10
prevalence O 0 3.7107665828983727e-09
estimates O 0 1.5611329937104124e-11
of O 0 9.164365100122751e-11
HH B-Disease 0 0.008208191953599453
showed O 0 7.105088428716044e-08
some O 0 6.777589340450918e-12
disagreements O 0 2.8119053752106993e-09
with O 0 1.0350924110891224e-11
the O 0 7.855613937124417e-10
RFLP O 0 1.3780912411220925e-08
data O 0 3.934470804711765e-10
, O 0 1.1669776256439945e-11
particularly O 0 1.7077478320359774e-11
in O 0 2.6883317794101913e-10
Finns O 0 1.75372662170048e-07
. O 0 2.9405644141888843e-08

The O 0 1.1750741890637073e-07
newly O 0 1.3189959702231135e-07
described O 0 1.5251723439746456e-08
HFE O 0 0.00020908055012114346
marker O 0 2.609224338812055e-07
provides O 0 1.1903125707313222e-10
a O 0 1.7774202248910242e-11
new O 0 2.1560343788085135e-11
approach O 0 7.949665231654635e-11
to O 0 8.375269336564906e-13
the O 0 1.1531135421516403e-11
screening O 0 4.4977996327411063e-10
of O 0 2.34561425838109e-10
HH B-Disease 0 7.4302038228779566e-06
as O 0 1.293290058379526e-10
well O 0 2.7692993297828705e-12
as O 0 3.848149555084335e-13
studies O 0 6.379522019157868e-13
of O 0 5.651903424441773e-12
the O 0 2.813081148231311e-12
relationship O 0 2.1830534070992752e-13
between O 0 1.5004338049795507e-11
the O 0 2.4486515037835943e-09
HFE O 0 4.235273809172213e-05
Tyr O 0 8.582806287904532e-08
allele O 0 2.128228010489508e-10
and O 0 1.379285661379237e-11
different O 0 6.254598228228048e-11
disorders O 1 0.9999992847442627
including O 0 8.454406952296267e-07
cancer B-Disease 1 0.9999979734420776

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999686479568481
associated O 0 2.8410748753593396e-10
with O 0 1.2041770575468846e-12
a O 0 3.3535778320992193e-11
missense O 0 5.512606482405147e-10
mutation O 0 2.7814124267666607e-11
encoding O 0 3.321633593178497e-11
Gly23 O 0 5.817871624458348e-07
- O 0 1.7087007790905773e-06
- O 0 3.909255212874996e-07
> O 0 7.432120696648781e-08
Val O 0 9.302160819402161e-09
in O 0 1.0175095210840368e-09
neurophysin O 0 5.490363037097268e-06
II O 0 0.0005763666122220457
. O 0 1.5388805252314341e-07

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 1.7067572244400253e-08
ADNDI B-Disease 1 0.951468825340271
) O 0 3.0773792802224476e-12
is O 0 2.7632618957752764e-13
an O 0 2.9801675450330523e-12
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 7.678654583287425e-06
by O 0 2.950931859979633e-11
progressive O 1 0.9999970197677612
degeneration O 1 1.0
of O 0 7.558488164249866e-07
the O 0 2.7177300410130556e-09
magnocellular O 0 3.112645430292105e-08
neurons O 0 3.3477175892526745e-11
of O 0 9.217183266629903e-11
the O 0 1.1381332681859035e-10
hypothalamus O 0 1.7583830225209596e-10
leading O 0 2.680038135860485e-10
to O 0 1.904021428369984e-12
decreased O 0 1.0919401494113856e-10
ability O 0 2.221539141880613e-12
to O 0 1.1017045565761552e-12
produce O 0 8.081586788666328e-11
the O 0 1.8162368276009033e-09
hormone O 0 5.236803879427043e-09
arginine O 0 1.2122729486918615e-08
vasopressin O 0 5.3732960303420896e-09
( O 0 2.758694939153372e-10
AVP O 0 3.207314023256913e-07
) O 0 8.726003947190364e-11
. O 0 1.3991250380485099e-09

Affected O 0 4.096680328302682e-08
individuals O 0 1.5887870880026966e-11
are O 0 2.1319636594324676e-12
not O 0 1.7405659162236797e-12
symptomatic O 0 1.2268897009448665e-09
at O 0 7.676010382873244e-10
birth O 0 1.311443953433411e-09
, O 0 1.4851573746851865e-12
but O 0 2.6805771144444712e-12
usually O 0 9.464042743934087e-11
develop O 0 3.043817002890137e-07
diabetes B-Disease 1 1.0
insipidus I-Disease 1 0.9999102354049683
at O 0 2.2530048227054067e-06
1 O 0 4.522114977589808e-06
- O 0 1.4698488826070388e-07
6 O 0 2.5082133703335785e-08
yr O 0 1.3552393340887647e-07
of O 0 1.6499090982335929e-09
age O 0 7.30828775274972e-09
. O 0 7.888049324833446e-09

The O 0 2.1746464629046613e-09
genetic O 0 1.439688479543122e-09
locus O 0 7.050004469100202e-10
of O 0 1.3218306449402917e-09
the O 0 7.36962713077105e-09
disease O 0 0.00015186684322543442
is O 0 6.560103155139885e-11
the O 0 1.7606465618769107e-08
AVP O 0 0.0382208451628685
- O 0 1.4425224890146637e-06
neurophysin O 0 0.0005016589420847595
II O 1 0.9999394416809082
( O 0 1.949533867673381e-09
NPII O 0 9.018148375616875e-06
) O 0 6.418630817822679e-12
gene O 0 1.5968195515858596e-11
, O 0 1.6537187201223769e-12
and O 0 8.180013090497429e-12
mutations O 0 2.3115611855195617e-11
that O 0 3.6704758156480555e-12
cause O 0 1.483057143758515e-08
ADNDI B-Disease 1 0.9037073850631714
have O 0 1.497229076830031e-11
been O 0 1.1214791031596838e-12
found O 0 4.3004255755388354e-14
in O 0 3.95953174490548e-14
both O 0 2.0816067782241515e-13
the O 0 6.929044577691501e-12
signal O 0 5.070650010985389e-10
peptide O 0 8.347115360018975e-11
of O 0 6.265514773673431e-10
the O 0 1.8983130622984845e-09
prepro O 0 5.160893124411814e-05
- O 0 0.00070628069806844
AVP O 0 0.0014676220016553998
- O 0 3.935803931653936e-07
NPII O 0 1.860536212916486e-05
precursor O 0 1.6303465599776246e-07
and O 0 8.70597594015976e-10
within O 0 1.1041533021227679e-08
NPII O 0 9.820779087021947e-05
itself O 0 1.8030186765827239e-07
. O 0 5.449126305734353e-08

An O 0 3.5112313057084066e-10
affected O 0 3.208039611735103e-09
girl O 0 6.069111879725142e-09
who O 0 8.888237368331886e-11
presented O 0 1.227793311464609e-09
at O 0 3.5200846681959774e-09
9 O 0 4.321912550064866e-10
months O 0 3.136615099597062e-12
of O 0 5.153426990700538e-11
age O 0 1.4484989596663667e-10
and O 0 1.1831259583150455e-10
her O 0 3.941484291725139e-11
similarly O 0 3.649626989510324e-10
affected O 0 2.52808551870487e-10
younger O 0 2.007821339744531e-11
brother O 0 8.670165696500476e-10
and O 0 5.068889752379846e-10
father O 0 5.569051331200114e-10
were O 0 1.0513631631958731e-10
all O 0 7.48789832222263e-12
found O 0 7.312135380695139e-13
to O 0 2.520334743856545e-13
have O 0 2.994325165421585e-13
a O 0 1.5905295743662284e-12
novel O 0 7.951966342345518e-12
missense O 0 6.361500215490423e-10
mutation O 0 1.1403229055462205e-11
( O 0 1.1577585678351765e-12
G1758 O 0 2.3892339218178904e-09
- O 0 4.201259784508693e-08
- O 0 3.074827503724009e-08
> O 0 4.7513233347729056e-09
T O 0 2.322141506860831e-10
) O 0 4.889795843622882e-15
encoding O 0 1.0369607733248798e-13
the O 0 1.4059371722385805e-11
amino O 0 7.110813327049215e-11
acid O 0 1.5827528523915113e-11
substitution O 0 5.532894697957147e-10
Gly23 O 0 2.5273268988712516e-07
- O 0 1.01325554169307e-07
- O 0 3.563938122397303e-08
> O 0 2.37988420082047e-08
Val O 0 3.014877592022458e-08
within O 0 3.277834892401188e-08
NPII O 0 0.00010412958363303915
. O 0 5.975887518161471e-08

The O 0 5.1677663037708044e-08
mutation O 0 1.5012910914435906e-09
was O 0 4.54934312443811e-10
confirmed O 0 4.8699620724956816e-11
by O 0 5.798816288260511e-12
restriction O 0 1.6125315527304451e-09
endonuclease O 0 1.3935514964202866e-08
analysis O 0 7.243421418223761e-10
. O 0 2.5625064292711386e-09

A O 0 3.982375801570015e-06
T1 O 0 1.6223817738136859e-06
- O 0 9.753170493453922e-10
weighted O 0 9.869392803008026e-11
magnetic O 0 1.969670086754416e-11
resonance O 0 1.6177330308675408e-11
imaging O 0 3.9492711323418916e-08
of O 0 2.584762626156589e-07
the O 0 1.0587050383037422e-06
fathers O 0 5.040579367232567e-07
pituitary O 0 1.070568396244198e-05
gland O 0 3.6719816876029654e-07
demonstrates O 0 1.8301115067842488e-09
an O 0 3.26946282547258e-11
attenuated O 0 1.5893355964635703e-07
posterior O 0 1.1337603211813985e-07
pituitary O 0 0.12113678455352783
bright O 0 5.747132036049152e-06
spot O 0 2.011178912653122e-05
. O 0 1.893883627701598e-08

This O 0 1.2908755175899955e-09
mutation O 0 1.5341284909098363e-09
may O 0 1.9131486325707492e-11
be O 0 9.498809074373615e-13
valuable O 0 2.1292286510321556e-12
for O 0 2.38099064119382e-13
developing O 0 3.789488688121789e-12
models O 0 5.208307309739757e-12
of O 0 1.3197944126464023e-10
dominantly B-Disease 0 6.1990948552193e-07
inherited I-Disease 0 6.92800895194523e-05
neurodegeneration I-Disease 1 1.0
, O 0 5.982277173632866e-11
as O 0 7.85516725450297e-13
the O 0 1.18786642848423e-12
early O 0 3.485998642527299e-11
age O 0 7.71120667319991e-12
of O 0 4.3511080155544946e-11
onset O 0 0.07382681965827942
of O 0 5.413581902757869e-07
symptoms O 0 0.0016787025379016995
suggests O 0 9.772437720156901e-11
that O 0 4.510963542807278e-13
this O 0 1.5243142035062385e-12
mutation O 0 7.065509288750604e-11
may O 0 1.926554575593098e-11
be O 0 1.1806435169792184e-11
particularly O 0 9.398540973259983e-12
deleterious O 0 5.651919487981161e-10
to O 0 2.696233340759857e-11
the O 0 2.2454753612066725e-09
magnocellular O 0 5.223678272159304e-07
neuron O 0 1.245441172414985e-08
. O 0 2.443882041180956e-10
. O 0 2.1678878692199532e-09

Frequent O 0 3.264177905748511e-08
inactivation O 0 1.5418583643622696e-05
of O 0 2.009599938901374e-06
PTEN O 1 0.999842643737793
/ O 0 0.15526333451271057
MMAC1 O 0 0.40590372681617737
in O 0 1.4869063313938113e-08
primary O 1 0.999997615814209
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.9494179873145185e-06

Sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 1.2557240580690632e-08
the O 0 8.458215239315336e-10
most O 0 1.2729911742781486e-11
common O 0 3.082012867139383e-09
male B-Disease 0 2.1541888065024217e-11
cancer I-Disease 0 1.5795027785703297e-10
in O 0 1.1816572026424055e-11
the O 0 3.2131144966918157e-10
Western O 0 3.942834059245115e-09
world O 0 3.778968804546423e-10
, O 0 1.505618871765202e-12
yet O 0 3.083360389927181e-12
many O 0 4.9772902813161046e-14
of O 0 2.2543121883100703e-12
the O 0 4.158400186693445e-12
major O 0 7.5605910421217e-11
genetic O 0 7.06642591663531e-11
events O 0 3.2535794804861018e-12
involved O 0 1.6939715689195944e-13
in O 0 5.105657108032957e-13
the O 0 1.7432213658685747e-11
progression O 0 1.0311608455992882e-08
of O 0 6.164977417455475e-10
this O 0 1.6762614907239737e-10
often O 0 1.3586700653434036e-09
fatal O 0 0.14263670146465302
cancer B-Disease 0 1.2544857781904284e-05
remain O 0 1.5177867851434712e-08
to O 0 2.620881116299767e-11
be O 0 3.777909651780931e-10
elucidated O 0 3.641815169430629e-07
. O 0 9.442721271568644e-09

Numerous O 0 5.115600831828715e-09
cytogenetic O 0 5.660427177645033e-06
and O 0 1.9104267057201696e-09
allelotype O 0 1.5326938864745898e-06
studies O 0 5.891983012595858e-10
have O 0 2.432277036029662e-12
reported O 0 6.366300715765494e-12
frequent O 0 6.42034897468946e-11
loss O 0 2.4208210991361057e-09
of O 0 6.422363529878794e-09
heterozygosity O 0 4.009167696494842e-06
on O 0 2.65993094217265e-07
chromosomal O 1 0.9992252588272095
arm O 0 1.7234971210200456e-06
10q O 0 1.4305773277101252e-07
in O 0 2.2423423118311803e-09
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.5475962982236524e-06

Deletion O 0 3.1885694085076466e-08
mapping O 0 1.1275339772964799e-08
studies O 0 9.807641365711106e-10
have O 0 3.672493906203833e-11
unambiguously O 0 2.0628840857739306e-09
identified O 0 1.0991765136969534e-10
a O 0 6.904997407186642e-11
region O 0 4.239823214735594e-10
of O 0 2.0457378013816196e-09
chromosome O 0 2.187439562817417e-08
10q23 O 0 1.2114591996237323e-08
to O 0 1.3827099187846414e-11
be O 0 2.6186214654999596e-12
the O 0 8.122643183061662e-12
minimal O 0 1.0451342014050624e-08
area O 0 8.479957847029596e-10
of O 0 6.696322940591415e-10
loss O 0 4.675816711596781e-08
. O 0 3.835540951513394e-08

A O 0 2.5003325276884425e-07
new O 0 2.3540596139071113e-09
tumor B-Disease 0 2.3442526142503084e-08
suppressor O 0 3.144588234249568e-08
gene O 0 7.354513664736828e-10
, O 0 7.55492543524916e-11
PTEN O 0 4.107053428015206e-06
/ O 0 7.211114620986336e-07
MMAC1 O 0 4.375890057417564e-05
, O 0 3.39798571225014e-11
was O 0 9.569325332137169e-10
isolated O 0 1.6939976088536923e-09
recently O 0 1.1593839777113146e-10
at O 0 1.9644111337591141e-10
this O 0 7.017153243020491e-13
region O 0 2.921034247815868e-11
of O 0 6.413873598898334e-11
chromosome O 0 1.5022573407463824e-08
10q23 O 0 4.8964114540694936e-08
and O 0 9.276283213788261e-11
found O 0 5.064400721704887e-12
to O 0 1.1158093763188881e-13
be O 0 1.670708113955116e-13
inactivated O 0 1.2210527033928997e-10
by O 0 3.7489970980061904e-13
mutation O 0 2.2708805322291248e-11
in O 0 2.2100319838069815e-11
three O 0 3.6827689342544545e-08
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9991645812988281
lines O 0 1.4113530788506523e-08
. O 0 9.951302004651552e-10

We O 0 4.024430211302388e-08
screened O 0 9.354755547974491e-07
80 O 0 3.3525890330565744e-07
prostate B-Disease 1 0.9907461404800415
tumors I-Disease 1 1.0
by O 0 8.748948614190066e-12
microsatellite O 0 3.965588746268622e-09
analysis O 0 1.900459477288674e-11
and O 0 2.5049918736530508e-11
found O 0 6.043262678473438e-12
chromosome O 0 5.557220239538196e-10
10q23 O 0 1.4633536604691244e-09
to O 0 2.2198584984089997e-11
be O 0 7.549563404984916e-12
deleted O 0 1.0265123820407673e-11
in O 0 1.3446690592597288e-12
23 O 0 5.814959069816439e-10
cases O 0 8.751288582686811e-11
. O 0 2.5333770636848385e-09

We O 0 2.2074182481901516e-09
then O 0 1.9012316027078313e-11
proceeded O 0 5.123961584890813e-12
with O 0 1.4307389366134682e-14
sequence O 0 2.8235728100241275e-13
analysis O 0 4.48464345086802e-13
of O 0 6.333457369667173e-11
the O 0 2.801026632859305e-10
entire O 0 4.88405937915104e-09
PTEN O 0 4.360920229373733e-06
/ O 0 3.585812180517678e-07
MMAC1 O 0 3.763870608963771e-06
coding O 0 2.5205959985896698e-08
region O 0 7.503231369554442e-10
and O 0 9.794788244366082e-12
tested O 0 4.845619131638168e-12
for O 0 9.660307493178366e-13
homozygous O 0 1.4633110001494032e-10
deletion O 0 4.368020875555878e-11
with O 0 7.843309877443583e-13
new O 0 4.2028724250853244e-11
intragenic O 0 6.652520756489366e-09
markers O 0 1.532864113418242e-10
in O 0 4.475767412942533e-12
these O 0 4.153610506756056e-13
23 O 0 5.5544728538858834e-11
cases O 0 1.3577302259912272e-12
with O 0 4.073569606632965e-12
10q23 O 0 5.964978555539346e-08
loss O 0 5.92129190124524e-08
of O 0 5.6697729178267764e-08
heterozygosity O 0 2.5583780370652676e-05
. O 0 1.294365432613631e-07

The O 0 2.1795381055511598e-09
identification O 0 1.5001518915980228e-09
of O 0 1.2591074849410688e-09
the O 0 4.0091721609236686e-10
second O 0 1.8811456836687057e-09
mutational O 0 6.600324553573955e-08
event O 0 3.692212757755442e-09
in O 0 7.743369834223301e-11
10 O 0 1.4821874283477143e-10
( O 0 2.8222172862579775e-12
43 O 0 1.702538526826558e-10
% O 0 1.870161664419001e-10
) O 0 5.828239557637005e-10
tumors B-Disease 1 1.0
establishes O 0 2.1570829744632647e-07
PTEN O 0 0.0016189340967684984
/ O 0 1.1466320302133681e-06
MMAC1 O 0 1.8323954691368272e-06
as O 0 1.5077347356728943e-11
a O 0 3.569774684186733e-12
main O 0 1.7886610248485368e-10
inactivation O 0 5.0848703025963005e-09
target O 0 2.7972896221584165e-10
of O 0 6.04138683524269e-11
10q O 0 2.0114429233331066e-08
loss O 0 2.6298172528527175e-09
in O 0 1.3450654479107982e-10
sporadic B-Disease 1 0.9999998807907104
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.6665525848225116e-08
. O 0 4.029036215769111e-09

Risk O 0 5.628548649383447e-08
reversals O 0 6.019456044725757e-10
in O 0 9.782502932709214e-12
predictive O 0 8.03471345012241e-10
testing O 0 7.0184129619121904e-09
for O 0 7.2895356417745916e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.1556918622090961e-07

The O 0 1.5619824877965982e-10
first O 0 1.0286447908736118e-11
predictive O 0 2.4189922287476406e-10
testing O 0 2.213599081812845e-09
for O 0 9.278664059308994e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 3.9929969053442704e-12
HD B-Disease 0 4.274505194246103e-09
) O 0 6.294200864719393e-14
was O 0 1.2654977976991888e-12
based O 0 1.3158763900560089e-13
on O 0 3.489351516061667e-11
analysis O 0 2.9645771514735797e-12
of O 0 1.6104437228214863e-10
linked O 0 1.5236421013753443e-09
polymorphic O 0 3.2685668061027684e-10
DNA O 0 2.265625048680775e-10
markers O 0 2.1632513488856198e-11
to O 0 1.3897794590503332e-12
estimate O 0 1.4776308648878356e-11
the O 0 9.631243719221416e-12
likelihood O 0 5.719837797846239e-11
of O 0 2.1873580724474095e-10
inheriting O 0 2.651331654224265e-10
the O 0 1.790982501193028e-10
mutation O 0 3.570634413141427e-11
for O 0 1.500940344234536e-11
HD B-Disease 0 2.3471952772524673e-06
. O 0 1.8365676979215095e-08

Limits O 0 1.273051264405467e-08
to O 0 2.8843444993542633e-11
accuracy O 0 2.5611271436964955e-10
included O 0 9.97401813918053e-12
recombination O 0 9.831205944818566e-13
between O 0 5.084978878938662e-12
the O 0 8.449632660223472e-11
DNA O 0 1.2032598528666227e-10
markers O 0 2.418049788177612e-11
and O 0 1.0273741926636326e-11
the O 0 1.4512145651845998e-10
mutation O 0 5.2324949928461706e-11
, O 0 1.1367420026109354e-11
pedigree O 0 1.76043665756076e-10
structure O 0 9.595296779352225e-10
, O 0 9.73091832806583e-12
and O 0 8.514891916555634e-12
whether O 0 3.2150545246911744e-12
DNA O 0 8.325172495826649e-11
samples O 0 3.460234486094005e-12
were O 0 1.1574655296719971e-11
available O 0 1.0916210643752144e-11
from O 0 3.088117608851526e-11
family O 0 1.2075822286572446e-10
members O 0 2.500205598110483e-10
. O 0 6.9298482507917925e-09

With O 0 4.642874626425986e-11
direct O 0 4.294860300735337e-10
tests O 0 8.694023972966036e-11
for O 0 6.180559536383967e-12
the O 0 6.08127298518113e-11
HD B-Disease 0 1.2324539966357406e-07
mutation O 0 3.2627723439704326e-11
, O 0 1.4782616320277442e-12
we O 0 1.754146957896885e-12
have O 0 7.120751200056369e-14
assessed O 0 2.774305958574974e-12
the O 0 7.60775502924721e-13
accuracy O 0 3.974292422936898e-11
of O 0 1.3654726654932503e-11
results O 0 1.2527598316353084e-12
obtained O 0 5.227632020841921e-13
by O 0 7.946351909815519e-13
linkage O 0 1.2953644823454624e-09
approaches O 0 1.1458461263158526e-10
when O 0 1.3645900381886733e-11
requested O 0 2.0376667367316692e-11
to O 0 1.2104941181367845e-11
do O 0 1.0565128633066578e-11
so O 0 3.556065760867283e-13
by O 0 1.546279380579274e-12
the O 0 1.4694417904692614e-10
test O 0 1.3153168554325134e-09
individuals O 0 1.3412885385699624e-11
. O 0 6.491824855459072e-09

For O 0 4.025794364537205e-09
six O 0 2.8313265620916184e-10
such O 0 1.2626559520168001e-11
individuals O 0 4.21816715671236e-13
, O 0 1.554529833851237e-12
there O 0 2.5982629676263302e-12
was O 0 6.657998458114989e-11
significant O 0 6.922624366106911e-12
disparity O 0 2.457651616938339e-11
between O 0 4.677163170652143e-12
the O 0 3.608683352140929e-10
tests O 0 1.675082850205456e-09
. O 0 2.0718666782215678e-09

Three O 0 4.787353291568763e-10
went O 0 3.2879690636811176e-10
from O 0 6.23449035452861e-12
a O 0 3.206672080646733e-11
decreased O 0 2.0815551504682617e-09
risk O 0 8.098823001123634e-11
to O 0 2.6521672228177473e-13
an O 0 1.1823120336495324e-13
increased O 0 4.726796037912706e-11
risk O 0 2.7174074102020995e-10
, O 0 2.519109324351093e-13
while O 0 1.2996134929939979e-13
in O 0 2.0541791737656995e-13
another O 0 3.189578809403848e-12
three O 0 4.147611941396345e-12
the O 0 2.0960921887080985e-10
risk O 0 1.9589232458372408e-09
was O 0 3.86450826894702e-09
decreased O 0 2.2194766913230524e-08
. O 0 8.876928525580752e-09

Knowledge O 0 8.632156323074014e-08
of O 0 1.0547208262323693e-07
the O 0 1.0770128122672418e-09
potential O 0 1.299379909225351e-10
reasons O 0 5.580681403105636e-11
for O 0 8.553499163295453e-13
these O 0 4.77648960152139e-14
changes O 0 5.501925954762288e-13
in O 0 3.159043935729161e-13
results O 0 2.881566079498965e-12
and O 0 6.778141416197148e-13
impact O 0 3.510740656520461e-11
of O 0 1.5563076868896353e-11
these O 0 4.838902173918969e-13
risk O 0 6.54974815703091e-12
reversals O 0 1.1048131159929753e-11
on O 0 1.8631939047164536e-10
both O 0 2.1999509852710375e-11
patients O 0 1.2405647689672783e-11
and O 0 1.489521353481571e-11
the O 0 4.906646200453224e-09
counseling O 0 2.8256632589318542e-09
team O 0 2.875034585403391e-11
can O 0 2.9597898025708613e-13
assist O 0 6.321723092922449e-12
in O 0 4.0337590039019044e-12
the O 0 4.9333672563767195e-11
development O 0 1.957349837766742e-10
of O 0 1.531156972045533e-11
strategies O 0 1.794578721736606e-11
for O 0 3.1279521073984684e-12
the O 0 1.171496510909975e-10
prevention O 0 2.369542118074719e-09
and O 0 4.664030121316609e-13
, O 0 2.002239655541152e-13
where O 0 1.0622204071192298e-12
necessary O 0 1.0873948269596312e-10
, O 0 1.0948531144194806e-11
management O 0 8.976562271278965e-10
of O 0 4.55241566665876e-10
a O 0 2.9343649732282984e-10
risk O 0 1.409546507291637e-10
reversal O 0 2.6613114489926204e-11
in O 0 8.844141239673642e-13
any O 0 8.281157010125995e-12
predictive O 0 4.34036778740321e-10
testing O 0 1.7150515452257764e-09
program O 0 4.779516227237934e-10
. O 0 5.4864428972178914e-11
. O 0 1.3617521554820655e-09

A O 0 4.202237491313099e-08
novel O 0 6.070834390747848e-10
common O 0 3.0138799789192205e-10
missense O 0 6.499642601909272e-09
mutation O 0 3.408624771328306e-11
G301C O 0 2.337695592657951e-10
in O 0 1.627720874752825e-11
the O 0 1.504357471926454e-10
N O 0 2.885653138662292e-08
- O 0 9.27684062901335e-09
acetylgalactosamine O 0 5.852596700606227e-07
- O 0 5.828934490637039e-08
6 O 0 6.052871981410135e-08
- O 0 7.189839390520092e-09
sulfate O 0 1.2992195097538684e-09
sulfatase O 0 3.575813707357156e-07
gene O 0 9.168076298138317e-10
in O 0 3.3541747157528334e-10
mucopolysaccharidosis B-Disease 0 1.2588587196660228e-05
IVA I-Disease 1 1.0
. O 0 1.6226836123678368e-06

Mucopolysaccharidosis B-Disease 1 0.9983739852905273
IVA I-Disease 1 1.0
( O 1 0.9992340803146362
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 5.474842246222522e-10
is O 0 2.845079206947876e-12
an O 0 5.004014997506134e-12
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 3.750930588353185e-08
by O 0 4.174086857405834e-12
a O 0 6.0029372583869645e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 2.091325113084963e-09
N O 0 2.1489684343123372e-07
- O 0 6.141929631553467e-09
acetylgalactosamine O 0 4.3671570892911404e-07
- O 0 3.0004844830955335e-08
6 O 0 1.0216039214583361e-07
- O 0 2.0184604210271573e-08
sulfate O 0 4.083470450666482e-09
sulfatase O 0 4.680417532654246e-06
( O 0 6.191668844302001e-10
GALNS O 0 1.0038015716418158e-05
) O 0 3.9818515151779366e-10
. O 0 2.72900191333747e-09

In O 0 2.6243254236391067e-09
previous O 0 2.236525808996248e-08
studies O 0 6.633562588120867e-10
, O 0 2.6646701511978677e-10
we O 0 2.0836556091641256e-10
have O 0 7.846336427808076e-12
found O 0 3.6224443583643406e-12
two O 0 5.427609316849269e-13
common O 0 2.2711522332935496e-12
mutations O 0 1.4171416861177843e-12
in O 0 5.257833664978895e-12
Caucasians O 0 4.199156578010843e-10
and O 0 1.1627916511602887e-11
Japanese O 0 7.621670405910663e-09
, O 0 6.775770916567225e-11
respectively O 0 4.454295599032321e-09
. O 0 2.465152881825361e-08

To O 0 1.1597516280659192e-09
characterize O 0 4.841385958798128e-09
the O 0 1.3928863618062337e-09
mutational O 0 1.0971734809572808e-07
spectrum O 0 1.0341264511382064e-09
in O 0 2.3661784337436487e-12
various O 0 1.9032334302310217e-12
ethnic O 0 2.884360979227285e-11
groups O 0 5.07233751528835e-12
, O 0 1.1847868606335021e-12
mutations O 0 1.7392682346434318e-12
in O 0 9.336541956228572e-12
the O 0 4.438561740371938e-10
GALNS O 0 9.473308182350593e-07
gene O 0 3.9355516068262375e-10
in O 0 5.517569040547343e-11
Colombian O 0 3.634477707237238e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 5.272119665278296e-07
were O 0 1.1949256861765178e-10
investigated O 0 1.1540184086111793e-10
, O 0 5.783760189531639e-12
and O 0 1.936368600186089e-11
genetic O 0 4.20129797618074e-09
backgrounds O 0 1.271070193542556e-10
were O 0 1.8914116800550218e-11
extensively O 0 5.4067718184558355e-12
analyzed O 0 5.444907545670841e-12
to O 0 1.2993217612944363e-12
identify O 0 5.307284559746828e-12
racial O 0 2.1461383017951086e-11
origin O 0 8.002476719476403e-13
, O 0 5.87362528948511e-14
based O 0 2.0349692796736013e-13
on O 0 1.20630228028773e-10
mitochondrial O 0 1.017004536141286e-10
DNA O 0 1.6432595562054786e-10
( O 0 2.867240516193914e-12
mtDNA O 0 5.256562893296568e-11
) O 0 1.555826995014442e-11
lineages O 0 2.095397855228498e-09
. O 0 1.2630118284562286e-08

Three O 0 3.821511107560127e-09
novel O 0 2.5902113787168446e-09
missense O 0 1.0298324326640795e-07
mutations O 0 8.235894743968686e-10
never O 0 5.276202807991126e-10
identified O 0 3.537816914422898e-11
previously O 0 5.305830080848395e-11
in O 0 3.6013980426324865e-12
other O 0 1.1643135457498066e-12
populations O 0 4.92580498959172e-12
and O 0 2.1159777489204723e-12
found O 0 7.599605081516636e-13
in O 0 2.5274125240587475e-12
16 O 0 7.874331742208085e-11
out O 0 3.029299033840971e-12
of O 0 8.892849651109813e-11
19 O 0 6.6210259497268e-09
Colombian O 0 1.2784743375959806e-05
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
unrelated O 0 4.0463660866407736e-08
alleles O 0 2.7106195760184804e-11
account O 0 3.88376613855157e-12
for O 0 5.276723502589675e-11
84 O 0 6.947042408000925e-08
. O 0 4.825936628094496e-08

2 O 0 9.869143013929715e-08
% O 0 1.0696586671965491e-10
of O 0 4.756625648916213e-10
the O 0 8.306203641561538e-11
alleles O 0 1.6964718475495633e-12
in O 0 3.667214535513219e-12
this O 0 5.871290433001608e-12
study O 0 5.0654275912664914e-11
. O 0 1.337825294989159e-09

The O 0 9.394364752779438e-08
G301C O 0 3.096999989793403e-07
and O 0 1.5153649446375539e-09
S162F O 0 2.5414800930434467e-08
mutations O 0 9.808851647585826e-11
account O 0 1.3073243876338125e-11
for O 0 9.094157371603018e-11
68 O 0 1.5983432888333482e-07
. O 0 4.6200639758353645e-08

4 O 0 6.883112746436382e-07
% O 0 2.7679094571908536e-09
and O 0 1.076866928961806e-09
10 O 0 1.4912092893837325e-08
. O 0 2.8399888662988815e-08

5 O 0 3.5291147781890686e-08
% O 0 1.0842508835207099e-10
of O 0 3.0636196357569645e-10
mutations O 0 4.2660059512700244e-11
, O 0 1.0092146736362384e-11
respectively O 0 6.314713335564548e-11
, O 0 1.7024890178185537e-11
whereas O 0 8.194586675891458e-11
the O 0 6.320234335888131e-10
remaining O 0 1.7069069713215868e-08
F69V O 0 1.2267320016690064e-05
is O 0 2.281338659648746e-11
limited O 0 1.6647138528780303e-11
to O 0 3.1148187328022825e-12
a O 0 6.404179964114576e-11
single O 0 1.1657551590715798e-09
allele O 0 3.266324766215689e-09
. O 0 1.2742830790557491e-08

The O 0 1.3085114325406266e-08
skewed O 0 1.26564214664171e-09
prevalence O 0 2.607356774930736e-09
of O 0 1.2595056941844263e-10
G301C O 0 6.959608445100685e-10
in O 0 1.3431394017826559e-11
only O 0 7.513563556049707e-12
Colombian O 0 6.989237189003461e-09
patients O 0 1.217001759784564e-11
and O 0 2.1861880795254196e-12
haplotype O 0 3.085309438488615e-11
analysis O 0 9.21212975693586e-13
by O 0 5.790744403086356e-13
restriction O 0 1.2653705340481824e-11
fragment O 0 2.3058091894179178e-12
length O 0 2.344810001546349e-13
polymorphisms O 0 2.0183571827758762e-11
in O 0 2.8477517219349657e-11
the O 0 1.0461668198402663e-09
GALNS O 0 4.7519197323708795e-06
gene O 0 8.321748290462949e-10
suggest O 0 1.4402830490756191e-11
that O 0 1.5035404019904386e-13
G301C O 0 5.602269759208411e-10
originated O 0 1.604773432195561e-11
from O 0 8.29775918115283e-12
a O 0 9.02042607275888e-11
common O 0 2.405011190198536e-10
ancestor O 0 3.812788751389462e-09
. O 0 1.717059028294443e-08

Investigation O 0 2.212363447995358e-08
of O 0 2.7432296434426462e-08
the O 0 2.405039944974874e-09
genetic O 0 5.2616737633570665e-09
background O 0 1.5812511022783582e-10
by O 0 1.579312201849259e-11
means O 0 2.398204412834559e-10
of O 0 1.3438454793401888e-09
mtDNA O 0 5.555121918021655e-10
lineages O 0 4.664256827990876e-11
indicate O 0 2.0780781609386345e-11
that O 0 1.0106960407485488e-11
all O 0 8.131362805308129e-10
our O 0 1.6742244923761973e-08
patients O 0 4.868968075943947e-11
are O 0 6.078193504066576e-13
probably O 0 8.586522118325668e-12
of O 0 8.080646568542349e-11
native O 0 3.5794123220966867e-10
American O 0 5.0031943032990966e-08
descent O 0 2.686994548639632e-06

Low O 0 1.2783191394305504e-08
frequency O 0 2.5136190906493994e-09
of O 0 3.5349740912238303e-09
BRCA1 O 0 3.957201677451394e-09
germline O 0 3.238483925471769e-09
mutations O 0 1.9738061012020136e-12
in O 0 5.635903527721753e-13
45 O 0 1.1675259370402813e-10
German O 1 0.9999572038650513
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.649804725114336e-08
. O 0 3.069934351174197e-08

In O 0 3.5172373347158725e-10
this O 0 3.72644970436653e-12
study O 0 2.936293352559516e-12
we O 0 2.2864778646825012e-12
investigated O 0 7.49133047261985e-11
45 O 0 3.083834021477827e-10
German O 1 0.9997312426567078
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.318561509977556e-10
for O 0 7.880356089895457e-11
germline O 0 1.2895719159189412e-08
mutations O 0 1.0139128252262264e-11
in O 0 1.0484649606845586e-11
the O 0 3.4836208917532474e-10
BRCA1 O 0 2.2459250015316456e-09
gene O 0 2.7314235317987823e-09
. O 0 3.0612612444969045e-09

We O 0 1.4283786375912655e-09
identified O 0 7.664068685242498e-11
four O 0 1.878289884738038e-11
germline O 0 6.2872937967028975e-09
mutations O 0 8.933527528842689e-12
in O 0 1.9035720916216192e-11
three O 0 9.56607792979014e-10
breast B-Disease 0 0.24867993593215942
cancer I-Disease 0 0.00012207491090521216
families O 0 1.8630881342893146e-13
and O 0 1.3540166167100298e-12
in O 0 6.569246813192819e-10
one O 1 0.9995627999305725
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.00015065213665366173
. O 0 7.501324561509648e-11
among O 0 2.1891243971641078e-13
these O 0 2.5176827853426453e-13
were O 0 6.369142626500013e-12
one O 0 4.2300937058703525e-12
frameshift O 0 3.761582600958491e-09
mutation O 0 6.236253874414288e-11
, O 0 1.4752877738888337e-11
one O 0 2.443750236891251e-11
nonsense O 0 3.2333917765470233e-09
mutation O 0 3.8999657669958054e-11
, O 0 6.193635014584142e-12
one O 0 1.9752372480696945e-12
novel O 0 1.7643083174978536e-11
splice O 0 3.7039427080998166e-09
site O 0 2.2680679556685845e-10
mutation O 0 2.7164317670247407e-11
, O 0 5.961748022337288e-12
and O 0 5.14717921062946e-11
one O 0 4.6274234444254603e-10
missense O 0 3.119683071872714e-07
mutation O 0 1.1893293816456207e-07
. O 0 6.783978534485868e-08

The O 0 5.1096936459771314e-08
missense O 0 4.4503241269922e-07
mutation O 0 5.510790934692977e-09
was O 0 2.8361020198985898e-08
also O 0 1.0289592788925717e-10
found O 0 4.072078178124494e-12
in O 0 3.562987752059321e-11
2 O 0 7.99419694885728e-08
. O 0 1.505877733620764e-08

8 O 0 8.46784985242266e-07
% O 0 9.940773759709032e-10
of O 0 1.9178381105433573e-09
the O 0 2.9111685284632927e-10
general O 0 2.1802271099602422e-10
population O 0 4.1486401987367305e-12
, O 0 3.3962732799708295e-12
suggesting O 0 5.0119236018331126e-12
that O 0 2.405548904602789e-13
it O 0 3.7216036459161717e-13
is O 0 1.5461466742333618e-12
not O 0 1.6477813905013683e-11
disease O 0 1.384882182264846e-07
associated O 0 2.5826880634127747e-09
. O 0 4.9190904682916425e-09

The O 0 1.6532166746685562e-09
average O 0 6.832444332527388e-11
age O 0 4.5098177969826736e-10
of O 0 1.8936308521233514e-08
disease O 1 0.9979004859924316
onset O 1 0.9915729761123657
in O 0 9.206206352807556e-10
those O 0 3.1444097325916687e-11
families O 0 2.8218621016262713e-12
harbouring O 0 4.484364168888533e-08
causative O 0 5.1247244670094005e-08
mutations O 0 2.2659114584655526e-09
was O 0 5.1965458602865056e-09
between O 0 2.2360042706282e-09
32 O 0 1.135962790499434e-07
. O 0 7.221439091154025e-08

3 O 0 2.9397958769550314e-06
and O 0 2.289912970354635e-08
37 O 0 2.6343678882767563e-07
. O 0 8.013844876586518e-08

4 O 0 2.5493602606729837e-07
years O 0 1.0629110924753604e-09
, O 0 5.94076315918457e-11
whereas O 0 8.40642208621567e-11
the O 0 1.0014111762046696e-10
family O 0 1.8318350308854647e-11
harbouring O 0 2.4140767607150337e-08
the O 0 4.631220129613922e-10
missense O 0 2.6983723699913753e-08
mutation O 0 9.968908337709692e-11
had O 0 4.548817919558523e-12
an O 0 4.6243258923711963e-14
average O 0 8.361734156643597e-13
age O 0 6.135401908746729e-11
of O 0 6.195936652630962e-09
onset O 1 0.980575442314148
of O 0 5.9895751292060595e-06
51 O 0 4.014265186924604e-07
. O 0 1.2183814135369175e-07

2 O 0 3.5274908896099078e-06
years O 0 5.717086892786938e-08
. O 0 9.203264283996759e-08

These O 0 1.0333372352233638e-10
findings O 0 2.002703732018052e-11
show O 0 1.2882775402012214e-10
that O 0 6.883637757026939e-12
BRCA1 O 0 3.7114653017589205e-10
is O 0 2.1139286068144747e-12
implicated O 0 6.26648819640474e-12
in O 0 1.1615120757563213e-12
a O 0 2.0640104209102006e-12
small O 0 2.243077820924047e-13
fraction O 0 3.38570491087431e-12
of O 0 2.6259297669639636e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 6.922205864068331e-11
suggesting O 0 2.27379313294529e-11
the O 0 9.411403080472613e-12
involvement O 0 8.834388776080004e-11
of O 0 1.4880852106102793e-10
another O 0 4.185018304125876e-11
susceptibility O 0 6.721022405287158e-09
gene O 0 2.5807185277670897e-09
( O 0 7.203809215816648e-10
s O 0 1.4175884643918835e-07
) O 0 8.069934942511736e-09

Paternal O 0 5.331188503987505e-07
transmission O 0 0.002049824455752969
of O 1 0.9496777653694153
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9991064667701721

We O 0 6.8282690612875285e-09
report O 0 3.468880044321665e-11
a O 0 5.819336332257841e-12
rare O 0 3.181742022628775e-11
case O 0 4.585955313413104e-12
of O 0 2.0928922483953727e-10
paternally O 0 0.0004232754581607878
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DM B-Disease 1 1.0
) O 0 8.784791227789412e-10
. O 0 1.8616638230994909e-09

The O 0 7.493570564065521e-08
proband O 0 5.048065077062347e-07
is O 0 4.762433156169088e-11
a O 0 7.940795590521965e-12
23 O 0 5.704910849280154e-11
year O 0 1.6863749979778575e-11
old O 0 6.544301101030214e-09
, O 0 3.6430147787314127e-09
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 1.5478670789548232e-08
who O 0 3.36463967798295e-09
suffers O 1 0.9999997615814209
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 0 9.812560165300965e-05

He O 0 1.6626402477015745e-09
presented O 0 3.006818793949151e-09
with O 0 3.9041875288248207e-10
respiratory O 1 1.0
and O 0 6.647018579997166e-08
feeding O 0 4.940880060644304e-08
difficulties O 0 7.33508954908757e-07
at O 0 1.1528699133123155e-06
birth O 0 1.2891190408481634e-06
. O 0 7.880292685058521e-08

His O 0 4.2269967082120274e-08
two O 0 1.4493627631395611e-08
sibs O 1 0.8671239018440247
suffer O 0 2.1455078069720912e-07
from O 0 1.8109718169512234e-09
childhood O 1 0.999488115310669
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 3.159186599077657e-05

Their O 0 5.712168515970006e-09
late O 0 8.239469195814308e-08
father O 0 2.3840536211849894e-09
had O 0 3.7415454068323584e-10
the O 0 4.801140388033254e-11
adult O 0 3.576844376240729e-11
type O 0 7.766700060862775e-10
of O 0 1.1407062174839666e-06
DM B-Disease 1 1.0
, O 0 2.680886623807055e-10
with O 0 1.4595139333217766e-11
onset O 0 0.23625189065933228
around O 0 6.214290193540251e-10
30 O 0 1.0237291014902894e-09
years O 0 4.366557115886849e-10
. O 0 4.020852539809994e-09

Only O 0 1.1447217618254513e-09
six O 0 1.786189390839965e-10
other O 0 5.197982886132047e-13
cases O 0 1.533809429292432e-13
of O 0 1.2170063568017753e-11
paternal O 0 4.4384684816378694e-10
transmission O 0 4.335599896876374e-06
of O 0 0.0010578864021226764
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 1.1058984838996366e-08
been O 0 4.627438709992049e-11
reported O 0 8.43396602556723e-11
recently O 0 2.9856228600522172e-09
. O 0 6.028972876492844e-09

We O 0 3.2889555523496483e-09
review O 0 2.2659968346161463e-10
the O 0 2.4215206229083464e-11
sex O 0 2.415766588506618e-12
related O 0 2.049804553524992e-12
effects O 0 3.074460686036673e-10
on O 0 2.2347838857239566e-10
transmission O 0 2.7671779889715253e-07
of O 0 1.1613635706453351e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.00011484659626148641

Decreased O 0 1.76336641288799e-07
fertility O 0 1.9872656409347655e-08
of O 0 1.2155826345505716e-10
males O 0 4.995855888267203e-14
with O 0 1.0119991189451102e-13
adult O 0 1.6051056039856348e-09
onset O 1 0.9999998807907104
DM B-Disease 1 1.0
and O 0 2.702170709412144e-10
contraction O 0 1.6746324327243656e-09
of O 0 8.317891930786914e-10
the O 0 1.484484896119298e-10
repeat O 0 6.728957946400271e-10
upon O 0 3.463161701855455e-11
male O 0 3.2806301078491806e-12
transmission O 0 1.846163499852338e-11
contribute O 0 1.4219414491353777e-13
to O 0 4.276967506284396e-13
the O 0 2.0332138750411843e-11
almost O 0 5.327772511359852e-12
absent O 0 3.798109049490961e-11
occurrence O 0 1.722504777701417e-11
of O 0 5.002366229578392e-11
paternal O 0 5.00933905467349e-10
transmission O 0 4.793315838469425e-06
of O 0 3.8694412069162354e-05
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.00014465559797827154

Also O 0 4.390058983005929e-09
the O 0 1.6815813186354944e-09
fathers O 0 2.875414351066752e-10
of O 0 7.189392831064012e-11
the O 0 6.161565702100802e-11
reported O 0 3.23300164417617e-10
congenitally O 0 5.403333034337265e-07
affected O 0 1.5337356384925727e-10
children O 0 2.905241368658662e-12
showed O 0 2.04919289870098e-10
, O 0 3.965143751533118e-12
on O 0 1.0442628983753366e-09
average O 0 4.016341773049881e-11
, O 0 5.776134431867419e-11
shorter O 0 4.017188359739521e-09
CTG O 0 2.4558898985560518e-06
repeat O 0 3.0332365952290274e-08
lengths O 0 1.179485509261724e-09
and O 0 8.158510325650958e-12
hence O 0 1.5585267451601048e-11
less O 0 4.700415404124136e-12
severe O 0 1.1933551604670356e-06
clinical O 1 0.8919802904129028
symptoms O 0 4.8534948291489854e-05
than O 0 8.789789100564771e-13
the O 0 2.68929444685595e-11
mothers O 0 5.34990779975375e-13
of O 0 1.7505606339507374e-12
children O 0 4.490637462578606e-12
with O 0 3.818567684277241e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.00024234211014118046

We O 0 7.92068466370921e-10
conclude O 0 2.909719687416157e-10
that O 0 2.347118810072657e-13
paternal O 0 9.230466391230152e-11
transmission O 0 6.03346137495464e-08
of O 0 1.0677204954845365e-05
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 2.5189235586253744e-08
rare O 0 5.509012135362923e-10
and O 0 1.362087851362881e-12
preferentially O 0 8.697332134002811e-13
occurs O 0 1.7377817392548456e-13
with O 0 1.2940851461164943e-13
onset O 1 0.9889390468597412
of O 1 0.9954032897949219
DM B-Disease 1 1.0
past O 0 6.124536611196163e-08
30 O 0 1.2545568750521596e-10
years O 0 3.734098533852981e-12
in O 0 9.31980013996192e-12
the O 0 1.9632125092261532e-10
father O 0 2.586152125783059e-10
. O 0 5.499479205361979e-10
. O 0 8.005362595042698e-09

The O 0 3.894853648489516e-07
RB1 O 0 2.2413967599277385e-05
gene O 0 2.127944931373804e-09
mutation O 0 2.534482346217004e-10
in O 0 2.4957589814245118e-11
a O 0 6.364607174624837e-10
child O 0 7.466345763873505e-09
with O 0 4.7093338118031625e-09
ectopic B-Disease 1 0.9999997615814209
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 7.494022611354012e-06

The O 0 4.773580712935654e-07
RB1 O 0 1.7378881238983013e-05
gene O 0 3.1132791900034817e-09
mutation O 0 2.2698726231951127e-10
was O 0 1.458039800006361e-10
investigated O 0 1.6113194112321594e-10
in O 0 6.490753073906674e-11
a O 0 2.989497760452764e-09
child O 0 2.5949946191872186e-08
with O 0 3.858983799176485e-09
ectopic B-Disease 1 0.9999171495437622
intracranial I-Disease 1 0.9997544884681702
retinoblastoma I-Disease 0 3.331269181217067e-05
using O 0 4.1973691883301356e-11
DNA O 0 4.978304227187813e-11
obtained O 0 1.4769286054566733e-12
from O 0 1.2889151551620515e-12
both O 0 5.521335125213689e-12
the O 0 5.056018936855367e-10
pineal B-Disease 0 0.001830728375352919
and I-Disease 0 4.753526461342972e-09
retinal I-Disease 1 0.999996542930603
tumours I-Disease 1 1.0
of O 0 5.069504709354078e-07
the O 0 5.896070121025332e-08
patient O 0 1.1945890321385377e-07
. O 0 2.724031844536512e-08

A O 0 4.2552650825200544e-07
nonsense O 0 7.814554692231468e-08
mutation O 0 3.263060377456384e-10
in O 0 8.355111047464447e-11
exon O 0 1.4062101705292207e-08
17 O 0 4.444884016407968e-09
( O 0 2.9362779568886666e-11
codon O 0 7.924251255175818e-10
556 O 0 5.762456137259342e-11
) O 0 8.954795997599685e-13
of O 0 2.2226262497149207e-10
the O 0 1.3839493995249086e-08
RB1 O 0 1.924245907503064e-06
gene O 0 2.1485322410086383e-09
was O 0 6.163464405517516e-09
found O 0 9.359721331314574e-12
to O 0 8.243095876020456e-13
be O 0 2.2695456625143606e-12
present O 0 6.715668385975926e-12
homozygously O 0 4.664715724800317e-09
in O 0 1.2889878053812254e-10
both O 0 5.905029937247619e-11
the O 0 6.383341077942362e-10
retinal B-Disease 0 7.772714525344782e-07
and I-Disease 0 3.621510424878238e-09
the I-Disease 0 1.3517464481083152e-07
pineal I-Disease 1 0.9999985694885254
tumours I-Disease 1 1.0
. O 0 8.004883511603111e-07

The O 0 5.091314037031225e-09
same O 0 2.33048330633423e-10
mutation O 0 7.383717248732324e-11
was O 0 3.369036993827734e-10
present O 0 2.8844324498344953e-11
heterozygously O 0 7.70955566053999e-09
in O 0 1.4285575500316838e-10
the O 0 2.5537663650432307e-10
DNA O 0 4.198572045588378e-10
from O 0 1.2744633473560363e-11
the O 0 2.2504006991219683e-10
constitutional O 0 2.80494294457867e-08
cells O 0 1.0857865301305836e-10
of O 0 3.0938848705197586e-10
the O 0 6.037876865150338e-10
patient O 0 8.334328782666489e-10
, O 0 2.2336705401970747e-11
proving O 0 6.556029052973145e-10
it O 0 4.881824111624411e-13
to O 0 6.380008825933314e-13
be O 0 4.100213224500493e-12
of O 0 1.159324233834802e-10
germline O 0 1.317763320685117e-08
origin O 0 3.23800652957118e-10
. O 0 2.001262489059741e-09

The O 0 2.2073097127872643e-08
initial O 0 5.2011368545379355e-09
mutation O 0 4.733645697641009e-10
was O 0 2.846536895084739e-10
shown O 0 7.555353911947726e-12
to O 0 1.7484084926383536e-12
have O 0 1.0639825609101705e-12
occurred O 0 5.7893589228141806e-11
in O 0 1.3385998039183722e-11
the O 0 4.817103382848131e-10
paternally O 0 4.6633452654987195e-09
derived O 0 4.44815545508348e-10
RB1 O 0 1.425316895620199e-06
allele O 0 2.431831980231891e-08
. O 0 1.9204673407102746e-08

The O 0 3.21850954776437e-08
mutation O 0 1.4783477220170482e-10
is O 0 4.347635532836458e-13
in O 0 1.3981537824205026e-13
an O 0 4.1552326087313657e-14
area O 0 2.496001669238801e-11
of O 0 1.7504055149775155e-10
the O 0 1.6892924559197553e-10
gene O 0 1.513988240331443e-11
that O 0 6.900829191934521e-13
encodes O 0 1.4845511972505498e-12
the O 0 1.990107557914289e-11
protein O 0 1.552450529240801e-11
- O 0 1.6747146724949147e-10
binding O 0 2.791160358395217e-10
region O 0 1.6132535585189345e-10
known O 0 5.883669940143221e-11
as O 0 1.5811267226051307e-11
the O 0 8.913226406948027e-11
pocket O 0 8.908068949153858e-09
region O 0 4.92757668002497e-10
and O 0 5.40279522509568e-11
has O 0 4.73534796444075e-12
been O 0 8.479395029008241e-13
detected O 0 4.319049024675836e-12
in O 0 1.3181151049118656e-12
other O 0 1.047273270708693e-12
cases O 0 2.8450900489696007e-12
of O 0 3.1146199508391703e-10
retinoblastoma B-Disease 0 7.926057321583357e-08
. O 0 1.3749373861671188e-09
. O 0 1.08196305248498e-08

Low O 0 1.5064873082337726e-07
levels O 0 1.999408194564012e-09
of O 0 8.211332169771879e-10
beta O 0 7.662530521201916e-08
hexosaminidase O 0 9.893764172375086e-07
A O 0 3.413240801108941e-09
in O 0 1.596889634414289e-11
healthy O 0 4.8776961636409766e-11
individuals O 0 4.7037650467360304e-14
with O 0 2.991569448759779e-12
apparent O 0 0.0014014375628903508
deficiency O 1 0.999845027923584
of O 0 0.0012589013203978539
this O 0 1.0549297435602512e-08
enzyme O 0 1.0341763001520121e-08
. O 0 5.970918426356775e-09

Appreciable O 0 4.339784709372907e-07
beta O 0 2.2090392803875147e-07
hexosaminidase O 0 7.165949682530481e-06
A O 0 5.298314249557734e-07
( O 0 9.914240262087759e-11
hex O 0 7.103380994522013e-08
A O 0 1.4663914527091038e-08
) O 0 6.046649726060283e-13
activity O 0 4.2416976181458566e-11
has O 0 6.973842618836212e-13
been O 0 1.2983159469390215e-12
detected O 0 4.3956178974458027e-11
in O 0 1.3296459766554136e-10
cultured O 0 3.8558300730073825e-07
skin O 0 0.0010363784385845065
fibroblasts O 1 0.8537899255752563
and O 0 1.638845361640051e-07
melanoma B-Disease 1 0.999651312828064
tissue O 0 8.425311648352363e-08
from O 0 8.443478555220096e-11
healthy O 0 1.299417101696676e-10
individuals O 0 2.0490050560667376e-14
previously O 0 2.4646553895002477e-11
reported O 0 4.614400875291302e-12
as O 0 1.4334151920980531e-11
having O 0 4.224471883418346e-09
deficiency B-Disease 0 0.0009620145428925753
of I-Disease 0 0.0003520010504871607
hex I-Disease 0 0.001966624055057764
A I-Disease 0 2.8848219812971365e-08
activity O 0 9.02546926084824e-11
indistinguishable O 0 2.3163400451192695e-12
from O 0 1.0573599524968998e-14
that O 0 4.41355368661152e-15
of O 0 1.067611168741045e-12
patients O 0 3.676487066173184e-12
with O 0 2.0043262605184964e-09
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.1441130709499703e-06
TSD B-Disease 1 0.9999918937683105
) O 0 1.7150777464891576e-09
. O 0 1.5671705710929018e-08

Identification O 0 5.8653924384088896e-08
and O 0 2.3199291376840847e-09
quantitation O 0 3.3857475500553846e-05
of O 0 1.1259886605330394e-06
hex O 0 4.0951512346509844e-05
A O 0 2.2185672321484162e-07
, O 0 7.43467717945201e-11
amounting O 0 6.715799444334536e-11
to O 0 1.163426716077609e-10
3 O 0 7.418921654789301e-08
. O 0 2.049980629692527e-08

5 O 0 5.503765123648918e-07
% O 0 1.2954738615178485e-08
- O 0 1.2332347409937938e-07
6 O 0 4.49031290372659e-07
. O 0 6.367199034684745e-08

9 O 0 5.5201670789983837e-08
% O 0 6.554925352508789e-11
of O 0 1.956767525790326e-10
total O 0 3.5262515130085603e-10
beta O 0 1.112087666399475e-08
hexosaminidase O 0 2.3731619336331278e-08
activity O 0 1.239667146712975e-09
, O 0 3.0380017078390775e-12
has O 0 3.2805661941311126e-13
been O 0 5.759437116678937e-14
obtained O 0 4.633740223122795e-13
by O 0 1.4975231124592092e-11
cellulose O 0 1.291336275244248e-06
acetate O 0 5.288580950946198e-08
gel O 0 1.692815554399374e-09
electrophoresis O 0 1.407493982474861e-10
, O 0 9.157306163354306e-11
DEAE O 0 1.8946678892461932e-06
- O 0 1.243969105502174e-08
cellulose O 0 4.6524294816663314e-07
ion O 0 5.836730654351641e-09
- O 0 1.8866144202434043e-09
exchange O 0 1.276127814531236e-10
chromatography O 0 4.0102639958794484e-11
, O 0 6.499075149574152e-12
radial O 0 3.2411701100798496e-10
immunodiffusion O 0 1.4157559569127898e-08
, O 0 8.054887312702874e-11
and O 0 2.7601110286212815e-10
radioimmunoassay O 0 1.122660478358739e-06
. O 0 4.219119276172023e-08

Previous O 0 0.00011085192090831697
family O 0 6.793519080616761e-09
studies O 0 3.135453452429715e-09
suggested O 0 1.771357172053456e-09
that O 0 5.3144767232782275e-12
these O 0 3.7120567036863505e-12
individuals O 0 1.2263356562874916e-12
may O 0 1.4765612343925483e-10
be O 0 3.395905778802444e-11
compound O 0 3.3080291284015573e-10
heterozygotes O 0 4.312835852338104e-11
for O 0 2.0216621345742203e-12
the O 0 6.233435295710521e-11
common O 0 6.328507162756125e-11
mutant O 0 1.5573849765360137e-08
TSD B-Disease 0 1.9805545434792293e-06
gene O 0 8.320347189005872e-11
and O 0 5.611686029055596e-12
a O 0 2.044690285141204e-11
rare O 0 3.1846034143079294e-10
( O 0 6.0174061913831345e-12
allelic O 0 1.753366896117825e-09
) O 0 6.486096815888631e-12
mutant O 0 3.818021454549125e-09
gene O 0 9.750755758375362e-09
. O 0 9.705501291534802e-09

Thus O 0 2.9441828974796636e-09
, O 0 3.948398899500383e-11
the O 0 5.217755394415491e-11
postulated O 0 2.243855934391803e-10
rate O 0 9.075980245132342e-11
mutant O 0 1.9730778122450943e-10
gene O 0 1.8246933478072158e-11
appears O 0 7.421648473733555e-13
to O 0 1.5907404110311954e-14
code O 0 6.287373779164523e-14
for O 0 1.1809891714738285e-13
the O 0 1.4999722384306802e-12
expression O 0 2.6189923493791234e-11
of O 0 2.8428566792304544e-11
low O 0 2.188176029260802e-10
amounts O 0 7.877872833239596e-12
of O 0 5.346080245161033e-10
hex O 0 5.136791401127994e-07
A O 0 2.953527769022912e-07
. O 0 1.7969687959862313e-08

Heterozygotes O 0 1.2686030004260829e-06
for O 0 6.992770806846238e-09
the O 0 4.0806522605407736e-09
rare O 0 2.6878459458146153e-09
mutant O 0 1.8647565269702682e-08
may O 0 1.0633810498816842e-10
be O 0 1.330037750942037e-12
indistinguishable O 0 7.671728703695369e-12
from O 0 3.7677069038462296e-13
heterozygotes O 0 2.3399659987433097e-10
for O 0 1.730361687268811e-11
the O 0 9.740118711576429e-10
common O 0 9.367253639425144e-09
TSD B-Disease 0 1.4232348803489003e-05
mutant O 0 2.7771926625064225e-07
. O 0 3.479334864664452e-08

However O 0 1.0237720671213424e-09
, O 0 1.1430906568521415e-11
direct O 0 7.091147113946761e-11
visualization O 0 1.0508951042709214e-08
and O 0 9.938971867740065e-10
quantitation O 0 3.682115493575111e-05
of O 0 1.5601805216647335e-06
hex O 0 5.7910688155971e-06
A O 0 9.683866153409326e-09
by O 0 2.7231639252583983e-12
the O 0 1.499103445545824e-11
methods O 0 2.5944114911968796e-11
described O 0 1.207507965145238e-11
may O 0 4.3733289559200195e-12
prevent O 0 1.3335286867810492e-11
false O 0 2.038836981188563e-11
- O 0 1.0450473819645367e-10
positive O 0 2.1926692232721035e-12
prenatal O 0 6.2205427475703345e-09
diagnosis O 0 7.3421557722497255e-09
of O 0 3.916800217496075e-10
TSD B-Disease 0 7.71605391491903e-06
in O 0 7.376439736805906e-11
fetuses O 0 5.098171884654334e-10
having O 0 1.2234906664188028e-11
the O 0 1.667336269051134e-10
incomplete O 0 1.545442174233358e-08
hex B-Disease 0 0.04679001122713089
A I-Disease 1 0.5118061900138855
deficiency I-Disease 0 0.08831946551799774
of O 0 4.3780022679129615e-05
the O 0 2.833106904631677e-08
type O 0 4.840287282092959e-09
described O 0 1.69176242459379e-10
in O 0 5.271251490857054e-11
the O 0 1.3585871316834641e-09
four O 0 1.9042931675983255e-09
healthy O 0 6.940102537100756e-08
individuals O 0 3.424940331342441e-09

The O 0 1.2662940207519569e-07
tumor B-Disease 0 6.750425427526352e-07
suppressor O 0 4.727051248210046e-07
gene O 0 5.701000560520697e-09
Smad4 O 0 1.0129924703505822e-06
/ O 0 3.7646029795723734e-06
Dpc4 O 0 1.2924525663038366e-06
is O 0 1.429704531846765e-11
required O 0 4.850390488558842e-12
for O 0 2.590839869032191e-12
gastrulation O 0 6.264588137128158e-08
and O 0 3.107710963567989e-11
later O 0 5.252746571038358e-10
for O 0 2.939135740342991e-11
anterior O 0 4.284265164855583e-10
development O 0 1.2716455666250681e-09
of O 0 7.168268756352347e-10
the O 0 3.388927583003465e-09
mouse O 0 3.3340668892378744e-08
embryo O 0 2.1143964801240145e-08
. O 0 1.0148295537248941e-08

Mutations O 0 1.0697699615036527e-08
in O 0 1.1751761785916415e-09
the O 0 2.546555499804981e-08
SMAD4 O 0 0.3563685119152069
/ O 0 0.00022250479378271848
DPC4 O 0 8.72014497872442e-05
tumor B-Disease 0 8.764348535805766e-08
suppressor O 0 1.4047974339348457e-08
gene O 0 1.6999134044848319e-10
, O 0 2.7191935769027564e-12
a O 0 1.7061817236818655e-11
key O 0 7.906998611417748e-09
signal O 0 1.0691722174271945e-08
transducer O 0 4.829580291243474e-09
in O 0 1.490627621336671e-10
most O 0 1.3050951985782433e-10
TGFbeta O 0 0.0024310885928571224
- O 0 7.703142159698473e-07
related O 0 7.490980280522308e-09
pathways O 0 7.69969510372448e-09
, O 0 1.4509862495543091e-12
are O 0 1.4382849837339673e-14
involved O 0 1.1591494264277542e-14
in O 0 2.3096989273420354e-13
50 O 0 1.2341406542548672e-11
% O 0 3.0793183974919813e-11
of O 0 3.104279855392633e-08
pancreatic B-Disease 1 1.0
cancers I-Disease 1 0.9999998807907104
. O 0 2.020546162384562e-06

Homozygous O 0 1.2213157560836407e-06
Smad4 O 0 2.774593303911388e-05
mutant O 0 9.363929166283924e-06
mice O 0 1.4376937542692758e-06
die O 0 3.704983342345258e-08
before O 0 4.606912906712779e-10
day O 0 1.5265161357191914e-09
7 O 0 5.991752516365523e-08
. O 0 1.3221766792526068e-08

5 O 0 6.180071068229154e-07
of O 0 9.85941568387716e-08
embryogenesis O 0 1.3623131053464022e-05
. O 0 7.073784900057944e-07

Mutant O 0 3.400040213819011e-07
embryos O 0 3.4318865971272317e-08
have O 0 1.6997869778379027e-10
reduced O 0 3.375810186945216e-10
size O 0 2.5773069442514007e-11
, O 0 6.455861539800267e-11
fail O 0 1.2419516970396671e-08
to O 0 7.199643659028254e-11
gastrulate O 0 1.921044486152823e-06
or O 0 8.383401750577946e-10
express O 0 7.307054267213786e-11
a O 0 6.032567501090824e-11
mesodermal O 0 7.184315364838767e-09
marker O 0 7.936855617174388e-09
, O 0 8.082030704403831e-12
and O 0 1.359347877316619e-11
show O 0 2.822926781220758e-09
abnormal O 0 3.3057872883546224e-08
visceral O 0 1.897749797308279e-07
endoderm O 0 4.009355052403407e-06
development O 0 6.701809951437099e-08
. O 0 8.363601367022966e-09

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 6.695589490846032e-06
the O 0 7.116318556654733e-08
Smad4 O 0 0.0006399554549716413
- O 0 1.931379074449069e-06
deficient O 0 1.4725969776918646e-08
embryos O 0 3.572509787996836e-10
results O 0 7.640569427147526e-11
from O 0 7.172720317000225e-12
reduced O 0 1.89446081044764e-09
cell O 0 1.6516164436097824e-08
proliferation O 0 1.350795457710774e-07
rather O 0 6.295885037269078e-13
than O 0 2.2282841533310255e-14
increased O 0 2.333026133394256e-11
apoptosis O 0 2.0784428045317327e-07
. O 0 2.325387216117747e-09

Aggregation O 0 2.3856788544662777e-08
of O 0 1.4930904512766574e-08
mutant O 0 1.5646952533643343e-07
Smad4 O 0 3.571784691303037e-05
ES O 0 8.419813821092248e-05
cells O 0 6.280048703288799e-11
with O 0 1.5224227043961203e-12
wild O 0 3.1093165375750687e-08
- O 0 1.0659407578827995e-08
type O 0 1.825904050178906e-08
tetraploid O 0 1.2615284958883421e-06
morulae O 0 5.517091994988732e-05
rescues O 0 1.614266807337117e-06
the O 0 7.021763082093457e-08
gastrulation B-Disease 0 0.00664118817076087
defect I-Disease 0 0.0006616226746700704
. O 0 1.7692349274511798e-07

These O 0 1.2903241808359667e-09
results O 0 4.0890646424429633e-10
indicate O 0 2.2579969144453926e-11
that O 0 2.149176669963282e-12
Smad4 O 0 2.2585730619084643e-08
is O 0 8.913120241871297e-12
initially O 0 5.830591218169978e-12
required O 0 4.672426182940337e-13
for O 0 1.923960123162427e-13
the O 0 1.8218200385777816e-12
differentiation O 0 1.8844259486172632e-11
of O 0 2.9651101018934867e-11
the O 0 3.054981961847503e-11
visceral O 0 9.58946033691177e-10
endoderm O 0 1.0142566786441876e-08
and O 0 6.9382889190949815e-12
that O 0 4.094677884518977e-13
the O 0 3.560481076636535e-11
gastrulation B-Disease 0 9.368353062200185e-07
defect I-Disease 0 5.7874466108387423e-08
in O 0 1.6696244387048864e-10
the O 0 2.8322517664491897e-09
epiblast O 0 3.922964424418751e-06
is O 0 1.013116882053744e-10
secondary O 0 3.5921421392970387e-09
and O 0 1.1590191306698472e-10
non O 0 4.216906859255687e-07
- O 0 6.030229116049668e-08
cell O 0 1.5316855979108368e-06
autonomous O 0 2.5140957404801156e-07
. O 0 4.878671333585771e-08

Rescued O 0 1.1825427463918459e-06
embryos O 0 1.0463851651820733e-07
show O 0 3.6814560644415906e-07
severe O 0 0.11408867686986923
anterior O 0 8.896694794202631e-07
truncations O 0 0.006990181282162666
, O 0 1.0361521640689375e-09
indicating O 0 2.0393291499942734e-09
a O 0 2.965558354439679e-10
second O 0 1.2938459192923801e-09
important O 0 1.5658664642703712e-10
role O 0 1.2865979115428416e-10
for O 0 7.829881187859655e-11
Smad4 O 0 2.8999639312132786e-07
in O 0 5.969923999593618e-10
anterior O 0 2.4404176457437643e-09
patterning O 0 1.541594230047849e-08
during O 0 4.3353995948791635e-08
embryogenesis O 0 2.475368773957598e-06
. O 0 4.9670724422412604e-08

Prevalence O 0 2.4135163130267756e-06
of O 0 2.6164798327954486e-08
p16 O 0 1.3100796891762911e-08
and O 0 1.9230028680539135e-09
CDK4 O 0 6.81244200677611e-05
germline O 0 3.86279396025202e-07
mutations O 0 1.347941896989724e-10
in O 0 5.0679883900617284e-11
48 O 0 9.381687249288007e-08
melanoma B-Disease 1 1.0
- O 1 0.9993612170219421
prone O 0 2.447271754135727e-06
families O 0 1.9635560538633356e-11
in O 0 6.699222843131736e-10
France O 0 9.079037226911169e-06
. O 0 5.927495294599794e-07

The O 0 2.178862246182689e-07
French O 0 0.00014613641542382538
Familial B-Disease 1 0.9999986886978149
Melanoma I-Disease 1 1.0
Study O 0 3.935248571451666e-07
Group O 0 1.336897952342042e-07
. O 0 5.191199292653437e-08

Germline O 0 1.3454460940920399e-06
mutations O 0 7.977739024944697e-10
in O 0 1.2382747605066413e-10
the O 0 7.665242329757405e-10
p16 O 0 2.053564429616017e-09
and O 0 6.1501320702817e-10
CDK4 O 0 3.0198181775631383e-05
genes O 0 1.0825688956384028e-10
have O 0 1.354726877553225e-12
been O 0 5.402326264287993e-13
reported O 0 4.706881043779754e-13
in O 0 1.1355084624312117e-12
a O 0 3.1817479206885935e-11
subset O 0 2.8600646828635945e-07
of O 0 1.5782040918566054e-07
melanoma B-Disease 1 0.6896346211433411
pedigrees O 0 4.101715234128278e-08
, O 0 1.1379683306778077e-10
but O 0 1.075158365115847e-11
their O 0 2.8774101157313936e-11
prevalence O 0 7.554097791739878e-09
is O 0 1.5991473553342295e-12
not O 0 1.1242333019384487e-12
well O 0 2.386867613279886e-11
known O 0 2.187421799249023e-09
. O 0 6.534709218186663e-09

We O 0 2.834883661151366e-09
searched O 0 2.1426709018168566e-10
for O 0 1.5715317502190684e-12
such O 0 1.7915008018731804e-11
germline O 0 5.619792187161465e-09
mutations O 0 6.384613757820512e-12
in O 0 6.880304052186981e-12
48 O 0 2.2181636527562887e-09
French O 0 0.38593724370002747
melanoma B-Disease 1 1.0
- O 1 0.9998084902763367
prone O 0 2.5850556539808167e-07
families O 0 5.654671067327477e-13
selected O 0 2.299949727196937e-12
according O 0 6.151882388921726e-13
to O 0 3.4553853918775634e-13
two O 0 9.568124287664959e-13
major O 0 1.0201737232762298e-09
criteria O 0 8.721038113890245e-09
families O 0 1.0855736204710628e-13
with O 0 2.0811779762649335e-13
at O 0 1.7581658351417673e-09
least O 0 3.098986345317911e-11
three O 0 5.98366980963938e-11
affected O 0 4.774932671480769e-10
members O 0 2.696804238255801e-11
( O 0 3.5028598945052725e-12
n O 0 2.8500533044706344e-09
= O 0 1.6736234620395862e-09
20 O 0 1.1957830559072846e-10
) O 0 2.815398738795216e-13
or O 0 1.1891041536843394e-12
families O 0 2.3487656115287088e-14
with O 0 1.4685653951587718e-13
two O 0 7.909882818180058e-12
affected O 0 6.147678199841522e-11
members O 0 4.637252387640345e-12
, O 0 6.848880837462268e-12
one O 0 8.624273170609875e-12
of O 0 6.182169220991796e-10
them O 0 1.664297866188491e-11
affected O 0 1.0019035080743866e-11
before O 0 6.756695897225384e-11
the O 0 3.885531826841593e-11
age O 0 7.170507937415138e-11
of O 0 7.761457587740495e-10
50 O 0 1.7792085860168783e-10
( O 0 3.421246142290557e-12
n O 0 4.3449649433924264e-10
= O 0 4.420523669335097e-10
28 O 0 4.69311034478892e-10
) O 0 7.202479715071042e-13
, O 0 7.665464400383182e-13
and O 0 2.734421846936619e-12
one O 0 1.856087549281793e-12
additional O 0 1.0262872149335855e-11
minor O 0 1.0810017769813385e-08
criterion O 0 6.345759175019339e-05
. O 0 4.1857589394567185e-08

Sixteen O 0 1.5213872472941148e-07
different O 0 2.823954126096595e-10
p16 O 0 5.964873484032296e-09
germline O 0 2.3949887406615744e-08
mutations O 0 3.09844268298054e-11
were O 0 1.257910876156787e-11
found O 0 7.520595474500014e-14
in O 0 6.568910996748722e-13
21 O 0 1.815889383305347e-10
families O 0 3.034820387614462e-13
, O 0 2.0854069339437675e-12
while O 0 2.1602577365831266e-11
one O 0 5.8205381486819974e-11
germline O 0 9.026996394823072e-08
mutation O 0 1.2732030707507391e-10
, O 0 4.416769033843693e-12
Arg24His O 0 2.8208129165818718e-08
, O 0 1.765196842862249e-11
was O 0 1.3872648862989223e-10
detected O 0 5.1963034569668665e-11
in O 0 4.802331102227164e-11
the O 0 1.9749351043429897e-09
CDK4 O 0 3.4560645872261375e-05
gene O 0 6.78144260746194e-08
. O 0 2.5622926003165958e-08

The O 0 9.865577244028145e-10
frequency O 0 1.3520418118417865e-09
of O 0 2.4775013152122938e-09
p16 O 0 8.935837070289665e-10
gene O 0 8.993214506425318e-11
mutation O 0 7.212807608125704e-12
in O 0 2.8469141107045903e-12
our O 0 5.975546012865207e-12
sample O 0 4.938898140287307e-13
( O 0 3.8991138334547315e-13
44 O 0 2.777594126923688e-12
% O 0 1.8608552199150807e-12
) O 0 9.002331215549053e-14
is O 0 6.065127919211225e-14
among O 0 4.4515325263840347e-14
the O 0 4.473351810502235e-12
highest O 0 7.071013219395184e-10
rates O 0 7.755431019607073e-11
yet O 0 2.1786203483614708e-12
reported O 0 3.221186555338318e-12
and O 0 3.0004893968732516e-12
the O 0 3.6761052535361216e-10
CDK4 O 0 9.351596418127883e-06
mutation O 0 7.415218439277282e-11
is O 0 8.736587299960907e-13
the O 0 9.293333463888942e-12
second O 0 7.812650526517473e-11
mutation O 0 2.4253188433270845e-12
detected O 0 2.0610089156158917e-12
in O 0 9.39952109202391e-13
this O 0 7.550553064727961e-13
gene O 0 3.6389155577687404e-10
worldwide O 0 1.9372461412814346e-09
. O 0 1.401393223687819e-08

In O 0 1.546709427202586e-09
summary O 0 7.794964318463826e-08
, O 0 1.4320877816942357e-10
our O 0 8.79115599761171e-11
results O 0 5.828734196688945e-12
show O 0 1.8458359840600735e-11
frequent O 0 9.943570272730184e-12
involvement O 0 7.109904331947803e-11
of O 0 2.1278383222078645e-10
the O 0 2.5314050855484993e-10
p16 O 0 3.2519448245338367e-10
gene O 0 5.581628909068215e-11
in O 0 1.717950608159935e-11
familial B-Disease 0 2.970215575714974e-07
melanoma I-Disease 0 5.609261279460043e-05
and O 0 7.585912453755839e-11
confirm O 0 1.6785330070323567e-10
the O 0 9.11930878033651e-11
role O 0 1.4509932144690652e-10
of O 0 3.853350083460327e-09
the O 0 1.003477212435655e-08
CDK4 O 0 0.0006131623522378504
gene O 0 1.1798618970715324e-08
as O 0 1.0206914202726125e-09
a O 0 3.867863362927437e-09
melanoma B-Disease 0 3.532551272655837e-05
- O 0 1.4204790943495027e-07
predisposing O 0 2.3131684656618745e-07
gene O 0 9.83914283381182e-09
. O 0 7.663282786118941e-10
. O 0 4.914260998134523e-09

Progression O 0 3.991599896835396e-06
of O 0 3.08924199998728e-07
somatic O 0 4.712238478532527e-06
CTG O 0 1.7272770492127165e-05
repeat O 0 7.030403814667352e-09
length O 0 2.992432690529512e-11
heterogeneity O 0 3.608903731411317e-10
in O 0 1.6913227762760386e-11
the O 0 5.130496721905686e-11
blood O 0 3.7096162947003464e-11
cells O 0 4.114524276843667e-09
of O 0 1.128940198213968e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.67416912317276
. O 0 1.940878924244771e-08

The O 0 4.842713452468672e-10
genetic O 0 6.119241779956042e-10
basis O 0 2.1593331567260066e-09
of O 0 0.2785181999206543
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 3.364174563924571e-11
is O 0 1.7326651181523434e-13
the O 0 5.348142176515858e-13
expansion O 0 2.2200788082904488e-11
of O 0 2.1561823507210143e-11
an O 0 6.742261263181781e-12
unstable O 0 4.66290073219966e-09
CTG O 0 5.2433233577176e-07
repeat O 0 6.913939198938124e-09
in O 0 8.719964333936403e-11
the O 0 3.8159081450217514e-10
34 O 0 2.264805232243816e-09
UTR O 0 9.072858119907323e-06
of O 0 4.397838537784082e-08
the O 0 4.27442614636675e-07
DM B-Disease 1 0.9999973773956299
protein O 0 1.2245267910770963e-08
kinase O 0 1.5227945127094245e-08
gene O 0 1.6735851593452367e-09
on O 0 8.319847033533279e-09
chromosome O 0 5.8865968100008104e-08
19 O 0 7.255844991505e-08
. O 0 2.8225352721733543e-08

One O 0 2.020007716652117e-09
of O 0 7.869504159430107e-09
the O 0 1.4021197536351337e-09
principal O 0 2.5615596754846592e-08
features O 0 1.4648866564215268e-09
of O 0 3.3282084643815324e-08
the O 0 0.0001374289277009666
DM B-Disease 1 1.0
mutation O 0 4.012366261463285e-08
is O 0 4.489506856553138e-12
an O 0 3.212735795714988e-13
extraordinarily O 0 8.12032316388489e-11
high O 0 1.598762566779044e-09
level O 0 1.0219098811603544e-07
of O 0 2.16300999333896e-09
somatic O 0 2.283198000441189e-06
mosaicism O 0 2.9849477868992835e-05
, O 0 7.701138338145341e-12
due O 0 7.946227564836761e-10
to O 0 5.396795749006145e-13
an O 0 2.010743324230499e-13
extremely O 0 5.2362766900238e-12
high O 0 3.416415761403613e-11
degree O 0 1.4940355619330603e-09
of O 0 3.932192349509478e-09
somatic O 0 5.814854375785217e-07
instability O 0 5.3836807012430654e-08
both O 0 5.922330334473536e-12
within O 0 3.509602330975525e-11
and O 0 1.5457692634571196e-12
between O 0 7.8028026748167e-12
different O 0 3.589213995458529e-11
tissues O 0 9.95130733372207e-09
. O 0 8.946175356072672e-09

This O 0 7.045622418822006e-10
instability O 0 1.0940931360892137e-07
appears O 0 9.545221557605288e-11
to O 0 1.8154132711001303e-12
be O 0 2.0286224956811427e-12
biased O 0 3.925816269290117e-12
towards O 0 3.982650526642567e-13
further O 0 5.6554556908871775e-14
expansion O 0 1.8251971115046395e-12
and O 0 1.5096036671147922e-13
continuous O 0 5.006292047582406e-10
throughout O 0 6.258703277861599e-11
the O 0 7.683491343168924e-11
life O 0 8.987996978626622e-12
of O 0 1.4956884342165466e-10
an O 0 1.7196348511827608e-12
individual O 0 2.8933962430838234e-12
, O 0 1.809260900820231e-11
features O 0 6.822316600541001e-10
that O 0 6.313023454690425e-12
could O 0 2.522437770810515e-12
be O 0 5.232439915375808e-13
associated O 0 2.2817206023900694e-12
with O 0 2.6612680158535906e-13
the O 0 7.287095926677978e-11
progressive O 0 2.1967387908716773e-07
nature O 0 1.1676356548306899e-09
of O 0 7.803316881549449e-10
the O 0 7.851798322633385e-09
disease O 0 9.739152119436767e-06
. O 0 6.669799823555422e-09

Although O 0 7.978712690537293e-10
increasing O 0 7.212646452314786e-11
measured O 0 2.0012375437361563e-11
allele O 0 5.901807254710123e-12
size O 0 1.1361843540655392e-12
between O 0 1.867590630755256e-11
patients O 0 4.984622437032016e-11
clearly O 0 1.2192361920418393e-12
correlates O 0 8.176167804862383e-14
with O 0 9.349406734983118e-16
an O 0 1.4666883701476563e-15
increased O 0 6.459820742557576e-13
severity O 0 7.857771655572776e-10
of O 0 6.123702100957473e-10
symptoms O 0 4.0245605958944e-08
and O 0 1.3433488262742932e-12
an O 0 3.548949464382903e-14
earlier O 0 2.0617018509083707e-11
age O 0 1.2328750000067945e-11
of O 0 5.004115455342628e-10
onset O 0 7.744103527329571e-07
, O 0 6.898670545409102e-13
this O 0 1.8283868546248826e-14
correlation O 0 1.1996356599069946e-12
is O 0 3.0539885399229194e-13
not O 0 2.629621238640911e-13
precise O 0 3.488646177496335e-11
and O 0 3.5802482940133773e-12
measured O 0 1.789001412288993e-11
allele O 0 1.311487637239983e-11
length O 0 5.902527598633522e-12
cannot O 0 6.70381762254979e-12
be O 0 1.366526520846928e-13
used O 0 3.1122914439856916e-14
as O 0 7.165151311898724e-14
an O 0 2.0594821759979155e-14
accurate O 0 5.5879346289033904e-11
predictor O 0 1.87264781459362e-08
of O 0 7.266987012144455e-10
age O 0 1.5405736686346927e-09
of O 0 9.720247717837083e-09
onset O 0 0.001797822187654674
. O 0 1.2110852765090385e-07

In O 0 8.346991431373851e-10
order O 0 1.0707261466347262e-10
to O 0 3.2534493762254035e-12
further O 0 2.545287765276516e-12
characterize O 0 2.4657040298414756e-11
the O 0 6.218448672656862e-11
dynamics O 0 6.661291518383905e-10
of O 0 4.682492544816341e-07
DM B-Disease 1 1.0
CTG O 0 0.01371661014854908
repeat O 0 1.3579406754615775e-07
somatic O 0 5.0145061436523974e-08
instability O 0 6.436490895822544e-09
, O 0 3.1394400967776903e-12
we O 0 9.249772172162385e-13
have O 0 5.331833200861516e-14
studied O 0 2.8150563477491453e-12
repeat O 0 2.8571041366109995e-11
length O 0 2.935485513520797e-13
changes O 0 1.9758314721753795e-13
over O 0 6.657962213236363e-14
time O 0 1.442123330475109e-13
in O 0 6.607454600821017e-12
111 O 0 1.971148230950348e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 3.0030591346985602e-09
with O 0 1.4294194625695533e-13
varying O 0 6.069264882335723e-12
clinical O 0 8.4585742854415e-09
severity O 0 5.525780579773709e-07
and O 0 1.3881171212482002e-10
CTG O 0 1.025699702950078e-06
repeat O 0 1.213907974140227e-09
size O 0 3.1651495660534046e-12
over O 0 1.902464080369426e-12
time O 0 2.8747425447062103e-12
intervals O 0 8.545712748553314e-11
of O 0 6.156329335205157e-10
1 O 0 2.5156586147545568e-08
- O 0 2.420405653680291e-09
7 O 0 3.3165095114640053e-09
years O 0 7.847167915464581e-10
. O 0 3.000551140885932e-09

We O 0 3.9771927973220045e-09
have O 0 9.452221123862348e-12
found O 0 6.7928057926811e-13
a O 0 6.108015026921876e-13
direct O 0 7.921689346157557e-12
progression O 0 5.412877701616026e-09
of O 0 8.161942788298404e-10
the O 0 2.7420224077423505e-11
size O 0 9.81703975923287e-13
heterogeneity O 0 6.548776798620537e-11
over O 0 1.798714996392725e-11
time O 0 3.888423263931351e-11
related O 0 1.0871998440409314e-10
to O 0 3.379790197710619e-11
initial O 0 1.0020693608225884e-08
CTG O 0 1.013101609714795e-06
repeat O 0 5.67297231413022e-09
size O 0 2.5547054055552465e-11
and O 0 4.881677527490691e-12
the O 0 1.0665370496487636e-11
time O 0 4.182470342284361e-12
interval O 0 1.8486566721875874e-09
and O 0 9.660243438514016e-11
always O 0 4.202447764778405e-11
biased O 0 1.6070490424513473e-11
towards O 0 1.6233670224047314e-12
further O 0 6.105083018986823e-12
expansion O 0 2.580723412748398e-09
. O 0 3.655438840510783e-09

Attempts O 0 1.687130257721492e-08
to O 0 4.8302025573709884e-11
mathematically O 0 4.865489677818857e-10
model O 0 2.195203047117289e-10
the O 0 3.7786085371749323e-10
dynamics O 0 4.954540111512529e-10
have O 0 2.6519068191399597e-11
proved O 0 1.290046069968298e-09
only O 0 4.7445717493710404e-11
partially O 0 1.0409186401716397e-08
successful O 0 2.9774946397331803e-10
suggesting O 0 3.13513347227623e-11
that O 0 2.5023483719160966e-13
individual O 0 3.8930179745025675e-14
specific O 0 2.0174788489119022e-12
genetic O 0 1.6806986358197662e-10
and O 0 2.939758159126171e-11
/ O 0 7.361327192256795e-08
or O 0 4.223001462411169e-11
environmental O 0 1.1282224043895894e-08
factors O 0 1.8811724747380687e-11
also O 0 2.085025077938618e-12
play O 0 5.51503322177016e-11
a O 0 8.303838519574391e-12
role O 0 9.383996184275656e-12
in O 0 3.566462403181703e-11
somatic O 0 4.237361750369928e-08
mosaicism O 0 8.003028142411495e-07
. O 0 1.2958808470742156e-09
. O 0 9.243600551656073e-09

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 2.4439776424856063e-08
Palestinian O 0 7.348126587203296e-07
Arabs O 0 1.390488080232899e-07
. O 0 7.174635641149507e-08

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.9999994039535522
AGU B-Disease 1 1.0
) O 0 2.7458754714437816e-10
is O 0 4.325595003712435e-12
a O 0 2.5418446861213972e-11
rare O 0 4.443360808181751e-07
disorder B-Disease 1 1.0
of I-Disease 0 0.15102416276931763
glycoprotein I-Disease 0 0.0001606504083611071
metabolism I-Disease 1 0.999771773815155
caused O 0 1.8908012933138707e-08
by O 0 1.3694764072758048e-11
the O 0 1.1505168373560082e-07
deficiency B-Disease 1 0.9861035346984863
of I-Disease 0 0.21572867035865784
the I-Disease 0 2.802724156936165e-05
lysosomal I-Disease 1 0.9438658952713013
enzyme I-Disease 0 7.91931409338531e-09
aspartylglucosaminidase I-Disease 0 6.594335104637139e-07
( O 0 3.0263913597394776e-10
AGA O 0 6.477281999650586e-07
) O 0 3.3366592822048347e-10
. O 0 3.2226479262931207e-09

AGU B-Disease 1 1.0
is O 0 1.690509243701399e-08
inherited O 0 1.2145692096510174e-07
as O 0 1.2376961955329335e-10
an O 0 2.9099068640792147e-11
autosomal O 0 0.00013984261022415012
recessive O 0 8.984772648545913e-06
trait O 0 2.0125008326488114e-09
and O 0 8.797323980402894e-12
occurs O 0 7.66765774137812e-13
with O 0 3.757012604667376e-14
a O 0 2.7552532737978863e-12
high O 0 9.856614656411633e-12
frequency O 0 3.199176340507037e-11
in O 0 5.4835944812703374e-12
Finland O 0 2.0255364052701452e-09
because O 0 2.8494635470610596e-11
of O 0 1.3749766880621905e-09
a O 0 1.2936213211744985e-09
founder O 0 2.1037042330362965e-08
effect O 0 7.482115904622333e-08
. O 0 1.433108476334155e-08

While O 0 3.739706322392067e-09
very O 0 5.3700426050351524e-11
few O 0 6.176791716994146e-11
patients O 0 7.941056839877447e-11
with O 0 7.574552651767874e-10
AGU B-Disease 1 1.0
have O 0 1.0271704493913791e-11
been O 0 7.145761304720721e-13
reported O 0 2.585507220646821e-13
from O 0 1.2783629406779018e-12
non O 0 3.424981187549747e-08
- O 0 5.09807474013968e-10
Finnish O 0 5.134378699978015e-09
origin O 0 3.216792457405582e-11
, O 0 6.033058601306873e-12
we O 0 2.703911920753921e-11
diagnosed O 0 3.4868882892169495e-08
the O 0 3.1416119705696133e-10
disorder O 0 2.107410637108842e-06
in O 0 1.2156196882440184e-10
8 O 0 1.5351045590250578e-07
patients O 0 2.1263765054291284e-11
originating O 0 9.152237995246892e-12
from O 0 1.360785008980292e-11
3 O 0 2.6042123124625505e-08
unrelated O 0 3.834673689695478e-10
families O 0 3.250767981622521e-13
, O 0 7.673846367378667e-13
all O 0 3.79925908441936e-12
Palestinian O 0 9.289071178919528e-10
Arabs O 0 1.0759748127198154e-11
from O 0 1.725038731650863e-12
the O 0 9.948426631101182e-12
region O 0 6.150809722660355e-11
of O 0 5.796831348270359e-10
Jerusalem O 0 7.22829383903445e-07
. O 0 1.1250597964362896e-07

The O 0 3.490633115887931e-09
clinical O 0 1.6291436622850597e-05
diagnosis O 1 0.9999464750289917
of O 1 0.9999996423721313
AGU B-Disease 1 1.0
is O 0 1.368960624859028e-07
often O 0 1.0181296777878046e-11
difficult O 0 5.085114621050657e-12
, O 0 2.6606286076223673e-13
in O 0 3.7007506434316717e-13
particular O 0 2.8205491327953913e-12
early O 0 8.672096374340299e-11
in O 0 3.5141757125795037e-12
the O 0 5.710278083714826e-11
course O 0 1.8191871342665422e-09
of O 0 2.6535576513886383e-10
the O 0 2.1846240372269676e-09
disease O 0 2.9418545182124944e-06
, O 0 2.336845994488357e-12
and O 0 3.2581626199096325e-12
most O 0 7.192128836930323e-13
of O 0 8.165410708693699e-11
the O 0 1.215541445276358e-09
patients O 0 5.8013191472916503e-11
are O 0 1.9045589758071024e-12
diagnosed O 0 6.004388652947057e-10
after O 0 1.729029558417139e-10
the O 0 1.272739275082202e-10
age O 0 1.0527377580782371e-10
of O 0 5.469060204710274e-10
5 O 0 9.713983395442938e-09
years O 0 3.381999125195989e-09
. O 0 1.2822972017545453e-08

However O 0 2.6947706288638074e-09
, O 0 3.142502924546875e-11
since O 0 2.3846208341282704e-10
these O 0 1.4627578662218532e-11
patients O 0 8.902280822231656e-12
excrete O 0 1.1702949720415745e-10
early O 0 2.1784771209176768e-10
large O 0 1.0382436013353646e-12
amounts O 0 5.341964392537035e-13
of O 0 3.473766066464101e-11
aspartylglucosamine O 0 3.452381713842101e-09
in O 0 3.2658979687294476e-11
urine O 0 8.494048346630034e-12
, O 0 1.7024684613453633e-12
biochemical O 0 3.988966379431247e-10
screening O 0 3.842751450378046e-09
is O 0 9.40300528412541e-12
easy O 0 5.18838028096269e-11
by O 0 9.407382858817037e-12
urine O 0 4.433948000426291e-11
chromatography O 0 9.972635217625481e-11
. O 0 4.010510534779854e-10
. O 0 7.341749430622713e-09

Detection O 0 8.541911711290595e-08
of O 0 2.2961879064808954e-09
heterozygous O 0 1.8098521292753134e-10
carriers O 0 3.5165629089228823e-12
of O 0 8.524777411755835e-11
the O 0 2.067633886326803e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.0258914926453144e-06
ATM O 0 9.677991329226643e-05
) O 0 4.683081613471307e-12
gene O 0 1.564856404179249e-11
by O 0 1.2786732610237106e-11
G2 O 0 2.2904333718543057e-07
phase O 0 3.362857725619506e-08
chromosomal O 0 1.8708594780036947e-06
radiosensitivity O 0 2.7224507448408986e-06
of O 0 2.2105587049736641e-07
peripheral O 0 0.0010737900156527758
blood O 0 1.5479852066846433e-08
lymphocytes O 0 4.231191397252587e-08
. O 0 4.3270289573627e-09

In O 0 1.6946469258982688e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 1.0
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.1825912471508104e-10
patients O 0 5.16282936541268e-12
, O 0 3.161236734623013e-14
mutations O 0 5.459960486660885e-14
in O 0 2.2820284615969466e-13
a O 0 1.7499630217132633e-12
single O 0 7.445983933596079e-12
gene O 0 4.865734985065595e-12
, O 0 4.3856224533032895e-13
ATM O 0 1.067095634077475e-09
, O 0 1.5447922617744386e-14
result O 0 1.1510665467659442e-13
in O 0 5.3691226405182604e-14
an O 0 4.026750460850437e-11
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 3.197860309889222e-10
embraces O 0 3.454310171235875e-10
a O 0 6.124837507830161e-13
variety O 0 2.586248272831715e-12
of O 0 1.1284273862544048e-11
clinical O 0 7.420418501880022e-09
features O 0 3.7590131007902983e-10
and O 0 6.080353668475036e-12
manifests O 0 2.288372616399137e-11
extreme O 0 1.762111523362364e-08
radiosensitivity O 0 7.881801025177992e-07
and O 0 1.403504951147383e-10
a O 0 4.4799058906974665e-10
strong O 0 1.0969402053362387e-09
pre O 1 0.8716253042221069
- O 0 3.942019702662947e-06
disposition O 0 5.223655989539111e-06
to O 0 7.423150538699019e-09
malignancy B-Disease 0 0.4929693341255188
. O 0 7.801597945444882e-08

Heterozygotes O 0 1.0341904754795905e-07
for O 0 4.083803573085021e-10
the O 0 1.7131912555257145e-09
ATM O 0 1.7850679512321221e-07
gene O 0 1.1748753359075437e-10
have O 0 2.7798184761007594e-13
no O 0 3.2368408626158585e-13
clinical O 0 2.0096230235466805e-10
expression O 0 6.674441554999078e-10
of O 0 4.046324306727911e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 1.612638356185414e-10
may O 0 1.9509427406916302e-10
be O 0 8.318411237606682e-11
cancer B-Disease 0 1.6001291669454076e-06
prone O 0 2.7147342707145583e-10
with O 0 1.3246150053561334e-12
a O 0 7.442878258157037e-11
moderate O 0 1.034625607410078e-09
increase O 0 8.313520878655556e-12
in O 0 5.7841136394398696e-12
in O 0 6.709539174254431e-11
vitro O 0 1.9671075790483883e-07
radiosensitivity O 0 1.0562721399764996e-05
. O 0 8.459481648515066e-08

We O 0 3.0753888324852596e-09
performed O 0 3.1213178708355827e-09
a O 0 2.01362496121682e-10
blind O 0 2.407242849500335e-09
chromosomal O 0 2.7621201326155642e-08
analysis O 0 2.7604727531604922e-11
on O 0 4.062852276831563e-09
G2 O 0 4.0417070579223946e-08
- O 0 6.283942810547671e-11
phase O 0 2.166518492385805e-10
lymphocytes O 0 6.622380161608321e-12
from O 0 1.2315529726667634e-13
7 O 0 2.989142544596035e-10
unrelated O 0 7.741962804175273e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 3.992271846442463e-09
, O 0 7.613388001634358e-13
13 O 0 3.528429631804997e-11
obligate O 0 6.792715723236142e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 8.143477003841326e-08
( O 0 6.593351082120891e-13
parents O 0 2.778083922031372e-14
of O 0 1.947750554592842e-12
the O 0 1.8784439281827048e-11
patients O 0 2.0216842794035933e-13
) O 0 6.632431877876465e-15
, O 0 7.444229694480997e-14
and O 0 1.201682958869299e-12
14 O 0 1.2993080222845066e-10
normal O 0 3.9632952475443517e-10
controls O 0 2.296639101118103e-09
following O 0 6.543283276316814e-11
X O 0 1.5860432966974258e-08
- O 0 5.5284929412202644e-11
irradiation O 0 2.6359562102507006e-11
with O 0 1.5893226405078176e-12
1 O 0 8.264692263892925e-10
Gy O 0 5.818002080104634e-09
in O 0 8.393596147987514e-13
order O 0 4.738745420368451e-12
to O 0 5.549267642623867e-13
evaluate O 0 5.834506922736127e-12
this O 0 9.662187499745456e-13
cytogenetic O 0 3.653480407095344e-09
method O 0 1.2590252451705197e-10
as O 0 1.220646934224634e-11
a O 0 1.4743426965391215e-11
tool O 0 6.19344020513779e-10
for O 0 1.4682475721339294e-11
detection O 0 3.5425085087581465e-08
of O 0 1.1267729860264808e-08
ATM O 0 1.3537369341065641e-05
carriers O 0 6.913622563331501e-09
. O 0 7.957652314871666e-09

Both O 0 1.734132865749416e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 3.738895486549154e-07
and O 0 9.538700558586743e-12
heterozygotes O 0 2.1080159839925727e-10
showed O 0 9.69198245964753e-12
significantly O 0 6.032178337563032e-14
increased O 0 2.6270646899181904e-13
levels O 0 1.7541838207707494e-12
of O 0 5.972959106481657e-12
radiation O 0 4.542356236925116e-06
- O 0 1.1748747397177794e-07
induced O 0 1.7262049368582666e-05
chromatid O 0 7.457313586201053e-06
damage O 0 1.5032797762160044e-07
relative O 0 1.243189856614535e-10
to O 0 4.794711719671718e-13
that O 0 3.6247648762741114e-13
of O 0 1.443738323336774e-10
normal O 0 1.6367298627528726e-08
controls O 0 6.298182029240706e-07
. O 0 9.509251164274701e-09

These O 0 9.137886280985441e-11
results O 0 4.84170412096141e-11
show O 0 6.600139185186649e-11
that O 0 1.7069426384505593e-12
the O 0 3.0959745878078593e-10
G2 O 0 7.936387760310026e-07
- O 0 4.39449898692601e-09
phase O 0 1.370602031869339e-08
chromosomal O 0 1.7256236333196284e-06
radiosensitivity O 0 8.504148496513153e-08
assay O 0 1.5861665314531592e-09
can O 0 6.973576447202867e-13
be O 0 6.27262862961872e-14
used O 0 9.903730294896513e-15
for O 0 4.5018760990106835e-14
the O 0 1.4885605768844012e-12
detection O 0 6.2366760644749775e-09
of O 0 1.289050004515957e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 5.421691639639903e-06
. O 0 1.77814172275248e-08

In O 0 1.5741561387727643e-09
combination O 0 9.36994815070591e-10
with O 0 4.767011004686017e-12
molecular O 0 9.719913762751275e-09
genetic O 0 2.467386073234934e-09
analyses O 0 3.4287472167049415e-11
, O 0 2.8320258464720194e-12
this O 0 7.065475591747084e-13
test O 0 1.5566795075194761e-10
may O 0 5.736482794858888e-13
be O 0 2.0335016426265527e-14
of O 0 1.1593048569735753e-13
value O 0 1.0107818309559521e-13
in O 0 2.7146665652704426e-14
studies O 0 2.9267975304621274e-13
of O 0 3.534867494200955e-12
familial B-Disease 0 8.385528937893127e-10
and I-Disease 0 3.388930455705541e-11
sporadic I-Disease 0 1.05196193089796e-06
cancers I-Disease 0 4.6568681000280776e-07
aimed O 0 1.1009604339307089e-09
at O 0 4.0012959612312216e-10
determination O 0 2.1249749182494782e-10
of O 0 4.823189625469126e-10
the O 0 7.070362351146997e-11
potential O 0 2.2602071256261347e-11
involvement O 0 2.8046617805976837e-10
of O 0 6.612709491093938e-09
ATM O 0 0.0003262183163315058
mutations O 0 1.3125200926111802e-09
in O 0 1.2360147350065631e-09
tumor B-Disease 0 0.000683253281749785
risk O 0 7.803502910519455e-08
or O 0 4.136434944568279e-11
development O 0 2.5591508912015115e-09
. O 0 2.9578586802081475e-10
. O 0 5.8658371493436334e-09

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 8.927461294661043e-07
identification O 0 7.176429051014566e-08
and O 0 6.624692114320929e-12
detection O 0 7.471845364648289e-09
of O 0 5.256237223250082e-09
founder O 0 2.3733255716251733e-07
- O 0 3.2022504647954975e-09
effect O 0 4.676991682828202e-09
mutations O 0 1.2622561849917613e-11
in O 0 9.158034573741869e-12
the O 0 8.805924045507396e-11
ATM O 0 3.386674052308081e-08
gene O 0 7.40388375608525e-11
in O 0 5.041886179391053e-12
ethnic O 0 1.5100293238035079e-10
populations O 0 7.096035425924185e-10
. O 0 4.070368042619066e-09

To O 0 2.7338875607796354e-10
facilitate O 0 8.283456698343628e-10
the O 0 3.8126782286873606e-10
evaluation O 0 8.691574682195835e-10
of O 0 8.22820567236704e-09
ATM O 0 0.0001300186850130558
heterozygotes O 0 1.2722794373587476e-08
for O 0 2.3203961321827116e-11
susceptibility O 0 2.877747595775304e-09
to O 0 1.6202149214286643e-12
other O 0 5.919777688878636e-12
diseases O 0 0.279274046421051
, O 0 1.3313373840861953e-12
such O 0 3.3940798088716306e-11
as O 0 5.436199046471302e-09
breast B-Disease 0 0.0020951339974999428
cancer I-Disease 0 0.0022034936118870974
, O 0 3.5306260692813396e-10
we O 0 8.639193527226752e-11
have O 0 1.3823558183551077e-12
attempted O 0 2.053049223682546e-11
to O 0 1.3738204909623242e-13
define O 0 6.7778478142488385e-12
the O 0 6.257040892354571e-12
most O 0 4.336753124580678e-13
common O 0 9.663975349127885e-13
mutations O 0 1.1561118815756055e-13
and O 0 3.0872355317795516e-14
their O 0 3.201472832496666e-14
frequencies O 0 2.8028892141290784e-12
in O 0 7.17256365412311e-10
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 1.0
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 6.520608358817626e-11
homozygotes O 0 5.1720427940438185e-09
from O 0 5.421001321448404e-12
10 O 0 2.9772944526440526e-11
ethnic O 0 2.0205692674579723e-10
populations O 0 6.37754848931138e-10
. O 0 4.451738977451214e-09

Both O 0 1.797907267508947e-09
genomic O 0 5.8943829372992695e-08
mutations O 0 9.350719087919401e-10
and O 0 1.7561707643665159e-10
their O 0 5.04194706818506e-11
effects O 0 6.41834718706491e-09
on O 0 2.2741899474709726e-09
cDNA O 0 1.908180813359195e-08
were O 0 3.067069098694475e-10
characterized O 0 9.959794766700725e-09
. O 0 1.3953706634595164e-08

Protein O 0 5.19789411512761e-09
- O 0 3.3057225845567473e-09
truncation O 0 5.320156759580641e-08
testing O 0 2.205574611835459e-09
of O 0 2.7800031721092466e-10
the O 0 1.358000933926462e-10
entire O 0 2.3799182069517144e-10
ATM O 0 3.171312101812873e-09
cDNA O 0 2.6443974787682123e-10
detected O 0 2.9707996479499954e-11
92 O 0 1.4643217194354463e-10
( O 0 3.625755294958677e-12
66 O 0 2.2677695832307165e-10
% O 0 9.58987056431937e-12
) O 0 1.091114611856403e-12
truncating O 0 6.993460810456043e-10
mutations O 0 1.1384842721340327e-11
in O 0 1.125046843880595e-11
140 O 0 8.709775262127906e-11
mutant O 0 1.371859403853648e-09
alleles O 0 7.616998004555953e-11
screened O 0 2.284285649523099e-08
. O 0 6.713527067603309e-09

The O 0 3.270828301538131e-07
haplotyping O 0 0.013840778730809689
of O 0 0.00033836354850791395
patients O 0 2.7424134074749418e-08
with O 0 2.0177925996733848e-10
identical O 0 1.2497127954702592e-07
mutations O 0 7.835681548051809e-10
indicates O 0 3.872172305019461e-10
that O 0 2.2258141510467233e-12
almost O 0 5.817619302961319e-11
all O 0 3.4449915142786836e-11
of O 0 7.025761639134487e-10
these O 0 1.1528886569370234e-12
represent O 0 4.423352743115894e-12
common O 0 3.548616608894939e-11
ancestry O 0 4.022633788569596e-12
and O 0 9.470790471310941e-12
that O 0 3.8078047659428904e-12
very O 0 3.256629688141999e-11
few O 0 3.8032213489636035e-10
spontaneously O 0 9.182146709640904e-10
recurring O 0 4.840927303462195e-08
ATM O 0 8.907629307941534e-06
mutations O 0 1.798709958755751e-09
exist O 0 3.4794127579118594e-09
. O 0 7.0909242921857185e-09

Assays O 0 4.0573247872544016e-08
requiring O 0 4.462968050678029e-10
minimal O 0 5.616180853706965e-09
amounts O 0 1.0972320274582614e-11
of O 0 5.2993668481216005e-11
genomic O 0 1.0487660739855187e-09
DNA O 0 2.4322297509371538e-09
were O 0 2.8510400637560274e-11
designed O 0 1.6043815581623377e-11
to O 0 1.3027810167459686e-12
allow O 0 7.622269135310056e-12
rapid O 0 2.8297339471627936e-10
screening O 0 1.4964417205387548e-10
for O 0 1.5676936745284697e-12
common O 0 1.1151871960601856e-11
ethnic O 0 6.874850688731726e-11
mutations O 0 5.93929294634421e-10
. O 0 2.281898225930945e-09

These O 0 3.4873040566374414e-10
rapid O 0 1.6654395640358644e-09
assays O 0 1.5234409567188578e-10
detected O 0 3.4469895687783136e-11
mutations O 0 9.640594529278235e-13
in O 0 5.719799091828681e-13
76 O 0 1.015006551030595e-10
% O 0 6.597090061732924e-12
of O 0 4.171862300061946e-10
Costa O 0 0.0003455167752690613
Rican O 0 9.72052730503492e-05
patients O 0 1.7096072335576196e-09
( O 0 2.263536580393577e-12
3 O 0 1.801898907860533e-10
) O 0 8.67861961765734e-14
, O 0 9.085648086746417e-14
50 O 0 4.1439245155976134e-13
% O 0 1.8840791015002634e-13
of O 0 3.303840534485403e-11
Norwegian O 0 1.7959602018891019e-06
patients O 0 1.4789182101182519e-09
( O 0 3.6986707099839755e-12
1 O 0 3.3191022152934124e-10
) O 0 4.5162729486085754e-14
, O 0 3.6279237670662837e-14
25 O 0 4.752737374665028e-13
% O 0 3.3768097367804784e-13
of O 0 3.413588856027161e-11
Polish O 0 6.984321885283862e-07
patients O 0 2.125705611533135e-09
( O 0 1.26105289405265e-11
4 O 0 2.7156781268189434e-09
) O 0 3.3914616449394475e-13
, O 0 1.3006102813663267e-13
and O 0 6.387752739950292e-13
14 O 0 3.8384625339338285e-11
% O 0 5.232313280562062e-12
of O 0 1.0100091873965766e-09
Italian O 0 3.6710433050757274e-05
patients O 0 6.1617950741776895e-09
( O 0 1.1740906857848898e-11
1 O 0 4.5275485582862984e-09
) O 0 5.259736873472476e-13
, O 0 3.1820482663744154e-13
as O 0 6.674545898616158e-13
well O 0 4.052063318129434e-13
as O 0 4.3959486658445845e-13
in O 0 2.9756806827624382e-12
patients O 0 3.063885299983693e-12
of O 0 1.247384556757325e-10
Amish O 0 2.965912138108706e-08
/ O 0 1.4616784937970806e-07
Mennonite O 0 4.062474445731823e-08
and O 0 2.417294697742989e-10
Irish O 0 1.6645003597659525e-08
English O 0 9.214467411311489e-09
backgrounds O 0 2.1572223118937472e-08
. O 0 2.4842787382794995e-08

Additional O 0 2.408795163333366e-09
mutations O 0 3.893858013803708e-10
were O 0 3.074975343797526e-11
observed O 0 2.0077448384392405e-11
in O 0 1.425228424861702e-11
Japanese O 0 6.074057257166032e-09
, O 0 3.086368660643046e-11
Utah O 0 1.5383948559488658e-09
Mormon O 0 4.505662856701953e-11
, O 0 5.168189660953448e-12
and O 0 9.866225891830283e-12
African O 0 9.355964891710755e-10
American O 0 5.599634089747951e-09
patients O 0 7.094346887726033e-09
. O 0 1.2612112243459705e-08

These O 0 1.3585864377940737e-10
assays O 0 5.014625381605242e-10
should O 0 5.389114501874737e-12
facilitate O 0 5.921946093223607e-12
screening O 0 6.797585827555963e-10
for O 0 8.370959037051762e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 7.909562782515422e-09
in O 0 4.401857784525065e-12
the O 0 5.286331702242242e-12
populations O 0 3.4723400370306745e-12
studied O 0 2.0803873901353853e-10
. O 0 1.4222500954730322e-10
. O 0 3.3134870403017658e-09

The O 0 1.9856988728861324e-06
von B-Disease 1 0.9999977350234985
Hippel I-Disease 1 0.9999997615814209
- I-Disease 1 0.9999572038650513
Lindau I-Disease 0 0.04024582728743553
tumor I-Disease 0 1.1257223377469927e-05
suppressor O 0 3.8418454550992465e-07
gene O 0 4.28181240463843e-11
is O 0 1.32613104525392e-13
required O 0 2.8141958164848435e-13
for O 0 7.971110750626398e-13
cell O 0 1.9242207827119273e-09
cycle O 0 2.3263897475089834e-09
exit O 0 1.1862154591923968e-09
upon O 0 7.79860724609005e-12
serum O 0 1.0901089059212055e-10
withdrawal O 0 3.872735465648702e-09
. O 0 9.182671845131551e-10

The O 0 6.44993818355033e-08
inactivation O 0 1.0295786523784045e-05
of O 0 3.4551246130831714e-07
the O 0 2.8277739261284296e-07
von B-Disease 1 0.9999990463256836
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 0.9999997615814209
( I-Disease 0 4.400970283313654e-06
VHL I-Disease 0 0.2488669604063034
) I-Disease 0 8.265149120667559e-10
tumor I-Disease 0 1.1584896810745704e-06
suppressor O 0 2.0212388335494325e-05
gene O 0 2.526945408476422e-08
predisposes O 0 6.528177443065886e-10
affected O 0 1.514349236286794e-11
individuals O 0 3.9224140835304386e-14
to O 0 1.4293348948000995e-13
the O 0 2.650507591184237e-10
human O 1 0.9999693632125854
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 3.033018280973465e-11
is O 0 2.152494355716142e-13
associated O 0 3.481538625102476e-12
with O 0 2.1383819194531473e-12
sporadic B-Disease 1 1.0
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 1.586442621714923e-08
RCC B-Disease 1 0.9613000750541687
) O 0 1.416146089283643e-10
and O 0 2.831247014611904e-09
brain B-Disease 1 0.7075116038322449
hemangioblastomas I-Disease 0 0.029905101284384727
. O 0 1.4117036073457712e-07

VHL O 1 0.9944894313812256
- O 0 1.1554858247109223e-05
negative O 0 6.75298181818107e-08
786 O 0 2.9996999728609808e-06
- O 0 3.869322608807124e-05
0 O 0 2.5061531232495327e-06
RCC B-Disease 0 0.0014274285640567541
cells O 0 3.1249931531363018e-09
are O 0 1.7473749227073232e-12
tumorigenic O 0 4.251908158892093e-09
in O 0 6.057876422715935e-11
nude O 0 3.551626326370183e-09
mice O 0 2.678116617360615e-10
which O 0 5.396960547736362e-13
is O 0 1.2125333560559365e-13
suppressed O 0 1.0175744795393182e-11
by O 0 9.575372179188024e-13
the O 0 1.0820981610759617e-10
reintroduction O 0 6.613607439476255e-08
of O 0 8.97230467700183e-09
VHL B-Disease 0 5.2857685659546405e-05
. O 0 1.1443135150557282e-07

Remarkably O 0 1.9040949439386168e-07
, O 0 1.0932405675179169e-10
this O 0 2.7495729217758003e-12
occurs O 0 7.892973601097975e-12
without O 0 4.828682245716642e-11
affecting O 0 2.1881624984176895e-11
the O 0 3.89526744193347e-11
growth O 0 1.5530473573832637e-09
rate O 0 2.2860104920141566e-09
and O 0 7.798164891603676e-11
cell O 0 7.034738018774078e-07
cycle O 0 8.01040727083091e-08
profile O 0 6.273272179502243e-11
of O 0 1.2294494589060179e-10
these O 0 1.7449369857022723e-12
cells O 0 6.925728220086302e-12
in O 0 5.607727390083417e-12
culture O 0 5.99580551874368e-10
. O 0 1.4116835478361622e-09

The O 0 3.6943038139725104e-07
786 O 0 2.2466488758254854e-07
- O 0 1.9189555189313978e-07
0 O 0 1.6866218643940556e-08
cell O 0 6.699330867832032e-08
line O 0 2.8991071765460674e-09
, O 0 2.1993793505176162e-12
like O 0 2.9454982290039178e-12
many O 0 8.554983436069585e-13
cancer B-Disease 0 8.007588481184769e-10
cells O 0 4.6615798027227484e-11
, O 0 1.3129587477997418e-12
fails O 0 7.140155827700667e-11
to O 0 1.929042862947039e-12
exit O 0 8.010464291885455e-09
the O 0 1.2431496110298923e-10
cell O 0 9.200413209065061e-10
cycle O 0 1.757263085044869e-10
upon O 0 8.814320801020514e-12
serum O 0 1.2923037640000246e-10
withdrawal O 0 7.659224365852424e-09
. O 0 1.8205998930653777e-09

Here O 0 2.1858589605017187e-08
, O 0 1.895203438628812e-11
it O 0 1.074331121568746e-13
is O 0 2.359807533029116e-14
shown O 0 1.1248676144194614e-13
that O 0 3.399957724213587e-14
reintroduction O 0 1.5036977218940706e-10
of O 0 3.167724069164102e-11
the O 0 9.44453126816569e-11
wild O 0 7.659896716916137e-09
- O 0 2.3950055272337067e-09
type O 0 3.734737852312264e-09
VHL B-Disease 0 2.814080630741955e-07
gene O 0 2.269162635570865e-10
restores O 0 2.302933843623123e-09
the O 0 4.081177062964514e-11
ability O 0 1.7478024236239342e-11
of O 0 6.71734401436197e-09
VHL O 1 0.9931446313858032
- O 0 2.789849713735748e-05
negative O 0 6.64053061427694e-08
RCC B-Disease 1 0.9999022483825684
cancer I-Disease 0 6.916295660630567e-07
cells O 0 1.5422192689573677e-10
to O 0 8.139920161520653e-12
exit O 0 7.867032536523766e-08
the O 0 3.932534853312575e-10
cell O 0 2.0481749629652768e-08
cycle O 0 1.05043562736995e-09
and O 0 1.2524046036355152e-11
enter O 0 4.2796344246198714e-10
G0 O 0 1.2982834505237406e-06
/ O 0 3.926473812754239e-09
quiescence O 0 1.1762352869482129e-08
in O 0 9.799165645585362e-11
low O 0 1.97556495606932e-08
serum O 0 1.3641965779243037e-08
. O 0 1.6271988201310705e-08

Both O 0 1.6944646574756916e-07
VHL O 0 0.005599353462457657
- O 0 4.407794165217638e-07
positive O 0 1.9312362820045337e-09
and O 0 1.1463697546787444e-08
VHL O 0 0.030594980344176292
- O 0 5.471157464853604e-07
negative O 0 2.6922444718024963e-08
RCC B-Disease 0 0.0008517854730598629
cells O 0 7.015256642262102e-08
exit O 0 2.5922990971594118e-06
the O 0 6.73148758956188e-10
cell O 0 6.755659143209414e-09
cycle O 0 2.6189736490600524e-10
by O 0 4.801586645647449e-12
contact O 0 1.1908944941296795e-09
inhibition O 0 5.0044352661871017e-08
. O 0 2.8167148613533755e-09

The O 0 9.190178928975001e-08
cyclin O 0 1.1172544134296913e-07
- O 0 2.681635891121914e-08
dependent O 0 1.2954088912664474e-09
kinase O 0 3.1525981825097915e-09
inhibitor O 0 1.1177095915471114e-09
, O 0 5.884901507074991e-12
p27 O 0 7.458399453597053e-10
, O 0 8.21374706531236e-13
accumulates O 0 7.544463643226196e-13
upon O 0 6.43791389556142e-13
serum O 0 1.2047466973683085e-12
withdrawal O 0 2.2627694856725e-11
, O 0 8.351449414835399e-14
only O 0 3.192302176183333e-14
in O 0 1.1420850159690743e-13
the O 0 3.1925124436421592e-12
presence O 0 3.5726697208277036e-12
of O 0 5.775575573352398e-10
VHL B-Disease 0 1.7469039903517114e-06
, O 0 1.784914750724287e-11
as O 0 4.7489516659393605e-12
a O 0 8.65089683915743e-12
result O 0 2.087071140910446e-11
of O 0 5.991915297265393e-11
the O 0 7.297778353843043e-11
stabilization O 0 4.311024781600281e-08
of O 0 3.97492527781651e-09
the O 0 1.4921511137799826e-08
protein O 0 9.200982731272234e-08
. O 0 4.459245062093942e-08

We O 0 2.3348980526805008e-09
propose O 0 3.1465652305939784e-10
that O 0 1.082611105797382e-12
the O 0 5.088629517757681e-11
loss O 0 5.635417688054645e-10
of O 0 4.043278156729002e-09
wild O 0 7.574731171189342e-07
- O 0 7.496115017602278e-08
type O 0 6.084680848061907e-08
VHL B-Disease 0 7.620998985657934e-06
gene O 0 2.978653435015133e-10
results O 0 1.9250375599133562e-11
in O 0 2.0983182639350284e-12
a O 0 3.729955580511479e-12
specific O 0 1.47439335046462e-11
cellular O 0 5.021923243475612e-06
defect O 0 5.716792088605871e-07
in O 0 1.1193475313309165e-10
serum O 0 3.862002717625046e-09
- O 0 4.264311925794573e-08
dependent O 0 8.799011519400324e-10
growth O 0 9.710013904040693e-10
control O 0 1.2362111334596193e-08
, O 0 2.9030534486745863e-12
which O 0 3.0511138320726827e-12
may O 0 4.810132153698632e-11
initiate O 0 1.359478862816843e-09
tumor B-Disease 0 9.67506394999873e-08
formation O 0 1.2255362058510855e-08
. O 0 8.432445852690762e-09

This O 0 1.3163702072827022e-10
is O 0 5.9874106540791505e-12
corrected O 0 3.143792171034221e-11
by O 0 5.505169887662364e-13
the O 0 2.074411128982767e-11
reintroduction O 0 3.6829075344968487e-09
of O 0 1.0322169785581536e-09
wild O 0 5.395526727625111e-07
- O 0 4.463279310584767e-07
type O 0 3.66040211474683e-07
VHL B-Disease 0 0.03219696879386902
, O 0 1.812692773661695e-09
implicating O 0 1.8850153082894394e-07
VHL B-Disease 0 3.175048914272338e-05
as O 0 5.028091276670921e-10
the O 0 3.3916805475264766e-10
first O 0 1.6275322756165167e-10
tumor B-Disease 0 4.0699097425545006e-09
suppressor O 0 5.660779844873787e-09
involved O 0 3.8240283335710945e-12
in O 0 5.5991448456860216e-12
the O 0 2.4514451579804586e-10
regulation O 0 3.537957482535603e-08
of O 0 4.360458660812583e-09
cell O 0 2.006792328757001e-06
cycle O 0 1.1381457198922362e-07
exit O 0 7.286953973562049e-08
, O 0 2.41861153500722e-12
which O 0 3.568397747427676e-13
is O 0 1.818153375250653e-13
consistent O 0 7.639531368619501e-12
with O 0 6.156366649107126e-13
its O 0 6.074514502518724e-11
gatekeeper O 0 1.068273292048616e-08
function O 0 6.237803051867274e-10
in O 0 5.188518711896073e-11
the O 0 2.3068242871460143e-09
kidney O 0 2.307009481228306e-06
. O 0 1.3495478068392686e-09
. O 0 7.820887937270982e-09

Piebaldism B-Disease 1 1.0
with O 0 0.13707058131694794
deafness B-Disease 1 1.0
: O 0 2.2453809922495793e-09
molecular O 0 8.902714676572998e-10
evidence O 0 1.4586094485014023e-11
for O 0 1.4622380997003637e-12
an O 0 5.321759959792116e-12
expanded O 0 2.089110182623699e-07
syndrome O 1 0.9997424483299255
. O 0 1.3991636649279826e-07

In O 0 3.6008451775870753e-10
a O 0 2.2688510792345795e-10
South O 0 3.457423014552319e-09
African O 0 1.1206532368746025e-09
girl O 0 4.4814951749572174e-10
of O 0 3.956308891606142e-10
Xhosa O 0 3.4201741527795093e-07
stock O 0 2.8073485203172766e-10
with O 0 3.3369867199345427e-12
severe O 0 1.470659117330797e-05
piebaldism B-Disease 0 1.140224230766762e-05
and O 0 4.953075172231536e-10
profound O 1 0.9998915195465088
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 1.1727204984879336e-08
identified O 0 6.7220499999631755e-12
a O 0 6.013296414628111e-13
novel O 0 4.271092160501588e-12
missense O 0 2.4333235426610145e-10
substitution O 0 3.5787159347044906e-10
at O 0 1.0778862247207144e-09
a O 0 4.0853442156985054e-11
highly O 0 1.4288129707162867e-11
conserved O 0 5.0246085070426716e-11
residue O 0 1.9725219235766644e-09
in O 0 1.3929228603881683e-10
the O 0 8.875993273704808e-10
intracellular O 0 5.375487277525792e-10
kinase O 0 1.959719275745897e-09
domain O 0 1.9615216118040735e-09
of O 0 1.3213020011448862e-08
the O 0 2.5661710978397423e-08
KIT O 0 6.80100265526562e-06
proto O 0 7.957016237014614e-07
- O 0 1.4348869115110574e-07
oncogene O 0 1.1583118748603738e-06
, O 0 1.0339253897484468e-09
R796G O 0 3.8210254160730983e-07
. O 0 3.3785834574473483e-08

Though O 0 1.4494318634206138e-08
auditory B-Disease 0 8.831368177197874e-06
anomalies I-Disease 0 4.072104729857529e-06
have O 0 6.551034454488347e-12
been O 0 6.123331008911492e-13
observed O 0 2.231497755675327e-12
in O 0 2.3210322552813523e-12
mice O 0 2.4087204453238087e-10
with O 0 8.1698155185439e-12
dominant O 0 3.102933260379359e-05
white O 0 1.1066581429020061e-08
spotting O 0 1.6680003511737596e-07
( O 0 1.0618533829998e-09
W O 0 0.0008899705717340112
) O 0 2.6008873874050487e-11
due O 0 1.7000512997356054e-08
to O 0 1.0232445446511917e-10
KIT O 0 0.0010501152137294412
mutations O 0 3.3778728703026673e-09
, O 0 1.973497631979626e-08
deafness B-Disease 1 1.0
is O 0 3.847347995744599e-10
not O 0 9.891357481348062e-13
typical O 0 7.325917650291558e-12
in O 0 4.613283713372773e-12
human O 0 2.844594004791645e-10
piebaldism B-Disease 0 1.2984477848476672e-07
. O 0 1.5801582264884928e-08

Thus O 0 4.695133726251299e-10
, O 0 1.670316988021392e-12
the O 0 6.293351798893065e-13
occurrence O 0 4.950260756864111e-10
of O 0 5.951228487788285e-08
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 8.744206247968123e-09
this O 0 1.1135803217043883e-11
patient O 0 9.424502150912062e-11
extends O 0 2.300449978079322e-12
considerably O 0 1.494080873560774e-13
the O 0 4.283751901378724e-13
phenotypic O 0 2.938649601436083e-10
range O 0 4.205197995377219e-11
of O 0 4.94497359726509e-11
piebaldism B-Disease 0 4.735213110507175e-08
due O 0 1.4861414854294708e-07
to O 0 8.058702594126999e-10
KIT O 0 1.2000259630440269e-05
gene O 0 4.408735321259627e-10
mutation O 0 1.8035245172298708e-11
in O 0 2.7566304273973774e-12
humans O 0 4.713451417365233e-12
and O 0 3.794450430943952e-12
tightens O 0 5.072274822381928e-10
the O 0 8.808774890067816e-12
clinical O 0 5.749526410525618e-10
similarity O 0 1.729754534052219e-11
between O 0 2.8352971012668426e-11
piebaldism B-Disease 0 4.092478533834765e-08
and O 0 6.3217473790511125e-12
the O 0 4.377159659035845e-12
various O 0 3.3983792342706653e-12
forms O 0 1.2971142215878473e-10
of O 0 2.6158412325116842e-08
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 0.9999191761016846
. O 0 1.5706479672417117e-08
. O 0 7.232328869122284e-08

Cycloheximide O 0 4.248442564858124e-06
facilitates O 0 4.542200837676091e-09
the O 0 5.307755901462485e-10
identification O 0 1.1321796833385633e-09
of O 0 2.1727393217929603e-09
aberrant O 0 1.4452185004287799e-09
transcripts O 0 8.467641587905916e-10
resulting O 0 5.268949512804433e-11
from O 0 4.3312168088172065e-12
a O 0 2.2565071339242238e-11
novel O 0 7.31423532851494e-11
splice O 0 1.436784202724084e-08
- O 0 5.1240669485252965e-09
site O 0 5.546017534108216e-10
mutation O 0 2.487560851749393e-11
in O 0 7.792391731875625e-12
COL17A1 O 0 1.4565677020073053e-06
in O 0 3.9399507961723756e-11
a O 0 1.9625311098447895e-10
patient O 0 2.0037564940622588e-09
with O 0 1.177367647819949e-10
generalized O 1 0.9999074935913086
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999998807907104
. O 0 1.1891597750945948e-06

Patients O 0 3.699031125847796e-08
with O 0 2.142160060447651e-10
generalized O 1 0.9990783929824829
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
often O 0 6.625769377599511e-11
show O 0 4.906379122426863e-11
decreased O 0 2.328457149314289e-10
expression O 0 4.1569295228249814e-10
of O 0 1.8169505899834348e-09
type O 0 6.328576063197033e-08
XVII O 0 1.5293416026906925e-06
collagen O 0 6.721268164255889e-08
, O 0 2.2370910679470057e-10
a O 0 2.8654828509999675e-10
transmembrane O 0 3.531651637800337e-09
hemidesmosomal O 0 1.6830291826863686e-08
protein O 0 1.3251974517736187e-10
encoded O 0 4.066412137571085e-12
by O 0 5.5667442877549433e-11
COL17A1 O 0 5.360254817787791e-06
. O 0 4.151711863187302e-08

This O 0 5.2066040368004e-10
report O 0 9.444170445682687e-11
documents O 0 4.2826128060502455e-11
a O 0 7.28420518347761e-11
novel O 0 1.6345569342490762e-10
splice O 0 1.4557682170845965e-08
- O 0 3.963486427949192e-09
site O 0 5.156162719011093e-10
mutation O 0 2.6883046136405575e-11
in O 0 8.010223560839247e-12
COL17A1 O 0 9.835353012022097e-07
in O 0 4.339355610949447e-11
a O 0 3.337805032366248e-10
patient O 0 1.7220466164147297e-09
with O 0 8.798385631170191e-11
generalized O 1 0.9999746084213257
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 2.6797530860989127e-09
and O 0 1.4611356569105283e-10
applies O 0 1.2399148374697688e-10
a O 0 2.5215203189321578e-11
new O 0 1.7783630471002176e-11
methodology O 0 2.7297178406548994e-11
to O 0 7.699767472918451e-13
define O 0 2.7575258049195028e-11
and O 0 1.6755060880391248e-11
characterize O 0 3.4461103415317496e-10
the O 0 2.282384559126882e-10
resulting O 0 2.2294535662048531e-10
mRNA O 0 6.727932100325518e-10
splice O 0 3.0310680187994876e-08
variants O 0 4.49691839321531e-09
. O 0 1.3748620020237468e-08

Mutational O 0 2.496037723176414e-06
analysis O 0 1.6057914997702483e-09
of O 0 2.787651887103948e-08
COL17A1 O 0 0.05335596203804016
identified O 0 1.7277917763180994e-08
a O 0 4.322731061989771e-09
maternally O 0 4.384469232121546e-09
inherited O 0 1.8115047240030435e-08
G O 0 3.84848272005911e-06
- O 0 9.739363804328605e-07
to O 0 5.188388030319402e-08
- O 0 0.3572896718978882
T O 0 1.2414254342729691e-05
transversion O 0 4.3013005779357627e-07
at O 0 5.982397244252979e-09
the O 0 1.4019373162366122e-10
- O 0 5.813215533945204e-11
1 O 0 1.4759501953953702e-10
position O 0 6.789366985282541e-11
of O 0 3.7839456568100616e-10
exon O 0 4.2092487717582117e-08
32 O 0 8.882111046659702e-09
. O 0 1.6995455709434282e-08

This O 0 8.877639956494932e-09
acceptor O 0 1.5296522937191526e-09
splice O 0 1.8355352437993133e-07
- O 0 3.2849570175130793e-08
site O 0 2.9969422499220855e-09
mutation O 0 3.1051172744156474e-10
led O 0 1.899199270072316e-10
to O 0 5.92148335573639e-12
the O 0 1.2613760036472854e-10
formation O 0 2.7282615056023474e-10
of O 0 2.4527557762610286e-09
aberrant O 0 2.42579911713392e-09
transcripts O 0 2.975514723502215e-09
present O 0 3.4404951110289517e-10
at O 0 3.83146101512466e-08
extremely O 0 2.534711107671228e-09
low O 0 1.246553864575617e-07
levels O 0 1.795074950905473e-07
. O 0 1.0297928731972661e-08

Based O 0 2.352156247553694e-09
on O 0 1.9658372707453964e-08
our O 0 2.684775735062317e-10
recent O 0 3.2758799145549133e-11
finding O 0 1.9353569094548995e-11
that O 0 1.3097821438545765e-12
cycloheximide O 0 9.35802191293078e-09
stabilized O 0 3.382142566010771e-08
mutant O 0 1.2652686898206866e-08
COL17A1 O 0 3.1659897103963885e-07
transcripts O 0 5.186938101253702e-10
in O 0 2.9855098428177573e-12
keratinocytes O 0 1.6101335542639816e-10
homozygous O 0 7.99833393960725e-11
for O 0 1.0188309397529682e-11
a O 0 1.3836973233871674e-10
frameshift O 0 1.2496814250084753e-08
mutation O 0 7.104360155718581e-11
, O 0 3.4486842635100823e-12
the O 0 5.118797052894308e-11
effects O 0 1.1303401947770908e-07
of O 0 3.8568742866118555e-08
the O 0 8.122794881160189e-09
splice O 0 3.138788073897558e-08
- O 0 1.941903748914342e-09
site O 0 2.6387594886934096e-10
mutation O 0 9.192475773633912e-12
on O 0 1.6817375270150592e-10
splicing O 0 1.2030585416766826e-09
of O 0 1.2857129805254885e-09
COL17A1 O 0 3.0871626677253516e-07
transcripts O 0 1.4025959282903955e-09
were O 0 2.2478085365262856e-11
determined O 0 1.2065272392280946e-11
using O 0 1.2975244143009768e-11
reverse O 0 5.5825286615629466e-09
transcriptase O 0 1.0807518213695744e-09
polymerase O 0 1.9210551205350868e-10
chain O 0 2.4203177240167406e-09
reaction O 0 2.211495223058968e-11
of O 0 3.962856709449625e-10
total O 0 3.169967899285808e-10
RNA O 0 6.975423016974958e-10
from O 0 1.087553918449613e-11
keratinocytes O 0 6.83163969839029e-10
incubated O 0 1.695005108492964e-10
for O 0 5.292659713274084e-11
2 O 0 1.5310131828982776e-08
. O 0 6.459735857333726e-09

5 O 0 1.989139661873196e-07
h O 0 5.956540594098669e-09
in O 0 1.0268771249988262e-10
the O 0 1.305538455120825e-10
presence O 0 1.1076262823594973e-10
or O 0 7.810103258565348e-11
absence O 0 1.3065411863522058e-08
of O 0 1.794762916063064e-08
10 O 0 1.4787665314486276e-08
microg O 0 5.962533577985596e-07
cycloheximide O 0 8.827973374536668e-07
per O 0 2.8557070042012356e-09
ml O 0 1.5405045417082874e-07
. O 0 8.24570722812723e-09

Using O 0 1.0508879877413335e-10
this O 0 6.014950690302889e-12
approach O 0 1.8457771422397684e-10
, O 0 5.797400753904114e-12
an O 0 1.1085361144649863e-12
abnormally O 0 7.290459902442592e-11
spliced O 0 7.615722497078536e-10
transcript O 0 1.5276432341337909e-09
was O 0 8.07570510463762e-10
identified O 0 1.2133368311809112e-12
that O 0 4.252083711173138e-14
contains O 0 3.9572690827341384e-13
an O 0 3.6914498828576406e-14
extra O 0 8.605241085674065e-13
264 O 0 1.3099021650350706e-12
bases O 0 2.1087992463364458e-11
upstream O 0 1.7577272103108665e-12
from O 0 2.746700436540017e-12
exon O 0 4.5983186702791556e-10
32 O 0 5.855725626613406e-11
, O 0 2.3755346648113296e-12
resulting O 0 1.0742132877661348e-11
in O 0 1.8791856959410325e-11
a O 0 1.266634686025725e-09
premature O 0 2.402441623416962e-08
termination O 0 3.679672389012012e-08
codon O 0 1.9450592247949317e-08
27 O 0 3.101089873780438e-08
bp O 0 2.037968238610688e-09
downstream O 0 2.9730229389457463e-10
from O 0 3.8122834750131673e-11
the O 0 2.5754520738274778e-09
cryptic O 0 5.677778691648427e-09
splice O 0 1.9137415563363902e-07
site O 0 1.1014844858436845e-07
. O 0 1.5008167153496288e-08

Three O 0 8.777225168898894e-09
other O 0 1.1647499631450842e-10
splice O 0 2.751078831408904e-08
variants O 0 1.332243648732856e-09
, O 0 4.5293491179876355e-11
including O 0 2.6116196011338744e-11
one O 0 2.6486300132300133e-12
derived O 0 4.700753675201952e-13
from O 0 3.5159191096728604e-12
the O 0 1.4843405671260967e-10
skipping O 0 1.263731674860935e-09
of O 0 6.64224786284251e-10
exon O 0 5.010870385291355e-09
32 O 0 6.082470638268944e-10
, O 0 9.24957055392639e-11
were O 0 4.656836583016855e-10
also O 0 2.2912736985514215e-10
identified O 0 1.2622959344454898e-09
. O 0 1.6696960258855142e-08

These O 0 4.252636021107037e-10
results O 0 2.0596474525902408e-10
indicate O 0 1.7626466258802154e-11
the O 0 2.6090006891021922e-11
usefulness O 0 5.256615698279177e-10
of O 0 1.0604825351201441e-10
cycloheximide O 0 2.1772290637045444e-08
treatment O 0 1.0424634072636607e-10
in O 0 3.5019780044581728e-12
evaluating O 0 1.4036220970237157e-11
the O 0 3.6074428166887884e-11
abnormal O 0 1.291810824977091e-10
processing O 0 1.4434251571771028e-09
of O 0 9.597236338976245e-10
mRNA O 0 3.6071004516635696e-10
due O 0 1.527748150209618e-09
to O 0 1.532641201451579e-11
splice O 0 1.0014924001211511e-08
- O 0 1.7996226731042952e-09
site O 0 2.0790150156990705e-10
mutations O 0 3.882129860632855e-12
, O 0 1.5283230410390036e-12
because O 0 2.116098962723356e-12
( O 0 1.6967048425964304e-12
i O 0 2.63949816864395e-11
) O 0 7.908550658970726e-13
aberrant O 0 3.224722919248357e-11
splicing O 0 2.8760835379948446e-10
often O 0 2.294331716799769e-13
generates O 0 2.311779240260492e-13
a O 0 1.4103795388520357e-11
premature O 0 3.1371089059817336e-10
termination O 0 2.709406310419382e-10
codon O 0 3.0281294138845283e-10
, O 0 4.8570279742587985e-12
( O 0 4.2244633897785266e-13
ii O 0 5.211094333823496e-10
) O 0 1.3617605307270075e-12
transcripts O 0 1.6429431426434604e-10
with O 0 3.040472734694433e-11
premature O 0 8.065796031075934e-09
termination O 0 7.791478018326359e-10
codons O 0 2.9205399210141536e-10
can O 0 6.604288513636924e-13
occur O 0 2.4922613885841605e-12
at O 0 4.183998703055636e-10
low O 0 3.340672627416552e-09
or O 0 1.2197090559773471e-11
undetectable O 0 1.1640354102837591e-07
levels O 0 3.658855163291008e-10
due O 0 6.270189367718615e-10
to O 0 1.4902792541682253e-12
nonsense O 0 2.9949578927990217e-10
- O 0 7.964047823993958e-12
mediated O 0 8.425653230670349e-11
mRNA O 0 1.2999247511746859e-11
decay O 0 4.846594792162762e-10
, O 0 4.83045569689422e-13
and O 0 9.708943718433893e-13
( O 0 5.616715859774191e-13
iii O 0 1.0919256471231265e-10
) O 0 5.618644655439042e-13
the O 0 1.7986806488679008e-11
levels O 0 1.1221906043301644e-10
of O 0 4.9821036185448975e-11
these O 0 1.5435684414671913e-12
transcripts O 0 4.554766980247038e-11
can O 0 3.4186480144145215e-13
be O 0 2.260053987490282e-13
increased O 0 1.8294528218720796e-12
by O 0 8.465517349620644e-12
cycloheximide O 0 2.74896848395656e-07
. O 0 2.155848477514155e-08

A O 0 2.136213907988349e-07
deletion O 0 2.2205014715837024e-08
mutation O 0 1.5202364367361554e-10
in O 0 3.615460708594753e-11
COL17A1 O 0 1.3504080698112375e-06
in O 0 3.0276733897771635e-10
five O 0 2.0695434255202372e-10
Austrian O 0 3.2588090448371076e-08
families O 0 2.785548181005737e-11
with O 0 4.435700973193235e-10
generalized O 1 0.9999922513961792
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999998807907104
represents O 0 3.8054892570471566e-08
propagation O 0 1.831218287406955e-05
of O 0 4.5774616097560283e-08
an O 0 7.455309980475278e-11
ancestral O 0 1.9849851540243435e-08
allele O 0 2.911698970819998e-08
. O 0 2.465087156622303e-08

Patients O 0 5.5506475860056526e-08
with O 0 6.264666563282617e-10
generalized O 1 0.9997366070747375
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 2.3521518066615954e-09
a O 0 1.440640939875948e-10
usually O 0 9.733256735311446e-12
nonlethal O 0 3.801352121968193e-09
form O 0 2.4222471251000854e-10
of O 0 1.2110387359598462e-08
junctional B-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9952462315559387
, O 0 5.674459860327552e-11
have O 0 2.2926660570021795e-12
generalized O 0 2.174712854241534e-09
blistering B-Disease 0 8.448079711342871e-07
, O 0 1.0859657173512005e-08
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 4.0919758248492144e-07
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 0 1.5935412989165343e-09
and O 0 6.303314137312555e-08
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 1.9229772078688256e-05

Skin B-Disease 1 0.9991633892059326
fragility I-Disease 0 0.22023779153823853
in O 0 1.3667020404284358e-08
most O 0 8.41807179519094e-11
cases O 0 7.153947573224073e-12
is O 0 1.048246450578716e-12
due O 0 2.606937721250091e-10
to O 0 7.594866575921788e-13
mutations O 0 7.27880917431728e-13
in O 0 2.6670421513635967e-12
the O 0 2.6438564879049942e-11
gene O 0 4.9604941682046544e-11
encoding O 0 6.773974436935504e-11
type O 0 1.771358171254178e-08
XVII O 0 8.389573622480384e-07
collagen O 0 1.0151338614150518e-07
( O 0 1.135124660933684e-09
COL17A1 O 0 8.863421498972457e-06
) O 0 3.1918639953332217e-10
. O 0 2.9519875432981735e-09

Recently O 0 6.921013806504561e-08
, O 0 1.596862919672759e-10
we O 0 1.8010837612991715e-11
reported O 0 4.392382985107801e-11
five O 0 3.184176533554961e-11
Austrian O 0 4.759967975331847e-09
families O 0 1.486056416810655e-11
with O 0 1.0048972765019926e-10
generalized O 1 0.9990857839584351
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
who O 0 2.473961302484895e-08
share O 0 1.029783897044112e-10
the O 0 1.6292446280985473e-09
same O 0 8.502214043915046e-09
COL17A1 O 0 0.08387147635221481
mutation O 0 1.6832434823754738e-07
. O 0 1.7792409323647007e-08

Affected O 0 5.4814204730746496e-08
individuals O 0 2.5373448134247134e-11
in O 0 2.768124618413026e-10
three O 0 6.386215445353116e-10
families O 0 3.7399575623930925e-12
are O 0 5.695555247049733e-13
homozygous O 0 1.032202587292197e-10
for O 0 8.173763055285832e-11
4003delTC O 0 4.571118594753898e-08
, O 0 2.956362585293526e-11
whereas O 0 1.2353276387933043e-11
those O 0 1.4488401797740913e-12
in O 0 1.0951120218982702e-11
two O 0 4.230458691689698e-11
others O 0 1.275594907479416e-10
are O 0 2.09210895135703e-11
compound O 0 2.275892185821249e-08
heterozygotes O 0 1.7162641086088115e-07
. O 0 2.417043809543884e-08

To O 0 5.387249535360183e-10
determine O 0 4.777429007951639e-10
if O 0 4.357758077999652e-12
the O 0 8.108340388002233e-12
occurrence O 0 3.46572048837146e-10
of O 0 4.5263459647060245e-10
4003delTC O 0 1.1474957650747797e-09
in O 0 2.0092618541189822e-11
these O 0 1.116731923947456e-12
unrelated O 0 1.3332845244518055e-11
families O 0 5.89351091258121e-14
signifies O 0 3.954780947168501e-12
propagation O 0 9.503938080968055e-09
of O 0 8.478178714632634e-10
an O 0 2.258301618623948e-12
ancestral O 0 7.837206439376132e-10
allele O 0 2.3117034675390613e-10
or O 0 2.1461475652184703e-10
a O 0 2.080733585430039e-09
mutational O 0 0.00036103787715546787
hot O 1 0.9894968271255493
spot O 0 3.807564644375816e-05
, O 0 1.9398443962259648e-10
haplotypes O 0 2.5374728984672856e-09
were O 0 2.918746633273628e-10
determined O 0 1.4677108139959927e-10
for O 0 5.6616811933141165e-11
polymorphisms O 0 7.726661976903415e-09
both O 0 4.0393449696196626e-10
within O 0 8.615703706027489e-09
and O 0 6.942165065026984e-09
flanking O 0 2.3661943487240933e-05
COL17A1 O 0 0.19707810878753662
. O 0 1.1989756103503169e-06

Five O 0 7.2126283612306e-08
intragenic O 0 1.838081857385987e-06
polymorphisms O 0 2.728114338879095e-07
were O 0 5.234047417701504e-09
chosen O 0 1.533062982117528e-10
based O 0 8.17480735881837e-11
on O 0 1.056444318692229e-07
their O 0 9.502126196991867e-09
informativeness O 0 3.3467188131908188e-06
. O 0 1.0854959953121579e-07

One O 0 2.2301778201949674e-09
of O 0 5.610078623874415e-09
these O 0 1.1319195580838937e-11
, O 0 3.3784862928099013e-12
not O 0 7.175563311936917e-13
previously O 0 3.2666456345475936e-11
reported O 0 1.2881637596884321e-11
, O 0 1.0590670701526861e-11
was O 0 9.790674937448784e-09
2988 O 0 1.932742634380702e-06
A O 0 9.379751304550155e-07
or O 0 2.5049837204527137e-10
C O 0 4.8903075366979465e-08
that O 0 1.170263018435147e-11
introduces O 0 8.339046814187512e-11
a O 0 1.1991970784441808e-11
new O 0 3.0082256130548046e-12
restriction O 0 7.32094870836697e-11
site O 0 4.764777114529828e-11
for O 0 1.802533990125088e-11
Eco0109 O 0 8.496463266283172e-08
I O 0 1.1720986776708742e-06
. O 0 3.761096678545073e-08

All O 0 3.3886109473968418e-09
the O 0 3.4450980956890476e-10
4003delTC O 0 2.6036492961623026e-09
alleles O 0 2.050454771251875e-11
showed O 0 5.086281396060599e-11
the O 0 1.1292067107759873e-11
same O 0 5.057277079750788e-12
haplotype O 0 1.7810998509393272e-10
for O 0 2.8942530663766952e-11
these O 0 1.1006759739751182e-11
five O 0 2.2966731294538079e-10
polymorphic O 0 2.614604177608726e-08
markers O 0 4.711708001536863e-08
. O 0 1.730417054091049e-08

Fourteen O 0 7.138776680903902e-08
microsatellite O 0 2.5917503876371484e-07
polymorphisms O 0 2.260023705957792e-07
were O 0 9.73857772201825e-10
selected O 0 1.232395348965687e-11
based O 0 2.5655163757298816e-11
on O 0 3.3307490099332426e-08
their O 0 1.3317457137063116e-09
high O 0 1.0182652943058201e-08
heterozygosity O 0 4.232095562883842e-08
and O 0 9.964345321078483e-11
their O 0 4.398486089240983e-11
location O 0 1.028928497959214e-09
within O 0 9.459373284670392e-10
10q23 O 0 2.0693880742328474e-07
- O 0 3.8282618675111735e-07
q25 O 0 1.0375745205237763e-06
near O 0 5.141328074387275e-06
COL17A1 O 0 0.00041626207530498505
. O 0 3.10524228552822e-07

Three O 0 1.153717454904779e-09
families O 0 1.1322239153177538e-11
shared O 0 2.2922791442780976e-10
microsatellite O 0 1.5234984118706052e-07
polymorphisms O 0 9.788537909116712e-07
covering O 0 4.039949544676347e-06
at O 0 9.054834663402289e-06
most O 0 5.672287639590934e-10
19 O 0 3.2442226682860564e-08
cM O 0 2.318062630735085e-09
, O 0 3.495100042716359e-11
whereas O 0 3.266832290793609e-11
the O 0 3.243563473365185e-10
others O 0 1.0550367871009492e-11
shared O 0 3.611860810437406e-12
smaller O 0 5.572199060673022e-13
regions O 0 1.0910797439145359e-11
consistent O 0 2.8434221643891533e-10
with O 0 5.130983745521567e-12
cross O 0 6.389065942968841e-10
- O 0 1.238029123662443e-10
over O 0 1.8128673909267867e-11
events O 0 9.019372922136615e-12
during O 0 8.03104735491722e-11
passage O 0 5.275898468104501e-11
of O 0 4.7579999835900555e-12
this O 0 3.1494604016760186e-13
mutation O 0 1.6991498269156025e-12
through O 0 1.2664420293712064e-12
several O 0 1.8214178429398764e-11
generations O 0 3.990138497389495e-10
. O 0 3.907377976730686e-09

These O 0 6.901103022372013e-10
results O 0 2.9131125289794113e-10
indicate O 0 3.275055227014434e-11
that O 0 5.733857399298214e-13
4003delTC O 0 9.941152345760429e-10
occurs O 0 4.3873064903277026e-12
on O 0 3.0682922869118556e-10
a O 0 3.0525183075669204e-11
single O 0 9.823455937585379e-11
ancestral O 0 4.455296409577869e-10
allele O 0 2.2130870747094633e-10
. O 0 1.3190645797855893e-10
. O 0 1.4707800533031445e-09

The O 0 4.63049190102538e-07
haptoglobin O 0 3.7674619761673966e-06
- O 0 9.928010058501968e-08
gene O 0 3.213288080061716e-09
deletion O 0 2.258046416514503e-09
responsible O 0 3.4321794295522068e-09
for O 0 4.814164067390436e-10
anhaptoglobinemia B-Disease 0 4.100184924027417e-06
. O 0 1.911908213969582e-07

We O 0 1.4163096473396308e-08
have O 0 2.021647606265109e-11
found O 0 1.0563087947737526e-12
an O 0 4.0363429287294805e-13
allelic O 0 4.251048402181823e-09
deletion O 0 1.164977225798225e-09
of O 0 2.7688244585988286e-08
the O 0 4.056450464418049e-08
haptoglobin O 0 4.367111614556052e-07
( O 0 7.560147508023363e-10
Hp O 0 4.102636452785191e-09
) O 0 8.48745726478306e-12
gene O 0 1.3743643376140646e-11
from O 0 3.545177823180423e-12
an O 0 8.073844869581348e-13
individual O 0 4.2873916222818664e-12
with O 0 3.756167599178184e-10
anhaptoglobinemia B-Disease 0 0.0001901652867672965
. O 0 4.2200773009426484e-07

The O 0 4.5090826006344287e-07
Hp O 0 4.2352692020131144e-08
gene O 0 9.189715655111286e-10
cluster O 0 3.015313110310558e-09
consists O 0 2.6452437462687328e-11
of O 0 3.4196364490091113e-11
coding O 0 7.563868420490394e-10
regions O 0 1.2305075014484856e-10
of O 0 1.6257616364256933e-09
the O 0 1.1448221259868774e-09
alpha O 0 5.355061394318739e-10
chain O 0 1.508857483401016e-10
and O 0 2.831993754087714e-12
beta O 0 1.533484172977495e-10
chain O 0 3.68465508104876e-10
of O 0 2.566853951613268e-10
the O 0 2.1915592951504692e-10
haptoglobin O 0 3.2103535385630266e-09
gene O 0 3.799869793819077e-11
( O 0 2.276339273327155e-12
Hp O 0 3.8211649122654734e-11
) O 0 2.0803286393880627e-13
and O 0 3.488937220727517e-12
of O 0 4.690551280717159e-10
the O 0 1.2329843812608487e-09
alpha O 0 1.1488315854180087e-09
chain O 0 5.936676705786681e-10
and O 0 2.5192369024207295e-11
beta O 0 2.652769781619213e-09
chain O 0 2.5517323809509662e-09
of O 0 7.899939591382577e-10
the O 0 1.5687968701882937e-09
haptoglobin O 0 1.2854516739935207e-07
- O 0 4.4115302522129696e-09
related O 0 2.7285529391463115e-10
gene O 0 1.2677338345756795e-10
( O 0 7.438475183030313e-12
Hpr O 0 2.050300373923619e-09
) O 0 1.3711013661238391e-12
, O 0 1.5283840816213146e-12
in O 0 1.0443076958743802e-11
tandem O 0 1.1845401326482374e-09
from O 0 1.6130012603365884e-10
the O 0 1.779559966053057e-08
5 O 0 2.435309340853564e-07
side O 0 3.749694030830142e-07
. O 0 1.8499557441487013e-08

Southern O 0 1.2585695685629616e-07
blot O 0 3.288195671302674e-07
and O 0 1.4234069478646916e-09
PCR O 0 1.9601801071189584e-08
analyses O 0 3.730550035552227e-10
have O 0 5.1064681996781935e-12
indicated O 0 8.275615435981987e-12
that O 0 1.535439798309307e-13
the O 0 6.769888902941057e-12
individual O 0 1.1722858740594727e-13
with O 0 6.361866328880028e-13
anhaptoglobinemia B-Disease 0 6.058437307387976e-09
was O 0 3.472058751619045e-10
homozygous O 0 3.962930331113945e-11
for O 0 4.348682872135079e-12
the O 0 6.8884715639927485e-12
gene O 0 2.0154594139454307e-12
deletion O 0 2.5418820694123045e-12
and O 0 3.6966729590609537e-13
that O 0 5.40945834946651e-14
the O 0 4.331125735834718e-12
gene O 0 3.4133464284213932e-12
deletion O 0 9.249424143265017e-12
was O 0 8.991636601951569e-11
included O 0 1.560222090413177e-11
at O 0 4.867039549161234e-10
least O 0 4.165123541205462e-12
from O 0 2.138883471378139e-12
the O 0 1.6915591150024056e-10
promoter O 0 1.8947478963582398e-07
region O 0 6.480097347605351e-09
of O 0 8.008004925841306e-09
Hp O 0 1.2573321939157722e-08
to O 0 1.1019457568650637e-09
Hpr O 0 2.769374418676307e-07
alpha O 0 2.183583625026131e-08
but O 0 3.8818354780589814e-11
not O 0 8.402410711649821e-12
to O 0 9.791389053714905e-12
Hpr O 0 1.9525378647244906e-08
beta O 0 1.3980186786000104e-08
( O 0 3.4890586947389224e-11
Hpdel O 0 4.185271862411355e-08
) O 0 1.0774355019282922e-10
. O 0 2.020963618676319e-09

In O 0 2.450960101541e-09
addition O 0 3.146229110573273e-10
, O 0 1.3392492670405431e-10
we O 0 5.2009636181127306e-11
found O 0 1.6198542507339653e-11
seven O 0 5.924465345391594e-12
individuals O 0 1.6259652925823022e-14
with O 0 7.947534774385701e-13
hypohaptoglobinemia B-Disease 0 3.654158220456338e-08
in O 0 2.3870555532212734e-10
three O 0 5.5841203189244126e-11
families O 0 6.389909760172452e-13
, O 0 2.1971276794457983e-12
and O 0 1.471825265830784e-11
the O 0 2.15801029823659e-10
genotypes O 0 1.2479371980234077e-09
of O 0 9.868216466202284e-09
six O 0 1.1247754949650357e-09
of O 0 5.275440972951628e-09
the O 0 2.917957431236573e-09
seven O 0 4.819998289384841e-10
individuals O 0 4.463201509763426e-12
were O 0 7.951836966668679e-10
found O 0 1.7943013394527974e-11
to O 0 1.9663368155953265e-11
be O 0 9.206768125658016e-10
Hp2 O 0 6.736220530001447e-05
/ O 0 0.00023936167417559773
Hpdel O 0 0.00039428609306924045
. O 0 7.46230455206387e-07

The O 0 1.81132513432658e-08
phenotypes O 0 2.092625850380614e-09
and O 0 1.2264485434176908e-11
genotypes O 0 2.176678698395662e-10
in O 0 1.694118803574618e-11
one O 0 4.33184477871551e-12
of O 0 1.9362550451873517e-10
these O 0 2.0293460922110595e-12
three O 0 4.441953315587055e-12
families O 0 1.6537557998366759e-13
showed O 0 1.7465102974956181e-10
the O 0 5.732815888670473e-10
father O 0 1.388736764473819e-10
to O 0 1.0999644771414463e-11
be O 0 6.337481234242048e-11
hypohaptoglobinemic B-Disease 0 5.2691586205355634e-08
( O 0 3.092791994729893e-11
Hp2 O 0 2.434157053698982e-08
) O 0 4.438836451181594e-12
and O 0 2.240399359088041e-11
Hp2 O 0 1.777603415575868e-07
/ O 0 4.782516498380573e-07
Hpdel O 0 3.0452965802396648e-06
, O 0 5.310246686818232e-10
the O 0 1.2105900726311347e-09
mother O 0 6.80946826703277e-11
to O 0 1.587911573064371e-11
be O 0 3.061363315626231e-11
Hp2 O 0 3.9592612210981315e-07
- O 0 2.2138957334050247e-08
1 O 0 9.141312595772888e-09
and O 0 1.3302624279898367e-10
Hp1 O 0 1.2558579101096257e-06
/ O 0 3.782517694617127e-07
Hp2 O 0 9.94639435702993e-07
, O 0 1.0953047496764512e-10
one O 0 3.355175512420594e-12
of O 0 2.730125292504937e-10
the O 0 4.258528807365991e-10
two O 0 1.681922830176763e-11
children O 0 2.02651090353001e-12
to O 0 3.193139546178725e-12
be O 0 3.8448078054642565e-11
hypohaptoglobinemic B-Disease 0 1.5058438407322683e-07
( O 0 6.819372150301817e-11
Hp2 O 0 2.9014438496233197e-07
) O 0 2.2392544415938964e-11
and O 0 1.0716537379718005e-10
Hp2 O 0 2.3383699954138137e-06
/ O 0 5.326256086846115e-06
Hpdel O 0 1.4090705917624291e-05
, O 0 4.2342793160621284e-10
and O 0 1.37383826537274e-10
the O 0 8.185343514099941e-10
other O 0 2.5506690509713437e-11
child O 0 1.1051635995240616e-10
to O 0 6.7193585764901975e-12
be O 0 5.411324166537668e-11
Hp1 O 0 2.558923313245032e-07
and O 0 6.612441150188886e-10
Hp1 O 0 2.45416540565202e-05
/ O 0 1.149376475950703e-05
Hpdel O 0 1.9807434910035226e-06
, O 0 4.5269569343142635e-11
showing O 0 2.9398886103315647e-10
an O 0 4.246455184014897e-12
anomalous O 0 3.049623220618969e-09
inheritance O 0 5.2555457763503455e-09
of O 0 5.943117997730951e-08
Hp O 0 1.4417337546035469e-08
phenotypes O 0 1.8528749645696507e-09
in O 0 1.6189252716181102e-10
the O 0 2.5972510808713878e-09
child O 0 5.202335229270716e-10
with O 0 1.8634498111236297e-10
Hp1 O 0 0.00021309875592123717
. O 0 5.597756285169453e-07

The O 0 3.540644684107974e-07
Hp2 O 0 0.00014179346908349544
/ O 0 0.0002972561924252659
Hpdel O 0 1.0393480806669686e-05
individuals O 0 1.5281467757866096e-10
had O 0 1.2223908552044804e-09
an O 0 1.0046975404409686e-11
extremely O 0 2.7585531081619763e-10
low O 0 7.338235796794379e-09
level O 0 2.1736322253218532e-07
of O 0 1.3213850458271281e-08
Hp O 0 3.431734230119332e-09
( O 0 1.3749098214110855e-11
mean O 0 7.56620252562179e-11
+ O 0 7.177236669569931e-12
/ O 0 1.165977037143051e-10
- O 0 1.979930455697776e-11
SD O 0 3.308698037773894e-10
= O 0 1.3568662686480604e-11
0 O 0 4.353795535899652e-12
. O 0 6.777789592592176e-14
049 O 0 1.0908904855833068e-11
+ O 0 3.842326305215915e-13
/ O 0 1.4927807254205838e-11
- O 0 8.66716507591514e-12
0 O 0 1.2128653116560972e-11
. O 0 8.723133435202535e-13
043 O 0 5.314198525674385e-10
mg O 0 9.89861387301616e-11
/ O 0 1.286548784174002e-10
ml O 0 1.4655169439103943e-11
; O 0 2.955890537220153e-14
n O 0 3.347268859657526e-12
= O 0 5.844765210011316e-12
6 O 0 5.300729039731111e-12
) O 0 1.7950783851169386e-15
, O 0 2.0381757821877388e-15
compared O 0 7.755519215388047e-15
with O 0 4.5950457421538044e-15
the O 0 2.2838454218077064e-12
level O 0 3.57961715824473e-10
( O 0 6.416274575451325e-14
1 O 0 2.5335326284819937e-12
. O 0 5.653827354749376e-14
64 O 0 9.94842121009032e-13
+ O 0 5.182045656297596e-13
/ O 0 1.9495318553941487e-11
- O 0 8.633127199231261e-12
1 O 0 1.0015386089912148e-11
. O 0 4.3385566948946075e-13
07 O 0 1.889356553153032e-11
mg O 0 8.451373628703962e-11
/ O 0 6.103455935102531e-11
ml O 0 6.679898387901284e-12
) O 0 3.3736773835305435e-15
obtained O 0 3.65412778161045e-13
from O 0 2.6574450105731895e-12
52 O 0 2.582021818575697e-10
healthy O 0 6.273705999149115e-10
volunteers O 0 2.6775328482164795e-11
having O 0 5.811065170724383e-11
phenotype O 0 4.670339670553858e-10
Hp2 O 0 3.687970462351586e-08
, O 0 2.4818739077780982e-11
whereas O 0 1.1731370215539716e-11
the O 0 4.881139936685486e-11
serum O 0 1.1323065401969146e-10
Hp O 0 8.688706976123228e-10
level O 0 3.1619340035149435e-08
of O 0 2.1469294397835625e-10
an O 0 1.3992350030370138e-12
individual O 0 1.0283402818514475e-12
with O 0 1.3288188258075984e-11
Hp1 O 0 3.55046104232315e-05
/ O 0 4.870371049037203e-05
Hpdel O 0 4.0338069084100425e-05
was O 0 5.396283313530148e-07
0 O 0 2.4770568529675074e-07
. O 0 1.5000354736116606e-08

50 O 0 1.077334275123576e-07
mg O 0 3.088305220444454e-07
/ O 0 2.708172246457252e-07
ml O 0 7.733827800393556e-09
, O 0 4.458054585210203e-12
which O 0 5.453864356658178e-13
was O 0 2.1922729256940165e-11
approximately O 0 3.5597916216330294e-13
half O 0 9.904684494452254e-13
the O 0 4.2642872739862e-12
level O 0 5.248540491109566e-10
of O 0 6.79066178288501e-11
Hp O 0 4.2774860042893437e-11
in O 0 6.8062057725915e-12
control O 0 1.931652615638768e-09
sera O 0 3.507243828693163e-09
from O 0 5.250317975519225e-12
the O 0 6.828131809966109e-11
Hp1 O 0 1.785084258187908e-08
phenotype O 0 1.8522415545785265e-10
( O 0 1.3015440504873799e-12
1 O 0 5.208309478144102e-11
. O 0 7.134770747298236e-13
26 O 0 2.7066156607635783e-11
+ O 0 3.6072069810322294e-12
/ O 0 9.211172102840948e-11
- O 0 3.8287595316433e-11
0 O 0 2.026052069170614e-11
. O 0 7.986800782365522e-13
33 O 0 1.103216996922729e-11
mg O 0 1.256271475735815e-10
/ O 0 2.4604951409656906e-10
ml O 0 2.944342686328483e-11
; O 0 6.699094133155031e-14
n O 0 9.507495485339135e-12
= O 0 8.63724543276323e-12
9 O 0 1.3806437763885793e-11
) O 0 8.204470394355349e-15
, O 0 2.1710933357653624e-14
showing O 0 1.0991717085129249e-11
a O 0 1.7535457461081982e-11
gene O 0 1.820814193864706e-10
- O 0 1.2888778933017875e-09
dosage O 0 2.247310249003931e-08
effect O 0 2.8419936626278286e-08
. O 0 2.5126316582912978e-09

The O 0 9.260845246217286e-08
other O 0 2.095716378214263e-10
allele O 0 1.8115522415484975e-09
( O 0 6.60541621400057e-11
Hp2 O 0 1.0184248822042719e-07
) O 0 5.944613724884196e-12
of O 0 1.2830297935195745e-10
individuals O 0 4.125219046566264e-13
with O 0 4.472748560413464e-11
Hp2 O 1 0.9342761635780334
/ O 1 0.9887737035751343
Hpdel O 1 0.8809057474136353
was O 0 2.7454286737338407e-06
found O 0 4.683414420170173e-11
to O 0 2.3898183779125226e-12
have O 0 2.2920363523804e-12
, O 0 4.3376546386870996e-13
in O 0 1.919665164676343e-12
all O 0 6.542634489736798e-11
exons O 0 2.836015511320511e-08
, O 0 2.2230406751533316e-11
no O 0 6.93756441183524e-11
mutation O 0 1.3566643468354567e-11
, O 0 7.29785426967916e-13
by O 0 4.7726969945594e-12
DNA O 0 1.1859259130275746e-09
sequencing O 0 1.1231076069151413e-09
. O 0 4.233812855858332e-09

On O 0 5.974144556830652e-08
the O 0 4.6085563143449804e-10
basis O 0 3.345351218264625e-10
of O 0 5.633569166718644e-10
the O 0 1.4875176090889397e-10
present O 0 2.747288681270721e-11
study O 0 2.687298517392578e-12
, O 0 2.856312625656998e-12
the O 0 6.915356481895785e-11
mechanism O 0 4.0996406269755425e-09
of O 0 2.7147355474710366e-09
anhaptoglobinemia B-Disease 0 8.136790370372182e-07
and O 0 1.845746333550835e-09
the O 0 2.215757577417321e-09
mechanism O 0 1.4942015624797023e-08
of O 0 8.401201401220248e-10
anomalous O 0 1.7926074846741358e-08
inheritance O 0 9.372310927346916e-09
of O 0 4.0507288190383406e-08
Hp O 0 5.464978514169161e-08
phenotypes O 0 2.9303238946454258e-08
were O 0 2.2970729762761266e-09
well O 0 1.7486045944536954e-09
explained O 0 6.561538867799754e-08
. O 0 4.260921926402261e-08

However O 0 2.7031115124032112e-08
, O 0 2.9100971632445294e-10
the O 0 7.123591161395382e-10
mechanism O 0 2.5908450496103796e-08
of O 0 1.2025910933743944e-08
hypohaptoglobinemia B-Disease 0 1.544380393170286e-05
remains O 0 3.9464584915549494e-06
unknown O 0 8.222220458264928e-06

ATM O 0 7.147739779611584e-06
mutations O 0 1.828443729756657e-09
and O 0 1.0643707269719638e-11
phenotypes O 0 3.779540236337198e-09
in O 0 5.7810041198536055e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 6.633059879135317e-09
in O 0 4.614396920121777e-10
the O 0 8.893600300652338e-10
British O 0 2.0236905484694034e-09
Isles O 0 2.4521021657619713e-08
: O 0 7.171845149006595e-12
expression O 0 2.902540013893784e-11
of O 0 2.1642581823910767e-11
mutant O 0 3.2651270576167235e-10
ATM O 0 2.5720563456843593e-08
and O 0 4.480223700711883e-13
the O 0 1.166438473587661e-12
risk O 0 1.7007168243154958e-11
of O 0 6.25367951867517e-11
leukemia B-Disease 1 1.0
, O 0 8.926217560656369e-06
lymphoma B-Disease 1 1.0
, O 0 2.6095578959939303e-06
and O 0 1.7691112589091063e-05
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0006500416784547269

We O 0 3.2359646073842896e-09
report O 0 5.0023759440298576e-11
the O 0 1.4175912180225403e-11
spectrum O 0 8.341516366527912e-10
of O 0 2.281019151340047e-09
59 O 0 2.9777291743471324e-09
ATM O 0 2.2402145916089466e-08
mutations O 0 2.2054464157705844e-11
observed O 0 3.945229559709773e-11
in O 0 2.3438757601468296e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 1.0
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.4142620408108542e-10
patients O 0 1.1736071316159613e-11
in O 0 1.9796198100913154e-12
the O 0 2.4331101022845303e-10
British O 0 3.1445028803034347e-09
Isles O 0 3.58411654133306e-07
. O 0 4.1541831308222754e-08

Of O 0 2.1285727598296944e-06
51 O 0 3.1466589689443936e-07
ATM O 0 1.694352067715954e-05
mutations O 0 7.217080821853017e-10
identified O 0 1.330115323439074e-10
in O 0 1.260230635125037e-11
families O 0 2.508340757323424e-13
native O 0 4.766683575629926e-12
to O 0 3.676409870978503e-12
the O 0 3.35083016889115e-10
British O 0 1.8974659621306955e-09
Isles O 0 3.136190684926987e-08
, O 0 1.6049578333010572e-10
11 O 0 6.205989944163548e-09
were O 0 1.3095343698310558e-09
founder O 0 2.0181216697778837e-08
mutations O 0 1.3206455373726556e-10
, O 0 1.775549846039226e-11
and O 0 1.366877184355575e-11
2 O 0 5.530604862968858e-10
of O 0 7.509699112562274e-11
these O 0 9.393929861420403e-13
11 O 0 8.412470026142316e-11
conferred O 0 3.628076727935081e-10
a O 0 2.973185933563549e-11
milder O 0 3.0770830328208376e-10
clinical O 0 1.5550452037160767e-09
phenotype O 0 2.6771754951804283e-11
with O 0 4.805603817984415e-14
respect O 0 1.2674043238514177e-11
to O 0 3.646415634717126e-12
both O 0 2.3084253952809775e-10
cerebellar B-Disease 1 0.9999998807907104
degeneration I-Disease 1 1.0
and O 0 2.1889241530459458e-09
cellular O 0 2.4557397182434215e-07
features O 0 2.6215953852215534e-08
. O 0 5.649863688006462e-09

We O 0 6.412249620169064e-10
report O 0 4.544213096091543e-12
, O 0 1.5749967790471692e-13
in O 0 1.5342227271605835e-12
two O 0 2.69693933852011e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 4.768338501826008e-12
, O 0 1.1538763651161577e-12
an O 0 4.0271226024041207e-13
ATM O 0 1.3863727588159236e-07
mutation O 0 1.3674385235251663e-10
( O 0 3.253802826133634e-12
7271T O 0 1.1296134694305238e-08
- O 0 3.7856247558920586e-07
- O 0 1.1833319035758905e-07
> O 0 2.2270842947591518e-08
G O 0 5.002466885173362e-09
) O 0 3.658715108764872e-14
that O 0 9.46416678208363e-15
may O 0 2.983525834157272e-14
be O 0 1.8016983711162046e-15
associated O 0 8.96015168528122e-15
with O 0 5.331888702695385e-16
an O 0 1.5331761154632642e-15
increased O 0 2.9470436507805786e-12
risk O 0 1.350304035252492e-10
of O 0 9.000323819563505e-10
breast B-Disease 0 1.1915780305571388e-05
cancer I-Disease 0 7.946493241206554e-08
in O 0 8.289394864968713e-11
both O 0 3.4129771925295316e-11
homozygotes O 0 7.785006417293516e-09
and O 0 1.2012436184649644e-11
heterozygotes O 0 7.27254756416329e-10
( O 0 1.1432623511081763e-12
relative O 0 1.0133932581979366e-10
risk O 0 2.1439136577150464e-10
12 O 0 2.9556124908625137e-11
. O 0 6.80308728188278e-13
7 O 0 5.602708297303138e-10
; O 0 2.588735649455831e-12
P O 0 2.0366092812196257e-08
= O 0 1.0768520103399126e-10
. O 0 5.547133065386678e-12
0025 O 0 6.966036081301752e-10
) O 0 4.9117275595063695e-14
, O 0 2.3257405455169057e-14
although O 0 4.8013435810729047e-14
there O 0 6.447040844974675e-14
is O 0 2.5495561269280563e-14
a O 0 6.748060226921537e-13
less O 0 1.1873097123527021e-11
severe O 1 1.0
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 7.835512794152066e-11
in O 0 3.781153043664123e-14
terms O 0 6.893541184931073e-13
of O 0 3.3866266453512484e-13
the O 0 3.096495499246843e-13
degree O 0 4.543350973218452e-10
of O 0 1.8456371986275144e-09
cerebellar B-Disease 1 0.9999728202819824
degeneration I-Disease 1 1.0
. O 0 1.7750386405168683e-07

This O 0 1.9687021457492904e-10
mutation O 0 1.0149116963509286e-10
( O 0 5.91772334260221e-12
7271T O 0 4.2377878983757e-09
- O 0 8.810455653929239e-08
- O 0 6.908300065333606e-08
> O 0 2.077582017534496e-08
G O 0 5.451067597306292e-09
) O 0 1.833119295463828e-13
also O 0 4.7582855082321796e-14
allows O 0 1.2840357947643388e-14
expression O 0 8.702691887442493e-13
of O 0 4.667983447698143e-12
full O 0 2.448621340411794e-11
- O 0 1.3585132151161528e-11
length O 0 3.725859898384698e-12
ATM O 0 1.3043599977891063e-08
protein O 0 8.03001762306188e-12
at O 0 6.613547903766559e-11
a O 0 3.1981192867569508e-12
level O 0 1.5841036815622545e-10
comparable O 0 4.19490180439408e-12
with O 0 1.1433665429369522e-13
that O 0 4.426152641016229e-13
in O 0 1.7042499356190177e-11
unaffected O 0 8.501825021767218e-09
individuals O 0 1.7787089509613274e-11
. O 0 3.94966104266814e-09

In O 0 4.564553457431231e-10
addition O 0 7.4615834344538e-11
, O 0 4.65750701894585e-12
we O 0 9.128574632311093e-13
have O 0 4.498837283609114e-14
studied O 0 2.2890973838674e-11
18 O 0 1.688117663434241e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 8.447203492245592e-10
, O 0 1.4259528616483025e-13
in O 0 1.6901278011675902e-13
15 O 0 3.7564864413530685e-12
families O 0 3.702759212659496e-15
, O 0 5.5373704888972766e-14
who O 0 2.400590793857904e-12
developed O 0 3.1249507514985453e-07
leukemia B-Disease 1 1.0
, O 0 0.0009932086104527116
lymphoma B-Disease 1 1.0
, O 0 2.4053981633187504e-06
preleukemic O 1 1.0
T O 1 1.0
- O 0 8.950887036007771e-07
cell O 0 1.880000581877539e-06
proliferation O 0 0.015938779339194298
, O 0 3.6398072056353925e-12
or O 0 4.204680603692168e-09
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 6.317125156307668e-10
mostly O 0 1.645839497674273e-12
in O 0 8.066752127389165e-12
childhood O 0 2.3887983502390853e-07
. O 0 2.4187224667571172e-08

A O 0 4.6550789534194337e-07
wide O 0 7.09503744644735e-09
variety O 0 1.8901584741826127e-09
of O 0 4.360411054449287e-08
ATM O 0 0.00028502699569799006
mutation O 0 8.567390685776388e-10
types O 0 1.9827582631304352e-10
, O 0 6.10119506999629e-12
including O 0 6.799319440808915e-11
missense O 0 5.183521523122181e-08
mutations O 0 3.7413311337886057e-10
and O 0 1.5602912017964599e-10
in O 0 1.5864054514480586e-09
- O 0 2.919651542754309e-08
frame O 0 9.721082605551601e-09
deletions O 0 6.865903956487784e-10
, O 0 8.542062890359858e-11
were O 0 1.5954502996518016e-10
seen O 0 1.2697036477771206e-10
in O 0 4.2386164023078265e-11
these O 0 2.530381737475551e-10
patients O 0 1.7432829624297597e-09
. O 0 9.260329392191124e-09

We O 0 1.5568644151642275e-09
also O 0 4.072225629619952e-12
show O 0 1.4999549996161377e-12
that O 0 1.8578493710358183e-14
25 O 0 5.846244712295889e-13
% O 0 1.4750219546211946e-13
of O 0 1.5654056176317432e-11
all O 0 1.2557936024393257e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 7.10294489891794e-09
carried O 0 9.309783499666935e-11
in O 0 8.521087307977737e-11
- O 0 1.4447693041930165e-09
frame O 0 2.8244133698507312e-09
deletions O 0 1.6884388331916966e-10
or O 0 6.119681844607427e-11
missense O 0 2.952128319577696e-09
mutations O 0 4.891988897304245e-11
, O 0 5.452733316951841e-12
many O 0 8.310568487719661e-13
of O 0 3.0939559247933346e-10
which O 0 5.606187389317618e-12
were O 0 1.3298862878985407e-11
also O 0 4.555901012351371e-13
associated O 0 5.336027301440505e-13
with O 0 2.452704109690701e-13
expression O 0 1.0533764138731527e-10
of O 0 2.7135538260836256e-10
mutant O 0 1.0318966126021678e-08
ATM O 0 1.048834519679076e-06
protein O 0 1.869443089219658e-08
. O 0 5.2543729367471315e-09

The O 0 1.4064542419589543e-08
DMPK O 0 8.670818715472706e-06
gene O 0 9.133243494829912e-09
of O 0 8.121213923573123e-09
severely O 1 0.998350977897644
affected O 1 0.9999854564666748
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
is O 0 9.930729572005248e-10
hypermethylated O 0 1.0834462216280372e-07
proximal O 0 4.428695188352094e-09
to O 0 1.0429222589702913e-11
the O 0 1.1057623566790298e-10
largely O 0 3.708415519110275e-10
expanded O 0 3.1021515911611175e-10
CTG O 0 1.2184236766188405e-06
repeat O 0 2.1503132074940368e-07
. O 0 1.2524351333809136e-08

Using O 0 8.326451528262169e-09
methylation O 0 1.9688091015268583e-06
- O 0 6.481076297859545e-07
sensitive O 0 5.118013746141514e-08
restriction O 0 6.087673032340035e-09
enzymes O 0 1.944460148450844e-10
, O 0 9.061705379120877e-12
we O 0 2.5375029768376356e-12
characterized O 0 5.487517992092128e-12
the O 0 2.400471748459365e-12
methylation O 0 1.1693533641388143e-10
pattern O 0 8.70710101241734e-11
on O 0 2.0721700744186222e-10
the O 0 6.256304502239018e-11
5 O 0 2.1883513057208148e-10
side O 0 1.773343971667174e-10
of O 0 9.28205290406936e-11
the O 0 5.36540756268522e-10
CTG O 0 2.430121810448327e-07
repeat O 0 1.3674887888726062e-09
in O 0 4.330938038754617e-11
the O 0 3.904880307992187e-10
DMPK O 0 1.7177294466819149e-06
gene O 0 5.92106849661711e-11
of O 0 7.448203165338896e-11
normal O 0 5.2778406645082043e-11
individuals O 0 2.901168481882557e-14
and O 0 4.831791976071809e-13
of O 0 1.5373879946878333e-10
patients O 0 4.1829292807271656e-10
affected O 0 6.880311320678345e-10
with O 0 1.981400828299229e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 3.757982813823446e-09
showing O 0 1.1188970583386748e-10
expansions O 0 1.5456977919825476e-09
of O 0 6.852298173321003e-10
the O 0 9.38121358373678e-10
repetitive O 0 3.728711206463231e-08
sequence O 0 3.2047740017304704e-09
. O 0 8.986467570082368e-09

The O 0 6.906179095267362e-08
gene O 0 2.4876252169292457e-09
segment O 0 6.420082243607794e-10
analyzed O 0 2.00217672302605e-11
corresponds O 0 5.4440974298075595e-12
to O 0 1.4485058118240968e-12
the O 0 3.2429867818928315e-11
genomic O 0 1.5074869352815767e-08
SacI O 0 1.8972625639435137e-06
- O 0 1.6737773833597203e-08
HindIII O 0 8.793365680048737e-08
fragment O 0 2.531483467294038e-09
carrying O 0 5.04527808420363e-10
exons O 0 1.7260568085930572e-07
11 O 0 4.291163691050315e-08
- O 0 7.103245991402218e-08
15 O 0 3.717186203289202e-08
. O 0 2.5231647882151265e-08

There O 0 7.1285692904154985e-09
is O 0 1.0728665178483254e-10
constitutive O 0 8.5384872505756e-09
methylation O 0 6.515754158442633e-09
in O 0 2.738093640708428e-10
intron O 0 1.3159146661223531e-08
12 O 0 9.69239910553199e-10
at O 0 4.678935017210506e-10
restriction O 0 2.127110987348857e-11
sites O 0 2.2433229319301917e-12
of O 0 1.8747284974418577e-11
SacII O 0 4.255813124132146e-08
and O 0 2.0365099884234183e-10
HhaI O 0 1.5831318478376488e-07
, O 0 3.2809949201961786e-11
localized O 0 3.806489345947739e-09
1 O 0 7.783996558430317e-09
, O 0 8.301115003717108e-12
159 O 0 5.395339730540627e-11
- O 0 3.330624942510241e-10
1 O 0 8.186045730163016e-10
, O 0 1.0112359734304466e-11
232 O 0 2.0475001902275913e-11
bp O 0 2.6026587135463686e-11
upstream O 0 8.501131222582448e-12
of O 0 1.7776143057535165e-10
the O 0 1.975164920509087e-09
CTG O 0 7.638475835847203e-06
repeat O 0 7.643612320862303e-08
, O 0 1.29498092804603e-10
whereas O 0 2.5777199819110308e-11
most O 0 2.3207622889404034e-12
, O 0 1.7098295435752364e-12
if O 0 1.242780943259969e-12
not O 0 8.704336080037067e-13
all O 0 3.462274737742188e-12
, O 0 2.2814161584200354e-12
of O 0 3.620090685552135e-11
the O 0 1.6408064143491607e-11
other O 0 3.3327230948912434e-13
sites O 0 8.534468270982032e-12
of O 0 1.6118358037164882e-10
SacII O 0 1.1574268654612752e-07
, O 0 3.656413227748345e-10
HhaI O 0 6.408147896763694e-07
, O 0 4.3127887372484963e-10
and O 0 2.2109016006854887e-10
HpaII O 0 1.5908551631582668e-07
in O 0 3.640095724843917e-10
this O 0 1.6683120163119014e-11
region O 0 1.017375628187267e-09
are O 0 8.479060335797595e-12
unmethylated O 0 2.0752776208610157e-07
, O 0 2.7808182839761386e-11
in O 0 2.6742510983446266e-11
normal O 0 1.5961847399381668e-09
individuals O 0 2.2374588076398694e-13
and O 0 1.0408992244526072e-11
most O 0 7.618708615375613e-12
of O 0 1.192360543633697e-09
the O 0 1.0864338761962244e-08
patients O 0 1.4528827030346747e-09
. O 0 3.733933162664016e-09

In O 0 1.9325840927564286e-10
a O 0 1.6139669462011952e-11
number O 0 1.2674575798621301e-11
of O 0 7.316289796222009e-10
young O 0 8.042667226648703e-11
and O 0 6.140922437225527e-09
severely O 1 0.7027100920677185
affected O 0 1.7547529651551486e-08
patients O 0 1.3429511946938533e-09
, O 0 1.921424304385244e-11
however O 0 9.0902375904367e-11
, O 0 2.6991341019882986e-12
complete O 0 2.8062097090497673e-09
methylation O 0 8.255164551940197e-09
of O 0 2.7685839731894646e-10
these O 0 1.358472931584434e-13
restriction O 0 3.3664833073987488e-12
sites O 0 1.0408729000238592e-12
was O 0 2.3574989183039463e-11
found O 0 5.912845625448415e-13
in O 0 1.5673170226937483e-12
the O 0 1.939674254547441e-10
mutated O 0 8.38912772582745e-10
allele O 0 3.0575617593342486e-09
. O 0 9.63078061744227e-09

In O 0 5.426554317011778e-09
most O 0 7.598220663762589e-11
of O 0 1.7717830536057022e-09
these O 0 1.0055875576675533e-10
patients O 0 3.508585436073908e-11
, O 0 8.983604875625884e-13
the O 0 8.72862979811595e-12
onset O 0 4.570531473291339e-06
of O 0 3.193247888333417e-09
the O 0 1.2538309057674724e-08
disease O 1 0.9999741315841675
was O 0 8.656425961817149e-06
congenital O 1 1.0
. O 0 3.7932893519609934e-06

Preliminary O 0 1.622970913217614e-08
in O 0 4.5331280396077034e-10
vivo O 0 4.7133617897543445e-08
footprinting O 0 1.1456941138021648e-06
data O 0 1.7454389045212793e-09
gave O 0 1.2667265014698614e-09
evidence O 0 1.9459739375449203e-10
for O 0 8.590277794651158e-11
protein O 0 1.0355116070170922e-10
- O 0 5.700095950800232e-10
DNA O 0 1.7298905363727357e-10
contact O 0 4.2971112779177645e-11
in O 0 2.1354973345211192e-11
normal O 0 4.95753604834448e-10
genes O 0 7.410463735701978e-12
at O 0 1.2973715157738042e-10
an O 0 5.354626898129711e-12
Sp1 O 0 2.766380191587814e-08
consensus O 0 4.075322301844153e-10
binding O 0 2.8203247029456868e-11
site O 0 5.910055778102219e-11
upstream O 0 1.464244849501417e-12
of O 0 1.4944956730489345e-11
the O 0 6.16703577094313e-10
CTG O 0 9.321067295786634e-07
repeat O 0 4.597469960287981e-09
and O 0 2.4761430753028613e-11
for O 0 1.014558922984854e-11
a O 0 2.0564078218043846e-11
significant O 0 6.515100958726094e-11
reduction O 0 1.6817969239468766e-08
of O 0 3.417558458451708e-10
this O 0 1.114132115558053e-12
interaction O 0 4.3825225566618276e-12
in O 0 4.195670286893938e-12
cells O 0 6.188368394111077e-12
with O 0 7.705262209528607e-13
a O 0 2.2470679483799216e-10
hypermethylated O 0 3.445457252837514e-07
DMPK O 0 2.982526166306343e-05
gene O 0 7.124097312072308e-09
. O 0 5.208659614730493e-10
. O 0 3.800656234176358e-09

The O 0 2.633101985338726e-06
hemochromatosis B-Disease 1 1.0
gene O 0 5.234287225874823e-09
product O 0 2.941256960209415e-10
complexes O 0 9.408746351469155e-12
with O 0 1.323170522801731e-12
the O 0 2.8284605213535485e-10
transferrin O 0 2.9362867692839245e-09
receptor O 0 9.188273752958054e-11
and O 0 2.418635777767797e-11
lowers O 0 5.944019165760039e-10
its O 0 4.052645372065733e-12
affinity O 0 1.4936314988653332e-12
for O 0 1.9362357203678293e-11
ligand O 0 9.005783896398611e-10
binding O 0 7.040749760989229e-09
. O 0 4.8212878134279435e-09

We O 0 8.11497447017473e-09
recently O 0 1.3901579887232174e-09
reported O 0 4.350336063607685e-11
the O 0 4.9307710692225726e-11
positional O 0 2.83086496466467e-08
cloning O 0 4.937881659117238e-09
of O 0 2.497564932646412e-10
a O 0 3.317081678777534e-11
candidate O 0 1.125191120832092e-10
gene O 0 2.6523447882453866e-09
for O 0 2.6068359915143446e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999569654464722
HFE O 1 0.9925326704978943
. O 0 4.8811937602977196e-08

The O 0 1.5547257703474315e-08
gene O 0 5.588822182822639e-10
product O 0 8.190699785082245e-10
, O 0 1.077040453351108e-11
a O 0 1.389038103288831e-11
member O 0 2.981994512429864e-11
of O 0 3.8517974920715403e-10
the O 0 1.0266386629709245e-09
major O 0 3.4464296305714015e-08
histocompatibility O 0 7.81620769885194e-07
complex O 0 2.2420148582114052e-07
class O 0 2.1869285549147577e-10
I O 0 1.442044439414758e-08
- O 0 6.453254597360569e-10
like O 0 1.6613418973854266e-11
family O 0 1.8599184692380533e-12
, O 0 1.1002240785096262e-12
was O 0 1.0491376517540729e-10
found O 0 8.299970411483615e-13
to O 0 3.851490795129392e-13
have O 0 9.728797628616448e-13
a O 0 9.175869265798386e-12
mutation O 0 2.3773262872173184e-11
, O 0 1.124036540928186e-11
Cys O 0 1.509163325863483e-06
- O 0 6.828805965142237e-08
282 O 0 2.8104269134132664e-08
- O 0 8.207116479752585e-06
- O 0 1.121364675782388e-06
> O 0 1.0631391944571078e-07
Tyr O 0 7.653722633449433e-08
( O 0 3.2463207469413113e-12
C282Y O 0 1.08880807148104e-10
) O 0 4.7800078375711055e-14
, O 0 1.787286274925262e-14
in O 0 1.241870376065407e-13
85 O 0 4.593810401520848e-11
% O 0 1.7647288144684303e-11
of O 0 1.5946998166427306e-09
patient O 0 3.258784531112724e-08
chromosomes O 0 1.6620893106278345e-08
. O 0 4.052375146557097e-08

This O 0 5.987302875709588e-10
mutation O 0 1.3969784218303971e-09
eliminates O 0 5.3506148844917334e-08
the O 0 1.1548887401957586e-09
ability O 0 9.656080102171671e-11
of O 0 5.124907609399543e-09
HFE O 0 2.054164906439837e-05
to O 0 1.3205447846331708e-10
associate O 0 2.1323653953686517e-09
with O 0 3.630802256071597e-11
beta2 O 0 0.00021403891150839627
- O 0 0.0002830809389706701
microglobulin O 0 0.00032613155781291425
( O 0 1.6687529136305557e-09
beta2m O 0 2.500666823834763e-06
) O 0 6.775563443639498e-11
and O 0 8.651280386517968e-11
prevents O 0 3.521365421477185e-10
cell O 0 9.622757488614297e-07
- O 0 1.1534957877756824e-08
surface O 0 1.4370246104178364e-09
expression O 0 2.757603745351389e-08
. O 0 4.079850679516994e-09

A O 0 3.609437726481701e-07
second O 0 3.967888684286436e-09
mutation O 0 1.0432251590364316e-10
that O 0 4.150118020507937e-13
has O 0 2.082845885782031e-13
no O 0 9.218421382142794e-13
effect O 0 9.481242874143092e-11
on O 0 2.7940594282682696e-09
beta2m O 0 6.143209816400486e-07
association O 0 1.8422151581987123e-09
, O 0 7.28853782883121e-12
H63D O 0 2.0329149208464514e-07
, O 0 1.217514804252584e-11
was O 0 6.286879350447805e-11
found O 0 2.9421278781305293e-13
in O 0 8.46821039939688e-13
eight O 0 1.7605802232756318e-11
out O 0 5.2037094251666804e-12
of O 0 1.2149156125573768e-09
nine O 0 8.393437944675952e-09
patients O 0 2.0454469715214252e-11
heterozygous O 0 2.1352815349207077e-11
for O 0 2.3456667164190037e-11
the O 0 4.2534470390265255e-10
C282Y O 0 2.735935034081649e-08
mutant O 0 1.2497177692694095e-07
. O 0 1.757348755404564e-08

In O 0 7.248824873684612e-10
this O 0 1.3909735342709784e-11
report O 0 1.3896953032777049e-11
, O 0 4.750310388101919e-12
we O 0 6.444428757995668e-12
demonstrate O 0 4.523236993292379e-11
in O 0 4.5018315464329106e-11
cultured O 0 8.638406656658049e-10
293 O 0 1.9586793298387306e-10
cells O 0 1.0350243995205233e-09
overexpressing O 0 2.2693993173561466e-07
wild O 0 1.318560833851734e-07
- O 0 1.9372203841072633e-09
type O 0 6.983357225820441e-10
or O 0 5.805669486824705e-11
mutant O 0 1.2564860263353239e-08
HFE O 0 1.741923142617452e-06
proteins O 0 2.5959052615820433e-12
that O 0 2.1669078749224358e-13
both O 0 5.811879298135703e-13
the O 0 1.000097851755477e-10
wild O 0 2.821932376662062e-08
- O 0 2.9774565035722844e-09
type O 0 3.521152258656457e-09
and O 0 6.522493212202107e-09
H63D O 0 0.03226616606116295
HFE O 0 0.00010509631101740524
proteins O 0 9.309570475624085e-11
form O 0 4.351555921155992e-11
stable O 0 3.100998069438532e-10
complexes O 0 3.8011438614760085e-12
with O 0 9.404578895158555e-13
the O 0 3.6283120952163017e-10
transferrin O 0 7.45179118410988e-09
receptor O 0 6.594040313778748e-10
( O 0 2.270962758121886e-11
TfR O 0 5.7933778663255e-08
) O 0 6.405034835843537e-11
. O 0 1.3952209387824155e-09

The O 0 8.426549413798057e-08
C282Y O 0 5.97613905028993e-07
mutation O 0 6.809488972692179e-09
nearly O 0 4.678631371213271e-10
completely O 0 5.215213150222553e-09
prevents O 0 9.100230291547717e-11
the O 0 4.612478732290981e-10
association O 0 9.074045403956177e-10
of O 0 4.798881847456471e-10
the O 0 5.258540825003877e-10
mutant O 0 1.6461127572142686e-08
HFE O 0 3.5406144434091402e-06
protein O 0 6.274783470594514e-10
with O 0 2.379817003184126e-11
the O 0 5.211584053199658e-09
TfR O 0 9.988150850404054e-06
. O 0 6.430921928313182e-08

Studies O 0 6.225908233403743e-09
on O 0 1.0696842522861516e-08
cell O 0 9.725031446805588e-09
- O 0 1.2033195273541963e-10
associated O 0 2.8744151156501196e-11
transferrin O 0 1.554025352845656e-09
at O 0 5.032994576659178e-10
37 O 0 3.845863905116431e-11
degrees O 0 1.0952948548137442e-09
C O 0 7.025859449782956e-09
suggest O 0 6.5518970457367764e-12
that O 0 2.040803642614289e-13
the O 0 1.5610414350053503e-10
overexpressed O 0 2.205732130278193e-07
wild O 0 1.596734335862493e-07
- O 0 9.828712954629282e-09
type O 0 6.739288682666711e-09
HFE O 0 9.651653272158e-07
protein O 0 4.614993109886001e-11
decreases O 0 2.0014732059203677e-12
the O 0 7.09829872831691e-13
affinity O 0 4.861372806044817e-13
of O 0 1.7120896367295302e-10
the O 0 5.274231051899392e-10
TfR O 0 4.745004389405949e-08
for O 0 2.0495798114250618e-10
transferrin O 0 1.2889945821825677e-07
. O 0 4.407242926163235e-08

The O 0 1.4230120086722309e-06
overexpressed O 0 9.16777498787269e-05
H63D O 0 0.043611831963062286
protein O 0 1.703582874768017e-08
does O 0 9.150073927710611e-12
not O 0 3.1896317184698653e-13
have O 0 1.775492865794051e-14
this O 0 3.875442972583283e-15
effect O 0 2.9668227510132317e-12
, O 0 7.681560194785358e-14
providing O 0 2.2699298495541809e-13
the O 0 5.028630506789811e-13
first O 0 2.552579187516807e-13
direct O 0 4.947780466585394e-13
evidence O 0 4.0493669073264627e-13
for O 0 1.8778687914562664e-13
a O 0 1.6533908573854172e-12
functional O 0 6.534456309381653e-10
consequence O 0 7.722503192475472e-10
of O 0 8.491918834785395e-10
the O 0 5.170583516900251e-09
H63D O 0 9.877919364953414e-05
mutation O 0 8.245144300644824e-08
. O 0 2.441312751955138e-08

Addition O 0 1.9472150558641488e-09
of O 0 2.730070569612053e-08
soluble O 0 7.221218112363204e-08
wild O 0 2.489203143341001e-05
- O 0 4.425777206051862e-06
type O 0 1.4930533325241413e-05
HFE O 1 0.9999992847442627
/ O 0 0.012659852392971516
beta2m O 0 7.144325081753777e-06
heterodimers O 0 4.467247904926808e-08
to O 0 1.8662162093452395e-11
cultured O 0 7.294994469608795e-11
cells O 0 2.1016438589427366e-11
also O 0 2.6778113147024607e-13
decreased O 0 3.179138159323247e-12
the O 0 3.6511324020584157e-13
apparent O 0 4.36575298481956e-12
affinity O 0 4.160643455198426e-13
of O 0 1.484904005311094e-10
the O 0 1.2345793831691765e-10
TfR O 0 3.0706235332189635e-09
for O 0 4.195277805707498e-12
its O 0 1.1910659090952347e-11
ligand O 0 1.4280501260677259e-11
under O 0 3.1439795211696264e-10
steady O 0 1.2126844417537086e-08
- O 0 2.652333075392477e-10
state O 0 2.5731415262408852e-11
conditions O 0 3.710166751602628e-08
, O 0 3.605054189198542e-12
both O 0 2.403935557560022e-12
in O 0 2.0411209181170342e-11
293 O 0 6.723464146540792e-11
cells O 0 3.277042179283818e-11
and O 0 2.7557485807183646e-11
in O 0 7.136428670229122e-10
HeLa O 0 8.598738645559934e-07
cells O 0 5.370160760520548e-09
. O 0 3.081154664741348e-09

Furthermore O 0 7.537574120419777e-09
, O 0 8.582138472101875e-11
at O 0 4.1926023763849685e-10
4 O 0 7.233398324757445e-10
degrees O 0 4.533044162258193e-09
C O 0 5.470776898164331e-08
, O 0 2.2632918109111166e-11
the O 0 1.0168241248997845e-10
added O 0 3.390406289049963e-10
soluble O 0 1.058871670900352e-10
complex O 0 8.847984567239564e-10
of O 0 3.0934026451490126e-09
HFE O 0 0.00034816315746866167
/ O 0 3.832002448689309e-07
beta2m O 0 6.342920499946558e-08
inhibited O 0 1.815750882983025e-10
binding O 0 5.724497958992103e-11
of O 0 8.777450988262103e-11
transferrin O 0 2.7712057093509657e-09
to O 0 1.425819184941446e-10
HeLa O 0 3.875838103795104e-07
cell O 0 1.8659844158719352e-07
TfR O 0 1.9882438806462233e-08
in O 0 6.618844361483411e-12
a O 0 4.648403884033314e-11
concentration O 0 5.521756918369647e-08
- O 0 2.943319543646794e-08
dependent O 0 2.6073965209150174e-09
manner O 0 1.2123468451363806e-08
. O 0 6.1184515232071135e-09

Scatchard O 0 2.7990063244942576e-05
plots O 0 7.812885627345167e-08
of O 0 3.535677350896549e-08
these O 0 2.0066344419422677e-11
data O 0 6.915171907317941e-11
indicate O 0 1.057785196240113e-11
that O 0 3.3741976226964177e-12
the O 0 1.2088364753637393e-09
added O 0 2.5218354071654403e-09
heterodimer O 0 4.884057047682688e-10
substantially O 0 1.8656005559836153e-11
reduced O 0 3.70473027255791e-11
the O 0 3.9199949709856075e-12
affinity O 0 1.7399758717173697e-11
of O 0 1.1752344653004343e-09
TfR O 0 9.588060123633113e-08
for O 0 6.4546085143391e-10
transferrin O 0 3.0151826990731934e-07
. O 0 4.289723420924929e-08

These O 0 7.804894508467441e-10
results O 0 2.099513340958481e-10
establish O 0 1.025088486317216e-10
a O 0 1.072534595858432e-11
molecular O 0 6.4811905842177e-11
link O 0 1.2116752046154033e-10
between O 0 1.4725588803887746e-10
HFE O 0 1.6791191228548996e-05
and O 0 3.839612308653706e-11
a O 0 2.0525098287649257e-10
key O 0 2.7062586838155767e-08
protein O 0 1.5433551658894373e-10
involved O 0 6.99785715485568e-12
in O 0 6.024529486392538e-11
iron O 0 8.749599089696858e-08
transport O 0 1.700180218833225e-09
, O 0 1.017098991834553e-11
the O 0 2.077655270049661e-10
TfR O 0 2.79800275393427e-07
, O 0 7.528572903980901e-11
and O 0 6.344168940186634e-11
raise O 0 3.0646641474563197e-11
the O 0 4.499530609214375e-11
possibility O 0 4.582451432200152e-11
that O 0 2.0046967287145473e-13
alterations O 0 7.959512215993669e-11
in O 0 3.71088836742528e-12
this O 0 4.220857170722514e-12
regulatory O 0 4.5583958829809035e-09
mechanism O 0 2.1700401475754916e-08
may O 0 6.65883598260919e-11
play O 0 5.5208532190320625e-11
a O 0 2.7774668415886383e-12
role O 0 1.7525017895203554e-12
in O 0 1.2999860519655182e-12
the O 0 5.843932282534325e-11
pathogenesis O 0 2.5364881821587915e-06
of O 0 3.541739260981558e-06
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 3.8132056943140924e-06
. O 0 5.635918043367383e-08

Genomic O 0 4.7500665800725983e-07
organization O 0 4.047763866310561e-07
of O 0 1.2378750113839487e-07
the O 0 1.892205432341143e-07
UBE3A O 1 0.6250320672988892
/ O 0 0.0002805464609991759
E6 O 0 0.00013843851047568023
- O 0 5.806846274936106e-07
AP O 0 9.587097338226158e-07
gene O 0 1.283534722951174e-09
and O 0 4.1313334697701265e-11
related O 0 2.238718321834199e-09
pseudogenes O 0 3.4140541060878604e-07
. O 0 4.436111566974432e-08

The O 0 2.3007272886843566e-07
UBE3A O 0 1.4235580238164403e-05
gene O 0 3.304814644167209e-09
encodes O 0 4.052293778311622e-10
the O 0 1.6067197572411374e-09
E6 O 0 1.4502692238238524e-06
- O 0 3.47659579347237e-07
AP O 0 4.86688622913789e-06
ubiquitin O 0 2.4368651097006477e-08
- O 0 5.647730283442343e-09
protein O 0 2.264527731998811e-10
ligase O 0 7.323249645585506e-12
and O 0 4.146781008851352e-12
has O 0 2.076254532884514e-12
recently O 0 7.462490694831736e-12
been O 0 3.0895224529745025e-13
shown O 0 2.312140821685016e-13
to O 0 8.95817437156915e-14
be O 0 2.884094059494441e-13
mutated O 0 1.0334555433644255e-10
in O 0 4.0019904057331246e-10
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 5.579248409048887e-06
who O 0 7.437460647352623e-10
lack O 0 3.542380682119983e-07
15q11 O 0 7.550029863523378e-07
- O 0 1.1850756465037193e-07
q13 O 0 7.326742235136408e-08
deletions O 0 5.429443117321853e-09
or O 0 3.958181005181416e-10
chromosome O 0 9.510270615464833e-08
15 O 0 1.2564241558266076e-07
paternal O 0 1.210973778142943e-06
uniparental B-Disease 0 0.005431263707578182
disomy I-Disease 0 0.0004635784716811031
. O 0 5.421662763183122e-07

Previous O 0 2.821895463966939e-07
UBE3A O 0 6.140190635051113e-06
cDNA O 0 1.10727462754312e-08
analysis O 0 1.0363987446027068e-10
has O 0 1.7488786027003433e-12
shown O 0 2.0099967697195797e-12
a O 0 9.657769375892578e-12
coding O 0 1.105577407400915e-09
region O 0 3.8973055338509255e-10
of O 0 6.171401167875956e-10
approximately O 0 1.4369416767578969e-10
2 O 0 9.426007352431043e-08
. O 0 1.8803106627274246e-08

6 O 0 1.2621107998711523e-06
kb O 0 4.104312665731413e-06
and O 0 2.4419073429982063e-09
a O 0 2.4642867746393904e-09
3 O 0 1.3737590620621631e-07
- O 0 4.270685494134341e-08
untranslated O 0 3.1798833788343472e-06
region O 0 1.5778242712372048e-08
( O 0 1.1893776241667098e-10
UTR O 0 1.2390305528242607e-06
) O 0 6.442941666295887e-12
of O 0 4.758748950450808e-10
< O 0 7.868033335967084e-09
50 O 0 2.934459897296904e-10
bp O 0 4.616393031731114e-11
, O 0 1.3830415762292048e-12
whereas O 0 3.114355344793762e-12
Northern O 0 1.7435870455773106e-11
analysis O 0 1.816046987269948e-12
has O 0 1.0285128868373072e-12
indicated O 0 3.5665353049357806e-12
mRNA O 0 6.404909155127703e-12
sizes O 0 4.507930053548881e-12
of O 0 1.2090803358510982e-10
5 O 0 1.550174566489204e-08
- O 0 4.849725243616376e-08
8 O 0 5.282078419099889e-08
kb O 0 1.652428409215645e-06
. O 0 4.741485071235729e-08

We O 0 3.013779448224341e-08
have O 0 2.0807237877118467e-11
analyzed O 0 6.571771772601043e-12
additional O 0 5.9025956865299545e-12
cDNA O 0 2.0650885446116263e-09
clones O 0 3.850785912362653e-09
and O 0 2.5814591783634988e-11
provide O 0 2.665267312407238e-12
evidence O 0 1.168293847081392e-11
for O 0 4.97533047746912e-12
an O 0 4.624348213383422e-12
additional O 0 2.784816544032509e-10
0 O 0 4.184705204579586e-08
. O 0 8.175049082126407e-09

5 O 0 4.124797499116539e-07
kb O 0 2.672315986274043e-06
of O 0 1.5256938468155568e-07
5 O 0 1.1201173037989065e-06
- O 0 9.902552164930967e-07
UTR O 0 2.392781971138902e-05
and O 0 4.236525019685189e-10
> O 0 2.707181367966882e-09
2 O 0 2.1616819445569035e-09
kb O 0 4.615017701325996e-08
of O 0 1.5219089988249834e-08
3 O 0 3.609975237850449e-06
- O 0 6.272769951465307e-06
UTR O 0 0.0002978780830744654
. O 0 9.337573914081077e-08

We O 0 8.064318990363972e-09
have O 0 4.441622850764881e-12
established O 0 1.2599855186978814e-11
the O 0 6.130310235136216e-12
genomic O 0 7.589215922365611e-10
organization O 0 5.660971691412442e-10
of O 0 2.4178032909105696e-09
UBE3A O 0 1.0312168114978704e-06
and O 0 2.3156573880633857e-10
the O 0 1.0984304438244052e-10
sequence O 0 2.099233009644763e-10
of O 0 4.148757337674169e-09
intron O 0 1.0515738040339784e-06
- O 0 2.6373995751782786e-06
exon O 0 7.085113225002715e-07
borders O 0 2.2906556651491883e-08
. O 0 2.2791894593865436e-08

We O 0 6.441860023187473e-08
have O 0 1.1015943018888308e-10
also O 0 8.134798390457831e-12
mapped O 0 1.1931333698811386e-10
two O 0 1.985213209099168e-11
highly O 0 6.554850412454627e-11
homologous O 0 2.4832847583811102e-11
processed O 0 3.719530239365554e-10
pseudogenes O 0 2.1575214947944232e-09
, O 0 1.0003248923640129e-10
UBE3AP1 O 0 2.6667261408874765e-05
and O 0 1.5852439361196957e-09
UBE3AP2 O 0 0.0002014815981965512
, O 0 7.674132163071334e-11
to O 0 7.424668518885014e-12
chromosomes O 0 3.039388532521947e-11
2 O 0 7.50411899286263e-10
and O 0 1.4156159751366193e-11
21 O 0 2.20983495391458e-10
, O 0 3.5960095578352336e-12
respectively O 0 2.0860445315573628e-11
, O 0 3.432475441031424e-12
and O 0 1.0346739957867168e-11
determined O 0 2.059242776297765e-10
their O 0 4.083287527545387e-11
genomic O 0 7.374056032460885e-09
organization O 0 4.433404754422554e-08
. O 0 2.274919985723045e-08

These O 0 2.395567522128772e-09
results O 0 5.421533777472121e-10
will O 0 1.7287606892887886e-12
form O 0 3.760735754927691e-13
the O 0 2.9417576230886255e-13
basis O 0 1.8010656984909779e-12
for O 0 9.901809054765551e-14
studies O 0 4.637188528132385e-13
of O 0 6.2909308838621225e-12
mutation O 0 1.4960073110859007e-11
and O 0 7.43932606489528e-12
imprinting O 0 6.973646549113255e-08
of O 0 1.5079909587711882e-07
UBE3A O 0 0.002659623511135578
. O 0 4.800323836207099e-07

Mutation O 0 1.2994780362873826e-08
spectrum O 0 3.177022733780177e-08
and O 0 5.176501449710713e-10
genotype O 0 1.132096443257069e-07
- O 0 2.9781110910676034e-08
phenotype O 0 7.211989339062086e-10
analyses O 0 4.6990730750984255e-11
in O 0 2.7372357852550877e-11
Cowden B-Disease 0 0.042158953845500946
disease I-Disease 0 0.22388006746768951
and O 0 1.416538553122848e-09
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 9.586753613177734e-10
two O 0 1.708133967603942e-09
hamartoma B-Disease 1 0.9999657869338989
syndromes I-Disease 0 0.1932690590620041
with O 0 2.8916254279920395e-08
germline O 1 0.9960946440696716
PTEN O 1 0.9991074204444885
mutation O 0 5.430268288364459e-07
. O 0 1.5436215861086566e-08

The O 0 7.499584626202704e-06
tumour B-Disease 1 1.0
suppressor O 0 9.476477862335742e-05
gene O 0 8.537790563423187e-08
PTEN O 0 4.211122359265573e-06
, O 0 3.1008782347408115e-11
which O 0 1.0641346744749702e-12
maps O 0 6.923697726257672e-11
to O 0 9.059273470279905e-11
10q23 O 0 4.065711038947484e-07
. O 0 3.203400567031167e-08

3 O 0 4.2839346292566916e-08
and O 0 6.333360919041908e-11
encodes O 0 3.6153916666004093e-11
a O 0 1.0260255145499997e-10
403 O 0 2.9348728308731253e-11
amino O 0 1.0882336143325233e-09
acid O 0 6.264953555934483e-10
dual O 0 8.602484946607092e-09
specificity O 0 7.140966484797673e-09
phosphatase O 0 1.1461506801424548e-05
( O 0 2.4872788273455626e-09
protein O 0 6.529451646031248e-09
tyrosine O 0 2.4461975556278048e-08
phosphatase O 0 3.076035781646169e-08
; O 0 6.546100900922669e-12
PTPase O 0 3.561462680323757e-09
) O 0 1.8707796000261984e-13
, O 0 8.514428718282493e-14
was O 0 5.900749073389777e-12
shown O 0 1.7463153319241531e-12
recently O 0 7.242640081422946e-12
to O 0 5.386881804340937e-13
play O 0 1.5476056547392147e-10
a O 0 5.554970719523489e-11
broad O 0 4.144697640651174e-10
role O 0 1.352695646467117e-11
in O 0 2.921602543226598e-11
human O 0 9.32920407592519e-09
malignancy B-Disease 0 3.605139863793738e-05
. O 0 3.999278064270584e-08

Somatic O 0 5.6996439525391906e-05
PTEN O 0 2.7281628717901185e-05
deletions O 0 1.232956847729838e-08
and O 0 7.26239693382702e-11
mutations O 0 1.5799117222825565e-11
were O 0 1.3604572112954627e-12
observed O 0 9.487890074294514e-13
in O 0 1.0380238335550018e-12
sporadic B-Disease 0 9.370550105813891e-05
breast I-Disease 1 0.5964054465293884
, I-Disease 0 8.694580166945798e-09
brain I-Disease 1 1.0
, I-Disease 0 4.1082248571910895e-06
prostate I-Disease 1 1.0
and I-Disease 1 0.9999994039535522
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999983310699463
lines O 0 6.36676822374227e-10
and O 0 2.4455009415072504e-13
in O 0 5.491022675614687e-13
several O 0 5.00755686916321e-12
primary O 0 1.2046961046507931e-06
tumours B-Disease 1 1.0
such O 0 6.475802533101316e-11
as O 0 9.245305632177292e-10
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 5.725806659029331e-06
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9999755620956421
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 8.656681529828347e-06

In O 0 2.4033617318508504e-09
addition O 0 1.4317498298055398e-09
, O 0 8.082670088782606e-10
PTEN O 0 6.1884675233159214e-06
was O 0 5.805088854060614e-09
identified O 0 3.6669715874904085e-11
as O 0 3.0407842042945443e-12
the O 0 8.33838987440716e-12
susceptibility O 0 8.562289766089748e-11
gene O 0 5.525643744647146e-12
for O 0 1.500304112715678e-12
two O 0 1.380565523012578e-10
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 3.009807125753383e-10
CD B-Disease 1 0.9996193647384644
; O 0 7.161859438831186e-10
MIM O 0 8.007151336641982e-06
158350 O 0 3.130238468429525e-08
) O 0 4.106239653856036e-12
and O 0 3.773939494244871e-11
Bannayan B-Disease 0 6.90737124386942e-06
- I-Disease 0 1.6369804143323563e-05
Zonana I-Disease 0 0.0020679328590631485
( I-Disease 0 7.634732290817681e-10
BZS I-Disease 0 1.256095060853113e-06
) I-Disease 0 1.0087644261580486e-11
or I-Disease 0 4.000751813171277e-11
Ruvalcaba I-Disease 0 3.930339005364658e-07
- I-Disease 0 3.0203163987607695e-06
Riley I-Disease 0 1.5771007383591495e-05
- I-Disease 1 0.9999954700469971
Smith I-Disease 0 0.0007741739391349256
syndrome I-Disease 1 1.0
( O 0 5.520546153547912e-08
MIM O 1 0.9944354295730591
153480 O 0 3.850909706670791e-05
) O 0 2.8401605511874095e-09
. O 0 1.3741987103799147e-08

Constitutive O 0 8.278937002614839e-07
DNA O 0 8.121601169364112e-09
from O 0 1.957644740757658e-10
37 O 0 1.4821430749378806e-09
CD B-Disease 0 4.432949936017394e-06
families O 0 2.7024927434782242e-12
and O 0 4.8138012673226704e-12
seven O 0 2.967380230423089e-10
BZS B-Disease 0 4.611111307895044e-06
families O 0 1.3905251949886122e-11
was O 0 5.524268820167322e-10
screened O 0 1.3033552903607415e-08
for O 0 2.3485298150660583e-09
germline O 0 6.449713055189932e-06
PTEN O 0 8.33713638712652e-05
mutations O 0 8.49592893814588e-08
. O 0 3.3281960298836566e-08

PTEN O 0 0.000262640678556636
mutations O 0 9.11639652656504e-09
were O 0 2.019675399145271e-10
identified O 0 7.139008134648961e-12
in O 0 5.118257380420932e-12
30 O 0 7.962609738232374e-11
of O 0 1.3150710520548614e-09
37 O 0 1.1931590160330074e-09
( O 0 1.6007807926432527e-11
81 O 0 4.5296102979541786e-10
% O 0 1.6739538574728208e-11
) O 0 2.199635222230323e-12
CD B-Disease 0 3.7171795952417597e-07
families O 0 5.201057141392129e-13
, O 0 1.9776487305417367e-13
including O 0 9.01020360752347e-13
missense O 0 1.6760959287154265e-09
and O 0 3.7735525815207893e-10
nonsense O 0 6.087269355248281e-08
point O 0 6.4667866617185155e-09
mutations O 0 2.080390373859764e-11
, O 0 3.2325299121477302e-12
deletions O 0 4.536482300920852e-11
, O 0 2.195386233916352e-11
insertions O 0 5.965712923661215e-10
, O 0 9.837743120133524e-11
a O 0 3.512778679048978e-10
deletion O 0 8.381003113733243e-10
/ O 0 1.703784491269289e-08
insertion O 0 8.114134919523508e-10
and O 0 3.0735709533047384e-09
splice O 0 1.1648666031760513e-06
site O 0 7.057761308715271e-08
mutations O 0 1.0586870047291086e-08
. O 0 1.9822344654585322e-08

These O 0 1.062327448231315e-09
mutations O 0 3.8054126516584574e-10
were O 0 9.04644345545158e-11
scattered O 0 8.455097733062189e-11
over O 0 1.4803143433272936e-10
the O 0 8.763001990708119e-10
entire O 0 1.3872285542504414e-09
length O 0 2.488718953141955e-11
of O 0 6.350168391122679e-09
PTEN O 0 4.196857389615616e-06
, O 0 1.539778894665833e-11
with O 0 7.557079419705237e-13
the O 0 5.290520105338814e-11
exception O 0 2.2454815784556104e-11
of O 0 7.931732354249377e-11
the O 0 3.6204428344177586e-11
first O 0 3.974966883424358e-11
, O 0 1.3127015099922978e-11
fourth O 0 3.6116323265389383e-09
and O 0 4.1836872854972285e-10
last O 0 2.698207879348047e-08
exons O 0 7.4528984441712964e-06
. O 0 1.1896094775920574e-07

A O 0 4.0044710658548865e-06
hot O 0 1.7686425053398125e-06
spot O 0 8.626906122799483e-08
for O 0 2.2931360976752302e-10
PTEN O 0 5.826855726809299e-07
mutation O 0 2.2535822166713793e-11
in O 0 7.960099593362635e-12
CD B-Disease 0 8.05976742412895e-06
was O 0 6.645440864261332e-10
identified O 0 9.367918767100303e-12
in O 0 1.3123534377268431e-11
exon O 0 9.288468882928669e-10
5 O 0 1.1720552306471177e-10
that O 0 3.946926607160256e-13
contains O 0 3.185645107081636e-12
the O 0 3.9690806197256734e-11
PTPase O 0 6.693302623261843e-08
core O 0 1.53028679505951e-07
motif O 0 3.4754730204866746e-09
, O 0 3.6842369433021105e-12
with O 0 8.309395380969031e-13
13 O 0 4.038944456663529e-10
of O 0 6.478017566813321e-10
30 O 0 4.6047254897985113e-10
( O 0 2.422105918609141e-12
43 O 0 5.7351207116695946e-11
% O 0 1.0077624498783244e-11
) O 0 2.087237500891792e-12
CD B-Disease 0 2.1281292106323235e-07
mutations O 0 4.5495659323213644e-11
identified O 0 1.0023966899586068e-11
in O 0 9.989458045478461e-12
this O 0 7.592224071650833e-11
exon O 0 1.6925895351960207e-07
. O 0 1.2801784521343507e-08

Seven O 0 8.789286631838422e-09
of O 0 1.3953122213195002e-08
30 O 0 5.058172547478534e-09
( O 0 4.7082508031204284e-11
23 O 0 1.0494624058665636e-09
% O 0 2.0864025784828044e-11
) O 0 1.041730829202947e-12
were O 0 2.5054553917658318e-11
within O 0 1.2893713874362334e-10
the O 0 3.372515322563885e-10
core O 0 2.462780344103521e-07
motif O 0 5.88311488414206e-09
, O 0 1.137069431667026e-11
the O 0 2.8800347523505465e-11
majority O 0 1.3569438107874365e-11
( O 0 2.249518496824643e-12
five O 0 1.8717593447403758e-11
of O 0 5.451022966340702e-10
seven O 0 1.8614072783140756e-10
) O 0 1.771455811899747e-12
of O 0 2.0827536917344958e-10
which O 0 3.228932746179858e-11
were O 0 6.02614180778005e-10
missense O 0 5.3143050848802886e-08
mutations O 0 1.4921417434976547e-09
, O 0 2.9110186483549683e-10
possibly O 0 5.41642786178187e-10
pointing O 0 3.4362127032672163e-10
to O 0 5.300011297892926e-12
the O 0 6.08565906001779e-11
functional O 0 2.6313125012222827e-09
significance O 0 2.98698815681675e-10
of O 0 1.82274625948331e-10
this O 0 2.2949465244836986e-11
region O 0 2.4908299867121286e-09
. O 0 9.546505808089023e-09

Germline O 0 0.0006388165638782084
PTEN O 0 0.00028267072048038244
mutations O 0 2.7872357755143184e-09
were O 0 9.994476080077419e-11
identified O 0 5.783584115098828e-12
in O 0 6.28373568456464e-12
four O 0 1.8978802904245917e-11
of O 0 1.062388177430762e-09
seven O 0 1.5125869445853368e-09
( O 0 5.1403603595900904e-11
57 O 0 3.521555269614396e-09
% O 0 3.47009282419819e-10
) O 0 1.707256974681215e-10
BZS B-Disease 0 5.4434822231996804e-06
families O 0 1.2085955500285017e-11
studied O 0 1.2616948374954973e-08
. O 0 3.6536981440349336e-08

Interestingly O 0 1.524433557165139e-08
, O 0 4.1134709527490543e-10
none O 0 3.249650548653449e-10
of O 0 3.5211975002447105e-10
these O 0 4.343526840283607e-12
mutations O 0 7.143366627382353e-12
was O 0 4.237260542439003e-10
observed O 0 6.505564142944564e-11
in O 0 3.5276760679270325e-11
the O 0 2.1387480675372217e-09
PTPase O 0 6.587529696844285e-06
core O 0 6.347017915686592e-05
motif O 0 2.741117214100086e-06
. O 0 1.145883814501758e-07

It O 0 5.194105701100682e-10
is O 0 1.6884797379712602e-11
also O 0 5.6602535158933875e-12
worthy O 0 2.8926857437161502e-11
of O 0 1.436174512647881e-10
note O 0 3.2616836315169095e-11
that O 0 4.355935913618464e-13
a O 0 1.368831263615089e-11
single O 0 2.3383106562135936e-10
nonsense O 0 1.035127539239511e-08
point O 0 1.34798117112922e-09
mutation O 0 2.0317716259432572e-11
, O 0 6.715228958835417e-13
R233X O 0 1.694003270991118e-10
, O 0 2.8418144573660875e-12
was O 0 3.142053631166597e-11
observed O 0 3.560818957401568e-12
in O 0 1.2814534589705717e-12
the O 0 5.3626832141606684e-11
germline O 0 4.038468670586326e-09
DNA O 0 2.49330972534878e-10
from O 0 5.171295683337185e-12
two O 0 1.906263558462684e-12
unrelated O 0 1.3589700198490817e-10
CD B-Disease 0 0.0002327342954231426
families O 0 1.6604169428280358e-11
and O 0 2.7356086840235605e-10
one O 0 4.4060390891331735e-09
BZS B-Disease 0 0.0009843825828284025
family O 0 4.241283235728588e-08
. O 0 1.741347119832426e-07

Genotype O 0 9.568076166033279e-06
- O 0 3.1799318094272166e-06
phenotype O 0 1.4391593694540461e-08
studies O 0 3.646224433495604e-10
were O 0 4.85766982194491e-11
not O 0 4.2815222396110075e-13
performed O 0 2.384657193932327e-10
on O 0 2.510978758252236e-09
this O 0 5.9210652873786795e-12
small O 0 7.431756599007855e-11
group O 0 1.9567525377794937e-10
of O 0 2.3364096435329884e-08
BZS B-Disease 0 0.002854741644114256
families O 0 1.5588850210690453e-09
. O 0 3.490681521611805e-08

However O 0 2.0602572980976674e-09
, O 0 1.432759882957768e-10
genotype O 0 1.158339646423201e-08
- O 0 8.894740943787838e-09
phenotype O 0 1.2634376878040143e-09
analysis O 0 8.816713331638582e-11
inthe O 0 1.4700816564072738e-07
group O 0 6.10138717327402e-10
of O 0 9.184445204368785e-09
CD B-Disease 1 0.9999992847442627
families O 0 4.566882896156477e-12
revealed O 0 1.3036298429636162e-10
two O 0 3.4662125600326554e-12
possible O 0 1.1645856501374396e-10
associations O 0 6.316375200654534e-11
worthy O 0 6.911390904029702e-10
of O 0 1.8297207082795808e-09
follow O 0 1.3624112948917855e-10
- O 0 8.397912920621309e-11
up O 0 7.105698408144123e-12
in O 0 5.441284575691263e-12
independent O 0 1.6278396686164598e-10
analyses O 0 4.332305625354138e-09
. O 0 2.2307402147703215e-08

The O 0 6.458824142185904e-09
first O 0 9.544662837868145e-10
was O 0 5.796281676850867e-09
an O 0 1.7430485874103674e-11
association O 0 4.902854788824129e-10
noted O 0 5.022596574755234e-11
in O 0 1.3626939854294307e-11
the O 0 2.4825427824559654e-10
group O 0 7.215866099086199e-11
of O 0 5.214474407821967e-10
CD B-Disease 1 0.9999916553497314
families O 0 1.6450023634928534e-11
with O 0 4.5428050210460924e-10
breast B-Disease 1 0.9999954700469971
disease I-Disease 1 0.9999997615814209
. O 0 9.180496931548987e-07

A O 0 4.304564260593224e-09
correlation O 0 1.6766769916909396e-10
was O 0 4.167051148584733e-10
observed O 0 8.380531511809064e-12
between O 0 6.890241415619114e-13
the O 0 2.7283993207088963e-12
presence O 0 5.079656747314365e-12
/ O 0 3.0721643007325383e-09
absence O 0 1.0481501222514567e-09
of O 0 1.2049117259493869e-09
a O 0 8.733501144497779e-10
PTEN O 0 5.75505691813305e-06
mutation O 0 1.1028557234116221e-10
and O 0 2.1591775676427227e-12
the O 0 1.3185005171001407e-11
type O 0 1.1840002311913622e-09
of O 0 1.4152051974747337e-08
breast O 0 1.727428571030032e-05
involvement O 0 1.5083503512869356e-07
( O 0 6.988983614064637e-09
unaffected O 1 0.8522371053695679
versus O 1 0.9617554545402527
benign O 1 0.9999998807907104
versus O 0 8.139628334902227e-05
malignant O 0 0.00026008329587057233
) O 0 6.305677091589246e-10
. O 0 6.4280989420240076e-09

Specifically O 0 1.9284793761897845e-09
and O 0 1.1521072984521652e-10
more O 0 1.1846507932608552e-13
directly O 0 3.122877661760476e-13
, O 0 1.8034615684517363e-12
an O 0 7.229666518226985e-12
association O 0 9.857588523232153e-09
was O 0 5.213293796657581e-09
also O 0 3.486808498182059e-12
observed O 0 6.319682190752962e-13
between O 0 2.2446142709277306e-13
the O 0 1.5022455935459478e-12
presence O 0 6.752785179989229e-13
of O 0 2.932371706565462e-11
a O 0 4.783519691464733e-10
PTEN O 1 0.7592447400093079
mutation O 0 3.2794332582852803e-07
and O 0 8.82634676457883e-09
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 2.1328255570551846e-06

Secondly O 0 4.3416642370175396e-07
, O 0 2.0446220272418714e-09
there O 0 2.730718706711599e-10
appeared O 0 3.7755973347763927e-10
to O 0 2.1606605393742484e-12
be O 0 1.7525084031536076e-12
an O 0 1.420968811366441e-12
interdependent O 0 3.0844311993405427e-08
association O 0 1.512774461254196e-09
between O 0 3.631344114296553e-10
mutations O 0 2.12525858023227e-10
upstream O 0 3.324942404736575e-11
and O 0 8.884571030265409e-12
within O 0 5.971928507264579e-10
the O 0 1.991461218153745e-09
PTPase O 0 1.3432986634143163e-06
core O 0 5.157819032319821e-06
motif O 0 7.471306417983214e-08
, O 0 1.5431578237468102e-10
the O 0 9.028383596287881e-10
core O 0 5.707531869347804e-08
motif O 0 7.094411169639159e-10
containing O 0 3.2059242413562394e-12
the O 0 1.734260478281069e-11
majority O 0 5.88955013230974e-12
of O 0 2.1936334693162252e-10
missense O 0 1.0614732204317079e-08
mutations O 0 1.638486707422615e-10
, O 0 3.523070030153619e-11
and O 0 1.9833244421785245e-11
the O 0 3.278306792697805e-10
involvement O 0 2.0342660889127728e-10
of O 0 6.78291145472798e-10
all O 0 1.1083468864914181e-10
major O 0 5.348788434389462e-08
organ O 1 0.9999949932098389
systems O 1 0.8341192603111267
( O 0 9.582187487922056e-09
central O 1 0.9994096755981445
nervous O 1 0.9880244135856628
system O 1 0.9956521391868591
, O 0 2.378649632817087e-08
thyroid O 1 1.0
, O 0 3.4329748359596124e-06
breast O 1 1.0
, O 0 0.00010552763706073165
skin O 1 1.0
and O 1 0.9996238946914673
gastrointestinal O 1 1.0
tract O 1 0.9986151456832886
) O 0 6.132117591484132e-10
. O 0 9.914155718604434e-09

However O 0 1.4306618822956807e-07
, O 0 2.4399321452150957e-10
these O 0 2.2618059768858556e-12
observations O 0 1.78684254892314e-11
would O 0 2.80683341152832e-11
need O 0 1.2304646017369247e-11
to O 0 1.4837925809904617e-12
be O 0 8.371261041133227e-13
confirmed O 0 3.2649868052236908e-12
by O 0 5.013747663568102e-13
studying O 0 1.5996514876603918e-11
a O 0 7.294866100071573e-12
larger O 0 9.552716690591767e-13
number O 0 2.175391117242853e-11
of O 0 9.06347719098477e-10
CD B-Disease 0 0.0008259119931608438
families O 0 1.9730138356433002e-10
. O 0 3.953143146162574e-09

Molecular O 0 0.0074875978752970695
defects O 1 0.9999918937683105
leading O 0 1.502477964265836e-08
to O 0 1.5266078332021316e-11
human O 0 1.5041285994499276e-09
complement B-Disease 0 1.8892951914040168e-07
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 6.815839004303825e-10
an O 0 2.122777214424998e-12
African O 0 9.382090659926234e-10
- O 0 1.8604427998170081e-09
American O 0 1.3647007968131675e-09
family O 0 9.3540553081084e-10
. O 0 7.364708398682751e-09

Complement B-Disease 0 2.679555791473831e-06
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 3.139338744517772e-08
C6D B-Disease 0 0.0016497146571055055
) O 0 5.483950533263782e-12
was O 0 1.1884387918215111e-10
diagnosed O 0 2.7045993222785114e-10
in O 0 5.426173399492029e-12
a O 0 2.101964435841097e-11
16 O 0 5.1283640528643204e-11
- O 0 2.3076582311709615e-11
year O 0 6.843957258556577e-12
- O 0 1.5756541904554666e-10
old O 0 8.605565704478124e-10
African O 0 3.570472806302405e-10
- O 0 6.880464947789378e-11
American O 0 1.546648920047744e-11
male O 0 1.7706664259820037e-11
with O 0 1.179937120232566e-10
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 9.179632343148114e-08

The O 0 2.3116005820611463e-07
patients O 0 1.9103465476177917e-09
father O 0 1.3073382376660447e-09
and O 0 1.4031096284838895e-09
two O 0 1.0293916830050875e-09
brothers O 0 4.2618526663318335e-07
also O 0 4.473034387331154e-09
had O 0 6.230065796586359e-09
C6D B-Disease 0 0.04002575948834419
, O 0 2.0377961817974466e-10
but O 0 1.4447072010925766e-11
gave O 0 1.2574269403486937e-10
no O 0 1.5665408206744225e-11
history O 0 3.272089196815209e-11
of O 0 5.8908851130468065e-09
meningitis B-Disease 1 1.0
or O 0 5.00745722664675e-10
other O 0 1.0167679198591628e-10
neisserial B-Disease 0 0.00012392047210596502
infection I-Disease 0 0.00046959900646470487
. O 0 5.242423029017118e-08

By O 0 5.263126601207091e-10
using O 0 1.2015008432619823e-10
exon O 0 2.3194912657231725e-09
- O 0 1.548391137529137e-10
specific O 0 4.194471853180559e-11
polymerase O 0 4.087037375199998e-10
chain O 0 8.12575517983305e-09
reaction O 0 5.118044876795125e-11
( O 0 1.924173927830841e-12
PCR O 0 1.1330324178882023e-10
) O 0 3.7488472070558443e-13
/ O 0 4.704902439867098e-11
single O 0 3.767114745145683e-11
- O 0 4.3717383879648963e-11
strand O 0 9.058080674417823e-11
conformation O 0 2.5080947735345305e-11
polymorphism O 0 4.0680046137220316e-11
as O 0 1.540298054034106e-12
a O 0 1.876827686320137e-12
screening O 0 2.4352166116958784e-11
step O 0 1.1105047437176552e-11
and O 0 3.861030418994549e-13
nucleotide O 0 4.4001790058811885e-12
sequencing O 0 6.318444465552853e-12
of O 0 1.9124675454396112e-10
target O 0 1.4266278158814316e-09
exons O 0 9.016186908183954e-09
, O 0 2.4471317333629727e-11
we O 0 1.0700845591571362e-11
determined O 0 2.1793030921535284e-11
that O 0 2.820590711948706e-13
the O 0 2.2687938333598723e-11
proband O 0 6.42450759258395e-09
was O 0 4.861790525723109e-09
a O 0 4.5894602007656715e-10
compound O 0 5.4577884434081625e-09
heterozygote O 0 6.406971841954601e-09
for O 0 1.2180241537596004e-10
two O 0 2.0085471064135163e-09
C6 O 0 4.314876059652306e-05
gene O 0 9.429873415456314e-08
mutations O 0 3.150964644760279e-08
. O 0 3.20139079690307e-08

The O 0 1.745709354850078e-08
first O 0 6.602824953461095e-10
, O 0 1.3635831179470426e-11
1195delC O 0 4.241877682442663e-10
located O 0 1.0297741132037075e-10
in O 0 3.509769905263305e-11
exon O 0 3.3793552400851468e-09
7 O 0 4.624593596957993e-09
, O 0 3.71642040059017e-12
is O 0 2.0075128083323068e-13
a O 0 4.67880291801781e-13
novel O 0 1.1059742531516203e-12
mutation O 0 8.993068334288423e-13
, O 0 1.0694856865346367e-13
while O 0 1.9385690698103114e-13
the O 0 5.207174535309944e-12
second O 0 2.2242875943878637e-11
, O 0 5.472641654083454e-13
1936delG O 0 4.701995737210751e-11
in O 0 2.4017277749921462e-11
exon O 0 2.2541863931024864e-09
12 O 0 8.716023042198984e-11
, O 0 3.503614716057757e-12
has O 0 1.0827370900898248e-12
been O 0 2.201532359191738e-12
described O 0 5.3207546875377876e-12
before O 0 5.512340930935444e-11
to O 0 1.0296380067997823e-11
cause O 0 2.3213722055714925e-09
C6D B-Disease 0 5.5824102673796006e-06
in O 0 4.332243591642637e-11
an O 0 1.435770339425213e-12
unrelated O 0 3.099779599669006e-10
African O 0 8.284942176750576e-10
- O 0 1.4172411022528308e-09
American O 0 6.408191199902546e-10
individual O 0 4.961925870183848e-10
. O 0 3.9983930832931946e-08

Both O 0 3.6451692775330002e-09
mutations O 0 1.7459650392126491e-09
result O 0 1.9847192778144063e-09
in O 0 1.1803114041697427e-09
premature O 0 4.573534440055482e-08
termination O 0 5.701797434198852e-08
codons O 0 6.471922375794747e-08
and O 0 1.0741863398777696e-08
C6 O 0 5.332458022166975e-05
null O 0 3.5229885497756186e-07
alleles O 0 1.0765650593214104e-09
. O 0 5.346858067412086e-09

Allele O 0 2.1349221057676004e-08
- O 0 2.28951013703238e-09
specific O 0 5.334180666616284e-11
PCR O 0 1.2604483012879086e-09
indicated O 0 1.9032235856752955e-11
that O 0 1.6922890226731685e-13
the O 0 2.0307061587843123e-11
probands O 0 3.072042886742565e-08
two O 0 2.868293380586806e-10
brothers O 0 1.0662173366426941e-08
also O 0 1.6086169896123437e-10
inherited O 0 4.4511344610143055e-10
the O 0 5.327299712476474e-10
1195delC O 0 5.333341768221089e-09
mutation O 0 2.9498511272540995e-11
from O 0 3.2431273378624725e-12
their O 0 1.1972041413788048e-11
heterozygous O 0 6.153626219695951e-11
mother O 0 3.3300705942762576e-11
and O 0 4.0836611869821127e-11
the O 0 3.8334599383738066e-10
1936delG O 0 2.411849031602742e-08
mutation O 0 1.4520534774575822e-10
from O 0 1.6022530524573142e-11
their O 0 5.201439973179234e-11
homozygous O 0 4.9105222110767954e-09
father O 0 3.831195805048537e-09
. O 0 1.2632304091653168e-09
. O 0 6.873178914901246e-09

PAX6 O 0 0.00892719067633152
mutations O 0 1.0941157597699203e-06
reviewed O 0 4.5951625793350104e-07
. O 0 1.3649311370045325e-07

Mutations O 0 2.130374454623052e-08
in O 0 3.1806044464843808e-09
PAX6 O 0 0.00858230795711279
are O 0 2.2435808419429826e-11
responsible O 0 1.3006395960246664e-10
for O 0 1.667319581011295e-11
human O 0 1.3026916434455416e-08
aniridia B-Disease 1 1.0
and O 0 4.951962839783164e-09
have O 0 8.594747309687012e-12
also O 0 8.422559524823292e-13
been O 0 3.505283899512407e-13
found O 0 6.782949717306849e-14
in O 0 1.1043174838118452e-12
patients O 0 2.66398144863067e-12
with O 0 2.754748902947246e-12
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 2.7501159682863374e-10
with O 0 6.743244398421666e-07
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 1.5568208056038202e-08
with O 0 1.7477709279845044e-09
autosomal B-Disease 1 0.9999891519546509
dominant I-Disease 1 0.999929666519165
keratitis I-Disease 1 1.0
, O 0 4.2604295091841493e-10
and O 0 7.177514138589913e-11
with O 0 2.3981677754747466e-10
isolated B-Disease 1 0.9999910593032837
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 0.0005650069215334952

No O 0 1.9385074878641717e-08
locus O 0 7.404216351147852e-09
other O 0 5.144156281500223e-11
than O 0 4.70539406050019e-12
chromosome O 0 1.3241781005035591e-08
11p13 O 0 1.1807403410557527e-07
has O 0 1.9670542972249905e-10
been O 0 4.9751241321116524e-11
implicated O 0 7.792633205383481e-11
in O 0 2.5151378202359354e-10
aniridia B-Disease 1 1.0
, O 0 2.6816040499255678e-09
and O 0 2.284445521638645e-09
PAX6 O 1 0.8261123299598694
is O 0 4.1133846329088897e-10
clearly O 0 2.342720288595057e-11
the O 0 2.8690964534727748e-11
major O 0 3.2695097740287338e-09
, O 0 1.791613558899119e-11
if O 0 5.39687001685496e-12
not O 0 1.8302134981162954e-12
only O 0 1.3890877380642874e-12
, O 0 3.534806778879296e-12
gene O 0 1.5266639341593446e-10
responsible O 0 9.654284482962794e-09
. O 0 7.349217234775551e-09

Twenty O 0 5.0358224257252004e-08
- O 0 1.0749569234747014e-08
eight O 0 5.193828145344526e-10
percent O 0 1.5522647056620542e-10
of O 0 9.684970603274223e-10
identified O 0 1.4871219811141145e-08
PAX6 O 0 0.0158051960170269
mutations O 0 1.0116600890341942e-08
are O 0 1.8498548526313385e-10
C O 0 0.014151623472571373
- O 0 0.14353804290294647
T O 0 7.832623850845266e-06
changes O 0 9.69456181998396e-10
at O 0 2.4678943333356074e-09
CpG O 0 1.4776972534491506e-07
dinucleotides O 0 1.7826037534973693e-08
, O 0 2.1050739276717856e-11
20 O 0 3.805541645696131e-11
% O 0 2.6130833608029036e-12
are O 0 6.906662741723579e-13
splicing O 0 2.243065289064816e-09
errors O 0 2.605380302611593e-07
, O 0 9.127765904226592e-11
and O 0 9.198930679688022e-12
more O 0 1.3308008395360865e-13
than O 0 3.116017372514074e-13
30 O 0 3.115247990126413e-11
% O 0 7.874268077856517e-12
are O 0 8.231186999357876e-13
deletion O 0 1.9621483257625805e-11
or O 0 9.294077660260136e-12
insertion O 0 4.202568154587638e-11
events O 0 2.218070616066825e-09
. O 0 2.349875138918378e-08

There O 0 3.787875790806083e-09
is O 0 8.615398672251473e-11
a O 0 2.2226559481808295e-10
noticeably O 0 1.4179549756576648e-09
elevated O 0 1.7716916822507756e-09
level O 0 2.3020070294421657e-09
of O 0 1.0948661421927852e-10
mutation O 0 6.342569264933262e-12
in O 0 1.2707860805316606e-11
the O 0 4.692517208138014e-11
paired O 0 9.179755913746313e-12
domain O 0 7.786968986289722e-12
compared O 0 8.032188195811196e-13
with O 0 7.679513492134249e-13
the O 0 3.194324527111547e-10
rest O 0 2.371566831804728e-10
of O 0 4.339043291334832e-10
the O 0 1.0372042114070723e-09
gene O 0 5.8677058767386825e-09
. O 0 6.8804326680549366e-09

Increased O 0 9.55165613270026e-10
mutation O 0 1.3831222278604116e-10
in O 0 2.7945043848398576e-11
the O 0 6.781087913410033e-10
homeodomain O 0 7.248569033890817e-08
is O 0 7.184413220590047e-12
accounted O 0 2.4695682998565616e-11
for O 0 3.2969269675442447e-12
by O 0 3.0288153929358685e-11
the O 0 3.1175335646338453e-09
hypermutable O 0 1.0181437346545863e-06
CpG O 0 1.3750131984124891e-05
dinucleotide O 0 2.1340606508601923e-06
in O 0 9.148132029679346e-09
codon O 0 1.628985017987361e-07
240 O 0 9.872151984779975e-09
. O 0 1.7448671840725183e-08

Very O 0 4.374244966243168e-09
nearly O 0 5.108937717324125e-10
all O 0 5.118230492207054e-11
mutations O 0 4.2725448179403713e-11
appear O 0 2.982921548655426e-11
to O 0 3.413099013485632e-12
cause O 0 3.009859916858204e-09
loss O 0 2.9697089232172402e-09
of O 0 8.533337925165085e-10
function O 0 8.797568229468311e-10
of O 0 6.571625188467323e-11
the O 0 2.1741412923464987e-12
mutant O 0 2.2291038806465657e-11
allele O 0 2.3928879711032636e-12
, O 0 2.3123614568271167e-13
and O 0 9.393602838940127e-14
more O 0 3.759146619474688e-15
than O 0 5.5307206026349726e-14
80 O 0 8.116588130768765e-12
% O 0 1.3363925851356262e-12
of O 0 1.4217185761999929e-10
exonic O 0 3.0082834001632364e-08
substitutions O 0 1.63308688794217e-09
result O 0 8.083086977528353e-10
in O 0 2.2307891645034772e-10
nonsense O 0 6.143619657450472e-08
codons O 0 4.268217779213046e-08
. O 0 1.918647640763993e-08

In O 0 6.6156866651567725e-09
a O 0 9.100304398934611e-10
gene O 0 1.953780193186816e-10
with O 0 4.202613951287404e-12
such O 0 4.18866968887599e-10
extraordinarily O 0 1.7865445789411183e-09
high O 0 1.804861482490594e-09
sequence O 0 1.0102244735188393e-10
conservation O 0 3.4537894766373256e-10
throughout O 0 4.667244455497377e-12
evolution O 0 1.4240383178210081e-11
, O 0 1.401411755738713e-12
there O 0 8.245521453120741e-12
are O 0 4.164321665278692e-12
presumed O 0 8.993291444880924e-09
undiscovered O 0 1.3099843272357248e-06
missense O 0 4.1238300241275283e-07
mutations O 0 1.1115569575892437e-09
, O 0 6.286207665517907e-11
these O 0 2.9259058283853667e-12
are O 0 3.678631563860252e-13
hypothesized O 0 9.26951766212769e-13
to O 0 1.5932918775562327e-13
exist O 0 1.3291812095417299e-11
in O 0 2.1753869539065107e-11
as O 0 9.419057200865666e-11
- O 0 1.206146515997375e-09
yet O 0 5.53281795379057e-11
unidentified O 0 3.1690186585997537e-10
phenotypes O 0 2.0916113285807114e-10
. O 0 4.8893208925981924e-11
. O 0 1.239492175564294e-09

Genetic O 0 1.7548808273204486e-07
heterogeneity O 0 2.556418223775836e-07
and O 0 9.885543494903004e-10
penetrance O 0 1.2873410071279068e-07
analysis O 0 1.24844135029889e-10
of O 0 1.0195323696393643e-08
the O 0 1.9253159067034176e-08
BRCA1 O 0 1.6114837464442644e-08
and O 0 7.89849297078149e-10
BRCA2 O 0 1.3397359666100783e-08
genes O 0 1.7909107530300616e-10
in O 0 3.5780693963261e-09
breast B-Disease 1 0.998551070690155
cancer I-Disease 1 0.93099445104599
families O 0 1.2498952983719391e-09
. O 0 1.2692647999301698e-07

The O 0 0.0005500416737049818
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9974230527877808
Consortium O 0 1.0423251524116495e-06
. O 0 7.100265264625705e-08

The O 0 2.745505156553918e-09
contribution O 0 8.778560656175216e-10
of O 0 3.5028318023933025e-09
BRCA1 O 0 1.9706352105686165e-08
and O 0 5.933371571842372e-10
BRCA2 O 0 1.5498795846724533e-07
to O 0 4.0251419974879354e-09
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 0.008403071202337742
assessed O 0 5.980683170925261e-10
by O 0 8.837379612824936e-13
linkage O 0 2.2831432300307597e-09
and O 0 1.2240672017660437e-11
mutation O 0 3.6153898885088465e-12
analysis O 0 3.86565806491726e-13
in O 0 1.3286002072815384e-12
237 O 0 9.204967517384421e-12
families O 0 1.1345120670821704e-13
, O 0 3.1760997911550737e-13
each O 0 3.0724263465429363e-14
with O 0 8.786570646415748e-13
at O 0 1.6976851036076823e-09
least O 0 7.165691651156436e-12
four O 0 2.054877752330486e-12
cases O 0 3.997897065483036e-12
of O 0 8.328614597985506e-08
breast B-Disease 1 0.9218230247497559
cancer I-Disease 0 4.5783094719809014e-06
, O 0 8.582690981528973e-12
collected O 0 1.2895201399742984e-12
by O 0 8.363062846405978e-12
the O 0 5.724965035369678e-07
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 0.0008008357835933566
Consortium O 0 1.8452192662721245e-08
. O 0 9.444756976506596e-09

Families O 0 1.892474399411981e-09
were O 0 1.3599430470634388e-09
included O 0 4.248014995322791e-10
without O 0 1.6660296753290282e-10
regard O 0 1.487580059134075e-10
to O 0 1.1614167743853598e-12
the O 0 1.2550492763108156e-11
occurrence O 0 6.424853182807055e-08
of O 0 4.307282779336674e-06
ovarian B-Disease 1 1.0
or I-Disease 0 1.3504416074283654e-06
other I-Disease 0 1.3383854025050823e-07
cancers I-Disease 1 0.9999874830245972
. O 0 7.948582378958235e-07

Overall O 0 7.368553838205116e-07
, O 0 1.1187766268960786e-08
disease O 0 0.06307817250490189
was O 0 7.91555763157703e-08
linked O 0 1.6505238065178673e-08
to O 0 4.428217514895749e-11
BRCA1 O 0 7.836843674002836e-11
in O 0 6.143358391441645e-13
an O 0 2.8357256999381533e-14
estimated O 0 4.707860078341508e-13
52 O 0 4.658981967581299e-12
% O 0 1.4067840859235958e-12
of O 0 1.670678734244646e-10
families O 0 1.1471198340176625e-12
, O 0 1.2145800858121003e-12
to O 0 2.5600598030361965e-12
BRCA2 O 0 2.2216504677596838e-11
in O 0 1.0345353046448125e-12
32 O 0 1.0291922696026301e-11
% O 0 2.331370339836436e-12
of O 0 8.506909759953274e-11
families O 0 5.029359090649721e-13
, O 0 7.982460721069062e-13
and O 0 1.9160727691980295e-12
to O 0 8.1917182455718e-13
neither O 0 1.011201278960927e-11
gene O 0 7.557295718038648e-13
in O 0 4.224310246221663e-13
16 O 0 9.742766489406751e-12
% O 0 2.48143573831211e-13
( O 0 5.0097109755920313e-14
95 O 0 9.205060325090386e-11
% O 0 1.3966519780972408e-11
confidence O 0 5.409297010317005e-09
interval O 0 1.5071591974447074e-08
[ O 0 7.715175165401433e-09
CI O 0 5.154676728125196e-06
] O 0 1.8734890028238027e-10
6 O 0 2.8410584995697263e-10
% O 0 5.887977605478767e-12
- O 0 4.321077870517165e-11
28 O 0 1.1257750981430448e-10
% O 0 5.280154351944288e-12
) O 0 3.938496664218638e-13
, O 0 1.9282264587111575e-12
suggesting O 0 4.826776478505934e-11
other O 0 2.0476837239713497e-11
predisposition O 0 8.863376699252967e-09
genes O 0 2.2618742434588057e-09
. O 0 5.9044058531299015e-09

The O 0 8.658040506759335e-09
majority O 0 3.058965858393492e-10
( O 0 1.0267747589665088e-11
81 O 0 2.8876268043376285e-10
% O 0 2.0498435848032015e-12
) O 0 4.9949410926841686e-14
of O 0 1.6120809548381132e-11
the O 0 9.761934052221477e-06
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.877377086070055e-09
were O 0 8.754644925668131e-11
due O 0 1.7245357142314788e-08
to O 0 5.824333203230392e-12
BRCA1 O 0 1.3784499930391547e-10
, O 0 2.0513209457884846e-13
with O 0 1.68287082945133e-13
most O 0 6.495580549131796e-12
others O 0 2.881582559371987e-12
( O 0 1.4530543923033795e-13
14 O 0 7.325362538779245e-11
% O 0 3.2027830908221144e-12
) O 0 6.772959471913753e-13
due O 0 5.705515171428033e-09
to O 0 1.1709051506159085e-09
BRCA2 O 0 7.755176056889468e-08
. O 0 1.3673669307934233e-08

Conversely O 0 1.3572358348312719e-08
, O 0 7.285455572159094e-11
the O 0 4.000355255384669e-11
majority O 0 4.065054716451133e-12
of O 0 6.10609965367992e-11
families O 0 1.5391225620386972e-13
with O 0 2.200705329774566e-12
male B-Disease 0 1.1072481820306734e-10
and I-Disease 0 1.3728671532931003e-09
female I-Disease 0 4.952031318339323e-08
breast I-Disease 1 0.9999992847442627
cancer I-Disease 1 1.0
were O 0 6.67885331040452e-07
due O 0 0.03355597332119942
to O 0 4.907018125166474e-10
BRCA2 O 0 1.4416752236456887e-09
( O 0 1.896388645075686e-12
76 O 0 9.021652869201091e-10
% O 0 2.5725822513922303e-11
) O 0 1.8381138625067628e-11
. O 0 1.1538385802367657e-09

The O 0 1.076403322031183e-08
largest O 0 1.8498911291686682e-09
proportion O 0 8.932015543861027e-11
( O 0 1.709145845685267e-11
67 O 0 5.0865582856829406e-09
% O 0 2.8555951006592473e-11
) O 0 1.4763399920972309e-12
of O 0 3.5921401964067456e-10
families O 0 1.4085855962533977e-12
due O 0 2.373495622265409e-09
to O 0 6.050921048939006e-12
other O 0 3.774232662512311e-12
genes O 0 9.182767393700608e-12
was O 0 3.4890604294623984e-10
found O 0 1.4276844680430334e-12
in O 0 2.084404697455522e-12
families O 0 3.951602161266464e-14
with O 0 4.904876960316884e-13
four O 0 1.3515015495624283e-11
or O 0 4.191894227567605e-12
five O 0 6.422598564093107e-12
cases O 0 4.321965962200691e-12
of O 0 1.3475884408364891e-08
female O 0 2.422591549589015e-08
breast B-Disease 0 0.0074189165607094765
cancer I-Disease 0 0.002388011198490858
only O 0 3.3338888982825665e-08
. O 0 9.110610932339114e-08

These O 0 5.419538706696869e-10
estimates O 0 5.90854865034629e-10
were O 0 5.716478332362662e-11
not O 0 1.7282563184381483e-12
substantially O 0 1.3444080917968115e-11
affected O 0 1.6136674245090243e-12
either O 0 5.472735437571374e-13
by O 0 4.013106036718228e-13
changing O 0 9.747375649682422e-12
the O 0 2.3120639083828998e-11
assumed O 0 2.6054416957244086e-10
penetrance O 0 1.5158569510731468e-08
model O 0 1.0686797974335249e-10
for O 0 2.8429760282056016e-11
BRCA1 O 0 1.1043713166181135e-10
or O 0 7.199142540784131e-13
by O 0 1.3513746328561171e-12
including O 0 7.184006167726409e-11
or O 0 3.08445768926191e-10
excluding O 0 3.603102172178296e-08
BRCA1 O 0 2.8739808755062768e-08
mutation O 0 2.6282476195405025e-09
data O 0 1.087225776075229e-08
. O 0 1.4478955812080585e-08

Among O 0 3.5225360406343498e-09
those O 0 8.40313582606278e-11
families O 0 1.5494530571785736e-12
with O 0 5.441504885572712e-11
disease O 1 0.9884196519851685
due O 0 5.684770439984277e-05
to O 0 1.2513115543733022e-10
BRCA1 O 0 1.2553467987341804e-10
that O 0 6.728729986388293e-13
were O 0 1.778487513509619e-12
tested O 0 4.894195942614643e-13
by O 0 2.0170159758994138e-13
one O 0 4.2124826847220187e-13
of O 0 3.026667111383219e-11
the O 0 3.905206019672036e-11
standard O 0 1.6605128383417878e-10
screening O 0 4.3289229839649224e-11
methods O 0 1.0838782128763658e-11
, O 0 7.552583775397026e-13
mutations O 0 2.480631531350669e-13
were O 0 1.2707634423902991e-12
detected O 0 8.560059670641162e-13
in O 0 2.25713436656505e-12
the O 0 2.5592410135555355e-11
coding O 0 2.302620732974603e-10
sequence O 0 3.738939366448868e-11
or O 0 1.0169050497499388e-11
splice O 0 1.748653583044657e-10
sites O 0 2.4758537234270683e-12
in O 0 3.036626939484366e-13
an O 0 4.3566319714131996e-14
estimated O 0 1.0384555628600856e-12
63 O 0 2.015875834315839e-11
% O 0 3.653684126081469e-12
( O 0 1.4072832526038082e-12
95 O 0 1.3815882882184383e-09
% O 0 1.2379559877206958e-10
CI O 0 7.97965412857593e-07
51 O 0 2.1328443178258993e-10
% O 0 3.536575546303489e-11
- O 0 4.618781745957534e-10
77 O 0 3.7337746783272507e-10
% O 0 4.077567103411006e-11
) O 0 1.0844199670179133e-11
. O 0 5.510272793607385e-10

The O 0 8.926608785486678e-09
estimated O 0 2.1387511206505394e-10
sensitivity O 0 2.390436182331257e-10
was O 0 1.482137412800455e-09
identical O 0 1.387788148288216e-11
for O 0 1.555535322946e-12
direct O 0 1.5878812154035415e-11
sequencing O 0 2.2475726141335528e-11
and O 0 1.551837824909086e-11
other O 0 2.5898729341666815e-11
techniques O 0 4.434808786868416e-08
. O 0 3.167390616454213e-08

The O 0 5.868682606546827e-08
penetrance O 0 4.777771209774073e-06
of O 0 4.2620030171747203e-07
BRCA2 O 0 1.097497470681219e-08
was O 0 7.041900951243463e-10
estimated O 0 3.812725309082499e-12
by O 0 1.3125881674971862e-12
maximizing O 0 5.160668559156534e-10
the O 0 7.508270671863215e-10
LOD O 0 1.9150125808664598e-05
score O 0 4.395873887119706e-09
in O 0 1.0445297959904565e-09
BRCA2 O 0 5.24994732131745e-08
- O 0 3.915340229809772e-08
mutation O 0 1.0635661240598893e-09
families O 0 2.5030132046882647e-12
, O 0 3.4145446886624242e-12
over O 0 8.298175341314717e-11
all O 0 2.0010323953378872e-10
possible O 0 6.8200947112018184e-09
penetrance O 0 2.632795712997904e-06
functions O 0 4.2229919472447364e-07
. O 0 4.848088153153185e-08

The O 0 4.850793100530382e-10
estimated O 0 4.533221020786016e-11
cumulative O 0 1.6446596973196392e-08
risk O 0 6.772211236238945e-09
of O 0 9.58306500820072e-09
breast B-Disease 0 8.175426773959771e-05
cancer I-Disease 0 5.94150833421736e-07
reached O 0 1.3952242916559499e-08
28 O 0 1.5883704351793426e-09
% O 0 1.7173371015186123e-12
( O 0 8.963660434561926e-14
95 O 0 1.3607752424871222e-10
% O 0 1.0417950356556016e-11
CI O 0 1.2825056217025121e-07
9 O 0 3.003876869467348e-10
% O 0 1.1985218590152003e-12
- O 0 1.6347985248507668e-12
44 O 0 2.3809497125618084e-13
% O 0 6.502279590410096e-14
) O 0 7.829860332553241e-16
by O 0 1.029738546900116e-14
age O 0 8.427701895727391e-13
50 O 0 7.174468267742706e-13
years O 0 2.692925906138538e-13
and O 0 5.72457933920717e-13
84 O 0 2.3131401308273958e-11
% O 0 9.750997752300261e-13
( O 0 1.9907091654367687e-13
95 O 0 1.2358797318867687e-10
% O 0 1.6253384055309184e-11
CI O 0 1.4335108744489844e-07
43 O 0 7.637684928951671e-11
% O 0 6.389462309935867e-12
- O 0 1.185133154807394e-11
95 O 0 4.232210068511044e-11
% O 0 5.804013953475406e-13
) O 0 1.2587392404978838e-14
by O 0 2.2428167992510212e-13
age O 0 3.6429415040117874e-11
70 O 0 3.8308139993503687e-10
years O 0 2.995415027129411e-10
. O 0 2.46938225423321e-09

The O 0 2.3021620165764034e-08
corresponding O 1 0.9999954700469971
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9998006224632263
were O 0 8.764075687395234e-09
0 O 0 6.232077254253454e-08
. O 0 5.5896460793292135e-09

4 O 0 4.8215483161584416e-08
% O 0 7.71173888636234e-11
( O 0 6.051983133387173e-12
95 O 0 9.374970799669313e-10
% O 0 9.763494873693546e-11
CI O 0 2.513010031179874e-06
0 O 0 4.822876542576182e-10
% O 0 4.162264716917052e-12
- O 0 3.746597216497394e-12
1 O 0 3.879250219662733e-12
% O 0 5.028829186837919e-14
) O 0 4.0747112850731196e-16
by O 0 4.09308046508375e-15
age O 0 3.8644489084443956e-13
50 O 0 3.0401679437797036e-13
years O 0 7.801455336776952e-14
and O 0 2.1499586778852414e-13
27 O 0 1.5095648689400498e-11
% O 0 7.607769665976538e-13
( O 0 8.195996507344427e-14
95 O 0 6.799228541298774e-11
% O 0 1.207931844826593e-11
CI O 0 9.30141865751466e-08
0 O 0 5.6979188728378816e-11
% O 0 1.4660891858170322e-12
- O 0 3.4522382782314898e-12
47 O 0 2.3936640430183287e-12
% O 0 3.211124671286675e-13
) O 0 5.146638679603488e-15
by O 0 8.358477755418536e-14
age O 0 3.0696192115931e-11
70 O 0 5.492759580505435e-10
years O 0 4.805595366086379e-10
. O 0 3.420233651851845e-09

The O 0 3.7251408624427995e-09
lifetime O 0 2.1759669621701505e-08
risk O 0 8.181791599781718e-08
of O 0 4.162797893059178e-07
breast B-Disease 1 0.9999814033508301
cancer I-Disease 1 0.9218201041221619
appears O 0 1.2804878268823927e-09
similar O 0 6.555609787656236e-12
to O 0 7.86941367104943e-13
the O 0 3.8319980522061314e-10
risk O 0 5.868407981779455e-10
in O 0 1.445512026049256e-11
BRCA1 O 0 6.906129834671759e-11
carriers O 0 1.442252621584178e-13
, O 0 5.122314519160481e-14
but O 0 4.7307027273377905e-14
there O 0 2.7426522966784994e-13
was O 0 2.5851104243357348e-11
some O 0 8.88327497498842e-14
suggestion O 0 8.652712227275039e-12
of O 0 3.1673132866449905e-11
a O 0 2.455464720441114e-10
lower O 0 3.1164517633186506e-09
risk O 0 3.2632715973868187e-10
in O 0 8.65826299545347e-11
BRCA2 O 0 9.621797802950027e-10
carriers O 0 1.100449245616808e-11
< O 0 9.773075682062426e-10
50 O 0 2.8052490885777104e-11
years O 0 1.271520649187563e-11
of O 0 3.147711535866904e-10
age O 0 5.532074798253461e-09
. O 0 1.0231947733529978e-08

Eye B-Disease 1 0.9999877214431763
movement I-Disease 0 0.18558259308338165
abnormalities I-Disease 0 0.01930251531302929
correlate O 0 3.635904632925957e-10
with O 0 7.231941608065728e-12
genotype O 0 8.990410194087417e-09
in O 0 3.960854144668957e-10
autosomal O 0 0.2311268448829651
dominant O 1 0.9999866485595703
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 0.9999961853027344
. O 0 9.360113750744858e-08

We O 0 4.695637656482177e-09
compared O 0 4.233019490484935e-10
horizontal O 0 2.377239383122287e-08
eye O 0 2.2538840767083457e-06
movements O 0 4.700147115954678e-08
( O 0 3.0107027981784995e-10
visually O 0 1.9708135123863713e-10
guided O 0 1.6336602071120865e-09
saccades O 0 6.67927395170409e-07
, O 0 4.727625235734223e-11
antisaccades O 0 2.3335770649168808e-08
, O 0 2.5250962779055364e-11
and O 0 3.0492405475590623e-12
smooth O 0 1.3466749937407485e-10
pursuit O 0 1.4197294728734988e-10
) O 0 1.8266345467449208e-13
in O 0 1.4727737258912743e-12
control O 0 1.3920683494816899e-09
subjects O 0 9.28191135063372e-11
( O 0 2.233230527587393e-12
n O 0 4.898396133157235e-10
= O 0 5.917548118183902e-10
14 O 0 9.446494975140496e-11
) O 0 5.960630751998541e-13
and O 0 4.847107090699687e-12
patients O 0 5.529235923285025e-13
with O 0 9.827039084819161e-14
three O 0 1.3138104970264464e-12
forms O 0 1.5633766850542408e-11
of O 0 8.158020925463916e-10
autosomal O 0 6.320749889709987e-06
dominant O 0 0.0005368013516999781
cerebellar B-Disease 1 0.9999970197677612
ataxias I-Disease 1 0.9976388216018677
type I-Disease 1 0.9154664874076843
I I-Disease 1 0.5170026421546936
spinocerebellar B-Disease 1 0.9998276233673096
ataxias I-Disease 0 8.166470252035651e-06
1 I-Disease 0 3.5295261113788e-07
and I-Disease 0 8.331575013231785e-11
2 I-Disease 0 2.7364399635132486e-09
( O 0 8.99969595374861e-12
SCA1 B-Disease 0 4.423378641149611e-08
, O 0 1.494752412123379e-11
n O 0 1.4508796941647972e-10
= O 0 1.4832225725402992e-10
11 O 0 7.524410261527947e-11
; O 0 1.0946019481442026e-12
SCA2 B-Disease 0 9.652001864424165e-09
, O 0 3.2535671205813355e-12
n O 0 2.6886996101760374e-11
= O 0 2.488305915482325e-11
10 O 0 6.542680893589781e-12
) O 0 2.463266678305598e-13
and O 0 3.764873482414721e-11
SCA3 B-Disease 1 1.0
/ O 0 1.611013249203097e-05
Machado B-Disease 0 2.307121803823975e-06
- I-Disease 0 2.1782441308459966e-06
Joseph I-Disease 0 5.958122528681997e-07
disease I-Disease 1 0.9999605417251587
( O 0 1.6773432642835928e-09
MJD B-Disease 1 1.0
) O 0 1.6917066705812722e-11
( O 0 2.1095625246658756e-12
n O 0 3.2603228450334143e-10
= O 0 1.2424699047386412e-09
16 O 0 1.7152151920996062e-09
) O 0 2.3462438589194612e-11
. O 0 7.002523561006058e-10

In O 0 1.1706510427700323e-08
SCA1 B-Disease 0 7.628670118720038e-06
, O 0 3.9575015486903453e-10
saccade O 0 1.6145728309879814e-08
amplitude O 0 1.4015582028292783e-09
was O 0 1.9047932675597679e-10
significantly O 0 2.2904675118368134e-12
increased O 0 6.873470542734239e-12
, O 0 6.822279828740119e-13
resulting O 0 2.2119086076632932e-11
in O 0 5.87178639044339e-11
hypermetria B-Disease 0 6.273658073041588e-07
. O 0 4.663338870614098e-08

The O 0 3.707146234432912e-08
smooth O 0 4.8650580453113434e-08
pursuit O 0 3.258013592244424e-08
gain O 0 6.675399788491632e-09
was O 0 2.8354095960025916e-08
decreased O 0 2.0001613165732124e-07
. O 0 1.7796956797155872e-08

In O 0 4.080965609887244e-08
SCA2 B-Disease 0 4.744972466141917e-05
, O 0 2.0921788745909e-09
saccade O 0 1.0769356606488145e-07
velocity O 0 1.522549863963718e-09
was O 0 7.397228607430861e-09
markedly O 0 3.2786835468812114e-09
decreased O 0 1.8080839936374105e-08
. O 0 5.832034410957476e-09

The O 0 5.651070722478835e-09
percentage O 0 1.055617593337388e-09
of O 0 1.0216945067753613e-09
errors O 0 4.76261334370065e-07
in O 0 1.630792834106387e-09
antisaccades O 0 1.404425688633637e-06
was O 0 1.2605354982042627e-08
greatly O 0 5.4183654091266575e-12
increased O 0 2.3930293510665557e-12
and O 0 8.793528513857674e-13
was O 0 4.341557668929852e-11
significantly O 0 1.6276393210654105e-12
correlated O 0 6.124720956096619e-13
with O 0 1.3094518145576745e-13
age O 0 5.214076947979152e-10
at O 0 6.889389965181181e-07
disease O 1 0.9811510443687439
onset O 1 0.926522433757782
. O 0 4.873193404364429e-08

In O 0 7.105434574050662e-10
addition O 0 9.420458857434255e-11
, O 0 3.1226111106563703e-12
a O 0 1.1726912843568194e-12
correlation O 0 2.0795600484679877e-12
between O 0 9.930245861711207e-12
smooth O 0 2.170361890208028e-09
pursuit O 0 1.092511525691009e-09
gain O 0 1.3565459866526908e-10
and O 0 4.4481935496110125e-12
the O 0 1.71962912659529e-11
number O 0 5.340013500831908e-11
of O 0 2.55435694818118e-09
trinucleotide O 0 8.099505066638812e-07
repeats O 0 2.308000546236144e-08
was O 0 1.0635528724378673e-07
found O 0 4.293404742838902e-09
. O 0 2.0546702117485438e-08

In O 0 1.7860573109373945e-07
SCA3 B-Disease 1 1.0
, O 0 7.43827612836867e-08
gaze B-Disease 0 8.180664735846221e-06
- I-Disease 0 2.6239119961246615e-06
evoked I-Disease 0 1.427206086646038e-07
nystagmus I-Disease 0 0.027609774842858315
was O 0 2.0851325999160508e-08
often O 0 2.618057246689398e-12
present O 0 4.4498398021897145e-12
as O 0 9.673237037766125e-12
was O 0 9.775499298925183e-10
saccade O 0 3.5822981914179763e-08
hypometria O 0 7.681450853169736e-08
and O 0 1.1805134647602245e-10
smooth O 0 2.6538222730465577e-09
pursuit O 0 4.253197793957497e-09
gain O 0 1.601228261094434e-09
was O 0 3.070477205824318e-09
markedly O 0 1.5356597105053993e-09
decreased O 0 6.837692190231337e-09
. O 0 3.524175617997116e-09

Three O 0 1.1264371657659922e-09
major O 0 8.118659522438065e-09
criteria O 0 1.4169120987617134e-08
, O 0 2.7267983010448305e-11
saccade O 0 8.22503576358713e-09
amplitude O 0 3.7569056199338036e-10
, O 0 1.3170577475851708e-11
saccade O 0 1.528698501118697e-09
velocity O 0 4.6372284484563764e-11
, O 0 2.8941632077006396e-12
and O 0 1.5008365644025856e-12
presence O 0 1.3436159303215067e-11
of O 0 3.609414989114157e-09
gaze B-Disease 0 1.2952312999914284e-06
- I-Disease 0 6.88324405473395e-07
evoked I-Disease 0 9.719023807974736e-09
nystagmus I-Disease 0 1.6082710772025166e-06
, O 0 6.750638242847273e-12
permitted O 0 8.62305539472974e-12
the O 0 2.341406929451395e-11
correct O 0 4.805409889452328e-11
assignment O 0 8.148930315254876e-12
of O 0 1.099809826543563e-10
90 O 0 1.211864775196858e-10
% O 0 4.1226883018552485e-12
of O 0 1.1457958193350493e-10
the O 0 2.5774654632826355e-10
SCA1 B-Disease 0 6.345782139760558e-07
, O 0 1.212301006109362e-11
90 O 0 3.51476070470369e-11
% O 0 1.1726577825096896e-12
of O 0 5.0465357587237136e-11
the O 0 3.922197844286046e-10
SCA2 B-Disease 0 1.2234047517267754e-06
, O 0 5.76959140186073e-12
and O 0 1.1178230650138454e-12
93 O 0 7.016304204299217e-11
% O 0 1.882492208990505e-12
of O 0 1.4271114845421096e-10
the O 0 1.994840959085309e-09
patients O 0 2.0269383393944906e-10
with O 0 2.610132110447694e-10
SCA3 B-Disease 1 1.0
to O 0 3.519955160680155e-10
their O 0 1.9395336725569479e-10
genetically O 0 8.499648762594347e-10
confirmed O 0 1.7284032538533722e-10
patient O 0 2.06274339831225e-08
group O 0 1.0478082845821746e-09
and O 0 7.296344084473105e-11
, O 0 5.000611383310094e-11
therefore O 0 3.7765912619391884e-10
, O 0 1.903840800288048e-11
may O 0 8.551925140265482e-11
help O 0 2.92577906346736e-11
orient O 0 8.776409288202558e-08
diagnoses O 0 1.9233191039802477e-08
of O 0 4.462050728903932e-09
SCA1 B-Disease 0 0.00011107179307145998
, O 0 2.392465947576028e-10
SCA2 B-Disease 0 7.1667423071630765e-06
, O 0 1.847767355789287e-10
and O 0 1.8235192245086296e-09
SCA3 B-Disease 1 1.0
at O 0 2.0690480440066494e-08
early O 0 1.3082934735564322e-09
clinical O 0 8.687655395078764e-08
stages O 0 4.5161488060330157e-07
of O 0 9.896301556011622e-09
the O 0 2.3103922330847126e-08
diseases O 0 0.0006483022007159889
. O 0 1.001430716129903e-09
. O 0 8.860622457973477e-09

Genetic O 0 4.2437249270221855e-09
basis O 0 5.272802194866699e-10
and O 0 1.0774596492790778e-11
molecular O 0 3.314232888129709e-09
mechanism O 0 1.2421072881352302e-07
for O 0 1.7523089468340913e-07
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 1.4243850273487624e-05

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 0 5.410913672676543e-07
more O 0 1.3645582060128891e-12
than O 0 1.1071816206909002e-12
300 O 0 3.0883752586557955e-12
, O 0 1.7729972221283696e-12
000 O 0 7.704932525331998e-11
sudden O 0 8.384952732143347e-10
deaths O 0 4.0151160174417555e-11
each O 0 1.0585954855757418e-13
year O 0 1.695598414279409e-12
in O 0 1.8409137061969894e-11
the O 0 2.2540143085336695e-09
USA O 0 1.8809676305409084e-07
alone O 0 3.1375051445792224e-09
. O 0 7.4247643588876144e-09

In O 0 2.0349306684153134e-09
approximately O 0 1.9747456447838374e-10
5 O 0 8.716896537919183e-09
- O 0 2.9812410318186267e-09
12 O 0 2.25981608426018e-10
% O 0 9.770997379254798e-12
of O 0 6.614733066845346e-11
these O 0 5.415490104965226e-13
cases O 0 3.4491956816748437e-13
, O 0 9.312308682420806e-14
there O 0 1.1519120889352114e-13
are O 0 1.1987263632618535e-14
no O 0 1.6047540900288038e-12
demonstrable O 1 0.9745003581047058
cardiac O 1 1.0
or O 0 4.912534222967224e-06
non O 1 1.0
- O 1 1.0
cardiac O 1 1.0
causes O 0 2.044393477262929e-05
to O 0 1.4440680422278529e-11
account O 0 1.3337162320728457e-12
for O 0 3.686577518952072e-12
the O 0 7.330813733830155e-11
episode O 0 1.707843172438217e-10
, O 0 8.929246231303978e-13
which O 0 9.08911482319294e-14
is O 0 3.199830605018529e-14
therefore O 0 4.899117678376641e-13
classified O 0 3.371527666426455e-12
as O 0 4.882026449770649e-10
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 3.3684607387840515e-06
IVF B-Disease 1 1.0
) O 0 2.347553484938203e-09
. O 0 1.1053712611897026e-08

A O 0 7.008328850588441e-08
distinct O 0 3.936169168383685e-09
group O 0 2.260369003082019e-09
of O 0 2.3640492145204917e-05
IVF B-Disease 1 1.0
patients O 0 1.611672450962942e-05
has O 0 9.09773090196353e-11
been O 0 8.366716174046385e-12
found O 0 3.334656227364785e-13
to O 0 1.8171617368386433e-13
present O 0 1.9830929433306554e-12
with O 0 5.305361618773707e-12
a O 0 4.0780592791556103e-10
characteristic O 0 1.1899329166453754e-07
electrocardiographic O 0 3.081575869146036e-06
pattern O 0 1.0090643627336249e-06
. O 0 7.307677662993228e-08

Because O 0 6.2145066870300525e-09
of O 0 1.3113287877786206e-07
the O 0 6.739661273513775e-09
small O 0 1.3802172078858366e-11
size O 0 2.610333607253046e-12
of O 0 2.5245677770513453e-10
most O 0 3.743761377295041e-12
pedigrees O 0 8.088556907592803e-11
and O 0 4.632169647855733e-12
the O 0 3.129051878714151e-11
high O 0 7.48048234466836e-10
incidence O 0 6.73181403954004e-08
of O 0 1.715597996998497e-09
sudden B-Disease 0 3.986483321227752e-08
death I-Disease 0 3.264794301571783e-08
, O 0 5.127539885740884e-12
however O 0 2.4434831328440376e-12
, O 0 1.9856845659936562e-13
molecular O 0 4.6417234639273275e-11
genetic O 0 5.377042908150109e-11
studies O 0 6.824860555171286e-12
of O 0 3.4381222313584203e-09
IVF B-Disease 1 1.0
have O 0 3.353987573784245e-11
not O 0 8.65193116802998e-13
yet O 0 8.106639491634038e-12
been O 0 1.5581818821330806e-11
done O 0 5.449754536535067e-10
. O 0 5.535874425532938e-09

Because O 0 5.331503771799362e-08
IVF B-Disease 1 1.0
causes O 0 6.943484913790599e-05
cardiac O 1 1.0
rhythm O 1 1.0
disturbance O 1 0.9998138546943665
, O 0 1.2776030233752067e-11
we O 0 3.513586123438106e-12
investigated O 0 3.141382640126089e-11
whether O 0 5.4065445696804826e-12
malfunction O 0 5.549709953811544e-07
of O 0 5.740913300300576e-10
ion O 0 6.770529137334336e-10
channels O 0 8.384712368858516e-10
could O 0 2.2991318571197183e-10
cause O 0 1.8338714991017468e-09
the O 0 3.157868411207687e-10
disorder O 0 9.089410335505477e-10
by O 0 1.5397654939269811e-13
studying O 0 9.22315284042352e-13
mutations O 0 1.50998381550152e-13
in O 0 3.270332680875565e-13
the O 0 3.6455272828250784e-11
cardiac O 0 5.674224325957766e-07
sodium O 0 1.9568804354719305e-09
channel O 0 2.6704885414119417e-08
gene O 0 2.458729042587038e-08
SCN5A O 0 1.0979436410707422e-05
. O 0 1.5544973308578847e-08

We O 0 9.163028558134556e-09
have O 0 2.333796177145242e-11
now O 0 3.9720470836057675e-12
identified O 0 1.1918408100719535e-11
a O 0 2.0155720842351954e-11
missense O 0 6.230540972040899e-09
mutation O 0 1.1215059436686659e-10
, O 0 7.357592833601156e-12
a O 0 7.266082874268776e-11
splice O 0 4.01300894736778e-08
- O 0 1.1400246080484067e-08
donor O 0 1.812938354994742e-09
mutation O 0 5.48550427303951e-10
, O 0 3.9488642390728135e-12
and O 0 7.790757622361255e-12
a O 0 8.716555949250804e-11
frameshift O 0 4.833598854503407e-09
mutation O 0 7.426538550792117e-12
in O 0 1.639773169678782e-12
the O 0 1.1507406139088516e-11
coding O 0 7.881156838251968e-10
region O 0 1.2764807266751887e-10
of O 0 1.0933447897043536e-10
SCN5A O 0 2.4438338641630253e-07
in O 0 1.552081241307235e-10
three O 0 1.4166735562426425e-09
IVF B-Disease 1 1.0
families O 0 1.075126654370706e-09
. O 0 1.0146475659666976e-08

We O 0 4.439094924979514e-10
show O 0 2.6597078706114274e-11
that O 0 6.829202459611439e-14
sodium O 0 4.803093212328753e-14
channels O 0 2.0889647162677244e-13
with O 0 2.1137219307753446e-13
the O 0 4.827236527171763e-11
missense O 0 1.5146662590836968e-08
mutation O 0 1.4968727646280655e-10
recover O 0 1.8666834744607286e-10
from O 0 4.801064927562049e-12
inactivation O 0 2.672659071834005e-08
more O 0 1.8082827986723449e-13
rapidly O 0 5.215452093636219e-13
than O 0 5.523201152349017e-15
normal O 0 1.945214822551833e-12
and O 0 3.327394241213477e-13
that O 0 1.5212347169706736e-13
the O 0 5.844500577945055e-11
frameshift O 0 6.986464740066367e-09
mutation O 0 1.36344538090305e-11
causes O 0 4.222146070265165e-12
the O 0 8.90323231805823e-12
sodium O 0 3.415690907199176e-12
channel O 0 4.3658885534592073e-11
to O 0 1.9825367476161704e-12
be O 0 7.796956656702658e-12
non O 0 6.010487219043625e-09
- O 0 1.0912931669437853e-09
functional O 0 4.466966530003447e-08
. O 0 3.166440665225423e-09

Our O 0 1.9461948497223602e-08
results O 0 1.5241762019169158e-10
indicate O 0 4.663044689962037e-12
that O 0 2.0560449501792755e-13
mutations O 0 1.5982235066630546e-12
in O 0 3.905531714004651e-12
cardiac O 0 1.0526302958169254e-06
ion O 0 2.8237614468906713e-09
- O 0 6.022697451868453e-09
channel O 0 2.82292550446428e-10
genes O 0 1.0889233308455926e-12
contribute O 0 4.842500234353633e-14
to O 0 3.175225991966686e-14
the O 0 5.367571838388319e-12
risk O 0 2.9704197435087565e-11
of O 0 2.5172581033516828e-11
developing O 0 5.338929742748633e-09
IVF B-Disease 1 1.0
. O 0 1.876340194328918e-09
. O 0 7.035903859531345e-09

Molecular O 0 4.956555166302223e-09
heterogeneity O 0 1.597214982496098e-08
in O 0 5.808208913826718e-10
mucopolysaccharidosis B-Disease 0 6.543306881212629e-06
IVA I-Disease 1 1.0
in O 0 5.413931525311e-09
Australia O 0 1.6063123053911e-09
and O 0 2.7065124447167577e-11
Northern O 0 5.709488881677771e-09
Ireland O 0 2.5614912857463423e-08
: O 0 1.9618265345577868e-11
nine O 0 5.509513331669602e-11
novel O 0 5.679762649785092e-12
mutations O 0 5.218947236179661e-12
including O 0 4.311780966992362e-12
T312S O 0 6.378172656695824e-09
, O 0 4.578450119030464e-11
a O 0 5.106042325064841e-11
common O 0 3.0247859772458696e-11
allele O 0 1.6585875034502706e-11
that O 0 6.663581362045812e-13
confers O 0 1.5768214511879819e-09
a O 0 6.476275071776172e-10
mild O 0 2.9482919217116432e-06
phenotype O 0 1.2374924551750155e-07
. O 0 9.918089460825286e-09

Mucopolysaccharidosis B-Disease 1 0.9987494945526123
IVA I-Disease 1 1.0
( O 1 0.9999575614929199
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 8.537537898867242e-10
is O 0 8.878338168816224e-12
an O 0 1.4750740559565934e-11
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 4.747937509819167e-08
by O 0 7.004213181671659e-12
a O 0 1.1549555090084596e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 1.919228553859398e-09
N O 0 4.1957548546633916e-07
- O 0 1.0016031559700878e-08
acetylgalactosamine O 0 1.263499370907084e-06
- O 0 8.851217359051589e-08
6 O 0 1.444577719666995e-07
- O 0 1.8302417359450374e-08
sulfate O 0 2.8377942218327235e-09
sulfatase O 0 2.9666277896467363e-06
( O 0 6.693219867237588e-10
GALNS O 0 6.752241915819468e-06
) O 0 2.252728281693095e-10
. O 0 2.455793790545613e-09

Previous O 0 1.0555415208557406e-08
studies O 0 2.991646375072321e-10
of O 0 2.6768516292463573e-09
patients O 0 2.3741453247794198e-11
from O 0 3.2008594993276906e-12
a O 0 2.8913068120250962e-11
British O 0 2.179238789423721e-09
- O 0 3.004267723483167e-09
Irish O 0 1.2763621271005832e-09
population O 0 5.604067015128888e-13
showed O 0 1.3738140833274848e-11
that O 0 5.141463426880377e-13
the O 0 1.3257234199315349e-10
I113F O 0 1.1253940890298963e-08
mutation O 0 9.404947654001461e-11
is O 0 7.744144409939369e-13
the O 0 3.213570902438345e-12
most O 0 2.0868461852226877e-13
common O 0 3.276877900970643e-12
single O 0 8.403377299570636e-11
mutation O 0 1.0041658615733695e-09
among O 0 3.7063718760776965e-10
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 2.409868102404289e-05
and O 0 1.2377388003415035e-10
produces O 0 3.764824840768455e-10
a O 0 2.711629254470438e-10
severe O 0 0.000160436233272776
clinical O 0 0.0001626075099920854
phenotype O 0 3.849363849894871e-07
. O 0 5.18513054714731e-09

We O 0 7.780310840033167e-10
studied O 0 4.073620607503159e-10
mutations O 0 6.636149962879756e-12
in O 0 6.239688887105244e-12
the O 0 5.66167009108387e-11
GALNS O 0 7.689572356639474e-08
gene O 0 1.0186852229809862e-11
from O 0 1.1448640429775891e-12
23 O 0 1.0088650054251858e-10
additional O 0 1.78342929313402e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 6.900615403537813e-07
( O 0 7.864406174895588e-12
15 O 0 4.877268380831801e-11
from O 0 4.2136342158494156e-12
Australia O 0 1.1199390720362246e-10
, O 0 2.276200278608642e-12
8 O 0 1.0018848944914893e-10
from O 0 4.372119853657264e-12
Northern O 0 1.0226635094312542e-09
Ireland O 0 1.137426375308337e-09
) O 0 4.872874564791629e-13
, O 0 2.306124583829894e-13
with O 0 8.80253579445614e-14
various O 0 5.92218635242503e-11
clinical O 0 2.289883923367597e-06
phenotypes O 0 1.1240344832685878e-07
( O 0 6.541751584876465e-10
severe O 0 0.410881370306015
, O 0 3.22270155006521e-10
16 O 0 3.2005591510397835e-09
cases O 0 1.856024535451528e-11
; O 0 1.4711201007377994e-12
intermediate O 0 6.953557729616477e-10
, O 0 1.912779179838453e-12
4 O 0 1.9997008215977274e-10
cases O 0 2.0699045776007008e-12
; O 0 2.0460781506581593e-12
mild O 0 4.180461132818891e-08
, O 0 3.3023410395127684e-11
3 O 0 1.7861494505666542e-09
cases O 0 1.3741023076330183e-11
) O 0 8.228114370401052e-12
. O 0 1.333392729563343e-09

We O 0 1.7911242267132366e-08
found O 0 2.147642202965372e-10
two O 0 9.482774808444727e-12
common O 0 3.025108635812401e-11
mutations O 0 3.90402727507011e-12
that O 0 3.133874453345453e-13
together O 0 9.851140085961885e-13
accounted O 0 4.1718760390718757e-11
for O 0 4.721522218337215e-12
32 O 0 7.784493188944808e-11
% O 0 7.4113683939947e-12
of O 0 1.288390505393977e-10
the O 0 4.510402606960895e-10
44 O 0 1.2285282513513351e-10
unrelated O 0 1.1506160607632765e-10
alleles O 0 1.5276264411431817e-12
in O 0 9.658580359117597e-12
these O 0 4.7881455744747115e-11
patients O 0 3.538007664616316e-10
. O 0 2.531942211447813e-09

One O 0 3.0947602258635243e-09
is O 0 4.0600588863126674e-11
the O 0 1.8112956967630822e-10
T312S O 0 3.002385184913692e-08
mutation O 0 3.049825114675997e-10
, O 0 5.395902908517103e-12
a O 0 3.7604576570704484e-12
novel O 0 8.124052645885893e-12
mutation O 0 8.45672316895918e-12
found O 0 1.0879325055852124e-13
exclusively O 0 8.311313334612158e-13
in O 0 2.1177313375142504e-11
milder O 0 3.9099145254795076e-08
patients O 0 9.435586756367798e-10
. O 0 5.021031146412724e-09

The O 0 1.7912716998580436e-07
other O 0 1.1809098143800156e-10
is O 0 6.074372341929868e-12
the O 0 2.49405062574537e-11
previously O 0 1.351481565547985e-10
described O 0 2.3257441111868005e-11
I113F O 0 1.104342395308322e-09
that O 0 1.7175401725855188e-12
produces O 0 6.180515821352373e-11
a O 0 2.3982865693383815e-10
severe O 0 1.142476230597822e-05
phenotype O 0 1.5925915874959173e-07
. O 0 1.298665353033357e-08

The O 0 2.2765652474276976e-08
I113F O 0 7.718873007434013e-08
and O 0 5.209404574380017e-10
T312S O 0 1.3034846091386498e-08
mutations O 0 5.377699327513419e-11
accounted O 0 7.645394733968303e-11
for O 0 1.7596537074671126e-11
8 O 0 1.6275176761837429e-09
( O 0 7.609946743938889e-13
18 O 0 4.907127829079094e-11
% O 0 2.1105404750254575e-12
) O 0 6.434829340380699e-14
and O 0 1.6466873437731566e-12
6 O 0 3.7288638843335775e-10
( O 0 4.000832054974063e-13
14 O 0 1.6084689136164343e-11
% O 0 6.177421313195708e-13
) O 0 5.409386182259404e-14
of O 0 7.0954323146132925e-12
44 O 0 4.257210903246822e-11
unrelated O 0 8.40379363320487e-11
alleles O 0 2.944700473045403e-12
, O 0 8.194473745393172e-12
respectively O 0 8.639824411460495e-10
. O 0 7.3569590419708675e-09

The O 0 3.3654885100986576e-08
relatively O 0 1.9966719388975207e-09
high O 0 4.372451289924584e-09
residual O 0 1.064526600202953e-06
GALNS O 0 9.31194590521045e-05
activity O 0 3.6035814332535665e-09
seen O 0 1.5716525303410833e-11
when O 0 4.431753358388746e-13
the O 0 4.921006744457168e-12
T312S O 0 9.622820595911463e-11
mutant O 0 1.4546232274259552e-10
cDNA O 0 1.7770118709847793e-09
is O 0 2.046847066838886e-12
overexpressed O 0 2.284078481906704e-10
in O 0 1.5753341556581923e-12
mutant O 0 1.744971944717122e-10
cells O 0 6.496311301396052e-12
provides O 0 6.454398511967704e-14
an O 0 2.3539579234953777e-15
explanation O 0 8.28312367155172e-14
for O 0 2.2055450456422154e-13
the O 0 3.3489374468009814e-11
mild O 0 7.538915269833524e-08
phenotype O 0 5.722055607115806e-10
in O 0 8.733009974892791e-12
patients O 0 9.770899367378405e-13
with O 0 1.1242498902316878e-13
this O 0 7.875198757001378e-12
mutation O 0 1.397575388750738e-09
. O 0 2.2368533691974335e-09

The O 0 9.980937187847871e-10
distribution O 0 1.0375458825429007e-10
and O 0 1.595518747503355e-12
relative O 0 6.36666457401458e-12
frequencies O 0 5.161017880422891e-12
of O 0 4.986666982120802e-11
the O 0 6.993563367307942e-11
I113F O 0 1.1408266553658564e-09
and O 0 2.5674009793141828e-11
T312S O 0 1.1150967926809585e-09
mutations O 0 5.265320297820342e-12
in O 0 5.616493815169266e-12
Australia O 0 1.797850583684646e-11
corresponded O 0 3.0228098669982106e-13
to O 0 2.1673843275671345e-12
those O 0 8.485834647811719e-13
observed O 0 6.5746305968894525e-12
in O 0 6.5955049581567504e-12
Northern O 0 4.474118409092398e-09
Ireland O 0 3.638426449015242e-08
and O 0 2.0148620272220086e-10
are O 0 2.7336030574559578e-12
unique O 0 1.042793022071331e-11
to O 0 1.2149694228122399e-12
these O 0 1.24880195160465e-12
two O 0 5.92668871878671e-13
populations O 0 5.793583928576096e-13
, O 0 3.517117695174543e-13
suggesting O 0 7.751991865263819e-13
that O 0 1.326024928966288e-13
both O 0 2.0371371690225404e-12
mutations O 0 9.69826909752447e-12
were O 0 3.590604202852177e-11
probably O 0 3.3071176006038705e-12
introduced O 0 7.686492935199407e-12
to O 0 1.8892762788241813e-12
Australia O 0 1.6423281137822876e-11
by O 0 6.591443103137751e-12
Irish O 0 6.815400688253703e-09
migrants O 0 1.3281802740960913e-11
during O 0 4.273726511572207e-11
the O 0 9.990207966437126e-11
19th O 0 9.177878901311942e-09
century O 0 8.70450662660005e-08
. O 0 6.274741082279434e-08

Haplotype O 0 1.338178634568976e-07
analysis O 0 6.22585760723382e-10
using O 0 2.8328769885455074e-10
6 O 0 6.551059783532764e-08
RFLPs O 0 1.1260021182124547e-07
provides O 0 2.6785646617399905e-11
additional O 0 1.7698752619726976e-12
data O 0 2.1493130192284937e-11
that O 0 1.0969448006187266e-12
the O 0 1.0321436066940137e-10
I113F O 0 2.026058210091719e-09
mutation O 0 1.6861016055580436e-11
originated O 0 5.489402335467908e-12
from O 0 1.0017004586915235e-12
a O 0 3.4600319137600977e-11
common O 0 9.620196306237006e-11
ancestor O 0 1.547438399640555e-09
. O 0 1.0704802377858869e-08

The O 0 7.348280917085503e-08
other O 0 2.2178239800219046e-10
9 O 0 1.2688212258638032e-08
novel O 0 9.406238982156978e-11
mutations O 0 1.191702205666223e-11
identified O 0 4.65436370000738e-12
in O 0 5.981623616563292e-12
these O 0 5.25008725729692e-12
23 O 0 4.4133816601288345e-09
patients O 0 3.561554523523469e-11
were O 0 2.7020559401069733e-11
each O 0 1.4039848927546728e-13
limited O 0 2.99411676007999e-11
to O 0 9.941654270650968e-12
a O 0 1.0404496153526566e-09
single O 0 1.3636294760033252e-08
family O 0 1.2848867525505625e-09
. O 0 1.5193798219570454e-08

These O 0 1.1007143113639373e-10
data O 0 1.5544217302210228e-10
provide O 0 4.298773576688619e-12
further O 0 7.482612077690243e-13
evidence O 0 8.682183661248843e-13
for O 0 2.965887626639463e-13
extensive O 0 1.001548705081845e-10
allelic O 0 8.925956640482013e-10
heterogeneity O 0 6.959077758494914e-10
in O 0 1.6653538548183633e-09
MPS B-Disease 1 0.9999994039535522
IVA I-Disease 1 1.0
in O 0 5.57828949698802e-10
British O 0 4.953410837060801e-08
- O 0 1.8022088852376328e-06
Irish O 0 1.5430070732236345e-07
patients O 0 6.6426746048176e-11
and O 0 9.017183159008846e-13
provide O 0 4.688218129683674e-13
evidence O 0 2.733175664959564e-12
for O 0 2.4406887101646735e-12
their O 0 5.297312935526044e-12
transmission O 0 2.2485385775539157e-10
to O 0 1.0232395443107722e-12
Australia O 0 3.18835756407676e-11
by O 0 4.4023530480774564e-12
British O 0 2.5978916795565965e-08
- O 0 6.190906987058042e-08
Irish O 0 1.234731161758873e-08
migrants O 0 1.0291005547724552e-10
. O 0 2.17790282336372e-11
. O 0 1.0210886580708234e-09

Identification O 0 6.355466553031874e-08
of O 0 2.3257253900510477e-08
constitutional O 0 1.3793129255645908e-05
WT1 O 0 0.00020969245815649629
mutations O 0 2.1762139312819784e-10
, O 0 2.197559408750882e-12
in O 0 3.9637525033053844e-12
patients O 0 1.6920091629873957e-12
with O 0 8.877384504585306e-13
isolated O 0 4.772757051796361e-07
diffuse B-Disease 1 0.9999688863754272
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 2.42591363663891e-10
and O 0 3.5921844925707047e-12
analysis O 0 3.176162241200209e-12
of O 0 4.77930639508628e-10
genotype O 0 1.424771234326272e-08
/ O 0 7.177018090942511e-08
phenotype O 0 8.899840586718e-11
correlations O 0 1.3912175231278745e-11
by O 0 5.989772480091693e-13
use O 0 5.143299848520133e-12
of O 0 1.1778707176279823e-10
a O 0 1.8940986279414318e-10
computerized O 0 1.649723486707444e-07
mutation O 0 2.1682806661260656e-09
database O 0 5.789354329266416e-09
. O 0 4.789237006974645e-09

Constitutional O 0 4.706404297394329e-07
mutations O 0 4.419208332606672e-10
of O 0 3.3971336854676792e-09
the O 0 1.4533343417610922e-09
WT1 O 0 3.2405867500528984e-07
gene O 0 5.624858911978947e-11
, O 0 5.0117804871463445e-12
encoding O 0 2.8994690329242623e-11
a O 0 8.188231759298503e-10
zinc O 0 2.2544247713085497e-07
- O 0 1.8659449779079296e-05
finger O 0 6.427319021895528e-05
transcription O 0 2.5540330170770176e-06
factor O 0 7.824991321569996e-09
involved O 0 2.0239624212714524e-11
in O 0 1.7673437713305873e-10
renal O 1 1.0
and O 0 3.468294762498658e-09
gonadal O 1 1.0
development O 0 3.8089751797087956e-06
, O 0 5.019912437120855e-12
are O 0 4.8443847132546847e-14
found O 0 3.655764384789817e-14
in O 0 9.327188001985454e-14
most O 0 3.720460896826372e-13
patients O 0 2.096636801890775e-13
with O 0 1.0337186835684964e-12
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.9017563065281138e-05
DDS B-Disease 1 1.0
) O 0 1.4715566265532942e-10
, O 0 2.7142047290262816e-11
or O 0 3.703405804245108e-09
diffuse B-Disease 1 0.9999997615814209
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 3.653434305306291e-06
DMS B-Disease 0 0.03221013769507408
) O 0 7.34707162729914e-13
associated O 0 8.511839670599652e-12
with O 0 2.998464324055483e-12
pseudohermaphroditism B-Disease 1 1.0
and O 0 1.9146591867524876e-08
/ O 0 7.00113014318049e-05
or O 0 1.3847970770086704e-08
Wilms B-Disease 1 0.9999291896820068
tumor I-Disease 1 0.8749516010284424
( O 0 2.2761264872883658e-08
WT B-Disease 1 1.0
) O 0 3.414261651180084e-10
. O 0 2.089873607502568e-09

Most O 0 2.895503836697344e-09
mutations O 0 8.0340276653601e-09
in O 0 3.022990924250735e-08
DDS B-Disease 1 1.0
patients O 0 3.737804377124121e-07
lie O 0 1.2099812707333513e-08
in O 0 5.310570871941422e-10
exon O 0 5.6996015018739854e-08
8 O 0 4.265345054932368e-08
or O 0 2.325119957680144e-10
exon O 0 6.287269371796356e-09
9 O 0 3.393423098074777e-09
, O 0 3.6801933028796086e-11
encoding O 0 1.1545078226760097e-09
zinc O 0 2.122887252653527e-07
finger O 0 1.1296992852294352e-05
2 O 0 4.031603384646587e-05
or O 0 2.5061814312721253e-07
zinc O 0 4.6592580815740803e-07
finger O 0 5.215179498918587e-06
3 O 0 1.4538514392370416e-07
, O 0 2.7847568001559964e-11
respectively O 0 2.3452240149879344e-11
, O 0 1.7083724842756332e-12
with O 0 1.3818391960199183e-12
a O 0 6.66636246204888e-10
hot O 0 1.9769247217027441e-07
spot O 0 6.129187823944449e-08
( O 0 7.699537188377015e-12
R394W O 0 1.0405845074501485e-09
) O 0 2.1472550300327686e-12
in O 0 4.9178938699157015e-11
exon O 0 3.309446228172419e-08
9 O 0 9.208321216647164e-08
. O 0 2.332540027794039e-08

We O 0 1.7782324501780522e-09
analyzed O 0 6.486298304020366e-11
a O 0 2.4026992201386932e-11
series O 0 1.7751443370794817e-10
of O 0 1.0879326328705474e-09
24 O 0 3.0871092349116225e-08
patients O 0 2.8850394295787396e-10
, O 0 2.563774713360001e-11
10 O 0 1.5232695660394313e-10
with O 0 1.0858320492745932e-10
isolated B-Disease 0 0.00020634906832128763
DMS I-Disease 1 0.9989973902702332
( O 0 1.6621493514890062e-08
IDMS B-Disease 0 0.06019729748368263
) O 0 1.7441924640704265e-11
, O 0 6.4518204147268055e-12
10 O 0 3.647071533663393e-11
with O 0 9.66579108419019e-11
DDS B-Disease 1 1.0
, O 0 1.6864465379740068e-10
and O 0 2.902058454656853e-11
4 O 0 5.045896145361439e-09
with O 0 2.232900531140558e-10
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 0.9999963045120239
and O 0 5.945487657754711e-08
/ O 0 0.21279506385326385
or O 0 8.360321771760937e-06
WT B-Disease 1 1.0
. O 0 6.91592674684216e-07

We O 0 3.074276122561059e-08
report O 0 2.28965846282847e-09
WT1 O 0 2.386740561632905e-06
heterozygous O 0 5.64467972363758e-10
mutations O 0 1.5067402187041168e-11
in O 0 1.1483595324657259e-11
16 O 0 1.0239776138121215e-08
patients O 0 1.5598568270380753e-10
, O 0 1.158377560539492e-11
4 O 0 5.5163114076606234e-09
of O 0 2.1233390601338442e-09
whom O 0 2.804715348858622e-10
presented O 0 1.3612803329010603e-08
with O 0 3.138427073778871e-09
IDMS B-Disease 0 0.16687269508838654
. O 0 2.945333790194127e-07

One O 0 9.035175274618723e-09
male O 0 3.16045911663565e-10
and O 0 2.8721351685856433e-11
two O 0 2.0455144522646407e-10
female O 0 3.854732089081381e-09
IDMS B-Disease 1 0.9999967813491821
patients O 0 6.820992659584135e-09
with O 0 6.677230435236936e-10
WT1 O 1 0.9999978542327881
mutations O 0 1.5953827414705302e-07
underwent O 0 4.933440141030587e-05
normal O 0 8.662536856718361e-06
puberty O 0 1.422800687578274e-05
. O 0 3.859712549569849e-09

Two O 0 1.2365035217953846e-08
mutations O 0 6.459538237635343e-09
associated O 0 7.1070100915449075e-09
with O 0 1.230036517085864e-09
IDMS B-Disease 1 0.9980077147483826
are O 0 1.4305657353164136e-12
different O 0 2.0108726492208857e-14
from O 0 7.547802985917451e-13
those O 0 1.4847269464227097e-12
described O 0 2.5950314119782547e-10
in O 0 1.5882744008877125e-08
DDS B-Disease 1 1.0
patients O 0 5.485279075401195e-07
. O 0 2.8364103954459097e-08

No O 0 8.534760809197905e-07
WT1 O 0 6.533111445605755e-05
mutations O 0 1.393125503845738e-09
were O 0 3.815513183180741e-11
detected O 0 3.2111462794359724e-11
in O 0 9.31054278813237e-12
the O 0 6.201797964067168e-10
six O 0 4.930004404712918e-09
other O 0 1.3456877390183308e-08
IDMS B-Disease 1 1.0
patients O 0 7.830515791340531e-09
, O 0 1.0400498171025951e-11
suggesting O 0 9.409535650650724e-12
genetic O 0 3.2943908712113057e-10
heterogeneity O 0 9.917744403509232e-10
of O 0 4.076200765812388e-10
this O 0 2.4059837455681077e-10
disease O 0 5.025042264605872e-05
. O 0 6.244341488326199e-09

We O 0 1.1614855743857788e-08
analyzed O 0 3.991152741633641e-09
genotype O 0 2.8230735082956926e-08
/ O 0 5.6905527401340805e-08
phenotype O 0 2.2189919346438103e-10
correlations O 0 7.82955228428861e-11
, O 0 2.2161725579672442e-12
on O 0 4.196744340934089e-11
the O 0 7.675954056401979e-13
basis O 0 5.688988776592074e-12
of O 0 1.2227020611266237e-11
the O 0 1.6852174170023382e-11
constitution O 0 4.147059778913942e-11
of O 0 1.4404651083044229e-10
a O 0 8.062915335393939e-10
WT1 O 0 1.1192438478246913e-06
mutation O 0 8.513369870177812e-11
database O 0 5.024053048585664e-11
of O 0 7.213736830102846e-10
84 O 0 1.7243943162270625e-08
germ O 0 0.00040517846355214715
- O 0 5.3258495427144226e-06
line O 0 5.2900841041036983e-08
mutations O 0 1.3747897265048437e-10
, O 0 2.9769008438873534e-12
to O 0 6.883739455190718e-13
compare O 0 4.460937695627276e-12
the O 0 2.2162034360451166e-11
distribution O 0 4.831429700757894e-10
and O 0 9.295566920364262e-12
type O 0 2.754231565038623e-10
of O 0 1.4402983250505486e-09
mutations O 0 8.830863124087429e-12
, O 0 4.73484912302119e-13
according O 0 1.3897151658615048e-13
to O 0 3.912209640445641e-13
the O 0 2.9055032685354476e-11
different O 0 2.4233549195118442e-11
symptoms O 0 7.535342092523933e-07
. O 0 1.1910904262890654e-08

This O 0 2.608280535998375e-10
demonstrated O 0 2.5830328986842233e-09
( O 0 3.256629688141999e-11
1 O 0 1.2023679829553657e-09
) O 0 9.520339161114832e-13
the O 0 1.860266975184377e-11
association O 0 4.9772195913344586e-12
between O 0 3.7163333391557196e-13
mutations O 0 1.1288853966201495e-12
in O 0 2.623645875207692e-12
exons O 0 4.9998152285013475e-09
8 O 0 2.4340582882587114e-09
and O 0 3.470964834995094e-11
9 O 0 1.0599598532223808e-08
and O 0 7.456095740820956e-10
DMS B-Disease 0 3.8284957781797857e-07
; O 0 1.0687770980732925e-11
( O 0 3.998361971374598e-12
2 O 0 2.194604636907016e-10
) O 0 7.885730913745337e-13
among O 0 2.2457459069452623e-12
patients O 0 6.525930403705749e-12
with O 0 5.230526949062675e-12
DMS B-Disease 0 1.0400652854514192e-06
, O 0 4.5012969046576146e-12
a O 0 4.51620902133798e-12
higher O 0 5.932007055703403e-12
frequency O 0 3.825532945977983e-11
of O 0 3.123912795111039e-10
exon O 0 4.197613368006614e-09
8 O 0 9.146488011424481e-10
mutations O 0 1.7313915925964984e-11
among O 0 7.219796050068894e-13
46 O 0 5.7296650063376475e-11
, O 0 6.737945618118246e-11
XY O 0 1.439738070985186e-06
patients O 0 2.1599364657953757e-11
with O 0 1.4338000188171551e-12
female O 0 3.8286626473371665e-12
phenotype O 0 1.945360539323815e-11
than O 0 3.433888102252064e-13
among O 0 1.2477448544864767e-12
46 O 0 3.652983748825278e-10
, O 0 3.6957409355053983e-10
XY O 0 7.689242193009704e-05
patients O 0 6.077655045899633e-11
with O 0 1.140581227555837e-12
sexual O 0 3.3576166152959885e-11
ambiguity O 0 1.3120845521186197e-09
or O 0 2.9450294980470915e-10
male O 0 1.381774035469352e-11
phenotype O 0 1.9886162161419918e-11
; O 0 1.142782808487286e-12
and O 0 1.5430306338215516e-11
( O 0 1.5969375344662695e-12
3 O 0 2.0287833912835396e-10
) O 0 7.023925169789835e-14
statistically O 0 8.465303653372447e-13
significant O 0 9.055203960793567e-13
evidence O 0 8.506841064903625e-12
that O 0 1.2282265048763064e-13
mutations O 0 3.422119087669734e-13
in O 0 3.4668342415583586e-12
exons O 0 6.256811957427999e-09
8 O 0 8.289229747049376e-09
and O 0 2.477472116346746e-10
9 O 0 8.013520513827643e-09
preferentially O 0 7.827521963932327e-11
affect O 0 1.2348690126007256e-10
amino O 0 4.2687731821589026e-11
acids O 0 1.849094662109696e-12
with O 0 1.6809619560013978e-13
different O 0 4.950914352964964e-13
functions O 0 6.447041789314767e-10
. O 0 8.134662388137315e-11
. O 0 1.3293272038694681e-09

The O 0 4.264458652869507e-07
185delAG O 0 7.795908459229395e-06
BRCA1 O 0 1.1529266430443386e-07
mutation O 0 4.1471570622064746e-10
originated O 0 4.972259062818729e-11
before O 0 1.6686301645973955e-11
the O 0 8.146940587427931e-12
dispersion O 0 1.0232484304317779e-10
of O 0 1.8700332948817788e-10
Jews O 0 2.3159434439645743e-11
in O 0 8.699178530302554e-12
the O 0 4.872944756040276e-11
diaspora O 0 5.226689914206162e-11
and O 0 1.1291233226184971e-10
is O 0 1.2304669436136173e-11
not O 0 7.0295345065696235e-12
limited O 0 5.524479762542001e-10
to O 0 6.935160223875414e-10
Ashkenazim O 0 2.8674678560491884e-06
. O 0 4.8617373238357686e-08

The O 0 2.032879642399621e-08
185delAG O 0 1.4721230456871126e-07
mutation O 0 1.6854184714532039e-09
in O 0 1.1511999686852903e-10
BRCA1 O 0 1.2596280962728912e-10
is O 0 2.605656304870835e-13
detected O 0 2.2307188648346132e-12
in O 0 1.992711985004947e-12
Ashkenazi O 0 3.11459469326536e-11
Jews O 0 7.045088254095666e-13
both O 0 2.742092577306954e-13
in O 0 1.4825713573474175e-11
familial B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 8.646797141409479e-06
in O 0 1.79833842262056e-10
the O 0 1.0583144083309293e-10
general O 0 3.8481554054392575e-10
population O 0 3.466596150761281e-12
. O 0 3.914858159870249e-10

All O 0 4.467792891205136e-08
tested O 0 5.6088829580858146e-08
Ashkenazi O 0 5.93720415054122e-08
mutation O 0 4.3036019192754793e-10
carriers O 0 2.954647377456654e-12
share O 0 2.6062492008288585e-12
the O 0 1.599157264942086e-11
same O 0 2.9571466803046675e-11
allelic O 0 7.280337221970967e-09
pattern O 0 6.210489900126959e-09
at O 0 1.9418751051603067e-08
the O 0 2.0731554251085527e-09
BRCA1 O 0 4.532620501151996e-09
locus O 0 6.156954945879534e-09
. O 0 5.620928611449472e-09

Our O 0 4.057347879893314e-08
previous O 0 5.584520401669124e-09
study O 0 3.723659575127769e-11
showed O 0 1.4096648848216375e-10
that O 0 5.855675102792168e-13
this O 0 5.1616679680455135e-12
Ashkenazi O 0 1.3517226449266673e-08
mutation O 0 3.21541987480245e-10
also O 0 1.3735389561841949e-11
occurs O 0 1.1963383842600317e-12
in O 0 1.749883007592934e-12
Iraqi O 0 6.380160982866201e-11
Jews O 0 1.5142770717901932e-11
with O 0 8.55379243998311e-13
a O 0 7.049248684776188e-11
similar O 0 9.469097728143083e-11
allelic O 0 1.6779672762368136e-07
pattern O 0 3.5088186223219964e-07
. O 0 1.2444620267615392e-07

We O 0 1.3701891177220205e-08
extended O 0 2.8269895313570714e-09
our O 0 1.9633210335268103e-10
analysis O 0 4.936301367663987e-12
to O 0 5.9277994839124215e-12
other O 0 2.9013000335531558e-11
non O 0 4.581969221817417e-07
- O 0 1.7430178189670187e-08
Ashkenazi O 0 3.2806852789946106e-09
subsets O 0 1.164345135862277e-07
354 O 0 8.446349730739655e-10
of O 0 1.7852263001216784e-09
Moroccan O 0 1.4018895910794527e-07
origin O 0 5.42815625781401e-10
, O 0 1.2646016178674557e-10
200 O 0 1.7817862463243017e-10
Yemenites O 0 5.1398092892895875e-08
and O 0 2.492886452820642e-10
150 O 0 3.1385755105972635e-10
Iranian O 0 1.2806636862094933e-09
Jews O 0 5.7720654922377435e-09
. O 0 1.3970910650584756e-08

Heteroduplex O 0 3.84930854124832e-06
analysis O 0 8.552043517795482e-10
complemented O 0 5.210935571930975e-10
by O 0 1.1568409424844717e-11
direct O 0 2.974531732036212e-10
DNA O 0 7.101044752211294e-10
sequencing O 0 1.5568547839794888e-10
of O 0 3.466396503171154e-09
abnormally O 0 6.111450234769222e-10
migrating O 0 3.976898671487206e-12
bands O 0 2.7126445534264576e-09
were O 0 9.111472132339316e-10
employed O 0 4.0995309369407096e-09
. O 0 1.992290599162061e-08

Four O 0 9.91926274451771e-09
of O 0 1.3933813214350721e-08
Moroccan O 0 8.661807555654377e-07
origin O 0 4.42664904731771e-10
( O 0 1.4988290122919246e-11
1 O 0 3.4414204819199767e-10
. O 0 9.587489222667722e-13
1 O 0 3.82818256261519e-11
% O 0 6.014029877397797e-13
) O 0 2.7311874346868693e-14
and O 0 7.76040906882991e-13
none O 0 2.0603338479752153e-11
of O 0 5.061335239808784e-10
the O 0 1.0050608123535199e-09
Yemenites O 0 2.7749202047289145e-08
or O 0 1.7064030743974e-11
Iranians O 0 5.279169809635498e-11
was O 0 6.280674313963175e-10
a O 0 3.3067472371417495e-11
carrier O 0 2.6669567596004917e-11
of O 0 4.945400755573814e-10
the O 0 4.802940267722988e-09
185delAG O 0 5.008016046303965e-07
mutation O 0 8.539647922134463e-08
. O 0 2.6360556404370072e-08

BRCA1 O 0 4.656291821447667e-06
allelic O 0 1.3011157307118992e-06
patterns O 0 6.14626785022665e-08
were O 0 1.0842969855318074e-09
determined O 0 2.577794921965193e-10
for O 0 3.38258900056676e-11
four O 0 1.891606489501374e-11
of O 0 1.8063552043035003e-10
these O 0 2.535896622898881e-12
individuals O 0 1.3246546329455378e-13
and O 0 3.1167917639157716e-12
for O 0 2.4377356036553444e-11
12 O 0 4.770872585879715e-10
additional O 0 6.750140030264973e-11
non O 0 1.2264736142242327e-06
- O 0 2.473729843188721e-08
Ashkenazi O 0 1.166515883888053e-09
185delAG O 0 2.2799837573472814e-09
mutation O 0 1.4567277939470102e-10
carriers O 0 9.767047413899999e-12
who O 0 2.3050715849959325e-11
had O 0 1.0155540763889803e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9848558306694031

Six O 0 2.373473080297117e-06
non O 0 0.03393673151731491
- O 0 2.574268137323088e-06
Ashkenazi O 0 1.340782063152801e-07
individuals O 0 1.8973156379331613e-11
shared O 0 2.296731027584542e-09
the O 0 1.0801670669025043e-08
common O 0 1.0988547849422048e-08
Ashkenazi O 0 8.313136845572444e-09
haplotype O 0 1.4905467082826362e-08
, O 0 2.0415125145945012e-09
four O 0 2.77449530017293e-09
had O 0 5.5257891595772435e-09
a O 0 4.957640409308794e-10
closely O 0 6.538841690328923e-11
related O 0 7.271312996159907e-10
pattern O 0 2.855339005236601e-07
, O 0 3.961345418357354e-10
and O 0 8.587611177723886e-10
the O 0 1.2657055847853371e-08
rest O 0 6.598283253111958e-09
( O 0 1.0219313242854078e-11
n O 0 4.688028298893698e-10
= O 0 5.322800533669181e-10
6 O 0 1.947187966422348e-10
) O 0 2.0124200428902478e-13
displayed O 0 1.4040077260524253e-11
a O 0 4.2824740281721674e-11
distinct O 0 2.0229061481469301e-10
BRCA1 O 0 7.2831429775988e-09
allelic O 0 4.83739199808042e-08
pattern O 0 1.514323173523735e-07
. O 0 6.277781494645751e-08

We O 0 2.9392397404848225e-09
conclude O 0 1.3512889696087882e-09
that O 0 2.6849061168787713e-12
the O 0 1.9657717120757923e-10
185delAG O 0 2.138651780114742e-07
BRCA1 O 0 2.622260453222225e-08
mutation O 0 1.1396277671549271e-10
occurs O 0 2.029117759233534e-12
in O 0 1.268731539098844e-12
some O 0 2.042249399106244e-12
non O 0 3.17939993692562e-05
- O 0 1.8891540776166948e-06
Ashkenazi O 0 3.3268250376750075e-08
populations O 0 1.6726174612013978e-10
at O 0 3.4296336881567413e-09
rates O 0 9.442086001953953e-10
comparable O 0 6.831506194071579e-11
with O 0 2.543453512041105e-12
that O 0 1.2970517888899469e-11
of O 0 3.295840045325349e-08
Ashkenazim O 0 5.567889729718445e-06
. O 0 3.9485932745719765e-08

The O 0 1.590296250242318e-08
majority O 0 1.8656191869137473e-10
of O 0 1.9608521473202245e-09
Jewish O 0 8.301174858615923e-09
185delAG O 0 3.777200561216887e-07
mutation O 0 8.929163186621736e-09
carriers O 0 3.4809093107934785e-11
have O 0 1.718755996901744e-12
a O 0 7.346067330826767e-12
common O 0 2.076540848994224e-11
allelic O 0 1.921653502989784e-09
pattern O 0 9.059812899891995e-10
, O 0 7.034349665258066e-12
supporting O 0 7.080105252077473e-11
the O 0 3.647643298521075e-10
founder O 0 1.3194785708492418e-08
effect O 0 2.1300047947647727e-08
notion O 0 2.32403030153705e-09
, O 0 6.636251010522232e-12
but O 0 7.248578907242953e-13
dating O 0 8.592567629639447e-12
the O 0 2.7584094730581654e-11
mutations O 0 7.913938059565806e-13
origin O 0 3.449143097869478e-13
to O 0 2.0197878742786446e-13
an O 0 1.5114850289345977e-13
earlier O 0 5.1260658912033463e-11
date O 0 5.787179180316571e-09
than O 0 4.710395268281431e-12
currently O 0 3.3285717931930137e-11
estimated O 0 4.882166337871752e-10
. O 0 4.680525744760189e-09

However O 0 5.195218033549054e-09
, O 0 2.7106247801889083e-11
the O 0 1.0524219516694355e-11
different O 0 5.008738649531219e-13
allelic O 0 3.746917887070822e-09
pattern O 0 2.6551285614573317e-09
at O 0 1.7011672071021167e-08
the O 0 1.1147501810526705e-09
BRCA1 O 0 2.2094136242767348e-10
locus O 0 5.914498751868891e-11
even O 0 1.0691843460933215e-12
in O 0 8.712690399877154e-13
some O 0 6.775208107219488e-13
Jewish O 0 9.306783121942885e-11
mutation O 0 7.922357908585198e-11
carriers O 0 6.499285918476483e-12
, O 0 1.1209279164592356e-11
might O 0 1.2205491825567627e-11
suggest O 0 5.365852293742757e-12
that O 0 5.433161516174567e-13
the O 0 3.779399709857856e-11
mutation O 0 1.906544366825358e-11
arose O 0 2.1243081078925474e-12
independently O 0 4.767938648064796e-12
. O 0 4.448908255683115e-11
. O 0 2.0919834753385658e-09

Crystal O 0 4.601798082148889e-06
structure O 0 4.300758860154019e-07
of O 0 4.881123913946794e-07
the O 0 2.072701818178757e-06
hemochromatosis B-Disease 1 1.0
protein O 0 5.652028448821511e-06
HFE O 0 0.0024704672396183014
and O 0 1.0689917007145056e-10
characterization O 0 1.1001035499225154e-10
of O 0 4.591902968975603e-10
its O 0 3.380718621714962e-11
interaction O 0 2.8350268313492855e-11
with O 0 9.997502825598303e-12
transferrin O 0 8.268783346920827e-08
receptor O 0 1.5089396399048383e-08
. O 0 4.795553287806342e-09

HFE O 1 0.9999221563339233
is O 0 2.404041232750842e-08
an O 0 8.626683811741032e-10
MHC O 0 2.9342120910769154e-07
- O 0 1.1914033848370309e-07
related O 0 2.7082517561893837e-08
protein O 0 1.2464836940395685e-09
that O 0 1.320493085536778e-12
is O 0 1.1072844979245419e-13
mutated O 0 3.826908408222085e-13
in O 0 9.983511413402812e-13
the O 0 8.721100508424229e-10
iron B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 2.1143834601389244e-05

HFE O 0 2.207420220656786e-05
binds O 0 1.2865070120327005e-10
to O 0 5.409363582065119e-11
transferrin O 0 2.710348390166928e-09
receptor O 0 4.7415685960894294e-11
( O 0 6.3509219584700904e-12
TfR O 0 2.682151389876708e-09
) O 0 1.8972848194864084e-13
and O 0 3.628576389011484e-13
reduces O 0 1.5947642512115223e-12
its O 0 3.035659831146509e-13
affinity O 0 2.5123821209213637e-13
for O 0 6.024184623365514e-11
iron O 0 2.5687134552754287e-07
- O 0 5.776812361801831e-09
loaded O 0 1.39946859656348e-10
transferrin O 0 2.0029045089131614e-09
, O 0 5.2651820403593064e-11
implicating O 0 1.3319394476241087e-08
HFE O 0 3.085853313677944e-05
in O 0 5.2267477457235145e-08
iron O 0 0.00029454290051944554
metabolism O 0 0.00011894268391188234
. O 0 8.266733431128159e-08

The O 0 1.6785318166512297e-06
2 O 0 4.556122348731151e-06
. O 0 1.1315081849261333e-07

6 O 0 3.0447188692050986e-05
A O 0 6.260562486204435e-07
crystal O 0 4.52939502793015e-07
structure O 0 1.175190718072372e-07
of O 0 1.3225051986864855e-07
HFE O 0 5.930025508860126e-05
reveals O 0 8.318605804191748e-10
the O 0 1.7370081067946685e-11
locations O 0 6.504832089637702e-11
of O 0 2.696469003637958e-08
hemochromatosis B-Disease 1 1.0
mutations O 0 1.4575936901906061e-08
and O 0 9.734362205193747e-10
a O 0 5.801391367299402e-09
patch O 0 0.0002969647175632417
of O 0 4.03565754822921e-05
histidines O 1 0.768660306930542
that O 0 6.567280053104696e-10
could O 0 6.338919666948328e-11
be O 0 5.6403584060282785e-12
involved O 0 6.632998837685644e-12
in O 0 1.0634662594988242e-10
pH O 0 1.1452960535507373e-07
- O 0 7.641251187351372e-08
dependent O 0 1.536354865550038e-08
interactions O 0 6.635147542510822e-09
. O 0 1.2799000970176166e-08

We O 0 9.458492655767259e-09
also O 0 5.2223152885444435e-11
demonstrate O 0 1.3176462698716307e-10
that O 0 1.0983879604464786e-11
soluble O 0 3.5062408532127165e-09
TfR O 0 7.433694122482848e-07
and O 0 1.2670672289161189e-09
HFE O 0 6.626121376029914e-06
bind O 0 5.610171771586181e-10
tightly O 0 7.72412800387201e-09
at O 0 3.1187112892183677e-09
the O 0 6.136235963793979e-10
basic O 0 8.054699662807252e-08
pH O 0 4.124094399315936e-09
of O 0 3.7153700116476784e-09
the O 0 1.7988334155560892e-09
cell O 0 1.4852559182543246e-09
surface O 0 6.435044771352372e-12
, O 0 1.2595764275341592e-12
but O 0 2.0223794427315367e-12
not O 0 6.193292406697637e-12
at O 0 1.5891553628577526e-09
the O 0 1.315464848161696e-09
acidic O 0 2.1900561364418536e-09
pH O 0 1.0588122378862863e-08
of O 0 1.1723381376782527e-08
intracellular O 0 1.84033410732809e-07
vesicles O 0 2.3357961254077964e-06
. O 0 3.410815097026898e-08

TfR O 0 0.0013129302533343434
HFE O 0 0.0002386761480011046
stoichiometry O 0 9.244114806961079e-08
( O 0 1.2815971617285982e-09
2 O 0 4.8982302658373555e-09
1 O 0 3.4319291852824563e-10
) O 0 1.7156370454071007e-13
differs O 0 1.0513555222810625e-13
from O 0 1.088858929236547e-12
TfR O 0 2.2923107856342995e-09
transferrin O 0 2.90385382406555e-10
stoichiometry O 0 6.039777011856984e-10
( O 0 7.95099489719897e-12
2 O 0 3.904775947027872e-10
2 O 0 1.0385180215788381e-10
) O 0 4.050415669640435e-14
, O 0 6.09732669085497e-14
implying O 0 1.9299583361564315e-13
a O 0 4.72397891203985e-13
different O 0 7.152681631662425e-15
mode O 0 1.0792865906550375e-10
of O 0 1.464745685852975e-11
binding O 0 5.554578672017918e-11
for O 0 3.693596470344396e-11
HFE O 0 1.1807329656221555e-06
and O 0 1.1897043072917057e-10
transferrin O 0 5.8958193882574506e-09
to O 0 8.241720500512528e-11
TfR O 0 2.048859499836908e-07
, O 0 1.9323433478324326e-11
consistent O 0 2.1261263583038925e-10
with O 0 4.458998274781134e-12
our O 0 5.839266292717582e-10
demonstration O 0 1.207399247249441e-08
that O 0 9.070022510826448e-12
HFE O 0 5.792128945358854e-07
, O 0 2.7240067840272886e-11
transferrin O 0 4.625590577234107e-09
, O 0 1.4581566509797028e-10
and O 0 4.244694318256137e-10
TfR O 0 3.449205223660101e-07
form O 0 7.306835136944301e-10
a O 0 1.4069740927880048e-09
ternary O 0 7.049311534501612e-07
complex O 0 9.802204203879228e-07
. O 0 3.032461748375681e-08

Identification O 0 8.459945632921517e-09
of O 0 2.6875845993146186e-09
three O 0 1.8501996809638932e-11
novel O 0 1.8368102178145662e-11
mutations O 0 6.829951968573278e-12
and O 0 4.9042996226600355e-12
a O 0 4.634821172688763e-12
high O 0 1.9103081963511848e-11
frequency O 0 3.10770076339395e-10
of O 0 7.384946543176341e-10
the O 0 5.434039884733011e-10
Arg778Leu O 0 4.431427100826113e-07
mutation O 0 6.02516481151838e-10
in O 0 5.25605149681585e-11
Korean O 0 8.232510140260274e-08
patients O 0 7.632122017708909e-11
with O 0 1.9829349967581678e-11
Wilson B-Disease 0 4.28296471000067e-06
disease I-Disease 1 0.9652952551841736
. O 0 6.84492391656022e-08

Four O 0 9.270897827207136e-09
mutations O 0 8.434758447251056e-10
- O 0 1.7453466227834724e-08
- O 0 8.522217598283532e-09
R778L O 0 1.6084744203226364e-08
, O 0 2.8668152921018653e-11
A874V O 0 1.1583610737275762e-09
, O 0 4.262742069049974e-12
L1083F O 0 1.4925109759200694e-10
, O 0 1.3816706025820968e-12
and O 0 7.820156197949069e-13
2304delC O 0 6.710536987197813e-11
- O 0 2.2605953567400583e-11
- O 0 1.060734920038664e-11
in O 0 3.481013871250993e-12
the O 0 2.1231477687067013e-10
copper O 0 6.749773184822061e-09
- O 0 3.3084852635312245e-09
transporting O 0 9.498515307626576e-10
enzyme O 0 8.494457914842712e-11
, O 0 1.807589078417493e-10
P O 0 3.396286774659529e-05
- O 0 1.232670285844506e-07
type O 0 6.912185490648426e-09
ATPase O 0 3.946242443930714e-09
( O 0 2.7802350699435152e-11
ATP7B O 0 4.6907078399271995e-07
) O 0 5.211682864783573e-13
, O 0 9.618988141809129e-14
were O 0 2.3396814542199496e-13
identified O 0 1.0770624843392529e-12
in O 0 3.2077654334855543e-12
Korean O 0 1.0648353310216407e-08
Patients O 0 3.6459515961873024e-11
with O 0 1.4295490138871436e-11
Wilson B-Disease 0 4.057304977322929e-06
disease I-Disease 1 0.9925886392593384
. O 0 4.867721870027708e-08

Arg778Leu O 0 6.385012511600507e-06
, O 0 1.8937309498312516e-09
the O 0 4.777456208415742e-10
most O 0 5.660577041821657e-12
frequently O 0 7.790322206768785e-13
reported O 0 2.190729585585527e-12
mutation O 0 2.9562032075741707e-12
of O 0 2.768272278075301e-10
this O 0 7.056360704082998e-12
enzyme O 0 2.1564651106475985e-12
, O 0 5.75388423972728e-13
was O 0 5.1078738461107775e-11
found O 0 2.1249310904608576e-13
in O 0 2.0261158202583562e-13
six O 0 1.3567568292807697e-12
of O 0 4.211820475719108e-11
eight O 0 1.42935357994034e-10
unrelated O 0 4.0505007681268523e-10
patients O 0 3.030651250790495e-12
studied O 0 7.707225135877849e-11
, O 0 1.520634963433909e-12
an O 0 2.3777049665101024e-13
allele O 0 2.1236529895718448e-11
frequency O 0 1.6126729951437824e-09
of O 0 7.139046243054281e-09
37 O 0 5.901492983184653e-08
. O 0 3.4656249425779606e-08

5 O 0 8.26432184908299e-08
% O 0 4.121520902344855e-10
, O 0 4.1082626883737206e-11
which O 0 4.204859117146187e-12
is O 0 2.3092419903364414e-12
considerably O 0 3.957550433197898e-12
higher O 0 7.19645480359854e-12
than O 0 6.010736206723058e-14
those O 0 2.853371022532719e-13
in O 0 4.1852957731458584e-12
other O 0 9.644662672669835e-12
Asian O 0 7.415193459259228e-10
populations O 0 1.4314814611449123e-10
. O 0 1.0117386928243377e-09

The O 0 6.198537239043844e-09
novel O 0 2.3205519450453238e-10
single O 0 1.8059417850047055e-10
nucleotide O 0 1.2983772945673877e-09
deletion O 0 4.4511683228165566e-10
, O 0 2.2380972075630723e-11
2304delC O 0 2.3337405341550266e-09
, O 0 5.650051954075863e-11
was O 0 9.554115276699804e-10
found O 0 4.724855489496305e-12
in O 0 2.224007610018841e-11
one O 0 2.232031920401667e-10
patient O 0 5.050453211197237e-08
. O 0 5.251910906167723e-08

Since O 0 2.783846042575533e-09
a O 0 4.035040634953191e-10
mutation O 0 5.487992352226634e-11
at O 0 1.4287899752218891e-09
cDNA O 0 1.589532061530008e-08
nucleotide O 0 1.458912777252408e-07
2302 O 0 1.4386824659595732e-05
( O 0 3.338401777241984e-11
2302insC O 0 2.4574853263459318e-09
) O 0 1.2947160704657179e-11
had O 0 7.068771262774831e-11
been O 0 2.3165663831647976e-11
previously O 0 2.7494184706711167e-10
described O 0 4.077403692459569e-11
, O 0 3.11130353251865e-12
this O 0 7.931694580645687e-13
region O 0 1.2148176908866049e-10
of O 0 9.573926096351215e-10
the O 0 1.1914903730314563e-08
ATP7B O 0 0.00033001930569298565
gene O 0 8.259826600465203e-09
may O 0 2.6492694149560236e-10
be O 0 3.3850932473766804e-11
susceptible O 0 1.0033771591366758e-09
to O 0 1.7239015770442734e-11
gene O 0 1.717153885749667e-08
rearrangements O 0 5.318134753906634e-06
causing O 0 3.8142425182741135e-06
Wilson B-Disease 0 2.2704198272549547e-06
disease I-Disease 0 0.4726184904575348
. O 0 6.565507248978975e-08

Disruption O 0 5.420890374807641e-06
of O 0 1.0207526912608955e-07
splicing O 0 1.0125093652391115e-08
regulated O 0 8.1553286346292e-10
by O 0 8.374891058426925e-12
a O 0 2.3726481890307127e-10
CUG O 0 2.7039654924010392e-06
- O 0 5.966068528096002e-09
binding O 0 6.1578941945583665e-09
protein O 0 1.993605813765953e-08
in O 0 7.623341957696539e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 5.614364454231691e-06

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 8.596789391468462e-10
is O 0 4.935162088021139e-12
caused O 0 3.531479622620459e-11
by O 0 1.6265873196974479e-12
a O 0 8.752040064896605e-11
CTG O 0 3.7057112933780445e-08
expansion O 0 1.929615356388581e-10
in O 0 2.7761957229616163e-12
the O 0 1.0732057603712875e-11
3 O 0 2.6768653960118627e-10
untranslated O 0 9.105726839209183e-09
region O 0 1.636856344910953e-10
of O 0 5.316885265393978e-10
the O 0 5.821612703016399e-08
DM B-Disease 1 1.0
gene O 0 3.975204663220211e-07
. O 0 6.867259116916102e-08

One O 0 2.725681902404631e-10
model O 0 9.190381788926061e-10
of O 0 7.281561806848913e-07
DM B-Disease 1 1.0
pathogenesis O 1 0.9987163543701172
suggests O 0 1.0200083000455606e-09
that O 0 1.153645321633201e-12
RNAs O 0 2.0707041636924828e-10
from O 0 4.511277809648995e-11
the O 0 5.623678953070588e-11
expanded O 0 1.0074416127714425e-11
allele O 0 9.754797664074388e-12
create O 0 5.464466986543348e-12
a O 0 1.681236400097319e-11
gain O 0 1.9873924728130987e-10
- O 0 5.205312847422761e-10
of O 0 3.935900849683094e-08
- O 0 6.413036324204313e-09
function O 0 9.166122083570372e-09
mutation O 0 1.2032454026200678e-11
by O 0 1.165348850404313e-12
the O 0 4.536681100231199e-11
inappropriate O 0 1.3257151453005545e-11
binding O 0 4.5112864832663746e-11
of O 0 1.1483994311056733e-10
proteins O 0 3.627090164673441e-12
to O 0 1.1602084744322116e-11
the O 0 2.3372774826668774e-09
CUG O 0 1.971998244698625e-05
repeats O 0 2.409720707419183e-07
. O 0 3.648280255674763e-08

Data O 0 2.8135483276514606e-08
presented O 0 5.953212145470843e-09
here O 0 2.355562966904756e-10
indicate O 0 7.574775875984763e-12
that O 0 4.507996081461185e-13
the O 0 9.134205544714114e-12
conserved O 0 1.2297778073655508e-10
heterogeneous O 0 1.2842472640883784e-09
nuclear O 0 3.1048011805978604e-07
ribonucleoprotein O 0 1.7885263048356137e-08
, O 0 2.2719040537744206e-10
CUG O 0 1.2864283007729682e-06
- O 0 1.7678941643950452e-09
binding O 0 8.7010454397074e-10
protein O 0 4.402198050534878e-10
( O 0 8.358358276339128e-12
CUG O 0 1.415668862136954e-06
- O 0 1.2548765582209853e-08
BP O 0 1.5146222054340797e-09
) O 0 6.7777413455955e-13
, O 0 1.0356428171640064e-12
may O 0 8.732143480516541e-12
mediate O 0 1.3800712794775905e-09
the O 0 2.2319905923495753e-09
trans O 0 7.344340691162188e-09
- O 0 5.286258542014366e-09
dominant O 0 9.627143526813597e-09
effect O 0 6.470105784472935e-09
of O 0 3.1028100089258714e-09
the O 0 2.6368187633352136e-09
RNA O 0 4.4790898101609855e-08
. O 0 8.942047102777906e-09

CUG O 1 0.9934194684028625
- O 0 3.5700140870176256e-05
BP O 0 3.6082332144360407e-07
was O 0 7.032817883612097e-09
found O 0 1.0844840650503507e-11
to O 0 2.379555699618535e-13
bind O 0 6.440800583845663e-13
to O 0 7.156646694532476e-13
the O 0 8.422616076808609e-11
human O 0 6.412659558918676e-08
cardiac O 1 1.0
troponin O 1 0.998803973197937
T O 0 0.00026887605781666934
( O 0 1.0432922754877172e-11
cTNT O 0 9.120461608169705e-10
) O 0 6.91463704870221e-13
pre O 0 4.274701037587647e-09
- O 0 9.967880687522523e-11
messenger O 0 2.1404315819761877e-11
RNA O 0 4.543617218577545e-11
and O 0 1.1673377108695204e-12
regulate O 0 8.409048631030647e-12
its O 0 2.37954014131736e-11
alternative O 0 1.7989157941045164e-09
splicing O 0 2.209268323838387e-08
. O 0 4.202788339568997e-09

Splicing O 0 4.8104421779271433e-08
of O 0 1.962446916081717e-08
cTNT O 0 6.357503252729657e-07
was O 0 7.972376891984823e-08
disrupted O 0 7.567102784378221e-06
in O 0 3.5030146250392136e-07
DM B-Disease 1 1.0
striated O 1 0.6205053925514221
muscle O 0 0.25225090980529785
and O 0 6.810049768546378e-08
in O 0 8.051727062863279e-10
normal O 0 7.671374646633922e-09
cells O 0 6.973464167225885e-11
expressing O 0 9.507477270742637e-12
transcripts O 0 7.961561271363493e-11
that O 0 1.4619035149099346e-12
contain O 0 2.900930606841712e-10
CUG O 0 2.222964894826873e-06
repeats O 0 4.684484622430318e-08
. O 0 1.2551111261416281e-08

Altered O 0 2.6129141517117205e-08
expression O 0 3.837280271312693e-09
of O 0 1.0724456878108413e-09
genes O 0 8.330668793687934e-11
regulated O 0 5.727002205802023e-10
posttranscriptionally O 0 1.2859072917592584e-08
by O 0 8.603826540110049e-10
CUG O 1 0.9991816878318787
- O 0 2.1801812181365676e-05
BP O 0 7.182618588785772e-08
therefore O 0 1.7193807488879997e-10
may O 0 2.917787886302925e-11
contribute O 0 1.891656969954525e-11
to O 0 6.356963844211805e-10
DM B-Disease 1 1.0
pathogenesis O 0 0.0006692856550216675
. O 0 1.7417308706413337e-09
. O 0 4.066992076445786e-09

Identification O 0 1.1237060171254143e-08
of O 0 3.1468307959414688e-09
a O 0 6.446005534899157e-11
novel O 0 7.164766002709655e-11
nonsense O 0 1.559518403304594e-09
mutation O 0 2.6225115828948375e-11
and O 0 1.2095612055354477e-12
a O 0 2.653742243313717e-12
missense O 0 1.2433132301481464e-10
substitution O 0 5.3634503088817453e-11
in O 0 6.874664032485711e-12
the O 0 9.046236676413244e-11
vasopressin O 0 1.9077104340681217e-09
- O 0 7.341595331666895e-09
neurophysin O 0 1.0492911428627849e-07
II O 0 6.344020562210062e-07
gene O 0 3.913340831940282e-11
in O 0 1.327232486240948e-12
two O 0 3.551293916055631e-13
Spanish O 0 3.3045985392554655e-10
kindreds O 0 3.965983808029705e-08
with O 0 6.770073390782727e-11
familial B-Disease 1 0.999998927116394
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 0 8.519796779182798e-07

Familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 2.967694626931916e-06
FNDI B-Disease 1 1.0
) O 0 7.2154083922970624e-12
is O 0 1.4640318037745237e-13
an O 0 3.6676952165463905e-13
autosomal B-Disease 1 0.9999974966049194
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 2.442696711568715e-07
by O 0 1.635435536995189e-11
deficiency O 0 3.377125949555193e-06
in O 0 6.345189373924143e-10
the O 0 4.989281521261546e-08
antidiuretic O 0 1.1043745189454057e-06
hormone O 0 1.384958192574004e-08
arginine O 0 8.967633746692627e-09
vasopressin O 0 1.3332426274104137e-09
( O 0 1.0519142848441909e-11
AVP O 0 5.008039538623166e-10
) O 0 6.132008200770414e-15
encoded O 0 1.7179806839281997e-14
by O 0 4.961502129280371e-13
the O 0 1.3051780767270316e-09
AVP O 0 8.34090678836219e-06
- O 0 3.7361829186011164e-07
neurophysin O 0 3.382110662641935e-05
II O 1 0.9998517036437988
( O 0 1.4587484997719002e-07
AVP O 0 0.0001414210710208863
- O 0 2.1003148731324472e-07
NPII O 0 4.061656454723561e-06
) O 0 4.177067719490779e-11
gene O 0 4.538474873694298e-10
on O 0 2.770793594564225e-09
chromosome O 0 6.40580140043312e-08
20p13 O 0 1.0253222626488423e-06
. O 0 6.334553859232983e-08

In O 0 1.5468097913640122e-09
this O 0 1.3447260666099581e-11
study O 0 6.15880089982479e-12
, O 0 4.238161471076252e-12
we O 0 4.812727039810172e-12
analyzed O 0 7.441312323275273e-12
two O 0 1.7118266439769547e-12
families O 0 2.795994230413157e-13
with O 0 4.806599129131284e-12
FNDI B-Disease 1 1.0
using O 0 8.112644583890827e-11
direct O 0 2.1807428085551805e-10
automated O 0 7.265480217455433e-09
fluorescent O 0 2.703052226493696e-10
, O 0 3.6220299762940167e-12
solid O 0 1.349644979109499e-10
phase O 0 8.007726148839822e-10
, O 0 3.4922861043978903e-12
single O 0 2.684999445001779e-11
- O 0 6.862365536930426e-11
stranded O 0 1.65378988281617e-10
DNA O 0 7.81313815728657e-12
sequencing O 0 4.2237324748839455e-12
of O 0 1.3859106917646358e-10
PCR O 0 7.249744271575764e-08
- O 0 2.5077263217099244e-06
amplified O 0 5.156668521522079e-06
AVP O 0 0.0003273651236668229
- O 0 1.915640041261213e-06
NPII O 0 8.85110639501363e-05
DNA O 0 9.87482621894742e-07
. O 0 2.566038936890891e-08

In O 0 5.863708407716217e-10
one O 0 3.8250878159340473e-11
of O 0 1.1611926975518827e-09
the O 0 6.178231815034962e-10
families O 0 5.471149249793028e-13
, O 0 1.7677531530604917e-12
affected O 0 2.303848518209195e-12
individuals O 0 5.077385519945861e-14
presented O 0 8.196868878096453e-11
a O 0 2.5379497115007865e-11
novel O 0 1.951734607263944e-11
nonsense O 0 3.6271771697293786e-10
mutation O 0 3.812455993262853e-12
in O 0 3.4306953979046373e-12
exon O 0 1.9112422755540592e-10
3 O 0 1.7133278129577434e-10
of O 0 7.075556113234072e-11
the O 0 1.723276903120574e-11
gene O 0 2.314573229258987e-12
, O 0 3.401905222365914e-13
consisting O 0 5.946867347519924e-13
in O 0 4.9909082942833916e-12
a O 0 2.489489170365289e-10
G O 0 3.300249318272108e-08
to O 0 4.2826553414698765e-10
T O 0 1.0414055395813193e-07
transition O 0 2.7194930751761603e-09
at O 0 1.4064052145101869e-09
nucleotide O 0 3.5781971829962345e-10
2101 O 0 1.5008167153496288e-08
, O 0 5.384375671019237e-13
which O 0 1.4666722765216585e-14
produces O 0 3.408242722877271e-14
a O 0 1.6782495532163821e-12
stop O 0 1.500465203474466e-11
signal O 0 5.617967202553587e-10
in O 0 7.751615321849314e-11
codon O 0 4.440367629143793e-09
82 O 0 2.650382580071664e-09
( O 0 3.184105201725629e-10
Glu O 0 7.112965931810322e-07
) O 0 6.155680132291508e-11
of O 0 8.233087989140131e-09
NPII O 0 8.843884279485792e-05
. O 0 1.844375390191999e-07

The O 0 4.922673610963102e-07
premature O 0 3.2687543694009946e-07
termination O 0 1.0353545576435863e-08
eliminates O 0 1.6099754418519296e-08
part O 0 1.8088652797842997e-10
of O 0 3.400718595614194e-09
the O 0 2.5617832299928978e-09
C O 0 3.948458413560729e-07
- O 0 1.935698490385107e-09
terminal O 0 5.01248376139074e-10
domain O 0 1.2836507898295046e-11
of O 0 1.2938204674295406e-10
NPII O 0 6.434431156776554e-07
, O 0 4.371994953566993e-12
including O 0 1.5927852569860845e-12
a O 0 2.3437571328166484e-11
cysteine O 0 3.363725270544293e-11
residue O 0 1.45474043922178e-09
in O 0 2.394902678948263e-11
position O 0 5.660917290484235e-10
85 O 0 4.181015256232712e-10
, O 0 9.025275318763626e-12
which O 0 2.6600464452658512e-12
could O 0 2.61700860634817e-12
be O 0 1.1994915694382713e-12
involved O 0 3.813697675800892e-13
in O 0 5.5292177086885275e-12
the O 0 6.237005911735594e-10
correct O 0 8.453316269196876e-09
folding O 0 2.9317495986447284e-08
of O 0 8.544401630672382e-09
the O 0 4.9090260745288106e-08
prohormone O 0 0.00012502860045060515
. O 0 2.605646045594767e-07

In O 0 1.6708356920247525e-09
the O 0 3.02551006470253e-09
second O 0 1.0601540090249273e-08
family O 0 6.895429366382544e-11
, O 0 2.0005656853339104e-11
a O 0 6.174388778035222e-11
G279A O 0 1.7976844457479046e-09
substitution O 0 2.6210438264229197e-09
at O 0 3.338003873309958e-09
position O 0 1.0588959570290157e-10
- O 0 1.8272392279805594e-11
1 O 0 1.1334452820754848e-10
of O 0 3.1000504246980753e-11
the O 0 3.871232501229116e-11
signal O 0 1.6718366691037545e-09
peptide O 0 8.406069590405352e-11
was O 0 6.530092439005486e-11
observed O 0 4.243467556508396e-12
in O 0 1.2220323494446794e-12
all O 0 1.7057815229759576e-11
affected O 0 7.600453599820867e-11
individuals O 0 1.2217207280562636e-11
. O 0 1.345787925544073e-08

This O 0 4.6322273794530133e-10
missense O 0 8.741409374124487e-08
mutation O 0 1.2657508374758208e-09
, O 0 4.241034259888643e-11
which O 0 2.597244641577845e-10
replaces O 0 4.25128791903262e-06
Ala O 0 1.3457565728458576e-06
with O 0 2.2571196300891216e-10
Thr O 0 1.4315084627014585e-05
, O 0 7.120246059422186e-11
is O 0 3.5360612007928616e-12
frequent O 0 1.1888287576589107e-10
among O 0 6.272438124454993e-10
FNDI B-Disease 1 1.0
patients O 0 1.176672640212928e-06
and O 0 7.823196535028387e-10
is O 0 6.388319734318415e-11
thought O 0 4.307902992661816e-11
to O 0 3.0504388078000932e-12
reduce O 0 3.8868830376515007e-10
the O 0 6.613093406215853e-11
efficiency O 0 8.073533508401454e-10
of O 0 4.74306982578554e-11
cleavage O 0 1.9152407090827772e-11
by O 0 2.7673365335378897e-11
signal O 0 6.428322052443036e-08
peptidases O 0 4.22010117517857e-07
. O 0 9.393317235151244e-10
. O 0 5.108395040309688e-09

Genetic O 0 7.088330988835878e-08
heterogeneity O 0 8.100441561964544e-08
of O 0 2.703885968458053e-07
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 5.583167261846711e-09
due O 0 1.00404486147454e-05
to O 0 8.984407107170966e-10
TWIST O 0 1.057643021340482e-05
and O 0 8.453284294773766e-09
FGFR O 0 0.16478349268436432
mutations O 0 8.820511254725716e-08
. O 0 2.4042705604188086e-08

Thirty O 0 2.0184122604405275e-06
- O 0 1.0078131253976608e-06
two O 0 1.1922825227106415e-10
unrelated O 0 4.512513029908405e-09
patients O 0 2.9737570912680145e-12
with O 0 5.787374296158457e-14
features O 0 2.5821894622524155e-10
of O 0 6.079959291582782e-08
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 6.473373503901314e-10
a O 0 2.7785185263695666e-10
common O 0 1.5120107832444774e-08
autosomal B-Disease 0 0.03705132007598877
dominant I-Disease 1 0.9834891557693481
condition I-Disease 1 0.9999998807907104
of O 1 0.844434916973114
craniosynostosis B-Disease 1 1.0
and O 0 3.494913471513428e-06
limb B-Disease 1 0.9999998807907104
anomalies I-Disease 1 0.999983549118042
, O 0 2.845908397830499e-09
were O 0 2.992525394152068e-10
screened O 0 5.430548233320565e-10
for O 0 1.2359262918648639e-11
mutations O 0 1.2605960546252515e-11
in O 0 6.323921247775033e-11
TWIST O 0 1.2528010984169669e-07
, O 0 1.4571613360381264e-10
FGFR2 O 0 1.9311624782858416e-05
, O 0 5.309385708862635e-10
and O 0 1.7343085856325047e-09
FGFR3 O 0 0.0001359542366117239
. O 0 1.52381801399315e-07

Nine O 0 1.7221262638145163e-08
novel O 0 4.015592858230832e-10
and O 0 2.774303287100821e-10
three O 0 2.947142252462953e-10
recurrent O 0 0.00029517823713831604
TWIST O 0 8.12538928585127e-05
mutations O 0 9.829538072381183e-09
were O 0 4.734160841124435e-10
found O 0 1.5699117353329406e-11
in O 0 3.3529512499796965e-11
12 O 0 5.0850155197679214e-09
families O 0 7.064673845924574e-11
. O 0 6.976730304586454e-09

Seven O 0 5.679687475890205e-08
families O 0 5.5665951015360093e-11
were O 0 1.553953354882509e-10
found O 0 1.240512727262999e-11
to O 0 8.749699749455164e-12
have O 0 1.6532780353073484e-11
the O 0 5.102374633914053e-10
FGFR3 O 0 9.064649930223823e-05
P250R O 0 1.78044700760438e-07
mutation O 0 8.200485290821291e-10
, O 0 7.622312503396955e-12
and O 0 4.716283787120634e-12
one O 0 2.1690301464649675e-12
individual O 0 2.884583847825861e-13
was O 0 8.571329757067758e-10
found O 0 3.407570016086825e-12
to O 0 6.909179174965918e-13
have O 0 8.420728307353964e-13
an O 0 2.770842366314752e-12
FGFR2 O 0 2.448182385705877e-06
VV269 O 0 9.770568709654981e-08
- O 0 7.275080093904762e-08
270 O 0 4.342373571830649e-09
deletion O 0 2.551709421538817e-08
. O 0 9.92550841516504e-09

To O 0 3.1239191788934306e-10
date O 0 3.923832991858944e-08
, O 0 5.517032317103876e-11
our O 0 3.570607351455202e-11
detection O 0 9.804554945702648e-10
rate O 0 1.0764331093149337e-10
for O 0 1.7831520982003468e-11
TWIST O 0 5.8106635947297036e-08
or O 0 3.131238601739028e-10
FGFR O 0 3.5648261018650373e-06
mutations O 0 2.0315740409393435e-11
is O 0 4.764509099752789e-13
68 O 0 2.522746941902021e-11
% O 0 1.9854194785624835e-13
in O 0 1.0142082486341852e-12
our O 0 4.744791781696733e-10
Saethre B-Disease 1 0.9999964237213135
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 8.59535109754006e-09
, O 0 5.551684546106772e-12
including O 0 7.166706811334578e-11
our O 0 2.482070327047836e-09
five O 0 2.2847582159535307e-10
patients O 0 1.1629291279957599e-11
elsewhere O 0 3.417856275778064e-11
reported O 0 2.5509171164284083e-11
with O 0 5.556645421567197e-11
TWIST O 0 8.628190698800609e-06
mutations O 0 4.9882252994848386e-08
. O 0 3.63858596585942e-08

More O 0 1.050519893297519e-09
than O 0 1.531306609292571e-10
35 O 0 1.7968377896693255e-09
different O 0 2.0721532129064357e-11
TWIST O 0 6.43648121467777e-08
mutations O 0 1.4656965918735665e-10
are O 0 1.928862668545972e-12
now O 0 1.0507226599204555e-12
known O 0 1.313149025281013e-12
in O 0 1.974498906390232e-12
the O 0 6.201203439637482e-11
literature O 0 1.574617797261979e-10
. O 0 1.3853722613532682e-09

The O 0 5.594224461447084e-08
most O 0 8.976214216360745e-11
common O 0 2.3221757849967162e-11
phenotypic O 0 1.1140274258636396e-09
features O 0 5.791137361321752e-11
, O 0 1.0062138839153634e-12
present O 0 1.022962422235485e-12
in O 0 1.1765920269329877e-12
more O 0 5.930825085600014e-14
than O 0 3.167853620481692e-13
a O 0 3.2825096807354015e-11
third O 0 2.741941562689476e-09
of O 0 3.574298901298789e-08
our O 0 7.669929402709386e-08
patients O 0 3.753358387981187e-11
with O 0 4.077642737354559e-12
TWIST O 0 1.1786792697421333e-07
mutations O 0 9.893593583276683e-11
, O 0 7.985159408696596e-12
are O 0 3.0521034918157275e-12
coronal B-Disease 0 5.73307886497787e-07
synostosis I-Disease 0 1.9309813978907187e-06
, O 0 3.587532215743039e-10
brachycephaly B-Disease 0 3.5335983739059884e-06
, O 0 2.5626432087477724e-09
low B-Disease 0 0.00010326052870368585
frontal I-Disease 1 0.9999996423721313
hairline I-Disease 1 1.0
, O 0 7.905855170520226e-08
facial B-Disease 1 1.0
asymmetry I-Disease 1 0.9999706745147705
, O 0 2.673780841178086e-08
ptosis B-Disease 1 0.9999947547912598
, O 0 3.183305175014084e-09
hypertelorism B-Disease 0 9.983505879063159e-05
, O 0 1.1994338855458864e-09
broad B-Disease 0 1.9106028048554435e-06
great I-Disease 0 1.600259383849334e-05
toes I-Disease 0 8.321901987073943e-06
, O 0 1.4717987939505406e-09
and O 0 7.187508366257589e-09
clinodactyly B-Disease 0 9.812813368625939e-05
. O 0 4.6839932110742666e-07

Significant O 0 3.040326390646442e-08
intra O 0 3.86403153243009e-05
- O 0 2.38232883020828e-06
and O 0 1.9753418900592123e-09
interfamilial O 0 6.484142431872897e-07
phenotypic O 0 1.2775822710864304e-07
variability O 0 1.4704919060193333e-08
is O 0 1.3732736735966311e-12
present O 0 1.7782194987325806e-12
for O 0 1.2792831030616902e-11
either O 0 8.296485165537604e-10
TWIST O 0 2.5014011839630257e-07
mutations O 0 2.4022661637701503e-09
or O 0 2.263043530348341e-09
FGFR O 0 0.0003286033752374351
mutations O 0 8.273153184745752e-08
. O 0 1.8349359365288365e-08

The O 0 5.305592409854398e-09
overlap O 0 7.680004548982211e-11
in O 0 1.5989924662118682e-11
clinical O 0 1.847945441113552e-08
features O 0 3.479532217909309e-09
and O 0 4.434235270633913e-11
the O 0 5.226530319646372e-11
presence O 0 6.24245013319813e-12
, O 0 5.731615811306601e-13
in O 0 1.4515259653957724e-12
the O 0 1.1237878683179048e-11
same O 0 2.4117797602779545e-12
genes O 0 4.572109834830029e-13
, O 0 2.585364105960053e-13
of O 0 7.091008336068683e-12
mutations O 0 6.354771851964369e-13
for O 0 1.364808114613647e-12
more O 0 7.443675396120314e-14
than O 0 3.54482448169241e-13
one O 0 5.108133967896e-12
craniosynostotic B-Disease 0 5.81246411002212e-07
condition I-Disease 0 0.0030976098496466875
- O 0 2.1384911619293234e-09
such O 0 4.878552423148719e-11
as O 0 7.350947628381732e-11
Saethre B-Disease 0 2.320859266546904e-06
- I-Disease 0 1.3874203830255283e-07
Chotzen I-Disease 0 9.546361070533749e-07
, I-Disease 0 2.730271009276919e-10
Crouzon I-Disease 0 1.2980160590814194e-06
, I-Disease 0 4.621125704318274e-10
and I-Disease 0 2.3409580940381147e-09
Pfeiffer I-Disease 0 8.667346264701337e-06
syndromes I-Disease 0 0.0003119887551292777
- O 0 3.77899814338889e-05
support O 0 9.704319836600916e-08
the O 0 4.562834376997671e-08
hypothesis O 0 4.524950192319466e-09
that O 0 1.0982371262402424e-11
TWIST O 0 1.312033077738306e-07
and O 0 5.580322315346109e-10
FGFRs O 0 3.755459090371005e-07
are O 0 3.0708064129719714e-12
components O 0 2.8076804770016395e-10
of O 0 7.038558069716316e-10
the O 0 8.056946776413554e-11
same O 0 1.1918749841244303e-11
molecular O 0 1.2798352655440937e-10
pathway O 0 8.679092167174218e-12
involved O 0 3.17176975872871e-14
in O 0 5.703194806607609e-14
the O 0 2.011707207066893e-12
modulation O 0 9.021584035373564e-10
of O 0 8.701647402631352e-09
craniofacial O 1 1.0
and O 0 1.5071187590365298e-05
limb O 1 0.9999572038650513
development O 0 1.2754775013945618e-07
in O 0 2.403181542653954e-10
humans O 0 2.082221478572066e-10
. O 0 9.461461475401833e-11
. O 0 2.138613730551242e-09

Mutation O 0 1.5427877864127026e-09
analysis O 0 5.083614085243937e-11
of O 0 6.15871353915054e-10
UBE3A O 1 0.995622456073761
in O 0 4.726383849629201e-06
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.0022080850321799517
. O 0 1.1203636063328304e-07

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.999957799911499
AS B-Disease 1 1.0
) O 0 2.7656373718931704e-11
is O 0 9.19110382420485e-13
caused O 0 1.2364733369130132e-11
by O 0 4.482841615277566e-12
chromosome O 0 1.1392703669343973e-08
15q11 O 0 2.2808816879660299e-07
- O 0 1.978038532968185e-08
q13 O 0 5.534100733228797e-09
deletions O 0 7.940996471500483e-11
of O 0 9.704232556417836e-11
maternal O 0 5.5122042347255373e-11
origin O 0 1.1267191606795235e-12
, O 0 2.1962928708780388e-13
by O 0 2.5603774742727348e-12
paternal O 0 2.5395030078811942e-08
uniparental B-Disease 0 0.1466185301542282
disomy I-Disease 1 0.9944979548454285
( O 0 1.4947310091883992e-06
UPD B-Disease 1 1.0
) O 0 6.003537944554438e-11
15 O 0 1.2958159545384262e-10
, O 0 1.8023302034847477e-12
by O 0 2.3255711592562456e-11
imprinting O 1 0.9112485647201538
defects O 1 0.9999984502792358
, O 0 1.0565315289312593e-10
and O 0 1.6027483160097056e-11
by O 0 1.0654066170956433e-11
mutations O 0 3.540834292437012e-11
in O 0 5.6386940255892526e-11
the O 0 2.53840726216481e-09
UBE3A O 0 3.610558997024782e-05
gene O 0 2.686786437777755e-08
. O 0 1.2104798940981709e-08

UBE3A O 0 0.0017345512751489878
encodes O 0 9.931988387279489e-08
a O 0 2.3567336526753024e-08
ubiquitin O 0 2.2978321467803653e-08
- O 0 4.417038823589792e-08
protein O 0 2.488298900260588e-09
ligase O 0 5.339718250896297e-11
and O 0 1.7252140688261974e-11
shows O 0 7.887472897039061e-10
brain O 0 1.1026316997231334e-06
- O 0 3.1298505120958e-08
specific O 0 5.631874522293856e-09
imprinting O 0 4.365155746199889e-06
. O 0 5.274467440585795e-08

Here O 0 5.553421900117428e-08
we O 0 9.206241324832831e-10
describe O 0 1.053662268546418e-09
UBE3A O 0 1.0262661817250773e-05
coding O 0 2.584370690783544e-07
- O 0 2.43976732150486e-08
region O 0 6.451137957164121e-10
mutations O 0 1.5438665970646248e-11
detected O 0 2.6488941248792308e-11
by O 0 5.676946759902712e-12
SSCP O 0 6.657676294707926e-07
analysis O 0 2.567699698696746e-11
in O 0 8.949409963099342e-11
13 O 0 2.7704778915449424e-08
AS B-Disease 1 1.0
individuals O 0 4.041144155420007e-12
or O 0 9.483828999901078e-11
families O 0 3.376954965661483e-11
. O 0 4.061472935745769e-09

Two O 0 7.071125018853763e-09
identical O 0 9.241079901300964e-09
de O 0 1.551750528960838e-06
novo O 0 4.2221060425617907e-07
5 O 0 1.00806040848056e-07
- O 0 3.4397420467513484e-09
bp O 0 2.0586066185046548e-10
duplications O 0 1.1776714048394865e-09
in O 0 2.5813620685433136e-10
exon O 0 2.340441618287059e-08
16 O 0 7.162696658014056e-09
were O 0 4.29794377865278e-09
found O 0 2.64746224942769e-09
. O 0 1.0845788267488388e-08

Among O 0 5.2849480347560984e-09
the O 0 3.3407301369692277e-09
other O 0 4.684987120473494e-11
11 O 0 1.5148620136073987e-09
unique O 0 1.4452150587374035e-10
mutations O 0 2.6117790222213166e-11
, O 0 4.512164600289914e-11
8 O 0 2.5093711997214996e-08
were O 0 2.8463034706938117e-10
small O 0 1.6569211280792473e-11
deletions O 0 9.345472312682901e-11
or O 0 5.179115816766888e-11
insertions O 0 9.189820571187113e-10
predicted O 0 5.886369613961051e-09
to O 0 3.1413587009421207e-11
cause O 0 3.026129036243219e-08
frameshifts O 0 8.327629075211007e-07
, O 0 6.034834437729231e-11
1 O 0 1.4199469378084473e-09
was O 0 1.9562935993366892e-10
a O 0 4.981778444629326e-12
mutation O 0 4.59315745160449e-13
to O 0 2.5002111383835846e-13
a O 0 9.840215448031486e-12
stop O 0 1.0029518188181541e-10
codon O 0 1.504357471926454e-10
, O 0 7.735951636222982e-13
1 O 0 3.777590740217107e-11
was O 0 1.558633604126225e-11
a O 0 6.795012035681891e-12
missense O 0 3.46786294125323e-10
mutation O 0 7.593567268038282e-12
, O 0 3.2926583009608434e-13
and O 0 6.673082225683302e-13
1 O 0 9.33963351101852e-10
was O 0 5.358595789317633e-10
predicted O 0 4.0536465850671277e-10
to O 0 2.0082377601149393e-12
cause O 0 2.9610581347983e-11
insertion O 0 5.205466700047845e-12
of O 0 2.4017887678695615e-10
an O 0 1.6914516662303036e-11
isoleucine O 0 1.7762070569915522e-07
in O 0 1.0958292606666475e-10
the O 0 7.33757443693861e-10
hect O 0 2.2119793996466797e-08
domain O 0 8.742367940683948e-10
of O 0 6.081649850386839e-09
the O 0 3.988162244894511e-09
UBE3A O 0 1.8572723092802335e-06
protein O 0 2.715438707223683e-10
, O 0 4.052660550896148e-12
which O 0 4.822317675387544e-13
functions O 0 3.376001908583781e-11
in O 0 1.1563715957008114e-10
E2 O 0 1.0616518864026148e-07
binding O 0 1.1731023930039441e-09
and O 0 8.407721047154482e-11
ubiquitin O 0 1.885948730517839e-09
transfer O 0 5.707572636737268e-09
. O 0 1.1408272548862897e-08

Eight O 0 1.028931251312315e-07
of O 0 1.0242999337606307e-08
the O 0 8.550624652770011e-10
cases O 0 2.5088696745112493e-11
were O 0 8.088634623204527e-11
familial O 0 6.4406662225735545e-09
, O 0 1.9069054668641172e-10
and O 0 2.1710812314612582e-10
five O 0 4.533370623338584e-10
were O 0 7.060204643138945e-10
sporadic O 0 4.345506113168085e-06
. O 0 1.3601906800886354e-07

In O 0 1.0384610948932504e-09
two O 0 7.811339769459025e-11
familial O 0 2.5251290836081353e-08
cases O 0 1.1201847088804229e-10
and O 0 5.324727464506296e-11
one O 0 6.256873925220008e-12
sporadic O 0 3.75434510146988e-08
case O 0 1.213981554171184e-10
, O 0 6.5064919597956905e-12
mosaicism O 0 4.0364682263316354e-08
for O 0 3.438940243682964e-10
UBE3A O 0 2.256236712128157e-06
mutations O 0 4.3541776087452355e-12
was O 0 1.795335408116827e-11
detected O 0 1.7557336877763174e-12
in O 0 9.75183475637742e-13
the O 0 2.947208102566101e-11
mother O 0 3.4249807850939007e-12
of O 0 8.862172107271249e-10
three O 0 1.7455321632553478e-09
AS B-Disease 1 1.0
sons O 0 3.3562943535514478e-09
, O 0 4.027562571645715e-12
in O 0 8.139532450823772e-12
the O 0 2.3400598125888905e-10
maternal O 0 5.095450172909466e-10
grandfather O 0 4.74182415555191e-10
of O 0 1.2427761930666748e-08
two O 0 5.770807720573146e-10
AS B-Disease 1 1.0
first O 0 5.317780438218733e-09
cousins O 0 2.496799433870933e-09
, O 0 2.120342269817943e-11
and O 0 1.3375687710204254e-11
in O 0 2.5336547096466155e-11
the O 0 1.2169009133700115e-09
mother O 0 1.8559831449493913e-10
of O 0 5.968459060312625e-09
an O 0 1.0629233049286313e-09
AS B-Disease 1 1.0
daughter O 0 3.811555586707982e-07
. O 0 4.068418490987824e-07

The O 0 3.0691598151832977e-09
frequencies O 0 3.558064259889804e-11
with O 0 1.1905384447383205e-12
which O 0 1.1931663339639909e-12
we O 0 9.792541126943388e-13
detected O 0 1.5876381155924268e-12
mutations O 0 5.894312273511948e-13
were O 0 3.3231401571492958e-12
5 O 0 6.704613947361437e-11
( O 0 3.4771830055048414e-13
14 O 0 1.944781835572229e-11
% O 0 6.18714985928942e-13
) O 0 3.0553271230301243e-14
of O 0 2.9183205331462236e-12
35 O 0 2.356832394176389e-12
in O 0 1.8889726480057767e-13
sporadic O 0 1.0294309849001593e-09
cases O 0 3.3644486936018625e-12
and O 0 1.0680862444489847e-11
8 O 0 1.8550816438533957e-09
( O 0 8.453186609892749e-13
80 O 0 2.092137053877341e-11
% O 0 1.1565313593961402e-12
) O 0 1.2280297221820002e-13
of O 0 1.6838133318208826e-11
10 O 0 3.434376394384486e-11
in O 0 1.915474549807339e-11
familial O 0 1.5453419877076158e-08
cases O 0 3.5088013050632583e-10
. O 0 4.1988923449309823e-10
. O 0 6.398789942352323e-09

The O 0 3.958478828280931e-06
hemochromatosis B-Disease 1 1.0
845 O 0 4.250309189046675e-07
G O 0 5.841528150085651e-07
- O 0 5.045484741117434e-08
- O 0 7.488737630012565e-09
> O 0 3.4584519692515414e-09
A O 0 2.5252661073338345e-10
and O 0 1.0308007702616862e-12
187 O 0 6.008850535199617e-12
C O 0 2.179288749459829e-09
- O 0 1.1744464067930949e-08
- O 0 1.3869487780482359e-08
> O 0 1.3858248770759474e-08
G O 0 8.37691604971269e-09
mutations O 0 2.2538745175770813e-11
: O 0 1.5013396071055646e-13
prevalence O 0 8.830514097724063e-11
in O 0 2.2988926300787638e-12
non O 0 2.180058977785393e-08
- O 0 3.316623198301727e-09
Caucasian O 0 6.707754351964468e-09
populations O 0 2.077374938735943e-09
. O 0 3.2367917235376353e-09

Hemochromatosis B-Disease 1 0.9995380640029907
, O 0 2.4932444997460834e-09
the O 0 1.5324425817198062e-07
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999998807907104
, O 0 2.391293552062024e-10
leads O 0 6.680312969464808e-10
, O 0 6.260312147149394e-12
if O 0 2.805029819530347e-11
untreated O 0 4.587449531356924e-09
, O 0 8.485963667870244e-13
to O 0 1.1522165166422127e-11
progressive O 1 0.997877836227417
iron B-Disease 1 0.9315455555915833
overload I-Disease 0 8.012436592252925e-05
and O 0 1.226553347777326e-08
premature B-Disease 0 4.049007316098141e-07
death I-Disease 0 1.5814644882539142e-07
. O 0 5.228280475222391e-09

The O 0 5.146194325789111e-06
hemochromatosis B-Disease 1 1.0
gene O 0 3.47734527395005e-07
, O 0 8.968107922946444e-10
HFE O 0 0.0002920491970144212
, O 0 1.6779024003543697e-10
recently O 0 2.17172738126159e-10
has O 0 2.1095785708580284e-12
been O 0 9.516561800745893e-13
identified O 0 2.046999288823903e-12
, O 0 6.359597635834102e-13
and O 0 2.390994520429235e-12
characterization O 0 1.222831003122593e-10
of O 0 8.311976662511711e-10
this O 0 3.644267179692129e-12
gene O 0 6.877982124814386e-12
has O 0 1.2303977552519801e-13
shown O 0 1.2706804738190497e-13
that O 0 1.701895358853251e-14
it O 0 1.3730548917626189e-14
contains O 0 4.324732032993245e-14
two O 0 2.5679601199928188e-14
mutations O 0 6.027934363684109e-14
that O 0 6.030016031855281e-14
result O 0 7.801642144811272e-12
in O 0 2.5637847747561615e-11
amino O 0 1.5885241733126776e-10
acid O 0 5.615808165715386e-12
substitutions O 0 6.892128534552455e-11
- O 0 2.8046245881263587e-10
cDNA O 0 1.1253247222953178e-09
nucleotides O 0 1.5948440484914173e-11
845 O 0 9.834047465240303e-11
G O 0 3.617319777049488e-09
- O 0 1.7751156988765615e-08
- O 0 9.575829906793842e-09
> O 0 4.5416554961263955e-09
A O 0 8.635013259983282e-10
( O 0 1.686254082330571e-13
C282Y O 0 2.707142322810885e-11
) O 0 4.34995599653612e-14
and O 0 1.266844837583339e-13
187 O 0 5.809599329387183e-12
C O 0 1.3887798688827502e-09
- O 0 8.73230643350098e-09
- O 0 1.1737432359382183e-08
> O 0 8.290272468514104e-09
G O 0 1.879195643539333e-08
( O 0 3.010465488006986e-11
H63D O 0 3.9423966313734127e-07
) O 0 2.957045025508975e-11
. O 0 3.373512302839998e-10

Although O 0 8.811125553620514e-07
hemochromatosis B-Disease 1 1.0
is O 0 1.2110260017017538e-10
common O 0 1.555636869321475e-11
in O 0 9.264713995982277e-12
Caucasians O 0 3.994572228549487e-09
, O 0 3.091865999338417e-11
affecting O 0 4.961339117315333e-10
> O 0 3.4815503813234727e-09
= O 0 1.3757400774139228e-09
1 O 0 6.4301959312729196e-09
/ O 0 2.4550490529406943e-09
300 O 0 2.4459874230220446e-12
individuals O 0 1.64463915034406e-14
of O 0 6.174177141771153e-11
northern O 0 9.301553416385389e-10
European O 0 3.101057188814593e-10
origin O 0 6.310688083210891e-12
, O 0 1.554927193947453e-12
it O 0 5.605382152364113e-13
has O 0 5.620509483175717e-13
not O 0 1.8707796000261984e-13
been O 0 6.967726634381222e-13
recognized O 0 4.941576661754432e-12
in O 0 7.087641237801812e-12
other O 0 1.156549769149029e-11
populations O 0 1.4083050003943498e-10
. O 0 1.7020685971758098e-09

The O 0 7.103432508870355e-09
present O 0 1.6572096472877718e-10
study O 0 1.1065003080457103e-11
used O 0 5.2097575385656736e-12
PCR O 0 1.950664518801659e-09
and O 0 9.387723931553182e-11
restriction O 0 6.622364878694498e-09
- O 0 7.513714650464465e-10
enzyme O 0 7.821189876300316e-12
digestion O 0 5.94420901389725e-11
to O 0 3.2477186630124055e-13
analyze O 0 6.320936070565442e-13
the O 0 4.623534628073189e-13
frequency O 0 7.089696885120844e-12
of O 0 2.730353096391802e-11
the O 0 7.383717248732324e-11
845 O 0 4.704184958237434e-11
G O 0 1.3400368592542122e-09
- O 0 2.613605776247141e-09
- O 0 1.3360147432806002e-09
> O 0 7.778203636732428e-10
A O 0 1.5918999451969285e-10
and O 0 1.1435546520138784e-12
187 O 0 5.265079171257181e-12
C O 0 5.265546332289261e-10
- O 0 6.032949695367051e-10
- O 0 1.1182255121866547e-09
> O 0 1.1589290638269745e-09
G O 0 1.5549562748518042e-09
mutations O 0 6.610101355164488e-12
in O 0 6.7242171032655396e-12
HLA O 0 1.3287593247923724e-09
- O 0 1.1743153671694984e-10
typed O 0 1.0279308654270736e-11
samples O 0 1.6734676795346348e-12
from O 0 3.2655349778420995e-12
non O 0 1.0108735182257078e-07
- O 0 5.585383267003863e-09
Caucasian O 0 6.852964307135778e-10
populations O 0 2.515194302832313e-11
, O 0 1.3622229429535726e-12
comprising O 0 1.1091816701225277e-11
Australian O 0 7.184681183325381e-10
Aboriginal O 0 2.2378690012203606e-09
, O 0 1.7772134458526878e-11
Chinese O 0 1.6198828389768494e-10
, O 0 1.9636422696200917e-11
and O 0 3.8566569382503246e-10
Pacific O 0 1.5123865182431473e-07
Islanders O 0 5.416009116743226e-07
. O 0 1.0967696795205484e-07

Results O 0 5.565273575314222e-09
showed O 0 7.45055184214749e-10
that O 0 2.8414458286274424e-12
the O 0 1.4845104312488644e-10
845 O 0 4.961764887845277e-10
G O 0 7.97910075789332e-08
- O 0 2.4007152887861594e-07
- O 0 5.730133167958229e-08
> O 0 1.2268903226697603e-08
A O 0 7.401741441981358e-10
mutation O 0 1.0445327762453882e-11
was O 0 5.767907852727294e-12
present O 0 7.087133478819382e-14
in O 0 6.890383310578438e-14
these O 0 1.3249977151704936e-14
populations O 0 8.465347563560432e-14
( O 0 4.425709032921093e-15
allele O 0 6.02151114343849e-14
frequency O 0 8.617728058935015e-12
0 O 0 2.4032675155494232e-11
. O 0 1.1626219735202947e-13
32 O 0 1.2218226647445207e-12
% O 0 2.0129152522325305e-13
) O 0 2.967770682525163e-14
, O 0 1.0582078832990782e-13
and O 0 4.828622311020547e-13
, O 0 2.2366184154309215e-13
furthermore O 0 1.5700906286914007e-12
, O 0 2.358337592052451e-13
it O 0 1.9796793056855305e-13
was O 0 1.646224129236984e-10
always O 0 5.363335209979114e-12
seen O 0 1.5243026025429929e-12
in O 0 1.473801414025519e-13
conjunction O 0 1.3004455151621741e-11
with O 0 4.867786295575938e-12
HLA O 0 1.558993574235501e-07
haplotypes O 0 2.0875350337234977e-09
common O 0 1.5590528867903686e-11
in O 0 5.307709566998442e-12
Caucasians O 0 3.0427832475865557e-10
, O 0 4.627789037398022e-12
suggesting O 0 2.037651297692733e-11
that O 0 7.935088350286001e-12
845 O 0 1.3048967462125916e-09
G O 0 1.8660571186046582e-06
- O 0 0.000954788934905082
- O 0 0.00015855469973757863
> O 0 5.756336122431094e-06
A O 0 1.3132348897215707e-07
may O 0 5.999692409552893e-11
have O 0 3.023963458109735e-13
been O 0 2.649810980446393e-13
introduced O 0 1.4033403345631301e-12
into O 0 4.997657357939424e-14
these O 0 1.3591305171427055e-14
populations O 0 4.178431824717124e-14
by O 0 5.150866712322344e-13
Caucasian O 0 1.4114950319665809e-09
admixture O 0 4.7220812149362246e-08
. O 0 5.465958707873142e-08

187 O 0 4.581120904845193e-08
C O 0 1.425059821258401e-07
- O 0 3.3528539944427393e-08
- O 0 9.41924671593597e-09
> O 0 4.89709073292488e-09
G O 0 7.340390961729781e-09
was O 0 2.2490746764969316e-10
present O 0 2.8961566218149715e-12
at O 0 5.758278402712147e-12
an O 0 2.7566014724231085e-14
allele O 0 3.0645223771802454e-12
frequency O 0 2.4787338848142326e-10
of O 0 1.7708572386254673e-09
2 O 0 6.911779593110623e-08
. O 0 3.753255040095382e-09

68 O 0 2.2163764867855207e-07
% O 0 1.3370619889041535e-10
in O 0 2.183780239972677e-11
the O 0 1.272739275082202e-10
two O 0 5.382663498948448e-12
populations O 0 1.008454691281413e-11
analyzed O 0 7.879664976062628e-11
( O 0 2.8838329294011977e-11
Australian O 0 3.4172340512839128e-09
Aboriginal O 0 1.5492722660326308e-09
and O 0 7.355604320080644e-11
Chinese O 0 4.235200246061055e-10
) O 0 7.522027445361346e-11
. O 0 5.129200619791163e-09

In O 0 4.830260080801452e-10
the O 0 5.89968629505222e-10
Australian O 0 1.4831328387643339e-09
Aboriginal O 0 1.131259599884693e-10
samples O 0 5.3554643358877385e-12
, O 0 5.061639041931132e-12
187 O 0 4.057047753303067e-11
C O 0 6.149994735693554e-09
- O 0 2.8968255350036998e-08
- O 0 7.28228499724537e-08
> O 0 6.3721437015829e-08
G O 0 2.0548864654301724e-07
was O 0 3.4029379314404196e-09
found O 0 1.1923063448007754e-12
to O 0 4.561741677217186e-14
be O 0 1.6376095900334786e-13
associated O 0 2.3822998695272046e-12
with O 0 4.054036620293466e-12
HLA O 0 3.0115501203908934e-07
haplotypes O 0 1.6128453017572042e-09
common O 0 5.384288154219874e-11
in O 0 6.414555518696741e-12
Caucasians O 0 2.787670372317308e-10
, O 0 1.995382158115344e-12
suggesting O 0 2.2741257661718084e-12
that O 0 1.0627467601689172e-13
it O 0 2.6672389882680114e-13
was O 0 2.2233204860500067e-11
introduced O 0 3.836082059643919e-12
by O 0 1.787775765101085e-12
recent O 0 4.2672511357810805e-11
admixture O 0 6.800662255557199e-09
. O 0 7.44728723134358e-09

In O 0 7.738781837574038e-10
the O 0 5.414196868613885e-10
Chinese O 0 3.495959771671053e-11
samples O 0 1.8331239304281155e-12
analyzed O 0 1.3443055696393813e-11
, O 0 7.080182794216849e-12
187 O 0 4.7933081115392184e-11
C O 0 2.3040014340836024e-09
- O 0 8.369824833209805e-09
- O 0 9.150506130595204e-09
> O 0 6.248916939455285e-09
G O 0 7.070194207869918e-09
was O 0 1.866968246666545e-10
present O 0 2.8984501430906473e-12
in O 0 6.355211929626181e-12
association O 0 2.53716093273626e-11
with O 0 2.1877637234376385e-13
a O 0 9.703709190345133e-12
wide O 0 7.121427753054022e-11
variety O 0 5.035815167642177e-11
of O 0 4.4731435222544746e-10
HLA O 0 4.6874074399738674e-08
haplotypes O 0 1.0492002822104496e-09
, O 0 5.1149197724531525e-12
showing O 0 5.892732829471115e-11
this O 0 6.931407487906216e-13
mutation O 0 1.8724191034463766e-12
to O 0 7.538547151970942e-14
be O 0 4.834124094944825e-13
widespread O 0 4.470158410097014e-10
and O 0 1.983975310426711e-11
likely O 0 7.364416368393911e-12
to O 0 7.879581861124085e-13
predate O 0 3.6038411144190263e-10
the O 0 3.687922883743866e-11
more O 0 1.677755699126815e-13
genetically O 0 4.625488880805051e-11
restricted O 0 2.2188341441964354e-11
845 O 0 1.3966314216240505e-10
G O 0 7.791886957875249e-08
- O 0 7.274641689036798e-07
- O 0 3.6738242670253385e-07
> O 0 1.2512010982845823e-07
A O 0 1.2127261861394345e-08
mutation O 0 1.921037773300327e-09
. O 0 5.7238136452753e-10

Genotype O 0 8.373991477128584e-06
- O 0 5.722225182580587e-07
phenotype O 0 2.637368368141324e-08
correlations O 0 2.1091160817832133e-08
in O 0 5.763561627958325e-09
attenuated B-Disease 1 0.9999024868011475
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 0.00010252915672026575

Germ O 0 0.001878378796391189
- O 0 7.1978397500060964e-06
line O 0 7.071167829053593e-08
mutations O 0 3.3828098655597216e-10
of O 0 1.578964292647811e-09
the O 0 1.3902932138876167e-09
tumor B-Disease 0 2.33390480275375e-07
suppressor O 0 1.1464308045106009e-06
APC O 0 3.2889555523496483e-09
are O 0 2.8438517274582964e-13
implicated O 0 1.710000023524838e-11
in O 0 2.0315907289791824e-10
attenuated B-Disease 1 0.9999983310699463
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9995868802070618
AAPC B-Disease 1 1.0
) O 0 5.883430895248232e-12
, O 0 7.564881338538443e-13
a O 0 6.005424456334563e-12
variant O 0 8.721353417229238e-09
of O 0 5.087939030090638e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 2.7041616704082116e-05
FAP B-Disease 0 2.660340214788448e-05
) O 0 9.903643460873468e-10
. O 0 9.89130111150871e-09

AAPC B-Disease 1 1.0
is O 0 5.772602396092452e-10
recognized O 0 2.9525756839454687e-11
by O 0 1.0183952205838898e-12
the O 0 1.109532951626413e-11
occurrence O 0 7.995363815460621e-10
of O 0 2.3003128291065877e-09
< O 0 2.2325839665882086e-07
100 O 0 1.2594005838195699e-09
colonic B-Disease 0 3.54979420080781e-06
adenomas I-Disease 0 7.444179459525913e-07
and O 0 7.500902026238987e-13
a O 0 7.505596079544763e-13
later O 0 1.5152362004000608e-11
onset O 1 0.9970692992210388
of O 1 0.9999967813491821
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 3.2103397717975213e-10
age O 0 4.684220789030746e-10
> O 0 1.254265691308376e-09
40 O 0 3.380718621714962e-11
years O 0 7.0139050817319415e-12
) O 0 4.566430133329247e-12
. O 0 3.31609628645424e-10

The O 0 3.265653703010685e-08
aim O 0 1.6837292449167762e-08
of O 0 5.544705805604622e-10
this O 0 3.536938103509968e-12
study O 0 4.774272123475587e-12
was O 0 1.399393795287196e-10
to O 0 9.168923433000575e-12
assess O 0 5.233528721504399e-09
genotype O 0 1.0544975737047935e-07
- O 0 6.508490457690641e-08
phenotype O 0 6.006659614143928e-09
correlations O 0 1.3746915605850063e-08
in O 0 1.9957514751922645e-08
AAPC B-Disease 1 1.0
families O 0 6.706228905528633e-10
. O 0 7.951416414186951e-09

By O 0 4.877010462145392e-10
protein O 0 1.040532993101806e-09
- O 0 3.128088010839747e-09
truncation O 0 1.5060822988743894e-07
test O 0 3.186368147112262e-08
( O 0 1.6109374251227493e-11
PTT O 0 2.4825439481901412e-09
) O 0 1.6892189686965042e-13
assay O 0 9.075749700382385e-12
, O 0 4.0768476376913665e-13
the O 0 4.9574840760291394e-12
entire O 0 9.014814936203486e-12
coding O 0 3.308898294251961e-11
region O 0 2.3707152560503708e-11
of O 0 9.414226342929766e-11
the O 0 2.6136640074447826e-10
APC B-Disease 0 2.0119712562660652e-09
gene O 0 1.1961336435217795e-11
was O 0 4.0020417535480135e-11
screened O 0 1.3371256879501914e-10
in O 0 3.0993035828735804e-12
affected O 0 3.9596264635177736e-12
individuals O 0 2.1771321724595172e-13
from O 0 2.0767003394706052e-10
11 O 0 1.573196641402319e-05
AAPC B-Disease 1 1.0
kindreds O 0 2.0222587409080006e-05
, O 0 3.1059824157075866e-10
and O 0 3.978213244937301e-11
their O 0 3.145381524682911e-11
phenotypic O 0 1.8928002276652478e-08
differences O 0 1.7636875293547405e-09
were O 0 1.0629516156157592e-09
examined O 0 1.4180908891603394e-08
. O 0 3.163454209698102e-08

Five O 0 1.974664876058796e-08
novel O 0 2.9437448034741465e-09
germ O 0 2.8149413992650807e-05
- O 0 3.5946052321378374e-06
line O 0 5.120699029248499e-07
APC B-Disease 0 6.231767457620663e-08
mutations O 0 1.8537330004342323e-10
were O 0 9.624362418136911e-11
identified O 0 9.02049546169792e-11
in O 0 2.0311488602153815e-10
seven O 0 2.508270746659491e-08
kindreds O 0 2.458644303260371e-05
. O 0 3.1681582868259284e-07

Mutations O 0 9.727480154708701e-09
were O 0 1.0118892390664769e-09
located O 0 1.1289036372374994e-10
in O 0 5.32746720002808e-12
three O 0 1.252391961838184e-12
different O 0 1.558263473767571e-13
regions O 0 1.804062177424015e-10
of O 0 1.73119616420081e-08
the O 0 6.00938960815256e-08
APC B-Disease 0 3.6719672635854295e-08
gene O 0 3.112784752179465e-10
( O 0 1.431469786455919e-11
1 O 0 1.5210173121005255e-09
) O 0 1.1908586096398555e-12
at O 0 1.9131642103875635e-10
the O 0 4.323823243890246e-11
5 O 0 6.422944814898912e-11
end O 0 1.1263764226887574e-10
spanning O 0 1.0571201553011278e-10
exons O 0 1.3074834548376657e-08
4 O 0 4.4699643986234605e-09
and O 0 8.433757164860722e-11
5 O 0 1.780041114507469e-09
, O 0 2.2436063423780794e-11
( O 0 1.2296733726754883e-12
2 O 0 4.5706497614483865e-11
) O 0 1.2012859782438434e-13
within O 0 1.68777786885288e-11
exon O 0 1.6471413122332024e-10
9 O 0 6.044064138066574e-10
, O 0 4.5173114381069635e-12
and O 0 1.0085239067481044e-11
( O 0 1.8136376732022508e-12
3 O 0 2.225553352719345e-10
) O 0 5.255755683095109e-13
at O 0 3.773480694579945e-10
the O 0 5.167287708829349e-10
3 O 0 1.3459129366566458e-09
distal O 0 1.0412412598803655e-10
end O 0 1.6310759409776665e-09
of O 0 7.140812940953367e-10
the O 0 1.5930156083143743e-09
gene O 0 6.530560092699034e-09
. O 0 7.266242718628746e-09

Variability O 0 2.9395270217946745e-08
in O 0 5.994155866106965e-11
the O 0 2.6995471830160156e-11
number O 0 1.359146267754241e-10
of O 0 2.040848085016478e-05
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 4.186185105936602e-05
most O 0 8.00644966991726e-12
apparent O 0 3.3510222374744103e-10
in O 0 5.803828338063477e-12
individuals O 0 3.219242567290524e-14
with O 0 4.216268718708338e-13
mutations O 0 3.1900653993388595e-12
in O 0 5.8411097139665635e-12
region O 0 2.4285479183205894e-10
1 O 0 2.0269402156714023e-08
, O 0 6.382169792651382e-11
and O 0 4.132692854597053e-09
upper O 1 0.9999932050704956
- O 1 0.8030712604522705
gastrointestinal O 1 0.9986887574195862
manifestations O 1 0.8096984028816223
were O 0 4.5366055356765855e-10
more O 0 5.444302235597942e-13
severe O 0 9.403560596865645e-08
in O 0 2.444636992837701e-10
them O 0 4.1078257462245915e-10
. O 0 1.6504198896427624e-08

In O 0 1.0982005305137932e-09
individuals O 0 4.590435670470683e-12
with O 0 4.7764036649466934e-12
mutations O 0 2.6695371607710072e-11
in O 0 1.03098272974389e-10
either O 0 3.838193374239296e-10
region O 0 1.311509012502654e-09
2 O 0 1.122782578022452e-08
or O 0 1.2492219932103144e-11
region O 0 3.8515921008119847e-10
3 O 0 1.4986590857191118e-09
, O 0 3.875885289800207e-12
the O 0 1.5853270085575133e-11
average O 0 3.6072620585025916e-12
number O 0 9.109504123250289e-11
of O 0 2.0588442950497665e-08
adenomas B-Disease 0 0.004086169879883528
tended O 0 4.0689454583464624e-10
to O 0 2.132444741620443e-11
be O 0 3.846964760634286e-11
lower O 0 2.03852310032282e-10
than O 0 1.3797894304976716e-13
those O 0 7.205499218121414e-14
in O 0 4.499320295676956e-13
individuals O 0 2.3788285048926584e-14
with O 0 2.3059223801247253e-13
mutations O 0 2.2138616894568086e-12
in O 0 1.7352920315960585e-12
region O 0 3.803429793336477e-11
1 O 0 4.017209342954686e-10
, O 0 3.2623147347594916e-13
although O 0 1.946788650425413e-12
age O 0 2.204882630640892e-11
at O 0 1.762295420704163e-09
diagnosis O 0 2.5421005744874492e-08
was O 0 1.1062671889661146e-09
similar O 0 2.844670055068832e-10
. O 0 2.1478316902800998e-09

In O 0 6.00830034613864e-08
all O 0 5.136664071869745e-07
AAPC B-Disease 1 1.0
kindreds O 0 7.029224889265606e-06
, O 0 1.3086223771274774e-10
a O 0 3.7197269570077296e-11
predominance O 0 2.1407041472798483e-08
of O 0 4.180668611297733e-07
right O 1 0.9999997615814209
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 0.01797131635248661
rectal B-Disease 1 1.0
polyp I-Disease 1 0.9999089241027832
sparing O 0 5.7547328680129795e-08
was O 0 8.287316610733342e-09
observed O 0 2.327810166846689e-09
. O 0 2.590799352830686e-09

No O 0 1.8990847820532508e-05
desmoid B-Disease 1 0.9999926090240479
tumors I-Disease 1 1.0
were O 0 3.123737357668688e-08
found O 0 4.114567714319506e-11
in O 0 5.534791722161536e-11
these O 0 3.0664490391352217e-10
kindreds O 0 2.906541567426757e-06
. O 0 6.494563820069743e-08

Our O 0 8.647251092952501e-08
data O 0 2.7071036523551584e-09
suggest O 0 4.2676171624345116e-11
that O 0 2.1093693198387387e-12
, O 0 1.771855578924786e-11
in O 0 1.3858004743738661e-09
AAPC B-Disease 1 1.0
families O 0 5.8803790829731195e-12
, O 0 2.3962038950275932e-12
the O 0 1.5277145867798048e-11
location O 0 8.306793586321248e-10
of O 0 4.469435488374529e-09
the O 0 3.953469018824762e-08
APC B-Disease 0 9.965706340153702e-07
mutation O 0 3.5445884005724793e-09
may O 0 4.69952410320218e-10
partially O 0 3.795628700231646e-09
predict O 0 5.8050383944241446e-11
specific O 0 3.097538545104861e-11
phenotypic O 0 7.409362012822385e-08
expression O 0 1.2486069067563221e-08
. O 0 4.336274006533358e-09

This O 0 3.1246654152994324e-09
should O 0 1.2121582904089934e-10
help O 0 2.132939658228139e-12
in O 0 2.795654549872517e-12
the O 0 3.454440206107634e-11
design O 0 6.132319541052311e-09
of O 0 2.6854223289518586e-09
tailored O 0 3.9206811131009545e-09
clinical O 0 0.055103037506341934
- O 0 3.2159555303223897e-06
management O 0 5.442548633993738e-09
protocols O 0 3.694650141383704e-09
in O 0 4.8970463101261075e-12
this O 0 3.429495999251325e-13
subset O 0 2.4083588456846883e-09
of O 0 2.1231609803606943e-09
FAP B-Disease 0 1.5752043509564828e-06
patients O 0 2.927890707660197e-10
. O 0 9.430490416351134e-11
. O 0 3.5369434048249104e-09

Wilms B-Disease 1 0.9999969005584717
' I-Disease 0 4.367877045297064e-05
tumor I-Disease 0 4.1738684330994147e-07
1 O 0 5.00333783293172e-08
and O 0 1.8361524800614148e-10
Dax O 0 4.4304299080977216e-05
- O 0 5.1185018890009815e-08
1 O 0 2.0669180145205246e-08
modulate O 0 1.5833040434287682e-09
the O 0 1.0778800074717765e-09
orphan O 0 1.039105024247533e-09
nuclear O 0 2.7941302604972407e-08
receptor O 0 2.486935934964407e-10
SF O 0 6.696483524137875e-06
- O 0 1.5049149704182696e-09
1 O 0 5.091049248839852e-10
in O 0 2.3788672854491155e-12
sex O 0 3.1951925914125434e-12
- O 0 6.2966927678875795e-12
specific O 0 6.519236973173692e-12
gene O 0 2.1646720527179752e-10
expression O 0 2.6273205833149404e-09
. O 0 1.209872202423412e-09

Products O 0 7.969487825221222e-08
of O 0 3.3690337630787326e-08
steroidogenic O 0 1.2705789913525223e-06
factor O 0 5.524461332839792e-09
1 O 0 8.446422583574531e-08
( O 0 9.081798507670769e-11
SF O 0 0.0001447586837457493
- O 0 5.411786929698792e-08
1 O 0 8.059044098729373e-09
) O 0 4.470051499089189e-12
and O 0 1.0577010101098239e-10
Wilms B-Disease 0 7.645774894626811e-05
tumor I-Disease 0 1.6176186363736633e-06
1 O 0 3.807914765729947e-07
( O 0 3.366138270899377e-11
WT1 O 0 7.785290989659188e-08
) O 0 8.975931976851204e-13
genes O 0 5.704219648711151e-13
are O 0 5.3550703639233116e-14
essential O 0 1.944696487177211e-11
for O 0 5.5812004323696485e-12
mammalian O 0 2.5079788912307777e-08
gonadogenesis O 0 8.634030379539581e-09
prior O 0 1.878026623103324e-09
to O 0 3.357674208115391e-11
sexual O 0 1.5688110532874333e-10
differentiation O 0 1.6584603912406237e-08
. O 0 5.231991284659898e-09

In O 0 2.684787281381773e-09
males O 0 2.4150218283502944e-11
, O 0 1.353862993935806e-10
SF O 0 0.13054926693439484
- O 0 3.296752026926697e-07
1 O 0 1.4587172358915268e-08
participates O 0 1.8901134130056008e-11
in O 0 1.4250644934932222e-12
sexual O 0 2.000900530332861e-12
development O 0 3.1070989964937512e-12
by O 0 1.603180885571473e-13
regulating O 0 2.4535767514932694e-11
expression O 0 1.0546087614304867e-10
of O 0 1.2026793450026219e-10
the O 0 6.390833418024044e-10
polypeptide O 0 1.594159897422287e-07
hormone O 0 1.9777470772197603e-09
Mullerian O 0 3.491753375328699e-08
inhibiting O 0 1.342398081582985e-09
substance O 0 1.7346063474477091e-09
( O 0 4.927800181797615e-11
MIS O 0 2.2950061975279823e-06
) O 0 4.636547396019708e-11
. O 0 4.927520613762226e-10

Here O 0 2.8799950868574342e-08
, O 0 1.870539834136764e-10
we O 0 2.0487346194530964e-11
show O 0 1.193807136479208e-10
that O 0 4.428504785103371e-11
WT1 O 0 4.630620878742775e-06
- O 0 1.1417637324484531e-07
KTS O 0 3.4508182125136955e-06
isoforms O 0 4.550855692286859e-09
associate O 0 2.248702557494653e-09
and O 0 1.4372753855129705e-11
synergize O 0 7.60610241457016e-09
with O 0 1.261094562110543e-10
SF O 0 0.024705134332180023
- O 0 1.1245126074754808e-07
1 O 0 7.744027641365392e-09
to O 0 3.3416762412752377e-11
promote O 0 4.575748224766585e-09
MIS O 0 4.521907612797804e-05
expression O 0 1.4300202799688577e-08
. O 0 2.2786796893825567e-09

In O 0 2.453719893935613e-09
contrast O 0 3.3786460296170162e-09
, O 0 8.039788279567972e-10
WT1 O 0 5.378129208111204e-05
missense O 0 3.881234178493287e-08
mutations O 0 8.962255243494255e-11
, O 0 1.266615935399673e-12
associated O 0 2.7848416281339716e-11
with O 0 5.7326574043337075e-12
male B-Disease 0 1.535538779462442e-10
pseudohermaphroditism I-Disease 1 1.0
in O 0 4.212178161822067e-09
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 4.0645096532898606e-07
fail O 0 2.7950686671829317e-06
to O 0 9.940123724128114e-11
synergize O 0 1.091473222913919e-07
with O 0 2.040290159044389e-09
SF O 1 0.9999964237213135
- O 0 1.940792571986094e-05
1 O 0 8.888646334526129e-07
. O 0 8.015370589475879e-09

Additionally O 0 1.6961710258556195e-08
, O 0 7.464800305667652e-11
the O 0 1.1137422928353402e-10
X O 0 6.907166607561521e-07
- O 0 6.985254685787368e-08
linked O 0 1.105685925040234e-07
, O 0 5.82998233022991e-11
candidate O 0 1.923904230372031e-10
dosage O 0 4.223199123742916e-09
- O 0 7.18243409192354e-10
sensitive O 0 2.037171542568217e-09
sex O 0 2.3921956429640012e-11
- O 0 7.024659326448912e-11
reversal O 0 6.363113924656716e-10
gene O 0 9.448657134480953e-11
, O 0 8.582036123416792e-12
Dax O 0 1.5717614587629214e-05
- O 0 3.795044278831483e-08
1 O 0 1.6219683374174565e-08
, O 0 1.8354514089158336e-11
antagonizes O 0 7.422792935862788e-10
synergy O 0 1.7869117296953618e-10
between O 0 8.964853859261268e-11
SF O 0 8.425587293459103e-05
- O 0 1.168190788547463e-08
1 O 0 1.4606152953788865e-09
and O 0 3.929864073048961e-11
WT1 O 0 1.1392613714633626e-06
, O 0 1.3444183266653198e-11
most O 0 7.19805779651056e-13
likely O 0 2.6811945675817017e-13
through O 0 5.972747795478239e-14
a O 0 6.268995197088179e-13
direct O 0 2.459160262577309e-12
interaction O 0 1.529507770436922e-11
with O 0 2.5942631723396836e-11
SF O 0 0.17483103275299072
- O 0 9.69850702858821e-07
1 O 0 2.2743827798876737e-07
. O 0 9.315725080227821e-09

We O 0 2.0656884203162917e-08
propose O 0 5.9173936861611764e-09
that O 0 3.6544940684724025e-11
WT1 O 0 6.82003974361578e-06
and O 0 5.917438539171371e-09
Dax O 1 0.6627362966537476
- O 0 7.795779879415932e-07
1 O 0 1.1215438178169279e-07
functionally O 0 3.524404323940189e-09
oppose O 0 1.5876275294424147e-10
each O 0 7.274947110653615e-14
other O 0 5.414495823810421e-14
in O 0 1.0425577501999017e-12
testis O 0 9.290258562444365e-10
development O 0 2.154546159538473e-11
by O 0 3.863684545912793e-12
modulating O 0 9.76652181350346e-09
SF O 0 0.0007718545966781676
- O 0 4.016133203776917e-08
1 O 0 2.9803384649085274e-08
- O 0 1.3756403793863115e-09
mediated O 0 3.0685001206620655e-08
transactivation O 0 4.662076094064105e-07
. O 0 3.2407684869006914e-10
. O 0 1.3497795103845078e-09

A O 0 3.190528019558769e-08
mouse O 0 8.35672475663074e-10
model O 0 5.04125456657345e-11
for O 0 1.943541549920269e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 0.9999996423721313
centre O 1 0.5041117072105408
mutations O 0 1.8031144577435043e-08
. O 0 7.425529524596186e-09

Imprinting O 0 1.0543311645960785e-06
in O 0 4.4192698389622365e-09
the O 0 1.5895562199830238e-08
15q11 O 0 5.93070694776543e-07
- O 0 1.3356579131595936e-07
q13 O 0 4.5458435238288075e-08
region O 0 8.83343231894429e-10
involves O 0 3.952384947103482e-11
an O 0 1.4355649915337443e-12
imprinting O 0 4.114558578294236e-07
centre O 0 6.821244460297748e-05
( O 0 2.4442875501407e-10
IC O 0 4.129736907998449e-07
) O 0 3.0193716450688246e-12
, O 0 2.85850228036455e-13
mapping O 0 3.3435233748324578e-12
in O 0 3.152563279873455e-12
part O 0 5.149307195917441e-12
to O 0 3.1005807730327684e-12
the O 0 2.867265314066003e-10
promoter O 0 8.922731353777635e-08
and O 0 2.719253155980539e-10
first O 0 1.150502582092372e-09
exon O 0 1.2003927452042262e-07
of O 0 3.4390225778224703e-08
SNRPN O 0 0.00022090229322202504
. O 0 2.7439369887360954e-07

Deletion O 0 9.262011957389404e-08
of O 0 4.8287727594242824e-08
this O 0 1.013759187706853e-09
IC O 0 1.2878883353550918e-05
abolishes O 0 2.8001917939945997e-07
local O 0 7.524245226875337e-09
paternally O 0 3.488248578875641e-10
derived O 0 2.717320455019462e-13
gene O 0 2.076456628169465e-12
expression O 0 9.652944242544148e-12
and O 0 1.3234349055014916e-13
results O 0 1.1654116040260565e-11
in O 0 1.0696795671449877e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999977350234985
PWS B-Disease 1 1.0
) O 0 2.304301283118093e-08
. O 0 3.965643102787908e-08

We O 0 1.3108969909580992e-08
have O 0 1.519264575255974e-11
created O 0 6.924780887596071e-11
two O 0 1.101383654417143e-11
deletion O 0 3.8000960711492837e-10
mutations O 0 1.6531456759061314e-11
in O 0 2.5528057098767043e-11
mice O 0 7.793737322181471e-10
to O 0 2.990252837009599e-11
understand O 0 1.5834800137781713e-08
PWS B-Disease 1 1.0
and O 0 1.0368520486636612e-09
the O 0 6.159195375943227e-10
mechanism O 0 8.111105564978516e-09
of O 0 1.24563526160415e-09
this O 0 5.796787494460887e-10
IC O 0 1.8872648070100695e-05
. O 0 6.881393943558578e-08

Mice O 0 1.2418718142725993e-05
harbouring O 0 2.4679749913048e-05
an O 0 5.236940880948282e-10
intragenic O 0 2.8557574296428356e-06
deletion O 0 2.1583417719739373e-08
in O 0 1.7062258272915187e-09
Snrpn O 0 9.688158024800941e-05
are O 0 2.488326211746994e-10
phenotypically O 0 3.6602056496803925e-08
normal O 0 9.568526415648648e-09
, O 0 1.0089261023860097e-11
suggesting O 0 2.3182901778828757e-11
that O 0 1.0264375070387355e-12
mutations O 0 6.564834786892959e-11
of O 0 4.156883726125216e-09
SNRPN O 0 0.00012842634168919176
are O 0 4.432525093495121e-12
not O 0 2.035711876846591e-12
sufficient O 0 1.6169841854374312e-10
to O 0 1.057406523452542e-10
induce O 0 4.438830274011707e-06
PWS B-Disease 1 1.0
. O 0 3.5324083569321374e-07

Mice O 0 8.811313279011301e-08
with O 0 6.110782713175666e-11
a O 0 1.4204337706047454e-10
larger O 0 2.2224642265422645e-11
deletion O 0 1.5156358112999868e-10
involving O 0 1.711226819967049e-11
both O 0 3.7945101921676994e-11
Snrpn O 0 1.6201757091494073e-07
and O 0 7.778144794912123e-10
the O 0 1.202292931878901e-08
putative O 0 6.610475975321606e-05
PWS O 1 1.0
- O 1 0.8150168061256409
IC O 1 0.97281813621521
lack O 0 6.910196930220991e-07
expression O 0 5.43424993892927e-09
of O 0 2.329799908551422e-09
the O 0 5.646111911339347e-10
imprinted O 0 1.4650376467528758e-09
genes O 0 1.0123114152493784e-10
Zfp127 O 0 6.815533737380974e-08
( O 0 1.7474199864864204e-10
mouse O 0 5.840204764240298e-09
homologue O 0 3.0557792740637524e-08
of O 0 3.806532866690304e-09
ZNF127 O 0 2.40968402067665e-05
) O 0 3.543288717988702e-10
, O 0 4.4043479974220645e-10
Ndn O 0 3.058372385567054e-05
and O 0 2.0284707247242295e-09
Ipw O 0 4.10094571634545e-07
, O 0 3.65557667469929e-10
and O 0 2.0098453457073617e-10
manifest O 0 4.937269260096855e-09
several O 0 5.2250256205033097e-11
phenotypes O 0 4.1542049800114e-09
common O 0 2.3633091039698684e-09
to O 0 2.1426732388363234e-08
PWS B-Disease 1 1.0
infants O 0 4.3672145693562925e-05
. O 0 3.7458473656215574e-08

These O 0 8.683069541159938e-11
data O 0 6.127507529152254e-11
demonstrate O 0 3.3175306252131165e-11
that O 0 6.192001664011293e-13
both O 0 2.7520494563781916e-12
the O 0 6.788719586481307e-11
position O 0 2.8553298614397704e-10
of O 0 6.767171822907869e-10
the O 0 1.6377845746262665e-09
IC O 0 4.793758989762864e-07
and O 0 5.963229909866641e-11
its O 0 3.607236384595147e-11
role O 0 2.509487236068697e-11
in O 0 1.2999098325527925e-11
the O 0 7.707034316295491e-11
coordinate O 0 3.6262570723977205e-10
expression O 0 4.4318722025593615e-09
of O 0 3.116213953546776e-09
genes O 0 3.72871785531137e-12
is O 0 1.6485719581994795e-13
conserved O 0 3.928932700014709e-12
between O 0 2.8842438420245697e-12
mouse O 0 3.3166864810141305e-09
and O 0 2.1931973598343646e-11
human O 0 1.8971213489038519e-10
, O 0 1.7719829509960094e-12
and O 0 1.6033681543917155e-12
indicate O 0 5.6883816233754825e-12
that O 0 6.035864082848397e-13
the O 0 1.0264228356149374e-10
mouse O 0 6.867829638323997e-10
is O 0 1.770428964022186e-12
a O 0 1.6352194121341257e-12
suitable O 0 6.914455986939405e-12
model O 0 3.692341137701005e-12
system O 0 3.399249631774737e-11
in O 0 1.4581495733079208e-12
which O 0 2.9385890422395367e-13
to O 0 5.61757292159154e-13
investigate O 0 4.605133982482634e-12
the O 0 1.683039645150597e-11
molecular O 0 1.5587325874477642e-10
mechanisms O 0 7.382721101123479e-10
of O 0 1.6904495858671709e-10
imprinting O 0 8.54169235342539e-10
in O 0 1.1721798011399276e-11
this O 0 2.8641669656652435e-13
region O 0 1.632957484509756e-11
of O 0 3.020755520721785e-11
the O 0 1.0289533808327533e-10
genome O 0 1.0882329759542841e-10
. O 0 2.53391724269747e-10
. O 0 6.154641685185425e-09

Mutations O 0 4.38256275714366e-09
of O 0 1.5851814083589488e-08
the O 0 3.0145654861257754e-09
ATM O 0 1.043943171907813e-07
gene O 0 4.3929023613165086e-11
detected O 0 1.3908833286502276e-11
in O 0 1.1905276244006391e-11
Japanese O 1 0.9999006986618042
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999996423721313
: O 0 1.8561274045536535e-11
possible O 0 5.6729013847567344e-11
preponderance O 0 6.800338070434009e-09
of O 0 1.3075600602263648e-09
the O 0 1.8344792351854267e-10
two O 0 1.1317553665068925e-11
founder O 0 5.773298727973497e-09
mutations O 0 3.2388094983737403e-10
4612del165 O 0 3.2736487298734573e-08
and O 0 5.228659283318393e-09
7883del5 O 0 8.593729603489919e-07
. O 0 1.0837996455848042e-07

The O 0 8.269799423032964e-07
ATM O 1 0.9944677352905273
( O 0 0.0018379540415480733
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 2.77197098608184e-10
mutated O 0 1.766035408190536e-11
) O 0 8.462199311502078e-14
gene O 0 4.099994215661651e-12
on O 0 1.0674778422314901e-10
human O 0 7.484916852984469e-11
chromosome O 0 3.6550136250923515e-09
11q22 O 0 6.849246858564584e-08
. O 0 1.1826940315984302e-08

3 O 0 4.505428705670056e-07
has O 0 1.2368985002897404e-10
recently O 0 6.214902897871966e-11
been O 0 4.933825917263768e-12
identified O 0 3.5006155960082275e-12
as O 0 1.746188805530624e-12
the O 0 7.455604709993846e-12
gene O 0 2.7811351312190258e-12
responsible O 0 3.706092724375942e-12
for O 0 1.4452127645656065e-13
the O 0 1.846018130025051e-12
human O 0 2.588981473650165e-09
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 1.0
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.5478278658775935e-09
. O 0 3.01373748179401e-09

In O 0 3.271487525324801e-09
order O 0 4.857366731059187e-10
to O 0 1.9320070716866145e-12
define O 0 5.87782600369735e-11
the O 0 2.3450718797390913e-11
types O 0 1.0478457684870435e-10
of O 0 2.9649602772963135e-09
disease O 0 0.025132980197668076
- O 0 1.011702455144814e-08
causing O 0 1.941089067258872e-09
ATM O 0 3.6043875439872863e-08
mutations O 0 5.041347981432631e-12
in O 0 3.3151760416710863e-12
Japanese O 0 3.80947494704742e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 3.518844593486392e-08
as O 0 1.8903441312279057e-11
well O 0 1.3344363591558106e-12
as O 0 3.6878274956367307e-13
to O 0 1.4798068098589162e-13
look O 0 3.150127186012097e-13
for O 0 1.634015188781146e-13
possible O 0 5.470661684076061e-12
mutational O 0 2.480021299433588e-09
hotspots O 0 5.174884964986859e-09
, O 0 9.957026522733337e-12
reverse O 0 4.4958786693527486e-10
- O 0 5.095272814781282e-11
transcribed O 0 9.01699895305974e-12
RNA O 0 9.147351279215066e-12
derived O 0 5.0823752216315465e-14
from O 0 1.231917129071447e-13
ten O 0 1.518612666173702e-11
patients O 0 9.04446764878053e-13
belonging O 0 9.356240608660027e-12
to O 0 1.2176281033796088e-12
eight O 0 5.431664146238191e-11
unrelated O 0 3.798598324777913e-09
Japanese O 1 0.9958041310310364
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 2.6008525194631815e-11
was O 0 1.3362486117607375e-10
analyzed O 0 6.652295467951541e-12
for O 0 2.612669629253883e-12
mutations O 0 1.9657133993461473e-12
by O 0 3.498606569382612e-12
the O 0 1.2717540909257252e-10
restriction O 0 9.657042943089778e-10
endonuclease O 0 4.5021448791260354e-09
fingerprinting O 0 6.3502532121617605e-09
method O 0 2.8512441296868474e-09
. O 0 4.515466223153908e-09

As O 0 1.5071038861336206e-09
has O 0 1.0735538326367422e-11
been O 0 1.4135350875910113e-12
reported O 0 1.6001938272711125e-12
by O 0 2.8720734557979855e-12
others O 0 1.0208617805262943e-11
, O 0 2.4450450344937202e-12
mutations O 0 3.682115376490991e-12
that O 0 2.227394050452469e-12
lead O 0 2.3422033756936855e-10
to O 0 5.3512395903343446e-11
exon O 0 9.167944625687596e-08
skipping O 0 1.2399515192385024e-08
or O 0 2.978823854249413e-10
premature O 0 1.0405012407233016e-09
protein O 0 1.4240905676921045e-10
truncation O 0 7.569619953073925e-08
were O 0 9.609784079600558e-10
also O 0 4.8170915173395557e-11
predominant O 0 8.308473353757506e-10
in O 0 8.272999646452561e-11
our O 0 1.7714855138351027e-09
mutants O 0 2.3282019867565396e-08
. O 0 8.537998752444764e-09

Six O 0 1.0632563274270979e-08
different O 0 8.098912165910299e-12
mutations O 0 4.902394115657849e-11
were O 0 5.4809625588125854e-11
identified O 0 3.671387499570855e-11
on O 0 2.4417585731129066e-09
12 O 0 1.2726670828300257e-09
of O 0 1.025116436181861e-09
the O 0 1.6378626233048976e-09
16 O 0 3.6407430403784247e-09
alleles O 0 1.6867940377807145e-10
examined O 0 5.609596787081728e-09
. O 0 2.1464527932835153e-08

Four O 0 3.117273550401478e-08
were O 0 1.2852986452926984e-09
deletions O 0 2.318986780380783e-09
involving O 0 2.7118415846238975e-10
a O 0 2.0922068522111203e-09
loss O 0 4.593545455122694e-08
of O 0 3.600787579216558e-07
a O 0 1.6347019737850133e-08
single O 0 5.313463802281149e-08
exon O 0 3.4462263442947005e-07
exon O 0 1.1353552764603592e-07
7 O 0 5.7451035928579586e-08
, O 0 1.913788433283159e-10
exon O 0 8.973690235336562e-09
16 O 0 1.9860786348857573e-09
, O 0 2.9893079678267043e-10
exon O 0 3.285308025624545e-08
33 O 0 4.482591631216337e-09
or O 0 2.428799161791062e-09
exon O 0 3.6969578331991215e-07
35 O 0 5.040665840283509e-08
. O 0 3.354683286715954e-08

The O 0 1.6477973474593455e-07
others O 0 1.688430062429802e-09
were O 0 2.186586467445295e-10
minute O 0 1.242455693883926e-09
deletions O 0 1.1356914714211186e-10
, O 0 1.2813613017859105e-11
4649delA O 0 8.455247058059001e-10
in O 0 2.3563268003456983e-10
exon O 0 1.1643469299826847e-08
33 O 0 6.57427334793681e-10
and O 0 8.24319848491406e-11
7883del5 O 0 1.4160853822886565e-08
in O 0 2.2509640817958143e-09
exon O 0 5.103956937091425e-07
55 O 0 5.958520432614023e-08
. O 0 4.3478955547016085e-08

The O 0 1.884788325412501e-08
mutations O 0 4.973494394100442e-10
4612del165 O 0 2.233055074185586e-09
and O 0 5.992074891825183e-11
7883del5 O 0 2.1618593581962386e-09
were O 0 4.9965878656799134e-11
found O 0 4.86169698249439e-13
in O 0 2.0120783836806433e-13
more O 0 2.3150697938539855e-14
than O 0 5.622565401545293e-14
two O 0 4.657460398252433e-13
unrelated O 0 1.2043957844931619e-11
families O 0 2.937478073825918e-14
; O 0 2.4802185180855876e-14
44 O 0 1.8233843254722437e-12
% O 0 1.5690847059157687e-12
( O 0 7.375110179681788e-13
7 O 0 1.273310457072796e-09
of O 0 1.5206170767001481e-09
16 O 0 6.690718534763107e-10
) O 0 5.084346030130582e-13
of O 0 1.2966090007227038e-11
the O 0 8.740091983483467e-12
mutant O 0 1.2831343626507064e-11
alleles O 0 3.406067203455543e-13
had O 0 7.027095051681531e-12
one O 0 3.8236688121306983e-13
of O 0 2.937488099985508e-11
the O 0 1.5673246034353383e-10
two O 0 5.764479171777026e-11
mutations O 0 1.6536739755323993e-09
. O 0 1.502139745923614e-08

The O 0 8.672920159824571e-08
4612del165 O 0 5.844731987281193e-08
mutations O 0 7.252901057519523e-11
in O 0 1.570393988459262e-11
three O 0 2.1517937171672274e-12
different O 0 1.3651692352522476e-13
families O 0 1.6251476347376587e-13
were O 0 3.2660022689784407e-12
all O 0 2.7920363503824985e-12
ascribed O 0 7.867816120832316e-11
to O 0 6.481274284625416e-12
the O 0 1.979859748368895e-10
same O 0 2.9392829836716317e-10
T O 0 1.1866506000046684e-08
- O 0 7.531592571830004e-10
- O 0 6.131848917512173e-10
> O 0 7.745367680556114e-10
A O 0 3.372206403007283e-10
substitution O 0 2.0716366122552898e-10
at O 0 1.425041612490574e-10
the O 0 2.2617727135632038e-11
splice O 0 2.0216612828249936e-09
donor O 0 1.797302862094341e-10
site O 0 3.989362451495282e-10
in O 0 1.972152302576191e-10
intron O 0 5.0393202855048e-07
33 O 0 1.3397952614013775e-07
. O 0 1.1792752019346153e-07

Microsatellite O 0 2.8895085506519536e-06
genotyping O 0 7.929722301014408e-07
around O 0 1.0239127323785624e-09
the O 0 2.3418380568074326e-09
ATM O 0 8.098539296952367e-07
locus O 0 4.662865205062872e-09
also O 0 2.850126558373578e-11
indicated O 0 7.186428101907394e-12
that O 0 2.44791844130135e-13
a O 0 4.110227783127307e-12
common O 0 5.578901056402241e-12
haplotype O 0 9.625995833761891e-11
was O 0 5.236631128724412e-10
shared O 0 2.3663185126643338e-12
by O 0 7.499199286727098e-13
the O 0 3.447586183549789e-12
mutant O 0 6.995578422097637e-11
alleles O 0 1.6564493917139989e-12
in O 0 2.381595571795958e-12
both O 0 2.9553422209449565e-11
mutations O 0 1.4950332083429885e-09
. O 0 6.731452284469697e-09

This O 0 2.1833241881097365e-09
suggests O 0 3.794092540143623e-10
that O 0 2.1382309985107373e-12
these O 0 4.175591730021244e-12
two O 0 4.801048794633722e-11
founder O 0 1.2130111315400427e-07
mutations O 0 4.04200395376364e-10
may O 0 1.619175488132285e-10
be O 0 2.1819733520000995e-11
predominant O 0 1.4376552170958234e-09
among O 0 5.733608900160281e-12
Japanese O 0 2.3728993880922644e-08
ATM O 0 7.922080271782761e-07
mutant O 0 6.42609094825275e-08
alleles O 0 9.33514487932996e-10
. O 0 2.5161277505958424e-09

W474C O 0 2.88262231151748e-06
amino O 0 9.35154815806527e-08
acid O 0 6.996502266432003e-10
substitution O 0 2.169417007147345e-10
affects O 0 7.623792005681529e-13
early O 0 5.358662298615702e-12
processing O 0 2.978345001181104e-11
of O 0 3.76405469293406e-11
the O 0 5.150999418668256e-11
alpha O 0 7.426399772914039e-11
- O 0 6.0622422880241e-12
subunit O 0 1.8601287177233417e-11
of O 0 1.6074178099678704e-10
beta O 0 3.8923545275793003e-08
- O 0 1.9808210183214214e-08
hexosaminidase O 0 7.441384042294885e-08
A O 0 3.0025608666051085e-09
and O 0 1.425643674293764e-12
is O 0 1.8731789394339088e-13
associated O 0 1.1491833526444672e-11
with O 0 9.054280936116044e-11
subacute O 1 0.8892865777015686
G B-Disease 0 0.009054278954863548
( I-Disease 0 4.275475529169626e-09
M2 I-Disease 0 3.872328306897543e-06
) I-Disease 0 1.6468960917226383e-10
gangliosidosis I-Disease 0 6.716641678394808e-07
. O 0 3.236552714724894e-08

Mutations O 0 7.347195074558499e-10
in O 0 2.0919464771562701e-10
the O 0 1.0891222368414333e-09
HEXA O 0 6.797007472414407e-07
gene O 0 5.339748782029474e-11
, O 0 7.593664195712502e-13
encoding O 0 6.072087277431137e-13
the O 0 2.502780621638223e-11
alpha O 0 4.40977566962264e-11
- O 0 5.528679944410975e-12
subunit O 0 1.048855013258132e-11
of O 0 8.831288478283739e-11
beta O 0 5.051134177591621e-09
- O 0 1.3464553916264776e-08
hexosaminidase O 0 1.2709823238310491e-07
A O 0 3.0302242493007725e-08
( O 0 4.7525399414494185e-12
Hex O 0 8.145585539409694e-09
A O 0 1.4562173689114388e-09
) O 0 2.4516890254067114e-13
, O 0 1.88410051449317e-13
that O 0 1.0545855638408042e-12
abolish O 0 2.9390951894470163e-08
Hex O 0 6.77377727242856e-08
A O 0 1.514544267777751e-09
enzyme O 0 1.0911796639867521e-11
activity O 0 2.698297696390739e-10
cause O 0 0.001299157040193677
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 2.4183262326005206e-07
TSD B-Disease 1 0.9999428987503052
) O 0 1.6689358228738627e-11
, O 0 7.4943705755115e-12
the O 0 2.1901895852494135e-09
fatal O 0 0.3784079849720001
infantile B-Disease 1 0.9704426527023315
form I-Disease 0 2.3308679431011115e-08
of I-Disease 0 4.421807716425974e-06
G I-Disease 0 1.7984479200094938e-05
( I-Disease 0 2.825732148270532e-10
M2 I-Disease 0 2.772963227926084e-07
) I-Disease 0 6.887341825329019e-12
gangliosidosis I-Disease 0 1.8689904734969787e-08
, I-Disease 0 1.2413937933164476e-10
Type I-Disease 0 1.6816782633100047e-08
1 I-Disease 0 3.787654350162484e-07
. O 0 1.3003035981284938e-08

Less O 0 1.4599077502452928e-09
severe O 0 0.00011747879034373909
, O 0 8.085877523100748e-10
subacute O 1 0.9999966621398926
( O 0 2.5508628098691588e-08
juvenile O 1 1.0
- O 0 0.00022716852254234254
onset O 1 1.0
) O 0 2.974004098543759e-10
and O 0 3.793862557444072e-09
chronic O 1 1.0
( O 0 9.388019250877733e-09
adult O 0 0.006557895801961422
- O 0 1.674781924521085e-05
onset O 1 0.9999935626983643
) O 0 4.928709350371374e-12
variants O 0 8.337822099413472e-11
are O 0 3.669561535061053e-14
characterized O 0 7.916383477565847e-13
by O 0 1.3667481046659297e-13
a O 0 6.2108950794892426e-12
broad O 0 2.997380954550266e-10
spectrum O 0 4.4986062097684965e-10
of O 0 5.790131915595076e-11
clinical O 0 7.713649097240705e-08
manifestations O 0 3.56332711817231e-05
and O 0 4.511983495159022e-11
are O 0 8.759307976212785e-14
associated O 0 1.0390639086990672e-12
with O 0 3.406177521026593e-13
residual O 0 8.536900963918015e-07
levels O 0 8.39212859204963e-08
of O 0 1.0966605401563356e-08
Hex O 0 4.0483455450157635e-06
A O 0 3.269194053245883e-07
enzyme O 0 1.2162273965721226e-10
activity O 0 2.3935762261118043e-09
. O 0 3.0992906019378097e-09

We O 0 3.881965415786226e-09
identified O 0 3.552153016173065e-10
a O 0 1.181567621522106e-10
1422 O 0 1.3840234736051116e-08
G O 0 4.633557182387449e-08
- O 0 3.189287056670764e-08
- O 0 8.977885102012806e-09
> O 0 4.456063518176734e-09
C O 0 1.3640248042179337e-08
( O 0 3.7037534497685876e-12
amino O 0 2.801602352886512e-11
acid O 0 3.4928123761324148e-12
W474C O 0 1.7970482740770066e-11
) O 0 1.9374656823415706e-15
substitution O 0 1.0837159078111447e-13
in O 0 3.957176315685755e-14
the O 0 3.1564543188401795e-13
first O 0 1.1376719878664066e-12
position O 0 1.3131346704442493e-11
of O 0 6.969634591680318e-11
exon O 0 1.6844799999304882e-09
13 O 0 3.837651862959035e-10
of O 0 2.6365221117430337e-09
HEXA O 0 0.0042017665691673756
of O 0 2.116482633596206e-08
a O 0 3.3378957375873597e-09
non O 0 6.611412572965492e-07
- O 0 7.099910881436244e-09
Jewish O 0 2.5653623669796843e-09
proband O 0 1.0041673704108689e-05
who O 0 2.405783350312163e-09
manifested O 0 2.1664794402909138e-08
a O 0 1.2279648409219135e-08
subacute O 0 0.40305355191230774
variant O 0 3.761154584935866e-05
of O 0 0.18576714396476746
G B-Disease 1 0.9890581965446472
( I-Disease 0 8.319084976449176e-09
M2 I-Disease 0 5.252509254205506e-06
) I-Disease 0 1.422429257713631e-10
gangliosidosis I-Disease 0 3.7305716205082717e-07
. O 0 3.5123068897746634e-08

On O 0 2.5271293679907103e-07
the O 0 1.0457862131829643e-08
second O 0 1.521395276427029e-08
maternally O 0 5.520795820501689e-09
inherited O 0 7.470248419849668e-09
allele O 0 3.711210505574769e-10
, O 0 8.364593739873527e-12
we O 0 1.8577025768379274e-12
identified O 0 2.4227898333395448e-12
the O 0 6.842874357426698e-12
common O 0 2.9511726395980986e-08
infantile O 1 1.0
disease O 1 1.0
- O 0 6.408795911738707e-07
causing O 0 4.3216903122811345e-07
4 O 0 8.297662930090155e-07
- O 0 1.1348352479956247e-08
bp O 0 4.968119249326719e-10
insertion O 0 2.1804517913448507e-10
, O 0 9.64948884685235e-11
+ O 0 1.891940382137136e-09
TATC O 0 9.434746175429609e-07
1278 O 0 1.4210291965355282e-07
, O 0 4.014196960944183e-11
in O 0 7.080511177370852e-11
exon O 0 2.6478019776732253e-08
11 O 0 2.1469684696739932e-08
. O 0 2.2343684236147965e-08

Pulse O 0 0.07829791307449341
- O 0 9.20534148463048e-06
chase O 0 1.5282502374702744e-08
analysis O 0 3.7310675382595804e-11
using O 0 3.521276326079459e-11
proband O 0 1.1576394953749514e-08
fibroblasts O 0 2.565274215271529e-09
revealed O 0 2.5060969965906565e-10
that O 0 9.856364856231092e-13
the O 0 1.626032815338352e-11
W474C O 0 2.5004917580950803e-10
- O 0 3.582353858000431e-11
containing O 0 3.0387799915265745e-11
alpha O 0 9.987673188494028e-11
- O 0 2.0953438636950317e-11
subunit O 0 4.411559312300639e-11
precursor O 0 4.58060950281336e-10
was O 0 1.4092219613459633e-09
normally O 0 6.022619469109314e-12
synthesized O 0 1.3972069334844406e-10
, O 0 4.68953521848281e-12
but O 0 2.9561975697228737e-12
not O 0 1.0516289445164362e-12
phosphorylated O 0 4.892343127838039e-11
or O 0 2.0740065481000824e-12
secreted O 0 4.765990119920405e-13
, O 0 9.374562758013294e-13
and O 0 7.1105387203229675e-12
the O 0 5.083238829861614e-10
mature O 0 6.350637238305978e-10
lysosomal O 0 5.828323423884285e-08
alpha O 0 3.0747437929079524e-09
- O 0 3.1598987315639704e-10
subunit O 0 5.47972167641575e-10
was O 0 8.540176898996776e-10
not O 0 3.2889083817488896e-11
detected O 0 4.244704587819115e-09
. O 0 5.50737588866923e-09

When O 0 9.326530658881893e-10
the O 0 6.153993425961346e-10
W474C O 0 1.6518865164627528e-09
- O 0 8.994004152551582e-11
containing O 0 3.367088899364212e-11
alpha O 0 2.0668530775758143e-10
- O 0 6.329593099652087e-11
subunit O 0 2.2367369068021503e-10
was O 0 7.229825627064201e-10
transiently O 0 3.5571248169219416e-09
co O 0 7.971807103324124e-10
- O 0 3.388652899949385e-11
expressed O 0 5.0764800349489825e-12
with O 0 3.8592119409007475e-13
the O 0 2.1340151867832446e-11
beta O 0 3.981211540993179e-11
- O 0 4.348517206043123e-12
subunit O 0 2.9569647511801245e-12
to O 0 1.628846661499636e-13
produce O 0 4.5517166424868805e-12
Hex O 0 1.0914727788247092e-08
A O 0 5.337667197125029e-09
( O 0 9.67398904039296e-13
alphabeta O 0 1.0996257238105045e-09
) O 0 5.433223315698399e-13
in O 0 1.3167462779850592e-11
COS O 0 2.666015461727511e-07
- O 0 5.911234612909766e-09
7 O 0 1.8865569106907287e-09
cells O 0 1.7958901726844445e-11
, O 0 7.007255561387871e-13
the O 0 6.685863668254299e-12
mature O 0 3.404659583775005e-12
alpha O 0 1.0938636281487835e-11
- O 0 1.510065184874565e-12
subunit O 0 4.713990916366262e-12
was O 0 1.4071820098049415e-11
present O 0 3.69209979429741e-13
, O 0 9.256368593705058e-14
but O 0 5.6509054298945274e-14
its O 0 4.057569980963488e-13
level O 0 1.4641764189970985e-10
was O 0 3.446437579768258e-11
much O 0 1.2038463758842766e-12
lower O 0 5.764135262847914e-12
than O 0 1.4096539148640563e-14
that O 0 2.0082585361390695e-14
from O 0 3.9307595264652384e-13
normal O 0 7.60097540464244e-11
alpha O 0 1.8531992607151437e-10
- O 0 1.6530856544738626e-11
subunit O 0 4.0562816994160755e-11
transfections O 0 9.314016224948318e-10
, O 0 3.7321044692173455e-12
although O 0 3.691087799989612e-12
higher O 0 4.914825057350525e-12
than O 0 4.6260460468804804e-14
in O 0 1.269888816497755e-12
those O 0 2.1981715492974674e-12
cells O 0 1.1693839473136958e-11
transfected O 0 2.9057306907831482e-11
with O 0 9.21075417542952e-14
an O 0 1.142704312249998e-12
alpha O 0 5.371059708103587e-10
- O 0 1.5808861164590127e-10
subunit O 0 3.9647243821328004e-10
associated O 0 6.779147798674501e-10
with O 0 6.978190802975348e-10
infantile O 1 0.9983962178230286
TSD B-Disease 1 0.7212890982627869
. O 0 1.4844769680166792e-07

Furthermore O 0 7.173484029010524e-09
, O 0 3.3308834856971004e-11
the O 0 1.5057977434396186e-11
precursor O 0 1.507298452718686e-10
level O 0 7.546518410173064e-10
of O 0 1.0955554519131994e-10
the O 0 1.2151862849307804e-10
W474C O 0 1.9561041675331126e-09
alpha O 0 4.778404338878772e-10
- O 0 4.7771987754519074e-11
subunit O 0 8.307027288267932e-11
was O 0 6.090585258355929e-10
found O 0 2.5507601673219193e-12
to O 0 3.236427239487055e-13
accumulate O 0 1.2950900660051168e-13
in O 0 3.928630695499563e-13
comparison O 0 1.1449688853276685e-12
to O 0 9.785054710942376e-13
the O 0 7.196238743789607e-11
normal O 0 1.0528186100700054e-09
alpha O 0 7.081162878286307e-10
- O 0 9.733335665229603e-11
subunit O 0 3.095425304966426e-10
precursor O 0 1.3166622236937542e-09
levels O 0 1.1619155415587556e-08
. O 0 8.83227047054902e-10

We O 0 2.9355027297839342e-09
conclude O 0 1.8080865693548276e-09
that O 0 2.8077635702561388e-12
the O 0 1.802325233501989e-10
1422 O 0 2.623175809901568e-08
G O 0 3.1926501264933904e-07
- O 0 9.208047231368255e-07
- O 0 1.7373959337874112e-07
> O 0 2.858498682201116e-08
C O 0 1.5829968447178544e-08
mutation O 0 1.7511159189353975e-11
is O 0 1.115254129281304e-13
the O 0 1.0157143138719849e-12
cause O 0 8.107911564358972e-11
of O 0 1.655305448267086e-09
Hex B-Disease 1 0.9841264486312866
A I-Disease 1 0.9999775886535645
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.0506139291877048e-09
the O 0 3.414588833905441e-09
proband O 0 1.7986717466556001e-06
. O 0 3.050701025131275e-08

The O 0 6.37104724532378e-09
resulting O 0 5.557538318434752e-10
W474C O 0 5.634969379997301e-09
substitution O 0 1.2317926678662161e-09
clearly O 0 1.0220249126169367e-11
interferes O 0 1.5955308905676868e-12
with O 0 2.589450463948151e-13
alpha O 0 4.928589480979184e-11
- O 0 9.814723686552007e-12
subunit O 0 1.9738708931238413e-11
processing O 0 2.2108213870719595e-10
, O 0 6.131149190777285e-13
but O 0 1.3112963135036154e-13
because O 0 1.5148155624832016e-13
the O 0 2.8788028818421685e-12
base O 0 1.2418905313837936e-11
substitution O 0 2.418600042464192e-10
falls O 0 4.6114229101945625e-10
at O 0 1.7753949699272908e-10
the O 0 2.3421885958496702e-11
first O 0 2.3382918865055835e-11
position O 0 9.582196841551038e-11
of O 0 4.4677714305940697e-10
exon O 0 1.4617113741621779e-08
13 O 0 1.480272793230597e-09
, O 0 4.365622099933297e-11
aberrant O 0 1.162739571292093e-09
splicing O 0 1.3729935410822236e-08
may O 0 5.198456665134188e-10
also O 0 6.071152261477586e-12
contribute O 0 8.000218326351116e-13
to O 0 1.7224817058791864e-11
Hex B-Disease 0 0.00026223232271149755
A I-Disease 0 0.0002609856892377138
deficiency I-Disease 0 5.089700039206946e-07
in O 0 1.2086052991744367e-10
this O 0 5.1185916616347527e-11
proband O 0 1.9015723751181213e-07
. O 0 8.808834772722207e-10
. O 0 5.703393757272579e-09

Two O 0 4.473774684043974e-10
frequent O 0 8.763770820152672e-10
missense O 0 3.1682762369200645e-07
mutations O 0 1.652026071496948e-08
in O 0 4.676467924014105e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.00013465466327033937

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 3.1010469747627667e-09
an O 0 1.4108794132994262e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 1.492464107855085e-08
by O 0 6.778720651207798e-14
early O 0 6.9075336561752465e-09
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 0 0.0003478549770079553
goiter B-Disease 1 1.0
. O 0 9.029662919601833e-07

A O 0 3.452416663662916e-08
century O 0 1.7787549211334408e-09
after O 0 6.917665745787005e-11
its O 0 5.743832059285081e-12
recognition O 0 9.437166326176083e-11
as O 0 1.427138685006213e-10
a O 0 1.2794827419781996e-08
syndrome O 0 9.607383617549203e-06
by O 0 1.1834531965515538e-10
Vaughan O 0 1.4543370525643695e-06
Pendred O 0 0.00028436636785045266
, O 0 7.454559747266387e-10
the O 0 6.551382103481274e-09
disease O 0 7.445732626365498e-05
gene O 0 1.3164010992383623e-09
( O 0 9.32327132163735e-11
PDS O 0 1.0484664016985334e-06
) O 0 1.4781037721914303e-12
was O 0 1.3689285816020913e-10
mapped O 0 6.094324350724989e-11
to O 0 3.357514266610906e-11
chromosome O 0 6.004611208254573e-08
7q22 O 0 3.7905808767391136e-06
- O 0 4.308100415073568e-06
q31 O 0 2.151216904167086e-06
. O 0 3.542792015309715e-08

1 O 0 1.253981281479355e-06
and O 0 5.404333647263115e-10
, O 0 6.707350647117138e-11
recently O 0 2.0055716809519453e-10
, O 0 6.025767992218212e-12
found O 0 1.2927511708685224e-12
to O 0 7.606478381189108e-13
encode O 0 2.0824704807798078e-11
a O 0 1.6576815475843887e-09
putative O 0 6.882587655354655e-08
sulfate O 0 2.7712175665328687e-08
transporter O 0 7.932074481686868e-07
. O 0 6.056718149238804e-08

We O 0 2.4878386017945786e-09
performed O 0 1.7256469586612866e-09
mutation O 0 2.7002013472388064e-11
analysis O 0 2.8539820246670233e-12
of O 0 2.624794825933918e-10
the O 0 1.7891157444438477e-09
PDS B-Disease 0 8.723254723008722e-06
gene O 0 5.655995671816072e-10
in O 0 8.895970765587791e-11
patients O 0 2.172741153660951e-11
from O 0 5.6965352573934425e-12
14 O 0 4.704189482396259e-09
Pendred B-Disease 0 4.0672895806892484e-07
families O 0 3.773361397646502e-12
originating O 0 2.833188891826488e-11
from O 0 1.2294229870257745e-11
seven O 0 2.1171698075250767e-11
countries O 0 1.7368349597077226e-12
and O 0 2.6726398871801393e-11
identified O 0 3.101069123712108e-10
all O 0 5.515172762926568e-10
mutations O 0 6.245973516172398e-09
. O 0 1.2233478230427863e-08

The O 0 9.173576387411231e-08
mutations O 0 5.307300154910877e-10
include O 0 2.300259149823347e-10
three O 0 8.667135759088396e-11
single O 0 5.988559093061951e-10
base O 0 1.4017293992196755e-09
deletions O 0 2.627771555907543e-09
, O 0 8.174125820659128e-10
one O 0 6.189838641645906e-10
splice O 0 9.727836669526368e-08
site O 0 6.3097829183789145e-09
mutation O 0 2.868556225887886e-10
and O 0 6.834790372556299e-11
10 O 0 1.267142168970281e-09
missense O 0 1.4596935216104612e-07
mutations O 0 1.3995528291843584e-08
. O 0 2.5607294062979236e-08

One O 0 6.363311211288192e-09
missense O 0 7.409305169403524e-08
mutation O 0 4.036611045421523e-10
( O 0 1.3370840892812375e-11
L236P O 0 8.966363207463246e-10
) O 0 1.640933916524645e-12
was O 0 6.730367652085789e-11
found O 0 1.4396333246607246e-13
in O 0 5.710454895405115e-14
a O 0 2.9033454243196366e-13
homozygous O 0 3.4638069322523446e-12
state O 0 5.650897501666141e-13
in O 0 1.8589821522418948e-12
two O 0 3.851456046449764e-12
consanguineous O 0 1.423595019645063e-08
families O 0 3.147352712652707e-13
and O 0 1.059284821317008e-12
in O 0 4.4648789873646955e-12
a O 0 5.8148646488176414e-12
heterozygous O 0 3.877756189069048e-12
state O 0 8.051315690538186e-13
in O 0 2.344301402307236e-12
five O 0 9.275393821062128e-12
additional O 0 8.364582637643281e-11
non O 0 6.108966317697195e-06
- O 0 7.612076728946704e-07
consanguineous O 0 5.644949851557612e-06
families O 0 9.900563702203158e-10
. O 0 2.106173369043063e-08

Another O 0 2.7124647417053893e-08
missense O 0 1.6441272521205974e-07
mutation O 0 2.7025212623321693e-10
( O 0 1.1267712457518897e-11
T416P O 0 5.76136083285661e-10
) O 0 1.570989323872174e-12
was O 0 5.3009544670468145e-11
found O 0 2.6745085638345267e-13
in O 0 2.1776306344083174e-13
a O 0 5.374996780126151e-13
homozygous O 0 1.2039433686106271e-11
state O 0 2.7754808000490794e-12
in O 0 1.2461520530748782e-11
one O 0 5.7497179760390704e-12
family O 0 1.9640795066722117e-12
and O 0 8.091419786797338e-13
in O 0 1.8858703661195353e-12
a O 0 4.847772790833593e-12
heterozygous O 0 4.303384038006897e-12
state O 0 1.7732340118828405e-12
in O 0 1.4723755201173638e-11
four O 0 1.1232913210701412e-10
families O 0 3.42047778989496e-11
. O 0 4.307044498830237e-09

Pendred B-Disease 1 0.9048367142677307
patients O 0 3.071955134714699e-08
in O 0 3.910529955408748e-10
three O 0 7.15376369253562e-10
non O 0 0.00018857418035622686
- O 0 1.5190051954050432e-06
consanguineous O 0 1.7077434677048586e-05
families O 0 3.5329753012014464e-11
were O 0 5.359411178740281e-11
shown O 0 1.8507397003819648e-11
to O 0 1.1319864316738926e-11
be O 0 1.8711740490395812e-11
compound O 0 6.286211551298493e-10
heterozygotes O 0 2.5728977282035714e-10
for O 0 7.572348997841871e-12
L236P O 0 7.1847812144199e-09
and O 0 3.1250274590277627e-10
T416P O 0 1.1189263915412084e-07
. O 0 1.2461943477148907e-08

In O 0 1.6766458221795233e-09
total O 0 1.7223027448665107e-09
, O 0 2.8138996688298334e-10
one O 0 2.811226772203579e-11
or O 0 1.5241202397375808e-11
both O 0 1.204359095091645e-11
of O 0 9.552985069660735e-10
these O 0 4.344504790643189e-12
mutations O 0 7.463130807794371e-12
were O 0 7.455618587781654e-12
found O 0 3.9213689803987983e-13
in O 0 1.821646132549315e-12
nine O 0 1.216011596971711e-10
of O 0 4.728015756683135e-10
the O 0 6.526683637986253e-10
14 O 0 2.191953285546333e-09
families O 0 5.248074978064787e-12
analyzed O 0 1.3878186377880297e-09
. O 0 1.4393707559179347e-08

The O 0 9.080924456839057e-09
identification O 0 9.064311079498566e-09
of O 0 5.579420481183206e-09
two O 0 3.3639707686106135e-10
frequent O 0 1.3709001045469904e-08
PDS B-Disease 0 3.228847708669491e-05
mutations O 0 1.466020776996757e-10
will O 0 4.10800169922676e-12
facilitate O 0 1.4625904654064215e-11
the O 0 7.537980656335819e-12
molecular O 0 6.82862077994173e-09
diagnosis O 0 6.972987875997205e-07
of O 0 1.9169289089404629e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.070522668873309e-06

Insertional O 0 5.639569735649275e-06
mutation O 0 2.3366935053559246e-09
by O 0 3.73092529093455e-11
transposable O 0 2.0018138968680432e-07
element O 0 3.6572679107393924e-08
, O 0 9.894919328345964e-10
L1 O 0 6.66912171709555e-07
, O 0 1.209363338638969e-11
in O 0 2.8947609934104612e-11
the O 0 2.014445144027377e-08
DMD B-Disease 1 1.0
gene O 0 1.6334232855186315e-09
results O 0 1.06877763583757e-10
in O 0 4.905218592421434e-11
X B-Disease 1 0.9999995231628418
- I-Disease 1 0.9999992847442627
linked I-Disease 1 0.9999955892562866
dilated I-Disease 1 0.9735307693481445
cardiomyopathy I-Disease 1 1.0
. O 0 1.4548821809512447e-06

X B-Disease 1 1.0
- I-Disease 1 1.0
linked I-Disease 1 1.0
dilated I-Disease 1 0.9999998807907104
cardiomyopathy I-Disease 1 1.0
( O 0 9.840568964136764e-07
XLDCM B-Disease 1 0.999984860420227
) O 0 1.1995012622056933e-11
is O 0 2.740147789660058e-13
a O 0 9.152076882804061e-13
clinical O 0 1.872365729127523e-08
phenotype O 0 4.736077752198753e-09
of O 0 1.1289843726558502e-08
dystrophinopathy B-Disease 0 4.687631644628709e-06
which O 0 7.331397641752169e-12
is O 0 2.3162019719726035e-13
characterized O 0 9.89303582631107e-13
by O 0 1.1988167620061163e-12
preferential O 0 1.9048535193633143e-08
myocardial B-Disease 1 0.9999960660934448
involvement I-Disease 0 2.1312756004476796e-09
without O 0 9.987058055549447e-12
any O 0 3.0247265195987305e-12
overt O 0 6.145770004017947e-10
clinical O 0 8.85815609308338e-07
signs O 0 1.1140334208903369e-05
of O 0 3.7539518871199107e-06
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 7.787155482219532e-05

To O 0 1.3601861303946805e-10
date O 0 5.63959279276105e-09
, O 0 4.511981500227025e-12
several O 0 5.441499572982067e-13
mutations O 0 2.158115049513687e-12
in O 0 5.791686574774246e-12
the O 0 7.448938532661487e-08
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 0 0.0047562518157064915
, O 0 1.1468333838138278e-08
DMD O 1 1.0
, O 0 1.88030441911069e-11
have O 0 1.4655125528915958e-13
been O 0 8.087819557958328e-14
identified O 0 9.705865261890392e-14
in O 0 6.519358078556359e-13
patients O 0 9.421294040051764e-13
with O 0 2.5398370472745624e-12
XLDCM B-Disease 1 0.99965500831604
, O 0 8.891136438204938e-11
but O 0 1.5842018452269513e-12
a O 0 8.472895779085277e-13
pathogenic O 0 2.3369305622578107e-12
correlation O 0 3.0642476403497376e-12
of O 0 3.111435414870911e-11
these O 0 7.12444968471726e-13
cardiospecific O 0 2.4473443271944006e-09
mutations O 0 2.938110171823993e-11
in O 0 1.2015352601757456e-10
DMD O 1 1.0
with O 0 7.060672879699581e-11
the O 0 1.0843574926866495e-08
XLDCM B-Disease 0 0.05551321431994438
phenotype O 0 2.657085573787299e-08
has O 0 8.450083688327226e-11
remained O 0 4.1047734100629896e-09
to O 0 2.2530151355670824e-11
be O 0 1.6732012997344725e-10
elucidated O 0 6.932745577614696e-07
. O 0 2.2525028953168658e-08

We O 0 6.142339525894158e-09
report O 0 3.500336825945638e-11
here O 0 1.1805713524826178e-11
the O 0 4.858121283729533e-12
identification O 0 4.63190701072147e-11
of O 0 6.869489005412177e-11
a O 0 3.182209357133203e-11
unique O 0 5.6702077061432377e-11
de O 0 1.805413774036424e-07
novo O 0 2.2209847827525664e-07
L1 O 0 1.9607676904342952e-07
insertion O 0 1.0916299114649419e-10
in O 0 7.819240394058014e-11
the O 0 9.331762029773927e-10
muscle O 0 7.926114875544954e-09
exon O 0 1.68537095390775e-08
1 O 0 5.250866408346155e-09
in O 0 1.4906589851371166e-10
DMD O 1 1.0
in O 0 3.940869852669948e-10
three O 0 8.270732432258399e-10
XLDCM B-Disease 1 0.5142120122909546
patients O 0 3.942696724656969e-10
from O 0 1.588093198612306e-11
two O 0 2.7984194822527897e-11
unrelated O 0 3.3252249842519177e-09
Japanese O 0 3.190480128978379e-07
families O 0 1.5253802387871218e-10
. O 0 8.549536190116669e-09

The O 0 1.6867119256858132e-08
insertion O 0 1.2708332164379499e-09
was O 0 1.2872914290085191e-08
a O 0 3.0553973240365906e-10
5 O 0 1.139580541043017e-09
- O 0 1.1861696347370554e-10
truncated O 0 2.324063511083274e-11
form O 0 4.929225864286346e-12
of O 0 1.3853451719114673e-10
human O 0 3.5555491884053936e-10
L1 O 0 4.830363664609649e-09
inversely O 0 8.556831458672587e-12
integrated O 0 2.938251586481755e-10
in O 0 1.187316651246606e-11
the O 0 1.309566205476287e-10
5 O 0 1.5778113260367377e-09
- O 0 1.0246004045200152e-09
untranslated O 0 3.850744079159085e-08
region O 0 1.7807329222296886e-10
in O 0 5.814834724837681e-11
the O 0 7.246322986098619e-10
muscle O 0 1.107031799563174e-08
exon O 0 1.538982630222563e-08
1 O 0 3.2402509564377624e-09
, O 0 2.284328975976635e-12
which O 0 5.270864040368695e-13
affected O 0 2.592139827437001e-12
the O 0 1.3301425065559425e-11
transcription O 0 1.0130202926506016e-10
or O 0 6.641696307513323e-12
the O 0 2.8449180511369576e-11
stability O 0 9.999310712771603e-09
of O 0 8.565004261384956e-10
the O 0 3.2423264073599967e-10
muscle O 0 5.232238531327482e-10
form O 0 2.066777998743774e-10
of O 0 2.470795568143558e-09
dystrophin O 0 1.060770848937409e-08
transcripts O 0 2.414893840452237e-10
but O 0 1.0369058042747348e-12
not O 0 1.6502141179149804e-13
that O 0 6.93223622494181e-14
of O 0 9.624564339949515e-11
the O 0 7.107630040081858e-10
brain O 0 1.2754023828165373e-06
or O 0 5.407429615189585e-09
Purkinje O 0 0.2373294234275818
cell O 0 0.17255789041519165
form O 0 8.265721440636753e-09
, O 0 1.4864201536290977e-10
probably O 0 1.77058871037028e-11
due O 0 3.871566678359528e-10
to O 0 1.080696621601207e-12
its O 0 7.337049370836901e-12
unique O 0 1.0049312944293565e-11
site O 0 1.362172319385735e-10
of O 0 4.602144221266258e-10
integration O 0 3.364166545338776e-08
. O 0 2.31506831482875e-08

We O 0 4.844804113446344e-09
speculate O 0 1.2185957798394043e-10
that O 0 2.491746500972447e-13
this O 0 9.682937096447755e-14
insertion O 0 2.6100447757942957e-12
of O 0 6.486990805631976e-11
an O 0 5.614416050125914e-12
L1 O 0 6.008827568848574e-08
sequence O 0 3.836568840398513e-10
in O 0 1.0442335884874865e-08
DMD O 1 1.0
is O 0 4.801939956777801e-10
responsible O 0 5.242067335764489e-10
for O 0 1.3023444302151521e-11
some O 0 5.220577117305558e-13
of O 0 2.22366829810694e-11
the O 0 6.8696172882132256e-12
population O 0 7.69050282982929e-14
of O 0 2.5837250741678197e-11
Japanese O 0 3.980944285331134e-08
patients O 0 9.648918469773449e-11
with O 0 5.664889043965893e-11
XLDCM B-Disease 0 0.017352815717458725
. O 0 7.193227791191248e-09
. O 0 2.0928466071268303e-08

Severe O 0 0.00010625120921758935
early O 0 0.00011402251402614638
- O 1 0.9999916553497314
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 2.415011977063841e-07
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9992334842681885
red O 1 0.9999921321868896
hair O 1 0.9993657469749451
pigmentation O 1 0.9998362064361572
caused O 0 5.562946512327471e-07
by O 0 7.018930991975481e-10
POMC O 0 9.032394882524386e-05
mutations O 0 2.0666125755131048e-10
in O 0 3.794684011459992e-11
humans O 0 2.570905988097394e-10
. O 0 8.387016081634613e-10

Sequential O 0 3.334130482812725e-08
cleavage O 0 5.716135564881597e-09
of O 0 1.3263393050522154e-08
the O 0 1.3481508132073827e-09
precursor O 0 1.1809284661268293e-09
protein O 0 1.4360210243147264e-10
pre O 0 6.553622142746462e-07
- O 0 1.9168777498634881e-07
pro O 0 1.5464262332898215e-06
- O 0 1.962233575625305e-08
opiomelanocortin O 0 1.5617553117408534e-07
( O 0 1.9995369249237172e-10
POMC O 0 1.4886195742747077e-07
) O 0 6.402365616831052e-13
generates O 0 1.512838574031783e-12
the O 0 5.559316548775506e-11
melanocortin O 0 1.8393603795630042e-07
peptides O 0 8.878969087744437e-11
adrenocorticotrophin O 0 9.47543021823094e-09
( O 0 1.752072237293234e-10
ACTH O 0 3.100155510082914e-08
) O 0 2.4959051752454497e-12
, O 0 9.969282344091113e-12
melanocyte O 0 1.326051375372117e-07
- O 0 4.668785535955067e-08
stimulating O 0 4.6990535906843434e-08
hormones O 0 2.3234982826636497e-09
( O 0 5.7831430616550605e-12
MSH O 0 3.5744218251920756e-08
) O 0 1.111474126169569e-13
alpha O 0 2.8000464360328214e-12
, O 0 1.2364949694568597e-14
beta O 0 5.663576161871187e-13
and O 0 5.74400214350089e-14
gamma O 0 8.964040989524469e-13
as O 0 2.5570916369586916e-13
well O 0 1.6740637196789587e-13
as O 0 5.63305587071572e-13
the O 0 5.233091304041038e-12
opioid O 0 9.202199419133805e-11
- O 0 1.1763119991958781e-11
receptor O 0 3.4647983267188653e-12
ligand O 0 2.0227196653732626e-11
beta O 0 2.8897273463002193e-09
- O 0 5.326693308660424e-09
endorphin O 0 1.614422586726505e-07
. O 0 1.240102354138628e-09

While O 0 2.9091327125030375e-09
a O 0 9.585267302103517e-11
few O 0 5.411465980181829e-12
cases O 0 9.391636773825596e-13
of O 0 5.213390830149933e-10
isolated O 1 0.7230727076530457
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9999727010726929
have O 0 7.140101010438826e-11
been O 0 2.8431061324663e-11
reported O 0 8.146416874410534e-11
( O 0 1.5099774208771066e-10
OMIM O 0 0.024736300110816956
201400 O 0 2.7511950406733376e-07
) O 0 7.44423706705577e-12
, O 0 2.0256918972089144e-12
an O 0 8.099684985218847e-12
inherited O 0 0.0006418273551389575
POMC O 1 1.0
defect O 1 0.9914855360984802
has O 0 7.708728655408947e-10
not O 0 2.1753371673427502e-11
been O 0 2.2774780325529598e-11
described O 0 5.597172378357662e-11
so O 0 6.603082663980686e-12
far O 0 3.296953682285775e-11
. O 0 1.5098947647729233e-09

Recent O 0 9.960563623900853e-11
studies O 0 8.827142142231459e-12
in O 0 1.8598438761285863e-12
animal O 0 3.607690535201158e-11
models O 0 1.7623969774879789e-12
elucidated O 0 3.7078851100602606e-10
a O 0 1.270836821193333e-11
central O 0 3.1385094523272983e-10
role O 0 1.828072415666071e-11
of O 0 7.734517470936453e-10
alpha O 0 8.848614285739131e-09
- O 0 8.157805986286348e-09
MSH O 0 6.308455908765609e-07
in O 0 7.509294401575328e-12
the O 0 5.919058299053148e-11
regulation O 0 9.805639633597707e-10
of O 0 8.012228380760433e-11
food O 0 6.434790200682272e-11
intake O 0 3.850344793433075e-13
by O 0 1.656441538024512e-14
activation O 0 1.1669019049642682e-11
of O 0 1.9791913941080708e-10
the O 0 5.956843907028997e-10
brain O 0 2.5401812209224772e-08
melanocortin O 0 8.194322731469583e-07
- O 0 1.3414690469559787e-09
4 O 0 6.998401413937927e-09
- O 0 4.083608728944199e-10
receptor O 0 1.5843031053730527e-10
( O 0 2.0640864017984484e-11
MC4 O 0 1.758584585331846e-05
- O 0 3.8137148550276834e-08
R O 0 3.563998873801211e-08
; O 0 3.885974441536488e-12
refs O 0 3.364310496856149e-10
3 O 0 2.0758092467154654e-10
- O 0 8.999421867439406e-12
5 O 0 1.3262607158337492e-12
) O 0 1.0699701131475009e-15
and O 0 2.0766950289806017e-15
the O 0 7.061847173651589e-14
linkage O 0 2.421189360113374e-10
of O 0 2.6039709277725365e-10
human O 0 2.0854226931987796e-06
obesity B-Disease 1 1.0
to O 0 1.2393608708749504e-11
chromosome O 0 6.145031705706572e-10
2 O 0 1.2895368106669025e-09
in O 0 1.3567368582767525e-11
close O 0 6.111704198286105e-11
proximity O 0 2.617051297892914e-10
to O 0 7.203252317539155e-12
the O 0 7.831228443500038e-10
POMC O 0 6.073399845263339e-07
locus O 0 2.8014221498118275e-10
, O 0 7.775852878255662e-12
led O 0 4.3204682886877066e-11
to O 0 1.877454355175834e-12
the O 0 6.415561831785155e-11
proposal O 0 1.3270154072819729e-11
of O 0 1.6368397956489922e-11
an O 0 4.589691474099489e-12
association O 0 1.4087946365037851e-09
of O 0 5.237742684016666e-09
POMC O 0 0.19898377358913422
with O 0 7.311881655702734e-10
human O 0 0.00011365626414772123
obesity B-Disease 1 1.0
. O 0 9.676226397914434e-08

The O 0 3.2298046459544594e-09
dual O 0 6.7691510174938685e-09
role O 0 7.333908480511298e-10
of O 0 2.1991068521742818e-08
alpha O 0 3.484572346224013e-07
- O 0 2.75127376880846e-07
MSH O 0 6.2198610066843685e-06
in O 0 4.467871558833103e-11
regulating O 0 2.9874056561851603e-09
food O 0 2.69531041929838e-09
intake O 0 7.296890314201221e-10
and O 0 3.171181719996419e-11
influencing O 0 4.3989455633663965e-08
hair O 0 5.3193190979072824e-05
pigmentation O 0 1.990584905797732e-06
predicts O 0 7.87672371771464e-10
that O 0 4.1455768397084813e-13
the O 0 6.990733079220712e-12
phenotype O 0 3.378507543172482e-11
associated O 0 8.277983333526695e-12
with O 0 1.3165447464852376e-12
a O 0 4.370990236424177e-10
defect O 0 1.4491492095203284e-07
in O 0 1.7216459369251425e-09
POMC O 0 0.156255841255188
function O 0 3.8674595970178416e-08
would O 0 2.1080271209172885e-11
include O 0 9.039997084236973e-10
obesity B-Disease 1 1.0
, O 0 4.3948694510020925e-12
alteration O 0 5.2411808226793255e-09
in O 0 1.67945851670126e-10
pigmentation O 0 0.1197599470615387
and O 0 3.451607426541159e-07
ACTH B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9998395442962646
. O 0 6.88160241679725e-07

The O 0 4.700144273783735e-09
observation O 0 2.2357417606144736e-07
of O 0 1.1037196046004283e-08
these O 0 9.129472178237563e-11
symptoms O 0 4.598173930503435e-08
in O 0 1.0823582308194801e-10
two O 0 1.1030282243140732e-10
probands O 0 1.4770436109756702e-06
prompted O 0 1.820384620820903e-09
us O 0 1.7125852819210863e-11
to O 0 4.6375802503773045e-12
search O 0 6.335100499743618e-11
for O 0 3.807087978202617e-11
mutations O 0 5.020297719204869e-11
within O 0 2.459839443247347e-09
their O 0 5.381018741701382e-09
POMC O 0 2.368515015405137e-05
genes O 0 1.1079887229925589e-08
. O 0 8.810922658142317e-09

Patient O 0 2.142617631761823e-06
1 O 0 2.0296251932450105e-06
was O 0 2.179173286265268e-08
found O 0 4.682402902911331e-12
to O 0 1.035816723192473e-12
be O 0 4.415008289515576e-12
a O 0 1.530934927440608e-11
compound O 0 3.257649983101629e-10
heterozygote O 0 2.48901899091436e-10
for O 0 1.7843113054791249e-12
two O 0 2.440041658308134e-12
mutations O 0 5.400309539826953e-12
in O 0 5.7742068071409136e-11
exon O 0 9.22832743555091e-09
3 O 0 5.583401740949512e-09
( O 0 1.5014786289291315e-11
G7013T O 0 2.1758743695698968e-09
, O 0 2.7541826458366003e-11
C7133delta O 0 9.405257683781088e-10
) O 0 3.265825923495086e-13
which O 0 6.646466959702585e-14
interfere O 0 4.902389258432116e-13
with O 0 4.5693178787106076e-14
appropriate O 0 2.3483482519681687e-11
synthesis O 0 3.74957509485796e-10
of O 0 4.177676871108815e-09
ACTH O 0 7.621694066983764e-07
and O 0 3.0451012822396706e-09
alpha O 0 1.552939352222893e-06
- O 0 6.681836566713173e-06
MSH O 0 0.0005591737572103739
. O 0 3.898543354807771e-08

Patient O 0 3.629991169873392e-07
2 O 0 3.213510169075562e-08
was O 0 2.6624752402781837e-10
homozygous O 0 1.0596475086277479e-10
for O 0 9.700063668960368e-12
a O 0 2.716530299318176e-11
mutation O 0 2.3467542145660936e-11
in O 0 2.8922884920401515e-11
exon O 0 6.191684054357438e-09
2 O 0 5.506514355602121e-09
( O 0 4.029583524495228e-12
C3804A O 0 3.925662850345901e-10
) O 0 3.2699600405888818e-12
which O 0 2.682378624774273e-11
abolishes O 0 2.723544128002686e-07
POMC O 0 7.80282607593108e-06
translation O 0 3.2698544316644984e-08
. O 0 2.9557806868751868e-08

These O 0 6.397297691584924e-10
findings O 0 4.0043628135588705e-11
represent O 0 4.510621910702728e-12
the O 0 1.1451092678249619e-11
first O 0 6.393521562869653e-12
examples O 0 1.6189801235744206e-11
of O 0 4.660284380619828e-10
a O 0 6.427939958086881e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 4.947374954156203e-09
the O 0 9.171084447423539e-10
POMC O 0 1.432944998214225e-07
gene O 0 4.464862073810805e-12
and O 0 1.7232785023187785e-13
define O 0 1.30163349716661e-12
a O 0 1.911736177348522e-12
new O 0 2.462917925161179e-10
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 0.9950897097587585
resulting O 0 4.165131781141973e-12
in O 0 3.5666880283643024e-14
early O 0 2.5972971329224492e-08
- O 1 0.9577928185462952
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 3.8810054547866457e-07
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999569654464722
red O 0 0.2780192196369171
hair O 0 1.7619084246689454e-05
pigmentation O 0 4.333969627623446e-05
. O 0 1.1672726119016374e-09
. O 0 3.925545222216442e-09

A O 0 6.210989766941566e-08
European O 0 1.5104138384458565e-08
multicenter O 0 3.0270416573330294e-07
study O 0 3.956037442076621e-10
of O 0 1.5242554809447029e-06
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 9.685842350393159e-09
classification O 0 8.54754755863496e-09
of O 0 8.278276397710727e-10
105 O 0 3.9708089594192586e-10
mutations O 0 7.048223116257191e-12
and O 0 3.0178283916965087e-12
a O 0 3.47269131853456e-12
general O 0 4.6418386495661323e-11
system O 0 6.995178047919381e-11
for O 0 3.2560317289598295e-12
genotype O 0 1.2651975300759233e-10
- O 0 6.409434094578614e-11
based O 0 3.173057303018645e-11
prediction O 0 3.4250597025220486e-08
of O 0 1.0572703601496869e-08
metabolic O 1 0.9845351576805115
phenotype O 0 3.5182276292289316e-07
. O 0 5.705787398113671e-09

Phenylketonuria B-Disease 1 0.9999569654464722
( O 0 3.966339932048868e-07
PKU B-Disease 0 0.0018610273255035281
) O 0 6.175990968637635e-11
and O 0 1.5367751515782402e-10
mild B-Disease 1 0.9999799728393555
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.8775269389152527
MHP B-Disease 1 1.0
) O 0 1.894221446363531e-10
are O 0 9.561001296232163e-11
allelic B-Disease 1 0.9999701976776123
disorders I-Disease 1 1.0
caused O 0 8.854911470734805e-09
by O 0 3.9658471819026264e-12
mutations O 0 1.6327572974206284e-12
in O 0 1.4683000908871646e-12
the O 0 1.8336072243885226e-11
gene O 0 1.328877702322373e-10
encoding O 0 4.790395302656236e-10
phenylalanine O 0 3.0293114150481415e-07
hydroxylase O 0 3.2920563626248622e-06
( O 0 2.3959743078449947e-09
PAH O 0 2.03729923669016e-05
) O 0 3.6998740182703216e-10
. O 0 3.468671572193216e-09

Previous O 0 1.6485422804635164e-07
studies O 0 1.922870751513983e-09
have O 0 1.0827500354637642e-11
suggested O 0 7.260371557432643e-12
that O 0 2.583013013549018e-13
the O 0 2.5898975672400404e-11
highly O 0 5.221162391322309e-10
variable O 0 3.096544531899781e-08
metabolic O 1 0.9999297857284546
phenotypes O 0 9.378624099554145e-07
of O 0 2.278790998389013e-05
PAH B-Disease 1 1.0
deficiency I-Disease 0 0.08919219672679901
correlate O 0 4.872335868100208e-09
with O 0 1.3177626767557626e-09
PAH O 1 0.9991220831871033
genotypes O 0 2.508070792828221e-06
. O 0 1.618374234624298e-08

We O 0 9.49085965373797e-09
identified O 0 3.2962071960795924e-10
both O 0 8.927174104111923e-12
causative O 0 2.8033744214894796e-09
mutations O 0 1.5923951046659113e-10
in O 0 9.259808197992214e-11
686 O 0 1.7510950911514556e-08
patients O 0 1.7283470488127506e-10
from O 0 5.317318460540399e-11
seven O 0 1.0934183558575228e-09
European O 0 1.3176757818200713e-07
centers O 0 2.6415317933015103e-08
. O 0 2.0385874321959818e-08

On O 0 1.5874537240279096e-08
the O 0 7.984433253449552e-11
basis O 0 6.290502146955035e-11
of O 0 7.522185652142355e-11
the O 0 2.348298985821451e-11
phenotypic O 0 5.75688163806376e-09
characteristics O 0 5.203704689371591e-10
of O 0 4.921443252925428e-10
297 O 0 2.879735339078593e-09
functionally O 0 6.345752012748562e-08
hemizygous O 0 1.5361549230874516e-05
patients O 0 8.668346596074628e-10
, O 0 1.834485341412062e-11
105 O 0 1.3541270327266375e-09
of O 0 4.73768579922762e-09
the O 0 8.797433892482331e-10
mutations O 0 2.7227029658627444e-11
were O 0 4.250590157628409e-11
assigned O 0 7.1401521847813676e-12
to O 0 1.5749345187374142e-12
one O 0 5.888808971704629e-12
of O 0 1.2756556921900142e-10
four O 0 5.261066235440204e-11
arbitrary O 0 1.7625954029654167e-08
phenotype O 0 2.0118340771091425e-08
categories O 0 1.5141809583951726e-08
. O 0 5.857172524770249e-09

We O 0 3.694220485073174e-09
proposed O 0 2.9958777125749236e-10
and O 0 2.3313980954120517e-11
tested O 0 3.6532048219850566e-11
a O 0 7.768737042557206e-12
simple O 0 2.1234008475146116e-12
model O 0 1.228287355723237e-13
for O 0 1.9660263204219174e-14
correlation O 0 3.6359199613762716e-13
between O 0 2.077268695596657e-12
genotype O 0 2.372494145586046e-10
and O 0 1.824943841877147e-11
phenotypic O 0 4.73048302751522e-08
outcome O 0 1.3887857974737017e-08
. O 0 5.683238768483534e-09

The O 0 2.564207735034074e-09
observed O 0 6.046774192469684e-10
phenotype O 0 5.013487403005001e-10
matched O 0 2.2054473525212615e-10
the O 0 4.849976670273648e-11
predicted O 0 1.61172519774766e-10
phenotype O 0 6.883113003175456e-12
in O 0 4.1052193111915103e-13
79 O 0 4.100387390737481e-11
% O 0 1.1518203925364734e-12
of O 0 3.151993943628639e-11
the O 0 4.141605808305471e-11
cases O 0 1.4130391735173164e-12
, O 0 9.254713965664574e-13
and O 0 5.6375488045185e-13
in O 0 1.3149084685665224e-12
only O 0 2.606820792214193e-12
5 O 0 7.15209558244112e-11
of O 0 1.334145016684829e-10
184 O 0 2.1343662948147823e-10
patients O 0 1.7740604124627524e-11
was O 0 2.5984339679929747e-10
the O 0 3.19904831791451e-11
observed O 0 2.242502711302663e-11
phenotype O 0 1.4189951297316483e-11
more O 0 5.20096559407119e-14
than O 0 7.762626668848457e-14
one O 0 1.2444009581460969e-12
category O 0 2.802988119388061e-10
away O 0 4.955822557883849e-11
from O 0 1.1845654665498806e-12
that O 0 2.789193789126676e-12
expected O 0 8.748072821695985e-10
. O 0 1.8329132656091929e-09

Among O 0 8.409986596014107e-10
the O 0 1.89067050904157e-09
seven O 0 2.904790019631065e-10
contributing O 0 6.848779876555966e-11
centers O 0 9.695370201123765e-11
, O 0 8.72935838197586e-13
the O 0 2.957647148027487e-12
proportion O 0 4.85782507969601e-12
of O 0 1.9925050498414976e-10
patients O 0 2.4220829335230842e-12
for O 0 1.72741259230752e-12
whom O 0 2.5782939151730577e-12
the O 0 4.018240167685816e-12
observed O 0 2.152899039598033e-11
phenotype O 0 1.0844262120224268e-11
did O 0 5.870570956439947e-13
not O 0 2.5622326526100747e-13
match O 0 2.1808510553000815e-10
the O 0 6.2183027824125325e-12
predicted O 0 4.9028520826555066e-11
phenotype O 0 3.9885061399458355e-12
was O 0 6.203708120128271e-12
4 O 0 4.8632507743118225e-11
% O 0 8.27538992193011e-13
- O 0 1.9805988446530698e-11
23 O 0 1.164261465014249e-10
% O 0 3.703656131781585e-11
( O 0 4.0436442388935845e-11
P O 0 2.327745249885993e-07
< O 0 2.3359896239583122e-09
. O 0 8.443989431283772e-12
0001 O 0 2.2813449618297454e-07
) O 0 1.6320839536614062e-13
, O 0 5.264380917953046e-14
suggesting O 0 2.869728380709008e-13
that O 0 7.896906801976682e-15
differences O 0 3.7833244973277044e-14
in O 0 7.023898742361881e-14
methods O 0 7.918150185005912e-13
used O 0 4.6768371917164583e-14
for O 0 7.163078723920746e-13
mutation O 0 1.2085148853868688e-11
detection O 0 6.1066991463576414e-09
or O 0 1.629839666006383e-11
phenotype O 0 7.210064212337386e-10
classification O 0 9.706236925310918e-10
may O 0 4.80216387488408e-12
account O 0 8.178912191611487e-14
for O 0 1.5307668869458946e-13
a O 0 4.7068989331156e-13
considerable O 0 2.797201272691785e-12
proportion O 0 9.870460351835142e-12
of O 0 1.607985133933454e-10
genotype O 0 1.1175229985838087e-07
- O 0 1.2991231415071525e-06
phenotype O 0 1.444986992282793e-07
inconsistencies O 0 1.3206775406615634e-07
. O 0 5.5227889816933384e-08

Our O 0 2.5144306192714794e-08
data O 0 7.299814086536571e-10
indicate O 0 2.486190073258676e-11
that O 0 3.0070783103158805e-12
the O 0 6.083123782474331e-09
PAH O 0 0.0020538296084851027
- O 0 8.31883539831324e-08
mutation O 0 1.822249157124034e-10
genotype O 0 1.0709692160881801e-10
is O 0 3.2914214973325806e-13
the O 0 2.0102112249092974e-12
main O 0 2.4534094200667766e-10
determinant O 0 1.2934566306910256e-08
of O 0 3.003832516057514e-09
metabolic O 1 0.9658239483833313
phenotype O 0 7.937714374683935e-10
in O 0 3.242533411912385e-12
most O 0 9.320581632887848e-12
patients O 0 9.614110618727523e-10
with O 0 2.6236159911263712e-08
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.9133451587549644e-06

In O 0 1.7029810894797492e-09
the O 0 4.975952427876962e-10
present O 0 2.005739151156316e-11
study O 0 6.314444626898119e-12
, O 0 2.19331323936256e-12
the O 0 5.287171048196093e-11
classification O 0 1.6884814657558422e-09
of O 0 6.7032650541420935e-09
105 O 0 2.388953248555481e-07
PAH O 0 9.487300121691078e-05
mutations O 0 1.829590645652246e-10
may O 0 3.6278859690680454e-12
allow O 0 3.726753606235478e-13
the O 0 2.750538078549747e-12
prediction O 0 2.0518288457171963e-10
of O 0 4.51491899422507e-11
the O 0 4.471332679112372e-11
biochemical O 0 2.7150048875768107e-09
phenotype O 0 4.445212253845199e-10
in O 0 7.302344839921204e-11
> O 0 2.9291042924484145e-09
10 O 0 1.2537508531362818e-10
, O 0 7.003264721611169e-12
000 O 0 8.227066944366257e-11
genotypes O 0 2.811774979516457e-10
, O 0 1.210574956250765e-11
which O 0 2.8342740480968853e-12
may O 0 6.491938497193983e-12
be O 0 4.0930849204770525e-13
useful O 0 5.669023193585754e-13
for O 0 1.2587694558571783e-12
the O 0 1.1026810714520607e-10
management O 0 2.340400095945938e-09
of O 0 1.205323174602313e-09
hyperphenylalaninemia B-Disease 1 1.0
in O 0 1.8197953366438924e-08
newborns O 0 1.1415154688165785e-07
. O 0 1.4223220823339489e-08

Somatic O 0 2.8157953693153104e-06
instability O 0 3.540340856034163e-07
of O 0 1.0011299167445031e-07
the O 0 4.2791896248672856e-08
CTG O 0 1.7858959836303256e-05
repeat O 0 1.6423808091303727e-08
in O 0 8.856794464495721e-11
mice O 0 2.850134794840642e-09
transgenic O 0 1.0467800848346087e-08
for O 0 8.070588641828635e-11
the O 0 2.115585630235728e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 6.302945257630199e-05
is O 0 4.021937644038687e-11
age O 0 3.171502296894779e-11
dependent O 0 5.255267141596187e-12
but O 0 1.1481436732341949e-13
not O 0 3.732093572985512e-14
correlated O 0 2.6118660728137455e-13
to O 0 7.856002225701056e-14
the O 0 6.329481209987886e-12
relative O 0 1.766167767591753e-10
intertissue O 0 2.5107835810445067e-08
transcription O 0 1.3357198902497203e-08
levels O 0 9.135334266829886e-09
and O 0 3.337320975127511e-10
proliferative O 0 3.617797119659372e-05
capacities O 0 4.252344183441892e-07
. O 0 5.962566973494177e-08

A O 0 1.0216550435870886e-05
( O 0 1.007694816479443e-08
CTG O 0 3.0680839699925855e-06
) O 0 4.551076529524245e-11
nexpansion O 0 7.78067210660538e-09
in O 0 1.445612102246585e-10
the O 0 8.694459596725324e-10
3 O 0 2.7947164582542428e-08
- O 0 7.47344142126849e-09
untranslated O 0 2.032484616165675e-07
region O 0 3.452730990005648e-09
( O 0 2.2127018967088574e-11
UTR O 0 3.2011288908506685e-07
) O 0 6.214770018053706e-12
of O 0 7.446829264345922e-10
the O 0 1.739498145525431e-07
DM O 1 1.0
protein O 0 3.608040088920461e-08
kinase O 0 3.3305902036318e-08
gene O 0 7.966278303683794e-09
( O 0 8.047285754431144e-11
DMPK O 0 4.1473319356555294e-07
) O 0 7.061110051699571e-13
is O 0 5.136236691494732e-14
responsible O 0 5.995833603916756e-12
for O 0 1.011278977225416e-10
causing O 1 0.9999886751174927
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DM B-Disease 1 1.0
) O 0 2.285618139197254e-09
. O 0 1.9819046404023766e-09

Major O 0 1.7920318668984692e-06
instability O 0 6.216196197783574e-05
, O 0 1.4755736632565686e-09
with O 0 3.6953932969208125e-11
very O 0 1.577075622871682e-11
large O 0 2.5105247741796788e-12
expansions O 0 4.241147363859277e-11
between O 0 2.903641736773377e-11
generations O 0 6.928744383793983e-11
and O 0 3.11822616338997e-11
high O 0 1.6396818347530484e-09
levels O 0 4.1727693522730647e-10
of O 0 1.6512745337760038e-10
somatic O 0 1.789126891083015e-08
mosaicism O 0 3.542995727912057e-07
, O 0 4.566038085823676e-12
is O 0 4.034787911763593e-13
observed O 0 1.6490390650214515e-11
in O 0 5.2999028776756774e-11
patients O 0 2.242003527275216e-10
. O 0 3.997056907678598e-09

There O 0 8.832376607870174e-09
is O 0 3.594811601170811e-11
a O 0 1.6389235454883355e-11
good O 0 7.931910336878012e-12
correlation O 0 8.798264200526873e-12
between O 0 4.301301675946334e-11
repeat O 0 3.2533797877931647e-09
size O 0 3.3302992308303914e-11
( O 0 2.2045789672964222e-12
at O 0 1.9882569202156475e-10
least O 0 2.385974230689758e-12
in O 0 2.2071580674243307e-12
leucocytes O 0 4.289762323139712e-09
) O 0 9.003778625449321e-13
, O 0 3.330816796421471e-13
clinical O 0 1.3300118784087545e-09
severity O 0 5.300234562355399e-08
and O 0 1.6454447179792275e-11
age O 0 2.5546578741320047e-10
of O 0 5.359662047510483e-09
onset O 0 0.009340861812233925
. O 0 7.202415019946784e-08

The O 0 4.0700521708458837e-07
trinucleotide O 0 0.0006772897322662175
repeat O 0 9.477076332586876e-07
instability O 0 2.2420904315367807e-06
mechanisms O 0 5.818320687467349e-07
involved O 0 1.1681857703393916e-09
in O 0 2.1575679909346945e-08
DM B-Disease 1 1.0
and O 0 5.476411768512435e-09
other O 0 2.5898544420144276e-10
human O 0 0.0015811431221663952
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 9.915564203044624e-11
unknown O 0 3.5686977817306342e-09
. O 0 1.0424997531899294e-09

We O 0 6.490892268118387e-10
studied O 0 1.0407354977814975e-09
somatic O 0 6.891701875844092e-09
instability O 0 1.5949278564519886e-09
by O 0 2.7030764779278904e-11
measuring O 0 1.1967613033903035e-07
the O 0 1.9231357839544216e-08
CTG O 0 6.627941729675513e-06
repeat O 0 1.7897651360954114e-08
length O 0 5.810289055441231e-11
at O 0 6.369501037717384e-10
several O 0 5.267972256334241e-12
ages O 0 7.828099279905132e-12
in O 0 1.086752974936711e-12
various O 0 6.180359609503361e-12
tissues O 0 4.497128364144842e-11
of O 0 4.316409452087555e-10
transgenic O 0 1.04491732599854e-07
mice O 0 3.734579590020104e-10
carrying O 0 1.4754229088476123e-11
a O 0 4.905350084460913e-11
( O 0 4.357328386994652e-11
CTG O 0 4.7402960490217083e-07
) O 0 1.599486688930174e-11
55expansion O 0 1.1814404565768655e-08
surrounded O 0 8.172722498756002e-10
by O 0 9.21969271761025e-12
45 O 0 1.178045994087995e-10
kb O 0 7.270293878036682e-08
of O 0 1.563799578718772e-08
the O 0 8.94969502951426e-08
human O 0 8.009603334357962e-06
DM B-Disease 1 1.0
region O 0 1.110358116562793e-08
, O 0 2.2836723831409778e-11
using O 0 6.697073451356061e-11
small O 0 1.5186951696222195e-09
- O 0 3.703270863297803e-07
pool O 0 3.383388502697926e-07
PCR O 0 1.7854829366115155e-06
. O 0 1.1447730230429443e-07

These O 0 1.2703729179719403e-09
mice O 0 2.354602957055363e-09
have O 0 7.130893098228341e-13
been O 0 1.0012224204011475e-13
shown O 0 1.6252467037111695e-13
to O 0 4.29957278276754e-14
reproduce O 0 2.747732813848658e-12
the O 0 3.0902723956172107e-12
intergenerational O 0 1.2672744797992408e-10
and O 0 9.895432997314435e-13
somatic O 0 5.969104099889933e-10
instability O 0 5.547963755070384e-10
of O 0 3.188432018408349e-10
the O 0 1.2719972852792694e-09
55 O 0 8.999778700058414e-09
CTG O 0 7.46970590626006e-06
repeat O 0 4.5692271299913045e-08
suggesting O 0 2.5207572140750756e-10
that O 0 1.1438120416096265e-12
surrounding O 0 3.654278268871991e-11
sequences O 0 4.421314009350752e-11
and O 0 8.514636912204665e-11
the O 0 6.304282096358804e-10
chromatin O 0 2.8800648532723017e-09
environment O 0 2.354297423678986e-09
are O 0 4.488717069480591e-13
involved O 0 8.08162564647219e-13
in O 0 1.3008002661130114e-11
instability O 0 7.881059360670406e-08
mechanisms O 0 1.8185274939241935e-06
. O 0 8.944831364487982e-08

As O 0 3.3806943355862984e-10
observed O 0 1.1428231277976764e-10
in O 0 1.4329942614466074e-11
some O 0 1.1951045621877432e-12
of O 0 1.1166777225124491e-10
the O 0 2.823167810639404e-10
tissues O 0 5.415604409364505e-09
of O 0 3.5572298656916246e-05
DM B-Disease 1 1.0
patients O 0 2.2645461061898686e-09
, O 0 1.944332065142995e-12
there O 0 2.904388101548916e-12
is O 0 7.14737026074469e-13
a O 0 3.1682540705540996e-12
tendency O 0 7.204146133810152e-12
for O 0 5.14534075068962e-12
repeat O 0 1.3010496013876605e-09
length O 0 1.0775767431137062e-11
and O 0 1.9223003397406124e-11
somatic O 0 6.0045750593928915e-09
mosaicism O 0 7.603752294471633e-09
to O 0 4.89591331885586e-13
increase O 0 4.221322456084836e-13
with O 0 2.043343115152793e-13
the O 0 5.898152799499456e-11
age O 0 8.415438484954407e-11
of O 0 6.455938006411088e-10
the O 0 1.8695707204585688e-09
mouse O 0 1.0940034655959607e-07
. O 0 1.3274655152883952e-08

Furthermore O 0 1.056381471187251e-08
, O 0 9.01282520837654e-11
we O 0 2.8999652072064785e-12
observed O 0 1.2754865523142978e-12
no O 0 2.205982656744085e-13
correlation O 0 4.294198460361165e-13
between O 0 5.354215334985035e-13
the O 0 7.204754154388482e-11
somatic O 0 4.271858600191081e-08
mutation O 0 6.049819534226231e-10
rate O 0 6.550079367784178e-10
and O 0 1.553632396344984e-11
tissue O 0 2.1190356136457922e-08
proliferation O 0 0.0002523459552321583
capacity O 0 1.3283823818710516e-08
. O 0 2.3498472057070785e-09

The O 0 7.048760863881398e-08
somatic O 0 3.03307479043724e-06
mutation O 0 4.038592127386664e-09
rates O 0 1.9828186315073992e-10
in O 0 4.522723341671142e-13
different O 0 2.9417237417707354e-13
tissues O 0 1.6714629680336657e-10
were O 0 1.1026200785746454e-10
also O 0 2.461187286958988e-12
not O 0 2.879592181023738e-13
correlated O 0 3.1462499706230718e-12
to O 0 1.8016531192280305e-12
the O 0 1.1028010449276593e-10
relative O 0 2.0076280637937316e-09
inter O 0 2.60002389040892e-06
- O 0 9.228304787001207e-10
tissue O 0 1.294341439583846e-10
difference O 0 1.2393561871215653e-11
in O 0 1.2606434993123194e-12
transcriptional O 0 3.168402484821087e-10
levels O 0 1.7991240441883605e-10
of O 0 4.4319777015022765e-11
the O 0 2.0269758094215717e-11
three O 0 2.8829128754376265e-12
genes O 0 3.722294174279828e-12
( O 0 9.959742232334978e-12
DMAHP O 0 2.1529531295527704e-06
, O 0 3.5768191186669185e-10
DMPK O 0 9.030059118231293e-06
and O 0 6.488825587958047e-10
59 O 0 8.159607434166105e-10
) O 0 1.4199826210703481e-12
surrounding O 0 5.0781483185158294e-11
the O 0 4.1151582141907284e-10
repeat O 0 2.3532122028768754e-08
. O 0 1.7699048893149438e-09
. O 0 1.0829086960484346e-08

A O 0 1.9661186456687574e-08
novel O 0 1.160658902321643e-09
missense O 0 4.215065274593144e-08
mutation O 0 3.5607680692884003e-10
in O 0 2.3544029573163705e-11
patients O 0 1.6544073402902093e-11
from O 0 5.750595746117915e-12
a O 0 3.9057143630394364e-10
retinoblastoma B-Disease 0 1.638062371966953e-06
pedigree O 0 3.379780677548183e-09
showing O 0 1.8459540562787424e-09
only O 0 2.8537002622064378e-11
mild O 0 3.147288651916824e-08
expression O 0 4.614064685881658e-09
of O 0 5.538617342537577e-10
the O 0 2.497974604942499e-10
tumor B-Disease 0 4.3211588973690596e-08
phenotype O 0 3.1845501791138986e-09
. O 0 1.338111177418e-09

We O 0 4.1798293715089585e-09
have O 0 3.5816076666972396e-12
used O 0 4.5241555727409954e-13
single O 0 1.5889173657357425e-11
strand O 0 3.435503270754481e-11
conformation O 0 5.38720283660421e-12
polymorphism O 0 7.461395216956657e-12
analysis O 0 2.8428428773367986e-13
to O 0 1.0396639603914293e-13
study O 0 1.931906647460388e-13
the O 0 3.0680490700069063e-12
27 O 0 2.808141497112615e-10
exons O 0 5.2888604606948775e-09
of O 0 8.122140182642568e-10
the O 0 3.033750139991298e-09
RB1 O 0 7.442888261266489e-08
gene O 0 7.592335614370338e-12
in O 0 1.7777007079930462e-12
individuals O 0 1.084615389038493e-13
from O 0 3.063090579791261e-12
a O 0 5.4639175128823325e-11
family O 0 4.402520882573757e-12
showing O 0 2.795295994673097e-09
mild O 0 1.027528469421668e-06
expression O 0 3.700470685430446e-08
of O 0 5.711678241482332e-09
the O 0 1.3205857518627795e-09
retinoblastoma B-Disease 0 8.687983950039779e-07
phenotype O 0 4.361891470239243e-08
. O 0 4.790863705750326e-09

In O 0 4.846781642697806e-09
this O 0 7.307444926940576e-11
family O 0 2.6614229917121257e-11
affected O 0 1.1507625581608227e-11
individuals O 0 1.9887963617539611e-13
developed O 0 2.401262966245099e-09
unilateral B-Disease 1 0.9999972581863403
tumors I-Disease 1 1.0
and O 0 6.800909169157876e-09
, O 0 1.9727117508971936e-11
as O 0 7.32234238520757e-12
a O 0 4.937459295584201e-12
result O 0 1.1994829608730218e-11
of O 0 4.646569240485121e-11
linkage O 0 1.1741994043745763e-09
analysis O 0 1.457605390553507e-11
, O 0 1.8592738459943803e-11
unaffected O 0 5.56634649484522e-09
mutation O 0 1.0161475133552145e-10
carriers O 0 1.9452295677013787e-12
were O 0 2.031372466071435e-11
also O 0 6.672296395948685e-12
identified O 0 1.84504408279329e-11
within O 0 2.1779121561760206e-10
the O 0 3.440418172573345e-09
pedigree O 0 7.733152784794584e-08
. O 0 2.6830274890699002e-08

A O 0 3.0725766464456683e-07
single O 0 6.691347032017347e-09
band O 0 1.0816617823650176e-08
shift O 0 7.253402878326654e-10
using O 0 6.225022580741424e-11
SSCP O 0 1.1342449113271869e-07
was O 0 2.9590607741880603e-10
identified O 0 1.5734790206889393e-11
in O 0 6.186562546972585e-12
exon O 0 1.1502261365592403e-09
21 O 0 1.2476081279189088e-10
which O 0 7.507371460602208e-13
resulted O 0 1.0245857114121737e-11
in O 0 3.975837020719908e-12
a O 0 8.638419146667076e-11
missense O 0 5.0947628338349205e-09
mutation O 0 1.2178755226521787e-10
converting O 0 3.3870839466487723e-10
a O 0 3.2873043176451233e-10
cys O 0 3.2609098070679465e-06
- O 0 1.624992478355125e-06
- O 0 2.7977011995972134e-07
> O 0 8.558203745678838e-08
arg O 0 1.6039410866142134e-07
at O 0 6.524492612847155e-10
nucleotide O 0 9.516414323229583e-10
position O 0 7.099582588487863e-10
28 O 0 3.083681088256185e-10
in O 0 4.5643596541244946e-11
the O 0 2.0293686731065463e-09
exon O 0 3.6065267750018393e-07
. O 0 1.3782043062349203e-08

The O 0 9.782782228739961e-08
mutation O 0 8.297122100486831e-09
destroyed O 0 1.0269368431181647e-06
an O 0 2.801277820818626e-10
NdeI O 0 2.689935172384139e-06
restriction O 0 3.9869098600320285e-07
enzyme O 0 3.543060733690595e-09
site O 0 8.799888817634383e-09
. O 0 4.5231294265590805e-09

Analysis O 0 1.2310035213403125e-09
of O 0 5.957543436352353e-08
all O 0 1.6168154592932638e-09
family O 0 9.025417913033351e-11
members O 0 3.672170206803216e-12
demonstrated O 0 6.78968730197238e-12
that O 0 2.62420510668826e-13
the O 0 6.09045522348417e-11
missense O 0 6.12651120945884e-08
mutation O 0 1.7114841099896694e-08
co O 0 1.4039988855074625e-05
- O 0 0.024889744818210602
segregated O 0 3.999540240329225e-06
with O 0 1.022358864233297e-10
patients O 0 9.104892839673084e-09
with O 0 4.900295724752368e-09
tumors B-Disease 1 1.0
or O 0 2.2206977519090287e-06
who O 0 4.368474915139586e-09
, O 0 1.6898329957548697e-11
as O 0 1.369147330232412e-11
a O 0 4.340594723928337e-12
result O 0 8.418500271889506e-12
of O 0 1.4104844896223323e-11
linkage O 0 2.2201984695158217e-10
analysis O 0 2.8030763474240494e-12
had O 0 1.1643785761961123e-11
been O 0 6.07319012788099e-12
predicted O 0 7.878778185421709e-11
to O 0 1.6419076384957543e-12
carry O 0 2.2117821463218945e-11
the O 0 3.759005884340638e-10
predisposing O 0 1.6078158182608604e-07
mutation O 0 1.0856819443461063e-08
. O 0 5.898563859574324e-09

These O 0 2.711510460606803e-10
observations O 0 2.679158839224982e-10
point O 0 1.2274280480895072e-09
to O 0 3.2884237867458754e-12
another O 0 6.837003185822255e-12
region O 0 1.7309038924384623e-10
of O 0 1.7319284895123133e-09
the O 0 1.2986627773159398e-08
RB1 O 0 9.389175374963088e-07
gene O 0 2.605108628817021e-10
where O 0 3.5028081130095146e-11
mutations O 0 7.293558118570687e-12
only O 0 2.8113592183409697e-12
modify O 0 7.3565823571764e-12
the O 0 9.481581318693255e-12
function O 0 1.4106626977650194e-10
of O 0 2.7975882721520406e-10
the O 0 1.6336779151693293e-10
gene O 0 1.9100832027163506e-10
and O 0 2.2244445868624396e-11
raise O 0 2.218055600300417e-11
important O 0 8.037449178432965e-12
questions O 0 9.625545803124136e-13
for O 0 6.038884670100941e-12
genetic O 0 5.8037601391447424e-09
counseling O 0 1.7136544960827393e-10
in O 0 1.932848499308637e-11
families O 0 3.710914496697637e-13
with O 0 6.945567710379963e-13
these O 0 3.261440770230273e-11
distinctive O 0 3.5345291138355606e-09
phenotypes O 0 1.9639736503762606e-09
. O 0 3.957705274615364e-10
. O 0 9.297655090279022e-09

Maternal B-Disease 0 3.682390342873987e-06
disomy I-Disease 0 0.00021575142454821616
and O 0 1.8808197637554258e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.999977707862854
with O 0 1.9155486918887021e-10
gamete O 0 3.9466965517931385e-07
complementation O 1 0.9998756647109985
in O 0 1.4900478073620604e-10
a O 0 5.348739506860767e-11
case O 0 2.2723493225962343e-11
of O 0 7.381454336652382e-10
familial O 0 9.23466956237462e-08
translocation O 0 4.677659148910607e-07
( O 0 1.3170835255760238e-10
3 O 0 7.52545048499087e-09
; O 0 1.1016393960255888e-12
15 O 0 4.766859129645695e-11
) O 0 2.3802913307925666e-13
( O 0 2.8405828579082526e-13
p25 O 0 2.231742568525874e-10
; O 0 9.402498311189555e-13
q11 O 0 2.8756996783840805e-10
. O 0 7.581815383850277e-12
2 O 0 4.174074974550024e-10
) O 0 1.0056752305920291e-11
. O 0 4.2697195778984565e-10

Maternal B-Disease 0 0.0016209648456424475
uniparental I-Disease 1 0.9998302459716797
disomy I-Disease 1 0.9999707937240601
( I-Disease 0 0.0006753560737706721
UPD I-Disease 1 1.0
) I-Disease 0 1.256175580222063e-10
for I-Disease 0 7.229173509815112e-11
chromosome I-Disease 0 1.7878782898606005e-08
15 I-Disease 0 1.762742618538482e-09
is O 0 3.0267693733321277e-12
responsible O 0 2.3594062467657828e-11
for O 0 8.020400207690848e-13
an O 0 5.5950395412649595e-14
estimated O 0 1.2705260021145248e-12
30 O 0 4.444733209957308e-12
% O 0 3.1589596390102503e-13
of O 0 4.211753775601457e-12
cases O 0 6.39936541257935e-12
of O 0 1.4514741053517355e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999986886978149
PWS B-Disease 1 1.0
) O 0 3.9816885788468426e-08
. O 0 6.955872322578216e-08

We O 0 2.81739720442431e-09
report O 0 2.164464614484718e-11
on O 0 4.4541977745060635e-11
an O 0 2.951683222927187e-13
unusual O 0 1.4383448425359102e-11
case O 0 2.352490424684106e-11
of O 0 1.0841584296983342e-09
maternal B-Disease 0 1.5318018853349713e-08
disomy I-Disease 0 2.0236607269907836e-06
15 I-Disease 0 2.3967068329966423e-08
in O 0 4.9893003506440436e-08
PWS B-Disease 1 1.0
that O 0 2.5686498067445385e-11
is O 0 1.6530124708272198e-12
most O 0 2.2542677360209984e-13
consistent O 0 1.981547391449734e-11
with O 0 6.307892576329355e-13
adjacent O 0 1.937774607441156e-09
- O 0 1.1098769681083809e-09
1 O 0 4.831469002652966e-09
segregation O 0 1.57269312239805e-07
of O 0 1.840557373178342e-09
a O 0 1.2841394614326873e-09
paternal O 0 1.7139757391149146e-09
t O 0 2.323808701021335e-09
( O 0 2.40492153101568e-12
3 O 0 1.415076805733051e-10
; O 0 2.7351558518073915e-13
15 O 0 9.201457304430782e-12
) O 0 4.8091799910877225e-14
( O 0 1.356342203264957e-13
p25 O 0 6.500987248525547e-11
; O 0 1.4821965269723458e-13
q11 O 0 2.9642677201735523e-11
. O 0 3.144628383643794e-13
2 O 0 2.7044419221439187e-12
) O 0 7.347877833258337e-15
with O 0 1.810262721245893e-14
simultaneous O 0 1.479019795525005e-09
maternal O 0 1.0527186233844077e-08
meiotic O 0 6.654071285083774e-07
nondisjunction O 0 2.479720535575325e-07
for O 0 1.3095943218743855e-09
chromosome O 0 9.864325534181262e-08
15 O 0 1.1494365281805585e-07
. O 0 3.63040619788535e-08

The O 0 1.664802766754292e-07
patient O 0 3.8208762020985887e-07
( O 0 1.0351171031430795e-09
J O 0 5.6347598729189485e-05
. O 0 4.7865475472086416e-11
B O 0 1.236406199645046e-09
. O 0 1.243961395480317e-13
) O 0 6.350233957652749e-15
, O 0 4.1824501490188987e-14
a O 0 1.0109887102829895e-12
17 O 0 3.006793078408343e-11
- O 0 3.2059077614832177e-11
year O 0 1.6212977141383256e-11
- O 0 1.3691382472202918e-09
old O 0 2.8923632378052844e-09
white O 0 4.322932636857679e-11
male O 0 1.0177350498810633e-12
with O 0 7.626849672648373e-12
PWS B-Disease 1 1.0
, O 0 3.0039171150519905e-10
was O 0 4.602163539146886e-09
found O 0 1.163292986244846e-11
to O 0 3.744797007210199e-12
have O 0 3.3244080231698003e-12
47 O 0 2.1385870505041815e-11
chromosomes O 0 4.3798320005505875e-12
with O 0 4.83943961293587e-12
a O 0 8.76393846382939e-10
supernumerary O 0 3.233534880564548e-05
, O 0 2.2360886753336473e-10
paternal O 0 1.3181800095907192e-09
der O 0 0.000604282773565501
( O 0 2.1480466710910306e-11
15 O 0 4.177696730223168e-11
) O 0 8.473133490411594e-14
consisting O 0 1.3054325415789991e-12
of O 0 1.320461656684202e-10
the O 0 5.591096030599374e-09
short O 0 7.99561217235123e-09
arm O 0 2.1621370649427263e-07
and O 0 2.5944733028637756e-09
the O 0 2.5798962610679155e-07
proximal O 0 8.212964894482866e-05
long O 0 9.285444662054942e-07
arm O 0 5.057432872490608e-07
of O 0 4.241024598172771e-08
chromosome O 0 7.395792067654838e-07
15 O 0 1.0531488925380472e-07
, O 0 4.273068565652238e-10
and O 0 1.5879100256910306e-09
distal O 0 3.1359311947198876e-07
chromosome O 0 0.000177948793862015
arm O 0 0.09174440056085587
3p O 0 0.0023752429988235235
. O 0 1.8872434566219454e-06

The O 0 3.0824616260360926e-05
t O 0 6.766351248188585e-07
( O 0 1.0115278753497492e-10
3 O 0 1.1521341658493611e-09
; O 0 6.262709534993194e-13
15 O 0 9.346946827637481e-12
) O 0 3.6136349988724614e-14
was O 0 1.579537282220267e-12
present O 0 8.440374321769945e-14
in O 0 2.796874331526672e-13
the O 0 7.506186644468116e-12
balanced O 0 9.24720196249229e-12
state O 0 3.1288993206264604e-13
in O 0 9.667311439212622e-13
the O 0 1.273975508420122e-10
patients O 0 8.472270628112621e-12
father O 0 1.3111031704760023e-10
and O 0 1.718541420281383e-10
a O 0 2.0403212452890784e-09
sister O 0 5.7773224426682646e-08
. O 0 7.356568687555409e-08

Fluorescent O 0 1.5103966077845143e-08
in O 0 4.5086545608086226e-11
situ O 0 7.00729363423136e-10
hybridization O 0 1.2281152657334093e-11
analysis O 0 4.049569707342826e-12
demonstrated O 0 1.1417571749161581e-11
that O 0 3.0985337993311157e-13
the O 0 4.2248407550182776e-10
PWS B-Disease 1 1.0
critical O 0 1.3324443770557082e-09
region O 0 7.610521240986046e-11
resided O 0 1.4104394041591917e-10
on O 0 8.842619969584575e-10
the O 0 2.998105583240651e-11
derivative O 0 5.143822520703445e-11
chromosome O 0 3.720942165497121e-10
3 O 0 6.088181070396104e-10
and O 0 1.236295787965247e-12
that O 0 5.825215662483632e-14
there O 0 5.211822184762738e-13
was O 0 5.5965423267911873e-11
no O 0 1.3825200533001958e-11
deletion O 0 3.907172849149099e-11
of O 0 3.6648545309603264e-10
the O 0 9.39285627055142e-09
PWS B-Disease 1 1.0
region O 0 2.7199962282509205e-09
on O 0 2.582825953112433e-09
the O 0 3.7130229446624696e-10
normal O 0 3.6256293522995975e-09
pair O 0 1.8273341173546953e-10
of O 0 4.702347955465314e-10
15s O 0 5.371799449704895e-09
present O 0 1.8612865415601476e-10
in O 0 2.285426292658599e-09
J O 0 0.0002491229970473796
. O 0 2.2606681682191265e-07

B O 0 0.00219735037535429
. O 0 7.504819450332434e-07

Methylation O 0 5.336570652048067e-08
analysis O 0 7.815143532319269e-10
at O 0 3.7774645633703585e-09
exon O 0 4.397316288873299e-09
alpha O 0 6.430462273776527e-10
of O 0 3.0371760662006864e-10
the O 0 2.2276386291153472e-10
small O 0 6.991536516398611e-11
nuclear O 0 1.1633306939984323e-07
ribonucleoprotein O 0 5.144163850445693e-08
- O 0 1.955564243871777e-08
associated O 0 6.59555254856059e-09
polypeptide O 0 1.3786032582174812e-07
N O 0 2.73247019322298e-06
( O 0 6.162741150728124e-11
SNRPN O 0 2.5138271553259983e-07
) O 0 9.093333182795538e-13
gene O 0 1.10946096060216e-11
showed O 0 5.327470062321815e-11
a O 0 4.132166397247117e-12
pattern O 0 1.7788218120706745e-10
characteristic O 0 2.602472681800805e-09
of O 0 1.8260669643055394e-09
only O 0 1.8913324031921697e-11
the O 0 9.76938044350284e-11
maternal O 0 6.56440943269665e-11
chromosome O 0 1.6954523340828587e-09
15 O 0 3.0018107999296717e-09
in O 0 1.1736799310213542e-09
J O 0 0.000549006974324584
. O 0 8.983592181266431e-08

B O 0 0.0019566139671951532
. O 0 1.4411406255021575e-06

Maternal B-Disease 0 7.812340072632651e-07
disomy I-Disease 0 1.6247105349975755e-06
was O 0 7.4485093648490874e-09
confirmed O 0 1.1861606141749803e-10
by O 0 1.1963891682897909e-11
polymerase O 0 3.7904468452865103e-10
chain O 0 3.824632166526953e-09
reaction O 0 1.5657192556362e-11
analysis O 0 3.0420720196350226e-12
of O 0 4.2014537682266706e-11
microsatellite O 0 4.47692682925549e-09
repeats O 0 1.7889620895772396e-09
at O 0 3.197776710095468e-09
the O 0 6.894683157732118e-10
gamma O 0 2.0545410706063194e-08
- O 0 6.166770560867008e-08
aminobutyric O 0 3.802003618602612e-07
acid O 0 5.031614680461871e-09
receptor O 0 1.9806717377335303e-10
beta3 O 0 7.387641165479408e-09
subunit O 0 1.0580747389354883e-09
( O 0 2.2945001801333298e-11
GABRB3 O 0 1.822835571374526e-07
) O 0 3.690977037895671e-11
locus O 0 5.813043824076658e-09
. O 0 5.397146285446297e-09

A O 0 0.00011822926899185404
niece O 0 2.655287289599073e-06
( O 0 4.65114036174441e-09
B O 0 1.1680314173645456e-06
. O 0 2.4305392767876022e-11
B O 0 8.299650966492322e-10
. O 0 1.7271087175436267e-13
) O 0 4.534759866198874e-15
with O 0 2.653486391929801e-14
45 O 0 4.762993818796524e-12
chromosomes O 0 1.2309522975581522e-12
and O 0 3.0732204975292277e-12
the O 0 6.131646579365935e-11
derivative O 0 8.70633704019852e-11
3 O 0 2.003988780474586e-10
but O 0 1.96537599563007e-12
without O 0 6.028986771627887e-12
the O 0 2.2648204492381474e-11
der O 0 4.0088014685579765e-08
( O 0 6.6666317648581e-13
15 O 0 6.536419409203242e-12
) O 0 8.755633208474417e-14
demonstrated O 0 6.666380988895604e-12
a O 0 2.268346751752026e-12
phenotype O 0 1.537005939189484e-11
consistent O 0 3.0751453466981715e-11
with O 0 5.1221098760004247e-14
that O 0 6.238920784076146e-14
reported O 0 9.025993385862463e-13
for O 0 3.5099757302037293e-12
haploinsufficiency O 0 9.50990752812686e-08
of O 0 2.5060039376967325e-08
distal O 0 3.611124554936396e-08
3 O 0 1.8010422309089336e-06
p O 0 4.776723471877631e-06
. O 0 5.6997645714318423e-08

Uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
associated O 0 5.066672059683697e-08
with O 0 5.060164787185073e-11
unbalanced O 0 3.0381528404177516e-08
segregation O 0 2.1181642750889296e-06
of O 0 4.730471570013606e-09
non O 0 3.424979240662651e-06
- O 0 2.475924887335168e-08
Robertsonian O 0 6.081363039811549e-07
translocations O 0 9.604276840491366e-08
has O 0 6.12277659128857e-11
been O 0 9.652613777721974e-12
reported O 0 3.7955669857092644e-11
previously O 0 2.8652002992402004e-09
but O 0 3.5022471034373837e-11
has O 0 1.634169535802421e-11
not O 0 2.6745916679310477e-12
, O 0 1.7690518104226949e-12
to O 0 3.6341121084637606e-12
our O 0 7.187637984795714e-11
knowledge O 0 4.1107863640865716e-11
, O 0 1.9699246574245155e-12
been O 0 7.626700920110308e-13
observed O 0 3.4350428317758697e-12
in O 0 1.6994319363208832e-12
a O 0 4.738042597152159e-11
case O 0 1.792889586793578e-10
of O 0 5.441067330025362e-08
PWS B-Disease 1 1.0
. O 0 1.1046452073060209e-06

Furthermore O 0 7.701085564804089e-07
, O 0 5.658512769457502e-09
our O 0 1.6341307196299226e-09
findings O 0 3.532106204739982e-11
are O 0 6.487949825821626e-13
best O 0 1.2737482509711517e-12
interpreted O 0 8.071273142028212e-13
as O 0 1.8444907060044535e-12
true O 0 3.767294115553099e-11
gamete O 0 7.227691778410872e-09
complementation O 0 1.2049042197759263e-05
resulting O 0 4.4867981552343394e-10
in O 0 1.9335352763327762e-10
maternal B-Disease 0 1.456694008084014e-06
UPD I-Disease 1 1.0
15 I-Disease 0 6.188408406160306e-06
and O 0 8.804483513813466e-06
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9999988079071045
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 0 5.925989171373658e-05
2 I-Disease 0 4.317873026593588e-05
and O 0 5.627075250203006e-09
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 6.673003261070676e-10
a O 0 7.046224020923475e-11
case O 0 6.322302056882556e-12
for O 0 4.393394068685774e-12
" O 0 6.100525640206911e-10
lumping O 0 5.1184989580121965e-09
" O 0 1.974246721658801e-08
. O 0 4.762710670291881e-09

Recent O 0 1.8432977366700243e-09
studies O 0 1.2168167862203205e-10
demonstrated O 0 1.0326279414885065e-10
the O 0 2.823273906327195e-11
existence O 0 1.5481076143242234e-10
of O 0 8.226098691110906e-10
a O 0 2.0584926818667526e-10
genetically O 0 4.632024208639507e-10
distinct O 0 2.939461174467084e-11
, O 0 1.1412498550356087e-11
usually O 0 4.047762992842596e-12
lethal O 0 2.9686808566964373e-11
form O 0 3.4361829787804554e-12
of O 0 3.3836405899378974e-11
the O 0 3.1508290421200513e-10
Schwartz B-Disease 1 0.9970734119415283
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 7.246657940385148e-09
SJS B-Disease 1 0.9854196906089783
) O 0 2.254477854402026e-10
of O 0 2.6800847763297497e-07
myotonia B-Disease 1 1.0
and O 1 0.9998741149902344
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 2.3550492755930463e-07
which O 0 1.3702537993154351e-09
we O 0 2.2618655837192136e-09
called O 0 1.1565210655817282e-07
SJS B-Disease 0 0.0011676591821014881
type I-Disease 0 4.011253622593358e-07
2 I-Disease 0 1.546299472465762e-06
. O 0 1.0686992624187042e-08

This O 0 2.533918186387041e-09
disorder O 0 0.09967148303985596
is O 0 2.1962364218919284e-11
reminiscent O 0 2.0999548766553744e-09
of O 0 4.689602595142617e-10
another O 0 3.656627778347854e-11
rare O 0 7.484678432589931e-10
condition O 0 6.64954171725185e-08
, O 0 7.0431568563456e-12
the O 0 4.925603813710211e-10
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.64138799113789e-07
SWS B-Disease 1 1.0
) O 0 7.152887310235556e-11
, O 0 6.9982040995508754e-12
which O 0 2.892982077853934e-12
comprises O 0 1.0406377148886037e-10
campomelia B-Disease 0 2.452360092775052e-07
at O 0 1.1262502397357821e-07
birth O 0 2.963436429581634e-07
with O 0 4.143980270043812e-09
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 1.0222428237227632e-08
contractures B-Disease 0 0.2472166121006012
, O 0 1.5192797020446847e-10
and O 0 9.264100597761171e-11
early B-Disease 0 1.694938021046255e-07
death I-Disease 0 3.1743158501740254e-07
. O 0 1.7452466138934142e-08

To O 0 6.766978644101584e-10
test O 0 1.408144600922867e-09
for O 0 1.2712539354531316e-11
possible O 0 1.5897881622262133e-10
nosologic O 0 4.610073034427842e-08
identity O 0 4.407429976538424e-11
between O 0 7.243196320505518e-11
these O 0 7.759603376511492e-11
disorders O 0 0.04432787001132965
, O 0 2.549023925962901e-12
we O 0 4.3607495002137564e-13
reviewed O 0 8.468501507680193e-13
the O 0 9.958444659174948e-13
literature O 0 2.55929717522807e-13
and O 0 1.349910715977773e-13
obtained O 0 1.3804219269400453e-12
a O 0 5.231445051462336e-12
follow O 0 2.0158670739622853e-12
- O 0 7.339036496578633e-12
up O 0 3.784735979478482e-12
of O 0 2.40545500185263e-11
the O 0 1.492473158948293e-11
only O 0 7.968936925270564e-13
two O 0 1.7242789227683852e-12
surviving O 0 3.690755256968714e-09
patients O 0 1.5968651748132778e-11
, O 0 3.6147003359271457e-12
one O 0 2.3653843640725203e-12
with O 0 2.9732310363739245e-11
SJS B-Disease 1 0.9705891609191895
type I-Disease 0 3.4834433790820185e-06
2 I-Disease 0 1.8801690657710424e-06
at O 0 4.710815737496432e-09
age O 0 3.610912263640742e-11
10 O 0 1.3039524321412088e-11
years O 0 1.4244911673844118e-12
and O 0 2.850945824903195e-12
another O 0 3.886923335277848e-12
with O 0 2.712238419966262e-11
SWS B-Disease 1 0.9998273253440857
at O 0 4.410119203157592e-08
age O 0 3.175930629595314e-09
7 O 0 1.1574941538583516e-07
years O 0 3.8608907182435814e-09
. O 0 9.380896059951738e-09

Patients O 0 2.467743787093468e-09
reported O 0 7.963930903631677e-11
as O 0 1.819043006501264e-11
having O 0 3.4300509654805467e-10
either O 0 5.659203772268029e-09
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 2.1275812400745053e-07
SWS B-Disease 1 0.9999998807907104
presented O 0 4.147497345563522e-10
a O 0 1.7648761141755842e-12
combination O 0 4.3860431779563225e-12
of O 0 3.782881126401794e-12
a O 0 3.3537361256164022e-12
severe O 0 1.5805893482934152e-08
, O 0 1.5852598097068626e-12
prenatal O 1 0.9712462425231934
- O 1 0.9995263814926147
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 6.49404401781295e-12
with O 0 1.6888801468439851e-10
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 0 7.74177533457987e-05
respiratory O 1 1.0
and O 0 2.8766053219442256e-06
feeding O 0 2.397210607796296e-07
difficulties O 0 2.5671215553302318e-06
, O 0 6.700293098127474e-11
tendency O 0 7.735840440448172e-11
to O 0 5.6044552679268556e-12
hyperthermia B-Disease 0 0.3602348268032074
, O 0 7.107663849842405e-12
and O 0 1.0700044366165895e-12
frequent O 0 1.4517067235819692e-11
death O 0 2.1577467590461197e-10
in O 0 1.958566295257036e-11
infancy O 0 5.380492718032315e-10
) O 0 1.0358517022650629e-13
with O 0 1.5518243970651796e-13
a O 0 3.862050609870771e-11
distinct O 0 4.5394816794441795e-09
campomelic B-Disease 1 0.9997609257698059
- I-Disease 1 0.9999996423721313
metaphyseal I-Disease 1 1.0
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 4.968893699697219e-05

The O 0 8.323149280897724e-09
similarity O 0 2.545845312340589e-09
of O 0 4.493062633059708e-08
the O 0 7.222703324316626e-09
clinical O 0 2.851516728696879e-05
and O 0 1.458415943567104e-09
radiographic O 0 1.427433562639635e-05
findings O 0 3.961836414489994e-10
is O 0 1.2656940599764521e-11
so O 0 3.539494001711385e-13
extensive O 0 7.185735895198775e-10
that O 0 2.2686725761889015e-11
these O 0 7.686925540539846e-10
disorders O 1 0.9205341935157776
appear O 0 1.547525996237198e-10
to O 0 1.8441810578639917e-12
be O 0 5.153650509820418e-12
a O 0 2.57802477282576e-11
single O 0 2.1220546153610798e-10
entity O 0 1.4556793992426265e-08
. O 0 5.506096911744862e-08

The O 0 1.6395927104895236e-07
follow O 0 3.7135066133231476e-09
- O 0 1.6366323851713105e-09
up O 0 6.435085103673188e-11
observation O 0 3.0403712880655576e-09
of O 0 6.900023885592077e-10
an O 0 2.2268419747062396e-12
identical O 0 4.8637423949449143e-11
and O 0 2.9302398181496603e-12
unique O 0 4.215235799298611e-11
pattern O 0 3.470122678095322e-08
of O 0 2.8042695703334175e-05
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 3.299966166991908e-08
the O 0 2.5867567643445e-08
two O 0 6.776627037297089e-10
patients O 0 1.090614265564227e-10
( O 0 3.343312822770561e-12
one O 0 1.1924207281299726e-11
with O 0 3.110980362208693e-10
SJS B-Disease 1 0.9996242523193359
type I-Disease 0 1.0239882612950169e-05
2 I-Disease 0 6.693046543659875e-07
, O 0 7.0424044200378955e-12
one O 0 9.851816628117516e-13
with O 0 4.9076684556503825e-12
SWS B-Disease 1 0.5997410416603088
) O 0 7.804603317784764e-12
surviving O 0 1.797033077899357e-09
beyond O 0 5.79971004555091e-09
infancy O 0 1.3137904986137983e-08
adds O 0 3.784102545201229e-11
to O 0 1.6191799420348096e-12
the O 0 1.7961847287306654e-11
evidence O 0 6.776038497663395e-12
in O 0 2.78672137449254e-12
favor O 0 4.0553067848225766e-11
of O 0 4.8064181107365656e-11
identity O 0 1.584826825329344e-09
. O 0 7.752214870038188e-09

The O 0 1.0839153929964596e-07
hypothesis O 0 4.754607374479747e-08
that O 0 6.756996073775667e-10
SWS B-Disease 1 1.0
and O 0 1.4469645748249604e-06
SJS B-Disease 1 0.9999995231628418
type I-Disease 0 0.0939522236585617
2 I-Disease 0 0.019577033817768097
are O 0 4.289520474931585e-11
the O 0 2.9688693170548675e-10
same O 0 1.341249000752498e-09
disorder O 0 3.8636003409919795e-06
should O 0 1.3544279413302274e-11
be O 0 6.664089310763621e-13
testable O 0 1.2676752009221914e-11
by O 0 5.983204247805504e-14
molecular O 0 1.1773557823113734e-11
methods O 0 5.22364998478686e-11
. O 0 3.9426573117395947e-11
. O 0 1.8580561533809714e-09

A O 0 6.005883079751584e-08
mouse O 0 2.6468158775827533e-09
model O 0 3.76405469293406e-11
of O 0 2.97868757437314e-10
severe O 1 0.9999816417694092
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9996167421340942
defects O 1 0.9999998807907104
in O 0 4.0989212024555854e-09
hemostasis O 1 0.99998939037323
and O 0 3.442209219883807e-07
thrombosis B-Disease 0 0.006588816177099943
. O 0 9.437301855541591e-07

von B-Disease 1 0.8664663434028625
Willebrand I-Disease 1 0.9996780157089233
factor I-Disease 0 2.0364386728033423e-05
( I-Disease 0 2.432323675805037e-08
vWf I-Disease 0 3.6424724385142326e-05
) I-Disease 0 1.889286096456999e-07
deficiency I-Disease 1 1.0
causes O 1 0.9939538836479187
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 2.721129476412898e-06
humans O 0 3.9857819267297145e-09
. O 0 7.057243123220758e-10

We O 0 2.7154709592025483e-09
generated O 0 4.626750024772086e-11
a O 0 5.522264590052117e-11
mouse O 0 2.416515598735458e-10
model O 0 1.019641662769466e-11
for O 0 2.1008251561982494e-12
this O 0 1.986780531759713e-12
disease O 0 7.866795409539051e-11
by O 0 6.22952969590862e-13
using O 0 5.704842848119895e-12
gene O 0 1.1419864359707432e-10
targeting O 0 2.0357264762793648e-09
. O 0 1.5530741137581572e-09

vWf B-Disease 0 0.003742263885214925
- I-Disease 1 0.999972939491272
deficient I-Disease 0 0.0008434416959062219
mice O 0 4.817273975277203e-07
appeared O 0 5.120432522431884e-09
normal O 0 3.431302131318148e-09
at O 0 1.000598270906039e-09
birth O 0 2.376747132437629e-10
; O 0 8.173988287445144e-13
they O 0 3.5516617858527555e-12
were O 0 1.2570905254249976e-11
viable O 0 4.568971867513483e-09
and O 0 2.651888153515358e-10
fertile O 0 2.086326134076444e-08
. O 0 1.1794433874001697e-08

Neither O 0 2.9088794235576643e-06
vWf O 0 7.542498224211158e-06
nor O 0 9.299491239289637e-07
vWf O 0 1.6234032500506146e-06
propolypeptide O 0 5.804731245007133e-06
( O 0 2.0960184698992634e-08
von B-Disease 0 0.002736597089096904
Willebrand I-Disease 1 0.9479990005493164
antigen O 0 7.42877955417498e-06
II O 1 0.9989839196205139
) O 0 6.668877255977534e-11
were O 0 2.974552895662619e-11
detectable O 0 1.8266660406496271e-09
in O 0 1.0469203629015489e-11
plasma O 0 3.98046395844176e-09
, O 0 2.9287551550627455e-11
platelets O 0 1.61376845220218e-09
, O 0 7.047930988823836e-11
or O 0 3.629638950508607e-11
endothelial O 0 3.413219706871473e-10
cells O 0 6.383042965713015e-12
of O 0 1.3316172817190441e-11
the O 0 6.8037272864251985e-12
homozygous O 0 2.2128970877943743e-10
mutant O 0 2.55837626639277e-08
mice O 0 3.303738438376058e-08
. O 0 1.1396370513949705e-09

The O 0 3.057486042123969e-09
mutant O 0 8.152365893465685e-08
mice O 0 2.2187572668030953e-08
exhibited O 0 2.8146864394784643e-08
defects O 0 7.374244160018861e-05
in O 0 4.771480086041002e-11
hemostasis O 0 5.360779482543876e-07
with O 0 1.2969651394523218e-11
a O 0 7.987757677518914e-10
highly O 0 1.0399125116578034e-08
prolonged O 0 0.08615784347057343
bleeding O 0 0.008786863647401333
time O 0 1.3617755811878851e-09
and O 0 2.3792964820579243e-10
spontaneous O 0 1.9838096250168746e-06
bleeding O 0 1.8680428581774322e-07
events O 0 8.341540132239533e-12
in O 0 1.0489465199214898e-12
approximately O 0 1.8905226505366163e-13
10 O 0 9.623787877721668e-12
% O 0 9.690318859834068e-12
of O 0 1.150926243198569e-09
neonates O 0 6.555459464152591e-08
. O 0 2.3639730173385942e-08

As O 0 2.614536642742138e-10
in O 0 2.623822166480938e-11
the O 0 1.187206166708421e-10
human O 0 1.6776896316628154e-08
disease O 0 1.396698735334212e-06
, O 0 5.081274810636582e-12
the O 0 2.5490788299609157e-11
factor O 0 2.43893533841133e-11
VIII O 0 7.85428000416033e-10
level O 0 1.1326288795743267e-09
in O 0 8.457460534856687e-13
these O 0 5.541039090235789e-13
mice O 0 3.2679930983547933e-10
was O 0 4.1134004535869906e-10
reduced O 0 4.816184673295254e-10
strongly O 0 1.7635671568927425e-12
as O 0 1.0350088841537541e-12
a O 0 6.8649933827880094e-12
result O 0 7.143424740618798e-11
of O 0 1.8572295090724111e-10
the O 0 2.181271135937024e-10
lack O 0 2.5953146298718366e-09
of O 0 2.522084485701015e-10
protection O 0 4.513425633234647e-09
provided O 0 2.5821091792499473e-11
by O 0 2.6642379968855323e-10
vWf O 0 5.09791505010071e-07
. O 0 3.866382769501797e-08

Defective O 0 0.004975762218236923
thrombosis B-Disease 0 7.833297388515348e-08
in O 0 1.6987207474006283e-10
mutant O 0 2.2662973719889123e-08
mice O 0 2.4260489173144606e-09
was O 0 1.1189717902260199e-10
also O 0 5.352683357315313e-13
evident O 0 5.069858920701831e-13
in O 0 1.0152136259205993e-14
an O 0 1.05460811185786e-15
in O 0 7.129462086885932e-14
vivo O 0 1.1740622363198838e-10
model O 0 9.680625051577962e-11
of O 0 2.513720787078455e-08
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 1.1532700909810956e-06

In O 0 3.614814281238665e-10
this O 0 1.5302919521842373e-12
model O 0 2.1926871776600798e-11
, O 0 6.277410449090359e-12
the O 0 1.3692837141920933e-10
exteriorized O 0 7.933135748317e-08
mesentery O 0 2.3716873442936048e-07
was O 0 7.657968481566968e-09
superfused O 0 7.906186993977826e-08
with O 0 4.581719448282229e-10
ferric O 0 2.6382901978649898e-06
chloride O 0 3.3080198136303807e-08
and O 0 2.914987140556491e-09
the O 0 5.027950056302188e-09
accumulation O 0 3.5016441302104795e-08
of O 0 7.780739110785362e-07
fluorescently O 0 2.98095233119966e-06
labeled O 0 2.0268011269308772e-08
platelets O 0 1.5863752533817888e-09
was O 0 5.932646596207292e-10
observed O 0 5.499654551210931e-11
by O 0 3.2291544438400877e-11
intravital O 0 1.341069832960784e-07
microscopy O 0 4.572993361762201e-08
. O 0 2.677741228751529e-08

We O 0 1.673461369477991e-08
conclude O 0 1.557085127501523e-08
that O 0 5.3771527161461385e-12
these O 0 2.3330027146273302e-12
mice O 0 6.868982049823558e-10
very O 0 7.891735225376562e-13
closely O 0 1.9827648203851744e-11
mimic O 0 1.0343799061729442e-07
severe O 1 0.9904284477233887
human O 0 0.49688276648521423
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.0029054677579551935
will O 0 6.421148057711434e-10
be O 0 4.3140842460875906e-12
very O 0 1.675919873798254e-13
useful O 0 1.369203280485523e-13
for O 0 1.2260504026959107e-12
investigating O 0 5.713575879778832e-12
the O 0 2.0526108590601666e-11
role O 0 2.4722829686241177e-11
of O 0 8.306013515868571e-11
vWf O 0 3.1029209757171827e-10
in O 0 1.8524808423348027e-11
normal O 0 1.258150206240316e-08
physiology O 0 1.068371169310467e-08
and O 0 7.613595517930172e-12
in O 0 1.3104556328968897e-10
disease O 0 4.983461394658661e-07
models O 0 9.374827580899137e-10
. O 0 2.7146618286622015e-10
. O 0 5.047147588754797e-09

Oral O 0 4.20592405134812e-05
contraceptives O 0 1.7492244523964473e-06
and O 0 9.552689195224673e-11
the O 0 3.076666421630847e-10
risk O 0 1.1890502804590142e-07
of O 0 1.045951466949191e-05
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.017264721915125847

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9999998807907104
Study O 0 2.5166241357510444e-07
Group O 0 5.399589042553998e-08
. O 0 2.1864844157448715e-08

BACKGROUND O 0 1.9823761249426752e-05
Women O 0 4.015223223352571e-11
with O 0 1.128043730473649e-12
mutations O 0 1.2555977091377457e-11
in O 0 7.416731812037725e-11
either O 0 4.1092051983326883e-10
the O 0 3.165353756884315e-09
BRCA1 O 0 2.9263624856668002e-09
or O 0 6.719118317288775e-11
the O 0 1.3934948750460308e-09
BRCA2 O 0 3.837659079408695e-10
gene O 0 7.671992381663717e-12
have O 0 6.629931521319465e-14
a O 0 2.1716120926235788e-13
high O 0 1.397637994920986e-11
lifetime O 0 5.442888362239273e-10
risk O 0 1.548573465015579e-07
of O 0 1.8647497199708596e-05
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.0939841457875445e-05

Oral O 0 0.0017306371591985226
contraceptives O 0 0.4694022238254547
protect O 0 7.212923947008676e-07
against O 1 0.9999996423721313
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 3.393677729945921e-07
general O 0 1.8990026262599713e-07
, O 0 2.6548017256766698e-11
but O 0 2.5080645026098747e-12
it O 0 3.94597088294521e-13
is O 0 4.4702024200315993e-13
not O 0 1.3285765987792325e-13
known O 0 2.9650971348355037e-12
whether O 0 2.239825512562188e-12
they O 0 1.431840540230822e-12
also O 0 8.531664957844853e-13
protect O 0 3.668473944756778e-12
against O 0 9.962900643367689e-11
hereditary B-Disease 0 1.4837845810689032e-05
forms I-Disease 0 6.853598222278379e-08
of I-Disease 0 9.719961963128299e-05
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.796259880393336e-06

METHODS O 0 2.5328768060717266e-07
We O 0 5.817466508517555e-10
enrolled O 0 2.9831564996030124e-10
207 O 0 4.3549791550745454e-10
women O 0 3.253983020534701e-12
with O 0 1.7066806301535564e-10
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.8973614618621468e-08
161 O 0 1.2030762497339254e-10
of O 0 3.734303533065031e-09
their O 0 2.3806774329671043e-09
sisters O 0 2.5409649939689416e-09
as O 0 2.5580844734141017e-11
controls O 0 1.3821952471460008e-08
in O 0 5.193727045660346e-11
a O 0 3.731802367124004e-10
case O 0 5.618481235813988e-10
- O 0 5.543280945374818e-09
control O 0 8.26872081916008e-08
study O 0 5.22441034878085e-10
. O 0 2.1133512717597114e-09

All O 0 6.994264278858964e-09
the O 0 4.9210515662423404e-09
patients O 0 5.211499287671728e-11
carried O 0 1.315200118950921e-11
a O 0 6.867219466688557e-12
pathogenic O 0 8.91914528344806e-11
mutation O 0 3.614467752877104e-11
in O 0 6.002667807258888e-11
either O 0 7.232459631190125e-10
BRCA1 O 0 6.274735731004455e-10
( O 0 1.2745192921881365e-11
179 O 0 1.322919551682844e-10
women O 0 1.0618786232263755e-11
) O 0 3.0976371641344702e-12
or O 0 1.2360165668745537e-10
BRCA2 O 0 1.2722035647172447e-09
( O 0 9.609224874140843e-12
28 O 0 3.1434073122227346e-08
women O 0 4.460497943226116e-11
) O 0 2.129372025927445e-11
. O 0 1.93398630443653e-09

The O 0 1.9739876222502062e-07
control O 0 4.493763481150381e-05
women O 0 2.3369287061036914e-10
were O 0 9.271931833421121e-11
enrolled O 0 1.164685570209656e-10
regardless O 0 5.849421502723828e-10
of O 0 1.716282116426271e-09
whether O 0 1.0862380439569108e-10
or O 0 9.278035284498998e-11
not O 0 2.4853412730618807e-11
they O 0 1.0921583082357245e-11
had O 0 1.2583194208826143e-10
either O 0 2.2081411699126363e-10
mutation O 0 4.94107510462527e-09
. O 0 4.659469254875148e-09

Lifetime O 0 1.5175697143376965e-08
histories O 0 3.912874468881e-09
of O 0 4.41479848234394e-08
oral O 0 4.304847971070558e-05
- O 0 1.0554811069596326e-06
contraceptive O 0 8.046684030205142e-08
use O 0 4.4599959142521683e-11
were O 0 2.680720445971674e-12
obtained O 0 5.935988462921205e-13
by O 0 5.411101796672091e-13
interview O 0 8.898143333269104e-11
or O 0 2.1891830796066936e-13
by O 0 5.1106237704224775e-14
written O 0 5.774275101035758e-14
questionnaire O 0 4.080779852623723e-15
and O 0 2.1626250391718928e-14
were O 0 1.1217523627647316e-13
compared O 0 8.206508525033032e-14
between O 0 1.3972188206770597e-12
patients O 0 9.073049603292027e-12
and O 0 1.0313677863138526e-11
control O 0 2.343771848245524e-05
women O 0 5.115668630893688e-13
, O 0 1.527124645272701e-13
after O 0 6.156628158671129e-12
adjustment O 0 1.354312217927145e-10
for O 0 8.200770249509881e-13
year O 0 1.4009574750284415e-12
of O 0 3.292134273524816e-11
birth O 0 6.658102957857182e-10
and O 0 7.191138240436601e-10
parity O 0 9.891018635244109e-07
. O 0 2.0461289551576556e-08

RESULTS O 0 4.340554227155735e-08
The O 0 5.450503381965177e-10
adjusted O 0 1.0435505792827371e-08
odds O 0 3.630260536624519e-08
ratio O 0 1.0531198135765862e-09
for O 0 5.529803388526489e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 3.286976095751015e-07
with O 0 2.0823861298507884e-12
any O 0 2.0688870755458666e-11
past O 0 1.6433370289559157e-11
use O 0 2.4809496904781847e-12
of O 0 8.703331805248737e-11
oral O 0 1.7509748317934282e-08
contraceptives O 0 3.135245663088426e-08
was O 0 7.286880432388898e-09
0 O 0 2.651481167958991e-08
. O 0 3.9348857505672186e-09

5 O 0 4.2862719595859744e-08
( O 0 1.182546144340435e-10
95 O 0 2.952978750414559e-09
percent O 0 3.94484056531752e-10
confidence O 0 7.288687431383778e-09
interval O 0 2.72471254447737e-08
, O 0 5.999806207412917e-11
0 O 0 1.8221137099150297e-10
. O 0 6.607841444156159e-13
3 O 0 1.4226563503638712e-11
to O 0 4.1896618552944576e-13
0 O 0 2.7722603726521022e-11
. O 0 1.1240939819592843e-12
8 O 0 1.7616559599975545e-10
) O 0 2.8939864827465245e-12
. O 0 1.8585903649448454e-10

The O 0 6.64989698861973e-08
risk O 0 3.7527039253859584e-09
decreased O 0 2.6267163791282577e-11
with O 0 2.08110929883357e-14
increasing O 0 1.2357700583318088e-12
duration O 0 2.9808797791242014e-11
of O 0 1.0311867679191344e-11
use O 0 5.8533776783886715e-12
( O 0 1.7877553821002423e-12
P O 0 4.378301277085939e-09
for O 0 2.6709314013967367e-12
trend O 0 1.5128350794313405e-09
, O 0 2.5427548521611554e-12
< O 0 8.829166564527924e-11
0 O 0 2.825191816602235e-11
. O 0 2.921995056939103e-13
001 O 0 5.198511326270916e-12
) O 0 4.531111271778576e-15
; O 0 7.121259568055487e-16
use O 0 1.957405557897942e-14
for O 0 2.1082421019450598e-13
six O 0 3.580077640591428e-12
or O 0 1.401576744204311e-13
more O 0 2.6171094608671338e-15
years O 0 3.5255199909607626e-13
was O 0 2.6032150393651143e-11
associated O 0 1.788239478370257e-12
with O 0 1.5180550230493167e-13
a O 0 1.0102952328894244e-11
60 O 0 1.1430318497263059e-11
percent O 0 1.7840331642537954e-11
reduction O 0 6.149455611392796e-09
in O 0 4.626337646307377e-10
risk O 0 1.591064631156769e-07
. O 0 1.697481799567413e-08

Oral O 0 0.001788943656720221
- O 0 8.03943294158671e-06
contraceptive O 0 1.1075028396589914e-06
use O 0 2.397829157452236e-10
protected O 0 1.5987288861651905e-06
against O 1 0.8183143138885498
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 2.4458952224692965e-11
for O 0 1.6257994299787026e-12
carriers O 0 1.9826569314269904e-13
of O 0 9.183450007388405e-12
the O 0 1.191962084590159e-10
BRCA1 O 0 3.123186154141422e-10
mutation O 0 8.433720735667727e-12
( O 0 6.662348082074609e-13
odds O 0 2.1494125923560148e-10
ratio O 0 6.630516448391521e-13
, O 0 1.4011224634940395e-13
0 O 0 3.385827642560235e-12
. O 0 8.998897682794063e-14
5 O 0 9.230966685480624e-13
; O 0 6.7943790716773304e-15
95 O 0 5.857152436672397e-12
percent O 0 9.294432411210973e-12
confidence O 0 1.8182738648064856e-10
interval O 0 7.653160882803434e-10
, O 0 4.839144709944954e-12
0 O 0 2.6833098243361775e-11
. O 0 2.407128045067014e-13
3 O 0 1.770638323461693e-12
to O 0 7.174930137868185e-14
0 O 0 2.368960279677812e-12
. O 0 5.2655962408257664e-14
9 O 0 1.9393837664277713e-12
) O 0 2.7094716275016372e-15
and O 0 5.759170555410436e-15
for O 0 4.8214047093956755e-14
carriers O 0 1.263917220667085e-13
of O 0 8.0738948513015e-12
the O 0 3.4661104542088594e-10
BRCA2 O 0 1.9039045895397066e-09
mutation O 0 6.073633956882318e-11
( O 0 5.7528226973802e-12
odds O 0 1.882882960657639e-09
ratio O 0 2.541334330474765e-12
, O 0 5.265408335036748e-13
0 O 0 2.1447468800950276e-11
. O 0 2.561484824161603e-13
4 O 0 1.6304801259137136e-11
; O 0 3.923850990222161e-14
95 O 0 5.4074241612189766e-11
percent O 0 4.4643792135312665e-11
confidence O 0 2.036149693296352e-09
interval O 0 2.6938817843102925e-09
, O 0 2.0113322465875605e-11
0 O 0 7.572294874469421e-11
. O 0 1.2680372160275843e-12
2 O 0 1.8426173781227462e-11
to O 0 5.495381710449165e-13
1 O 0 9.683967516771474e-11
. O 0 1.8570401293105387e-12
1 O 0 1.7913275029979303e-10
) O 0 1.9703644098256756e-12
. O 0 1.3978973534278794e-10

CONCLUSIONS O 0 1.4148725995255518e-06
Oral O 0 0.0006083286716602743
- O 0 5.357025202101795e-06
contraceptive O 0 3.7904331406934944e-07
use O 0 3.338363266380817e-11
may O 0 3.561307932581359e-12
reduce O 0 1.1358296247987454e-11
the O 0 4.449491556451912e-12
risk O 0 6.463642510112777e-09
of O 0 2.5105853637796827e-05
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.674210008990485e-07
women O 0 5.819075690055575e-14
with O 0 2.4023838135294427e-14
pathogenic O 0 2.39043958238927e-11
mutations O 0 3.918529997010145e-12
in O 0 1.9908213966246535e-11
the O 0 7.855823769276071e-10
BRCA1 O 0 1.057827070383155e-08
or O 0 2.3980684105140426e-09
BRCA2 O 0 1.617955263100157e-07
gene O 0 7.116208848856331e-07

A O 0 7.381664772765362e-07
Japanese O 0 1.6202497477024735e-07
family O 0 4.634542749570869e-10
with O 0 1.7002677044075654e-09
adrenoleukodystrophy B-Disease 1 1.0
with O 0 2.304020085830416e-08
a O 0 3.5523058272701746e-08
codon O 0 7.678331570559749e-08
291 O 0 2.509508822967632e-09
deletion O 0 7.954966463330493e-09
: O 0 2.5595144059753494e-11
a O 0 2.4054504915715924e-11
clinical O 0 1.7949716379916936e-08
, O 0 1.38537349994583e-11
biochemical O 0 9.478323015343904e-09
, O 0 2.4280279176114306e-11
pathological O 0 1.520550449640723e-05
, O 0 2.4101623474770406e-11
and O 0 4.54953158479654e-11
genetic O 0 2.054486003544298e-08
report O 0 1.1237439867528565e-09
. O 0 5.961211524407872e-09

We O 0 2.0147246093671356e-09
report O 0 3.404654683181185e-11
a O 0 1.3343071439408938e-11
Japanese O 0 1.279748085281085e-09
family O 0 3.580796423263699e-11
with O 0 4.706020462208471e-09
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.9993465542793274
ALD B-Disease 1 1.0
) O 0 2.124592862751129e-11
with O 0 2.909466938205707e-12
a O 0 8.125885381238263e-11
three O 0 6.756399606455687e-11
base O 0 2.748255845119729e-09
pair O 0 2.8446063282672185e-09
deletion O 0 3.1909099806881613e-09
( O 0 1.6881136766233595e-10
delGAG O 0 6.316974321407542e-08
291 O 0 1.696473517220909e-10
) O 0 1.5451708922781249e-12
in O 0 3.2729447624335606e-11
the O 0 3.2900864255225315e-08
ALD B-Disease 1 1.0
gene O 0 6.270111043704674e-07
. O 0 6.899951188188425e-08

A O 0 1.8467444817815704e-07
variety O 0 3.4083940114726374e-09
of O 0 2.805230492342048e-09
phenotypes O 0 1.5035004352625947e-09
were O 0 9.136753853500323e-11
observed O 0 9.678113865874138e-11
within O 0 1.8493750975068224e-10
this O 0 4.922529744932902e-11
family O 0 3.5303027168254175e-10
. O 0 8.83904949233738e-09

While O 0 8.104455773150221e-09
the O 0 1.1822181456011549e-08
proband O 0 3.7086978409206495e-05
( O 0 4.144122822680174e-09
patient O 0 1.2067316035313524e-08
1 O 0 1.768974478011387e-08
) O 0 4.0204761720362414e-13
was O 0 1.809695969468006e-11
classified O 0 1.0852822546897345e-12
as O 0 8.57905326639985e-13
having O 0 1.747608243014842e-12
a O 0 2.0914257738841036e-12
rare O 0 2.0629213615119824e-11
intermediate O 0 2.6422785834312457e-11
type O 0 3.116924079948902e-11
of O 0 1.4422384120305054e-10
adult O 0 1.56703838793959e-09
cerebral O 0 7.149486691560014e-08
and O 0 9.42236844103661e-10
cerebello O 1 0.9999555349349976
- O 1 0.719974160194397
brain O 0 0.0007545393891632557
stem O 0 1.7880777414269744e-10
forms O 0 2.0136699599437868e-11
, O 0 1.375821982382841e-12
his O 0 2.009998695262638e-10
younger O 0 1.223841306075002e-10
brother O 0 1.0958618013034993e-08
( O 0 8.916865856800626e-11
patient O 0 5.591767937573877e-09
2 O 0 3.3865386939169184e-08
) O 0 3.1730436420712715e-12
and O 0 7.234691318247499e-11
nephew O 0 8.483347357923776e-08
( O 0 1.7891967074579185e-10
patient O 0 4.090004779300216e-08
3 O 0 5.426764104754511e-08
) O 0 6.547050228344897e-12
had O 0 3.820773142315659e-10
a O 0 6.49573905775469e-09
childhood O 1 0.9998140931129456
ALD B-Disease 1 1.0
type O 0 0.0007503250963054597
. O 0 3.304133144865773e-07

Another O 0 1.784558548934001e-06
nephew O 0 0.0005149269127286971
( O 0 4.855389335034488e-08
patient O 0 7.412025979647296e-07
4 O 0 2.331185214643483e-06
) O 0 1.85025623294921e-11
of O 0 5.7094018401926405e-09
patient O 0 3.8805387703177985e-07
1 O 0 2.8878694138256833e-06
was O 0 3.625574063192971e-09
classified O 0 7.790430626986034e-12
as O 0 4.0030171018223815e-12
having O 0 2.2078368647204805e-11
an O 0 2.2649011572478672e-12
adolescent O 0 4.589418622913399e-09
form O 0 8.719220345732026e-10
. O 0 6.1465472711574876e-09

The O 0 4.003521425488543e-08
tau O 0 1.0028629482405904e-08
level O 0 2.3544950433773693e-09
in O 0 1.0129386045221178e-11
the O 0 1.5268357411724054e-10
cerebrospinal O 0 3.733420683715849e-09
fluid O 0 4.096064459835347e-11
( O 0 1.6271753389140997e-10
CSF O 0 1.967165275118532e-08
) O 0 1.729819521130438e-12
in O 0 1.8130991499831772e-11
patient O 0 2.3182924469011823e-09
1 O 0 2.430529022490191e-08
was O 0 1.8299196602455936e-09
as O 0 6.968261904993778e-12
high O 0 3.3275878580374396e-11
as O 0 1.3825344948731333e-13
that O 0 3.45432267046062e-14
of O 0 1.9382532037703903e-11
patients O 0 1.0283589257920056e-10
with O 0 5.915652412369354e-10
Alzheimers B-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
( O 0 3.069818357848142e-11
AD B-Disease 0 7.020671821678093e-10
) O 0 2.142269521498985e-11
. O 0 1.3071735915914928e-09

His O 0 4.859382229938092e-08
brain O 0 3.0485196589324914e-08
magnetic O 0 1.0459773047699628e-09
resonance O 0 5.247309808886769e-10
image O 0 7.706935090112665e-10
( O 0 2.4040914658324253e-12
MRI O 0 2.4677671017769853e-09
) O 0 8.884126615794907e-13
showed O 0 1.7566767485099888e-10
abnormalities B-Disease 0 8.014120567167993e-08
in I-Disease 0 4.223893804167211e-12
the I-Disease 0 1.6009549588802408e-11
bilateral I-Disease 0 3.084306143819049e-09
cerebellar I-Disease 0 8.878630615072325e-05
hemispheres I-Disease 0 3.4677338334176966e-08
and O 0 7.285556602454335e-10
brain O 0 3.1782718679096433e-07
stem O 0 2.582652425253684e-10
, O 0 4.604393580819044e-13
but O 0 1.7252550028792196e-13
not O 0 1.9423145817404341e-13
in O 0 2.6629145936929444e-12
the O 0 4.039098500108196e-10
cerebral O 0 1.2540366967073169e-08
white O 0 6.800237022791533e-12
matter O 0 1.393308753962208e-13
, O 0 1.3116758350859622e-14
where O 0 2.5892220022216174e-14
marked O 0 1.2121177542581685e-12
reductions O 0 9.693465474747143e-11
of O 0 4.939317704844015e-11
the O 0 8.781168153726426e-11
cerebral O 0 6.811563535435994e-10
blood O 0 3.3738114298825783e-12
flow O 0 4.810928131565584e-12
and O 0 1.324822803544512e-11
oxygen O 0 1.5563618449565553e-10
metabolism O 0 1.0207522826988225e-08
were O 0 3.934581480069532e-11
clearly O 0 6.027940299691004e-12
demonstrated O 0 2.427443012223418e-12
by O 0 4.4158231758684163e-13
positron O 0 3.0244855231398304e-11
emission O 0 8.507482496256102e-10
tomography O 0 1.665604876244231e-09
( O 0 1.1015984652251731e-10
PET O 0 1.7777280092445835e-08
) O 0 2.895473444342045e-11
. O 0 1.0842411413136688e-09

In O 0 5.381593393138928e-09
patients O 0 4.3765796542416524e-10
2 O 0 2.644459318190684e-09
and O 0 1.2945727823066022e-11
3 O 0 8.011224461590416e-10
, O 0 1.042013047028445e-12
the O 0 4.1529787421501485e-12
autopsy O 0 2.482094085820563e-09
findings O 0 5.97648059513789e-12
showed O 0 2.0235814413016584e-10
massive O 0 1.5029938182919977e-08
demyelination B-Disease 1 1.0
of I-Disease 0 7.34051297968108e-07
the I-Disease 0 1.02102141852356e-07
cerebral I-Disease 0 3.9048026678756287e-07
white I-Disease 0 3.069162632374223e-11
matter I-Disease 0 7.113206508188585e-13
with O 0 1.9246904688508676e-13
sparing O 0 1.814442346370626e-10
of O 0 8.310744092909772e-09
the O 0 8.135280182841598e-08
U O 1 0.9992228746414185
- O 0 7.109093758117524e-07
fibers O 0 3.462623299199663e-09
, O 0 1.3434801882095115e-11
compatible O 0 2.561690193303434e-09
with O 0 1.0414269273339993e-12
the O 0 5.3596356519580723e-11
findings O 0 2.4797445347113367e-11
of O 0 1.0795115912287656e-09
childhood O 0 0.026783589273691177
ALD B-Disease 1 1.0
. O 0 1.1687701544360607e-06

Oleic O 0 0.000492345483507961
and O 0 3.9111347405196284e-07
erucic O 0 0.00012958288425579667
acids O 0 2.2115660414101512e-08
( O 0 6.44372277758265e-10
Lorenzos O 0 1.1753626267818618e-06
Oil O 0 4.264594899439089e-09
) O 0 9.017652076448446e-12
were O 0 2.6493892149592746e-11
administered O 0 1.0900070429586961e-10
to O 0 5.257094065624912e-11
patients O 0 1.8397212919740724e-10
1 O 0 8.307764254311678e-09
and O 0 3.5377492602073346e-11
4 O 0 2.448717228986652e-09
, O 0 1.194338898613534e-12
but O 0 2.1931406885868088e-13
sufficient O 0 2.2878358929556697e-11
effectiveness O 0 1.8204948659672482e-10
was O 0 1.9877147150459962e-10
not O 0 9.250076399291984e-12
obtained O 0 1.5577220069395992e-10
. O 0 2.9956506164552366e-09

The O 0 8.077792301719455e-08
findings O 0 2.536267029729089e-10
in O 0 4.580039472679154e-11
this O 0 2.1601177443986153e-11
family O 0 1.2313426320242904e-11
suggest O 0 5.021291542284256e-12
that O 0 2.8945040266535604e-13
delGAG291 O 0 4.687241705880751e-10
is O 0 2.955797282280792e-12
part O 0 1.190911431969699e-11
of O 0 1.1287593776332372e-10
the O 0 2.9484353847308853e-10
cause O 0 3.2203377742234807e-09
of O 0 9.38950606155231e-09
Japanese O 0 1.3076503819320351e-05
ALD B-Disease 1 1.0
with O 0 2.5090303168440187e-09
phenotypic O 0 1.9953040464315563e-06
variations O 0 4.50402836804642e-07
. O 0 1.2438226804079022e-07

Moreover O 0 1.754023415401207e-08
, O 0 4.0791071909129784e-11
although O 0 6.0578729532689835e-12
the O 0 9.712412298024109e-12
scale O 0 2.18135953744536e-09
of O 0 5.086002730081418e-10
the O 0 1.334926474916287e-10
study O 0 1.837135044785443e-12
is O 0 1.6759135041104906e-13
limited O 0 3.1195690562008105e-12
, O 0 8.929825737365171e-13
there O 0 4.245289016158171e-12
is O 0 1.7077827867140183e-12
a O 0 1.6740303587781113e-11
possibility O 0 4.48185460966144e-10
that O 0 5.86008325198506e-11
PET O 0 1.647115368541563e-07
can O 0 6.1616918164975054e-12
detect O 0 4.852764301510604e-10
an O 0 2.1506579503394185e-11
insidious B-Disease 0 2.7455965323497367e-07
lesion I-Disease 0 2.318026963621378e-05
which O 0 2.7009788503007393e-11
is O 0 1.3640532930611626e-12
undetectable O 0 1.572420943452002e-10
by O 0 9.621287056990613e-13
computed O 0 1.7016457687368813e-10
tomogram O 0 6.62972325926603e-08
( O 0 2.4538716544841854e-11
CT O 0 2.1083644696773263e-07
) O 0 7.104474885992473e-13
or O 0 2.8534905558222357e-13
MRI O 0 7.382168487612972e-11
analysis O 0 3.3420870780044576e-13
, O 0 1.414883021941954e-13
and O 0 1.4257815577050498e-13
that O 0 1.2099736902519698e-13
the O 0 7.215724979331428e-12
higher O 0 1.2920886582890034e-11
level O 0 2.511743868449656e-10
of O 0 2.889504087388861e-11
tau O 0 4.656354815613106e-11
reflects O 0 2.741559420888634e-13
the O 0 2.952707793980186e-13
process O 0 8.943466626998298e-12
of O 0 4.9397697737818547e-11
neuronal B-Disease 0 1.1408313866922981e-06
degeneration I-Disease 1 0.9999300241470337
in O 0 4.7415849024901036e-08
ALD B-Disease 1 1.0
. O 0 2.466277351231838e-07

Lorenzos O 0 0.00017969751206692308
Oil O 0 1.0793292659627696e-07
should O 0 1.272957850240175e-10
be O 0 9.055256002497847e-13
given O 0 2.1465046808142457e-13
in O 0 6.002020712034262e-13
the O 0 1.4844925635970618e-11
early O 0 2.7184767770194185e-09
stage O 0 2.511324836973472e-08
. O 0 5.059530572282256e-10
. O 0 5.127811952831962e-09

Nonsense O 0 3.2827638278831728e-06
mutation O 0 4.145561671720088e-09
in O 0 3.315230034939276e-10
exon O 0 1.939694804775627e-08
4 O 0 1.965319995633763e-08
of O 0 5.345308196069709e-09
human O 0 4.4731454096336165e-09
complement O 0 5.9223843607014715e-09
C9 O 0 1.5533792065980379e-06
gene O 0 3.79776321501879e-10
is O 0 2.157637783717359e-12
the O 0 1.9180849616939888e-11
major O 0 1.1880086914217713e-09
cause O 0 7.1900450038242525e-09
of O 0 1.318678499728776e-08
Japanese O 0 3.459329036559211e-06
complement B-Disease 0 2.7350663003744557e-05
C9 I-Disease 1 0.9999988079071045
deficiency I-Disease 1 0.9992905855178833
. O 0 4.7359586119455344e-07

Deficiency B-Disease 0 0.039142411202192307
of I-Disease 0 9.796628728508949e-05
the I-Disease 0 1.452535116186482e-06
ninth I-Disease 0 2.0391964426380582e-05
component I-Disease 0 2.2271315458510799e-07
of I-Disease 0 1.1664813115430661e-07
human I-Disease 0 9.83349863759031e-08
complement I-Disease 0 9.129969669174898e-09
( O 0 8.517809235719653e-10
C9 O 0 3.3953265301533975e-06
) O 0 2.397332766329585e-12
is O 0 2.498023218399509e-13
the O 0 2.188879286157963e-12
most O 0 2.794311006540373e-12
common O 0 5.393969004785504e-08
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.3741521343035856e-07
Japan O 0 3.5181692510377616e-05
but O 0 1.3730333710271214e-11
is O 0 1.6991207702973798e-12
rare O 0 1.1746707773152565e-11
in O 0 4.8906057155406746e-12
other O 0 6.002779003033698e-12
countries O 0 6.517785616777516e-11
. O 0 2.08748329733055e-09

We O 0 1.0165454034094523e-09
studied O 0 2.712400026805284e-10
the O 0 1.582764995455843e-11
molecular O 0 1.97971136012276e-11
basis O 0 1.3070133864090394e-10
of O 0 6.460154633458615e-09
C9 B-Disease 1 0.6410073637962341
deficiency I-Disease 0 1.3362326001242764e-07
in O 0 8.270317763958701e-11
four O 0 1.637761870565413e-10
Japanese O 0 5.145047339283337e-07
C9 B-Disease 1 0.9999994039535522
- I-Disease 1 0.9998225569725037
deficient I-Disease 0 0.0008980287238955498
patients O 0 9.604305128974033e-10
who O 0 2.3354882264237098e-11
had O 0 4.90511853357134e-10
suffered O 0 0.004175211768597364
from O 0 3.3439516755606746e-07
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 4.6574633927320974e-08

Direct O 0 1.840367969130341e-09
sequencing O 0 1.2827979789520327e-09
of O 0 2.9862321504481315e-09
amplified O 0 1.0117565452105737e-08
C9 O 0 2.585931042631273e-07
cDNA O 0 4.136881059935149e-09
and O 0 2.6749194872999205e-11
DNA O 0 1.7612830638391586e-10
revealed O 0 1.0974838399180342e-10
a O 0 3.676201357216691e-11
nonsense O 0 4.176694823332383e-10
substitution O 0 1.053573894793658e-09
( O 0 2.7351065856606738e-11
CGA O 0 1.2827619855215744e-08
- O 0 3.218127098136847e-09
- O 0 4.79286521581912e-09
> O 0 2.5242752332843565e-09
TGA O 0 2.676076782393011e-08
) O 0 6.476822116824321e-13
at O 0 2.8802158574814385e-11
codon O 0 4.5928292419228356e-11
95 O 0 7.824312031612379e-11
in O 0 1.5881478424017992e-11
exon O 0 1.148540262896347e-09
4 O 0 5.012091297551535e-10
in O 0 3.315544366833123e-11
the O 0 5.706263239702025e-10
four O 0 2.5056490216002203e-09
C9 B-Disease 0 0.0005245313514024019
- I-Disease 0 3.2439804726891452e-06
deficient I-Disease 0 9.606127093775285e-08
individuals O 0 8.26273355292173e-11
. O 0 9.690148239371865e-09

An O 0 2.6992347246235227e-10
allele O 0 6.163296539796193e-10
- O 0 8.342598833976922e-10
specific O 0 4.926374308489301e-10
polymerase O 0 7.347997321716093e-09
chain O 0 1.214797862303385e-06
reaction O 0 1.0090964730480323e-09
system O 0 1.973334828875295e-09
designed O 0 7.728157003228375e-11
to O 0 5.37796044676464e-13
detect O 0 5.488135553649576e-12
exclusively O 0 3.380239664563245e-12
only O 0 4.013519388796488e-13
one O 0 1.2510615644573814e-13
of O 0 6.421655308203045e-12
the O 0 6.051417613534005e-12
normal O 0 6.780033565828569e-12
and O 0 1.8458059516598957e-13
mutant O 0 7.325415447845263e-12
alleles O 0 7.142051706987562e-14
indicated O 0 7.877448151248634e-13
that O 0 1.0703421723695823e-14
all O 0 3.146638223421039e-13
the O 0 5.469284313636136e-12
four O 0 5.618411985652827e-12
patients O 0 2.430495041338965e-13
were O 0 3.241456040213586e-13
homozygous O 0 2.4002703036957174e-12
for O 0 1.7286419691509014e-12
the O 0 1.2189438694520938e-11
mutation O 0 1.6821337074993115e-12
in O 0 4.5345073182434525e-12
exon O 0 5.552791559892967e-10
4 O 0 1.61892932393215e-09
and O 0 7.982037773801576e-12
that O 0 1.0975328718770827e-12
the O 0 2.14974871237672e-10
parents O 0 4.394986544836721e-12
of O 0 2.677340293910646e-10
patient O 0 3.145660620873514e-09
2 O 0 4.72968864073664e-08
were O 0 1.4178224150285246e-09
heterozygous O 0 5.5855320368891626e-09
. O 0 1.2371899948959708e-08

The O 0 4.7168242645057035e-08
common O 0 6.610111569216315e-09
mutation O 0 3.7473088521089437e-10
at O 0 4.3143377759236046e-09
codon O 0 5.059118013406305e-09
95 O 0 4.5334247467110345e-09
in O 0 6.863455914718486e-10
exon O 0 3.7384101148063564e-08
4 O 0 2.3003185134484738e-08
might O 0 1.8310698443602114e-11
be O 0 1.7614358322620705e-12
responsible O 0 2.6300352520824966e-11
for O 0 1.3610808660691198e-11
most O 0 8.364853254505533e-11
Japanese O 0 1.2558100479509449e-06
C9 B-Disease 1 0.999864935874939
deficiency I-Disease 0 3.0047398468013853e-05
. O 0 3.1935343258737703e-09
. O 0 1.2105722646538197e-08

BRCA1 O 0 7.051787065393e-08
required O 0 3.6409564252437576e-10
for O 0 8.99513588614731e-11
transcription O 0 1.5860469204653782e-07
- O 0 9.387268846694496e-07
coupled O 0 4.165069356076856e-07
repair O 0 1.4755948996025836e-06
of O 0 1.694390334705531e-07
oxidative O 0 0.0011241682805120945
DNA O 0 1.0808284969243687e-06
damage O 0 1.2039911780448165e-05
. O 0 1.073015098995711e-08

The O 0 3.2805166938487673e-06
breast B-Disease 1 1.0
and I-Disease 1 0.9999880790710449
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9999963045120239
gene O 0 1.7362894766392856e-07
BRCA1 O 0 4.094373728946721e-09
encodes O 0 1.1180095738083651e-10
a O 0 1.0960241603186205e-09
zinc O 0 2.7155243387255723e-08
finger O 0 4.313891679430526e-07
protein O 0 1.67754556912314e-08
of O 0 4.042879098165031e-08
unknown O 0 5.5976400403778825e-08
function O 0 4.112973073233661e-08
. O 0 1.5023280397485905e-09

Association O 0 4.50633564241798e-07
of O 0 5.3080444928355064e-08
the O 0 8.410135698966315e-09
BRCA1 O 0 4.4223114059604995e-10
protein O 0 4.6101343229021374e-12
with O 0 4.2341276968935193e-13
the O 0 1.6871640196036708e-10
DNA O 0 2.3619617373071833e-09
repair O 0 2.167293544630411e-08
protein O 0 4.939565423356385e-10
Rad51 O 0 1.6140515590734594e-09
and O 0 1.7811863095573699e-12
changes O 0 6.858786000089878e-13
in O 0 1.5597949093362068e-13
the O 0 1.927721627074594e-13
phosphorylation O 0 2.0338216787790797e-12
and O 0 1.0735122643254491e-12
cellular O 0 5.227001609320325e-10
localization O 0 1.4710472839851718e-08
of O 0 2.208781491042089e-10
the O 0 8.559970787747062e-11
protein O 0 4.364023725722532e-11
after O 0 7.59184728971185e-11
exposure O 0 2.0650166299152062e-10
to O 0 1.7171743194044353e-11
DNA O 0 2.4850985269608827e-08
- O 0 3.5327111902461183e-08
damaging O 0 5.612989628644982e-09
agents O 0 1.0095381128283343e-11
are O 0 1.8383118107184043e-13
consistent O 0 7.052902966514507e-12
with O 0 1.9911420331541335e-13
a O 0 9.033111064704613e-12
role O 0 2.9173982674102206e-11
for O 0 6.775499605815583e-11
BRCA1 O 0 2.157838574490256e-09
in O 0 2.618074645965862e-10
DNA O 0 2.314896505595243e-07
repair O 0 8.163823622453492e-06
. O 0 2.7322801088303095e-07

Here O 0 8.633177372985301e-08
, O 0 8.567484222066213e-11
it O 0 5.307788171655947e-13
is O 0 1.6773910006210452e-13
shown O 0 8.357525283810008e-13
that O 0 7.17615149161549e-13
mouse O 0 2.452872793767824e-09
embryonic O 0 9.555773949898594e-10
stem O 0 1.3130502241054387e-10
cells O 0 4.8917647710311485e-11
deficient B-Disease 0 1.564230550643586e-10
in I-Disease 0 5.787225733355772e-12
BRCA1 I-Disease 0 2.3320750885957864e-10
are O 0 4.580542217226535e-13
defective O 0 3.3597367943283274e-11
in O 0 2.2872413598523655e-12
the O 0 1.6487622031546856e-11
ability O 0 5.997831896940864e-13
to O 0 1.9476084698981377e-13
carry O 0 1.830716351083894e-12
out O 0 3.7716778485130664e-12
transcription O 0 2.3452857433881036e-08
- O 0 4.830357056562207e-07
coupled O 0 4.2952581935651324e-08
repair O 0 2.805238068503968e-07
of O 0 1.9010823137932675e-08
oxidative O 0 3.155276090183179e-06
DNA O 0 4.2152020540697777e-08
damage O 0 2.2322008419450867e-07
, O 0 1.5632663566411686e-11
and O 0 3.7655701473626735e-11
are O 0 8.504391635355546e-12
hypersensitive O 0 7.072217034220785e-09
to O 0 6.227517113099879e-11
ionizing O 0 5.573232328970334e-07
radiation O 0 3.4359482015133835e-07
and O 0 8.560460673656678e-11
hydrogen O 0 8.813658136652691e-10
peroxide O 0 8.06968891708948e-09
. O 0 1.7166136956348055e-08

These O 0 1.404041327646155e-09
results O 0 1.4615655352656631e-09
suggest O 0 1.753008294080871e-10
that O 0 1.0932796334905959e-11
BRCA1 O 0 5.862411112111943e-10
participates O 0 9.860092776980967e-12
, O 0 1.573247174896375e-12
directly O 0 1.5493400833122006e-13
or O 0 1.831392974554688e-13
indirectly O 0 1.7084138194834592e-13
, O 0 1.9695329351795965e-13
in O 0 6.0077615625375724e-12
transcription O 0 1.290549391796958e-07
- O 0 4.892826382274507e-06
coupled O 0 3.960522860779747e-07
repair O 0 9.496745292381092e-07
of O 0 3.3419805589574025e-08
oxidative O 0 4.378564881335478e-06
DNA O 0 3.251179236940516e-08
damage O 0 1.864650300831272e-07
. O 0 2.0691565127961553e-10
. O 0 1.685701245257576e-09

Truncation O 0 2.293483476023539e-06
mutations O 0 1.7621878400930768e-09
in O 0 9.28800300559196e-11
the O 0 1.3306759860665096e-10
transactivation O 0 6.106853334131301e-08
region O 0 1.4376578816310825e-09
of O 0 3.5545815180171303e-09
PAX6 O 0 7.496208127122372e-05
result O 0 1.3750423022429459e-09
in O 0 1.1204753097571185e-10
dominant O 0 8.100658277498951e-08
- O 0 1.6371389577329865e-08
negative O 0 1.2686343087153773e-09
mutants O 0 9.290213398571723e-08
. O 0 6.897843185527108e-09

PAX6 O 1 0.989753007888794
is O 0 2.9042153126823678e-09
a O 0 2.1462866206523046e-10
transcription O 0 1.3273611099151594e-09
factor O 0 5.4320683368080935e-11
with O 0 1.2099557467060151e-12
two O 0 1.0625817066511889e-11
DNA O 0 5.878086906108138e-10
- O 0 2.5420593408043146e-10
binding O 0 3.226520994825677e-10
domains O 0 6.434618116113455e-11
( O 0 2.307555839117792e-12
paired O 0 5.745609890639436e-11
box O 0 1.2587977327171984e-09
and O 0 1.3022399998618983e-11
homeobox O 0 2.6705265776527654e-10
) O 0 4.943063645033996e-13
and O 0 1.1064200770849464e-11
a O 0 4.772692796528588e-10
proline O 0 1.4166154471695336e-07
- O 0 1.3698760881197813e-07
serine O 0 2.6275506570527796e-06
- O 0 2.4386170025536558e-06
threonine O 0 4.905040259473026e-05
( O 0 1.044876518641047e-09
PST O 0 0.0002348698617424816
) O 0 4.567381542419646e-11
- O 0 1.0623071311499643e-09
rich O 0 6.531088864170087e-11
transactivation O 0 6.884654908390075e-07
domain O 0 1.1508635822110591e-07
. O 0 1.4077586207861259e-08

PAX6 O 1 0.9998407363891602
regulates O 0 8.46871807880234e-06
eye O 0 0.0005525121232494712
development O 0 1.0318297327671644e-08
in O 0 7.389916456546075e-11
animals O 0 5.911408862413481e-11
ranging O 0 4.6495235439536486e-10
from O 0 1.8808458263075423e-11
jellyfish O 0 3.2122594514905067e-12
to O 0 2.095246719180377e-12
Drosophila O 0 3.905505918666563e-10
to O 0 3.627493444513519e-11
humans O 0 7.190287809599738e-10
. O 0 1.7872500146509651e-09

Heterozygous O 0 1.2601532262124238e-08
mutations O 0 1.161641755009768e-10
in O 0 1.4313879942440266e-11
the O 0 9.892102414976733e-11
human O 0 2.123497155892551e-09
PAX6 O 0 7.067903879942605e-06
gene O 0 1.899735646571088e-10
result O 0 2.5943473064282685e-11
in O 0 4.695457889690446e-13
various O 0 2.034974185688432e-12
phenotypes O 0 5.380500212037731e-11
, O 0 9.159288995655435e-13
including O 0 3.964162678671279e-11
aniridia B-Disease 1 1.0
, O 0 8.541223728286695e-09
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 2.237805052374142e-09
autosomal B-Disease 0 0.0002846590359695256
dominant I-Disease 0 5.961754868621938e-05
keratitis I-Disease 1 0.9999998807907104
, O 0 2.361047357624102e-09
and O 0 1.2363124746173071e-08
familial B-Disease 1 0.9999998807907104
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.00022004189668223262

It O 0 1.8283277669617348e-10
is O 0 9.525592120640525e-12
believed O 0 2.111648876590433e-11
that O 0 2.1804941478711232e-13
the O 0 1.2365251184087711e-11
mutated O 0 2.9567969600519106e-11
allele O 0 4.040721923725954e-11
of O 0 7.283736391805462e-10
PAX6 O 0 7.398434718197677e-06
produces O 0 2.523156163170004e-11
an O 0 5.203419075824889e-13
inactive O 0 2.9893135189418274e-10
protein O 0 2.9339521923077427e-09
and O 0 1.6044504613788035e-09
aniridia B-Disease 1 1.0
is O 0 2.663338716235586e-10
caused O 0 5.660086288550303e-10
due O 0 4.05104394474165e-09
to O 0 3.3279944772202086e-11
genetic O 0 5.240543288209665e-08
haploinsufficiency O 0 1.6773334436948062e-06
. O 0 2.047901581647693e-08

However O 0 3.5548592958178915e-09
, O 0 3.6364578015479765e-11
several O 0 1.148414262991393e-11
truncation O 0 1.4112750079675607e-08
mutations O 0 1.225537171745117e-10
have O 0 2.2293493006503295e-12
been O 0 8.832324520195722e-13
found O 0 4.467438449880755e-14
to O 0 3.210210485567362e-14
occur O 0 3.3005369270977525e-13
in O 0 1.6314467138345279e-12
the O 0 7.590862660666886e-11
C O 0 5.377686917995561e-08
- O 0 1.6837862215624e-09
terminal O 0 8.909984972049756e-10
half O 0 2.552741221531485e-12
of O 0 6.601420365209831e-12
PAX6 O 0 1.222402516987131e-07
in O 0 1.6735482791241374e-11
patients O 0 4.491074612894552e-12
with O 0 2.573464228175504e-12
Aniridia B-Disease 1 1.0
resulting O 0 7.97065136115549e-10
in O 0 5.372283347349072e-12
mutant O 0 1.5252435425772148e-10
proteins O 0 2.735423432903561e-12
that O 0 1.122309276763156e-12
retain O 0 2.3049760711213452e-10
the O 0 3.2511077163732693e-10
DNA O 0 1.0369568537171858e-09
- O 0 8.57538137721825e-11
binding O 0 8.23678625305746e-11
domains O 0 1.921417018546645e-11
but O 0 6.66882304586891e-12
have O 0 5.7733449097818745e-12
lost O 0 1.3979993829238424e-09
most O 0 4.308172308481462e-12
of O 0 3.4967487239079276e-10
the O 0 1.8159006520690468e-09
transactivation O 0 1.091962076316122e-06
domain O 0 5.747657638721648e-08
. O 0 1.8360351461410573e-08

It O 0 5.804908220774507e-10
is O 0 7.671845797529997e-12
not O 0 7.588364615493393e-13
clear O 0 7.854767183901323e-12
whether O 0 3.856658373734001e-13
such O 0 1.235054419845838e-11
mutants O 0 4.730807745545462e-08
really O 0 1.1638484620490885e-10
behave O 0 9.720821153233472e-13
as O 0 6.7448724556939954e-12
loss O 0 2.0726521887670657e-10
- O 0 3.635959866521432e-10
of O 0 8.126421313647825e-09
- O 0 1.4357040001300447e-09
function O 0 1.047890219041392e-09
mutants O 0 5.884009390833e-10
as O 0 7.2327556270568305e-12
predicted O 0 7.087662678983975e-10
by O 0 5.14661958883611e-11
haploinsufficiency O 0 8.275313803096651e-07
. O 0 7.30922593561445e-08

Contrary O 0 5.397735591827768e-08
to O 0 4.2774943309620284e-11
this O 0 5.737164215924295e-12
theory O 0 3.9847461441588905e-10
, O 0 8.22968429514681e-12
our O 0 2.428176062996279e-11
data O 0 5.650914458588119e-11
showed O 0 1.8742682406092115e-10
that O 0 7.685813790958562e-13
these O 0 7.4897932907797e-13
mutants O 0 4.0624933972388533e-10
are O 0 6.53265202349429e-13
dominant O 0 2.02268229942959e-10
- O 0 3.019194616538101e-11
negative O 0 1.5037477556559264e-12
in O 0 2.1899190360413767e-12
transient O 0 6.112965689197836e-10
transfection O 0 1.833690532748733e-08
assays O 0 3.2022487439498093e-10
when O 0 5.2856281851365594e-11
they O 0 4.052490547995502e-12
are O 0 4.065781728217893e-13
coexpressed O 0 8.467447853988119e-10
with O 0 2.711876209704478e-11
wild O 0 3.469869398031733e-06
- O 0 1.658093879086664e-06
type O 0 1.3419517017609905e-06
PAX6 O 0 0.1615465134382248
. O 0 2.08438180493431e-07

We O 0 3.611873244935282e-09
found O 0 6.645003557820273e-12
that O 0 1.9403744019527713e-13
the O 0 1.2285346351337267e-11
dominant O 0 6.251539286239449e-09
- O 0 1.4041672269371475e-09
negative O 0 9.813361928623365e-11
effects O 0 3.2321361231879564e-07
result O 0 6.173991318192407e-10
from O 0 2.965589362621812e-12
the O 0 2.0663947983279307e-11
enhanced O 0 3.7911770944809575e-10
DNA O 0 3.007368243324038e-10
binding O 0 1.5499630745541282e-10
ability O 0 8.490404559968745e-12
of O 0 6.784111467039722e-11
these O 0 1.5404309772204527e-11
mutants O 0 6.669977903328572e-09
. O 0 4.362280314751388e-09

Kinetic O 0 3.2776910074971966e-08
studies O 0 5.009281878187721e-10
of O 0 7.910372912256491e-10
binding O 0 6.807238106532054e-10
and O 0 3.278855312260909e-11
dissociation O 0 7.688725350840642e-11
revealed O 0 1.5816003021140723e-11
that O 0 8.152310613683197e-14
various O 0 2.367194114338833e-12
truncation O 0 5.497691546452188e-08
mutants O 0 1.0682101425629753e-08
have O 0 2.365299969775414e-11
3 O 0 1.2588001752078526e-09
- O 0 3.8140454683421865e-10
5 O 0 1.4264944780961741e-09
- O 0 6.262921847799419e-10
fold O 0 1.3027748324567767e-10
higher O 0 1.6609267780576253e-11
affinity O 0 7.469108339631936e-13
to O 0 1.3233497414208428e-12
various O 0 8.776307805491435e-12
DNA O 0 7.385478340005136e-11
- O 0 2.9217346857873805e-12
binding O 0 1.688781818380558e-12
sites O 0 4.21837640773165e-13
when O 0 3.6413729562027874e-14
compared O 0 2.449243370237445e-14
with O 0 1.228948176947367e-13
the O 0 4.4788206476908954e-10
wild O 0 2.1650258474892325e-07
- O 0 1.1885923356658168e-07
type O 0 2.4114723373713787e-07
PAX6 O 0 0.000602889689616859
. O 0 1.5378873285953887e-07

These O 0 6.588269929608259e-10
results O 0 2.025384859827284e-10
provide O 0 7.825920467219305e-12
a O 0 1.4522494318214285e-11
new O 0 2.185647149377523e-11
insight O 0 4.831307923169881e-11
into O 0 1.5274166480228057e-12
the O 0 9.991402670495031e-12
role O 0 1.547599201567884e-11
of O 0 1.2514404790220368e-10
mutant O 0 4.033174860751387e-08
PAX6 O 0 4.63205979031045e-05
in O 0 1.2967833473709334e-09
causing O 0 1.9884075186382688e-07
aniridia B-Disease 1 0.9999998807907104
. O 0 1.1400876687162054e-08
. O 0 2.598565629341465e-08

Reversal O 0 4.696401489923119e-08
of O 0 3.4140956728379024e-08
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 1.2073189736838685e-07
excellent O 0 4.043016144095191e-09
neuropsychologic O 0 9.84584787033782e-08
outcome O 0 2.027086276612522e-09
in O 0 1.7956126169282882e-11
very B-Disease 0 1.500594093428731e-11
- I-Disease 0 6.216403392045322e-09
long I-Disease 0 2.0893446972536367e-08
- I-Disease 0 4.861962588620372e-05
chain I-Disease 1 0.9999994039535522
acyl I-Disease 1 1.0
- I-Disease 1 1.0
coenzyme I-Disease 1 0.9999998807907104
A I-Disease 1 0.999504804611206
dehydrogenase I-Disease 1 0.9999972581863403
deficiency I-Disease 1 0.9999836683273315
. O 0 7.46659125638871e-08

Very B-Disease 0 1.0168911046548601e-08
- I-Disease 0 9.189039928969578e-08
long I-Disease 0 3.8325133289163205e-08
- I-Disease 0 2.24166933548986e-06
chain I-Disease 1 0.9995458722114563
acyl I-Disease 1 0.998719334602356
- I-Disease 1 0.9999828338623047
coenzyme I-Disease 1 0.9433113932609558
A I-Disease 0 1.0914832273556385e-06
dehydrogenase I-Disease 0 1.2678317951042573e-08
( I-Disease 0 8.261894640648748e-12
VLCAD I-Disease 0 0.009134946390986443
) I-Disease 0 3.0533742201299674e-11
deficiency I-Disease 0 4.854231860917935e-08
is O 0 1.3060053255867232e-12
a O 0 6.006286440429776e-11
disorder O 1 0.6126896739006042
of O 0 2.091108399326913e-06
fatty O 0 6.147956099766816e-08
acid O 0 2.8763141868282105e-10
beta O 0 1.975201391335446e-10
oxidation O 0 3.1957261836801365e-10
that O 0 2.9282492771710855e-13
reportedly O 0 7.873802304603217e-12
has O 0 5.526302139968915e-14
high O 0 8.717433025440258e-12
rates O 0 3.2525076382183826e-11
of O 0 1.2703837114214078e-11
morbidity O 0 2.128205323970178e-06
and O 0 2.616232785968009e-10
mortality O 0 1.039113385559176e-06
. O 0 9.04019170633319e-09

We O 0 1.1425688173360982e-09
describe O 0 1.267342203403743e-10
the O 0 3.9816216296229e-11
outcome O 0 1.8263375534122162e-10
of O 0 2.1419395423993848e-10
a O 0 4.379031859347293e-11
5 O 0 1.2464997090066987e-10
- O 0 2.91598516166669e-11
year O 0 1.6602269906074163e-11
- O 0 1.8628574238732654e-09
old O 0 4.268208009250429e-09
girl O 0 4.0579478666202817e-10
with O 0 6.402814944905799e-10
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 3.831782535712591e-08
was O 0 2.5762283417662957e-09
first O 0 3.504819698352257e-11
seen O 0 1.4716766000288928e-11
at O 0 2.8568371626680467e-11
5 O 0 7.87366699617209e-12
months O 0 9.311265950981418e-13
of O 0 4.406570160847556e-12
age O 0 9.089002987738848e-12
with O 0 1.3835541219642256e-11
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 0 8.615404112788383e-06
hepatomegaly B-Disease 1 1.0
, O 0 0.00023172618239186704
encephalopathy B-Disease 1 1.0
, O 0 1.3192904191328125e-07
and O 0 3.3603048450459028e-06
hypotonia B-Disease 1 1.0
. O 0 1.2571409570227843e-05

Biochemical O 0 1.1144019254061277e-06
studies O 0 6.218244408273677e-08
indicated O 1 0.8147426247596741
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 0.05960799753665924
by O 0 1.589821468916952e-10
a O 0 1.0018701424030496e-09
stable O 0 6.81225813536912e-08
yet O 0 8.21858636701478e-10
inactive O 0 2.9015644997798518e-08
enzyme O 0 4.710815737496432e-09
. O 0 3.5969618394915415e-09

Molecular O 0 6.414482101035901e-08
genetic O 0 1.9791631444832092e-08
analysis O 0 2.5598770325707676e-10
of O 0 2.3531134374366047e-08
her O 0 5.912181855194376e-09
VLCAD O 0 0.4331955313682556
gene O 0 2.4950391974698505e-08
revealed O 0 5.16759568469638e-09
a O 0 1.9255490257830132e-10
T1372C O 0 1.941237171010357e-09
( O 0 1.29024898404273e-11
F458L O 0 2.2100341556807734e-09
) O 0 1.0290921760580662e-11
missense O 0 6.7769407863238484e-09
mutation O 0 4.1525788363472316e-10
and O 0 2.1647092451893002e-10
a O 0 4.764500349807577e-09
1668 O 0 1.1384619028831366e-05
ACAG O 0 0.002287212060764432
1669 O 0 3.102320079051424e-06
splice O 0 1.5104881185834529e-06
site O 0 5.9604527535839225e-08
mutation O 0 2.9216458585779037e-08
. O 0 1.4120397295869225e-08

After O 0 1.2814553862483535e-09
initial O 0 2.016089295509005e-09
treatment O 0 8.718156196962923e-10
with O 0 1.9603003248436224e-11
intravenous O 0 1.18200782495137e-09
glucose O 0 1.6247491885224008e-06
and O 0 1.66102825938097e-11
carnitine O 0 7.264229773262798e-10
, O 0 8.519241627251428e-13
the O 0 1.0070457488742246e-11
patient O 0 6.750731917914976e-11
has O 0 6.233059858182233e-13
thrived O 0 1.6312205058932605e-11
on O 0 3.781209373387995e-11
a O 0 3.602780573874753e-11
low O 0 8.047893018670038e-09
- O 0 3.2341751499131988e-09
fat O 0 1.5476477877029993e-09
diet O 0 1.6376869305112507e-10
supplemented O 0 1.0666341941634183e-12
with O 0 1.1829008909544636e-13
medium O 0 1.9522130578764063e-09
- O 0 6.515083139646549e-09
chain O 0 4.655491281368995e-08
triglyceride O 0 3.76015698577703e-08
oil O 0 6.177560130105064e-10
and O 0 7.001785956584072e-11
carnitine O 0 3.0224256875044375e-08
and O 0 2.6448060408412744e-10
avoidance O 0 3.077679480156803e-07
of O 0 1.2699373996838403e-08
fasting O 0 5.409061145655869e-07
. O 0 2.299287515938886e-08

Her O 0 2.3080279788700864e-05
ventricular O 1 1.0
hypertrophy O 1 0.999955415725708
resolved O 0 5.650491061715002e-07
significantly O 0 4.8041449290936455e-11
over O 0 1.2256066821147993e-11
1 O 0 2.3124177572775295e-10
year O 0 2.905568147193449e-12
, O 0 1.885410013877098e-12
and O 0 2.5874535153347367e-11
cognitively O 0 1.5476256010060752e-07
, O 0 1.487102802011364e-11
she O 0 7.30267582516042e-12
is O 0 4.0781852721216705e-13
in O 0 1.88299874824549e-12
the O 0 5.930901603168337e-11
superior O 0 3.3286245981756224e-10
range O 0 2.4110416441125437e-10
for O 0 3.563117162430629e-11
age O 0 7.084922426514595e-09
. O 0 2.0162710612225965e-08

Clinical O 0 1.0337206504118512e-06
recognition O 0 7.762499194541306e-07
of O 1 0.999953031539917
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 3.096444345374039e-08
important O 0 5.142706815952636e-10
because O 0 1.8090840240778117e-12
it O 0 3.804158865087365e-13
is O 0 2.741130618929416e-13
one O 0 3.808580512597304e-13
of O 0 6.489193210557076e-11
the O 0 2.3303989293843586e-10
few O 0 1.0120605048458131e-10
directly O 0 2.2646920450064556e-10
treatable O 1 0.9999977350234985
causes O 0 7.609309626843697e-09
of O 0 2.812325874401722e-07
cardiomyopathy B-Disease 1 1.0
in O 0 1.075908695469252e-08
children O 0 6.22675661032801e-11
. O 0 9.691690505686523e-11
. O 0 3.980076712650771e-09

Cloning O 0 1.8189474815244466e-07
of O 0 4.006552423163612e-09
a O 0 6.119121875869382e-11
novel O 0 5.248938436674955e-11
member O 0 6.910293171014104e-11
of O 0 8.136343265796597e-10
the O 0 2.7617079734199024e-09
low O 0 8.179747368330936e-08
- O 0 4.567551670220382e-09
density O 0 9.991107940976462e-10
lipoprotein O 0 3.3495371098979376e-07
receptor O 0 3.754387734034026e-08
family O 0 1.5158331256870383e-09
. O 0 1.0533373284715708e-08

A O 0 3.646728785611231e-08
gene O 0 5.46801492973259e-11
encoding O 0 9.470375005038445e-12
a O 0 1.4149196571333622e-11
novel O 0 1.081165105359938e-11
transmembrane O 0 2.9660152806032514e-11
protein O 0 1.5150512788775217e-11
was O 0 8.439179910446626e-11
identified O 0 5.083094860823534e-13
by O 0 1.271269602174524e-13
DNA O 0 1.1283192262456776e-12
sequence O 0 1.14225049232565e-13
analysis O 0 2.682395118199822e-14
within O 0 2.890642098515167e-13
the O 0 5.0075859257814326e-12
insulin B-Disease 1 1.0
- I-Disease 1 1.0
dependent I-Disease 1 1.0
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 4.970026612483025e-09
IDDM B-Disease 0 8.034466191020329e-06
) O 0 2.439445780794136e-12
locus O 0 3.606041021342321e-10
IDDM4 O 0 1.752870417703889e-07
on O 0 4.805707831678774e-09
chromosome O 0 2.687068345608168e-08
11q13 O 0 1.9009269180969568e-07
. O 0 2.099387330645186e-08

Based O 0 6.914239181199378e-10
on O 0 9.314340410071509e-09
its O 0 1.2215047029418002e-10
chromosomal O 0 2.471400932790857e-07
position O 0 2.3734017418064468e-08
, O 0 4.09557249225756e-11
this O 0 4.2588085835681966e-12
gene O 0 7.250743061515408e-11
is O 0 9.753731025977097e-13
a O 0 8.71915766583603e-13
candidate O 0 1.9793179682064954e-12
for O 0 6.265803847993467e-13
conferring O 0 1.2758168965731898e-09
susceptibility O 0 5.192763978811854e-07
to O 0 2.6635382788242623e-09
diabetes B-Disease 1 1.0
. O 0 1.0691766760828614e-07

The O 0 7.923215861183053e-08
gene O 0 6.097690796735833e-09
, O 0 2.7168994831683335e-10
termed O 0 1.1276630296208623e-08
low O 0 1.2652519032485543e-08
- O 0 5.160727956088351e-10
density O 0 6.893811216324153e-11
lipoprotein O 0 2.0596562233521354e-09
receptor O 0 1.2090618783933138e-10
related O 0 1.00625140164734e-10
protein O 0 1.61413701849078e-10
5 O 0 1.7064177848524764e-09
( O 0 1.3205635586779896e-12
LRP5 O 0 1.9341715784548796e-08
) O 0 1.2055645110670143e-13
, O 0 1.8629955705288387e-13
encodes O 0 5.230125143737552e-13
a O 0 5.2846277701079636e-12
protein O 0 3.408832938145423e-11
of O 0 3.0506528414520062e-09
1615 O 0 1.218541711978105e-07
amino O 0 1.515729097789631e-09
acids O 0 6.376593697510202e-12
that O 0 2.91777886574085e-13
contains O 0 4.755287309754497e-12
conserved O 0 2.3885981734195205e-11
modules O 0 7.805903146085313e-11
which O 0 4.910877477240505e-13
are O 0 9.532980416344927e-14
characteristic O 0 1.3188129754926337e-10
of O 0 6.080800307728396e-10
the O 0 9.868570405302535e-10
low O 0 9.705648729152472e-09
- O 0 5.492372112669841e-10
density O 0 7.214036312763739e-11
lipoprotein O 0 7.901032006429887e-08
( O 0 7.948789404466083e-10
LDL O 0 4.955650751981011e-07
) O 0 4.688580426681632e-11
receptor O 0 8.88424167566626e-10
family O 0 1.5540245479339632e-10
. O 0 3.3911971009104036e-09

These O 0 2.673314070111843e-10
modules O 0 2.1276040929052442e-09
include O 0 1.669458737918461e-10
a O 0 1.1194178917151021e-10
putative O 0 4.3486042544671477e-10
signal O 0 1.1432336188832437e-09
peptide O 0 1.2126925852395942e-10
for O 0 1.0355623476787645e-11
protein O 0 2.3919399447236422e-11
export O 0 1.4567062001091813e-09
, O 0 4.176077886275387e-12
four O 0 3.6815463871908705e-12
epidermal O 0 2.8192626011502853e-09
growth O 0 2.1086392354430217e-10
factor O 0 8.32335849548782e-12
( O 0 1.8096432555583797e-12
EGF O 0 1.2286038852948877e-09
) O 0 2.1659987714008067e-13
repeats O 0 1.7240200586576826e-11
with O 0 7.157260352962103e-13
associated O 0 2.453830749704622e-10
spacer O 0 3.6679335124745194e-09
domains O 0 1.3254661812567292e-09
, O 0 4.954842647286739e-10
three O 0 7.753467312632267e-10
LDL O 0 1.0196669109063805e-07
- O 0 1.9098740366985112e-08
receptor O 0 1.3810001753267187e-10
( O 0 9.961223686183462e-12
LDLR O 0 3.494372720069805e-07
) O 0 1.6940985289939925e-12
repeats O 0 1.0502748670759843e-10
, O 0 7.166949325676519e-12
a O 0 3.1291830238089346e-11
single O 0 1.7111952133053165e-10
transmembrane O 0 7.303741500486183e-10
spanning O 0 8.632641823602683e-10
domain O 0 3.347497390393528e-09
, O 0 6.676156849572124e-11
and O 0 4.451479809763903e-11
a O 0 9.628607910983078e-10
cytoplasmic O 0 2.422938116808382e-08
domain O 0 1.621525846928762e-08
. O 0 8.785599803218247e-09

The O 0 5.378415224299715e-08
encoded O 0 7.951185265753224e-10
protein O 0 6.005190233970836e-10
has O 0 1.0750188933483784e-11
a O 0 4.782492978028241e-12
unique O 0 1.1917135681049906e-11
organization O 0 4.756081084522634e-10
of O 0 3.952751015390277e-09
EGF O 0 2.4192659111577086e-06
and O 0 1.0053444743363116e-09
LDLR O 0 0.0001140597159974277
repeats O 0 1.6818740178337066e-08
; O 0 1.848781544522282e-11
therefore O 0 7.966756421229348e-11
, O 0 2.1470963895708906e-11
LRP5 O 0 2.739472438406665e-05
likely O 0 3.449852625792005e-10
represents O 0 3.394401730180685e-12
a O 0 3.0768627663074755e-12
new O 0 1.1055931344039482e-11
category O 0 5.69774782910315e-10
of O 0 1.5602324987540328e-09
the O 0 1.6865477903138526e-08
LDLR O 0 0.002368636429309845
family O 0 7.4162160856872106e-09
. O 0 6.137423724794644e-08

Both O 0 2.992796765965977e-08
human O 0 1.8370289467384282e-07
and O 0 1.1943254385471391e-08
mouse O 0 8.2448805187596e-06
LRP5 O 1 0.9967138767242432
cDNAs O 0 3.407040276215412e-05
have O 0 7.388369915872772e-10
been O 0 9.853273752469249e-11
isolated O 0 1.1131673360864625e-09
and O 0 3.243227908455992e-11
the O 0 2.885110761408072e-10
encoded O 0 2.8668933893527537e-10
mature O 0 1.039677510750181e-10
proteins O 0 1.6741444385307003e-12
are O 0 1.0065915250845672e-13
95 O 0 2.995824768814437e-11
% O 0 8.526654859605798e-13
identical O 0 1.3184199391946816e-11
, O 0 4.274602590295662e-13
indicating O 0 1.0909049705243312e-11
a O 0 7.038107076307032e-12
high O 0 3.9082983377403124e-11
degree O 0 7.236958254885906e-10
of O 0 1.4539769388477453e-10
evolutionary O 0 9.60690638152073e-10
conservation O 0 1.0547379636349774e-09
. O 0 5.7778865025781556e-11
. O 0 1.9744565982193762e-09

The O 0 9.651250820752466e-08
APC B-Disease 0 1.9475210422115197e-07
variants O 0 1.1447894854299534e-09
I1307K O 0 2.5937326952885087e-08
and O 0 1.1223875995280963e-10
E1317Q O 0 8.040283105970047e-09
are O 0 2.0180560781485335e-12
associated O 0 1.0378927717269448e-09
with O 0 6.052478966012131e-06
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 5.4220330447662946e-09
but O 0 8.357114479606853e-12
not O 0 3.0451372760170736e-12
always O 0 1.7980725415533971e-12
with O 0 2.28445409290734e-13
a O 0 4.5623227418190027e-11
family O 0 9.328727026969297e-12
history O 0 4.758748950450808e-10
. O 0 3.164568829205905e-09

Classical O 1 0.9997931122779846
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9496837854385376
FAP B-Disease 0 2.6072741093230434e-05
) O 0 1.3986781351171818e-11
is O 0 8.633468289234725e-13
a O 0 2.602226940873198e-11
high O 0 0.01119990274310112
- O 1 1.0
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
that O 0 1.9815397586664396e-11
predisposes O 0 3.6725709279261665e-11
to O 0 5.792246565196335e-13
hundreds O 0 2.3690190434355607e-12
or O 0 8.340963011423119e-13
thousands O 0 3.578957876587685e-12
of O 0 1.3203728599364695e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9998025298118591
carcinoma I-Disease 1 1.0
and O 0 3.6071299280848734e-09
that O 0 4.6341311864261936e-12
results O 0 3.00513607054409e-11
from O 0 3.5598611732023944e-12
truncating O 0 2.1234687341831204e-09
mutations O 0 8.212216497105462e-12
in O 0 1.4518230367910334e-11
the O 0 1.1569700753000234e-09
APC B-Disease 0 4.023739563763229e-08
gene O 0 9.000842737805215e-09
. O 0 1.966306228950998e-08

A O 0 6.131912044793353e-08
variant O 0 1.711973851570292e-08
of O 0 3.2874503119728615e-09
FAP B-Disease 0 3.752838608761522e-07
is O 0 5.399892755164615e-10
attenuated B-Disease 1 0.9943976402282715
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 1.3066184578747198e-08
which O 0 1.0575391257150457e-11
results O 0 4.2142310474613254e-11
from O 0 3.74792870350138e-11
germ O 0 0.00070574990240857
- O 0 1.2070381671946961e-07
line O 0 2.7293767246305833e-09
mutations O 0 3.373843522266884e-12
in O 0 4.21854782009512e-12
the O 0 7.188831474547186e-11
5 O 0 1.4308264295603834e-10
and O 0 5.424900546141531e-12
3 O 0 2.440639912393294e-10
regions O 0 1.371890101520279e-10
of O 0 7.327853879246504e-10
the O 0 6.8925825047472244e-09
APC B-Disease 0 1.3594619474588399e-07
gene O 0 2.2477431471656928e-08
. O 0 1.682624706234037e-08

Attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 0.004628132097423077
have O 0 2.7184221887410764e-11
" O 0 6.126202323208929e-10
multiple O 0 8.12431650842882e-08
" O 1 0.9999998807907104
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 1.2162650886438087e-09
typically O 0 9.198632307250154e-12
fewer O 0 7.736718709260015e-13
than O 0 1.4030157515377423e-13
100 O 0 6.242307452192231e-12
) O 0 9.883468419765243e-14
without O 0 7.870514136254503e-12
the O 0 4.029493405610651e-11
florid O 0 1.949080452590124e-09
phenotype O 0 3.415277505247616e-10
of O 0 2.3054771980390854e-10
classical O 0 4.6428377231677587e-07
FAP B-Disease 0 2.7506703190738335e-06
. O 0 2.0112393528393113e-08

Another O 0 5.8585833073721005e-08
group O 0 2.633965046072717e-08
of O 0 2.656821962432332e-08
patients O 0 2.8172827959416225e-10
with O 0 7.274454909972361e-12
multiple O 0 8.958507891065892e-08
adenomas B-Disease 1 0.9954195022583008
has O 0 4.207990206284151e-11
no O 0 2.0180879536924046e-11
mutations O 0 1.7094970187689351e-12
in O 0 5.070818764885132e-12
the O 0 3.537913295659223e-10
APC B-Disease 0 1.5813604870018594e-09
gene O 0 2.279851134268096e-11
, O 0 2.8760917258896512e-12
and O 0 7.303901407296198e-12
their O 0 1.4967778752539296e-11
phenotype O 0 1.075659353255709e-10
probably O 0 1.8899467494476463e-12
results O 0 1.9964327500204826e-12
from O 0 1.3702699998979773e-12
variation O 0 4.518341534254233e-10
at O 0 3.430085326883159e-09
a O 0 4.1853534527014347e-11
locus O 0 1.0213531409508647e-10
, O 0 4.196918854115772e-12
or O 0 2.035738981900903e-12
loci O 0 9.745926288218243e-12
, O 0 2.880978008240609e-12
elsewhere O 0 1.1260064061713315e-11
in O 0 1.802794458855006e-12
the O 0 9.494054847847266e-11
genome O 0 1.3938086240727898e-09
. O 0 7.468454299441873e-09

Recently O 0 2.444346058894098e-08
, O 0 4.002591313945203e-11
however O 0 1.568125143625032e-11
, O 0 1.935197228158936e-12
a O 0 1.41225850458504e-11
missense O 0 1.5172678669017614e-09
variant O 0 3.5885059368467864e-09
of O 0 1.4818674287653266e-07
APC B-Disease 0 3.9971350673795314e-08
( O 0 3.607360243851332e-11
I1307K O 0 4.403451381307377e-09
) O 0 4.5645839538699384e-12
was O 0 5.3438548724971113e-11
described O 0 2.4997547434790768e-12
that O 0 7.395954237498364e-14
confers O 0 7.773864885152193e-12
an O 0 2.425459701518081e-14
increased O 0 2.8976997884511135e-11
risk O 0 2.407574584140093e-08
of O 0 0.12583541870117188
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 8.777991111763583e-10
including O 0 1.9972042075711016e-10
multiple O 0 2.758356032472875e-08
adenomas B-Disease 1 0.8099133372306824
, O 0 3.1482100260049606e-10
in O 0 7.453966333059725e-09
Ashkenazim O 0 8.494358553434722e-06
. O 0 6.502236971073216e-08

We O 0 4.276503151601219e-09
have O 0 6.459503938682776e-12
studied O 0 4.6544549464622165e-11
a O 0 1.0339361311562101e-11
set O 0 1.7347279168689056e-10
of O 0 2.186964845329875e-11
164 O 0 3.256258596096018e-10
patients O 0 1.338275670836886e-11
with O 0 1.1630578444776773e-11
multiple O 1 0.9999998807907104
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 4.266136784281116e-06
/ I-Disease 1 0.9999990463256836
or I-Disease 0 4.137862561037764e-05
carcinoma I-Disease 1 1.0
and O 0 1.8622685615810042e-08
analyzed O 0 1.2342996624781222e-09
codons O 0 1.5074660408842533e-09
1263 O 0 3.1016991641763525e-08
- O 0 1.3178840241323542e-08
1377 O 0 7.712703364859408e-09
( O 0 5.402444810953533e-11
exon O 0 8.625372416304344e-09
15G O 0 2.431029777483218e-08
) O 0 1.9543635373237e-12
of O 0 1.0774642983379934e-10
the O 0 8.98509211477716e-10
APC B-Disease 0 2.4121100672402918e-09
gene O 0 4.378815018912796e-11
for O 0 1.1968395718930935e-10
germ O 0 1.8009098994298256e-06
- O 0 1.4468346876128635e-07
line O 0 3.677595472595385e-08
variants O 0 2.8882466196478163e-08
. O 0 1.4474013099174954e-08

Three O 0 5.6084978439230326e-08
patients O 0 4.1205855394466084e-10
with O 0 6.907680590723109e-12
the O 0 6.442505418036149e-10
I1307K O 0 4.641648843062285e-09
allele O 0 9.651623944506582e-11
were O 0 8.183976933640036e-12
detected O 0 2.4982212479263133e-11
, O 0 2.2033512167562996e-12
each O 0 8.834733617422985e-13
of O 0 1.6015825332615918e-09
Ashkenazi O 0 1.148079178392436e-07
descent O 0 6.479766057054803e-08
. O 0 8.148744257141516e-08

Four O 0 8.802008011343787e-08
patients O 0 4.254990582097662e-09
had O 0 8.122543193600507e-10
a O 0 1.015719841568341e-09
germ O 0 1.7250446035177447e-05
- O 0 2.664084206571715e-07
line O 0 1.9302172304946907e-08
E1317Q O 0 3.1585223325691913e-08
missense O 0 1.6246463729885363e-08
variant O 0 3.573274787171954e-09
of O 0 5.9691989129362355e-09
APC O 0 2.466002735346251e-09
that O 0 2.289436652411214e-12
was O 0 3.6836222960801024e-10
not O 0 8.400612020245668e-13
present O 0 1.059214131335362e-12
in O 0 4.524503167957494e-12
controls O 0 5.199381813980608e-09
; O 0 2.0360301986044327e-12
one O 0 6.57160914227517e-12
of O 0 2.79691603211063e-10
these O 0 3.861253330961212e-12
individuals O 0 8.77585168163747e-13
had O 0 8.260137573934401e-10
an O 0 6.402026912072367e-12
unusually O 0 1.312416703092012e-10
large O 0 1.4563576039572368e-11
number O 0 4.387177288123212e-10
of O 0 4.860707747411652e-08
metaplastic B-Disease 0 0.00027313095051795244
polyps I-Disease 0 8.626906492281705e-06
of I-Disease 0 1.7378465599904303e-07
the I-Disease 0 1.0476293965666628e-07
colorectum I-Disease 0 1.892431828309782e-05
. O 0 3.4678970450841007e-07

There O 0 1.0354849422355983e-08
is O 0 1.4609761317396774e-11
increasing O 0 8.110783746018146e-12
evidence O 0 1.1029392676942251e-11
that O 0 1.3317328468286094e-13
there O 0 5.824452248628931e-13
exist O 0 5.772485787980397e-12
germ O 0 1.0248236925747278e-08
- O 0 2.984089919610966e-10
line O 0 6.381317696479982e-11
variants O 0 8.136908681566357e-12
of O 0 1.4247127089195288e-10
the O 0 3.3895916629056444e-10
APC B-Disease 0 3.811690962862713e-09
gene O 0 1.772957648749074e-11
that O 0 2.6000661584694995e-13
predispose O 0 9.171140409602874e-13
to O 0 6.261464057747551e-14
the O 0 6.579268922203563e-13
development O 0 8.581806272556225e-12
of O 0 5.114180606780039e-11
multiple O 1 0.9999730587005615
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999438524246216
carcinoma I-Disease 1 1.0
, O 0 2.6494664795428946e-10
but O 0 3.478332422438002e-12
without O 0 2.1652409032402176e-11
the O 0 2.6277988465772673e-11
florid O 0 4.3349154821292757e-10
phenotype O 0 1.1283434256381675e-11
of O 0 8.635796071299051e-12
classical O 0 5.403091662969928e-08
FAP B-Disease 0 2.164864199016847e-08
, O 0 9.124293117931948e-13
and O 0 4.4062905993173807e-13
possibly O 0 1.4661863845417955e-13
with O 0 4.0860293393143315e-15
importance O 0 3.345146937228094e-10
for O 0 0.00014854669279884547
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 5.193531933400664e-07
in O 0 3.3274784837222793e-12
the O 0 5.248815704989029e-12
general O 0 3.609900225964857e-11
population O 0 2.4745919831488383e-13
. O 0 7.322482030447386e-12
. O 0 1.1692602441826239e-09

Genomic O 0 5.3430888158345624e-08
structure O 0 4.187617363982099e-09
of O 0 2.841578639056763e-10
the O 0 1.0966662022937612e-09
human O 1 0.7499259114265442
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 0.018081780523061752
CLD B-Disease 1 0.9999997615814209
) O 0 4.743759829395344e-10
gene O 0 1.8030455350981356e-08
. O 0 1.7631503368420454e-08

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999998807907104
CLD B-Disease 1 1.0
) O 0 3.495234934813851e-10
is O 0 8.096904223486856e-12
caused O 0 8.898839304327666e-11
by O 0 1.6327822340705955e-12
mutations O 0 4.488256988288697e-12
in O 0 8.139873323986802e-12
a O 0 1.2011198459449535e-11
gene O 0 7.018120893459434e-12
which O 0 5.279486700246472e-13
encodes O 0 4.1694395332136924e-12
an O 0 2.6365431105707104e-12
intestinal O 0 1.951821332113468e-06
anion O 0 2.384004815780827e-08
transporter O 0 6.100962650634756e-07
. O 0 1.1770162622326552e-08

We O 0 5.616877629677219e-09
report O 0 3.653135086101322e-11
here O 0 1.7728223403179477e-11
the O 0 8.746528674941079e-12
complete O 0 5.974207240022622e-10
genomic O 0 4.900538641550156e-09
organization O 0 4.593394109519977e-09
of O 0 3.3056719583868244e-09
the O 0 6.709789168724001e-09
human O 0 7.199324159046228e-08
CLD B-Disease 0 1.9813365724985488e-05
gene O 0 1.4451826402250845e-09
which O 0 2.3521944808591044e-11
spans O 0 1.248712799828411e-10
approximately O 0 1.2409291476334072e-11
39kb O 0 2.1538511418839335e-08
, O 0 2.2467637472711743e-10
and O 0 5.099047295509251e-10
comprises O 0 4.846735457419982e-09
21 O 0 1.8185363614975358e-07
exons O 0 6.599899279535748e-06
. O 0 1.4958675365051022e-07

All O 0 1.647838132612378e-07
exon O 0 1.1975779443673673e-06
/ O 0 3.789185996083688e-07
intron O 0 1.2202930577132065e-07
boundaries O 0 4.1865231281690285e-09
conform O 0 5.21620580062887e-10
to O 0 1.417234298667358e-11
the O 0 8.384328786803508e-10
GT O 0 1.8995021946466295e-06
/ O 0 1.3341625617613317e-06
AG O 0 2.3972474082256667e-05
rule O 0 1.4071886766942043e-07
. O 0 1.8494052511641712e-08

An O 0 7.249028460831752e-11
analysis O 0 9.667321804185391e-11
of O 0 5.505190969756768e-09
the O 0 6.400107999127158e-09
putative O 0 8.498258097233702e-09
promoter O 0 1.5439403000527818e-07
region O 0 1.2229226520332759e-09
sequence O 0 2.1789259285753815e-10
shows O 0 1.838845187229765e-09
a O 0 4.68845984258337e-09
putative O 0 1.8191053641203325e-07
TATA O 0 0.00014020793605595827
box O 0 4.258549779478926e-07
and O 0 5.651671908246669e-10
predicts O 0 2.582357883085251e-09
multiple O 0 3.0565922015668434e-10
transcription O 0 2.3311702790351774e-08
factor O 0 1.5616675730356633e-09
binding O 0 5.917525913723409e-10
sites O 0 6.399152319147561e-10
. O 0 1.815703365437571e-09

The O 0 6.892977300054781e-09
genomic O 0 2.3981243657544837e-08
structure O 0 2.980463520430021e-08
was O 0 7.763475196043146e-09
determined O 0 1.7495409287970887e-10
using O 0 9.094240117912822e-12
DNA O 0 4.8815961689596676e-11
from O 0 3.988549670663061e-13
several O 0 2.5723195275217936e-13
sources O 0 1.09782181175605e-12
including O 0 1.5575838145306942e-12
multiple O 0 2.241403590508284e-11
large O 0 1.1916488906749123e-09
- O 0 4.5949303029146904e-08
insert O 0 9.1168139704223e-09
libaries O 0 3.556658256798073e-08
and O 0 2.9287496039476224e-11
genomic O 0 5.25194820966135e-09
DNA O 0 6.130506768897703e-09
from O 0 1.5123727270527354e-10
Finnish O 0 4.732395973405801e-05
CLD B-Disease 1 0.9999994039535522
patients O 0 1.5591981039619895e-08
and O 0 1.0262433125518555e-09
controls O 0 2.7968233553110622e-05
. O 0 1.8857920736081724e-07

Exon O 0 7.600987373734824e-06
- O 0 4.827455768463551e-08
specific O 0 4.1408182438473773e-10
primers O 0 7.855494033037758e-10
developed O 0 2.4607193019332563e-11
in O 0 2.4677022578134533e-12
this O 0 2.721791704778792e-13
study O 0 3.522582345174413e-13
will O 0 2.576213168573732e-13
facilitate O 0 1.2552863262738079e-11
mutation O 0 4.418529778171809e-12
screening O 0 5.079029904986321e-11
studies O 0 3.0054669690471325e-12
of O 0 3.0579493798255086e-11
patients O 0 3.0103838258993543e-12
with O 0 1.4849958285614862e-12
the O 0 8.144156460332397e-09
disease O 0 0.002328132512047887
. O 0 1.1549686540490711e-08

Genomic O 0 1.0560450292018686e-08
sequencing O 0 3.920300084558903e-09
of O 0 2.7767944388301657e-08
a O 0 7.226481812949714e-08
BAC O 0 0.00015326148422900587
clone O 0 2.6173436708631925e-05
H O 1 1.0
_ O 0 3.528269898467329e-10
RG364P16 O 0 2.387452679997182e-09
revealed O 0 1.4920727153810986e-10
the O 0 1.585345223154011e-11
presence O 0 5.703972450615824e-12
of O 0 4.915954865403194e-10
another O 0 8.40775296606644e-11
, O 0 1.936804536195602e-11
highly O 0 2.974286442136709e-11
homologous O 0 2.941322879701502e-11
gene O 0 1.5919698892474798e-10
3 O 0 1.0277207529441057e-08
of O 0 1.0965726104927853e-08
the O 0 5.347727594084972e-08
CLD B-Disease 0 0.00013605605636257678
gene O 0 1.864890686320564e-09
, O 0 1.2830389528595276e-11
with O 0 1.5833983429969223e-12
a O 0 2.0848989201738277e-11
similar O 0 4.323161620356508e-12
genomic O 0 1.5903681704898531e-09
structure O 0 1.3252039465783128e-08
, O 0 1.3813707989973611e-11
recently O 0 7.596655943187258e-11
identified O 0 8.622069204433647e-12
as O 0 1.1010160665125834e-11
the O 0 1.3591684222546974e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 1.9313741006499185e-07
( O 0 8.575989918213622e-10
PDS B-Disease 0 1.5239270396705251e-06
) O 0 7.648643871038807e-12
. O 0 4.936868969185326e-11
. O 0 2.339703986109498e-09

The O 0 4.973765399540753e-08
APCI1307K O 0 0.0017387873958796263
allele O 0 3.283630007899774e-07
and O 0 8.199910972450652e-09
cancer B-Disease 0 0.007501210551708937
risk O 0 1.2036650787194958e-08
in O 0 3.158035638550771e-11
a O 0 8.013344154900182e-11
community O 0 7.278191938020484e-11
- O 0 7.254478268103881e-11
based O 0 7.151764857410425e-12
study O 0 8.720658743743837e-12
of O 0 3.4990571551318794e-10
Ashkenazi O 0 7.3807395750691285e-09
Jews O 0 1.487779344166995e-09
. O 0 9.208107165648016e-09

Mutations O 0 7.135207535924337e-09
in O 0 8.892718228459273e-10
APC O 0 7.95580490375869e-08
are O 0 2.240304079401123e-12
classically O 0 2.4014188415577564e-09
associated O 0 1.3043492952391489e-09
with O 0 2.6569740185777846e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 0.00013709162885788828
FAP B-Disease 0 2.7665391826303676e-06
) O 0 1.1665097056703932e-12
, O 0 2.7149062078318797e-13
a O 0 1.3423224337616446e-11
highly O 0 1.5198267533378385e-07
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 3.1556755857309327e-05
by O 0 1.6370677383137355e-11
multiple O 0 1.0279676665447823e-08
intestinal O 1 0.9999998807907104
polyps B-Disease 0 0.03710241615772247
and O 0 9.0069646185853e-11
, O 0 4.243912946760853e-12
without O 0 9.745577955744267e-11
surgical O 0 1.3657524505106267e-05
intervention O 0 1.1468924476787379e-08
, O 0 7.856890593856136e-13
the O 0 3.7941173640365644e-12
development O 0 6.340398206461373e-10
of O 0 1.019073351926636e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.6026476146180357e-07
CRC B-Disease 1 0.998794436454773
) O 0 2.9760299780079436e-10
. O 0 5.087702703576724e-09

APC B-Disease 0 1.4281511539593339e-05
is O 0 1.8505474930208266e-09
a O 0 6.194577739648821e-09
tumour O 1 1.0
- O 0 6.00271675921249e-07
suppressor O 0 2.0618591634047334e-07
gene O 0 5.803524327774312e-10
, O 0 4.322221833913398e-12
and O 0 2.373665326793617e-11
somatic O 0 9.95610207610298e-07
loss O 0 3.783335955631628e-08
occurs O 0 1.2880865263298347e-09
in O 0 4.710106082939092e-09
tumours B-Disease 1 1.0
. O 0 3.1243871490005404e-07

The O 0 3.933664913802204e-07
germline O 0 2.2646936486125924e-06
T O 0 6.695792365007947e-08
- O 0 1.3564761813800175e-10
to O 0 1.6913356132297608e-11
- O 0 2.2164327317941712e-10
A O 0 2.3471136145758464e-10
transversion O 0 2.5500050959692544e-09
responsible O 0 1.398385296447202e-10
for O 0 6.528221106055776e-12
the O 0 3.2722469178736446e-10
APC O 0 3.7023322185802954e-09
I1307K O 0 1.287968509622317e-09
allele O 0 1.1159750207268004e-10
converts O 0 9.75240235789876e-11
the O 0 1.8784841737673474e-10
wild O 0 3.320363983760899e-09
- O 0 9.551286150877303e-11
type O 0 4.920764837268443e-11
sequence O 0 2.6079161399850115e-11
to O 0 1.3120806524602457e-11
a O 0 1.943793570546859e-09
homopolymer O 0 0.0007083136588335037
tract O 0 0.001686273142695427
( O 0 1.37937650190878e-09
A8 O 0 4.973338718627929e-07
) O 0 2.656612451724938e-13
that O 0 1.813401588179192e-13
is O 0 5.035274714543236e-12
genetically O 0 2.760507156196468e-09
unstable O 0 1.7632478588325284e-08
and O 0 2.0252506338636067e-09
prone O 0 2.9554763969485975e-08
to O 0 5.313376960636162e-10
somatic O 0 4.90459096909035e-05
mutation O 0 8.802611972669183e-08
. O 0 9.196874373174069e-09

The O 0 4.3377568204050476e-08
I1307K O 0 1.479647551150265e-07
allele O 0 3.5721914315445247e-09
was O 0 1.8870678353266612e-09
found O 0 1.6424347992760602e-11
in O 0 5.145098236347678e-11
6 O 0 1.3881587790365302e-07
. O 0 4.167094402873772e-08

1 O 0 1.952523547288365e-07
% O 0 3.778925783404219e-10
of O 0 2.4172914780962174e-09
unselected O 0 1.2912235433759633e-05
Ashkenazi O 0 5.41283839083917e-07
Jews O 0 4.639869377598416e-09
and O 0 6.538620755947022e-10
higher O 0 2.7245188327640335e-09
proportions O 0 1.0416454365724803e-08
of O 0 1.3982701148052001e-06
Ashkenazim O 0 0.0005368607235141098
with O 0 2.8150768383028435e-09
family O 0 1.0425195151597677e-09
or O 0 1.1358518292592379e-10
personal O 0 7.190620987529428e-09
histories O 0 2.4434182677168792e-08
of O 0 0.0073221237398684025
CRC B-Disease 1 1.0
( O 0 1.0694021224111339e-09
ref O 0 4.163765865428104e-08
. O 0 1.8843694660208854e-10
2 O 0 4.322541435897165e-09
) O 0 2.911489105361653e-11
. O 0 1.2911340885324307e-09

To O 0 2.9620195185486864e-10
evaluate O 0 2.995072245770558e-10
the O 0 6.771919830450557e-11
role O 0 5.4780572439350195e-11
of O 0 3.697411821157459e-10
I1307K O 0 1.2502011870196839e-08
in O 0 5.485755738554587e-10
cancer B-Disease 0 1.6440206707102334e-07
, O 0 1.292471407676743e-10
we O 0 2.2221174900138863e-10
genotyped O 0 4.6161798650246055e-07
5 O 0 6.830929066836688e-08
, O 0 1.0913764336706322e-09
081 O 0 5.939960828982294e-06
Ashkenazi O 0 9.01166519184926e-09
volunteers O 0 3.7568895910888855e-11
in O 0 1.6394488197568613e-11
a O 0 9.709305581750982e-11
community O 0 4.660800079214766e-10
survey O 0 1.7908774463393229e-09
. O 0 2.7586979811644596e-08

Risk O 0 8.225149628060535e-08
of O 0 7.114849598366391e-09
developing O 0 0.0597403310239315
colorectal B-Disease 1 1.0
, I-Disease 0 1.0540085213506245e-06
breast I-Disease 0 0.15687651932239532
and I-Disease 0 3.570612605585666e-08
other I-Disease 0 6.356869697299317e-09
cancers I-Disease 1 0.9998894929885864
were O 0 3.2434890884225354e-10
compared O 0 6.586177350026423e-12
between O 0 3.0951952112445724e-10
genotyped O 0 1.5210393030429259e-05
I1307K O 0 1.0680822271069701e-07
carriers O 0 1.7174721714252605e-11
and O 0 6.019759777459166e-12
non O 0 1.0552758666904083e-08
- O 0 8.240620685828759e-11
carriers O 0 5.05619417862091e-13
and O 0 3.9741896839390334e-13
their O 0 8.361192055557354e-13
first O 0 1.768985131989087e-11
- O 0 1.715767389276479e-10
degree O 0 6.876405223010806e-09
relatives O 0 1.3511317620285013e-09
. O 0 2.360097228759628e-09

Sperm O 0 2.470682547439651e-09
DNA O 0 5.693044369259326e-10
analysis O 0 7.698465129268861e-12
in O 0 1.8825363143348817e-11
a O 0 4.941206999120595e-09
Friedreich B-Disease 1 0.9999997615814209
ataxia I-Disease 1 1.0
premutation O 1 0.9999914169311523
carrier O 0 2.6631669243215583e-06
suggests O 0 7.194283835332271e-09
both O 0 1.6189222185047925e-10
meiotic O 0 9.96951712295413e-07
and O 0 5.029789362787085e-10
mitotic O 0 1.0233742742116192e-08
expansion O 0 3.861899688928361e-09
in O 0 1.6450031614656524e-10
the O 0 1.9700816533685384e-09
FRDA B-Disease 0 1.0444652616570238e-05
gene O 0 5.775052969170247e-08
. O 0 2.7715877592981997e-08

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 0.0002303779765497893
usually O 0 2.333709447910337e-09
caused O 0 6.009759356828681e-11
by O 0 1.7760729139563308e-13
an O 0 5.32748216201806e-14
expansion O 0 2.3109847369084946e-10
of O 0 2.5921484958502106e-09
a O 0 1.9410455465163068e-08
GAA O 0 1.649369210099394e-06
trinucleotide O 0 7.331397000598372e-07
repeat O 0 1.775271485371377e-08
in O 0 5.620111043214138e-10
intron O 0 4.401346131999162e-08
1 O 0 5.009821535395531e-08
of O 0 5.130159852484439e-09
the O 0 1.756175826983508e-08
FRDA B-Disease 0 6.789108010707423e-05
gene O 0 1.0763730529106397e-07
. O 0 2.031057988460816e-08

Occasionally O 0 1.955448603041532e-08
, O 0 1.939848143228673e-10
a O 0 8.300945347761157e-11
fully O 0 2.5331581277043824e-10
expanded O 0 4.539857725860408e-11
allele O 0 7.387408046399813e-11
has O 0 5.1073741590135224e-12
been O 0 4.84734734990111e-12
found O 0 7.846287638710314e-13
to O 0 6.205811689183327e-13
arise O 0 3.644552108023058e-12
from O 0 2.0735279812611473e-12
a O 0 1.95949680092955e-11
premutation O 0 7.72406849591789e-09
of O 0 2.571790114203054e-09
100 O 0 1.3880304683411282e-09
or O 0 1.0526092497631367e-10
less O 0 2.724085956806732e-10
triplet O 0 3.238445742681506e-07
repeats O 0 3.372142884927598e-07
. O 0 9.233946940412352e-08

We O 0 2.454694580933392e-08
have O 0 4.5528303349584576e-11
examined O 0 1.2507293811747644e-10
the O 0 1.4958424776612134e-10
sperm O 0 3.5426651195935577e-11
DNA O 0 6.048653800050374e-10
of O 0 1.0488000468100722e-09
a O 0 2.76393685716414e-09
premutation O 0 1.6482732689837576e-06
carrier O 0 1.4013509996857465e-07
. O 0 9.813749812792594e-08

This O 0 7.689491265949755e-10
mans O 0 3.154618468670378e-07
leucocyte O 0 1.1634283225703257e-07
DNA O 0 1.787400005781592e-09
showed O 0 1.6406821734538113e-10
one O 0 9.088183222476232e-13
normal O 0 3.3900427603983374e-11
allele O 0 3.069406924807727e-12
and O 0 1.3172881839149109e-12
one O 0 7.426024313701707e-13
allele O 0 4.009190982673383e-12
of O 0 6.259383983353572e-11
approximately O 0 1.436099763413301e-11
100 O 0 6.587025369597654e-10
repeats O 0 1.6652561996011173e-08
. O 0 2.927491671300686e-08

His O 0 1.4355296507062576e-08
sperm O 0 8.802061857160481e-11
showed O 0 4.346711532376979e-11
an O 0 9.217855022032942e-14
expanded O 0 1.6069593572476393e-12
allele O 0 5.3652585846331036e-12
in O 0 3.4009097621412465e-11
a O 0 1.2079423017397062e-09
tight O 0 5.963465810054913e-08
range O 0 1.5449167500847238e-09
centering O 0 1.3439474533250007e-10
on O 0 6.208828451370607e-10
a O 0 2.316195325813286e-11
size O 0 7.546971728111806e-12
of O 0 1.937230376114485e-10
approximately O 0 1.5176983281239842e-10
320 O 0 6.721710965607031e-10
trinucleotide O 0 1.8347036530030891e-06
repeats O 0 3.7193922253209166e-07
. O 0 1.5473747794203518e-07

His O 0 9.240322356163233e-07
affected O 0 1.3430127410174464e-07
son O 0 1.872448365247692e-07
has O 0 1.853436959464716e-09
repeat O 0 2.0612489493032626e-08
sizes O 0 1.291013407289654e-09
of O 0 4.8298687715941924e-08
1040 O 0 7.616107922103765e-08
and O 0 2.2449184733375205e-09
540 O 0 2.6750358372851224e-08
. O 0 2.2935191523743015e-08

These O 0 1.005097116646425e-09
data O 0 1.0739152900285376e-09
suggest O 0 8.342144683370911e-12
that O 0 5.339079059505508e-14
expansion O 0 1.3839130362514052e-11
occurs O 0 1.4849981053860484e-13
in O 0 1.549440507538427e-13
two O 0 2.3033463157628997e-13
stages O 0 4.817038989912703e-10
, O 0 1.4982223361242886e-12
the O 0 8.18741168612247e-12
first O 0 7.616325105319621e-12
during O 0 4.011671550507856e-11
meiosis O 0 2.401736969026569e-11
followed O 0 2.0740234182858863e-11
by O 0 9.896078748128367e-12
a O 0 3.19885479216353e-10
second O 0 1.7266181817632287e-09
mitotic O 0 8.612141755293123e-08
expansion O 0 3.461734365828306e-07
. O 0 7.264873858048304e-08

We O 0 1.9775925341747325e-09
also O 0 5.078678363273914e-12
show O 0 2.6606603205359125e-12
that O 0 6.0714474626241e-14
in O 0 6.592369879154791e-13
all O 0 2.15011970901291e-12
informative O 0 1.554326112263027e-11
carrier O 0 1.6238571251547818e-11
father O 0 1.6822243251168878e-11
to O 0 4.735419955465003e-12
affected O 0 1.469068269810414e-11
child O 0 1.703456820045801e-11
transmissions O 0 4.548249554758854e-10
, O 0 6.652354990650811e-13
with O 0 1.0578224494267596e-13
the O 0 1.1814769648732515e-11
notable O 0 1.9863001868292152e-11
exception O 0 3.142820725887674e-11
of O 0 7.252420886061373e-10
the O 0 1.9684103236272676e-09
premutation O 0 7.298819326706507e-08
carrier O 0 5.551266668568644e-10
, O 0 4.275340845238951e-11
the O 0 1.374412250676471e-10
expansion O 0 3.1658592414274267e-10
size O 0 1.8705710591593316e-11
decreases O 0 1.496949925128277e-10
. O 0 9.109712290067407e-11
. O 0 4.361023986376722e-09

The O 0 6.103522309786058e-08
R496H O 0 3.0242830462157144e-07
mutation O 0 5.037933625828828e-09
of O 0 1.1812692157775473e-08
arylsulfatase O 0 1.543786856927909e-05
A O 0 2.95790243853844e-07
does O 0 4.132058584183085e-11
not O 0 6.09048991795369e-11
cause O 0 6.164360684124404e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 4.438041685261851e-07

Deficiency B-Disease 1 0.9993324875831604
of I-Disease 0 0.00152718520257622
arylsulfatase I-Disease 1 0.9999769926071167
A I-Disease 1 0.9406120777130127
( O 0 1.942875371696573e-08
ARSA O 0 0.03726373240351677
) O 0 2.668388010551581e-10
enzyme O 0 3.461254616254905e-10
activity O 0 6.822892029134664e-09
causes O 0 1.6076777455964475e-06
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 7.715862011536956e-06
MLD B-Disease 1 1.0
) O 0 1.3879165594588017e-09
. O 0 2.3389321590627787e-09

A O 0 4.6853337209995516e-08
number O 0 1.4046170893067256e-09
of O 0 2.2324556425701303e-08
ARSA O 0 0.0012543740449473262
gene O 0 1.5780589279756896e-08
mutations O 0 5.710749095833023e-10
responsible O 0 4.7265298341869766e-09
for O 0 2.9829645420420547e-09
MLD B-Disease 1 1.0
have O 0 2.4057282832501414e-09
been O 0 7.143782787544239e-10
identified O 0 5.124477286955198e-09
. O 0 1.9847655963189936e-08

Recently O 0 6.367903182535883e-08
, O 0 1.2693743278724412e-10
the O 0 1.5193986346861976e-10
R496H O 0 8.797404582594481e-09
mutation O 0 5.317970508400549e-10
of O 0 5.770348199263253e-09
ARSA O 0 0.0003760674153454602
was O 0 1.3010180488493006e-08
proposed O 0 1.259498338956888e-10
to O 0 1.4288804514595022e-12
be O 0 2.4648280378541942e-12
a O 0 1.166959757992192e-11
cause O 0 1.9565931097531575e-09
of O 0 8.047211395023623e-07
MLD B-Disease 1 1.0
( O 0 1.3504696250166148e-09
Draghia O 0 6.333103783617844e-07
et O 0 4.787344209944422e-07
al O 0 1.3382751795631975e-08
. O 0 2.9074435567433277e-11
, O 0 9.710040931032449e-12
1997 O 0 4.859331270701261e-10
) O 0 2.983803829015308e-11
. O 0 2.338655491485042e-09

We O 0 6.0096159160138996e-09
have O 0 1.99296412706218e-11
investigated O 0 1.06234514241077e-10
the O 0 4.053551244664888e-11
R496H O 0 2.4361761497004863e-09
mutation O 0 3.637116302579457e-11
and O 0 6.950099675460952e-13
found O 0 6.068436768716379e-14
this O 0 2.400625034317764e-14
mutation O 0 1.4191649157918595e-12
at O 0 3.9167235427184366e-11
a O 0 1.33910742737553e-12
relatively O 0 2.318606461340633e-13
high O 0 4.1754701909577085e-13
frequency O 0 1.4117083153505905e-12
in O 0 1.509094092093724e-13
an O 0 3.829272307771282e-14
African O 0 3.2511909831001162e-12
American O 0 1.7961599005009155e-12
population O 0 1.643780597748723e-13
( O 0 3.3306197426766215e-13
f O 0 1.4145540294663306e-09
= O 0 4.027743416568086e-10
0 O 0 2.5789997915026674e-10
. O 0 2.0592878530872882e-12
09 O 0 4.7888578519339475e-11
, O 0 1.7293642646382112e-12
n O 0 5.105136452465686e-11
= O 0 1.9004785245524403e-10
61 O 0 1.535998689350393e-10
subjects O 0 2.4929910913407127e-10
) O 0 4.581341556120222e-11
. O 0 7.770863397205119e-10

The O 0 1.1130807251902297e-05
ARSA O 0 0.07178819924592972
enzyme O 0 5.185909479621387e-10
activity O 0 4.6056190111665174e-11
in O 0 1.350565384354574e-12
subjects O 0 9.961717215012378e-12
with O 0 6.928010140398733e-13
and O 0 1.7000163429758963e-11
without O 0 1.232250274041391e-10
the O 0 6.523320078555273e-11
R496H O 0 4.619771232228231e-09
mutation O 0 8.862607175919024e-11
was O 0 3.397527259529909e-10
determined O 0 1.380112690796409e-10
and O 0 1.603641178182791e-11
found O 0 5.2135747975745605e-12
to O 0 2.3218380343359435e-12
be O 0 2.1677822731325236e-11
normal O 0 6.792624684948123e-09
. O 0 1.8351205000044502e-09

It O 0 4.5520684444078086e-10
is O 0 9.744884586770919e-12
therefore O 0 2.6471906264258216e-12
concluded O 0 5.767643741078077e-12
that O 0 9.987200817870509e-14
the O 0 5.751198562525817e-12
R496H O 0 6.672952190811543e-10
mutation O 0 2.4768232603777918e-11
of O 0 6.054644563491252e-10
ARSA O 0 9.896086339722387e-06
does O 0 8.91925942825278e-12
not O 0 1.2221699347003678e-12
negatively O 0 9.601537907842975e-14
influence O 0 1.4506486289977971e-12
the O 0 1.7770609636591495e-11
activity O 0 1.7957781095478964e-10
of O 0 2.1188808485561594e-09
ARSA O 0 0.0005896388902328908
and O 0 3.149525362733385e-10
is O 0 1.063445338733704e-11
not O 0 9.563878335117071e-12
a O 0 4.3470621546859434e-10
cause O 0 1.178300408355426e-07
of O 0 6.301021130639128e-06
MLD B-Disease 1 1.0

Down O 0 8.411408998654224e-06
- O 0 1.0362440860944844e-07
regulation O 0 6.687420039952485e-08
of O 0 9.556325508697228e-09
transmembrane O 0 2.8194417609483935e-06
carbonic O 0 3.614691650000168e-06
anhydrases O 0 5.917890666751191e-05
in O 0 1.5281153764590272e-06
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999680519104004
lines O 0 5.092010701979177e-10
by O 0 1.431524516981586e-11
wild O 0 4.6766018613197957e-07
- O 0 4.318942004033488e-08
type O 0 1.7441826116737502e-07
von B-Disease 1 0.9999257326126099
Hippel I-Disease 1 0.9999985694885254
- I-Disease 1 0.9867913722991943
Lindau I-Disease 0 0.007902116514742374
transgenes O 0 2.86483445961494e-05
. O 0 8.310128407629236e-08

To O 0 3.511588131388521e-09
discover O 0 2.4002786425114664e-09
genes O 0 8.125327494168388e-11
involved O 0 1.5071598483129556e-11
in O 0 3.1895758256794693e-10
von B-Disease 1 0.99998939037323
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( O 0 9.192182005790528e-06
VHL B-Disease 1 0.9983407258987427
) O 0 2.490771477958731e-10
- O 0 9.93584947650561e-09
mediated O 0 4.788728347193683e-07
carcinogenesis O 0 0.0003883356985170394
, O 0 1.0179380255381787e-10
we O 0 9.815159102144477e-11
used O 0 3.230069545168135e-09
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9998975992202759
lines O 0 3.1138371880956583e-09
stably O 0 2.8268237528550344e-08
transfected O 0 1.4241076096155325e-09
with O 0 3.481916794820239e-12
wild O 0 2.7106244715469074e-07
- O 0 1.1732489468840868e-07
type O 0 3.9232833159985603e-07
VHL O 0 0.1050342544913292
- O 0 4.151736447965959e-07
expressing O 0 6.461731594242792e-09
transgenes O 0 4.881743507212377e-07
. O 0 1.9582966359621423e-08

Large O 0 9.036195081080223e-08
- O 0 1.641926594686538e-08
scale O 0 8.544176921532198e-08
RNA O 0 6.540120889297896e-09
differential O 0 5.1341433326967945e-09
display O 0 4.418823085217127e-09
technology O 0 1.87439441745596e-09
applied O 0 2.482178074192376e-10
to O 0 3.935712866720564e-12
these O 0 4.704918312586903e-12
cell O 0 5.4497677481890605e-09
lines O 0 3.070392204373995e-11
identified O 0 3.823262453156451e-12
several O 0 4.760366905352809e-13
differentially O 0 4.908045497797886e-11
expressed O 0 3.7020633412120085e-13
genes O 0 2.3380930980372583e-13
, O 0 2.048310522931307e-13
including O 0 3.356513417901441e-12
an O 0 2.6475805922632212e-11
alpha O 0 4.8238383953957964e-08
carbonic O 0 7.001688118180027e-08
anhydrase O 0 9.446417692515752e-08
gene O 0 1.7902969107197464e-09
, O 0 3.6000760705867663e-10
termed O 0 4.838226459469297e-07
CA12 O 0 0.0003368877514731139
. O 0 3.4273543292329123e-07

The O 0 3.6812377146588915e-08
deduced O 0 1.138902638864181e-09
protein O 0 3.235800863365945e-11
sequence O 0 5.5609496174557904e-11
was O 0 6.266924756914705e-10
classified O 0 1.5998620830903754e-11
as O 0 2.033830569236894e-11
a O 0 2.0025138491863714e-10
one O 0 1.6890250309486987e-10
- O 0 7.092185683177377e-08
pass O 0 1.5917892781658338e-08
transmembrane O 0 1.4296527695023542e-07
CA O 0 4.232668686654506e-07
possessing O 0 1.177736574931032e-09
an O 0 5.098675301407063e-11
apparently O 0 1.2817414907217994e-09
intact O 0 1.5356947935529774e-09
catalytic O 0 1.2231832213771554e-10
domain O 0 4.973484957204732e-10
in O 0 1.623479961576635e-10
the O 0 1.804978611019692e-09
extracellular O 0 7.36205691964642e-08
CA O 0 2.1605372239719145e-05
module O 0 2.2792385152570205e-06
. O 0 3.296154105214555e-08

Reintroduced O 0 5.634193712467095e-06
wild O 0 2.145198595826514e-05
- O 0 3.3110643471445655e-06
type O 0 1.3569842849392444e-06
VHL B-Disease 0 0.0003997898893430829
strongly O 0 2.2257879983555995e-09
inhibited O 0 8.543158402929407e-10
the O 0 1.39937256227185e-10
overexpression O 0 3.853864338765334e-09
of O 0 3.4282801042451183e-09
the O 0 2.077565008917759e-09
CA12 O 0 1.054201447914238e-06
gene O 0 1.6239290467900958e-10
in O 0 1.858461995407623e-11
the O 0 1.0850996767786114e-09
parental O 0 0.0002447722654324025
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999973773956299
lines O 0 2.459180166169972e-07
. O 0 6.112456318874138e-09

Similar O 0 1.5046918377947804e-08
results O 0 1.1338091576718057e-09
were O 0 3.5240713125439527e-11
obtained O 0 7.075228857650329e-12
with O 0 1.5090899016523274e-11
CA9 O 0 1.0699355698307045e-05
, O 0 1.17117482378859e-10
encoding O 0 4.73810823908849e-10
another O 0 2.2102830676828944e-09
transmembrane O 0 1.7111732120156375e-07
CA O 0 1.4567967809853144e-06
with O 0 2.849218951050947e-11
an O 0 8.493972192269439e-11
intact O 0 5.566837657511314e-08
catalytic O 0 2.2370123531345598e-08
domain O 0 9.960045588286448e-08
. O 0 2.2919754982808627e-08

Although O 0 5.342311482081641e-09
both O 0 1.5982005996395543e-10
domains O 0 1.5069658854116597e-09
of O 0 6.129982921265764e-08
the O 0 1.498569019986462e-07
VHL B-Disease 0 6.935318197065499e-06
protein O 0 1.0898808522341596e-09
contribute O 0 1.380304117531983e-11
to O 0 1.73213162563135e-11
regulation O 0 2.2574058178292944e-08
of O 0 5.4413029637601085e-09
CA12 O 0 0.00010564996773609892
expression O 0 4.670700803899308e-08
, O 0 9.25214627134352e-11
the O 0 2.197352161337207e-10
elongin O 0 1.661566173538631e-08
binding O 0 2.32651853337984e-09
domain O 0 2.373160779001182e-09
alone O 0 1.0808934997053044e-10
could O 0 1.5012725437801855e-11
effectively O 0 7.084972608595308e-10
regulate O 0 3.4704386031592094e-09
CA9 O 0 3.888395440299064e-05
expression O 0 4.602754444249513e-08
. O 0 7.380077882146452e-09

We O 0 8.919821681274698e-08
mapped O 0 2.7471472208162595e-07
CA12 O 0 0.0001483278610976413
and O 0 8.69914558165874e-08
CA9 O 0 7.951816951390356e-05
loci O 0 5.514565692976703e-09
to O 0 1.9367463188757483e-10
chromosome O 0 2.8633005300093828e-08
bands O 0 1.6530179891560692e-07
15q22 O 0 2.4786376684460265e-07
and O 0 2.561060030714657e-09
17q21 O 0 5.997280823066831e-07
. O 0 2.6471202119182635e-08

2 O 0 1.4108449875038787e-07
respectively O 0 1.6687178305829775e-09
, O 0 6.888278142325177e-11
regions O 0 2.3761002054811797e-09
prone O 0 1.0494963786911171e-09
to O 0 8.793700143061578e-12
amplification O 0 1.1337831784530294e-09
in O 0 5.766524410755203e-11
some O 0 6.365744736891443e-11
human O 0 8.305771359573555e-08
cancers B-Disease 0 2.2356369299814105e-05
. O 0 2.5311855722520704e-08

Additional O 0 1.6907374389418806e-09
experiments O 0 1.1632370622294275e-08
are O 0 9.36420298941476e-12
needed O 0 2.219177099027636e-11
to O 0 1.1481924352269024e-12
define O 0 5.714930612077396e-11
the O 0 6.833551779994451e-11
role O 0 1.5659082364116728e-10
of O 0 2.1699904095839884e-08
CA O 0 5.33823185833171e-06
IX O 0 9.06922423382639e-07
and O 0 7.039461014102244e-09
CA O 0 4.468586212169612e-07
XII O 0 3.7063330182718346e-08
enzymes O 0 2.366847863533028e-11
in O 0 7.879781029063171e-12
the O 0 7.598134621478181e-11
regulation O 0 1.7187946621533001e-09
of O 0 1.792612586148934e-10
pH O 0 1.8879056651321946e-10
in O 0 1.2606682191218521e-11
the O 0 4.600000588772524e-11
extracellular O 0 7.558744602453871e-11
microenvironment O 0 1.839283503279887e-09
and O 0 8.174507078184678e-12
its O 0 6.201282976708855e-12
potential O 0 1.7812383512616492e-11
impact O 0 1.2938260463002393e-09
on O 0 2.832858214674161e-08
cancer B-Disease 0 8.541599640921049e-07
cell O 0 1.4927364873074112e-06
growth O 0 1.2371916113806947e-07
. O 0 6.350495684870339e-09

A O 0 1.3910636198488646e-07
gene O 0 8.473716728296665e-10
encoding O 0 5.850860906875255e-10
a O 0 6.111217087934051e-10
transmembrane O 0 4.763782701644459e-09
protein O 0 2.897447004546194e-10
is O 0 2.4991098600268824e-13
mutated O 0 1.3973440460279818e-12
in O 0 7.22321182901331e-13
patients O 0 1.1639460922863165e-10
with O 0 4.955222898672673e-09
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.8752806186676025
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 0 0.0002561543951742351
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 1.8576121196822726e-10
. O 0 5.57287660463146e-10

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.08378785848617554
WFS B-Disease 1 0.9999915361404419
; O 0 8.473025836508441e-09
OMIM O 0 0.2243945300579071
222300 O 0 1.965263862757638e-08
) O 0 6.164850531106825e-13
is O 0 1.4860747181433265e-13
an O 0 4.10544038001448e-12
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 2.754362848911285e-10
by O 0 2.581190740747613e-13
young O 0 1.5855228371539076e-12
- O 0 1.3382438490694426e-09
onset O 1 1.0
non O 1 1.0
- O 0 0.3239414691925049
immune O 1 0.9999896287918091
insulin B-Disease 1 1.0
- I-Disease 1 1.0
dependent I-Disease 1 1.0
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 9.945947567757685e-07
progressive O 1 0.9999923706054688
optic B-Disease 1 0.9999994039535522
atrophy I-Disease 1 0.978133499622345
. O 0 9.220184438163415e-08

Linkage O 0 5.747876343775715e-07
to O 0 8.137165385946332e-10
markers O 0 2.3489823419708955e-09
on O 0 7.201464313766337e-09
chromosome O 0 1.5515443152480657e-08
4p O 0 1.0093464197780122e-06
was O 0 1.1256596765818472e-09
confirmed O 0 9.443936604958125e-11
in O 0 3.191679906477951e-11
five O 0 1.6184405204899832e-10
families O 0 2.697313553068348e-11
. O 0 7.370526855510207e-09

On O 0 6.2289013946781324e-09
the O 0 5.945580833222053e-11
basis O 0 1.2917270031387318e-10
of O 0 4.269019304725674e-10
meiotic O 0 0.00015465302567463368
recombinants O 0 0.18235044181346893
and O 0 1.597017558196967e-07
disease O 1 0.9958921670913696
- O 0 4.537334508114554e-09
associated O 0 7.525633449745328e-10
haplotypes O 0 2.8363817961007953e-09
, O 0 3.490929420535416e-11
the O 0 5.275883285804639e-09
WFS B-Disease 0 5.445648275781423e-05
gene O 0 4.678756271303541e-10
was O 0 5.03697028531036e-10
localized O 0 1.6995220786242271e-09
to O 0 3.5708592333039135e-11
a O 0 2.268060628196622e-09
BAC O 0 5.645612418447854e-06
/ O 0 7.065586515864197e-08
P1 O 0 1.8140156043955358e-07
contig O 0 2.0824923296913767e-07
of O 0 4.389087759903987e-09
less O 0 9.029601372168017e-11
than O 0 2.678641163045281e-11
250 O 0 4.140920661921399e-10
kb O 0 8.663724884172552e-07
. O 0 8.52231849535201e-08

Mutations O 0 4.508699802396876e-10
in O 0 8.983819244079427e-11
a O 0 7.86622572634954e-11
novel O 0 7.69964370039844e-11
gene O 0 6.698299553908882e-11
( O 0 1.0528456578784429e-11
WFS1 O 0 4.180349577609377e-08
) O 0 3.5405829743734296e-12
encoding O 0 1.1432368073049926e-11
a O 0 1.7720694356349043e-10
putative O 0 4.8952419895442745e-09
transmembrane O 0 2.7571971372708504e-09
protein O 0 8.954741947952982e-10
were O 0 1.612204814094298e-10
found O 0 4.977463211562616e-13
in O 0 1.0302740648462927e-12
all O 0 9.662486089023758e-12
affected O 0 9.07357002033482e-12
individuals O 0 1.1730956375570478e-13
in O 0 2.9392044353926394e-10
six O 0 1.3722872438393097e-07
WFS B-Disease 1 0.9992218017578125
families O 0 5.56738899773479e-12
, O 0 9.24801294571731e-12
and O 0 1.2872796578689005e-11
these O 0 1.553732403153374e-12
mutations O 0 6.2843467409090525e-12
were O 0 1.887568877242951e-12
associated O 0 6.225993245262407e-12
with O 0 2.067615826814584e-12
the O 0 4.513322160448752e-09
disease O 0 0.0001570590102346614
phenotype O 0 5.1409173806860053e-08
. O 0 5.358527399579316e-09

WFS1 O 0 0.12567254900932312
appears O 0 2.367373852507626e-09
to O 0 6.301126287411307e-12
function O 0 2.6492996685334447e-10
in O 0 4.9267659396612373e-11
survival O 0 5.852116373716854e-07
of O 0 5.933770808042027e-09
islet O 0 1.1563423640836845e-07
beta O 0 3.4712613228293776e-08
- O 0 5.810161685104731e-09
cells O 0 1.7694180842742213e-10
and O 0 6.543008496118219e-11
neurons O 0 1.8426747627753315e-10
. O 0 6.473727803824048e-11
. O 0 1.803498794750169e-09

Stable O 0 3.285136358499585e-07
interaction O 0 3.027777195629966e-10
between O 0 1.4117905455801605e-10
the O 0 7.35677296859194e-10
products O 0 1.3847276658651708e-09
of O 0 7.1008585678100644e-09
the O 0 2.446374836040377e-08
BRCA1 O 0 2.4258188346948373e-08
and O 0 2.10712047810091e-09
BRCA2 O 0 7.415975833424682e-09
tumor B-Disease 0 1.726009912772497e-08
suppressor O 0 3.089412459189589e-08
genes O 0 5.37929943644766e-11
in O 0 3.8817612318942096e-11
mitotic O 0 5.533005875690833e-08
and O 0 1.8531683965150592e-09
meiotic O 0 6.729748747602571e-06
cells O 0 1.6633141797228745e-07
. O 0 3.016344152229067e-08

BRCA1 O 0 4.884588634013198e-06
and O 0 1.1947674849466239e-08
BRCA2 O 0 3.90650622961175e-09
account O 0 4.283811586708319e-12
for O 0 1.1670905127741937e-12
most O 0 1.2502934072181754e-13
cases O 0 9.714514484721395e-14
of O 0 3.2442531733983815e-12
familial O 0 4.715406953792467e-10
, O 0 1.6578875858958009e-12
early O 0 1.9966110986757712e-09
onset O 1 0.9999994039535522
breast B-Disease 1 0.8823404312133789
and I-Disease 0 8.00697580416454e-06
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.0002181837917305529
encode O 0 1.0345561213265242e-10
products O 0 1.7431134313738994e-09
that O 0 2.6076215839387906e-12
each O 0 1.0231375344388685e-13
interact O 0 2.4163922815803596e-13
with O 0 5.456312051482781e-12
hRAD51 O 0 1.452933844348081e-07
. O 0 1.3129162645952874e-08

Results O 0 1.0492987811971943e-08
presented O 0 2.23431628754156e-09
here O 0 2.4131488474132823e-10
show O 0 2.400185883377759e-10
that O 0 1.1513224401626942e-11
BRCA1 O 0 6.716341371948431e-10
and O 0 3.868715764410169e-11
BRCA2 O 0 1.9039106402551909e-10
coexist O 0 3.9839007093256384e-11
in O 0 2.9920998404625587e-12
a O 0 1.6722305831717854e-11
biochemical O 0 6.260226115273326e-09
complex O 0 2.4551720656518228e-08
and O 0 1.2915792046985786e-10
colocalize O 0 3.133664847609907e-07
in O 0 2.1373984804284873e-09
subnuclear O 0 2.4191135707951616e-06
foci O 0 7.279159603967855e-07
in O 0 4.724400315403443e-10
somatic O 0 8.537412554687762e-09
cells O 0 1.4769330203279196e-10
and O 0 6.227027140454089e-12
on O 0 4.079140636381595e-10
the O 0 1.862581963663068e-11
axial O 0 2.140933784422483e-11
elements O 0 2.5198676478765947e-10
of O 0 1.1706058344884696e-09
developing O 0 5.1036423975858725e-09
synaptonemal O 0 6.486022812168812e-07
complexes O 0 9.463315109314863e-08
. O 0 6.302015265191585e-08

Like O 0 1.963765470236467e-07
BRCA1 O 0 6.510067009912746e-07
and O 0 2.566959445005068e-08
RAD51 O 0 0.00017219202709384263
, O 0 1.012806816191869e-08
BRCA2 O 0 1.603405053174356e-08
relocates O 0 2.4286324062927633e-09
to O 0 2.6049745693867976e-10
PCNA O 0 5.881961442355532e-07
+ O 0 1.0103612391176853e-10
replication O 0 1.1343428280019552e-10
sites O 0 8.009321504631739e-12
following O 0 4.340398526703204e-11
exposure O 0 5.161436833489574e-10
of O 0 2.0667554334607985e-09
S O 0 2.3208864163848375e-08
phase O 0 6.638375182888012e-09
cells O 0 1.8431421666686987e-10
to O 0 5.963343707726665e-11
hydroxyurea O 0 1.2080619171683793e-07
or O 0 1.1059021476356179e-09
UV O 0 6.9984430410841014e-06
irradiation O 0 9.692204372413471e-08
. O 0 3.898221745401997e-09

Thus O 0 1.80912227421004e-08
, O 0 9.641987208652836e-10
BRCA1 O 0 3.842597795511438e-09
and O 0 1.178045994087995e-10
BRCA2 O 0 1.6891700538312904e-10
participate O 0 2.7677996613378886e-12
, O 0 1.2009772516752282e-12
together O 0 5.867145419675979e-13
, O 0 1.1445279403041186e-12
in O 0 1.3914166693829166e-11
a O 0 3.166976403345956e-10
pathway O 0 5.514499412662133e-10
( O 0 4.512782075111188e-12
s O 0 3.310798510347546e-11
) O 0 4.9235833102624985e-14
associated O 0 9.365716752487985e-13
with O 0 1.9807368093795186e-13
the O 0 1.592382128934311e-11
activation O 0 5.556147208984896e-11
of O 0 3.0592345323654513e-10
double O 0 8.027027931234443e-09
- O 0 2.1707107222823652e-08
strand O 0 4.953203003310591e-08
break O 0 2.815653488141834e-07
repair O 0 5.102136810819502e-07
and O 0 6.898208115835303e-10
/ O 0 5.8908764088982934e-08
or O 0 2.0190052407720316e-10
homologous O 0 1.2569958407482318e-09
recombination O 0 6.352348869143043e-09
. O 0 1.693358875343165e-08

Dysfunction O 1 0.9976105690002441
of O 0 6.086253051762469e-06
this O 0 1.9745622914513206e-09
pathway O 0 1.4331823727786741e-08
may O 0 2.3186175202027925e-11
be O 0 3.8039122090931243e-13
a O 0 3.9781562375870716e-13
general O 0 2.7974467360636357e-12
phenomenon O 0 2.8136729057770538e-11
in O 0 3.8582919953573935e-13
the O 0 2.0003664523426945e-12
majority O 0 2.3158309037790703e-13
of O 0 2.6729597268210226e-12
cases O 0 1.3084363236978702e-12
of O 0 4.801655739683497e-10
hereditary B-Disease 1 0.9999996423721313
breast I-Disease 1 0.991182804107666
and I-Disease 0 1.7960175682674162e-05
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00021266135445330292
. O 0 7.575859228836634e-08

A O 0 6.832480181628853e-08
novel O 0 9.504894649126072e-10
Arg362Ser O 0 4.398626884949408e-08
mutation O 0 8.816948560141924e-11
in O 0 1.1882931270912334e-11
the O 0 2.168875218311328e-10
sterol O 0 7.771463828021297e-08
27 O 0 5.580454853770789e-07
- O 0 2.3702810381109884e-07
hydroxylase O 0 6.572235520252434e-07
gene O 0 1.7924083328679785e-09
( O 0 2.3302955051707208e-11
CYP27 O 0 1.811373948612527e-07
) O 0 6.405443666798738e-13
: O 0 8.143700693180947e-14
its O 0 4.731968939949982e-13
effects O 0 1.3818379773766765e-10
on O 0 6.123959117587674e-10
pre O 0 1.468955623806778e-08
- O 0 1.7907467175781733e-10
mRNA O 0 1.691620316046638e-10
splicing O 0 7.984437555563773e-10
and O 0 7.065428797581319e-11
enzyme O 0 6.485494086216903e-11
activity O 0 1.2917819036672995e-09
. O 0 2.624445549770371e-09

A O 0 8.958438968420523e-08
novel O 0 4.749599602504873e-10
C O 0 7.233291299257871e-09
to O 0 8.177641723505769e-12
A O 0 2.0276072487668273e-10
mutation O 0 3.3726597903349642e-12
in O 0 2.83395507581774e-12
the O 0 9.845552845222372e-11
sterol O 0 4.613767856653794e-08
27 O 0 1.6708054317859933e-07
- O 0 3.7029273869393364e-08
hydroxylase O 0 7.941916635445523e-08
gene O 0 4.580696932876549e-10
( O 0 5.5383371500017375e-12
CYP27 O 0 3.2681210626606116e-08
) O 0 3.8568494643669016e-13
was O 0 1.003525387788251e-11
identified O 0 3.2285537633104655e-13
by O 0 5.235455081617491e-13
sequencing O 0 1.1349032824625738e-10
amplified O 0 9.017614210904412e-09
CYP27 O 0 2.9842235562682617e-06
gene O 0 1.5991467039455642e-09
products O 0 3.5084196658985434e-10
from O 0 7.77950186908738e-12
a O 0 1.0171267300629339e-10
patient O 0 2.1725816701234635e-09
with O 0 9.894958186151825e-10
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 8.101878279376251e-08
CTX B-Disease 0 0.00011924636055482551
) O 0 7.70180641485041e-10
. O 0 6.181842149288741e-09

The O 0 3.941054060874194e-08
mutation O 0 2.25771490391935e-09
changed O 0 4.532306752125237e-10
the O 0 5.124191626570962e-10
adrenodoxin O 0 1.1213877115778814e-07
cofactor O 0 3.877726939549575e-08
binding O 0 2.7081159537090116e-09
residue O 0 2.6205853487226705e-08
362Arg O 0 3.1901978836401668e-09
to O 0 1.3856958983038403e-11
362Ser O 0 1.617251221830429e-08
( O 0 5.443251960279838e-10
CGT O 0 2.2482463464257307e-06
362Arg O 0 1.70627547646518e-08
to O 0 1.6050680229362513e-10
AGT O 0 1.339876121164707e-06
362Ser O 0 7.871256979541386e-10
) O 0 5.226156421685169e-13
, O 0 1.0233580340556978e-13
and O 0 2.1307754822716407e-13
was O 0 5.967371041748493e-11
responsible O 0 2.581765912168521e-10
for O 0 2.0424850699640729e-10
deficiency O 0 8.388799699332594e-08
in O 0 5.004106018446919e-10
the O 0 5.974951200471423e-09
sterol O 0 7.980247573868837e-07
27 O 0 1.2455454907467356e-06
- O 0 1.566820984066908e-08
hydroxylase O 0 2.897737338969364e-08
activity O 0 3.033667761442871e-10
, O 0 5.049024349654263e-13
as O 0 1.2770681864435196e-13
confirmed O 0 3.3189830007593346e-13
by O 0 1.0373523735970544e-13
expression O 0 4.9392304482531735e-12
of O 0 1.5967007230277552e-11
mutant O 0 2.5492305488761247e-10
cDNA O 0 1.4828188676929699e-09
into O 0 1.0608568884462599e-10
COS O 0 2.146106453437824e-06
- O 0 1.1580528536114798e-07
1 O 0 6.630215665381911e-08
cells O 0 1.1245722575381478e-08
. O 0 2.9989264405116955e-09

Quantitative O 0 1.0247415360709056e-08
analysis O 0 1.5724058166632915e-10
showed O 0 1.7957539621971108e-10
that O 0 3.134119483036435e-13
the O 0 1.3304089600818525e-11
expression O 0 7.883708963429825e-11
of O 0 2.027839285378974e-10
CYP27 O 0 5.851067896855966e-08
gene O 0 1.0125097808788563e-11
mRNA O 0 1.5495190200387476e-11
in O 0 3.775622176016569e-12
the O 0 1.2297989016030186e-10
patient O 0 8.329179568278278e-10
represented O 0 7.649147426569414e-10
52 O 0 8.260397521553386e-08
. O 0 1.1906843866427153e-07

5 O 0 4.2907053909857495e-08
% O 0 3.4800215487074126e-10
of O 0 1.440825792009548e-09
the O 0 1.4076021459530352e-09
normal O 0 4.278871656993033e-08
level O 0 2.8100519102736143e-06
. O 0 1.1959347290257938e-08

As O 0 3.20825227495547e-10
the O 0 9.843768855599677e-11
mutation O 0 1.944511045237629e-11
occurred O 0 2.5326027386363137e-10
at O 0 7.711856847558707e-11
the O 0 3.477186594214032e-11
penultimate O 0 2.029008738801963e-09
nucleotide O 0 4.518522500607247e-10
of O 0 4.980056367287489e-09
exon O 0 1.0767585933990631e-08
6 O 0 1.063057641914611e-08
( O 0 8.08923154155261e-12
- O 0 1.0634702840572885e-10
2 O 0 2.622792816264763e-10
position O 0 1.0305344771976976e-10
of O 0 1.4600887165983067e-09
exon O 0 3.320536379192163e-08
6 O 0 1.319572220381815e-07
- O 0 2.588459402375065e-08
intron O 0 6.166440869037615e-08
6 O 0 4.040458279064296e-08
splice O 0 9.466686989867412e-09
site O 0 1.1823138301725322e-10
) O 0 7.457431888810082e-14
of O 0 6.389705604903373e-12
the O 0 4.138178688606331e-11
gene O 0 3.193908679199886e-11
, O 0 4.2163356139823804e-12
we O 0 2.727650137007709e-12
hypothesized O 0 1.6638431084292638e-12
that O 0 1.0499608317114315e-13
the O 0 1.579513950189515e-11
mutation O 0 4.252649968283784e-11
may O 0 1.4358094574395963e-11
partially O 0 2.3852622654807476e-10
affect O 0 1.463541202291474e-12
the O 0 2.498620234325788e-12
normal O 0 2.2070284835806753e-11
splicing O 0 1.981418848440164e-11
efficiency O 0 2.410548496922793e-11
in O 0 9.777237613278755e-13
exon O 0 2.420288969240403e-10
6 O 0 2.724371839235573e-10
and O 0 6.253628691277324e-12
cause O 0 1.232062230016595e-10
alternative O 0 1.9684844032585858e-10
splicing O 0 1.841898022991728e-10
elsewhere O 0 5.0311560473303985e-12
, O 0 4.7161889871931775e-14
which O 0 3.2841395212037175e-14
resulted O 0 1.5864939570398029e-12
in O 0 3.9616644383413946e-13
decreased O 0 2.3881291041916164e-11
transcript O 0 1.0991765136969534e-10
in O 0 2.3951129274335514e-11
the O 0 1.138837357750333e-09
patient O 0 1.50346686211833e-08
. O 0 2.1626604507218872e-08

Transfection O 0 2.5127440039796056e-06
of O 0 3.5685164334609e-07
constructed O 0 2.45467646209363e-07
minigenes O 0 1.24163875625527e-06
, O 0 1.8513691968369272e-10
with O 0 4.760904778050579e-12
or O 0 1.2544964199390218e-11
without O 0 3.7666907787281545e-11
the O 0 2.0479502815806683e-10
mutation O 0 1.1458352322524235e-10
, O 0 8.199163570310475e-12
into O 0 7.80483108697716e-11
COS O 0 1.2098555089323781e-05
- O 0 3.2345901956887246e-08
1 O 0 1.7363739335252149e-09
cells O 0 3.179884090417917e-12
confirmed O 0 1.6245254924260322e-12
that O 0 1.4596786642893586e-14
the O 0 1.5207365531774708e-12
mutant O 0 2.5312169027458253e-10
minigene O 0 9.185145977141929e-09
was O 0 8.416791152932035e-10
responsible O 0 5.213159764982933e-11
for O 0 6.22053320312177e-12
a O 0 2.5937137854148418e-11
mRNA O 0 4.923928972888625e-11
species O 0 2.125766061658943e-13
alternatively O 0 2.4353639764551627e-12
spliced O 0 1.5345609505335034e-10
at O 0 1.0308023323801763e-09
an O 0 2.6140815206909807e-11
activated O 0 4.022143329507344e-08
cryptic O 0 8.622081715259355e-09
5 O 0 1.3231479911723909e-08
splice O 0 5.595633112420728e-08
site O 0 9.546760715295477e-09
88 O 0 2.984501312752741e-09
bp O 0 1.5707991851687808e-10
upstream O 0 1.1523351717279695e-11
from O 0 4.63577570428142e-12
the O 0 1.3825789124677357e-10
3 O 0 1.860794185404302e-09
end O 0 1.5950830656308312e-09
of O 0 1.8474722862649173e-09
exon O 0 7.351420805434827e-08
6 O 0 1.0329604549497162e-07
. O 0 1.4340737486406852e-08

Our O 0 1.1990181292276247e-08
data O 0 1.5284469523368927e-10
suggest O 0 4.190999110254001e-12
that O 0 1.7712590563104952e-13
the O 0 2.834772694360055e-11
C O 0 7.638242260910033e-10
to O 0 2.219506045966768e-12
A O 0 3.1061897498574353e-10
mutation O 0 3.6090512089276272e-12
at O 0 4.01595839916169e-11
the O 0 1.1453451902176948e-11
penultimate O 0 6.056954937605497e-10
nucleotide O 0 7.909916471815492e-11
of O 0 3.5480904325702056e-10
exon O 0 1.774302482715484e-09
6 O 0 3.410083049271151e-10
of O 0 9.271649420439232e-11
the O 0 3.9492975556498777e-10
CYP27 O 0 5.077459377389459e-07
gene O 0 8.04282057620398e-11
not O 0 1.021258598521424e-12
only O 0 8.123940430961041e-13
causes O 0 5.173991443618853e-11
the O 0 1.8363172094026936e-10
deficiency B-Disease 0 6.113225481385598e-09
in I-Disease 0 6.457018947303439e-11
the I-Disease 0 1.6404075875442459e-09
sterol I-Disease 0 1.51712470142229e-07
27 I-Disease 0 2.2590820947243628e-07
- I-Disease 0 1.3642538654323744e-08
hydroxylase I-Disease 0 9.299783165772624e-09
activity I-Disease 0 3.457480690638448e-10
, O 0 1.3354727480124895e-12
but O 0 1.7739545726466743e-12
also O 0 1.4030680263454887e-11
partially O 0 1.032659957544979e-09
leads O 0 7.559101782017574e-12
to O 0 1.2904156909687714e-12
alternative O 0 5.021296156648702e-10
pre O 0 4.731193214979612e-09
- O 0 2.416583773368064e-11
mRNA O 0 3.410035795403665e-11
splicing O 0 1.1683501388581874e-10
of O 0 7.660517359342478e-11
the O 0 2.4930293940350623e-10
gene O 0 2.2383854769714162e-09
. O 0 3.4237448431895245e-09

To O 0 1.4925999325399175e-09
our O 0 8.150026764575102e-10
knowledge O 0 2.808093202411044e-10
, O 0 2.9986072219018167e-12
this O 0 8.447718436235818e-14
is O 0 5.859359221774274e-14
the O 0 6.50181189269794e-13
first O 0 5.09387063779565e-12
report O 0 9.95377391621588e-13
regarding O 0 6.39668981845809e-13
effects O 0 8.58621576615981e-11
on O 0 1.408253930135217e-10
pre O 0 6.146731457157273e-10
- O 0 4.26774544523556e-12
mRNA O 0 7.980972653587326e-12
splicing O 0 2.0547572324169927e-11
of O 0 4.0045616128692174e-11
a O 0 2.114865400859589e-11
mutation O 0 1.1950573343411097e-11
at O 0 1.5188661439680118e-09
the O 0 2.27459784341022e-09
- O 0 5.200601282950856e-09
2 O 0 1.155673867714313e-08
position O 0 3.4724514375028548e-09
of O 0 8.507697657478275e-09
a O 0 6.164604826608411e-09
5 O 0 6.287308451646823e-08
splice O 0 1.0639379297572304e-06
site O 0 1.6659906520999357e-07
. O 0 2.3977584362455673e-08

ATM O 0 4.997528776584659e-06
germline O 0 1.0314228404695314e-07
mutations O 0 3.621796612618411e-11
in O 0 1.347000549295485e-11
classical O 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.999930739402771
in O 0 8.128850925714914e-10
the O 0 1.2303649210565482e-09
Dutch O 0 5.378947776080167e-07
population O 0 4.8929402196584704e-11
. O 0 9.189610183923946e-10

Germline O 0 2.348424686715589e-06
mutations O 0 1.0716767473439859e-09
in O 0 2.1042519116054592e-10
the O 0 1.0045374532197116e-09
ATM O 0 5.026183771406068e-07
gene O 0 7.628105092027937e-11
are O 0 1.92366925204834e-14
responsible O 0 3.1412174836091544e-13
for O 0 1.1034473709108442e-13
the O 0 1.3431849410494578e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999765157699585
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.2568569518478512e-09
. O 0 3.6948968329397758e-09

In O 0 5.606013875336657e-09
our O 0 1.9263506345623682e-09
study O 0 1.0418546234070014e-11
, O 0 7.84632168265853e-12
we O 0 7.067325023812909e-12
have O 0 5.24951393118811e-13
determined O 0 5.663903374086843e-12
the O 0 1.587784417833582e-11
ATM O 0 4.565983591220402e-09
mutation O 0 1.8384881290967048e-12
spectrum O 0 6.830430318571779e-13
in O 0 5.012004740813196e-14
19 O 0 3.902421441548398e-11
classical O 1 0.9948506951332092
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 7.616221431305803e-09
, O 0 9.003984623862094e-13
including O 0 8.300746700239114e-13
some O 0 2.366109695325913e-13
immigrant O 0 6.326668789552459e-12
populations O 0 2.1263674414989664e-12
, O 0 3.968092673022061e-13
as O 0 2.063711397951029e-12
well O 0 4.658813265723261e-12
as O 0 3.0177423060440134e-12
12 O 0 6.804145441519083e-11
of O 0 7.568569382332413e-11
Dutch O 0 6.4696741297609606e-09
ethnic O 0 1.032131741185438e-10
origin O 0 1.6066238617273854e-10
. O 0 2.985617086892489e-09

Both O 0 1.0156792074056398e-09
the O 0 4.437046563499081e-10
protein O 0 7.174092570005897e-11
truncation O 0 2.0276596401913594e-08
test O 0 1.1488168638607021e-08
( O 0 3.3473408073136923e-11
PTT O 0 1.5958658394765735e-08
) O 0 1.048994550077731e-12
and O 0 2.9274857277911126e-12
the O 0 2.546979294137941e-11
restriction O 0 1.9873659662383858e-10
endonuclease O 0 7.863933948470958e-10
fingerprinting O 0 2.2621891027085894e-09
( O 0 1.8645118435300922e-11
REF O 0 4.029956646167676e-10
) O 0 6.334365811825476e-14
method O 0 7.022495649225413e-13
were O 0 1.011256725060028e-12
used O 0 5.809382922633555e-14
and O 0 3.1413310537867223e-13
compared O 0 3.326086964444003e-13
for O 0 1.0833940081861337e-12
their O 0 4.624330432467794e-12
detection O 0 1.9596023415058283e-10
efficiency O 0 3.42714571999192e-11
, O 0 2.7681307766813656e-13
identifying O 0 2.443609333976915e-12
76 O 0 3.3061667986666876e-11
% O 0 2.221729744622536e-12
and O 0 3.03878970597804e-12
60 O 0 1.532360523193166e-11
% O 0 4.574842674825996e-12
of O 0 1.2105016988783746e-10
the O 0 3.359290068338794e-10
mutations O 0 5.632072933026144e-11
, O 0 4.962008234854487e-11
respectively O 0 2.237062313170668e-09
. O 0 1.2688478712163942e-08

Most O 0 5.230028676805887e-08
patients O 0 5.538366654178617e-09
were O 0 6.371846383856905e-10
found O 0 3.155470676419192e-11
to O 0 2.1597303806464296e-11
be O 0 3.304604923037857e-10
compound O 0 9.29545933558984e-08
heterozygote O 0 3.5313306057105365e-07
. O 0 1.1642535824307743e-08

Seventeen O 0 1.288163815615917e-07
mutations O 0 4.788049512427506e-09
were O 0 2.1068342903607373e-10
distinct O 0 2.9927466754786636e-11
, O 0 1.5893538221622983e-11
of O 0 5.235462618990994e-10
which O 0 3.0234131170869816e-11
10 O 0 2.875480131780961e-10
were O 0 4.540593595558917e-11
not O 0 8.101368534352282e-12
reported O 0 3.8929295897993654e-10
previously O 0 1.1608698891052427e-08
. O 0 2.3236415458427473e-08

Mutations O 0 1.3980886137687776e-07
are O 0 2.1962501262073886e-10
small O 0 6.36829547429052e-11
deletions O 0 1.0061329547284004e-09
or O 0 4.893607741252026e-09
point O 0 1.6492670056322822e-06
mutations O 0 7.344620467364393e-09
frequently O 0 4.4592837755708103e-10
affecting O 0 1.6778551881202475e-09
splice O 0 9.948103496526528e-08
sites O 0 3.3893105211291186e-08
. O 0 2.4936642972761547e-08

Moreover O 0 1.1236014785254156e-07
, O 0 2.7519484468996325e-09
a O 0 3.344651000602994e-09
16 O 0 9.973486214676086e-08
. O 0 4.892947913504031e-08

7 O 0 1.4184284964358085e-06
- O 0 2.0238498876778976e-08
kb O 0 6.572236088686623e-08
genomic O 0 7.645125421618104e-09
deletion O 0 2.2309263325581696e-09
of O 0 7.48433937047821e-09
the O 0 5.600902519553586e-10
3 O 0 3.894870204135259e-09
end O 0 7.964253145864575e-10
of O 0 1.835396279403767e-10
the O 0 6.870262692082463e-11
gene O 0 9.525252808728624e-11
, O 0 1.3215948301004143e-11
most O 0 4.2942663314171625e-12
likely O 0 1.6004846753459034e-11
a O 0 1.1615813345910997e-11
result O 0 5.634813102228797e-11
of O 0 3.996701927744262e-11
recombination O 0 3.19234179022021e-12
between O 0 1.3357764547250461e-11
two O 0 5.2969621744392015e-11
LINE O 0 1.6243552281025586e-08
elements O 0 9.18274123407059e-10
, O 0 6.189033313619419e-11
was O 0 4.695870359228138e-09
identified O 0 7.340671182021197e-09
. O 0 1.1490908669031796e-08

The O 0 3.1804422206960226e-08
most O 0 6.495459031752304e-11
frequently O 0 7.465195128730784e-12
found O 0 7.860593144275174e-13
mutation O 0 6.334175263293662e-13
, O 0 6.423425566405225e-14
identified O 0 3.3448292963492166e-13
in O 0 6.858799010515948e-13
three O 0 1.7465051757245553e-12
unrelated O 0 2.309173963155331e-10
Turkish O 0 5.178422952667461e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 2.778570429295968e-11
, O 0 3.8184691519838054e-11
was O 0 2.6256323781836954e-09
previously O 0 3.310301477377209e-10
described O 0 5.509048078833345e-12
to O 0 4.5072222321605737e-13
be O 0 7.959245784151803e-13
a O 0 9.620595119164133e-12
Turkish O 0 1.2305369168075231e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 9.969826351152733e-05
mutation O 0 7.602695859532105e-07
. O 0 2.7999291773994628e-08

The O 0 8.116552763226537e-09
presence O 0 2.885887084858041e-10
of O 0 7.759211939628585e-09
a O 0 9.863230232554088e-09
founder O 0 2.5147261112579145e-05
mutation O 0 1.2993342402012331e-08
among O 0 6.61281272795744e-12
relatively O 0 3.5909786429144663e-12
small O 0 1.8109923554266577e-13
ethnic O 0 2.394234767041925e-12
population O 0 4.26061604345742e-14
groups O 0 1.2709204890749837e-13
in O 0 2.8248777015488225e-12
Western O 0 9.056759786574275e-09
Europe O 0 1.26075674344861e-08
could O 0 3.845570736848991e-11
indicate O 0 5.7368824968317966e-11
a O 0 1.0544860817862656e-10
high O 0 2.1516767534368597e-10
carrier O 0 2.517506385649182e-12
frequency O 0 3.849607091432894e-11
in O 0 8.802024213661053e-12
such O 0 5.644795394998958e-11
communities O 0 2.311244945429891e-10
. O 0 2.329098025555254e-09

In O 0 6.82306406929456e-08
patients O 0 2.3520352332440098e-09
of O 0 4.46244241558702e-09
Dutch O 0 1.1883854540428729e-06
ethnic O 0 3.408158477657963e-10
origin O 0 2.8377914601529497e-11
, O 0 5.899860461289208e-12
however O 0 9.619365200219665e-12
, O 0 3.5140618713513927e-12
no O 0 6.512516914636279e-11
significant O 0 3.8491390630390754e-10
founder O 0 4.287637622724105e-08
effect O 0 6.321084811133915e-08
could O 0 1.9020704455918747e-10
be O 0 2.382828309666074e-11
identified O 0 2.125591092028145e-10
. O 0 2.0841295356177625e-09

The O 0 2.4288917543913158e-09
observed O 0 4.075975390538389e-10
genetic O 0 5.179049411552228e-10
heterogeneity O 0 1.0080710710624885e-09
including O 0 3.947660948133702e-11
the O 0 1.500958385358686e-10
relative O 0 1.0011766971018687e-09
high O 0 6.6371095286399395e-09
percentage O 0 1.0139196149339114e-09
of O 0 1.2166601059959703e-08
splice O 0 1.6074677660071757e-06
- O 0 3.469163800673414e-07
site O 0 1.1996289295268525e-08
mutations O 0 4.980250933872554e-11
had O 0 7.458538647808766e-11
no O 0 4.5944237997419535e-11
reflection O 0 2.685169864236059e-10
on O 0 6.177834688259054e-09
the O 0 9.0726443024991e-10
phenotype O 0 1.6882889752878327e-08
. O 0 6.6969771950198265e-09

All O 0 2.5955722016135496e-09
patients O 0 9.828778763099066e-11
manifested O 0 4.4685385947040857e-10
classical O 1 0.7687941789627075
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
and O 0 1.3065148962709827e-10
increased O 0 4.049713064890881e-10
cellular O 0 2.887414751739925e-08
radioresistant O 0 1.0316333742821371e-07
DNA O 0 1.8324596950947125e-08
synthesis O 0 1.9230771641787214e-08
. O 0 4.5391348457712866e-09

Determination O 0 1.8526962719533913e-07
of O 0 4.46101502404872e-08
the O 0 7.367880194841803e-10
genomic O 0 6.830287890835507e-09
structure O 0 2.0759260976888072e-08
of O 0 1.544357708382904e-08
the O 0 1.0432998465148557e-08
COL4A4 O 0 1.0504047168069519e-05
gene O 0 1.8528528711314607e-10
and O 0 1.3871364994144653e-12
of O 0 2.9083142144559204e-11
novel O 0 2.740863092043355e-10
mutations O 0 8.072506219036768e-09
causing O 0 5.42426903393789e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 4.662614628614392e-06

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 7.334593488117491e-10
a O 0 2.324216596960582e-09
progressive O 1 1.0
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 1.0846098348338273e-06
by O 0 4.23600793331147e-10
glomerular B-Disease 1 0.9998118281364441
basement I-Disease 1 1.0
membrane I-Disease 0 0.00041456797043792903
abnormalities I-Disease 1 0.9999992847442627
and O 0 6.006653507917292e-11
associated O 0 1.7204961066941138e-10
with O 0 4.124135061234213e-12
mutations O 0 1.1244546960220703e-11
in O 0 3.5472039194850424e-10
either O 0 1.3281638011619634e-09
the O 0 1.479686329020069e-08
COL4A3 O 0 0.07098978012800217
or O 0 7.662245837813941e-10
the O 0 2.418213629340471e-09
COL4A4 O 0 7.658861704840092e-07
gene O 0 3.8990137507521894e-11
, O 0 1.5526482009808884e-12
which O 0 2.647476964219575e-13
encode O 0 2.9195675824850165e-12
the O 0 5.599374852671701e-10
alpha3 O 0 3.5085645322396886e-07
and O 0 5.04408692592051e-09
alpha4 O 0 1.0212243978457991e-05
type O 0 1.0430935617478099e-05
IV O 0 0.0271970983594656
collagen O 0 1.3171475075068884e-05
chains O 0 8.009878001757897e-06
, O 0 4.998325087157696e-10
respectively O 0 3.4480318600316195e-09
. O 0 6.362692595018871e-09

To O 0 1.3955077371452518e-10
date O 0 1.7776264016333698e-08
, O 0 1.3140090578123154e-11
mutation O 0 2.6343113888188663e-12
screening O 0 3.907724491214459e-11
in O 0 2.512301998380817e-12
the O 0 1.7041328417843893e-11
two O 0 3.3142657455270674e-12
genes O 0 9.969415917798763e-12
has O 0 1.0442360517948224e-11
been O 0 9.369526855762533e-12
hampered O 0 1.4284384786122928e-09
by O 0 4.9420667211363956e-12
the O 0 2.3946300498067785e-10
lack O 0 1.878997624160661e-09
of O 0 3.836003389934284e-11
genomic O 0 1.7056792644964958e-09
structure O 0 3.7401988173257905e-09
information O 0 3.19812260007879e-10
. O 0 1.0808121508887325e-08

We O 0 8.40470004703775e-09
report O 0 4.521459942563588e-11
here O 0 1.2534704177391554e-11
the O 0 5.258726180207285e-12
complete O 0 2.3495322354349923e-10
characterization O 0 2.3664415912949543e-11
of O 0 1.393842402608314e-10
the O 0 7.965723219927057e-11
48 O 0 4.1694520058754847e-10
exons O 0 1.880185074298879e-08
of O 0 6.930231943869103e-09
the O 0 1.1201708893793239e-08
COL4A4 O 0 1.8713712051976472e-05
gene O 0 1.5165099176428498e-09
, O 0 9.57353293862262e-12
a O 0 5.600992759868806e-12
comprehensive O 0 1.0564710217764173e-10
gene O 0 3.823007448805482e-12
screen O 0 1.2826083077566164e-11
, O 0 9.346692256967382e-13
and O 0 3.832116373357619e-13
the O 0 3.5624218418933706e-12
subsequent O 0 8.42462124367449e-12
detection O 0 2.8068669610803454e-10
of O 0 1.700411859928419e-11
10 O 0 7.095337338502983e-12
novel O 0 1.0849842075125182e-12
mutations O 0 1.4872975897736729e-12
in O 0 1.191572014669351e-12
eight O 0 3.4576982943512746e-10
patients O 0 1.697173512837935e-09
diagnosed O 0 2.0106542706344044e-06
with O 0 9.735666495203077e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 3.147924417135073e-06

Furthermore O 0 2.719307801157811e-08
, O 0 3.6950006943037295e-10
we O 0 6.93813409502475e-11
identified O 0 1.2204286192751823e-10
a O 0 1.520619186123895e-10
glycine O 0 1.4417411708933514e-09
to O 0 6.498136057020432e-11
alanine O 0 1.026615237265105e-09
substitution O 0 5.696175087166466e-09
in O 0 9.748440943369019e-11
the O 0 1.0424971996769727e-10
collagenous O 0 3.5828431332873834e-09
domain O 0 1.1014235530570904e-11
that O 0 1.922030785396489e-13
is O 0 6.139843950099533e-13
apparently O 0 3.904705118268348e-12
silent O 0 1.8584309091629336e-10
in O 0 2.4120742295880016e-12
the O 0 2.6484696380446593e-11
heterozygous O 0 7.696237397381012e-11
carriers O 0 3.028727225615202e-12
, O 0 1.2787555302845588e-12
in O 0 2.702901097384469e-11
11 O 0 2.261698384131705e-08
. O 0 2.21943015077386e-08

5 O 0 2.5434975015059536e-08
% O 0 1.0779144243855399e-10
of O 0 5.102997469030868e-10
all O 0 6.956340364849822e-11
control O 0 4.953635279747459e-09
individuals O 0 3.640728940112331e-13
, O 0 3.99804191489328e-12
and O 0 3.529174999114537e-12
in O 0 1.4802372869104907e-11
one O 0 5.9769363937312026e-12
control O 0 8.065391687850365e-10
individual O 0 4.5393856317084424e-13
homozygous O 0 4.929125163588566e-11
for O 0 4.211049217661689e-11
this O 0 9.709268111723901e-11
glycine O 0 5.313788165040023e-08
substitution O 0 9.639917664117092e-08
. O 0 8.579086774318512e-09

There O 0 1.5322393354111341e-09
has O 0 1.6096445357161038e-11
been O 0 1.8178767952764519e-12
no O 0 6.163772183626071e-12
previous O 0 1.3421848354955301e-10
finding O 0 5.728616192524072e-11
of O 0 8.061300516004621e-10
a O 0 3.4719196961852106e-10
glycine O 0 6.532889784693907e-09
substitution O 0 1.1864779159154182e-09
that O 0 1.0037010285401937e-12
is O 0 3.694988108884911e-13
not O 0 4.9711990979858095e-14
associated O 0 4.906103192973965e-13
with O 0 5.985601012233055e-14
any O 0 2.432037210509108e-11
obvious O 0 5.094864807819732e-11
phenotype O 0 3.129499437370953e-11
in O 0 7.496439450097037e-13
homozygous O 0 2.7448648909356166e-10
individuals O 0 7.414875137501387e-12
. O 0 7.308901484037733e-09

Founder O 0 0.0006785657024011016
BRCA1 O 0 9.093508310797915e-07
and O 0 3.2397999838451597e-09
BRCA2 O 0 2.199420423565357e-09
mutations O 0 3.717682411918943e-12
in O 0 1.6948546515890839e-12
French O 0 2.9230058373741485e-08
Canadian O 0 5.897638402529992e-06
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.43160388385877e-08
. O 0 8.142949070588656e-08

We O 0 9.220163299517026e-09
have O 0 1.891613775339973e-11
identified O 0 1.3168016156639428e-11
four O 0 2.055203012982232e-12
mutations O 0 7.435860195810495e-13
in O 0 7.960429732924157e-13
each O 0 1.3401108835912195e-13
of O 0 7.095196097317569e-10
the O 0 5.358016096579377e-06
breast B-Disease 1 0.9999985694885254
cancer I-Disease 1 0.9999879598617554
- O 0 1.7373593436786905e-05
susceptibility O 0 6.328225481411209e-07
genes O 0 1.3522732933424209e-10
, O 0 6.650189079970836e-12
BRCA1 O 0 1.1972275948402e-10
and O 0 4.063574129964387e-12
BRCA2 O 0 5.936059369743285e-12
, O 0 7.557331293422433e-15
in O 0 3.3904448665895634e-14
French O 0 3.304510554080764e-10
Canadian O 0 1.6461756402463834e-08
breast B-Disease 1 0.9312479496002197
cancer I-Disease 1 0.9999426603317261
and O 0 0.00214154995046556
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.651363351091618e-09
from O 0 5.597986518779408e-10
Quebec O 0 5.867965455763624e-07
. O 0 1.7504339311358308e-08

To O 0 2.5369939482544623e-09
identify O 0 3.4288358818912457e-09
founder O 0 1.6087190033431398e-06
effects O 0 0.00011254349374212325
, O 0 3.642977863815844e-10
we O 0 2.3161422432749212e-11
examined O 0 2.361238635173457e-11
independently O 0 9.345931147042297e-12
ascertained O 0 1.5534918906823236e-09
French O 0 2.2568032775893698e-08
Canadian O 0 1.8406426605110937e-08
cancer B-Disease 0 2.9233135023787327e-07
families O 0 1.5227944773210655e-12
for O 0 3.1301484841594895e-12
the O 0 6.479506601403395e-12
distribution O 0 5.692758764386241e-11
of O 0 1.817230393941216e-10
these O 0 1.3232065616819444e-11
eight O 0 7.526121392764651e-10
mutations O 0 1.0686292961636923e-09
. O 0 7.549761704694902e-09

Mutations O 0 3.806460036059889e-09
were O 0 4.0410866319895433e-10
found O 0 2.777901172978936e-12
in O 0 5.458331703289687e-12
41 O 0 8.80532369240683e-10
of O 0 6.83818779378953e-09
97 O 0 4.1000265582624706e-07
families O 0 8.180254806866571e-10
. O 0 2.6041625744710473e-08

Six O 0 1.278424033301917e-08
of O 0 1.1760154627893371e-08
eight O 0 1.3596654913072825e-09
mutations O 0 2.0577271830912736e-10
were O 0 1.3775196261445188e-10
observed O 0 3.037657070326105e-10
at O 0 4.810357445705904e-09
least O 0 4.350753368687066e-10
twice O 0 2.47506566353195e-08
. O 0 1.403573435254657e-08

The O 0 5.803020712846774e-07
BRCA1 O 0 1.3944679722044384e-07
C4446T O 0 5.0328459622051014e-08
mutation O 0 1.1077431194550513e-09
was O 0 1.1700277413595472e-09
the O 0 1.0738697431289523e-10
most O 0 5.921245698620181e-12
common O 0 1.5871637337738775e-11
mutation O 0 1.2534368508398952e-11
found O 0 6.39704326836632e-13
, O 0 1.4706507225122761e-13
followed O 0 2.5405250819732217e-12
by O 0 5.3279347080048556e-12
the O 0 1.8748340657737117e-09
BRCA2 O 0 5.173246719891722e-09
8765delAG O 0 2.0944638023934203e-08
mutation O 0 9.464051764496162e-09
. O 0 7.1695311909536485e-09

Together O 0 7.522007017257692e-09
, O 0 2.629083617478045e-10
these O 0 3.3123822695130256e-12
mutations O 0 1.1344958826542406e-11
were O 0 9.883364959772933e-12
found O 0 2.7181861904541915e-13
in O 0 4.961312936001272e-13
28 O 0 6.567292265557967e-10
of O 0 3.2216280754227e-09
41 O 0 2.9625411013256553e-09
families O 0 4.687147805298997e-12
identified O 0 1.0859999011181287e-10
to O 0 1.4564214417811527e-11
have O 0 3.5638103579316294e-11
a O 0 2.5888172161536716e-10
mutation O 0 5.603480346394463e-09
. O 0 8.111632254781398e-09

The O 0 8.86816664547041e-08
odds O 0 4.5120849279101094e-08
of O 0 1.251111769740021e-09
detection O 0 2.3039586238837728e-08
of O 0 1.2958092376891273e-09
any O 0 4.3949494044071e-10
of O 0 5.679533288116545e-09
the O 0 5.598598029621371e-09
four O 0 1.1928086296464357e-09
BRCA1 O 0 8.142976071212615e-09
mutations O 0 6.90810908476891e-10
was O 0 2.6833651745050702e-08
18 O 0 9.712208282053325e-08
. O 0 8.470154000406183e-08

7x O 0 7.522696978412569e-05
greater O 0 4.053449487173566e-08
if O 0 1.6244154632527597e-10
one O 0 3.3734638346660795e-12
or O 0 9.252437141102354e-13
more O 0 1.7059482420992735e-14
cases O 0 2.4379387397743812e-12
of O 0 0.004283767659217119
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 1.0386398798800656e-06
also O 0 2.5610561848327107e-12
present O 0 1.2490592327801808e-12
in O 0 7.532388775211007e-12
the O 0 1.250255343698825e-09
family O 0 4.604444603373281e-10
. O 0 6.61249455191637e-09

The O 0 1.5520893725806673e-07
odds O 0 1.04101630427067e-07
of O 0 2.30583041549437e-09
detection O 0 1.4232801603952794e-08
of O 0 1.2744452160262654e-09
any O 0 2.1477690459459353e-10
of O 0 4.801291808576025e-09
the O 0 5.820099957531966e-09
four O 0 9.563668745826703e-10
BRCA2 O 0 3.217538013799981e-09
mutations O 0 1.6087520204877137e-10
was O 0 2.4561558120694826e-08
5 O 0 1.1374197583791101e-07
. O 0 1.7902292981375467e-08

3x O 0 8.905828394745186e-07
greater O 0 4.576358847430129e-09
if O 0 1.3579950532138785e-11
there O 0 3.951086853526409e-12
were O 0 1.0733776714677568e-11
at O 0 2.826533625210903e-11
least O 0 3.8305450933591445e-13
five O 0 3.244715965095707e-13
cases O 0 7.082259583478245e-13
of O 0 7.1248993371852976e-09
breast B-Disease 0 0.03217725455760956
cancer I-Disease 0 1.697637162578758e-05
in O 0 6.323517709461157e-09
the O 0 6.482596859314071e-08
family O 0 6.504934924045358e-10
. O 0 7.662395162810753e-09

Interestingly O 0 5.162243965628477e-10
, O 0 2.9906394201362207e-12
the O 0 1.2835572448660626e-12
presence O 0 1.0791538019097602e-12
of O 0 3.669947123974282e-10
a O 0 1.435316647757645e-07
breast B-Disease 1 0.9992757439613342
cancer I-Disease 0 0.0011314026778563857
case O 0 7.166792714841108e-10
< O 0 3.7155543086697662e-09
36 O 0 4.678073033115293e-12
years O 0 5.288648208603974e-13
of O 0 1.7591065756827895e-11
age O 0 2.383382900761344e-11
was O 0 1.620850120787054e-10
strongly O 0 3.084293887997691e-13
predictive O 0 1.4785386456828142e-11
of O 0 1.0905539665762021e-10
the O 0 2.761094131109587e-11
presence O 0 2.918431989129555e-12
of O 0 8.020761138594068e-11
any O 0 5.107464451370447e-11
of O 0 3.997092934415747e-10
the O 0 3.049005214972311e-10
eight O 0 2.9920002586614203e-10
mutations O 0 2.990813430248096e-10
screened O 0 3.7029064259286315e-08
. O 0 1.7000933993926992e-08

Carriers O 0 1.2903241808359667e-09
of O 0 5.568459027216477e-09
the O 0 8.501237491742586e-10
same O 0 7.992691231084592e-11
mutation O 0 2.7090638760052244e-11
, O 0 9.956887744855258e-13
from O 0 3.654581249169092e-13
different O 0 8.109755000786784e-14
families O 0 3.095129878847962e-14
, O 0 2.2877289255693323e-13
shared O 0 2.6329700138910672e-12
similar O 0 4.052513966762428e-12
haplotypes O 0 1.407252370189127e-10
, O 0 4.400212399308101e-12
indicating O 0 3.951600852092341e-11
that O 0 7.500830468895603e-13
the O 0 1.946351413373293e-11
mutant O 0 2.4093224637589117e-10
alleles O 0 2.102448640531329e-12
were O 0 1.8526999379098186e-11
likely O 0 1.709167638148934e-12
to O 0 1.795148638029584e-13
be O 0 6.878135756262227e-13
identical O 0 2.773025732649703e-12
by O 0 6.709519008094023e-13
descent O 0 5.4128725807123246e-11
for O 0 5.559981728492369e-12
a O 0 1.698217608203656e-11
mutation O 0 3.801042380152664e-12
in O 0 3.321492603527987e-12
the O 0 8.467702233838637e-11
founder O 0 1.7305283872559585e-09
population O 0 1.5906609363014468e-11
. O 0 2.0184056648275828e-09

The O 0 3.420207450588464e-09
identification O 0 6.123623386145027e-09
of O 0 3.722811170447926e-09
common O 0 1.7833112764265024e-08
BRCA1 O 0 1.5999438218727846e-08
and O 0 2.5870500186542245e-10
BRCA2 O 0 3.6022326788121006e-10
mutations O 0 5.572647811952214e-12
will O 0 2.459825149559586e-13
facilitate O 0 2.3753579398572144e-12
carrier O 0 1.175174432592463e-12
detection O 0 2.2636717153523556e-11
in O 0 1.41337259279041e-13
French O 0 1.4992480590336754e-09
Canadian O 0 4.070424353130875e-08
breast B-Disease 1 0.9999651908874512
cancer I-Disease 1 0.9999897480010986
and O 0 0.10575313866138458
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.730393108800854e-07
. O 0 3.1630680297212166e-08

Are O 0 1.989912012945183e-09
Dp71 O 0 1.4167696917866124e-06
and O 0 2.335753368498672e-09
Dp140 O 0 4.0927602640294936e-07
brain O 0 6.24599351795041e-07
dystrophin O 0 4.678636145172277e-08
isoforms O 0 2.89101048656093e-10
related O 0 2.8172599669806786e-11
to O 0 7.008021767063166e-12
cognitive B-Disease 1 0.9996066689491272
impairment I-Disease 1 0.9999998807907104
in O 0 3.143445610476192e-06
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 0 0.028911523520946503

Molecular O 0 1.0900314606487882e-07
study O 0 3.6665187552742395e-10
and O 0 5.6909130186078016e-11
neuropsychological O 0 6.792563311819322e-08
analysis O 0 7.723571782136673e-12
were O 0 1.6805429660718407e-12
performed O 0 8.756610887783456e-12
concurrently O 0 4.779128481846584e-12
on O 0 7.062626178333531e-11
49 O 0 2.901810458588727e-10
patients O 0 9.40299227369934e-11
with O 0 1.4325209463095234e-08
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999996423721313
DMD B-Disease 1 1.0
) O 0 5.624470073711807e-12
in O 0 6.16518012856726e-13
order O 0 3.6411546520953575e-12
to O 0 2.891193415319876e-13
find O 0 7.159213001074749e-13
a O 0 3.48767103522038e-13
molecular O 0 3.4539703996222526e-12
explanation O 0 4.549943863514649e-13
for O 0 1.9476048107158056e-13
the O 0 3.3456751258320594e-11
cognitive B-Disease 0 3.3331689337501302e-06
impairment I-Disease 0 1.8224288567125768e-07
observed O 0 3.493773326201932e-11
in O 0 2.301596413456508e-11
most O 0 2.1419201967631807e-09
DMD B-Disease 1 1.0
patients O 0 1.232761945857419e-07
. O 0 1.5161866429025395e-08

Complete O 0 2.1915406378525404e-08
analysis O 0 1.4486620236731085e-10
of O 0 1.912753067045969e-09
the O 0 1.0742964295928914e-09
dystrophin O 0 2.954912581287772e-08
gene O 0 7.899939591382577e-10
was O 0 1.4654959468174411e-09
performed O 0 3.6239891643141675e-10
to O 0 6.096448866566018e-12
define O 0 1.2055983988901176e-10
the O 0 4.2089956520108274e-10
localization O 0 1.063082351038247e-07
of O 0 2.822984623840341e-10
deletions O 0 2.6315807172272443e-11
and O 0 2.567807425024604e-11
duplications O 0 1.3515518704210194e-09
in O 0 4.844762091504862e-11
relation O 0 4.3837811158908835e-10
to O 0 6.818982184464417e-11
the O 0 3.469260656530082e-09
different O 0 1.1792701926083282e-08
DMD B-Disease 1 1.0
promoters O 0 0.0004734297108370811
. O 0 2.430015229037963e-07

Qualitative O 0 5.846000128428841e-09
analysis O 0 2.0287910240668339e-10
of O 0 3.4411400395839564e-09
the O 0 3.6270890735323746e-09
Dp71 O 0 7.115564812920638e-07
transcript O 0 3.72763047096214e-08
and O 0 1.4107676138408465e-10
testing O 0 2.0010934576042416e-10
for O 0 4.635952646075969e-12
the O 0 1.6392985927038417e-11
specific O 0 1.7493758178166452e-12
first O 0 6.544281783149586e-11
exon O 0 1.693422624349239e-09
of O 0 4.977243062143089e-10
Dp140 O 0 1.1446656067448657e-08
were O 0 1.3110288410445037e-09
also O 0 1.1931720889091224e-10
carried O 0 1.8213214270090816e-10
out O 0 1.49608014865521e-09
. O 0 1.6636242605727602e-08

Neuropsychological O 0 4.583308691508137e-05
analysis O 0 4.279546939045531e-09
assessed O 0 8.112405858184957e-09
verbal O 0 9.620572782864656e-09
and O 0 7.703657711743972e-10
visuospatial O 0 1.3152593965060078e-06
intelligence O 0 2.919672281720409e-09
, O 0 1.3086098871184504e-10
verbal O 0 1.234387436710449e-08
memory O 1 0.6798486113548279
, O 0 9.387013388817422e-10
and O 0 1.0091175672855002e-09
reading O 0 2.1072226275009598e-07
skills O 0 1.487820497914072e-07
. O 0 3.4548801153277964e-08

Comparison O 0 3.205947729512104e-09
of O 0 4.015396015688566e-09
molecular O 0 5.285552884259914e-09
and O 0 2.5328347752484603e-10
psychometric O 0 6.549448130499513e-07
findings O 0 9.330761163717227e-11
demonstrated O 0 1.3632457662726694e-10
that O 0 2.882680801962606e-13
deletions O 0 9.468876203955201e-12
and O 0 4.1090048030767434e-12
duplications O 0 3.3912989083617617e-10
that O 0 3.874872644971106e-12
were O 0 4.3643564456852246e-11
localized O 0 2.9953135527449604e-09
in O 0 4.0979655779871393e-10
the O 0 1.883443179195865e-09
distal O 0 6.142535924347214e-10
part O 0 4.1693007379883795e-10
of O 0 9.607277640100165e-09
the O 0 9.732269212747724e-09
gene O 0 4.048595236838537e-09
seemed O 0 5.1031213976759915e-11
to O 0 4.3130614097580677e-13
be O 0 3.2433482440551165e-13
preferentially O 0 1.3768694301016793e-12
associated O 0 6.059329253627066e-12
with O 0 1.3265573535481412e-11
cognitive B-Disease 1 0.9999926090240479
impairment I-Disease 1 0.999995231628418
. O 0 4.703402467498563e-08

Two O 0 7.859889628036854e-09
altered O 0 2.2166338098372762e-08
Dp71 O 0 3.394765144548728e-07
transcripts O 0 6.215324699354596e-09
and O 0 1.9444341969876433e-10
two O 0 2.7794395257574322e-11
deleted O 0 4.387277485751184e-10
Dp140 O 0 1.5298682320974422e-09
DNA O 0 1.1971978963742913e-10
sequences O 0 3.2940924293844986e-12
were O 0 3.5522849852615e-12
found O 0 1.0727380897641858e-13
in O 0 5.401337471906686e-13
four O 0 2.3036650712016105e-11
patients O 0 4.411273429871798e-11
with O 0 1.740537713956769e-10
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 0 1.2098917068215087e-07

These O 0 1.6913083156211428e-09
findings O 0 1.0540578132545164e-10
suggest O 0 8.457916658710651e-12
that O 0 2.588843039681016e-13
some O 0 1.23704770927692e-13
sequences O 0 1.4994259089559647e-12
located O 0 5.280328257972755e-11
in O 0 7.184235411433759e-12
the O 0 3.713447882525145e-10
distal O 0 1.8315703120830307e-10
part O 0 5.667439781364969e-11
of O 0 7.351877440164856e-10
the O 0 1.4126577685402708e-10
gene O 0 9.34639518557212e-12
and O 0 6.884527128069029e-13
, O 0 1.2070462088609873e-13
in O 0 1.9285269182382075e-13
particular O 0 4.646513642597716e-12
, O 0 3.64574126096584e-12
some O 0 2.852437730460622e-11
DMD B-Disease 1 1.0
isoforms O 0 8.107930993261903e-10
expressed O 0 1.9708425863518286e-11
in O 0 1.562595712545356e-11
the O 0 8.233538850710431e-10
brain O 0 2.855219065622805e-07
may O 0 1.0836507906286652e-11
be O 0 1.714868210541537e-13
related O 0 1.8113310330802879e-13
to O 0 9.64244553343721e-14
the O 0 4.2953089002262246e-11
cognitive B-Disease 1 0.9595586061477661
impairment I-Disease 0 0.013601520098745823
associated O 0 1.2420955375347376e-09
with O 0 4.538838471734863e-10
DMD B-Disease 1 1.0
. O 0 4.787922058824279e-09
. O 0 7.368375687377693e-09

I1307K O 0 1.6009158571250737e-05
APC O 0 1.3183223472879035e-06
and O 0 7.338175622706444e-10
hMLH1 O 0 5.0941139306814875e-08
mutations O 0 2.3995083697769815e-10
in O 0 5.3512090592011674e-11
a O 0 2.458538927996301e-10
non O 0 1.5639464834293904e-07
- O 0 1.3170590174027552e-09
Jewish O 0 9.168827919125988e-10
family O 0 6.691298123223666e-12
with O 0 8.785535667021893e-12
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.7168766135000624e-05

We O 0 1.269120808444768e-09
describe O 0 4.480210993862421e-11
a O 0 1.802950150286975e-11
French O 0 1.5523307084208682e-09
Canadian O 0 7.739951790597388e-09
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 6.031452812749194e-06
HNPCC B-Disease 1 0.9862090945243835
) O 0 1.5655459567609498e-11
kindred O 0 4.939454623098527e-09
which O 0 1.1918727289839115e-11
carries O 0 6.2551795340648475e-12
a O 0 4.694734618421181e-12
novel O 0 2.5630022409961484e-11
truncating O 0 5.307343453608837e-09
mutation O 0 2.305195895280221e-10
in O 0 1.0398897021257625e-10
hMLH1 O 0 3.3835496537903964e-07
. O 0 4.1569492736925895e-08

Interestingly O 0 4.791246954738426e-09
, O 0 6.955677006592609e-11
the O 0 3.4829034101235834e-10
I1307K O 0 6.205495139965933e-08
APC O 0 1.6639100763882197e-08
polymorphism O 0 9.172116399724928e-10
, O 0 1.7056732545470132e-12
associated O 0 2.0318831252946756e-12
with O 0 2.5949569234942974e-14
an O 0 1.686211527395301e-14
increased O 0 3.0298437370124276e-11
risk O 0 2.226710549280142e-08
of O 1 0.9927592277526855
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.1104174468812289e-08
is O 0 4.998186326626852e-12
also O 0 4.685429019594956e-13
present O 0 3.127616438405867e-13
in O 0 2.872287043625965e-12
this O 0 1.1108923676783622e-11
family O 0 8.321966032953654e-11
. O 0 3.1679929790584538e-09

The O 0 2.214022565283358e-08
I1307K O 0 8.192269973505972e-08
polymorphism O 0 3.587617669609244e-08
has O 0 7.85803713765354e-11
previously O 0 1.465509241738161e-10
only O 0 1.3549595473394405e-12
been O 0 7.207522881476358e-13
identified O 0 4.740578047300603e-13
in O 0 3.12755680728638e-13
individuals O 0 1.7013671829886612e-13
of O 0 8.3078238732881e-10
self O 0 9.850691640167497e-07
- O 0 1.1476741690330527e-07
reported O 0 2.3167541218782617e-09
Ashkenazi O 0 5.351326937130807e-09
Jewish O 0 4.60831284243568e-09
origins O 0 6.345800329654594e-08
. O 0 6.872802060797767e-08

In O 0 9.215289642483526e-10
addition O 0 1.2253127679162645e-10
, O 0 6.7927313079918505e-12
in O 0 8.008603329112685e-12
this O 0 1.6630127830374875e-11
family O 0 1.7604022406469966e-11
, O 0 5.490711618011401e-12
there O 0 6.569891766033953e-12
appears O 0 7.470436595713448e-12
to O 0 2.6413186958798573e-13
be O 0 4.562962421100769e-13
no O 0 7.96606487371565e-13
relationship O 0 1.2957169720300386e-14
between O 0 5.366299852399559e-13
the O 0 2.3983722993725642e-11
I1307K O 0 1.0244591286401317e-10
polymorphism O 0 1.0808914180371332e-10
and O 0 1.1508722794206783e-11
the O 0 6.352911946505557e-11
presence O 0 5.367943242684525e-11
or O 0 6.178099698495032e-11
absence O 0 1.563841323104498e-08
of O 0 1.4385995505961091e-08
cancer B-Disease 0 4.0853041127775214e-07
. O 0 1.3162654299847532e-09
. O 0 1.0298006891673595e-08

Identification O 0 2.3881373323320076e-08
of O 0 4.1827084018564165e-09
a O 0 5.801972097208008e-11
novel O 0 1.5439521189319905e-11
mutation O 0 1.6358754628686967e-11
of O 0 2.72942751733396e-10
the O 0 2.017016331734567e-09
CPO O 0 1.9379405785002746e-05
gene O 0 2.904751161825203e-10
in O 0 3.088659536465421e-11
a O 0 5.435843442036514e-10
Japanese O 0 1.9933783335090993e-07
hereditary B-Disease 1 0.9999175071716309
coproporphyria I-Disease 1 0.999716579914093
family O 0 9.114661025932946e-08
. O 0 1.332321062363917e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999998807907104
( O 0 0.00012099550076527521
HCP B-Disease 1 0.9999985694885254
) O 0 3.012866692242433e-11
is O 0 8.664895515507476e-13
an O 0 3.5362095196500576e-12
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 4.969505251750661e-09
by O 0 2.301990629366424e-12
a O 0 3.989103491974788e-10
deficiency B-Disease 0 3.871519311360316e-06
of I-Disease 0 1.4896755601512268e-05
coproporphyrinogen I-Disease 1 0.9998189806938171
oxidase I-Disease 0 2.237195076304488e-06
( O 0 5.966028365778087e-11
CPO O 0 0.0009443459566682577
) O 0 2.6695751728991746e-13
caused O 0 4.538089088540476e-12
by O 0 2.972910546211738e-13
a O 0 3.4440631770105146e-12
mutation O 0 4.695809713295418e-12
in O 0 1.0165288749641732e-11
the O 0 2.1832742280736284e-09
CPO O 0 5.164161848369986e-05
gene O 0 3.107111368194637e-08
. O 0 9.23519483109203e-09

Only O 0 3.3017149014824554e-09
11 O 0 8.782182092659241e-09
mutations O 0 1.02772748644675e-10
of O 0 4.454253410557385e-09
the O 0 1.3086354222480168e-09
gene O 0 3.1074282036414047e-10
have O 0 1.9382225859010394e-12
been O 0 1.5635726220708523e-12
reported O 0 1.457877915611583e-11
in O 0 8.386631944468093e-10
HCP B-Disease 1 0.9999997615814209
patients O 0 1.2236760937867075e-07
. O 0 5.380251977271655e-08

We O 0 1.4742916221166524e-08
report O 0 1.8547657854028898e-10
another O 0 4.244619239424097e-11
mutation O 0 6.837071880871903e-11
in O 0 1.006984842732983e-10
a O 0 1.3795238285041478e-09
Japanese O 0 2.6655632723304734e-07
family O 0 3.943954496321567e-09
. O 0 3.58315901394235e-08

Polymerase O 0 4.937733066867622e-08
chain O 0 3.046326071398653e-07
reaction O 0 1.0323921717514395e-09
- O 0 2.0054962135418464e-09
single O 0 3.185131602911895e-10
strand O 0 2.0914397991234068e-10
conformational O 0 2.394802238459004e-11
polymorphism O 0 6.1561472065874145e-12
and O 0 9.635753973153902e-14
direct O 0 3.424952921098068e-13
sequence O 0 6.991969394957998e-13
analyses O 0 1.1295077286671562e-12
demonstrated O 0 7.458904154045154e-12
a O 0 4.630511252212699e-11
C O 0 4.153555277497389e-09
to O 0 4.15028844624743e-11
T O 0 2.0248180909732127e-09
substitution O 0 7.066830454149908e-11
in O 0 2.238962704473324e-12
exon O 0 4.043898896299858e-11
1 O 0 2.436791914084413e-11
of O 0 1.3199447611300652e-11
the O 0 5.577286896207845e-11
CPO O 0 2.0694039903901285e-07
gene O 0 4.329765365684857e-11
at O 0 2.407016530536765e-10
nucleotide O 0 3.840734674742663e-10
position O 0 8.304195664443625e-10
85 O 0 4.3880810096652567e-10
, O 0 5.5588259689765e-12
which O 0 9.498954357464728e-13
lies O 0 1.2715933341012065e-11
in O 0 7.686727122868664e-12
the O 0 3.4993305475516934e-10
putative O 0 3.3769840257491524e-09
presequence O 0 3.375131285565658e-08
for O 0 2.5201513098593864e-10
targeting O 0 1.8404380242031948e-09
to O 0 2.087968131725404e-10
mitochondria O 0 3.836038331428426e-08
. O 0 1.7124603957086038e-08

This O 0 1.424272505490265e-10
mutation O 0 5.0466224948975125e-11
changes O 0 2.872567808620552e-11
the O 0 6.461121221379429e-11
codon O 0 3.0447455667825807e-10
for O 0 6.432676440126794e-12
glutamine O 0 3.9440634785892215e-11
to O 0 4.452879037719626e-12
a O 0 1.1196080174080691e-10
termination O 0 1.0700760277870813e-08
codon O 0 1.5584845414196025e-08
at O 0 7.031371751509141e-08
amino O 0 3.2077537071018014e-08
acid O 0 3.2684437378804887e-09
position O 0 3.4866007858624926e-09
29 O 0 1.39028244916517e-07
. O 0 2.586963887551974e-08

MaeI O 0 4.503836407820927e-06
restriction O 0 1.0500595948315095e-08
analysis O 0 8.133436979473885e-11
showed O 0 3.67144564750177e-10
two O 0 6.210029886155599e-12
other O 0 2.0656605766167235e-12
carriers O 0 1.829808873865524e-12
in O 0 1.520479228633853e-11
the O 0 1.743435951162553e-09
family O 0 3.9809630592024803e-10
. O 0 6.289764709066503e-09

The O 0 5.213682470639469e-06
C O 1 0.999976634979248
- O 1 0.9995348453521729
T O 0 4.903832177660661e-06
mutation O 0 5.652660631239037e-11
is O 0 1.6861287214543774e-13
located O 0 9.1722072645406e-13
within O 0 1.982120847662805e-12
a O 0 2.037421013151297e-12
recently O 0 1.4499190043038013e-11
proposed O 0 3.663607178044925e-12
putative O 0 2.6701023336794805e-11
alternative O 0 7.860091744138487e-11
translation O 0 6.804327240539365e-11
initiation O 0 8.617601771065964e-11
codon O 0 2.2125383469795423e-10
( O 0 8.081752281285937e-12
TIC O 0 1.0786163073817079e-09
- O 0 2.3661459458423906e-09
1 O 0 1.316617037616652e-09
) O 0 3.8068734362767254e-13
, O 0 7.858254520189123e-13
supporting O 0 9.345253737524928e-12
that O 0 9.098490190428965e-12
TIC O 0 3.6291599059268265e-08
- O 0 2.498701512365642e-08
1 O 0 8.352076363848937e-09
is O 0 5.1434178097164995e-12
the O 0 3.318701563559401e-11
real O 0 2.6594481283837013e-08
TIC O 0 3.314626439987478e-08
rather O 0 1.458186522917959e-11
than O 0 1.6634751302119222e-12
TIC O 0 8.720987487720322e-09
- O 0 7.26794757710536e-09
2 O 0 5.950419712519306e-09
. O 0 1.4629593370063532e-10
. O 0 1.230686552666782e-09

Human B-Disease 0 1.3075433180631535e-08
complement I-Disease 0 1.4823021032839279e-08
factor I-Disease 0 3.976880179834552e-06
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999756813049316
associated O 0 1.2824591522075934e-07
with O 0 5.572881605075963e-07
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.01986701600253582

This O 0 3.658057884381449e-11
study O 0 1.4682076084418516e-12
reports O 0 1.2632478613508469e-12
on O 0 8.60781029787816e-11
six O 0 6.350328249360437e-12
cases O 0 2.7106439922514047e-12
of O 0 2.2123287646280687e-09
deficiency B-Disease 0 4.430556188594892e-08
in I-Disease 0 2.986167979557308e-10
the I-Disease 0 5.383305468065203e-10
human I-Disease 0 1.0465314725927044e-10
complement I-Disease 0 5.394135832448299e-11
regulatory I-Disease 0 3.0056206412609754e-09
protein I-Disease 0 1.57215462870397e-09
Factor I-Disease 0 9.572688419723363e-09
H I-Disease 1 1.0
( O 0 9.225537001000816e-11
FH O 0 7.384612032979021e-09
) O 0 1.4414240878364917e-14
in O 0 1.1917458800402361e-14
the O 0 6.287409693361487e-14
context O 0 5.562429314896755e-13
of O 0 3.063242368095409e-12
an O 0 5.350902360090615e-11
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 5.035677986597875e-06

Five O 0 2.665781195787531e-08
of O 0 8.344353652489644e-09
the O 0 6.326651424970464e-10
cases O 0 7.148137550622158e-12
were O 0 1.5610159649279143e-12
observed O 0 1.3684782473877277e-12
in O 0 2.2634015972231025e-13
children O 0 4.5438726023992737e-13
presenting O 0 1.5201406800002815e-10
with O 0 8.357138869818925e-10
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9993884563446045
HUS B-Disease 1 1.0
) O 0 1.019816181724309e-06
. O 0 9.895189805320115e-07

Two O 0 1.2657429271367704e-10
of O 0 6.429137777708149e-10
the O 0 2.2690199719122006e-10
children O 0 2.442108798170195e-12
exhibited O 0 3.2639815850110665e-10
a O 0 9.992918714729626e-10
homozygous O 0 0.001189965521916747
deficiency O 1 0.9999703168869019
characterized O 0 1.2363242873902891e-08
by O 0 1.9762707095805077e-11
the O 0 8.685028807242645e-10
absence O 0 1.0810265571592481e-08
of O 0 5.197557051417334e-09
the O 0 7.025252601877696e-10
150 O 0 2.1804840918959734e-11
- O 0 2.0070899803270592e-11
kD O 0 7.285011482949244e-11
form O 0 1.2051288786341097e-11
of O 0 1.4298286998837284e-09
Factor O 0 1.111714453827517e-08
H O 1 1.0
and O 0 5.3421024548416796e-11
the O 0 1.2741425102491544e-11
presence O 0 1.6766562097036974e-12
, O 0 1.247968064608737e-13
upon O 0 6.815308950872123e-13
immunoblotting O 0 3.5656683161633396e-10
, O 0 3.224665760109824e-12
of O 0 5.257856303120256e-11
the O 0 2.408196697611942e-10
42 O 0 2.5563445804621665e-10
- O 0 4.924748386869737e-10
kD O 0 1.5588523805121213e-09
Factor O 0 2.624570782927549e-09
H O 1 0.9994449019432068
- O 0 7.916384880957139e-09
like O 0 1.2961151596435627e-10
protein O 0 8.46786807340294e-10
1 O 0 4.647453621942077e-08
( O 0 2.9943908463891944e-11
FHL O 0 8.787430516576933e-08
- O 0 4.497568151240472e-10
1 O 0 2.667675524925528e-10
) O 0 1.72497541424399e-13
and O 0 1.357569655649482e-12
other O 0 7.995492289081252e-12
FH O 0 1.0333046702726278e-06
- O 0 1.865751775298463e-09
related O 0 4.717620183392057e-10
protein O 0 7.669409551880335e-10
( O 0 2.047464975341029e-11
FHR O 0 8.747585980017902e-07
) O 0 2.481163885459381e-11
bands O 0 1.731050858211347e-08
. O 0 7.055927842003484e-09

Southern O 0 2.2579484948437312e-08
blot O 0 3.0338558332232424e-08
and O 0 2.3320129161064074e-10
PCR O 0 8.166599063663682e-10
analysis O 0 2.561623005728486e-12
of O 0 2.99361993527647e-11
DNA O 0 1.3785184105330472e-10
of O 0 3.018677807720138e-10
one O 0 4.0946330527591446e-12
patient O 0 1.4014258503669552e-11
with O 0 3.4439712366662878e-12
homozygous O 0 1.7768079487723298e-06
deficiency O 0 0.012042972259223461
ruled O 0 3.8727196738364e-07
out O 0 2.6272777356450838e-11
the O 0 2.0256926344663917e-11
presence O 0 4.4301754105469104e-12
of O 0 1.293835455440373e-10
a O 0 1.7090806200825703e-11
large O 0 5.890448719070296e-12
deletion O 0 1.9361840256082452e-11
of O 0 6.653050332872112e-10
the O 0 4.887647175877419e-09
FH O 0 2.700648792597349e-06
gene O 0 9.330582834143897e-11
as O 0 3.5481272867704527e-12
the O 0 3.332987358328765e-11
underlying O 0 4.401455555580469e-07
defect O 0 2.235281186813154e-07
for O 0 5.392739588216955e-10
the O 0 6.030401777934458e-07
deficiency O 1 0.9902016520500183
. O 0 6.389925601979485e-07

The O 0 2.274707355809369e-08
other O 0 7.945404750797636e-11
four O 0 1.8907011373192617e-11
children O 0 1.88689233508732e-12
presented O 0 5.674134773148154e-11
with O 0 1.7095923635079835e-11
heterozygous O 0 3.2650842740622465e-07
deficiency O 0 0.0001322004827670753
and O 0 1.7818745090547594e-10
exhibited O 0 7.947478053438317e-08
a O 0 1.257010273647552e-09
normal O 0 4.916935125720556e-08
immunoblotting O 0 1.5131119823763584e-07
pattern O 0 9.101801978772528e-09
of O 0 9.092774311270091e-10
proteins O 0 2.071042816409463e-11
of O 0 2.5084032628797104e-09
the O 0 3.629312317343647e-08
FH O 0 0.0001994181948248297
family O 0 2.4444237745058217e-09
. O 0 1.0235031489003177e-08

Factor B-Disease 1 0.9953542947769165
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999985694885254
is O 0 7.959800180090681e-11
the O 0 7.232593690620348e-11
only O 0 1.2641072910657414e-10
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 5.710057280339242e-07
with O 0 2.240649443763232e-09
HUS B-Disease 1 1.0
. O 0 1.5012123810720368e-07

These O 0 1.569146201862992e-10
observations O 0 4.5888015609563126e-11
suggest O 0 7.807417906624536e-12
a O 0 7.413814354095827e-12
role O 0 3.0078311369363675e-11
for O 0 1.008524444512382e-10
FH O 0 1.02395906651509e-05
and O 0 9.382484789099976e-10
/ O 0 3.873436071444303e-06
or O 0 5.807104130894913e-09
FH O 0 6.7203336584498174e-06
receptors O 0 3.346893942546281e-11
in O 0 2.175348443045344e-12
the O 0 3.8665466661758074e-11
pathogenesis O 0 1.5072905625856947e-06
of O 0 1.3925311570517351e-08
idiopathic O 1 0.9999994039535522
HUS B-Disease 1 1.0
. O 0 1.1804385735558753e-07
. O 0 9.333816564094377e-08

Further O 0 2.4891899652601523e-10
evidence O 0 4.506195416809078e-11
for O 0 1.839628059260856e-12
a O 0 3.1842660019182345e-12
major O 0 1.0646514225776116e-10
ancient O 0 5.71558744777434e-10
mutation O 0 3.0181568035914097e-06
underlying O 1 0.9999946355819702
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 2.243625951692252e-09
linkage O 0 1.3937115284079482e-07
disequilibrium O 0 3.6531059066646776e-08
studies O 0 5.8363214434919986e-12
in O 0 1.7609150899586257e-12
the O 0 1.7551919986869002e-11
Japanese O 0 2.395457832093939e-09
population O 0 1.661563768518004e-11
. O 0 2.0067818518043623e-09

The O 1 0.8835412859916687
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 1.5056721147654883e-10
mutation O 0 6.987484202358729e-11
is O 0 7.919404064818392e-13
an O 0 8.292628736472629e-13
unstable O 0 3.82404863330521e-09
( O 0 1.6573897809735172e-10
CTG O 0 1.4974775695009157e-06
) O 0 1.860560533764599e-12
n O 0 1.5336479308736273e-10
repeat O 0 1.3335148540960517e-09
, O 0 1.692183394276514e-12
present O 0 2.4973623429652703e-12
at O 0 4.248223647862481e-11
a O 0 2.3607240294543086e-12
copy O 0 1.797727244845504e-11
number O 0 6.7147203595963045e-12
of O 0 6.141080699517687e-11
5 O 0 6.047604639292103e-10
- O 0 2.597482506860871e-10
37 O 0 6.460468271463071e-11
repeats O 0 1.8314237626437802e-10
on O 0 7.272505930799866e-10
normal O 0 1.5306028666728366e-10
chromosomes O 0 7.32966378563793e-12
but O 0 2.9558480229424644e-12
amplified O 0 4.216385920963184e-11
to O 0 5.218927286859687e-12
50 O 0 2.1190656174230327e-10
- O 0 1.620670819768577e-10
3000 O 0 4.4659630160648334e-11
copies O 0 4.052556623612702e-10
on O 0 9.820958979389616e-08
DM B-Disease 1 0.9999306201934814
chromosomes O 0 7.92372656377438e-09
. O 0 9.97091387233695e-09

Previous O 0 3.4604926923975654e-08
findings O 0 6.196332336116939e-11
in O 0 7.72750526761845e-12
Caucasian O 0 4.1393335981076973e-10
populations O 0 2.4206662715964278e-11
of O 0 3.2801974469975903e-09
a O 0 5.187010174267925e-06
DM B-Disease 1 1.0
founder O 1 0.9981886744499207
chromosome O 0 0.00011041053221561015
raise O 0 7.465150275720589e-09
a O 0 1.3320701486296826e-10
question O 0 8.03481239874948e-12
about O 0 3.3013664772849755e-14
the O 0 2.0278024051578747e-12
molecular O 0 1.9470234452478863e-11
events O 0 3.5188373482403223e-12
involved O 0 1.177694443701971e-12
in O 0 4.0818451049751125e-12
the O 0 6.554375098222209e-11
expansion O 0 1.0174324494016673e-08
mutation O 0 8.013658181482697e-09
. O 0 8.6802973697786e-09

To O 0 1.2263889903607605e-09
investigate O 0 1.2445096064794825e-09
whether O 0 1.128148130469242e-10
a O 0 8.829760256290342e-10
founder O 0 5.8107968214926586e-08
chromosome O 0 2.2638088736925965e-08
for O 0 5.723139295810142e-09
the O 0 3.5186442346457625e-06
DM B-Disease 1 1.0
mutation O 0 1.6097904120826456e-09
exists O 0 2.4187925967700252e-11
in O 0 1.1969364301783747e-12
the O 0 6.5637799015472176e-12
Japanese O 0 3.6549557824727685e-10
population O 0 7.548162941038716e-13
, O 0 6.092891816078527e-12
we O 0 1.3024691047913706e-10
genotyped O 0 1.4680425763913263e-08
families O 0 2.622730374893245e-12
using O 0 8.801705024541473e-12
polymorphic O 0 1.1628703555643938e-09
markers O 0 1.5073798875775424e-09
near O 0 6.01679843725833e-08
the O 0 3.629594180765139e-09
( O 0 2.8801624973873174e-10
CTG O 0 3.251576572438353e-07
) O 0 1.0759255465730977e-11
n O 0 7.805430191076823e-10
repeat O 0 6.363809035292434e-09
region O 0 1.430090490472935e-09
and O 0 1.1753124862234898e-10
constructed O 0 3.547566151951287e-08
haplotypes O 0 3.8897869103493576e-07
. O 0 4.406259535016943e-08

Six O 0 5.101063571544273e-09
different O 0 1.4207202254923335e-11
haplotypes O 0 6.830171095373316e-09
were O 0 1.600281795965941e-09
found O 0 4.123541508249673e-10
and O 0 4.935066133526789e-09
DM B-Disease 1 1.0
alleles O 0 9.266491463044702e-10
were O 0 1.4445736828960776e-09
always O 0 5.858801221947374e-10
haplotype O 0 1.1025144175391688e-07
A O 0 9.246704166798736e-07
. O 0 4.301275779994285e-08

To O 0 3.7896519256008787e-10
find O 0 1.0750865475639415e-11
an O 0 6.011194282140933e-14
origin O 0 3.735521007103282e-13
of O 0 6.289998383257611e-11
the O 0 2.4963361933139083e-10
( O 0 3.204085954888747e-11
CTG O 0 6.644876293648849e-08
) O 0 2.368214782264011e-12
n O 0 4.377647966347098e-10
repeat O 0 3.040440788026899e-09
mutation O 0 2.424228526254346e-11
and O 0 1.3856080996119124e-12
to O 0 3.465417514579572e-13
investigate O 0 1.3194514057734974e-11
the O 0 2.8536568941195384e-11
mechanism O 0 4.307625922628233e-10
of O 0 9.565160469238165e-11
the O 0 1.6352015227982797e-11
expansion O 0 3.831469863602166e-11
mutation O 0 7.572850224506211e-13
in O 0 2.0208822408464971e-13
the O 0 3.391217862080964e-12
Japanese O 0 7.464288215297543e-11
population O 0 4.751882277964116e-14
we O 0 9.914210294739711e-13
have O 0 1.966387393626673e-13
studied O 0 1.3394663156418574e-10
90 O 0 3.783897195575037e-09
Japanese O 0 1.2558363096104586e-06
DM B-Disease 1 1.0
families O 0 1.1103951785829125e-10
comprising O 0 1.0713063075540319e-10
190 O 0 2.613016192309914e-10
affected O 0 1.7569214139090406e-10
and O 0 8.881322760556642e-11
130 O 0 2.4411344057284623e-09
unaffected O 0 4.3802461391351244e-07
members O 0 1.994570730801115e-09
. O 0 1.5816508991406408e-08

The O 0 1.1795428633831762e-07
results O 0 3.376964707868524e-09
suggest O 0 9.466443601224839e-11
that O 0 2.1166640488956556e-12
a O 0 4.587033877734292e-11
few O 0 1.3727035133581644e-11
common O 0 7.447603297960903e-12
ancestral O 0 4.1071812617587966e-11
mutations O 0 1.0780860796102965e-12
in O 0 9.661782008132946e-13
both O 0 1.790775535671918e-12
Caucasian O 0 2.3143108263123935e-10
and O 0 4.8792407614239863e-11
Japanese O 0 1.5792874563658188e-08
populations O 0 2.32682224182712e-11
have O 0 7.458502131879596e-13
originated O 0 6.689189675258833e-13
by O 0 3.234427699630449e-13
expansion O 0 1.4858106411885785e-10
of O 0 6.42105882353583e-11
an O 0 1.2715004830271548e-12
ancestral O 0 3.88740012402522e-11
n O 0 4.4659309583749973e-10
= O 0 7.757106623706989e-10
5 O 0 4.918336848902527e-10
repeat O 0 5.210160081148274e-10
to O 0 7.822174331872933e-12
n O 0 2.588402547853974e-10
= O 0 6.219768589055263e-10
19 O 0 1.2012975059150222e-09
- O 0 5.611744957612075e-10
37 O 0 3.3100489016391066e-10
copies O 0 1.628092105576684e-09
. O 0 2.7720832296296294e-09

These O 0 7.783423905394216e-11
data O 0 1.7925579076649711e-10
support O 0 6.396611018644194e-11
multistep O 0 1.1720222570232863e-09
models O 0 4.707813583415543e-10
of O 0 4.311277557178528e-09
triplet O 0 1.0332032616133802e-06
repeat O 0 6.120730233760696e-08
expansion O 0 5.2265258787542734e-09
that O 0 2.2953217018034655e-12
have O 0 3.7839398498232257e-13
been O 0 2.6704612371246383e-13
proposed O 0 9.808019197157791e-13
for O 0 1.0171140188766636e-12
both O 0 9.806275791390817e-10
DM B-Disease 1 1.0
and O 0 2.2598012350272256e-08
Friedreichs B-Disease 0 0.046057894825935364
ataxia I-Disease 1 1.0
. O 0 1.6982274075871828e-07
. O 0 9.565264491584458e-08

The O 0 3.89039106485356e-10
molecular O 0 8.266552442570685e-10
basis O 0 9.625124697265619e-09
of O 0 0.005698116030544043
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 8.326927591895128e-09
the O 0 1.3791713326938293e-09
western O 0 1.1330092419825633e-09
Cape O 0 7.1632433318313815e-09
, O 0 1.3187167503814212e-11
South O 0 1.4971733852675584e-09
Africa O 0 2.5866517816552914e-09
. O 0 5.466643582252573e-09

Deficiency B-Disease 0 0.00036473083309829235
of I-Disease 0 3.2673287932993844e-06
the I-Disease 0 5.585886597714307e-08
sixth I-Disease 0 5.300148586684372e-07
component I-Disease 0 1.3025625023033172e-08
of I-Disease 0 1.670836624612093e-08
human I-Disease 0 2.0380818810394885e-08
complement I-Disease 0 4.337953551925011e-09
( O 0 1.1811807087980242e-09
C6 O 0 2.1635371012962423e-05
) O 0 2.3808372807965217e-12
has O 0 9.566226933863109e-13
been O 0 3.880410261777184e-13
reported O 0 3.9900258119209e-13
in O 0 6.122349805945393e-13
a O 0 4.0014445749914085e-12
number O 0 9.044886367659544e-12
of O 0 4.2046785497795724e-10
families O 0 3.0277204896879406e-13
from O 0 1.065967084566688e-12
the O 0 9.024402058965819e-11
western O 0 7.835412318968338e-10
Cape O 0 1.8870402129778086e-08
, O 0 6.055126539061817e-11
South O 0 6.7752345955796045e-09
Africa O 0 1.0247533488438876e-08
. O 0 1.2356052181416999e-08

Meningococcal B-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
is O 0 4.479817905522765e-11
endemic O 0 6.509560945833215e-11
in O 0 1.2460093720689791e-11
the O 0 6.91611212744192e-10
Cape O 0 1.6028057103767424e-08
and O 0 3.997538411404378e-12
almost O 0 2.922743427488661e-12
all O 0 1.5089020527839225e-12
pedigrees O 0 1.0746217110613188e-10
of O 0 4.90557705568051e-10
total O 0 4.0363502193940803e-05
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 1.8438543136767294e-08
C6Q0 O 0 0.0023127703461796045
) O 0 7.352935968429897e-12
have O 0 4.08322870957753e-13
been O 0 6.004906316116332e-13
ascertained O 0 1.1267976829376636e-10
because O 0 2.2652684849439053e-12
of O 0 4.5805312320901237e-10
recurrent O 1 0.9999949932098389
disease O 1 0.9999996423721313
. O 0 2.7141993541590637e-07

We O 0 9.584047999666723e-10
have O 0 3.140673918849979e-12
sequenced O 0 8.56630738566011e-11
the O 0 2.794243308956723e-11
expressed O 0 1.984709618874092e-11
exons O 0 2.649858288350515e-08
of O 0 1.9741714041288105e-08
the O 0 8.9840028749677e-08
C6 O 0 2.528490949771367e-05
gene O 0 1.3579906643634843e-10
from O 0 6.761784708542162e-12
selected O 0 5.430698425679115e-12
cases O 0 8.526053127400068e-13
and O 0 1.89901284801397e-12
have O 0 8.092823828610707e-13
found O 0 6.658524101012253e-13
three O 0 1.7271919571654193e-12
molecular O 0 8.586282547184965e-07
defects O 1 0.8358523845672607
leading O 0 3.0862952193899673e-09
to O 0 9.586598008481939e-12
total O 0 1.971003626977108e-08
deficiency O 0 0.0005174649995751679
879delG O 0 8.861823062034091e-07
, O 0 5.003511494017232e-11
which O 0 7.3557934916757e-13
is O 0 1.536321525726081e-13
the O 0 7.494813797359612e-12
common O 0 1.1181909564950132e-10
defect O 0 1.5532074515434147e-09
in O 0 5.045407234366417e-12
the O 0 8.483415359084034e-11
Cape O 0 1.422817974550128e-09
and O 0 1.3716924731482782e-12
hitherto O 0 3.700563466768614e-11
unreported O 0 1.4271461616643943e-11
, O 0 1.3825299412240089e-12
and O 0 3.976322309612312e-12
1195delC O 0 7.075276475809744e-10
and O 0 3.705380446916706e-11
1936delG O 0 1.4455686647707466e-09
, O 0 7.445997811383886e-12
which O 0 9.964981314072863e-13
have O 0 3.030655424968859e-13
been O 0 7.218226667424221e-13
previously O 0 7.531498862067831e-12
reported O 0 5.70101095238168e-13
in O 0 8.635285195235376e-12
African O 0 1.0820779827724891e-09
- O 0 1.598580290362861e-08
Americans O 0 9.082045671071626e-10
. O 0 9.259728983579407e-09

We O 0 1.3973016521617865e-08
also O 0 4.447584661670945e-11
show O 0 2.507109277127828e-11
that O 0 6.765625928419061e-13
the O 0 2.1497640473322477e-11
879delG O 0 3.142716087367603e-09
and O 0 1.1014619771820833e-10
1195delC O 0 4.2304154703742824e-06
defects O 1 0.9294300675392151
are O 0 3.721733424916218e-12
associated O 0 5.734672459123402e-11
with O 0 5.0457273775839084e-11
characteristic O 1 0.9998455047607422
C6 O 1 1.0
/ O 1 0.9999986886978149
C7 O 1 0.9135510921478271
region O 0 3.080321420156906e-08
DNA O 0 1.5947096088098078e-08
marker O 0 9.832257674702305e-09
haplotypes O 0 5.226752364251297e-10
, O 0 6.2818899387862e-12
although O 0 1.0920499747546497e-11
small O 0 3.1053037745365497e-12
variations O 0 3.567368900281309e-10
were O 0 3.0812119522494186e-10
observed O 0 2.8443567501312828e-09
. O 0 1.2784825642597752e-08

The O 0 4.582073742653847e-08
1936delG O 0 2.6456418709130958e-06
defect O 0 7.922526492620818e-06
was O 0 8.739587720185682e-09
observed O 0 2.4966601008813427e-10
only O 0 1.1314726065803082e-11
once O 0 5.122889612518833e-11
in O 0 6.4901933653771504e-12
the O 0 1.5820807164335093e-10
Cape O 0 1.6730657748098565e-08
, O 0 3.234046927827472e-12
but O 0 5.112040348323466e-13
its O 0 1.09423874041642e-12
associated O 0 1.5646116346967887e-11
haplotype O 0 6.789914186455803e-10
could O 0 1.0899779689932387e-10
be O 0 3.8640694810521126e-11
deduced O 0 4.0863512573707794e-10
. O 0 1.5491599114625387e-09

The O 0 9.515020771289073e-09
data O 0 1.027488982785485e-09
from O 0 2.8539288987605715e-11
the O 0 5.601615352124334e-11
haplotypes O 0 4.838170974963418e-10
indicate O 0 3.9886505556752105e-12
that O 0 1.6995800112325904e-13
these O 0 3.192918477355755e-13
three O 0 6.052167881437365e-12
molecular O 0 2.3814446592496097e-07
defects O 0 1.9219576643081382e-05
account O 0 2.0633373482015216e-12
for O 0 4.494950245348406e-11
the O 0 2.2474859306953476e-08
defects O 0 8.244148193625733e-05
in O 0 1.0009261475207865e-10
all O 0 5.41472366943907e-10
the O 0 2.8780278160667194e-09
38 O 0 8.379249294421243e-09
unrelated O 0 8.360220071779167e-09
C6Q0 O 0 9.119726200879086e-06
individuals O 0 6.139812182975879e-12
we O 0 5.371794328801194e-11
have O 0 1.1444317715714192e-12
studied O 0 1.6792663093401217e-10
from O 0 5.739585542952064e-11
the O 0 2.2309860625568945e-09
Cape O 0 3.975459037519613e-07
. O 0 2.22023039953001e-08

We O 0 1.100494984029865e-08
have O 0 2.2506012678502607e-11
also O 0 6.449183635043321e-13
observed O 0 6.641746614494126e-12
the O 0 2.6681422696239743e-11
879delG O 0 5.4949418348826384e-09
defect O 0 9.023103153538159e-09
in O 0 5.920119949820446e-11
two O 0 1.4926397895465016e-09
Dutch O 1 0.9999998807907104
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 0.0004922428634017706
, O 0 4.3284771600315963e-11
but O 0 2.004896682700208e-12
the O 0 6.241977767995621e-11
879delG O 0 3.18078789973697e-08
defect O 0 1.4423063987578644e-07
in O 0 2.1155280305329427e-10
the O 0 8.838627607588023e-09
Cape O 0 4.7087880261642567e-07
probably O 0 6.856674256150441e-11
did O 0 4.331473114210782e-12
not O 0 1.0045245885104137e-12
come O 0 6.487342672605034e-13
from O 0 5.674117859594263e-13
The O 0 8.42192565686517e-11
Netherlands O 0 3.641474322080285e-08
. O 0 4.860842284237776e-10
. O 0 6.655389128695788e-09

Complement B-Disease 1 1.0
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 7.862302808803179e-09
seven O 0 1.800583154798474e-10
further O 0 1.684722500394642e-11
molecular O 0 2.0446425423870096e-06
defects O 1 0.9910687208175659
and O 0 4.167639289232028e-10
their O 0 4.037712109106195e-10
associated O 0 2.9882607499587266e-09
marker O 0 1.652950345487625e-07
haplotypes O 0 6.181290501672265e-08
. O 0 1.6976729355633324e-08

Seven O 0 2.8017814734937474e-09
further O 0 3.123458436338211e-11
molecular O 0 1.582072362005249e-09
bases O 0 6.3786838033763615e-09
of O 1 0.7092577219009399
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 6.065721258607937e-09
described O 0 3.734375031427817e-09
. O 0 5.340987208057868e-09

All O 0 1.8153604175452642e-09
these O 0 1.7029240864663286e-11
new O 0 3.38393285614913e-10
molecular O 0 2.839239527929749e-07
defects O 0 2.6740265184344025e-06
involve O 0 6.342620872956672e-11
single O 0 1.4051556584959712e-09
- O 0 1.4222562016996676e-09
nucleotide O 0 4.563494027109982e-09
events O 0 1.4166519068936623e-09
, O 0 1.9803610140645134e-11
deletions O 0 6.310234279549576e-11
and O 0 4.519028901084354e-11
substitutions O 0 1.1330200111459021e-09
, O 0 1.0071846134884765e-10
some O 0 1.632428046904888e-11
of O 0 1.2960860162891663e-09
which O 0 2.834529486128723e-11
alter O 0 3.9327602285865737e-10
splice O 0 2.076297356268242e-09
sites O 0 1.1121226162202902e-10
, O 0 2.080076909327655e-11
and O 0 1.2483175604316443e-10
others O 0 3.958334104936512e-09
codons O 0 9.95508813161905e-08
. O 0 6.020690079822089e-08

They O 0 7.724506589923408e-10
are O 0 5.176227285338952e-13
distributed O 0 1.7345241996175043e-12
along O 0 3.89299426029055e-11
the O 0 1.5680698961517692e-09
C7 O 0 5.333636636351002e-06
gene O 0 3.701059736460621e-10
, O 0 3.5245870892014475e-12
but O 0 2.945856449401707e-13
predominantly O 0 1.0352967262780219e-13
towards O 0 5.747872880781935e-13
the O 0 1.2061775189753376e-11
3 O 0 1.568736918144964e-09
end O 0 2.2328304538632437e-08
. O 0 6.32863361715863e-09

All O 0 7.13572703148202e-08
were O 0 3.9358840631109615e-09
found O 0 3.4303632850951615e-11
in O 0 3.07646547126339e-11
compound O 0 7.284351344338802e-09
heterozygous O 0 6.520313178270953e-10
individuals O 0 2.336432783356379e-11
. O 0 8.168705711852908e-09

The O 0 5.6602657423354685e-05
C6 O 1 0.9999979734420776
/ O 1 0.9999890327453613
C7 O 0 0.2996423840522766
marker O 0 4.3651920123011223e-07
haplotypes O 0 1.0163113017824799e-08
associated O 0 6.769172999909756e-10
with O 0 2.5028773498192436e-10
most O 0 1.2486013645229832e-07
C7 B-Disease 1 1.0
defects I-Disease 1 1.0
are O 0 2.437476331884625e-10
tabulated O 0 2.461378878493292e-09
. O 0 2.91507457061968e-10
. O 0 5.450838447274009e-09

A O 0 2.2724269399532204e-07
genome O 0 2.6132667141354204e-09
- O 0 2.391814746260934e-09
wide O 0 7.276304558878621e-11
search O 0 3.653781270596124e-12
for O 0 5.97007415292089e-13
chromosomal O 0 6.123824647374931e-08
loci O 0 1.6864795115978382e-09
linked O 0 2.7629987187083316e-09
to O 0 1.6535807445539064e-11
mental O 1 1.0
health O 0 3.980825931648724e-05
wellness O 0 4.5547960780822905e-07
in O 0 2.35004962538532e-12
relatives O 0 2.45095653841898e-12
at O 0 3.980793819580164e-11
high O 0 1.4724248487141267e-09
risk O 0 5.587489915193089e-10
for O 0 3.325521247266039e-10
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 8.026274089800722e-10
the O 0 2.3785533542763915e-09
Old O 0 5.9063577140250345e-08
Order O 0 2.5888544641361477e-08
Amish O 0 2.7604775709733076e-07
. O 0 1.1307041525299155e-08

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 2.822299336457945e-07
BPAD B-Disease 1 1.0
; O 0 0.00011895073112100363
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 1.2152812089993859e-10
is O 0 4.252921528401926e-13
characterized O 0 1.0882900483566438e-12
by O 0 9.118599701273683e-14
episodes O 0 9.203274808911033e-10
of O 0 1.534533211611233e-08
mania B-Disease 0 4.271600118954666e-06
and O 0 4.129564690202869e-09
/ O 0 8.785175850789528e-06
or O 0 1.2608835087135617e-09
hypomania B-Disease 0 0.0002938854449894279
interspersed O 0 2.066652848853323e-09
with O 0 2.181547911067616e-12
periods O 0 4.38801848190451e-08
of O 0 1.100277131627081e-07
depression B-Disease 0 0.4310988783836365
. O 0 1.0623323731806522e-07

Compelling O 0 1.2981129948741454e-08
evidence O 0 7.347699670923191e-10
supports O 0 2.878059179867165e-10
a O 0 7.133046323742898e-12
significant O 0 2.277308550069357e-11
genetic O 0 4.6513154439153936e-10
component O 0 1.3745465876624507e-09
in O 0 5.536439015574324e-11
the O 0 3.9866088208384554e-10
susceptibility O 0 8.940086004827208e-09
to O 0 2.5827506799913635e-10
develop O 0 2.101194382930771e-07
BPAD B-Disease 1 1.0
. O 0 8.534988182873349e-07

To O 0 2.593962544761297e-10
date O 0 2.681318811426081e-08
, O 0 1.7581002625943754e-11
however O 0 4.4146886667151275e-12
, O 0 1.1166680644394966e-12
linkage O 0 1.3995147263301533e-09
studies O 0 3.5191141667390013e-11
have O 0 1.3016310035016132e-12
attempted O 0 9.050931532028628e-11
only O 0 5.097522881233885e-13
to O 0 1.1387770067206038e-12
identify O 0 1.0421448426445323e-11
chromosomal O 0 5.972913896812315e-08
loci O 0 2.2909590891018183e-10
that O 0 4.855564735006812e-12
cause O 0 1.7090391601914945e-10
or O 0 9.292318433815061e-13
increase O 0 2.225427958232884e-12
the O 0 3.613420326842309e-11
risk O 0 2.334999416042649e-10
of O 0 1.9335905099282513e-10
developing O 0 4.8713253875121154e-08
BPAD B-Disease 1 1.0
. O 0 2.3441056384854164e-07

To O 0 4.68437288958512e-10
determine O 0 1.7422914500020426e-10
whether O 0 5.302693700803829e-11
there O 0 8.690725222804119e-11
could O 0 2.8975781843354476e-11
be O 0 1.0821492139878597e-11
protective O 0 2.6891830429143226e-10
alleles O 0 3.679726337003919e-13
that O 0 4.7892706510690997e-14
prevent O 0 3.0004453782650486e-11
or O 0 4.29156406592246e-12
reduce O 0 1.4961393235424225e-10
the O 0 6.409520136863023e-11
risk O 0 7.484360353693376e-11
of O 0 8.51892584252667e-11
developing O 0 1.161755278644705e-07
BPAD B-Disease 1 1.0
, O 0 9.22103365885718e-11
similar O 0 3.5062287274956194e-12
to O 0 3.01092186122745e-13
what O 0 4.973351916924551e-14
is O 0 1.3023174762715178e-14
observed O 0 6.987966249486638e-14
in O 0 1.3039661581407125e-13
other O 0 1.0466987519774928e-11
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 3.1374228302155638e-12
we O 0 1.6489250286369495e-12
used O 0 1.648271796828027e-11
mental O 1 0.9999973773956299
health O 0 8.357816113857552e-05
wellness O 0 6.2078606788418256e-06
( O 0 2.9527755566159664e-13
absence O 0 2.3472153040660082e-11
of O 0 4.6423257599181866e-11
any O 0 1.407817773468878e-08
psychiatric B-Disease 1 1.0
disorder I-Disease 1 0.8838655352592468
) O 0 5.761176041438332e-13
as O 0 1.1877645134800163e-12
the O 0 1.276747891437724e-11
phenotype O 0 3.5604949544243425e-11
in O 0 1.0243394674147588e-11
our O 0 1.021380341414968e-10
genome O 0 1.042435512910167e-10
- O 0 1.2213979827535582e-09
wide O 0 6.691662779445551e-10
linkage O 0 1.7697766585555996e-09
scan O 0 1.6163775873323516e-09
of O 0 3.4296272488631985e-09
several O 0 1.3526600672886246e-10
large O 0 3.205291865260307e-10
multigeneration O 0 1.372454789816402e-07
Old O 0 3.0200203582353424e-07
Order O 0 1.3839943413529454e-08
Amish O 0 6.295096000030753e-08
pedigrees O 0 1.6959212922884603e-09
exhibiting O 0 6.432965271585545e-10
an O 0 9.745516893477912e-12
extremely O 0 2.6896448956925667e-10
high O 0 2.5338035669619785e-08
incidence O 0 0.008789119310677052
of O 0 3.3049833291443065e-05
BPAD B-Disease 1 1.0
. O 0 7.956114131957293e-06

We O 0 9.07122910120961e-09
have O 0 3.306545315329146e-11
found O 0 3.5706259997325684e-12
strong O 0 1.4935317522654645e-12
evidence O 0 3.10520879842624e-12
for O 0 2.1379618995315264e-12
a O 0 6.893965866922036e-12
locus O 0 4.3457501486265926e-11
on O 0 1.8063974760451629e-09
chromosome O 0 1.0526102656172043e-08
4p O 0 9.552599067319534e-07
at O 0 2.556717504376138e-08
D4S2949 O 0 6.3683263107350285e-09
( O 0 1.6074875805460742e-11
maximum O 0 4.58997861940702e-09
GENEHUNTER O 0 7.688954610785004e-07
- O 0 1.7948441621840061e-09
PLUS O 0 3.3069441629507423e-10
nonparametric O 0 2.286921985117374e-09
linkage O 0 1.5076040416062142e-09
score O 0 6.333714108741617e-10
= O 0 6.858531798048517e-11
4 O 0 6.802354513002484e-11
. O 0 7.87753814002895e-13
05 O 0 5.683485904128815e-10
, O 0 1.0421547305683454e-11
P O 0 1.6414091197347602e-09
= O 0 1.4158725407387163e-11
5 O 0 8.307466693724397e-12
. O 0 1.3060270909453359e-13
22 O 0 9.764229355613274e-13
x O 0 1.498371739183657e-11
10 O 0 2.1838218733361003e-11
( O 0 4.747463815298059e-13
- O 0 1.0345673102929442e-11
4 O 0 1.1540244454488757e-11
) O 0 5.759129474312494e-14
; O 0 1.0787683544849144e-13
SIBPAL O 0 7.297646487103293e-09
Pempirical O 0 1.2160283890949586e-09
value O 0 7.831553461290497e-11
< O 0 2.680963229195754e-10
3 O 0 5.3147229672756424e-11
x O 0 1.081784453682566e-10
10 O 0 6.658785328683692e-11
( O 0 1.3516142415362364e-12
- O 0 1.8604409679490175e-11
5 O 0 1.1620488425678754e-11
) O 0 1.8941489679904014e-14
) O 0 8.061634381426909e-15
and O 0 1.2538780506509556e-13
suggestive O 0 1.3565549508362529e-12
evidence O 0 1.1443925234527752e-12
for O 0 4.358495714947702e-13
a O 0 2.9918830000280616e-12
locus O 0 7.971832916009447e-11
on O 0 1.377783109823838e-09
chromosome O 0 2.061162440725184e-08
4q O 0 3.156968020334716e-08
at O 0 1.1580673087152604e-09
D4S397 O 0 1.1238897590359898e-09
( O 0 3.5226515714831264e-12
maximum O 0 1.4711981632942184e-09
GENEHUNTER O 0 2.563955661116779e-07
- O 0 5.872046737742664e-10
PLUS O 0 1.1824988210840104e-10
nonparametric O 0 3.2616040424038317e-10
linkage O 0 4.959522792447046e-10
score O 0 2.1290319507372146e-10
= O 0 2.3102037643996098e-11
3 O 0 1.061362282783751e-11
. O 0 2.119062439626465e-13
29 O 0 7.510258387410929e-11
, O 0 6.223927623283387e-12
P O 0 1.6929575519242235e-09
= O 0 2.8247173697315553e-11
2 O 0 1.4505553876109634e-11
. O 0 2.715817750808397e-13
57 O 0 2.3751044533892873e-12
x O 0 3.6512473600147644e-11
10 O 0 7.220547076913775e-11
( O 0 1.775724966374126e-12
- O 0 2.79995176349912e-11
3 O 0 3.539396553620122e-11
) O 0 1.1093138533408917e-13
; O 0 4.0773295655570363e-13
SIBPAL O 0 1.469160171296835e-08
Pempirical O 0 4.900118089068428e-09
value O 0 1.7722112666263001e-10
< O 0 5.565685134989451e-10
1 O 0 2.557851430662339e-10
x O 0 4.2772760333598114e-10
10 O 0 5.003915060086683e-10
( O 0 9.736654191239147e-12
- O 0 1.3637685425393897e-10
3 O 0 5.026717583844764e-11
) O 0 2.452618627125664e-14
) O 0 3.58089192385681e-15
that O 0 1.0713143967864408e-14
are O 0 6.145101381959187e-14
linked O 0 3.110736945810544e-10
to O 0 8.776513543695685e-11
mental O 1 1.0
health O 1 0.9400002360343933
wellness O 0 0.015931984409689903
. O 0 7.910437638258827e-09

These O 0 1.8552371860991457e-09
findings O 0 1.3378807783848146e-10
are O 0 1.4130553281296865e-12
consistent O 0 1.3084276717645338e-10
with O 0 2.7759838698571127e-12
the O 0 3.526224590100213e-10
hypothesis O 0 5.044082165839292e-11
that O 0 1.2031937674916032e-13
certain O 0 2.1381545839416205e-11
alleles O 0 4.801358095829489e-12
could O 0 3.57863023069116e-12
prevent O 0 3.820902622075906e-11
or O 0 3.1759440997231048e-12
modify O 0 1.1344785354194808e-11
the O 0 3.9474408984607745e-12
clinical O 0 1.9039081422533854e-09
manifestations O 0 5.971991754449846e-07
of O 0 7.408810631659435e-08
BPAD B-Disease 1 1.0
and O 0 9.581411358761116e-11
perhaps O 0 2.0703189596710247e-12
other O 0 2.3268034634454926e-12
related O 0 3.129331105355959e-08
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 0 1.8340476799494354e-06

Segregation O 0 0.00247219973243773
distortion O 1 0.9955940842628479
in O 0 5.7054858189076185e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0004464772646315396

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 4.49655590539777e-10
is O 0 8.582359540924844e-13
an O 0 1.3133895013228702e-12
autosomal B-Disease 1 0.9999995231628418
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
which O 0 1.1480572569000369e-11
, O 0 1.2218477369197595e-13
in O 0 5.347561044151405e-13
the O 0 1.7632518709009837e-11
typical O 0 2.512145005906241e-11
pedigree O 0 1.6303144815058013e-12
, O 0 6.500915528551837e-14
shows O 0 1.5942380878972151e-12
a O 0 3.3453732405791525e-12
three O 0 2.304608760772542e-12
generation O 0 2.4700122502885336e-10
anticipation O 0 1.874862931572352e-09
cascade O 0 1.2448977315671073e-07
. O 0 5.10474507109393e-08

This O 0 5.69635094302412e-12
results O 0 1.49624132528281e-11
in O 0 8.515412333598427e-12
infertility B-Disease 1 0.7659955024719238
and O 0 0.2444208413362503
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9993103742599487
CDM B-Disease 0 0.02351882867515087
) O 0 5.731864500179915e-14
with O 0 1.3202247692160104e-14
the O 0 6.113379334010682e-12
disappearance O 0 4.708055612034912e-10
of O 0 1.257833481815851e-08
DM B-Disease 1 1.0
in O 0 1.0973796316093853e-09
that O 0 1.4682342841521034e-10
pedigree O 0 1.6536400693212272e-08
. O 0 1.1566109847649386e-08

The O 0 6.019892362374435e-10
concept O 0 5.220107124337403e-10
of O 0 7.675907687243466e-10
segregation O 0 9.540590326651e-07
distortion O 0 4.074949799814931e-07
, O 0 2.0220090792694156e-12
where O 0 3.855158108977824e-13
there O 0 4.873466742465714e-14
is O 0 2.470299423460061e-14
preferential O 0 8.03977977942294e-12
transmission O 0 1.2225044587754752e-10
of O 0 1.0761702640138537e-10
the O 0 3.986135380107392e-11
larger O 0 1.5960423087324482e-12
allele O 0 3.3560333331794645e-12
at O 0 4.667614628139916e-10
the O 0 2.2672863586592484e-09
DM B-Disease 1 1.0
locus O 0 7.381383837490318e-10
, O 0 7.508478214179881e-12
has O 0 3.757396303816218e-12
been O 0 7.662778397921066e-12
put O 0 8.532585055176511e-11
forward O 0 1.1665435978303051e-11
to O 0 1.5919349172222041e-12
explain O 0 2.4751466501382602e-11
partially O 0 2.3775372781642545e-09
the O 0 1.9877563484094196e-10
maintenance O 0 1.833070200518705e-06
of O 0 5.132080787006998e-07
DM B-Disease 1 1.0
in O 0 1.533929427921521e-09
the O 0 1.1657685927701777e-09
population O 0 1.720465610255406e-11
. O 0 2.091369077916738e-09

In O 0 1.2860416065407776e-09
a O 0 2.29738714163652e-10
survey O 0 2.770601803536721e-10
of O 0 4.218612303930058e-08
DM B-Disease 1 1.0
in O 0 4.48533699071163e-09
Northern O 0 1.8894284892212454e-07
Ireland O 0 3.445013589953305e-07
, O 0 7.762345766160195e-10
59 O 0 1.4125379976803742e-08
pedigrees O 0 5.409609116213687e-08
were O 0 7.241628630083596e-09
ascertained O 0 1.8125420808701165e-07
. O 0 2.615901095737172e-08

Sibships O 0 6.301922439888585e-06
where O 0 2.483060201896592e-09
the O 0 3.9936562390430197e-10
status O 0 4.6012488263968976e-10
of O 0 4.976863365868667e-10
all O 0 5.979311490378336e-11
the O 0 2.1957013984774676e-10
members O 0 5.952022295169224e-12
had O 0 2.1129461028057683e-11
been O 0 6.081420523412762e-12
identified O 0 4.155799402522087e-12
were O 0 4.505574299068504e-12
examined O 0 2.289366829791306e-12
to O 0 1.257233114273712e-13
determine O 0 1.6116526516118945e-12
the O 0 6.596348033766075e-12
transmission O 0 9.572793668866098e-10
of O 0 5.683377102272402e-10
the O 0 3.41115331536912e-08
DM B-Disease 1 1.0
expansion O 0 8.523485028888445e-09
from O 0 9.842360954026574e-11
affected O 0 1.7836156163131278e-10
parents O 0 8.541145221641067e-12
to O 0 4.02654298792271e-11
their O 0 1.3625419681417839e-09
offspring O 0 7.624956666063554e-09
. O 0 4.976495660002911e-09

Where O 0 3.069727805282696e-09
the O 0 1.5624244120715503e-09
transmitting O 0 1.9256303573911282e-07
parent O 0 3.9193954748384385e-09
was O 0 1.9942700646424782e-07
male O 0 1.129115245745993e-09
, O 0 2.5551988303007533e-10
58 O 0 3.464157671828616e-08
. O 0 5.2152262952631645e-08

3 O 0 5.1937149692093953e-08
% O 0 1.4789400260006857e-10
of O 0 9.179256799107804e-10
the O 0 1.0964967822602034e-09
offspring O 0 1.3755976913110146e-10
were O 0 2.8059502638067002e-11
affected O 0 3.834289656612366e-12
, O 0 2.1185867730283414e-12
and O 0 4.800900128831831e-12
in O 0 1.665625450064656e-11
the O 0 1.751848388575894e-10
case O 0 2.574010449230002e-11
of O 0 1.4532282321955137e-10
a O 0 2.1254695226069487e-10
female O 0 1.1605537711401048e-11
transmitting O 0 2.154545519772455e-08
parent O 0 1.0583027787447463e-09
, O 0 3.2483511436254275e-09
68 O 0 3.039102921320591e-06
. O 0 4.854815642829635e-07

7 O 0 9.921506034515915e-07
% O 0 3.1029281366556916e-09
were O 0 1.5407264353228811e-09
affected O 0 6.167709454274473e-09
. O 0 2.2366794638628562e-08

Studies O 0 2.054344028223909e-09
on O 0 1.2771274704448388e-08
meiotic O 0 1.377068656438496e-06
drive O 0 2.83258270172837e-08
in O 0 1.0686130869075328e-09
DM B-Disease 1 1.0
have O 0 2.5227554420470533e-12
shown O 0 3.8932206525461865e-13
increased O 0 6.445839413442289e-13
transmission O 0 4.9299057891527553e-11
of O 0 4.154597152417061e-11
the O 0 2.6946859674192858e-11
larger O 0 2.735282486621138e-12
allele O 0 5.360267351511849e-12
at O 0 4.049998947319722e-10
the O 0 1.4666060588197638e-09
DM B-Disease 1 0.9999994039535522
locus O 0 1.1624667894949425e-09
in O 0 6.259625595639307e-10
non O 0 0.00027523870812729
- O 0 0.0007144932169467211
DM O 1 1.0
heterozygotes O 0 1.15591944904736e-06
for O 0 4.9671551316521345e-09
CTGn O 0 1.634291220398154e-05
. O 0 1.2835015184009535e-07

This O 0 2.7233745814037036e-10
study O 0 4.8665821372750884e-11
provides O 0 8.831469409942283e-12
further O 0 2.4924799637421335e-12
evidence O 0 1.5472036846153614e-11
that O 0 1.2191158672847369e-11
the O 0 9.944252354898708e-08
DM B-Disease 1 1.0
expansion O 0 2.6456419277565146e-07
tends O 0 9.41330971504506e-11
to O 0 5.985047527024001e-12
be O 0 2.8733187704133023e-11
transmitted O 0 2.1117060877706706e-10
preferentially O 0 9.616275553625542e-10
. O 0 1.645113822945632e-09

Diagnosis O 1 0.994408905506134
of O 0 0.00248252903111279
hemochromatosis B-Disease 1 1.0
. O 0 5.937477544648573e-05

If O 0 2.1108666814484423e-08
untreated O 0 6.623986701015383e-05
, O 0 7.211250707683803e-09
hemochromatosis B-Disease 1 1.0
can O 0 1.0542633432919502e-09
cause O 0 2.3100491830518877e-07
serious O 0 0.004090910777449608
illness O 1 0.7740209698677063
and O 0 2.035658447363531e-11
early B-Disease 0 5.7643969597620526e-09
death I-Disease 0 2.6419082477247002e-09
, O 0 8.19228094649932e-13
but O 0 6.948800801258315e-13
the O 0 9.010384105501146e-11
disease O 0 1.3438829000733676e-06
is O 0 1.5515261601525832e-12
still O 0 1.8072322067672064e-12
substantially O 0 3.405771845099714e-11
under O 0 2.1896477520044755e-08
- O 0 0.00021141859178896993
diagnosed O 0 4.081591669091722e-06
. O 0 2.7501187105372082e-08

The O 0 5.498813493431953e-08
cornerstone O 0 1.1307231943646912e-05
of O 0 1.8974597892906786e-08
screening O 0 1.0048446519306253e-08
and O 0 3.7405370467702426e-11
case O 0 4.332762013753433e-12
detection O 0 2.149178751631453e-10
is O 0 1.856982314229691e-13
the O 0 6.289655753687062e-13
measurement O 0 4.01384481207856e-11
of O 0 2.9567023829280004e-10
serum O 0 5.894295468378274e-11
transferrin O 0 4.939471054399291e-10
saturation O 0 7.439673876952213e-10
and O 0 1.6703497959791314e-11
the O 0 1.3325783532192048e-10
serum O 0 8.882733992798819e-10
ferritin O 0 4.5613248289555486e-07
level O 0 1.0504089686946827e-06
. O 0 1.142564975964433e-08

Once O 0 4.652384433256884e-08
the O 0 4.567813238764984e-09
diagnosis O 0 5.315724251886422e-07
is O 0 2.898169551568408e-11
suspected O 0 2.917897923282453e-08
, O 0 2.015665412358203e-10
physicians O 0 2.5977167084079156e-09
must O 0 5.49041312414289e-10
use O 0 1.2030004770124947e-10
serum O 0 1.5862693381052395e-09
ferritin O 0 8.371215471925098e-07
levels O 0 2.4917719443351416e-08
and O 0 2.4793816999491014e-10
hepatic O 1 1.0
iron O 1 0.7006628513336182
stores O 0 1.0602170732454397e-05
on O 0 3.0081168915785383e-06
liver O 0 9.22572235140251e-06
biopsy O 0 5.752998788466357e-08
specimens O 0 2.2652610690010455e-11
to O 0 5.523863050999056e-12
assess O 0 1.9531813943984844e-09
patients O 0 1.0127493461908887e-11
for O 0 5.532920475948e-12
the O 0 1.5391042607060257e-10
presence O 0 3.4191360853697006e-10
of O 0 4.5175962526400326e-08
iron B-Disease 0 7.783895853208378e-05
overload I-Disease 0 8.58320709085092e-06
. O 0 1.7045685751782003e-07

Liver O 1 0.9999998807907104
biopsy O 1 0.9999970197677612
is O 0 3.796412428869189e-08
also O 0 5.68301621040046e-11
used O 0 1.0077677624689696e-12
to O 0 6.963262974037099e-13
establish O 0 1.6762742582887569e-10
the O 0 9.32353777516326e-11
presence O 0 4.104417153372175e-11
or O 0 1.8103208168640528e-11
absence O 0 5.945450354261084e-09
of O 0 6.272465213896794e-09
cirrhosis B-Disease 1 0.9999904632568359
, O 0 3.131153322732949e-11
which O 0 1.830632433835744e-12
can O 0 2.456769379946544e-12
affect O 0 9.083166857548619e-11
prognosis O 0 6.496954796375576e-08
and O 0 3.986958263535456e-10
management O 0 9.835843428618318e-08
. O 0 1.222214329743565e-08

A O 0 1.6211106412811205e-07
DNA O 0 3.892523192661201e-09
- O 0 1.7412682407069724e-10
based O 0 2.1822897655621176e-11
test O 0 4.5256465242005106e-10
for O 0 1.2251952924424714e-11
the O 0 6.925497397780589e-10
HFE O 0 1.625159939067089e-06
gene O 0 3.067980244852997e-11
is O 0 1.380871464265812e-13
commercially O 0 3.219509728258352e-12
available O 0 1.5985161328294084e-12
, O 0 5.51053777261834e-13
but O 0 3.353702406928838e-13
its O 0 2.1727526462039792e-12
place O 0 5.613423267880613e-11
in O 0 2.0084639246881197e-12
the O 0 3.7371571115496494e-11
diagnosis O 0 8.874935275571261e-08
of O 0 4.1780936044233385e-08
hemochromatosis B-Disease 1 1.0
is O 0 2.0532784361648737e-09
still O 0 1.5015252929906353e-10
being O 0 7.343604890852617e-11
evaluated O 0 2.9616142871446982e-09
. O 0 7.1582713090379e-09

Currently O 0 6.32445829040762e-09
, O 0 4.041400547549756e-11
the O 0 3.7373208694457816e-11
most O 0 4.313941781922126e-13
useful O 0 6.574388928225205e-13
role O 0 2.911443005085279e-12
for O 0 1.391768970036844e-12
this O 0 1.910309882285563e-13
test O 0 2.5412809877278786e-12
is O 0 1.266839331869182e-14
in O 0 4.418390498850226e-14
the O 0 2.2413895826162156e-12
detection O 0 1.973447627534597e-09
of O 0 6.624980120051305e-09
hemochromatosis B-Disease 1 1.0
in O 0 7.779127564333521e-09
the O 0 1.6601502395019452e-08
family O 0 6.009518577210216e-11
members O 0 3.358204122769215e-12
of O 0 1.038724550816994e-09
patients O 0 9.115408948490167e-12
with O 0 2.8259233061239675e-12
a O 0 3.369094725425015e-10
proven O 0 2.1144761497282616e-09
case O 0 7.42645667184405e-11
of O 0 1.8106645072180072e-09
the O 0 6.88868198039927e-08
disease O 0 0.028123127296566963
. O 0 2.7384933432017533e-08

It O 0 4.21541496153921e-10
is O 0 3.1875429379324416e-11
crucial O 0 8.807730544901915e-09
to O 0 4.65324084819585e-10
diagnose O 1 0.9999947547912598
hemochromatosis B-Disease 1 1.0
before O 0 0.004435326904058456
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 1.039050516737916e-07
because O 0 7.196626627958835e-10
phlebotomy O 1 1.0
therapy O 0 0.0002680674660950899
can O 0 2.089791881210168e-11
avert O 0 1.1438291949161794e-05
serious O 1 0.9999998807907104
chronic O 1 1.0
disease O 1 1.0
and O 0 9.338327333630048e-11
can O 0 1.002748014830579e-12
even O 0 8.009073005493805e-13
lead O 0 1.9277050442023658e-11
to O 0 3.489308180500833e-13
normal O 0 6.347355974156699e-10
life O 0 8.571272164248356e-12
expectancy O 0 5.8089148075035624e-11
. O 0 6.340779030306054e-12
. O 0 3.7288497289900135e-10

Prevalence O 0 1.7694219422992319e-06
of O 0 4.79561990118782e-08
the O 0 1.1110276254555629e-08
I1307K O 0 2.7960075499322556e-07
APC B-Disease 0 6.117286943663203e-08
gene O 0 1.4216507138176127e-10
variant O 0 1.2405536320425625e-10
in O 0 1.1176993575459648e-12
Israeli O 0 7.692289166749688e-11
Jews O 0 1.9842998771890663e-12
of O 0 1.6303922188015685e-12
differing O 0 1.9487863200332717e-13
ethnic O 0 1.0023407884945934e-12
origin O 0 3.281187387765838e-12
and O 0 1.8145590932605593e-11
risk O 0 7.095663079326187e-08
for O 0 1.6513209857293987e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.585284816334024e-05

BACKGROUND O 0 0.00012744392734020948
& O 0 0.00040862333844415843
AIMS O 0 4.72720870448029e-07
Israeli O 0 1.1361390050979026e-08
Jews O 0 3.6211011966713613e-10
of O 0 1.3213264926648094e-09
European O 0 3.3313206415641616e-08
birth O 0 3.8267981494755077e-07
, O 0 1.4876034848398945e-09
i O 0 4.985832302573101e-10
. O 0 4.562050823914143e-12
e O 0 1.802502157949304e-12
. O 0 6.242434954367715e-13
, O 0 1.5974462421255997e-12
Ashkenazim O 0 3.7046474221646974e-10
, O 0 2.6783067950952866e-13
have O 0 1.3755745945521342e-13
the O 0 1.0575793712996884e-11
highest O 1 0.9999544620513916
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9991298317909241
of O 0 1.539613103673787e-09
any O 0 8.726037253881103e-11
Israeli O 0 4.2148622370064e-09
ethnic O 0 3.0352260704802347e-09
group O 0 6.715255462808045e-09
. O 0 2.7713657146932746e-08

The O 0 2.4928755237851874e-07
I1307K O 0 1.2121373629270238e-06
APC B-Disease 0 2.268109682290742e-07
gene O 0 6.637017602173501e-10
variant O 0 3.4424398887011876e-09
was O 0 1.1732232962913258e-09
found O 0 1.0089010356317818e-11
in O 0 3.389098723882711e-11
6 O 0 1.1442686798091017e-07
. O 0 2.319403868966674e-08

1 O 0 1.4642338008741262e-08
% O 0 1.2214317231251659e-11
of O 0 4.823398624953512e-11
American O 0 7.591803574680256e-11
Jews O 0 2.42202872341446e-11
, O 0 9.961484762066597e-13
28 O 0 5.837347966108908e-11
% O 0 3.638127993310647e-12
of O 0 1.2397258219998264e-10
their O 0 1.287020694462626e-07
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 1.5648265616619028e-07
, O 0 7.131795154435849e-12
but O 0 6.73308197390865e-13
not O 0 5.05127840597086e-13
in O 0 7.957640622835438e-12
non O 0 6.469281288445927e-08
- O 0 3.999161446444077e-09
Jews O 0 1.7790772188774895e-09
. O 0 6.657674411769676e-09

We O 0 4.053811064608226e-09
assessed O 0 2.837247770060003e-09
the O 0 2.510651686549181e-10
I1307K O 0 7.99294408437845e-09
prevalence O 0 1.1417257139711978e-09
in O 0 1.5176534074595738e-12
Israeli O 0 7.918837807707746e-11
Jews O 0 3.3173077999826273e-12
of O 0 4.166617571799147e-12
differing O 0 4.254868484453167e-13
ethnic O 0 1.9331316061799164e-12
origin O 0 1.3282049071694502e-12
and O 0 1.364944181986294e-11
risk O 0 5.0014293151434686e-08
for O 0 1.5531052213191288e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 9.724152187118307e-05

METHODS O 0 1.0645793508956558e-06
DNA O 0 1.0021114604796821e-08
samples O 0 3.726160352490737e-11
from O 0 6.267245056257309e-11
500 O 0 2.6641097314317186e-11
unrelated O 0 5.991686313766564e-11
Jews O 0 1.2517006875434333e-10
of O 0 6.9368173427619695e-09
European O 0 3.6465206676439266e-07
or O 0 1.4009168269879524e-09
non O 0 2.991267137986142e-06
- O 0 7.327354278885423e-09
European O 0 1.289167994578122e-09
origin O 0 1.1121475268494052e-11
, O 0 9.693585994660636e-13
with O 0 3.1632948213969336e-13
or O 0 1.397459491875308e-11
without O 0 8.901928499893685e-11
a O 0 1.4405193184130471e-11
personal O 0 5.98398899875896e-11
and O 0 4.5034140305766357e-10
/ O 0 3.7939732919767266e-06
or O 0 1.1916141684498172e-10
family O 0 2.6163650239385827e-12
history O 0 4.1439920939190245e-11
of O 0 1.7312414835046752e-09
neoplasia B-Disease 0 1.1137008186778985e-06
, O 0 2.590911651889627e-10
were O 0 1.026757637245801e-10
examined O 0 9.538233397554663e-11
for O 0 2.1970744668031728e-11
the O 0 3.213304622384783e-10
I1307K O 0 1.5613697001981564e-09
variant O 0 8.633527226464821e-11
by O 0 4.411262587850073e-12
the O 0 6.569945282253187e-11
allele O 0 4.821034890745146e-11
- O 0 2.791820663539113e-10
specific O 0 6.003217367656077e-11
oligonucleotide O 0 6.907615102136333e-08
( O 0 2.9786322297553625e-09
ASO O 0 0.1075916737318039
) O 0 1.3659864905868346e-10
method O 0 4.860640778758807e-09
. O 0 1.4881491594564977e-08

RESULTS O 0 1.8138004875822844e-08
In O 0 4.4102971274995184e-11
persons O 0 1.1363973130562588e-11
at O 0 5.3948560896355247e-11
average O 0 1.333900004341082e-11
risk O 0 8.987838917562385e-09
for O 0 3.234886776226631e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 9.167760994799323e-10
I1307K O 0 8.876048340766829e-09
was O 0 1.0723454346717176e-09
found O 0 5.169135952609594e-12
in O 0 9.035437328885898e-12
5 O 0 6.299116783736736e-09
. O 0 4.421335741966459e-09

0 O 0 6.093065962886612e-08
% O 0 1.7157836262882142e-10
of O 0 8.249226302048385e-10
120 O 0 4.153996868705434e-10
European O 0 8.473688417609537e-09
and O 0 1.3335350601551e-09
1 O 0 4.7470865638388204e-07
. O 0 4.4156152512186964e-08

6 O 0 3.4813402294275875e-07
% O 0 4.448919010968666e-10
of O 0 2.0420809487831093e-09
188 O 0 2.216252292797094e-09
non O 0 1.5407101727760164e-06
- O 0 2.5333299902285944e-08
European O 0 7.930092138508371e-09
Jews O 0 7.188094008903079e-10
( O 0 9.409092255330265e-11
P O 0 2.4956537458820094e-07
= O 0 1.2757196410362326e-09
0 O 0 6.18537721042145e-10
. O 0 6.5607259208677604e-12
08 O 0 5.882873355123053e-11
) O 0 2.312512594609961e-12
. O 0 9.481513491005344e-11

It O 0 4.980025836154311e-10
occurred O 0 7.07770952956821e-09
in O 0 3.9679620700283635e-10
15 O 0 3.0641253090379905e-08
. O 0 3.293407857540842e-08

4 O 0 3.0528259031825655e-08
% O 0 6.076693315204551e-11
of O 0 2.0548092394268025e-10
52 O 0 6.297059540472105e-10
Ashkenazi O 0 1.9296382269828882e-09
Israelis O 0 1.1925310738902795e-09
with O 0 2.1995745502767505e-10
familial O 1 0.999976396560669
cancer B-Disease 1 0.9999998807907104
( O 0 9.707037840200883e-09
P O 0 0.2335251122713089
= O 0 6.245508998858895e-09
0 O 0 2.545004207377133e-10
. O 0 4.683874273679611e-13
02 O 0 1.7980563218888967e-11
) O 0 1.3776744400503544e-14
and O 0 8.467027399301427e-14
was O 0 4.0502033150924266e-12
not O 0 3.887230706593747e-14
detected O 0 4.888905578114e-13
in O 0 5.708257759702573e-13
51 O 0 9.617443647025326e-11
non O 0 9.906579379048708e-08
- O 0 1.0204053157991666e-09
European O 0 1.674871352719265e-10
Jews O 0 2.391921903599492e-11
at O 0 2.8762042747487726e-10
increased O 0 1.4370054035595103e-09
cancer B-Disease 0 2.511998900445178e-06
risk O 0 2.880693443785276e-07
. O 0 1.2900098766976953e-08

Colorectal B-Disease 1 0.9999992847442627
neoplasia I-Disease 1 0.9998810291290283
occurred O 0 0.0001622714044060558
personally O 0 7.44450412426545e-09
or O 0 1.9953297694663696e-11
in O 0 1.0718760948269512e-11
the O 0 1.5154363874891885e-10
families O 0 1.2978547815449548e-13
of O 0 4.864725983155793e-11
13 O 0 1.0752434498328967e-09
of O 0 4.928406571735877e-09
20 O 0 8.902362402807285e-09
Ashkenazi O 0 5.955824278203181e-09
I1307K O 0 8.939217366332741e-09
carriers O 0 3.233518314216255e-11
, O 0 9.614907828248143e-12
8 O 0 1.0456739918396352e-09
of O 0 3.0061708677919796e-09
whom O 0 4.184325941292144e-10
also O 0 9.227829611546667e-10
had O 0 1.4249172952673916e-09
a O 0 2.7617380604638697e-10
personal O 0 4.209816495404084e-09
or O 0 5.551870074782528e-10
family O 0 4.462914413028152e-11
history O 0 8.549401742108387e-10
of O 0 4.636015304981811e-08
noncolonic O 0 0.00016469879483338445
neoplasia B-Disease 1 0.8348351120948792
. O 0 4.105130756215658e-06

CONCLUSIONS O 0 1.7771390048437752e-07
The O 0 1.2774855839836619e-08
I1307K O 0 1.2567421663334244e-06
APC O 0 2.2782425901368697e-07
variant O 0 1.181332365263188e-08
may O 0 1.301168062184388e-10
represent O 0 1.3015050842613007e-11
a O 0 2.6591701063338746e-11
susceptibility O 0 2.5913082790651742e-09
gene O 0 9.108744314367812e-10
for O 0 2.296731027584542e-09
colorectal B-Disease 1 1.0
, I-Disease 0 3.0257583105708363e-09
or I-Disease 0 2.0571858105888907e-10
other I-Disease 0 6.370724781046277e-11
, I-Disease 0 2.2477367189743802e-10
cancers I-Disease 0 2.533840870455606e-06
in O 0 2.4479498983431824e-10
Ashkenazi O 0 1.1730935112197471e-09
Jews O 0 1.1901938636038611e-11
, O 0 1.1949359687499217e-12
and O 0 2.3532612490606564e-12
partially O 0 1.2829937112712742e-09
explains O 0 1.1993223254791463e-12
the O 0 2.3945177438089438e-12
higher O 0 1.3897172301824412e-10
incidence O 0 0.00013499816122930497
of O 0 0.02804131619632244
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.2575888774790656e-08
European O 0 1.3139559662533884e-08
Israelis O 0 8.550253838279787e-09
. O 0 4.858990543255004e-09

Systematic O 0 1.9760315606021095e-09
analysis O 0 1.0384072074431927e-10
of O 0 8.91156537452531e-10
coproporphyrinogen O 0 2.704138296394376e-06
oxidase O 0 3.7675228668376803e-05
gene O 0 2.7542873795027845e-06
defects O 0 0.2590232491493225
in O 0 1.7141883468241303e-09
hereditary B-Disease 1 0.9999973773956299
coproporphyria I-Disease 1 0.9999475479125977
and O 0 7.788127476260343e-08
mutation O 0 4.4518266406612383e-08
update O 0 3.9423443354280607e-07
. O 0 2.7506066757609915e-08

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999995231628418
( O 0 1.2455501519070822e-06
HC B-Disease 1 0.999996542930603
) O 0 8.750253993605739e-11
is O 0 1.4385087088522597e-12
an O 0 8.52109398666312e-13
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 2.722341605476686e-06
autosomal O 1 1.0
dominant O 1 0.9999535083770752
inheritance O 0 2.7991717388431425e-07
caused O 0 8.359391401313587e-09
by O 0 3.651433756052258e-12
deficient B-Disease 0 8.807843343561217e-10
activity I-Disease 0 2.1974611019714985e-10
of I-Disease 0 1.060347587511501e-09
coproporphyrinogen I-Disease 0 2.1138578176760348e-06
III I-Disease 0 1.552511275804136e-05
oxidase I-Disease 0 3.6350623844327856e-08
( O 0 1.660772491751672e-10
CPO O 0 6.599395419470966e-06
) O 0 1.1213861089709454e-10
. O 0 1.2115556335956512e-09

Clinical O 0 1.5809102478669956e-05
manifestations O 1 0.757581889629364
of O 0 9.783786936168326e-07
the O 0 3.0660081051792076e-07
disease O 1 0.9007032513618469
are O 0 5.883862868498804e-14
characterized O 0 4.3876726796114596e-13
by O 0 8.128881004735786e-14
acute O 0 8.55944165323308e-07
attacks O 0 2.139078691953955e-09
of O 0 0.0018231137655675411
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 2.9655469746536767e-10
precipitated O 0 5.2695826868731643e-11
by O 0 8.474834874670767e-13
drugs O 0 1.1167457930616465e-10
, O 0 8.836907442778819e-13
fasting O 0 5.95153215598998e-09
, O 0 5.99388108590837e-11
cyclical O 0 2.07949269679375e-05
hormonal O 0 2.3717107069387566e-06
changes O 0 4.585708257565102e-09
, O 0 3.700535364248303e-11
or O 0 8.384429150964934e-09
infectious B-Disease 1 1.0
diseases I-Disease 1 0.9999998807907104
. O 0 7.884908370670018e-08

Skin O 1 1.0
photosensitivity O 1 0.9999998807907104
may O 0 6.134180694061797e-06
also O 0 1.1353629147947686e-09
be O 0 4.204066955670882e-11
present O 0 1.580295200254156e-10
. O 0 4.911103079763279e-09

The O 0 4.002086129162308e-08
seven O 0 8.156903597011933e-09
exons O 0 8.129850925797655e-08
, O 0 2.390436182331257e-10
the O 0 1.632454615929646e-09
exon O 0 1.8719550354262537e-08
/ O 0 1.3181253422089867e-08
intron O 0 6.3158633878401815e-09
boundaries O 0 6.474731861771943e-10
and O 0 2.6353278934077018e-11
part O 0 1.7009699204706408e-11
of O 0 2.429307588425189e-10
3 O 0 1.8443633287290595e-09
noncoding O 0 2.4886773197785317e-10
sequence O 0 3.1992741789110823e-11
of O 0 2.2014055023333867e-09
the O 0 6.548321440646987e-09
CPO O 0 1.351240098301787e-05
gene O 0 2.3274226990110947e-10
were O 0 2.239540497495085e-11
systematically O 0 1.0608137632206471e-11
analyzed O 0 5.251076266518662e-13
by O 0 3.056698232202504e-13
an O 0 6.833166844855132e-13
exon O 0 2.180543107188626e-10
- O 0 1.3765320827641148e-10
by O 0 5.046519313545161e-10
- O 0 1.957819080189438e-07
exon O 0 3.016393748112023e-07
denaturing O 0 1.7797148075260338e-06
gradient O 0 2.1003124572871457e-08
gel O 0 4.415621646103318e-09
electrophoresis O 0 4.4617592953599683e-10
( O 0 4.851826926333125e-11
DGGE O 0 2.8229828785697464e-07
) O 0 1.204277996769143e-12
strategy O 0 6.2827043914581715e-12
followed O 0 2.738967093494221e-13
by O 0 1.1826656021423753e-14
direct O 0 2.802893008836682e-13
sequencing O 0 1.6295808018956803e-12
in O 0 1.760011841128728e-12
seven O 0 5.6603419867906624e-11
unrelated O 0 2.9941369383834626e-09
heterozygous O 0 8.53575556902797e-08
HC B-Disease 1 1.0
patients O 0 4.750499105199424e-09
from O 0 1.556925248447083e-11
France O 0 1.911710789670451e-08
, O 0 4.4279302446881275e-11
Holland O 0 6.766001092728402e-09
, O 0 3.434638337629359e-11
and O 0 1.0232834718459927e-10
Czech O 0 2.295025979037746e-06
Republic O 0 5.365348897612421e-06
. O 0 8.134082918331842e-07

Seven O 0 1.6953915604744907e-08
novel O 0 7.582270922235068e-10
mutations O 0 9.108391818557493e-11
and O 0 2.737173161737605e-11
two O 0 1.0232889188777072e-11
new O 0 2.2328154603012962e-10
polymorphisms O 0 8.403228690667675e-08
were O 0 9.119422550440959e-09
detected O 0 1.039429093907529e-07
. O 0 6.208005487451373e-08

Among O 0 1.621315526278977e-08
these O 0 1.8124257650242726e-10
mutations O 0 2.0476650930412177e-10
two O 0 6.838741378745183e-11
are O 0 8.618781036084933e-12
missense O 0 6.436490895822544e-09
( O 0 2.0557736069015675e-10
G197W O 0 8.901075432277139e-08
, O 0 3.1402519473644475e-10
W427R O 0 7.345797303770496e-09
) O 0 8.348097386978726e-12
, O 0 9.767083843092994e-12
two O 0 5.307841839663485e-12
are O 0 3.134970148060967e-12
nonsense O 0 1.4789154345606903e-09
( O 0 1.1270141070385264e-11
Q306X O 0 2.868174586723171e-09
, O 0 2.313493147054757e-11
Q385X O 0 8.511328863924916e-10
) O 0 2.007735991349513e-12
, O 0 3.0867320418431765e-12
two O 0 3.5759281820368916e-12
are O 0 6.820224181421086e-13
small O 0 2.0516351204730165e-12
deletions O 0 3.9121841183265005e-11
( O 0 1.2722484524219091e-11
662de14bp O 0 5.2839199682352955e-09
; O 0 5.586538523449924e-11
1168del3bp O 0 1.5691723831423587e-07
removing O 0 1.5605226622028567e-07
a O 0 2.4380355512221286e-09
glycine O 0 8.674867935098973e-09
at O 0 1.4104999834785303e-08
position O 0 1.1258400878233488e-09
390 O 0 1.1122556868581324e-11
) O 0 2.425928652838999e-13
, O 0 3.788113757136752e-13
and O 0 8.218072489879491e-13
one O 0 6.129231779235245e-13
is O 0 7.008726281634847e-13
a O 0 1.5070132641792355e-11
splicing O 0 9.682901147556322e-10
mutation O 0 1.9148838070748297e-10
( O 0 7.488369299646358e-12
IVS1 O 0 2.85862483906385e-07
- O 0 5.4385012049351644e-09
15c O 0 1.4188700880879423e-08
- O 0 1.2358480461216459e-08
- O 0 1.9866963629766587e-09
> O 0 6.326433821257638e-10
g O 0 1.0434898084499267e-10
) O 0 1.5257794214271897e-13
which O 0 1.0964235026616684e-13
creates O 0 2.5823345198294767e-12
a O 0 2.296150596048374e-11
new O 0 2.2057630721938892e-10
acceptor O 0 2.2905527474748055e-10
splice O 0 8.211323887508115e-08
site O 0 2.3574619589794565e-08
. O 0 4.752429560994642e-09

The O 0 7.312917382762407e-09
pathological O 0 1.6358129073523742e-07
significance O 0 6.626382997865221e-09
of O 0 5.0909836346590964e-09
the O 0 5.991530049875848e-10
point O 0 1.1880654238183297e-09
mutations O 0 2.3155592027146454e-11
G197W O 0 7.801292944975557e-10
, O 0 1.033940034284031e-11
W427R O 0 2.2800838994641026e-09
, O 0 2.6344584500015422e-11
and O 0 1.8396079798366216e-11
the O 0 1.566141105691088e-10
in O 0 3.241943102860745e-10
- O 0 5.383461676444767e-09
frame O 0 1.2594491671791275e-08
deletion O 0 1.7180507017044988e-09
390delGly O 0 2.1503947067458284e-08
were O 0 4.3202974531197924e-10
assessed O 0 1.8548435010146136e-10
by O 0 3.694905492679368e-12
their O 0 1.4889985078259116e-11
respective O 0 1.6890855034090713e-11
expression O 0 4.894732882898545e-11
in O 0 8.341381405041481e-12
a O 0 1.1525286801317147e-11
prokaryotic O 0 3.14623782755874e-12
system O 0 7.067638835289713e-11
using O 0 5.96805070640638e-12
site O 0 2.5900370737019784e-10
- O 0 1.1648389197649323e-10
directed O 0 1.1744766270638252e-10
mutagenesis O 0 5.8667911417842333e-08
. O 0 8.455574018739753e-09

These O 0 2.8554222875065705e-10
mutations O 0 1.0693750746026964e-10
resulted O 0 8.51301251714176e-11
in O 0 6.3254861418227115e-12
the O 0 1.0011513840169073e-10
absence O 0 1.3507787111066705e-09
or O 0 8.379204448349942e-12
a O 0 1.2955089258304131e-11
dramatic O 0 5.267022928912013e-10
decrease O 0 6.398386709349779e-09
of O 0 6.980899058817158e-08
CPO O 0 0.16682596504688263
activity O 0 3.2746481792855775e-07
. O 0 2.503247387153351e-08

The O 0 1.0140284167903246e-08
two O 0 2.679985226794468e-11
polymorphisms O 0 1.0574513487071613e-09
were O 0 3.6910544065626993e-11
localized O 0 4.624626237514917e-10
in O 0 2.1908017067140406e-11
noncoding O 0 6.180471689987144e-10
part O 0 6.371782268477233e-11
of O 0 6.182687695144296e-10
the O 0 1.1983722347785886e-10
gene O 0 8.448838850760865e-12
1 O 0 8.820783686802613e-11
) O 0 4.92966331275789e-14
a O 0 3.18890963982299e-12
C O 0 9.947374035590428e-10
/ O 0 1.105906477505414e-09
G O 0 4.022806532333334e-10
polymorphism O 0 5.856094775769094e-11
in O 0 7.518208278156635e-12
the O 0 4.381421614407799e-11
promotor O 0 2.933282239325763e-08
region O 0 1.9356310998475124e-10
, O 0 7.34913605665577e-12
142 O 0 5.837615807413599e-11
bp O 0 4.792037253120718e-11
upstream O 0 2.554626215428568e-12
from O 0 3.0252053032781e-12
the O 0 2.933233170243632e-11
transcriptional O 0 2.344026639455876e-10
initiation O 0 5.464427868528965e-11
site O 0 3.7547763509504506e-11
( O 0 5.508478330591704e-13
- O 0 6.744888675358496e-11
142C O 0 1.3098240270181805e-09
/ O 0 1.5655365004363375e-08
G O 0 2.830728540459404e-09
) O 0 5.015593517766759e-13
, O 0 7.063440544269328e-13
and O 0 1.4662262289716343e-12
2 O 0 9.875004286508116e-11
) O 0 2.885722802208057e-13
a O 0 1.0241363312957219e-11
6 O 0 1.6980371275732153e-10
bp O 0 1.3871265247544784e-11
deletion O 0 4.381887214188751e-12
polymorphism O 0 5.069793976991699e-12
in O 0 1.3444946111301759e-12
the O 0 2.1609089517760083e-11
3 O 0 1.8861458228602856e-10
noncoding O 0 6.278850356311594e-11
part O 0 1.8439569315908955e-11
of O 0 2.5288907079534795e-10
the O 0 9.159040192940893e-10
CPO O 0 1.5076643649081234e-06
gene O 0 6.477025860096575e-11
, O 0 1.2656312629866218e-11
574 O 0 8.010608842923261e-11
bp O 0 3.4926141839752844e-11
downstream O 0 7.904303080119579e-12
of O 0 7.886837016801707e-11
the O 0 4.9623111175733925e-11
last O 0 7.318798345146149e-11
base O 0 5.8074638847882554e-11
of O 0 1.5330600677820883e-10
the O 0 7.443690663855307e-10
normal O 0 1.2267405757881988e-08
termination O 0 5.329782393204141e-09
codon O 0 1.833346807700309e-09
( O 0 2.6600884689420567e-11
+ O 0 4.991532187581527e-10
574 O 0 1.4625751720842572e-09
delATTCTT O 0 2.3229235424082617e-08
) O 0 1.8966182790958186e-10
. O 0 3.2503528757388267e-09

Five O 0 2.2017515277639177e-07
intragenic O 0 3.283586192992516e-05
dimorphisms O 0 7.666998135391623e-05
are O 0 1.8053908368287352e-10
now O 0 8.531669294653543e-12
well O 0 1.0645976288026215e-12
characterized O 0 1.959627425607291e-11
and O 0 7.014610788926012e-13
the O 0 5.139416670019159e-12
high O 0 1.3759118844269835e-11
degree O 0 2.4149354738156603e-10
of O 0 1.4957911298463245e-10
allelic O 0 6.770829230617892e-09
heterogeneity O 0 4.847318102463305e-09
in O 0 2.285730077433712e-10
HC B-Disease 0 0.03555862233042717
is O 0 1.2409606675589657e-10
demonstrated O 0 1.5534851183218734e-10
with O 0 1.2626022189571318e-12
seven O 0 4.0079238539103557e-11
new O 0 1.3317595290440742e-11
different O 0 3.2504516656386984e-13
mutations O 0 6.483075794955218e-13
making O 0 8.927849778905816e-13
a O 0 9.396098265765374e-13
total O 0 3.594692902716967e-12
of O 0 1.2902397206193683e-10
nineteen O 0 1.2907707969134208e-07
CPO O 1 0.9999411106109619
gene B-Disease 0 3.1583379040966975e-06
defects I-Disease 0 0.00033864250872284174
reported O 0 2.82558643149855e-10
so O 0 8.613029560400332e-12
far O 0 3.3135973132036867e-11
. O 0 4.876663656228075e-11
. O 0 3.724885067057926e-09

Coincidence O 0 2.699350432067149e-08
of O 0 4.82751794095293e-09
two O 0 1.557320244982563e-11
novel O 0 7.803580698295676e-11
arylsulfatase O 0 7.745962982141918e-09
A O 0 7.248714961605174e-10
alleles O 0 3.1121700268949004e-12
and O 0 4.910889403464402e-12
mutation O 0 1.8335732931973325e-10
459 O 0 1.0169138864313254e-09
+ O 0 2.6096021343846587e-08
1G O 0 0.002282004803419113
> O 0 4.567101257180184e-07
A O 0 6.07450889589245e-09
within O 0 5.727676666289483e-11
a O 0 2.498087674218663e-11
family O 0 2.932386755291616e-12
with O 0 7.552216491069075e-11
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 3.707232784644354e-11
molecular O 0 6.764316884400046e-11
basis O 0 4.5779435797754786e-11
of O 0 8.784467597777734e-11
phenotypic O 0 1.0995260879553825e-07
heterogeneity O 0 2.828399487952993e-07
. O 0 7.436446480824088e-08

In O 0 1.022355888835591e-08
a O 0 2.0548924783980738e-09
family O 0 1.2432414472907105e-11
with O 0 5.1149978350095715e-12
three O 0 1.7086772274854667e-10
siblings O 0 8.091056991066381e-11
, O 0 2.602047050048739e-12
one O 0 8.206888402369217e-13
developed O 0 5.542619835319229e-11
classical O 0 4.83651554361586e-08
late O 0 0.0009245541878044605
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 5.773742373094137e-08
MLD B-Disease 1 1.0
) O 0 2.7020611442774012e-11
, O 0 1.1952373986379161e-11
fatal O 0 6.862597956569516e-08
at O 0 4.678321285922493e-09
age O 0 4.2826392432360194e-10
5 O 0 5.491576082761185e-10
years O 0 1.1831953819485541e-11
, O 0 1.9291276475569274e-12
with O 0 1.637929895881296e-11
deficient O 0 1.513413678821962e-07
arylsulfatase O 0 2.015724021475762e-05
A O 0 3.529543391778134e-06
( O 0 7.406383839558828e-11
ARSA O 0 4.589692537138035e-07
) O 0 5.295713954162062e-13
activity O 0 9.407041985654008e-12
and O 0 4.175549608766843e-13
increased O 0 5.735547453644685e-11
galactosylsulfatide O 0 2.1263277005800774e-07
( O 0 1.0704189534749275e-08
GS O 1 0.9999998807907104
) O 0 3.7263825358735403e-10
excretion O 0 9.414756085845966e-09
. O 0 4.359368865891611e-09

The O 0 1.5048669865791453e-08
two O 0 7.51061643433637e-11
other O 0 4.14054728004043e-11
siblings O 0 9.707569192940468e-10
, O 0 2.57446841622766e-10
apparently O 0 4.7366919275759756e-09
healthy O 0 5.996608987146601e-09
at O 0 1.280174046769389e-07
12 O 0 5.8539897374032535e-09
( O 0 1.012430590752178e-11
1 O 0 1.3472852167240035e-08
/ O 0 1.1582380388119873e-08
2 O 0 3.58120144650087e-10
) O 0 4.6590752496257146e-14
and O 0 2.5414300655265953e-13
15 O 0 2.3790849932453506e-12
years O 0 5.135553440838159e-13
, O 0 3.1919321244293364e-13
respectively O 0 8.362568450215324e-12
, O 0 2.967122641334141e-12
and O 0 1.1830013531277661e-11
their O 0 8.306107884825664e-11
father O 0 6.635317989500678e-11
, O 0 5.2847511089471055e-11
apparently O 0 2.648996300091966e-10
healthy O 0 2.051448247386567e-11
as O 0 1.635961982202061e-12
well O 0 3.1513910404845635e-12
, O 0 1.4962175378871456e-12
presented O 0 1.105303293336135e-09
ARSA O 0 0.0007239931146614254
and O 0 9.378712917396115e-09
GS O 1 0.9999994039535522
values O 0 2.6589178081515286e-10
within O 0 4.3460235410464065e-11
the O 0 2.817421469736292e-11
range O 0 5.727023855151003e-10
of O 0 2.1111445036581244e-08
MLD B-Disease 1 1.0
patients O 0 4.470768146802584e-07
. O 0 3.510036350462542e-08

Mutation O 0 2.334630933020776e-09
screening O 0 1.630575119371258e-09
and O 0 1.2302276385101063e-11
sequence O 0 8.354182796932452e-12
analysis O 0 2.5832309381856877e-12
disclosed O 0 2.0999287378420384e-11
the O 0 3.7026957888652845e-11
involvement O 0 2.303345569831805e-10
of O 0 8.91426821247876e-10
three O 0 6.915040068333766e-11
different O 0 3.48697633267836e-11
ARSA O 0 5.6301028962479904e-05
mutations O 0 1.812726496686068e-10
being O 0 1.8730343664952187e-11
the O 0 2.822664194393476e-12
molecular O 0 1.530526226589668e-11
basis O 0 1.2589411457764044e-10
of O 0 6.800139895624113e-10
intrafamilial O 0 4.810249834008573e-07
phenotypic O 0 9.332247259408177e-07
heterogeneity O 0 6.647424015682191e-07
. O 0 7.483143349418242e-08

The O 0 2.3869851872859726e-08
late O 0 4.755950158141786e-06
infantile O 1 0.9997854828834534
patient O 0 1.1879770056566485e-07
inherited O 0 2.3817959160510327e-08
from O 0 1.3681507315954633e-10
his O 0 2.5629951494465786e-09
mother O 0 2.499242479636621e-10
the O 0 5.368601674327067e-10
frequent O 0 6.253014772639176e-10
0 O 0 1.2007896010857166e-08
- O 0 5.410380143899829e-09
type O 0 2.641349139409499e-09
mutation O 0 1.2930045922843192e-09
459 O 0 6.638017358007176e-10
+ O 0 1.9161086051155962e-09
1G O 0 2.3402596980304224e-06
> O 0 5.382958967459217e-09
A O 0 5.748550524486973e-10
, O 0 3.542161681156786e-13
and O 0 2.586493844623783e-13
from O 0 6.426871838535742e-13
his O 0 3.246582169769141e-11
father O 0 5.950413772826124e-11
a O 0 1.0202972147710376e-11
novel O 0 3.0844719139944132e-12
, O 0 2.434922706170961e-12
single O 0 7.53610090997725e-11
basepair O 0 2.4441874302283395e-08
microdeletion O 0 5.2853238230454735e-08
of O 0 7.0166592536224925e-09
guanine O 0 4.650208662582145e-09
at O 0 1.4208064946785726e-08
nucleotide O 0 4.6853489976683704e-09
7 O 0 3.283128080511233e-08
in O 0 6.286307585590123e-10
exon O 0 9.140877388347235e-09
1 O 0 4.809486142676178e-09
( O 0 1.2750250508175576e-11
7delG O 0 3.758255040509084e-09
) O 0 1.0028868013822745e-10
. O 0 2.447348990131104e-09

The O 0 4.953096599535911e-09
two O 0 3.0043526000334e-10
clinically O 0 8.188612241610826e-07
unaffected O 0 2.1639048952692974e-07
siblings O 0 7.983721461712889e-10
carried O 0 2.7153299053672697e-10
the O 0 7.15437820097975e-10
maternal O 0 6.515057826561588e-09
mutation O 0 1.6516660261700622e-09
459 O 0 1.554214978938262e-09
+ O 0 4.698557987126151e-09
1G O 0 2.6478546715225093e-05
> O 0 4.6162853095665923e-08
A O 0 1.5455475788073159e-09
and O 0 1.5559417903404649e-12
, O 0 3.44448184167942e-13
on O 0 6.062499807724109e-11
their O 0 3.5385978001956087e-12
paternal O 0 2.6540054876011965e-12
allele O 0 1.8860215039023798e-12
, O 0 1.7646395954716565e-13
a O 0 7.743199527746047e-13
novel O 0 8.551150239288763e-13
cytosine O 0 3.1732873273515594e-11
to O 0 9.510356911712758e-13
thymidine O 0 5.066628228078685e-10
transition O 0 2.4652928587443057e-09
at O 0 3.797938852301286e-09
nucleotide O 0 1.178474207108593e-08
2435 O 0 2.693662963793031e-07
in O 0 1.828498741307527e-10
exon O 0 1.0787690740698963e-08
8 O 0 2.2850297209942028e-09
, O 0 3.667508137461528e-12
resulting O 0 4.641358478107982e-12
in O 0 1.9378344415232895e-12
substitution O 0 2.8344010472025616e-10
of O 0 6.601905688796705e-10
alanine O 0 8.465769196774886e-10
464 O 0 3.268354753505065e-10
by O 0 6.748186454075267e-10
valine O 0 4.2531373765086755e-06
( O 0 5.770554589723531e-10
A464V O 0 1.0465708299989274e-07
) O 0 3.7116212880938804e-10
. O 0 5.660509838634198e-09

The O 0 2.7406784397498996e-07
fathers O 0 3.030530137948517e-08
genotype O 0 5.036434824745584e-09
thus O 0 4.6420095545229856e-10
was O 0 1.969416629776788e-09
7delG O 0 2.2293288282071444e-07
/ O 0 3.087055574724218e-06
A464V O 0 3.5856180602422683e-06
. O 0 1.1315039216697187e-07

Mutation O 0 4.245500306865324e-08
A464V O 0 5.858516161083571e-08
was O 0 3.0318760835257308e-09
not O 0 1.739487243482274e-12
found O 0 6.611043635272595e-13
in O 0 2.2517337387034653e-12
18 O 0 2.466106208132146e-09
unrelated O 0 1.1320441899442812e-06
MLD B-Disease 1 1.0
patients O 0 1.5583001555796727e-08
and O 0 4.1420106233758247e-10
50 O 0 9.118970467625331e-09
controls O 0 6.4735299929452594e-06
. O 0 3.762259126460776e-08

A464V O 0 1.1694290833474952e-06
, O 0 8.829070252680538e-10
although O 0 2.9209409890817994e-10
clearly O 0 1.037464766873164e-10
modifying O 0 7.953930847293122e-10
ARSA O 0 0.00018310415907762945
and O 0 4.770459227643187e-08
GS O 1 1.0
levels O 0 8.56911483992917e-08
, O 0 2.7507702712870064e-11
apparently O 0 1.8760923370386706e-10
bears O 0 1.2223383763498852e-11
little O 0 5.646125385803946e-13
significance O 0 5.669199484859e-12
for O 0 1.0665954881458606e-12
clinical O 0 1.8279556757150317e-09
manifestation O 0 2.580996181222872e-07
of O 0 1.1977729741374787e-07
MLD B-Disease 1 1.0
, O 0 1.2345751088105317e-09
mimicking O 0 2.6651964191160005e-08
the O 0 8.086205482982223e-09
frequent O 0 1.1466796934200829e-07
ARSA O 0 0.0023117652162909508
pseudodeficiency O 0 1.4123075743555091e-05
allele O 0 4.6986590973574494e-07
. O 0 8.859156253038236e-08

Our O 0 3.7716709755386546e-08
results O 0 3.504252998887125e-10
demonstrate O 0 5.960602844634622e-11
that O 0 1.2128480457365004e-13
in O 0 4.713915889575926e-13
certain O 0 9.780786423829735e-12
genetic O 0 1.147597039619086e-08
conditions O 0 6.044314068276435e-05
MLD B-Disease 1 1.0
- O 0 1.0089363058796152e-05
like O 0 3.6318792417944223e-09
ARSA O 1 0.9999481439590454
and O 0 2.1144857953458995e-07
GS O 1 1.0
values O 0 5.208463438322042e-09
need O 0 2.4717264693330243e-11
not O 0 2.655979006605663e-13
be O 0 2.939848749638693e-14
paralleled O 0 7.557497921743817e-13
by O 0 2.5270885102395e-13
clinical O 0 2.177779060730245e-05
disease O 0 0.00017016532365232706
, O 0 7.961766012101745e-13
a O 0 8.394236911471453e-13
finding O 0 7.99927127575345e-13
with O 0 2.6663285294936667e-13
serious O 0 1.611114974764405e-08
diagnostic O 0 1.9487845293042483e-07
and O 0 3.4037409002429797e-10
prognostic O 0 0.0010812865803018212
implications O 0 1.5901240146831697e-07
. O 0 1.0410735384880354e-08

Moreover O 0 3.4659155545568865e-08
, O 0 5.754090537379852e-10
further O 0 8.180692234738274e-10
ARSA O 0 1.9400244127609767e-05
alleles O 0 3.525780778446119e-10
functionally O 0 1.048426012673076e-09
similar O 0 2.0277260773249317e-11
to O 0 1.1587266736390323e-11
A464V O 0 1.1813435563112762e-08
might O 0 8.891997381466066e-12
exist O 0 4.757201143429368e-12
which O 0 1.7512177146773722e-13
, O 0 1.5710364595616227e-13
together O 0 1.606652094351957e-13
with O 0 1.0545011044915675e-12
0 O 0 6.499853544283951e-09
- O 0 8.689303720998964e-10
type O 0 4.237242154370158e-11
mutations O 0 1.0791728621839525e-11
, O 0 8.82491454044787e-13
may O 0 1.2672207033714855e-11
cause O 0 1.1858806159281698e-09
pathological O 1 0.9990383386611938
ARSA O 1 0.9999969005584717
and O 0 1.7999640533616912e-07
GS O 1 1.0
levels O 0 1.1096933150156474e-08
, O 0 3.901122317979261e-13
but O 0 4.0287953230683585e-14
not O 0 4.9884192778034894e-14
clinical O 0 1.9715692967103848e-10
outbreak O 0 6.073243019599772e-10
of O 0 1.5639471662165505e-10
the O 0 4.669262199108459e-10
disease O 0 5.2929205907048527e-08
. O 0 3.148821134391078e-11
. O 0 5.93289584127632e-10

Human O 1 0.5394769310951233
MLH1 O 1 1.0
deficiency O 1 0.9999997615814209
predisposes O 0 1.0679726756279706e-06
to O 0 2.2062575766312875e-08
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 0 2.349495389353251e-06
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.7034624218940735
1 I-Disease 1 0.8934929966926575
. O 0 4.847718315659222e-08

Heterozygous O 0 6.55139729133225e-08
germ O 0 8.170412002073135e-06
- O 0 8.53660182542626e-08
line O 0 2.982850855204333e-09
mutations O 0 1.4359491894155862e-11
in O 0 3.1194203036627455e-12
the O 0 7.185280148647166e-11
DNA O 0 1.4605770815023789e-08
mismatch O 0 7.321493740164442e-06
repair O 0 8.50137382713001e-07
genes O 0 6.229706195348683e-10
lead O 0 2.096929074824061e-09
to O 0 2.1785229176174425e-10
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.23418249131646e-06

The O 0 1.1098647973994957e-06
disease O 1 0.7486995458602905
susceptibility O 0 2.3086133182914637e-07
of O 0 2.6578153011769245e-08
individuals O 0 2.4299133885574697e-11
who O 0 4.9411412739175375e-09
constitutionally O 0 0.08577326685190201
lack O 0 0.00023854260507505387
both O 0 1.4648866564215268e-09
wild O 0 1.8170143789575377e-07
- O 0 1.6056108664841418e-09
type O 0 2.870838566870759e-10
alleles O 0 9.545399193289228e-12
is O 0 4.0448300091255884e-12
unknown O 0 2.9473461449214255e-09
. O 0 2.4786119823261288e-09

We O 0 5.008147674345764e-09
have O 0 5.7389366696358746e-12
identified O 0 2.976696580198057e-12
three O 0 6.808201463530394e-13
offspring O 0 4.1962063164480146e-12
in O 0 1.458060668729777e-12
a O 0 8.916207216991268e-10
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 2.055744374729329e-08
who O 0 7.221345743602114e-11
developed O 0 4.640057937876918e-08
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
at O 0 5.052867209087708e-07
a O 0 4.952373580668912e-11
very O 0 7.040077613755524e-13
early O 0 5.334478414553701e-10
age O 0 1.4308018658759636e-10
, O 0 6.197676486602299e-12
and O 0 1.7656143908029165e-11
at O 0 1.7532332252656602e-09
least O 0 1.0138799522163566e-11
two O 0 3.1153948778367413e-12
of O 0 7.28267723903997e-11
them O 0 4.142938596352064e-12
displayed O 0 2.422248179811959e-09
signs O 0 6.548598889821733e-07
of O 0 7.011644953536234e-08
neurofibromatosis B-Disease 1 0.5991456508636475
type I-Disease 0 1.3384483281697612e-06
1 I-Disease 0 6.441820460167946e-06
( O 0 7.740730834093767e-10
NF1 B-Disease 0 2.3023435460345354e-06
) O 0 3.896279965331928e-10
. O 0 5.536011649098782e-09

DNA O 0 2.199197934871222e-09
sequence O 0 2.826366744812514e-11
analysis O 0 6.398657645401151e-12
and O 0 2.9233735657913096e-12
allele O 0 2.8567484749303373e-12
- O 0 9.08718239545081e-12
specific O 0 2.1619385968951743e-12
amplification O 0 3.026367004221875e-11
in O 0 1.1862866591827448e-11
two O 0 1.3496081856245734e-11
siblings O 0 5.7141895382084584e-11
revealed O 0 2.834709411647651e-10
a O 0 1.2669384985564136e-10
homozygous O 0 2.5678700055209447e-08
MLH1 O 0 0.0002725232916418463
mutation O 0 2.8703091015103155e-09
( O 0 2.7193971033345754e-11
C676T O 0 1.2800154536307673e-07
- O 0 2.0785566903214203e-06
- O 0 7.044970402603212e-07
> O 0 9.855448723783411e-08
Arg226Stop O 0 4.3357385948183946e-07
) O 0 8.030557469007604e-11
. O 0 5.751072951198921e-10

Thus O 0 3.383598956574474e-09
, O 0 1.545204068864603e-11
a O 0 1.2145877185953946e-11
homozygous O 0 9.696651259716305e-10
germ O 0 0.00024421323905698955
- O 0 5.1126266953360755e-06
line O 0 1.9639939807802875e-07
MLH1 O 0 2.8426275093806908e-05
mutation O 0 3.176341134558669e-10
and O 0 3.2936587485155044e-12
consequent O 0 1.8604301033064985e-07
mismatch O 1 0.9999991655349731
repair O 1 1.0
deficiency O 1 0.9999992847442627
results O 0 2.1330825106247175e-08
in O 0 8.863401679271021e-11
a O 0 2.7901489452197836e-10
mutator O 0 8.167424675775692e-05
phenotype O 0 9.948132317916247e-10
characterized O 0 9.030268720289225e-12
by O 0 1.1892629893026085e-12
leukemia B-Disease 1 0.9999961853027344
and O 0 1.4991350383297686e-07
/ O 1 1.0
or O 1 0.9999927282333374
lymphoma B-Disease 1 1.0
associated O 1 0.9999910593032837
with O 0 3.125942527049119e-08
neurofibromatosis B-Disease 1 1.0
type I-Disease 0 0.00011152316437801346
1 I-Disease 0 2.593466342659667e-05
. O 0 2.29566129994474e-10
. O 0 1.0180783993618547e-09

Missense O 0 3.2392722459917422e-06
mutations O 0 1.5480611237350672e-09
in O 0 7.642089738801872e-10
the O 0 1.0159038055235214e-09
most O 0 1.430509096594923e-11
ancient O 0 1.4176161633461248e-10
residues O 0 1.149667383515407e-08
of O 0 1.8216844921425945e-08
the O 0 3.223688693765325e-08
PAX6 O 0 0.0018278001807630062
paired O 0 6.4419931611325865e-09
domain O 0 2.815468747030536e-09
underlie O 0 2.973489454660694e-09
a O 0 9.828268407452434e-12
spectrum O 0 1.2015541894783155e-09
of O 0 2.0519042021049927e-09
human O 1 0.9276154041290283
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 1.5733471627754625e-06

Mutations O 0 3.595692854574395e-09
of O 0 3.7010827735883822e-09
the O 0 1.2178342778668139e-09
human O 0 8.718394006734798e-09
PAX6 O 0 0.0007488003466278315
gene O 0 3.441989235852816e-07
underlie O 0 0.00026010879082605243
aniridia B-Disease 1 1.0
( O 1 0.9981288313865662
congenital B-Disease 1 1.0
absence I-Disease 1 0.9999998807907104
of I-Disease 1 0.9877324104309082
the I-Disease 0 1.7039573663168994e-07
iris I-Disease 0 3.097903444881922e-08
) O 0 8.544664975573824e-12
, O 0 5.3423645715589e-12
a O 0 8.848182603271582e-11
rare O 0 4.673427724810608e-07
dominant O 1 0.999976396560669
malformation B-Disease 1 1.0
of I-Disease 1 0.9999998807907104
the I-Disease 1 0.999380350112915
eye I-Disease 1 0.9999990463256836
. O 0 8.65871072619484e-07

The O 0 8.527176298400718e-09
spectrum O 0 3.598843889562886e-08
of O 0 1.4604460751854731e-08
PAX6 O 0 0.00021975798881612718
mutations O 0 1.537506011395351e-09
in O 0 2.1876596090208977e-09
aniridia B-Disease 1 1.0
patients O 0 2.929111353466851e-08
is O 0 7.353328883297205e-12
highly O 0 2.0971909972522518e-11
biased O 0 4.4307756248695984e-12
, O 0 7.610741464131321e-14
with O 0 6.001113234815891e-14
92 O 0 1.9269377760089412e-10
% O 0 1.1035405445350421e-12
of O 0 6.574947530868513e-11
all O 0 2.6121676002799354e-11
reported O 0 7.479993707759647e-11
mutations O 0 3.24348152502818e-11
leading O 0 2.662111198148409e-09
to O 0 6.841963801074158e-11
premature O 0 3.1644300513278267e-09
truncation O 0 5.0869196854819165e-08
of O 0 7.585720851466249e-08
the O 0 3.9219605341145325e-09
protein O 0 1.9909134063578193e-10
( O 0 7.824860551175483e-12
nonsense O 0 8.03383970460203e-10
, O 0 1.207095794847346e-11
splicing O 0 2.2492291362752326e-10
, O 0 2.387758827465669e-12
insertions O 0 6.580050306709273e-12
and O 0 2.097165973866111e-12
deletions O 0 7.888517963849928e-12
) O 0 5.456632324804533e-13
and O 0 9.001018680399042e-12
just O 0 4.053683083649062e-11
2 O 0 2.8035229693301744e-10
% O 0 3.2770654679464828e-12
leading O 0 5.728463189913491e-11
to O 0 2.4674387966855393e-12
substitution O 0 5.696367821883541e-10
of O 0 4.274953724348052e-09
one O 0 3.5494307493166843e-10
amino O 0 1.4298668915557755e-09
acid O 0 2.1280076659135894e-11
by O 0 2.1926523097182127e-12
another O 0 3.359807571046147e-11
( O 0 8.157981234990785e-12
missense O 0 1.7834505428027114e-08
) O 0 1.5261659991328003e-10
. O 0 4.667732422802828e-09

The O 0 4.5782013735617966e-09
extraordinary O 0 7.362359610851854e-10
conservation O 0 7.137752611185988e-09
of O 0 5.825049886887257e-10
the O 0 1.5768425454254498e-09
PAX6 O 0 2.4314695110660978e-06
protein O 0 1.2369415491875202e-09
at O 0 1.138803185085635e-08
the O 0 7.0831109866276165e-09
amino O 0 4.348791193820034e-08
acid O 0 4.206525794359095e-09
level O 0 5.749257638854033e-07
amongst O 0 3.4520508673807626e-10
vertebrates O 0 6.095268734185311e-10
predicts O 0 2.837176049652612e-10
that O 0 1.8488864952925788e-12
pathological O 0 0.0033327576238662004
missense O 0 1.7610605596019013e-07
mutations O 0 1.1446643632950781e-10
should O 0 3.159052013035346e-12
in O 0 1.842437227089766e-12
fact O 0 8.403517465227495e-12
be O 0 7.320694397905392e-12
common O 0 1.7689211206928235e-11
even O 0 1.863000205493126e-12
though O 0 3.2852765646795845e-12
they O 0 1.686518763185929e-12
are O 0 2.4925691393708205e-13
hardly O 0 1.4147144393461542e-11
ever O 0 5.9351989468992006e-12
seen O 0 7.585709838053845e-11
in O 0 2.558783462891512e-10
aniridia B-Disease 1 1.0
patients O 0 3.991801733604916e-08
. O 0 1.3557300171385123e-08

This O 0 9.443593823599272e-11
indicates O 0 1.4283688815064366e-11
that O 0 3.90469557728923e-13
there O 0 3.2610285999323807e-12
is O 0 1.0604997782714953e-12
a O 0 8.484414559806197e-12
heavy O 0 2.5875907638805984e-08
ascertainment O 0 1.0986105962729198e-06
bias O 0 1.439273922265727e-09
in O 0 9.298067524254883e-12
the O 0 4.911809847740756e-11
selection O 0 8.88252596475958e-11
of O 0 1.8566133352937442e-10
patients O 0 8.965721394471604e-12
for O 0 1.2066860531623202e-11
PAX6 O 0 3.627282012530486e-06
mutation O 0 2.9463650269567765e-11
analysis O 0 7.670934200343371e-13
and O 0 1.168337778953421e-12
that O 0 8.580051274499623e-13
the O 0 1.0102442216108898e-09
missing O 0 1.5991201252063547e-08
PAX6 O 0 0.0014649111544713378
missense O 0 1.7129624438894098e-06
mutations O 0 2.975713453423623e-09
frequently O 0 4.6046444435177136e-11
may O 0 9.494235259088768e-11
underlie O 0 2.7528042068070135e-09
phenotypes O 0 6.287326770326729e-10
distinct O 0 6.495112087057109e-11
from O 0 3.0148977758770457e-10
textbook O 0 0.0010307604679837823
aniridia B-Disease 1 1.0
. O 0 1.1436526392571977e-06

Here O 0 1.830601270569332e-08
we O 0 5.763115679124908e-11
present O 0 1.2456625141099575e-11
four O 0 3.3885667709288025e-12
novel O 0 6.035018318417684e-11
PAX6 O 0 1.4811951132287504e-06
missense O 0 4.9629789167227045e-09
mutations O 0 1.4388333406667453e-11
, O 0 1.5730911582037543e-12
two O 0 9.492126052182415e-13
in O 0 3.211648655354615e-11
association O 0 2.730512038695565e-09
with O 0 4.012742915726619e-11
atypical O 0 5.613291591544112e-07
phenotypes O 0 2.988222718158795e-07
ectopia B-Disease 0 1.183823769679293e-05
pupillae I-Disease 0 3.41540635417914e-06
( O 0 7.748348490599355e-11
displaced B-Disease 0 1.3986307945135223e-10
pupils I-Disease 0 9.761539493391425e-11
) O 0 1.437648177587958e-11
and O 0 3.7844083067284373e-07
congenital B-Disease 1 1.0
nystagmus I-Disease 1 1.0
( O 0 6.517071771128258e-09
searching B-Disease 0 9.344982565551163e-09
gaze I-Disease 0 2.836697099439789e-08
) O 0 3.976716525522228e-12
, O 0 3.1869457160077497e-12
and O 0 8.984431254521752e-12
two O 0 4.942754972675489e-12
in O 0 7.381408678730494e-11
association O 0 6.64470589661903e-10
with O 0 1.1502183754064088e-11
more O 0 3.3231799256849825e-11
recognizable O 0 1.477491650803131e-06
aniridia B-Disease 1 1.0
phenotypes O 0 7.531369305979752e-07
. O 0 2.5665137570740626e-08

Strikingly O 0 6.108834327278601e-07
, O 0 6.421579712423409e-09
all O 0 2.3847768204632303e-09
four O 0 7.437063742621319e-10
mutations O 0 9.433297198935264e-11
are O 0 7.724410520937308e-12
located O 0 2.822806988156401e-10
within O 0 3.1944480394230368e-09
the O 0 4.106654927227282e-08
PAX6 O 0 0.0007764228503219783
paired O 0 9.60720480946975e-09
domain O 0 6.935811924790869e-09
and O 0 1.1303844527077445e-09
affect O 0 3.3764557816340357e-09
amino O 0 3.6495662047997257e-09
acids O 0 6.279077952031642e-11
which O 0 3.9128912783514824e-12
are O 0 2.4224283061251295e-13
highly O 0 9.828207041609471e-13
conserved O 0 2.388005938824822e-11
in O 0 2.0924283139489575e-11
all O 0 8.03038954777513e-11
known O 0 4.2242684350490833e-10
paired O 0 1.116222447805626e-09
domain O 0 3.278370686032872e-09
proteins O 0 7.633581544652657e-10
. O 0 5.159647820107693e-09

Our O 0 3.625935462991947e-08
results O 0 6.850180978013043e-10
support O 0 1.0789449889081482e-10
the O 0 2.202084764535428e-10
hypothesis O 0 3.7773815325659044e-11
that O 0 7.629141052624758e-14
the O 0 3.0791994388296162e-12
under O 0 1.538551751278927e-11
- O 0 1.879078143085522e-11
representation O 0 2.7152301240729315e-11
of O 0 1.6224895038607912e-10
missense O 0 2.637448837106149e-08
mutations O 0 8.094298148408896e-11
is O 0 1.873987510309094e-12
caused O 0 4.1894588492796814e-11
by O 0 1.0341352774112522e-11
ascertainment O 0 3.5568122257245705e-05
bias O 0 6.32260395150297e-08
and O 0 9.764909714160552e-11
suggest O 0 1.455863381238931e-11
that O 0 4.628881913187888e-13
a O 0 3.2367869235577773e-12
substantial O 0 1.7194266843656436e-10
burden O 0 2.092933382158435e-09
of O 0 2.2235535368508863e-07
PAX6 B-Disease 1 1.0
- I-Disease 1 1.0
related I-Disease 1 0.7000224590301514
disease I-Disease 1 0.9999998807907104
remains O 0 2.2110937081265547e-08
to O 0 3.141944170115263e-12
be O 0 7.71798944199098e-12
uncovered O 0 1.5580913226287407e-09
. O 0 2.1073767730861448e-10
. O 0 6.694704346443814e-09

The O 0 1.5397606745182202e-08
chromosomal O 0 1.271569431082753e-06
order O 0 8.928703110200331e-09
of O 0 1.3012018129643366e-08
genes O 0 3.1823019219778814e-10
controlling O 0 8.42143599300016e-09
the O 0 3.3705234159242536e-09
major O 0 8.323834777002048e-08
histocompatibility O 0 2.433329655104899e-06
complex O 0 5.5071684101903884e-08
, O 0 2.5621324506452936e-11
properdin O 0 3.630018241551625e-08
factor O 0 1.9743700008234555e-09
B O 0 6.449175202760671e-07
, O 0 2.2747775885179067e-11
and O 0 4.6557888100373646e-10
deficiency B-Disease 0 2.756947310444957e-07
of I-Disease 0 1.1613414017119794e-06
the I-Disease 0 2.290227385515209e-08
second I-Disease 0 3.84801035480109e-09
component I-Disease 0 1.752598777216008e-08
of I-Disease 0 1.0311529408113529e-08
complement I-Disease 0 6.967264454260658e-08
. O 0 7.736988294482217e-08

The O 0 6.129875718130506e-09
relationship O 0 2.634493491415757e-11
of O 0 2.149913802540482e-09
the O 0 2.4574653423314885e-10
genes O 0 7.250089851390529e-12
coding O 0 1.6882359399339464e-10
for O 0 1.875923201499763e-11
HLA O 0 6.152924836300144e-10
to O 0 9.77216679971804e-13
those O 0 3.788056023371067e-13
coding O 0 1.0124967531055518e-10
for O 0 4.754825005948149e-12
properdin O 0 4.357066263338538e-09
Factor O 0 1.1325852061760955e-10
B O 0 2.855826908287895e-09
allotypes O 0 3.496895273347178e-10
and O 0 1.7891879384307474e-12
for O 0 1.214877330679709e-11
deficiency B-Disease 0 1.2515610769980867e-08
of I-Disease 0 1.9407494278311788e-08
the I-Disease 0 1.21121834784077e-09
second I-Disease 0 5.178762974011875e-10
component I-Disease 0 3.3314782044158164e-09
of I-Disease 0 1.785901559969716e-08
complement I-Disease 0 1.1155100843041055e-08
( O 0 6.223201065580497e-09
C2 O 0 5.323452789696148e-09
) O 0 2.2241750270973054e-13
was O 0 1.1235436192524872e-11
studied O 0 1.6734813187979647e-11
in O 0 3.4952912959795857e-12
families O 0 1.1368124052790057e-13
of O 0 5.924118140487877e-11
patients O 0 3.5496744432705896e-10
with O 0 2.688466338440776e-09
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 0 4.021983841084875e-05

Patients O 0 1.0118804283365535e-07
were O 0 1.3180190272521486e-09
selected O 0 7.327025097758622e-11
because O 0 1.2631545115437959e-11
they O 0 1.4199094374237053e-12
were O 0 2.0771498670385524e-12
heterozygous O 0 9.635065315038993e-12
or O 0 3.9689120046038084e-12
homozygous O 0 5.772255917690927e-08
for O 0 1.1085637197538745e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 2.534775944695866e-07

12 O 0 1.713310666673351e-07
families O 0 3.348011451409505e-11
with O 0 1.666079600670667e-11
15 O 0 1.92815186039752e-09
matings O 0 2.1606565425713598e-08
informative O 0 4.6496168693010986e-08
for O 0 5.162326488061808e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 7.225076359418381e-08
found O 0 7.035632076934917e-10
. O 0 3.081554122985608e-09

Of O 0 7.679406053284765e-07
57 O 0 6.085574710823494e-08
informative O 0 8.388007510795603e-10
meioses O 0 2.0494645980306814e-08
, O 0 1.439838092504031e-11
two O 0 9.82359592976989e-13
crossovers O 0 1.1041242573006649e-11
were O 0 7.863881421044105e-12
noted O 0 1.058638940398815e-11
between O 0 2.2579892122731593e-10
the O 0 0.3732578754425049
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 1.6974251171308907e-10
and O 0 6.1608569808246916e-12
the O 0 1.047102543560996e-10
HLA O 0 1.2366973578537e-07
- O 0 1.4136512405116264e-08
B O 0 8.74308891951614e-09
gene O 0 1.0169341063681614e-11
, O 0 8.961729199442187e-14
with O 0 4.304536734651629e-14
a O 0 1.5497605369146905e-12
recombinant O 0 1.3369872049751041e-11
fraction O 0 1.2748573030574306e-11
of O 0 8.416518038067977e-10
0 O 0 1.2055448905812227e-07
. O 0 1.0827991836492856e-08

035 O 0 0.003348877653479576
. O 0 4.155034275754588e-06

A O 0 2.3180800212685426e-07
lod O 0 1.6890352299014921e-06
score O 0 3.37887162693562e-09
of O 0 1.1879317529661648e-09
13 O 0 2.836726686883395e-10
was O 0 2.4907799781037632e-11
calculated O 0 5.530733748586314e-13
for O 0 8.052666606445102e-13
linkage O 0 1.905460891293842e-07
between O 0 3.809674672083929e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 9.584121274386348e-10
HLA O 0 2.0260442568087456e-07
- O 0 6.70339295183453e-09
B O 0 1.226953472155401e-08
at O 0 2.832162282473405e-11
a O 0 2.0537324824706354e-13
maximum O 0 1.4527086131255196e-12
likelihood O 0 6.611623683434875e-13
value O 0 4.650802854812286e-13
of O 0 1.9824233400689284e-12
the O 0 4.0760875577583455e-12
recombinant O 0 1.0299798340607236e-11
fraction O 0 6.242950600920949e-12
of O 0 2.3211055300009775e-10
0 O 0 5.762937860254169e-08
. O 0 9.355255237153415e-09

04 O 0 0.001296553178690374
. O 0 4.028803232358769e-06

18 O 0 1.796760216166149e-07
families O 0 1.7129641455282396e-11
with O 0 5.8506875559583005e-12
21 O 0 9.995606564672244e-10
informative O 0 7.44858341672483e-12
matings O 0 8.85199760713995e-11
for O 0 7.651868721980648e-12
both O 0 2.4765680825544756e-11
properdin O 0 4.666568642619495e-08
Factor O 0 6.887299619506848e-09
B O 0 1.6808100156140426e-07
allotype O 0 1.3878986848681052e-08
and O 0 1.448739461729076e-10
HLA O 0 2.3526024506281829e-07
- O 0 1.3762820572083e-07
B O 0 4.901635293208528e-07
were O 0 6.031109500703735e-10
found O 0 1.080798645025638e-10
. O 0 1.2041238006688104e-09

Of O 0 2.86623230749683e-06
72 O 0 1.1052563877456123e-06
informative O 0 4.483925675202727e-09
meioses O 0 4.891035132459365e-07
, O 0 4.574419176783806e-10
three O 0 1.9023788100369643e-10
recombinants O 0 5.116608576827275e-07
were O 0 3.991997843399986e-09
found O 0 6.400442675857931e-11
, O 0 8.425151201696401e-12
giving O 0 3.6693995064673857e-11
a O 0 3.258965666774749e-11
recombinant O 0 1.4052943531073225e-10
fraction O 0 9.688586044553915e-11
of O 0 4.161929467727532e-09
0 O 0 3.2501441182830604e-07
. O 0 2.038237312262936e-08

042 O 0 0.002422492951154709
. O 0 4.890120635536732e-06

A O 0 2.242934442620026e-07
lod O 0 1.3225699149188586e-06
score O 0 1.4264944780961741e-09
of O 0 5.646424439120779e-10
16 O 0 1.565484131216266e-10
between O 0 7.263893653242093e-11
HLA O 0 5.936207116974401e-07
- O 0 3.7499937377560855e-08
B O 0 3.125114034219223e-08
and O 0 2.1168821903727597e-12
Factor O 0 2.0731930061579362e-11
B O 0 1.0995817589787293e-09
allotypes O 0 1.9342581702996853e-10
was O 0 2.044339350582014e-11
calculated O 0 7.824110283272123e-13
at O 0 9.136975898105248e-12
a O 0 4.870291453115683e-13
maximum O 0 8.274211177328183e-12
likelihood O 0 1.6093151117280158e-12
value O 0 2.0186335242255993e-12
of O 0 6.386574429029235e-12
the O 0 7.583709701886043e-12
recombinant O 0 5.918919868119765e-12
fraction O 0 9.714728153864538e-12
of O 0 7.710596605647879e-10
0 O 0 7.943689439571244e-08
. O 0 1.0813482553828635e-08

04 O 0 0.0013399400049820542
. O 0 3.3787430311349453e-06

A O 0 5.968492811092574e-09
crossover O 0 3.658603975331687e-10
was O 0 2.0972999725810126e-10
shown O 0 4.853638758267609e-12
to O 0 5.065876104021205e-13
have O 0 1.0787046576072809e-13
occurred O 0 1.9882398678838786e-12
between O 0 9.635533066961258e-14
genes O 0 8.176666537861726e-14
for O 0 1.191014788962802e-13
Factor O 0 7.5602120050422e-12
B O 0 9.410281442967516e-10
and O 0 8.172558116359419e-12
HLA O 0 2.559469436391737e-08
- O 0 2.0509974163474e-08
D O 0 6.346220882136322e-09
, O 0 5.04675240400182e-13
in O 0 1.1358507450570654e-12
which O 0 4.2852986784081004e-12
HLA O 0 1.693433944183198e-07
- O 0 2.0156602431598003e-07
D O 0 7.070372021189542e-08
segregared O 0 1.6023228965877934e-08
with O 0 3.093942463339161e-11
HLA O 0 5.301720875650062e-07
- O 0 1.3686846322968904e-08
A O 0 5.004652248175034e-09
and O 0 1.3758022499033018e-10
B O 0 1.989856741602125e-07
. O 0 2.4016706401397414e-09

These O 0 1.326153353797821e-10
studies O 0 3.8616453784667826e-11
suggest O 0 1.7254368506885998e-12
that O 0 3.264473110234367e-14
the O 0 1.0562604393568598e-12
genes O 0 2.6029441731363623e-13
for O 0 5.609275522365509e-13
Factor O 0 2.652456032592454e-09
B O 1 0.999998927116394
and O 1 0.9848465919494629
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 6.801144716850338e-12
located O 0 1.4152408411849393e-11
outside O 0 1.7099380938967457e-11
those O 0 1.309102159357048e-13
for O 0 2.7719731891806543e-12
HLA O 0 5.912677902841779e-09
, O 0 1.9730684100438545e-12
that O 0 9.149033933881709e-14
the O 0 1.9582703514320343e-12
order O 0 4.912435475762367e-12
of O 0 3.6845759082693164e-11
genese O 0 1.7951727881992952e-09
is O 0 3.391981140410394e-12
HLA O 0 3.2496197399645155e-10
- O 0 1.2441388197448333e-10
A O 0 6.862225232495689e-10
, O 0 4.490740244944558e-12
- O 0 2.9481317387336503e-10
B O 0 6.22120710502827e-09
, O 0 2.1716267672999834e-11
- O 0 1.3118667263611883e-09
D O 0 8.51129611234569e-10
, O 0 6.070454468959374e-13
Factor O 0 8.125900646804851e-11
B O 0 6.135762191661343e-07
allotype O 0 0.0001569527230458334
, O 0 6.70909548716736e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 4.828539369554352e-13
that O 0 9.233827183506137e-15
the O 0 1.4237027355645804e-13
genes O 0 1.0481525586705787e-12
coding O 0 1.382775316471907e-08
for O 0 8.809773248685815e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 2.746776694984021e-10
Factor O 0 1.1574048386364666e-09
B O 0 6.353648274171064e-08
allotypes O 0 1.8338573992693341e-09
are O 0 5.91688224566185e-14
approximately O 0 4.144009422180246e-14
3 O 0 9.552010224456176e-12
- O 0 9.64234508210593e-12
- O 0 3.0021055086315585e-11
5 O 0 1.5767687502887817e-11
centimorgans O 0 1.1342064787367434e-10
from O 0 1.0506945790841882e-12
the O 0 2.219473389797333e-11
HLA O 0 2.6995448099143005e-09
- O 0 3.4759350953095236e-10
A O 0 7.48502149150454e-10
and O 0 1.0866602756509636e-11
HLA O 0 1.1561787083280706e-08
- O 0 7.925626266391816e-10
B O 0 2.958377987027916e-10
loci O 0 2.153698877224719e-12
, O 0 1.0649890257868888e-13
and O 0 2.197661879408709e-14
that O 0 8.536604718467969e-15
the O 0 9.11102465174507e-13
apparent O 0 9.8689036109878e-11
lack O 0 5.298460559188811e-10
of O 0 2.805120719040488e-11
recombinants O 0 3.9278125196773317e-10
between O 0 3.159775175884394e-12
the O 0 6.968185750633182e-11
Factor O 0 1.2907082069801845e-09
B O 0 1.873397923191078e-05
gene O 0 4.580571840051562e-06
and O 1 0.7919217944145203
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 4.9680672020713246e-08
suggests O 0 2.071066582121084e-11
that O 0 1.0633976880482232e-13
these O 0 1.4192561514046742e-13
two O 0 7.062133538550397e-13
genes O 0 5.235278356663375e-12
lie O 0 6.151678472177124e-11
in O 0 6.997269517278193e-12
close O 0 7.648793404202436e-11
proximity O 0 5.200271324667938e-10
to O 0 7.95397220310079e-11
one O 0 3.416991134486125e-10
another O 0 2.5137485426540707e-09
. O 0 3.429027373158533e-08

Distribution O 0 5.18510079317025e-09
of O 0 1.2722551012700478e-08
emerin O 0 2.821594193846977e-07
and O 0 3.0802010941854974e-10
lamins O 0 1.9652493676858285e-07
in O 0 1.0574085357317742e-10
the O 0 1.3116742136887183e-09
heart O 0 9.678142305347137e-07
and O 0 3.449666247101746e-11
implications O 0 4.2844774950090425e-10
for O 0 6.628701754163302e-11
Emery B-Disease 1 0.9999624490737915
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.00020119956752751023

Emerin O 0 0.0001722772722132504
is O 0 4.975651002325776e-09
a O 0 8.392936901024939e-10
nuclear O 0 7.08493885781536e-08
membrane O 0 2.884059935315264e-10
protein O 0 9.379150928134905e-11
which O 0 1.4709545430660609e-12
is O 0 6.060600372254088e-12
missing O 0 1.508486391355035e-10
or O 0 5.535382568977454e-11
defective O 0 7.022201931050631e-09
in O 0 4.959352373212766e-10
Emery B-Disease 1 0.9999994039535522
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.09899476170539856
EDMD B-Disease 1 1.0
) O 0 8.57195558978674e-09
. O 0 9.714224091794676e-09

It O 0 1.0604770395161722e-09
is O 0 7.669626045370137e-11
one O 0 5.11002698488916e-11
member O 0 1.8812997826245237e-09
of O 0 1.7074515312742733e-07
a O 0 9.139677104030852e-08
family O 0 1.2634497892349827e-09
of O 0 3.557127001840854e-07
lamina O 1 0.9999730587005615
- O 0 2.2195577912498266e-05
associated O 0 7.931910062097813e-08
proteins O 0 1.489638551399608e-10
which O 0 1.0540250963697595e-11
includes O 0 2.6104046008113002e-11
LAP1 O 0 6.518430836877087e-06
, O 0 4.027697342312564e-10
LAP2 O 0 4.679307312471792e-05
and O 0 7.3431363212250744e-09
lamin O 0 8.66566006152425e-06
B O 0 5.750721925323887e-07
receptor O 0 2.0600372518941867e-09
( O 0 1.9820435570583328e-10
LBR O 0 6.509490049211308e-07
) O 0 1.3967539624903935e-10
. O 0 5.396610713859218e-09

A O 0 2.4723756723687984e-05
panel O 0 9.328690708798604e-08
of O 0 8.71696315130066e-09
16 O 0 4.214605109353897e-09
monoclonal O 0 2.242255825457562e-10
antibodies O 0 4.7983023804265557e-11
( O 0 6.746715686123395e-11
mAbs O 0 1.8652321909229386e-09
) O 0 3.2758906264723775e-12
has O 0 5.205814078423909e-12
been O 0 3.5962222783014752e-12
mapped O 0 2.1473010869410558e-11
to O 0 5.149002751947407e-12
six O 0 1.958222646536445e-11
specific O 0 4.885160852230452e-12
sites O 0 4.9744031810350364e-11
throughout O 0 2.442889224241185e-10
the O 0 1.5631218541756198e-09
emerin O 0 3.168453943658278e-08
molecule O 0 4.0156062502960665e-11
using O 0 3.917993707247547e-11
phage O 0 6.546782005401042e-10
- O 0 8.452872429787206e-11
displayed O 0 7.772060772737177e-11
peptide O 0 1.021948931728689e-11
libraries O 0 1.658135087567736e-11
and O 0 2.533629122475345e-12
has O 0 1.0678534879265955e-12
been O 0 4.833377079647982e-13
used O 0 4.926122443987824e-13
to O 0 1.6518650596680784e-12
localize O 0 2.7153053139272743e-09
emerin O 0 1.7011476671768833e-08
in O 0 3.114202298815094e-11
human O 0 1.8655310629611677e-09
and O 0 4.0231518116939924e-10
rabbit O 0 1.3588129377239966e-06
heart O 0 0.00017004854453261942
. O 0 2.2689448542223545e-07

Several O 0 9.806973011450282e-09
mAbs O 0 1.1367051655497562e-07
against O 0 5.9788041184560825e-09
different O 0 3.0564040881531085e-11
emerin O 0 4.624340022019169e-08
epitopes O 0 1.279959178646095e-07
did O 0 1.0511806702862003e-10
not O 0 1.9669999136440186e-12
recognize O 0 2.0146880691518376e-11
intercalated O 0 1.5467646607980612e-10
discs O 0 1.2563392548514685e-09
in O 0 2.7339174327178917e-11
the O 0 4.938972009149722e-10
heart O 0 3.5111520446662325e-07
, O 0 8.335830289918356e-12
though O 0 3.2058388062250476e-12
they O 0 9.94815558055806e-13
recognized O 0 4.205045686656028e-11
cardiomyocyte O 0 2.480557270700956e-08
nuclei O 0 8.422861297319173e-10
strongly O 0 5.0694289044361796e-11
, O 0 1.5959912211260807e-11
both O 0 1.9834767162052458e-10
at O 0 1.9172287579749536e-07
the O 0 3.571995321749455e-08
rim O 0 3.4014597360965126e-08
and O 0 6.192740764632276e-11
in O 0 1.208886601933301e-10
intranuclear O 0 8.043001287205698e-08
spots O 0 4.346392579179792e-09
or O 0 1.1367794899852512e-10
channels O 0 3.920389790579293e-09
. O 0 1.4461209119076557e-08

A O 0 2.3177051389211556e-06
polyclonal O 0 2.297450009791646e-06
rabbit O 0 2.617858285702823e-07
antiserum O 0 1.7601135482436803e-07
against O 0 1.0169939557158614e-08
emerin O 0 2.329188646399416e-07
did O 0 1.297131568822607e-10
recognize O 0 5.6725551339509295e-11
both O 0 8.123494932288366e-12
nuclear O 0 1.5640045925024992e-09
membrane O 0 4.069934927269925e-12
and O 0 2.243030658129544e-13
intercalated O 0 4.869643317056971e-12
discs O 0 1.895255063999457e-10
but O 0 3.393966151957889e-13
, O 0 4.7374661160150267e-14
after O 0 4.783676709960161e-13
affinity O 0 3.152230809277262e-13
purification O 0 3.9725493727882366e-11
against O 0 6.152311299301161e-11
a O 0 4.5618963467886076e-11
pure O 0 6.547035358295261e-09
- O 0 4.546257592608072e-09
emerin O 0 1.0266749228549088e-07
band O 0 1.6337823538492557e-08
on O 0 1.7105107330550595e-09
a O 0 1.3329997695932239e-11
western O 0 1.337165794756956e-11
blot O 0 4.949441745338845e-09
, O 0 6.607823316295836e-11
it O 0 8.052041672312882e-12
stained O 0 2.1417131179646276e-08
only O 0 8.02216834627778e-11
the O 0 1.323871789971065e-09
nuclear O 0 2.956562923372985e-07
membrane O 0 1.1679501810135662e-08
. O 0 3.899463862921948e-09

These O 0 1.163906637735579e-09
results O 0 1.318466558153375e-09
would O 0 2.145917298024269e-11
not O 0 2.5011234403016225e-12
be O 0 1.2372913024000232e-12
expected O 0 2.054208712853889e-11
if O 0 2.0977900406365935e-12
immunostaining O 0 1.4664018888055352e-09
at O 0 3.258892877777697e-10
intercalated O 0 1.0532398564411238e-10
discs O 0 9.717188831359636e-09
were O 0 5.678725892299674e-11
due O 0 1.6744176878358275e-10
to O 0 6.750235678580629e-13
a O 0 4.6594889405171536e-12
product O 0 1.934441669348974e-11
of O 0 1.7742846081247876e-10
the O 0 2.73958244978445e-10
emerin O 0 1.089237144924482e-08
gene O 0 5.6216305915901543e-11
and O 0 7.059861376057519e-12
, O 0 9.028954884096607e-13
therefore O 0 7.937778039035503e-13
, O 0 2.257193591108722e-13
cast O 0 5.504552542945351e-12
some O 0 5.157925410566311e-13
doubt O 0 1.2346798063112008e-11
upon O 0 6.107875164841625e-13
the O 0 1.9721127942490257e-12
hypothesis O 0 1.6805759908700146e-11
that O 0 6.191305064115471e-13
cardiac B-Disease 1 1.0
defects I-Disease 1 0.999997615814209
in O 0 2.0084991092517157e-07
EDMD B-Disease 1 1.0
are O 0 1.9838097831126333e-10
caused O 0 3.3268471311131975e-10
by O 0 4.055258732982292e-12
absence O 0 2.2393260579178786e-08
of O 0 1.531749305172525e-08
emerin O 0 7.999968261174217e-07
from O 0 3.904016276923272e-10
intercalated O 0 6.354036230504789e-08
discs O 0 5.897446953895269e-06
. O 0 1.1445961689560136e-07

Although O 0 2.6867402524999306e-08
emerin O 0 1.4234830132409115e-06
was O 0 8.759029057614498e-09
abundant O 0 1.0546027245927903e-10
in O 0 2.3916982977434387e-11
the O 0 1.301679458665106e-10
membranes O 0 1.3038786716990103e-10
of O 0 1.1867088423045402e-09
cardiomyocyte O 0 5.7962402877365093e-08
nuclei O 0 3.492069966526401e-10
, O 0 1.1120945310472141e-11
it O 0 3.6221403480751757e-12
was O 0 7.041891514347753e-09
absent O 0 6.963582155350423e-09
from O 0 1.350205537653526e-11
many O 0 3.6747924148095024e-11
non O 0 1.650302351663413e-06
- O 0 2.4976342771765303e-08
myocyte O 0 4.192958442672534e-07
cells O 0 9.057251476596306e-11
in O 0 2.502690069072777e-11
the O 0 1.3997255576825296e-09
heart O 0 5.581728601100622e-06
. O 0 2.2252541143075177e-08

This O 0 1.823830496350265e-11
distribution O 0 5.324222174252213e-10
of O 0 2.0931609778784832e-09
emerin O 0 1.3165553980343248e-07
was O 0 5.479431575139415e-09
similar O 0 3.5768013984666114e-12
to O 0 4.959694764258837e-13
that O 0 6.045103653762318e-13
of O 0 1.1583920489499633e-09
lamin O 0 9.835558785198373e-07
A O 0 2.1808366668096824e-08
, O 0 1.5010548359839504e-11
a O 0 2.349867175843734e-11
candidate O 0 5.6565863104651726e-11
gene O 0 3.3854804376565184e-11
for O 0 6.711109532681059e-12
an O 0 3.7166259653220735e-12
autosomal O 0 2.240907015504945e-08
form O 0 2.2358561224677942e-08
of O 0 0.00014553456276189536
EDMD B-Disease 1 1.0
. O 0 8.657711987325456e-07

In O 0 4.790988716862898e-10
contrast O 0 2.0182824300718494e-09
, O 0 4.40338432383669e-09
lamin O 0 0.003981717396527529
B1 O 0 0.00032222815207205713
was O 0 1.5093073102434573e-07
absent O 0 4.3460385512616995e-08
from O 0 1.5987372536940825e-10
cardiomyocyte O 0 1.0013360451921471e-07
nuclei O 0 1.3664823717007835e-09
, O 0 2.6661381435921783e-11
showing O 0 6.591201806571689e-09
that O 0 7.35236815874174e-10
lamin O 0 0.011836863122880459
B1 O 0 9.035383072841796e-07
is O 0 1.323304421770033e-12
not O 0 1.5292931851429437e-13
essential O 0 6.965129167868511e-11
for O 0 6.808322135232192e-12
localization O 0 7.600957019349153e-08
of O 0 3.861669595206507e-10
emerin O 0 7.734388240976386e-09
to O 0 4.856141183617879e-11
the O 0 1.904878033087698e-09
nuclear O 0 4.306720256863628e-06
lamina O 0 6.139516335679218e-05
. O 0 2.0323528815424652e-07

Lamin O 1 0.9999852180480957
B1 O 0 0.49274173378944397
is O 0 9.713274629064017e-10
also O 0 4.275699932998478e-11
almost O 0 6.344313963069226e-11
completely O 0 3.482660915210545e-08
absent O 0 3.003415827151912e-08
from O 0 6.503421690062794e-10
skeletal O 0 0.0016896430170163512
muscle O 0 0.0015992510598152876
nuclei O 0 6.3387869886355475e-06
. O 0 9.663942535098613e-08

In O 0 6.188085421854339e-08
EDMD B-Disease 1 1.0
, O 0 3.353554101082068e-10
the O 0 3.234455758782673e-11
additional O 0 8.252680656906097e-12
absence O 0 1.0133262007272492e-09
of O 0 3.2005239347654424e-08
lamin O 0 0.4962500035762787
B1 O 0 0.0016555262263864279
from O 0 4.920404084174379e-09
heart O 1 0.9999995231628418
and O 0 1.0355379345128313e-05
skeletal O 1 1.0
muscle O 1 0.9999881982803345
nuclei O 0 1.7485357602708973e-05
which O 0 2.6791383000990265e-10
already O 0 5.492602483947451e-10
lack O 0 1.2886921751942282e-07
emerin O 0 9.70540895650629e-07
may O 0 1.5096031369399299e-10
offer O 0 1.4238989761578003e-12
an O 0 1.6680621185531652e-13
alternative O 0 1.782527181415361e-10
explanation O 0 5.198858270966111e-12
of O 0 2.698585799265629e-10
why O 0 2.8463181464544185e-11
these O 0 3.0156536989789373e-12
tissues O 0 1.8447388061559877e-10
are O 0 1.2355626504562123e-12
particularly O 0 5.98962719700058e-12
affected O 0 1.6537668803828787e-11
. O 0 6.441224636999365e-11
. O 0 4.684062471227435e-09

Genetic O 0 9.518234200811548e-09
mapping O 0 1.0261693716984155e-08
of O 0 4.1934622885264616e-08
the O 0 2.5919327129031444e-08
copper B-Disease 0 3.213434354165656e-07
toxicosis I-Disease 0 1.1869607988046482e-05
locus O 0 8.70719230050554e-09
in O 0 1.9982187016154285e-09
Bedlington O 0 1.553515517116466e-06
terriers O 0 2.0481014928463992e-07
to O 0 5.948805337219198e-10
dog O 0 2.1484842349650535e-08
chromosome O 0 3.3497646878544174e-09
10 O 0 3.1206615069834243e-10
, O 0 1.949768905357141e-12
in O 0 2.5297275125374385e-12
a O 0 2.0141386822269958e-11
region O 0 2.0190284166776706e-10
syntenic O 0 8.700253850690842e-09
to O 0 1.2650134412206526e-11
human O 0 1.757829576343184e-10
chromosome O 0 1.4576234663721266e-09
region O 0 4.122678642914934e-09
2p13 O 0 1.2604157006990135e-07
- O 0 1.422539668283207e-07
p16 O 0 4.874002001997724e-08
. O 0 1.7422799203359318e-08

Abnormal O 1 1.0
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9401869177818298
accumulation I-Disease 0 4.767935024574399e-07
is O 0 1.0038551934155038e-10
recognized O 0 1.3318923741678645e-10
as O 0 1.4802317357953676e-11
an O 0 4.914246440335113e-11
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 6.752157588607588e-08
man O 0 1.4051129149095232e-09
, O 0 8.274952771614164e-12
mouse O 0 1.7140715513619398e-08
, O 0 6.178585976179818e-10
rat O 0 2.1309399755864433e-07
and O 0 2.689327871507885e-09
dog O 0 7.131508823476906e-07
. O 0 4.662102526253875e-08

The O 0 5.0088758030142344e-08
major O 0 9.950624644261552e-07
cause O 0 8.063542736636009e-06
of O 0 0.00031306614982895553
hepatic B-Disease 1 1.0
copper I-Disease 0 0.0907631441950798
accumulation I-Disease 0 1.5065662637425703e-06
in O 0 1.6762413679316523e-07
man O 0 2.5952816784524657e-08
is O 0 3.440880566585314e-11
a O 0 2.244575081356004e-10
dysfunctional O 0 8.572135001827519e-09
ATP7B O 0 4.148731750319712e-05
gene O 0 3.376559032375326e-09
, O 0 1.729431181596297e-11
causing O 0 4.648603724177747e-09
Wilson B-Disease 0 7.36676284418536e-08
disease I-Disease 0 0.00016271606727968901
( O 0 3.830755712641576e-10
WD B-Disease 1 0.9999996423721313
) O 0 4.1697085784164756e-09
. O 0 2.5062526276542485e-08

Mutations O 0 1.8197537698938504e-08
in O 0 3.2724547516238545e-09
the O 0 3.5508698204012035e-08
ATP7B O 0 0.00013055550516583025
genes O 0 1.1237890618076563e-09
have O 0 1.6662449198179274e-11
also O 0 1.7396797977881073e-12
been O 0 1.4064460316862148e-12
demonstrated O 0 2.454868773538177e-11
in O 0 5.644192752063404e-11
mouse O 0 1.4621916477608465e-07
and O 0 1.1376308783894729e-08
rat O 0 1.2921876759719453e-06
. O 0 3.4128454728943325e-08

The O 0 2.810014905207936e-07
ATP7B O 0 0.00031344217131845653
gene O 0 1.2212566069536024e-08
has O 0 1.8445444824322088e-11
been O 0 1.374051805495824e-12
excluded O 0 4.296969897954472e-12
in O 0 2.331991750311596e-13
the O 0 2.609138816458967e-12
much O 0 2.063727010462313e-12
rarer O 0 8.886987257206158e-10
human O 0 3.329986597577772e-08
copper B-Disease 0 0.0001543248217785731
overload I-Disease 1 0.9999740123748779
disease O 1 1.0
non B-Disease 1 0.999789297580719
- I-Disease 0 3.1777597087057075e-07
Indian I-Disease 0 8.724793665315644e-10
childhood I-Disease 0 4.693281425716123e-06
cirrhosis I-Disease 1 0.9999358654022217
, O 0 7.103249238804565e-11
indicating O 0 1.634193003141604e-09
genetic O 0 2.8434630650053805e-08
heterogeneity O 0 2.4573841983510647e-07
. O 0 3.8175500094439485e-08

By O 0 1.334232169192262e-09
investigating O 0 3.962896677478511e-09
the O 0 3.5903680029036877e-09
common O 0 1.383026528856135e-07
autosomal O 0 0.048543013632297516
recessive O 1 0.9976145029067993
copper B-Disease 1 0.6156944036483765
toxicosis I-Disease 1 0.9999979734420776
( O 0 1.2721622644207287e-09
CT B-Disease 0 9.104828495765105e-05
) O 0 1.0481410878115938e-11
in O 0 2.996510678476838e-11
Bedlington O 0 7.03867186757634e-08
terriers O 0 1.872176369488443e-08
, O 0 2.936972887113143e-11
we O 0 6.058855240437255e-12
have O 0 1.4271529379279724e-13
identified O 0 1.4559645264596022e-13
a O 0 5.119892343744513e-14
new O 0 5.1362072147481674e-14
locus O 0 5.228741484925026e-12
involved O 0 1.7759680173961429e-13
in O 0 8.815906338277557e-11
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 4.3553367845561297e-07

We O 0 2.432201995361538e-09
examined O 0 3.254302383126628e-10
whether O 0 6.9714260406139594e-12
the O 0 4.473723336229085e-10
WD B-Disease 1 0.9998192191123962
gene O 0 7.279715674712861e-08
ATP7B O 0 0.0003717392683029175
was O 0 2.5616476051482095e-08
also O 0 5.6396809965109096e-12
causative O 0 5.786102499905077e-11
for O 0 1.432447650079327e-11
CT B-Disease 0 5.488398002739814e-08
by O 0 1.3762268234740471e-11
investigating O 0 1.0442205433669471e-10
the O 0 1.9265629369602522e-10
chromosomal O 0 1.9968949345638976e-05
co O 0 2.0040874005644582e-05
- O 0 9.24428888993134e-07
localization O 0 0.00019850023090839386
of O 0 2.6859981971938396e-07
ATP7B O 0 0.00017601490253582597
and O 0 8.105627280485805e-10
C04107 O 0 5.708181927133182e-09
, O 0 2.40431155887344e-12
using O 0 3.391183818132748e-13
fluorescence O 0 4.373613016889211e-12
in O 0 5.799169738168741e-12
situ O 0 2.0691337532241505e-09
hybridization O 0 3.342232324232697e-10
( O 0 3.847252794120237e-10
FISH O 0 9.176832094226484e-08
) O 0 5.974591654744899e-11
. O 0 2.734963366890497e-09

C04107 O 0 3.873931291309418e-06
is O 0 2.8934818430137454e-10
an O 0 3.5965173981328258e-12
anonymous O 0 4.39554226350225e-11
microsatellite O 0 2.0382064036539305e-08
marker O 0 6.837329635800415e-08
closely O 0 1.1008702838211093e-09
linked O 0 1.355357781562816e-08
to O 0 1.3380524466199972e-09
CT B-Disease 1 0.7381051778793335
. O 0 2.1760050117336505e-07

However O 0 1.1142687128540274e-07
, O 0 1.290019646660312e-08
BAC O 0 5.1332781367818825e-06
clones O 0 6.355442394578859e-08
containing O 0 3.3784528508107314e-09
ATP7B O 0 4.569036264001625e-06
and O 0 1.2498666546179038e-09
C04107 O 0 1.8575644133989044e-08
mapped O 0 9.572319603634583e-10
to O 0 1.6714532535822002e-10
the O 0 3.28619642608885e-09
canine O 0 9.932651323651953e-08
chromosome O 0 3.588199248838464e-08
regions O 0 6.473241054294476e-09
CFA22q11 O 0 1.919372607517289e-06
and O 0 1.4831440520168826e-09
CFA10q26 O 0 4.621051346020977e-07
, O 0 4.7368588218521523e-11
respectively O 0 1.0421433160878735e-10
, O 0 2.5987289577200645e-12
demonstrating O 0 1.0989249094039977e-10
that O 0 1.6267090105492876e-11
WD B-Disease 1 0.995133101940155
cannot O 0 1.2077993050141345e-09
be O 0 1.2496842970166622e-11
homologous O 0 3.190121777851829e-11
to O 0 1.3568952905718135e-10
CT B-Disease 0 6.748301530024037e-05
. O 0 4.5162693140810006e-08

The O 0 2.771635934095684e-07
copper O 0 1.3129944420597894e-07
transport O 0 1.2192061582538827e-08
genes O 0 6.811966546393933e-10
CTR1 O 0 9.212059012497775e-06
and O 0 1.551555106615865e-09
CTR2 O 0 0.000836291117593646
were O 0 1.4635740397395125e-09
also O 0 1.9884002430692327e-11
excluded O 0 1.417818917825997e-10
as O 0 1.0959519750053381e-11
candidate O 0 3.656223240833256e-11
genes O 0 1.0860835885154185e-12
for O 0 2.9473864755075185e-12
CT B-Disease 0 2.559846166150237e-07
since O 0 1.6828485271958016e-09
they O 0 5.8761970983534084e-12
both O 0 1.6159929297487885e-12
mapped O 0 1.2290578277340813e-10
to O 0 9.087013780328945e-11
canine O 0 7.08616880729096e-08
chromosome O 0 8.502137660570952e-08
region O 0 9.113652765790903e-08
CFA11q22 O 0 2.1744233890785836e-05
. O 0 2.0909278930503206e-07

2 O 0 1.264922866539564e-05
- O 0 9.342871862827451e-07
22 O 0 1.4513219070977357e-07
. O 0 6.7339591680593e-08

5 O 0 3.3099444408435374e-05
. O 0 9.555122915116954e-07

A O 0 1.046962196937784e-07
transcribed O 0 3.623505384631187e-10
sequence O 0 6.864944029905118e-11
identified O 0 4.1194048172599196e-11
from O 0 5.04373279253123e-12
the O 0 1.1383937542630562e-10
C04107 O 0 4.3440304686725995e-09
- O 0 1.5151915278011074e-09
containing O 0 2.6386789975241243e-10
BAC O 0 5.3562512647431504e-08
was O 0 3.0904112602314626e-10
found O 0 6.959238957673919e-13
to O 0 1.6684342709488709e-13
be O 0 5.616993957631433e-13
homologous O 0 8.141608589563865e-13
to O 0 1.2695182361951995e-12
a O 0 1.8577741775493983e-11
gene O 0 1.8346253335965734e-11
expressed O 0 5.225997043965813e-13
from O 0 8.921314208210074e-13
human O 0 3.153641583986122e-11
chromosome O 0 9.948606383147762e-10
2p13 O 0 6.232407034900689e-09
- O 0 4.873135672767148e-09
p16 O 0 2.8030630594422234e-10
, O 0 3.679727963307178e-12
a O 0 2.1074873617077383e-12
region O 0 2.40709344817569e-11
devoid O 0 6.446110756286316e-09
of O 0 5.4947900396395966e-11
any O 0 5.032828667705935e-11
positional O 0 6.500909677242817e-08
candidate O 0 1.6647669909275464e-08
genes O 0 4.487638705086283e-09
. O 0 1.5136842890228763e-08

Molecular O 0 7.165958937349615e-10
analysis O 0 8.156739866871376e-11
of O 0 1.595563792200494e-09
the O 0 3.875122445151646e-09
APC B-Disease 0 4.313498003227778e-09
gene O 0 1.5511513948296418e-11
in O 0 1.1285908839420156e-11
205 O 0 5.11420072957236e-11
families O 0 5.204262585115083e-13
: O 0 1.445406619914047e-12
extended O 0 6.001732444360641e-10
genotype O 0 5.0250354988179424e-09
- O 0 5.090459609391473e-09
phenotype O 0 3.2601985000546563e-10
correlations O 0 1.5944343068063915e-10
in O 0 3.514613253208232e-11
FAP B-Disease 0 9.059537009470375e-10
and O 0 7.675207583206223e-13
evidence O 0 1.3301113682695487e-12
for O 0 2.686876871167698e-13
the O 0 3.0551787228577654e-12
role O 0 1.0178365095203645e-11
of O 0 6.592744683509011e-10
APC B-Disease 0 4.6512845131019276e-08
amino O 0 1.4432296469024664e-09
acid O 0 1.485904038700525e-10
changes O 0 1.8729209849688289e-10
in O 0 9.217001917249945e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 0 0.0012725263368338346
. O 0 8.480127888788047e-08

BACKGROUND O 0 5.270817382552195e-07
/ O 0 5.291058187140152e-07
AIMS O 0 8.040497156969195e-09
The O 0 1.8996330550247187e-11
development O 0 6.05007377529887e-10
of O 0 8.169517400347104e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.2301467622322093e-09
a O 0 5.9794794983469846e-12
variable O 0 3.908544321529206e-11
range O 0 2.449592785558341e-11
of O 0 1.4022841915428685e-11
extracolonic O 0 4.7848661921534585e-08
manifestations O 0 9.407780453329906e-06
in O 0 8.7695312345204e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 5.640818017127458e-06
FAP B-Disease 0 1.5395337413792731e-06
) O 0 4.443698881084757e-12
is O 0 5.710479289953996e-13
the O 0 5.816251560236685e-12
result O 0 4.370021011723679e-11
of O 0 1.6963959403870632e-10
the O 0 1.5459004909512686e-10
dominant O 0 3.200139175874028e-08
inheritance O 0 2.2172171654233352e-08
of O 0 1.0182185405938071e-06
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 4.6980676415842026e-07
APC B-Disease 0 2.531683662709838e-07
) O 0 1.157614074043245e-10
gene O 0 6.81404888069892e-09
mutations O 0 2.6444807232905987e-08
. O 0 4.6275605569690015e-08

In O 0 1.8587358041610713e-10
this O 0 2.010265218177487e-12
study O 0 5.584817547657495e-13
, O 0 7.161872277953313e-14
direct O 0 6.753326738974386e-13
mutation O 0 1.0070624889557678e-12
analysis O 0 2.606670304952652e-13
of O 0 2.5736765149608765e-11
the O 0 1.9416360186319537e-10
APC B-Disease 0 1.5078801540724385e-09
gene O 0 1.378354722025854e-11
was O 0 1.9213666768713722e-10
performed O 0 7.120082995415444e-11
to O 0 2.6698413445325198e-12
determine O 0 4.342684198355151e-11
genotype O 0 9.728756689142415e-10
- O 0 4.593348201797909e-10
phenotype O 0 1.163596996534011e-11
correlations O 0 8.200758648546635e-12
for O 0 3.3938706879566016e-12
nine O 0 1.2180775832426605e-10
extracolonic O 0 3.747948795762568e-08
manifestations O 0 9.727482392918319e-07
and O 0 3.9898622600231803e-11
to O 0 1.6420517289644776e-12
investigate O 0 7.758830036785902e-12
the O 0 1.966967040634149e-11
incidence O 0 1.2932099835438748e-08
of O 0 1.391699422370607e-09
APC B-Disease 0 8.250332861337029e-09
mutations O 0 5.105448355746667e-11
in O 0 1.8376206112336035e-10
non O 1 0.9999998807907104
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.4457569856604096e-06

METHODS O 0 1.1006692375303828e-06
The O 0 8.666404482937651e-08
APC B-Disease 0 3.512594659582646e-08
gene O 0 1.0693485680279835e-10
was O 0 1.6597180574340342e-10
analysed O 0 6.90103391098873e-11
in O 0 1.7679293792816075e-11
190 O 0 1.9460703881701846e-10
unrelated O 0 7.545827851451747e-10
FAP B-Disease 0 1.0676703077194816e-08
and O 0 3.074043103401536e-11
15 O 0 4.4992778391872434e-09
non O 1 0.9999834299087524
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 2.0347881601878726e-08
using O 0 1.084867334855133e-10
denaturing O 0 2.6087266746799287e-07
gradient O 0 1.0066646405348934e-09
gel O 0 6.327564860963975e-11
electrophoresis O 0 1.1692323324818954e-11
, O 0 5.638927692841467e-12
the O 0 3.985222915559028e-11
protein O 0 4.2474215117271896e-11
truncation O 0 1.6028049998340066e-09
test O 0 3.6585201534933276e-10
, O 0 9.577345427141948e-13
and O 0 3.879662433328712e-13
direct O 0 3.6869521324867094e-11
sequencing O 0 8.141605722933321e-10
. O 0 4.946676401829109e-09

RESULTS O 0 3.8570397009607404e-06
Chain O 0 4.2806104261217115e-07
terminating O 0 2.2429508916843588e-08
signals O 0 3.646970725412757e-09
were O 0 4.946010961903724e-11
only O 0 6.179000453659933e-13
identified O 0 7.2418113172822984e-12
in O 0 2.3102301321964447e-11
patients O 0 1.1087650762797718e-11
belonging O 0 5.1461092331894775e-11
to O 0 1.9515817781257105e-11
the O 0 1.0201391731357035e-08
FAP B-Disease 0 1.121521904678957e-06
group O 0 1.7649124384178094e-09
( O 0 6.180869704941472e-11
105 O 0 2.5284640159384253e-08
patients O 0 2.217241501512035e-09
) O 0 4.868698846860475e-11
. O 0 3.2402387439844915e-09

Amino O 0 5.287743647386378e-07
acid O 0 1.0997641686216753e-09
changes O 0 4.831611846722872e-11
were O 0 5.088539398873104e-12
identified O 0 1.7405426058769713e-12
in O 0 1.8052787997130393e-12
four O 0 1.9235217585400477e-11
patients O 0 4.621305942087428e-12
, O 0 3.1982595825180704e-12
three O 0 1.1826223160482652e-11
of O 0 1.0216502310811393e-08
whom O 0 7.838147908501014e-10
belonged O 0 1.093031087862073e-08
to O 0 1.3267067132394228e-11
the O 0 2.319495484570666e-09
non O 0 6.862353620817885e-05
- O 0 1.9857614006468793e-06
FAP O 0 2.2144251943245763e-06
group O 0 5.06502706443257e-09
of O 0 0.0004378334851935506
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 0.0006536548025906086
. O 0 1.5435862366075526e-08

Genotype O 0 1.8416967577650212e-05
- O 0 2.3431093723047525e-06
phenotype O 0 8.652328631342243e-09
correlations O 0 1.0148057949521672e-09
identified O 0 4.847738530044943e-11
significant O 0 3.148262553431813e-11
differences O 0 3.289805580730665e-11
in O 0 1.692452254731247e-11
the O 0 4.1293638647355024e-11
nature O 0 3.9936789986150245e-10
of O 0 9.596774763753757e-11
certain O 0 9.81178957526474e-11
extracolonic O 0 9.83032961698882e-08
manifestations O 0 5.331773422767583e-07
in O 0 2.4288269173666777e-09
FAP B-Disease 0 1.2174538142062374e-06
patients O 0 1.6475559805328999e-10
belonging O 0 1.4281489879586218e-10
to O 0 3.4296239459497e-11
three O 0 3.926524105857254e-10
mutation O 0 1.399269855539842e-08
subgroups O 0 4.604589776135981e-07
. O 0 6.004016483984742e-08

CONCLUSIONS O 0 2.0889686425107357e-07
Extended O 0 3.7776899830532784e-08
genotype O 0 6.274274255702039e-08
- O 0 1.3624023686986675e-08
phenotype O 0 1.6951764991723905e-10
correlations O 0 6.979571781640104e-11
made O 0 3.787639039215529e-12
in O 0 1.6910153832760955e-12
this O 0 3.7529896725063683e-13
study O 0 1.2196549109208532e-12
may O 0 3.3508267775067546e-12
have O 0 3.000276351146358e-13
the O 0 1.920976398783747e-12
potential O 0 9.651909263150293e-13
to O 0 1.7782119093173732e-13
determine O 0 1.5924724646593225e-12
the O 0 5.259247898292685e-12
most O 0 6.708069971890496e-14
appropriate O 0 8.538828281598465e-13
surveillance O 0 1.0792784027602309e-10
and O 0 1.3915996827096322e-11
prophylactic O 0 9.403881335856568e-07
treatment O 0 1.4955872984501184e-08
regimens O 0 1.4454997199209174e-09
for O 0 2.13061512877033e-11
those O 0 8.47097739176128e-12
patients O 0 4.1451106327743126e-13
with O 0 3.9485738490734404e-14
mutations O 0 1.208525792460724e-12
associated O 0 4.6862002126002444e-12
with O 0 9.417502585054582e-13
life O 0 4.796913977145323e-10
threatening O 0 4.096695960242869e-08
conditions O 0 1.933115072461078e-06
. O 0 8.731273481998869e-09

This O 0 8.160210701602111e-11
study O 0 9.608895276680407e-12
also O 0 9.234295186150154e-13
provided O 0 2.876189141454849e-13
evidence O 0 5.420574471053097e-13
for O 0 1.8575738820400534e-13
the O 0 3.989594245246142e-12
pathological O 0 9.581292204074998e-09
nature O 0 2.0764588659627492e-10
of O 0 5.399532487793124e-10
amino O 0 4.3903417012991497e-10
acid O 0 1.0324797440619538e-11
changes O 0 4.841600211025199e-12
in O 0 1.55277336127968e-11
APC O 0 6.37235653133672e-10
associated O 0 1.180589393606768e-11
with O 0 3.2044495095612247e-13
both O 0 3.8244896832795305e-11
FAP B-Disease 0 2.7282331060973775e-08
and O 0 2.789787290069512e-10
non O 1 0.9999998807907104
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 8.694084385751921e-07
. O 0 1.7240898986248254e-10
. O 0 1.541643590563524e-09

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 0.05379030108451843
cancer B-Disease 1 0.9999994039535522
risk O 0 1.7842772649601102e-05
of O 0 6.034670718690904e-07
the O 0 6.80365474181599e-07
APC O 0 1.6712626802473096e-06
I1307K O 0 1.1775752000175999e-06
polymorphism O 0 1.3420335562841501e-06
. O 0 6.017027942561981e-08

Germ O 0 0.002769139828160405
- O 0 4.180607447779039e-06
line O 0 7.590193007445123e-08
and O 0 5.254588084091516e-11
somatic O 0 4.74121142346462e-09
truncating O 0 5.057052998580502e-09
mutations O 0 5.6621998756334335e-11
of O 0 8.206243462538509e-10
the O 0 1.6203379749057945e-09
APC B-Disease 0 7.551849812159617e-09
gene O 0 1.4076066701118606e-10
are O 0 1.2574904225542971e-12
thought O 0 6.421202545375815e-12
to O 0 2.6964940696982964e-12
initiate O 0 1.0989579379838688e-07
colorectal B-Disease 1 1.0
tumor I-Disease 0 2.2148803680011042e-07
formation O 0 1.830899737376157e-10
in O 0 1.718331588129729e-10
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 3.431589448155137e-07
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 0.9999995231628418
, O 0 4.8863237900320655e-09
respectively O 0 2.870419990586015e-08
. O 0 3.820806426801937e-08

Recently O 0 2.6656490348386797e-08
, O 0 8.225231606928674e-11
an O 0 1.3869202661331848e-11
isoleucine O 0 1.3992346339364303e-06
- O 0 1.2037497754135984e-06
- O 0 1.9098686152574373e-06
> O 0 6.947067845430865e-07
lysine O 0 1.9669214452733286e-06
polymorphism O 0 3.77043951615974e-09
at O 0 8.19135959062578e-09
codon O 0 1.692240902961828e-09
1307 O 0 1.0000793526643292e-09
( O 0 3.1856329640173042e-12
I1307K O 0 7.061521506424029e-11
) O 0 4.623930903967233e-13
of O 0 2.2537499644315062e-11
the O 0 3.245153867847961e-10
APC B-Disease 0 4.4161776457940505e-09
gene O 0 6.696217191848319e-11
has O 0 2.0763655551869764e-12
been O 0 5.698793216837861e-13
identified O 0 9.763317541586214e-13
in O 0 1.7828620524351635e-12
6 O 0 8.766612991095712e-10
% O 0 1.0196980412824352e-11
- O 0 3.0802246864247707e-10
7 O 0 2.631021400745226e-09
% O 0 3.1471159012141925e-11
of O 0 8.777505944301822e-10
the O 0 1.987287445714969e-09
Ashkenazi O 0 1.037643415635614e-09
Jewish O 0 5.104009437317814e-10
population O 0 6.68556182636948e-11
. O 0 5.228380395294607e-09

To O 0 6.587692058523942e-10
assess O 0 4.634049588503331e-09
the O 0 1.0902134750523373e-09
risk O 0 3.919363444904178e-10
of O 0 2.427449040387497e-11
this O 0 5.821156490865009e-12
common O 0 7.976065363735074e-10
APC B-Disease 0 2.6707992262231528e-08
allelic O 0 7.896029785570136e-08
variant O 0 1.783611338623814e-07
in O 0 7.319769235181184e-09
colorectal O 1 1.0
carcinogenesis O 1 0.9998297691345215
, O 0 1.3045085012208801e-09
we O 0 1.0949246370683952e-10
have O 0 1.601928442326872e-12
analyzed O 0 1.589584193439908e-11
a O 0 2.333070542315241e-11
large O 0 7.641313276574024e-11
cohort O 0 2.0456440985583413e-09
of O 0 8.44232295182934e-10
unselected O 0 5.581718141911551e-06
Ashkenazi O 0 4.195670300077836e-08
Jewish O 0 2.4612005766755374e-09
subjects O 0 4.766418371104919e-09
with O 0 1.4723848529296646e-10
adenomatous B-Disease 0 0.009402960538864136
polyps I-Disease 0 9.39736855798401e-05
and O 0 9.627836305980964e-10
. O 0 7.3620682883301924e-09
or O 1 0.9999998807907104
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 2.0958375035462495e-09
for O 0 3.9937780860199723e-10
the O 0 8.209346979981547e-09
APC O 0 1.195848540191946e-07
I1307K O 0 1.827667688303336e-07
polymorphism O 0 3.051478643101291e-07
. O 0 3.639432932800446e-08

The O 0 5.99541067458631e-07
APC O 0 3.5313678381498903e-07
I1307K O 0 2.967994738867219e-08
allele O 0 1.077641531566087e-09
was O 0 1.6524537294060337e-09
identified O 0 6.105132371869715e-11
in O 0 1.8104830135090566e-11
48 O 0 6.354126669272375e-10
( O 0 1.2381559319485369e-11
10 O 0 5.5662346259977014e-11
. O 0 1.9836831829933566e-12
1 O 0 7.098643894920542e-11
% O 0 1.6634337136889332e-12
) O 0 2.341940389446323e-13
of O 0 7.041937866159032e-11
476 O 0 1.5898313776574469e-09
patients O 0 3.763771516673842e-09
. O 0 1.164571195033659e-08

Compared O 0 1.2578083019576525e-10
with O 0 5.46604862067257e-13
the O 0 4.294397303039599e-12
frequency O 0 1.1437340657893813e-11
in O 0 2.390245661988699e-13
two O 0 2.2283139688907688e-14
separate O 0 9.445237289778391e-14
population O 0 2.8305379619493996e-14
control O 0 1.0913468045936625e-10
groups O 0 5.790968832936061e-12
, O 0 5.258736154867272e-12
the O 0 4.831808286809292e-10
APC O 0 1.4898816402819648e-08
I1307K O 0 9.398608113997398e-09
allele O 0 6.779325711914197e-11
is O 0 2.625797257578555e-13
associated O 0 5.620917143192572e-13
with O 0 2.5213768654322108e-14
an O 0 2.851911483120646e-14
estimated O 0 1.5154781726409161e-12
relative O 0 4.0007311352674435e-10
risk O 0 2.733148596334445e-09
of O 0 3.316205754444468e-09
1 O 0 1.7901256796903908e-06
. O 0 3.646061230710984e-08

5 O 0 6.070850304240594e-06
- O 0 1.154827486971044e-06
1 O 0 5.411671963884146e-07
. O 0 2.9437183357572394e-08

7 O 0 2.571350705693476e-06
for O 0 1.6902455968192953e-07
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9997163414955139
( O 0 6.3994729515570725e-09
both O 0 2.376508101420427e-09
P O 0 4.3983100113109685e-06
= O 0 1.7937148433233574e-09
. O 0 1.3040718678525298e-11
01 O 0 2.863572046152285e-09
) O 0 1.385534742492922e-11
. O 0 4.2224398977275257e-10

Furthermore O 0 4.622573879231595e-09
, O 0 1.3693118687541084e-11
compared O 0 3.0696996593942982e-12
with O 0 3.3267295168615263e-12
noncarriers O 0 1.0722706633714552e-07
, O 0 7.991811656893333e-10
APC O 0 3.766308154240505e-08
I1307K O 0 4.489111748995356e-09
carriers O 0 3.6570165298788204e-12
had O 0 9.38558367309661e-13
increased O 0 2.0561940279779922e-13
numbers O 0 1.1089330950904419e-13
of O 0 2.2804425015010565e-11
adenomas B-Disease 1 0.9999618530273438
and O 0 2.9753584385616705e-05
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999998807907104
per O 0 5.511239797861833e-10
patient O 0 1.1934173471672693e-07
( O 0 2.2656207465665545e-10
P O 0 7.005303632467985e-05
= O 0 1.7973997845643908e-09
. O 0 5.722235619370908e-12
03 O 0 1.5723608526307942e-10
) O 0 5.948679862501777e-14
, O 0 4.6306278174987683e-14
as O 0 1.1146458918625396e-13
well O 0 4.886537680569292e-13
as O 0 2.5269640980402075e-12
a O 0 2.5111676626998758e-11
younger O 0 1.2907314106413992e-11
age O 0 1.4590051389262726e-10
at O 0 1.4137994774898743e-08
diagnosis O 0 8.080602356130839e-07
. O 0 8.101581627784071e-09

We O 0 2.449842995133622e-09
conclude O 0 1.1573849656443258e-09
that O 0 4.338211647553214e-12
the O 0 2.8636906734824663e-10
APC O 0 1.7675040098197314e-08
I1307K O 0 2.0016758028873483e-08
variant O 0 3.6880056342170064e-08
leads O 0 8.38655200841032e-10
to O 0 1.5138409623083326e-11
increased O 0 5.964989924223119e-08
adenoma B-Disease 1 1.0
formation O 0 3.0293036967776743e-09
and O 0 5.633910005187204e-11
directly O 0 1.7653138065926166e-12
contributes O 0 3.247111780846357e-13
to O 0 1.599909305515998e-13
3 O 0 1.243699726538594e-10
% O 0 1.9582365243242528e-12
- O 0 1.3211209903829513e-11
4 O 0 3.201935591667926e-11
% O 0 5.656148834888575e-13
of O 0 8.44107509584413e-12
all O 0 2.6071702088903415e-11
Ashkenazi O 0 1.4945328530302504e-07
Jewish O 0 0.0013338513672351837
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.1726093564211624e-06

The O 0 2.2953166034511696e-09
estimated O 0 9.065271450170442e-11
relative O 0 1.981938835271535e-09
risk O 0 1.1788917619881545e-09
for O 0 1.4231286288302059e-11
carriers O 0 9.208005885552595e-12
may O 0 4.586593691652263e-12
justify O 0 1.4997691673637736e-12
specific O 0 3.4228305953454274e-13
clinical O 0 6.644905459207706e-11
screening O 0 5.085815796279647e-11
for O 0 6.075666770903598e-13
the O 0 5.7137289691255866e-12
360 O 0 8.396867402782338e-12
, O 0 4.881824111624411e-13
000 O 0 4.5036929914588075e-12
Americans O 0 1.869074692109965e-13
expected O 0 2.4224572001130262e-12
to O 0 5.2207961261444e-13
harbor O 0 3.4506353330243655e-10
this O 0 7.3540498235318e-14
allele O 0 1.648497310879904e-12
, O 0 1.5990458740108848e-13
and O 0 2.8560387019781197e-13
genetic O 0 1.7748930797312212e-11
testing O 0 3.5931181641135623e-11
in O 0 5.915621183009978e-13
the O 0 7.505199586810285e-12
setting O 0 3.7751796133633775e-10
of O 0 3.405869336559064e-11
long O 0 1.3417080814426274e-11
- O 0 7.944753882549449e-11
term O 0 5.982950940230936e-11
- O 0 3.124316430569429e-11
outcome O 0 3.092915853986078e-11
studies O 0 5.405748006344357e-13
may O 0 2.2960214458855877e-13
impact O 0 7.971129832584634e-12
significantly O 0 1.0498917707435496e-11
on O 0 3.064557404286461e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 1.9667204469442368e-05
in O 0 4.718683668629431e-13
this O 0 8.379180595902147e-14
population O 0 6.518052699140686e-13
. O 0 1.8747974006583235e-10

Localization O 0 1.8327365978620946e-05
of O 0 3.407251725207061e-08
human O 0 8.158429487536978e-09
BRCA1 O 0 6.490335491271537e-10
and O 0 5.783793582958552e-12
its O 0 4.062258862624901e-11
loss O 0 3.334744147487356e-10
in O 0 2.1367818625606105e-10
high O 0 9.12288555809937e-07
- O 0 1.1320079806864669e-07
grade O 0 3.762445999200281e-07
, O 0 9.392977506905709e-10
non B-Disease 1 0.9999988079071045
- I-Disease 1 0.999988317489624
inherited I-Disease 1 0.9999994039535522
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 1.9831606550724246e-05

Although O 0 8.599986833779383e-10
the O 0 1.1095589030896136e-10
link O 0 1.3041595581242404e-10
between O 0 7.992630862707628e-11
the O 0 3.652156577160781e-09
BRCA1 O 0 3.659214442564007e-08
tumour B-Disease 1 1.0
- O 0 1.4287552474456788e-08
suppressor O 0 9.65485646986508e-09
gene O 0 8.131482293061154e-11
and O 0 4.529332117697571e-11
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 8.163304698882712e-08
established O 0 1.5220533722271057e-09
, O 0 6.715856711893287e-13
the O 0 8.77853432307285e-12
role O 0 1.8610229676752077e-11
, O 0 8.195656609963353e-13
if O 0 2.0624510942406776e-13
any O 0 3.76372977922701e-12
, O 0 8.174767828807161e-13
of O 0 4.7020318194590516e-11
BRCA1 O 0 4.6112469398451594e-10
in O 0 2.448963254408909e-10
non B-Disease 1 0.9955452680587769
- I-Disease 0 0.051653310656547546
familial I-Disease 1 0.999556839466095
cancers I-Disease 1 0.9999994039535522
is O 0 1.719473452510556e-09
unclear O 0 1.0161505414885141e-08
. O 0 6.9891972209745745e-09

BRCA1 O 0 9.168921337732172e-07
mutations O 0 7.826927994614152e-10
are O 0 5.999033192947978e-13
rare O 0 3.1375724501153668e-12
in O 0 1.7654887968232558e-12
sporadic B-Disease 0 3.7813163089595037e-06
cancers I-Disease 0 0.008380746468901634
, O 0 2.2864267770761337e-11
but O 0 2.83330789385694e-11
loss O 0 2.24425615868995e-08
of O 0 1.492701073857461e-07
BRCA1 O 0 4.5100350121174415e-09
resulting O 0 7.373584381964449e-11
from O 0 1.485738181788987e-12
reduced O 0 3.6186362240009373e-10
expression O 0 2.7229588028809815e-10
or O 0 2.020178989370347e-11
incorrect O 0 4.823024202238457e-10
subcellular O 0 3.7398370977825834e-07
localization O 0 7.32028183847433e-07
is O 0 1.6674648857864516e-12
postulated O 0 4.623854250873638e-12
to O 0 7.098241130076496e-14
be O 0 7.470329828904512e-14
important O 0 1.7317664500766244e-13
in O 0 2.3941432603785673e-12
non B-Disease 0 3.770592593355104e-05
- I-Disease 0 0.0002225200878456235
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.8741915822029114

Epigenetic O 0 2.146886799891945e-05
loss O 0 3.3887761219375534e-06
, O 0 6.926788309602472e-11
however O 0 9.566469144628442e-12
, O 0 6.091679894890123e-13
has O 0 8.701658913822657e-14
not O 0 1.74321853881141e-14
received O 0 2.7171636183989482e-14
general O 0 7.424597395222499e-12
acceptance O 0 2.3190775688686216e-11
due O 0 1.0210200740434772e-10
to O 0 1.4870614776455598e-13
controversy O 0 5.875298077911983e-13
regarding O 0 2.4199069939730145e-13
the O 0 5.433661333376083e-12
subcellular O 0 1.3226937767285563e-08
localization O 0 2.8029060672452033e-07
of O 0 5.477676090492878e-09
BRCA1 O 0 3.063228282140784e-10
proteins O 0 1.1388139780146855e-12
, O 0 1.3326025396012686e-12
reports O 0 2.128388177508045e-12
of O 0 1.190603171608018e-10
which O 0 1.1678572171824886e-11
have O 0 2.4632255870432607e-12
ranged O 0 1.0757532017957594e-11
from O 0 1.0232375927468618e-12
exclusively O 0 1.2120097460377455e-11
nuclear O 0 8.68003180443111e-09
, O 0 1.5459490241773177e-12
to O 0 9.865807172951269e-13
conditionally O 0 7.21736048703292e-09
nuclear O 0 1.0737233324675799e-08
, O 0 2.0802901502109394e-12
to O 0 2.9185041969942427e-12
the O 0 6.271504982002796e-10
ER O 0 1.6414857384461357e-07
/ O 0 1.0955461426931379e-08
golgi O 0 9.34922628204049e-09
, O 0 9.50684739264851e-11
to O 0 5.398314434357232e-11
cytoplasmic O 0 7.898451670484974e-09
invaginations O 0 1.0168701436441552e-07
into O 0 1.8892457043229172e-10
the O 0 1.3530065956501858e-09
nucleus O 0 1.6652077494683226e-09
. O 0 5.845888662037169e-09

In O 0 1.921668157933709e-09
an O 0 4.669517550404123e-11
attempt O 0 1.2767176205130681e-09
to O 0 3.801957706994763e-11
resolve O 0 1.8791803668705143e-09
this O 0 9.166283183870139e-12
issue O 0 1.9588839231254873e-11
, O 0 3.027635434027509e-12
we O 0 8.69372109024713e-12
have O 0 1.5469608016446812e-12
comprehensively O 0 2.5193642727572296e-09
characterized O 0 8.664908790478876e-10
19 O 0 2.125702813771113e-08
anti O 0 4.940173312206753e-06
- O 0 6.355581376737973e-07
BRCA1 O 0 5.4465807863834925e-08
antibodies O 0 3.2976870123491153e-09
. O 0 1.104176483579522e-08

These O 0 4.678080145481545e-09
reagents O 0 2.2812987054976475e-08
detect O 0 1.1441809277812354e-08
a O 0 3.7121183904531563e-09
220 O 0 6.240813976710058e-10
- O 0 2.1435548891446388e-09
kD O 0 1.5528578423129602e-09
protein O 0 4.5780657043081874e-11
localized O 0 3.5500807848976024e-10
in O 0 2.9695401953383493e-12
discrete O 0 7.363974430241171e-10
nuclear O 0 3.2483717404829804e-07
foci O 0 4.469778858151585e-08
in O 0 7.862385742463118e-11
all O 0 8.68154645394803e-11
epithelial O 0 8.339245738397949e-09
cell O 0 6.090313036111183e-07
lines O 0 1.5027228073005716e-10
, O 0 4.0913832651673365e-13
including O 0 1.4052662028821161e-12
those O 0 1.1439648056957297e-12
derived O 0 3.790544267356921e-12
from O 0 8.323934597154192e-11
breast B-Disease 0 7.152589773795626e-07
malignancies I-Disease 0 1.5275198165909387e-05
. O 0 2.3852015829106676e-07

Immunohistochemical O 0 7.633280620211735e-05
staining O 0 1.4488104170595761e-05
of O 0 2.2530457499669865e-06
human O 0 1.1599895515246317e-05
breast O 0 2.004007683353848e-06
specimens O 0 1.0608613987272975e-09
also O 0 1.093303669819079e-09
revealed O 0 1.0726118659931672e-08
BRCA1 O 0 1.1856912784935503e-08
nuclear O 0 2.9566558623628225e-07
foci O 0 6.112948085501557e-07
in O 0 1.1223453277864337e-09
benign O 1 1.0
breast O 1 0.9995028972625732
, O 0 3.023740191565594e-08
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 0.0007093282765708864
low B-Disease 1 1.0
- I-Disease 1 1.0
grade I-Disease 1 1.0
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 6.285105428105453e-06

Conversely O 0 1.0315073950550868e-07
, O 0 1.033065855082782e-09
BRCA1 O 0 3.373096024716915e-09
expression O 0 4.09949985069602e-09
was O 0 4.051723845321931e-09
reduced O 0 4.77556161282422e-10
or O 0 1.1160142905294879e-12
undetectable O 0 1.2223295986490967e-10
in O 0 5.173868061411624e-13
the O 0 1.8293411490483136e-12
majority O 0 2.472525764858624e-13
of O 0 3.042630730698548e-11
high O 0 1.7096870408295217e-07
- O 0 1.849829089906052e-07
grade O 0 1.1861396131962465e-07
, O 0 5.433231642371084e-10
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 1.806658433967101e-10
suggesting O 0 2.566005567750107e-11
that O 0 9.339475807307318e-13
absence O 0 8.162708731163093e-09
of O 0 2.0669101985504312e-08
BRCA1 O 0 2.0151282864588893e-09
may O 0 1.1519659358361078e-11
contribute O 0 2.1311290677051425e-13
to O 0 2.353771745653571e-13
the O 0 1.7754719569551547e-11
pathogenesis O 0 2.1747263545535134e-08
of O 0 7.003655294601785e-11
a O 0 2.3232514002879956e-12
significant O 0 4.494956490352919e-12
percentage O 0 2.9303587334439385e-11
of O 0 2.730583537058351e-10
sporadic B-Disease 1 0.9999754428863525
breast I-Disease 1 0.9999903440475464
cancers I-Disease 1 0.9999130964279175
. O 0 6.67255122266397e-08
. O 0 1.698681018069692e-07

